id,event_name,actual,predicted,text
6407,all_events,DOWN,,15 nov 2024 07 00 cet techstep asa highlights from the third quarter 2024 profitability improving y y growth in both revenue and net gross profit for the first time in two years recurring revenue annualised up y y driven by in own software net gross profit margin remains steady at in line with the same quarter last year positive cash flow from operations positive ebita adj for the eight consecutive quarter up y y commercial momentum picking up several new signings and renewed contracts frame agreement secured with the norwegian procurement agency tradebroker total contract value estimated to exceed nok 600 million first new tradebroker customers already signed and onboarded improving market conditions across all three markets with strong comeback in sweden and continued acceleration in poland and europe strategic partnerships progressing according to plan first devicenow customer successfully onboarded to lif
6301,all_events,UP,,12 nov 2024 18 09 cet gbl groupe bruxelles lambert 20241112 transacties aandelen pdf gbl euronext gbl be0003797140 gblb euronext
304,all_events,DOWN,DOWN,toronto july 02 2024 globe newswire revive therapeutics ltd revive or the company otcqb rvvtf cse rvv frankfurt 31r a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases medical countermeasures and rare disorders announced today an update on the research study evaluating bucillamine as a potential treatment for nerve agent exposure in partnership with defence r d canada suffield research centre drdc an agency of the canadian department of national defence the drdc is investigating pharmacological compounds including bucillamine that can mitigate nerve agent induced brain injury control studies have been initiated and the drdc expects to evaluate the data this month treatment studies will follow after the conclusion of the control group evaluation the research study is expected to be completed in august 2024
12523,all_events,DOWN,,valmet oyj notification according to chapter 9 section 5 of the finnish securities markets act swedbank robur fonder ab s ownership in valmet decreased to below 5 percent valmet oyj s stock exchange release on november 11 2024 at 5 45 p m eet valmet oyj valmet has on october 22 2024 received the following notification from swedbank robur fonder ab pursuant to the finnish securities markets act as amended the sma stating that swedbank robur fonder ab s ownership and share of votes in valmet has fallen below the threshold of 5 percent on october 21 2024 valmet has one series of shares in which each share carries one vote the aggregate number of shares is 184 529 605 total positions of swedbank robur fonder ab swedbank robur nordenfond swedbank robur fokus swedbank robur europafond swedbank robur småbolagsfond norden swedbank robur småbolagsfond sverige swedbank robur sverige swedbank robur transfer 50 swedbank robur globalfond according to the notif
2417,all_events,DOWN,DOWN,irvine calif jan 16 2024 globe newswire biomerica inc nasdaq bmra the company a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the second quarter of fiscal 2024 ended november 30 2023
6312,all_events,DOWN,,november 13 2024 04 00 et source reykjavíkurborg reykjavíkurborg í dag miðvikudaginn 13 nóvember efnir reykjavíkurborg til útboðs í samræmi við útgáfuáætlun 2024 á skuldabréfaflokknum rvk 44 1 heimild til lántöku á árinu er 16 500 m kr en þetta er sjöunda útboð ársins rvk 44 1 ber fasta 3 verðtryggða vexti og greiðir jafnar greiðslur á sex mánaða fresti með lokagjalddaga 21 maí 2044 heildarstærð rvk 44 1 fyrir þetta útboð nemur alls 4 130 m kr að nafnvirði gert er ráð fyrir að viðskiptavakt hefjist með flokkinn við fyrsta útboð eftir að nafnverð útgáfu nemur 6 000 m kr útboðið verður með hollenskri aðferð þar sem öll skuldabréf verða seld á hæstu ávöxtunarkröfu sem tekið verður reykjavíkurborg áskilur sér rétt til að taka hvaða tilboði sem er að hluta eða í heild eða hafna öllum niðurstöður útboðsins verða birtar opinberlega eigi síðar en næsta virka dag eftir útboð áætlaður uppgjörsdagur er þriðjudagurinn 19 nóvember nk
8291,all_events,UP,,125 million of non dilutive capital extends projected cash runway into late 2025 excluding expected commercial sales from xolremdi mavorixafor
2655,all_events,UP,,08 nov 2024 12 47 cet hofseth biocare asa finansiell kalender for hofseth biocare asa regnskapsår 2024 11 04 2025 årsrapport 08 11 2024 kvartalsrapport q3 14 02 2025 kvartalsrapport q4 regnskapsår 2025 22 08 2025 halvårsrapport 23 05 2025 ordinær generalforsamling 16 05 2025 kvartalsrapport q1 07 11 2025 kvartalsrapport q3 13 02 2026 kvartalsrapport q4 denne informasjonen offentliggjøres i henhold til kravene i løpende forpliktelser more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site hofseth biocare asa oslo børs newspoint hofseth biocare no0010598683 hbc oslo børs
6249,all_events,UP,,denver nov 28 2023 globe newswire mydecine innovations group inc mydecine or the company neo myco otc mycof fse 0nfa a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and ptsd wishes to clarify certain statements made in the company s news release of january 13 2022 the prior release wherein the company announced it would be launching the special access support and supply program sassp to provide products and services to physicians clinics and hospitals in canada who are looking to treat patients through psychedelic assisted psychotherapy
5206,all_events,DOWN,,media release
5677,all_events,DOWN,,on november 5 2024 ab kn energies hereinafter kn received a formal notice from independent board member edvinas katilius regarding his resignation from the position of board member of kn effective december 31 2024 december 31 2024 will be edvinas katilius last day in office as an independent board member head of communication milda ancevičėm ancevice kn lt 370 694 29855
511,all_events,UP,UP,all patients treated in the ruby trial are free of vaso occlusive events post renizgamglogene autogedtemcel reni cel infusion
8,all_events,DOWN,UP,sydney australia may 09 2023 globe newswire radiopharm theranostics asx rad radiopharm or the company a developer of a world class platform of radiopharmaceutical products for both diagnostic and therapeutic uses is pleased to announce that the us food and drug administration fda has granted orphan drug designation to ga68 trivehexin rad 301 radiopharmaceutical technology for imaging of patients with pancreatic ductal adenocarcinoma pdac
4526,all_events,DOWN,,new haven conn feb 13 2024 globe newswire bioxcel therapeutics inc nasdaq btai a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno oncology today announced that it has terminated its proposed public offering of 60 0 million of shares of its common stock or in lieu of common stock to certain investors pre funded warrants to purchase shares of its common stock previously announced on february 8 2024 as a result of such termination no securities of the company are being sold pursuant to the offering
8426,all_events,DOWN,,immunocore to present at upcoming investor conferences
3375,all_events,UP,,norwood mass may 30 2024 globe newswire corbus pharmaceuticals holdings inc nasdaq crbp corbus or the company today announced that yuval cohen ph d chief executive officer of corbus will provide a corporate update and participate in one on one investor meetings at the 45th annual goldman sachs global healthcare conference to be held june 10 13 2024 in miami beach fl
1078,all_events,UP,UP,media release
2484,all_events,UP,DOWN,collaboration to accelerate research to determine role of gba gene collaboration to accelerate research to determine role of gba gene
6385,all_events,DOWN,,media release
10236,all_events,UP,,attachments 10111286 pdf relais 11 10 trades xlsx
5614,all_events,DOWN,,media release
6887,all_events,DOWN,,20 nov 2024 07 00 cet atea asa the shares in atea asa will be traded ex dividend nok 3 50 as from today 20 november 2024 for further information please contact steinar sønsteby ceo atea asa mobile 47 930 55 655 robert giori cfo atea asa mobile 47 934 09 188 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site atea asa oslo børs newspoint atea no0004822503 atea oslo børs
538,all_events,UP,UP,media release
9394,all_events,UP,,latvijas bankas uzraudzības komiteja 24 07 2024 pieņēma lēmumu atļaut akciju sabiedrības latvijas gāze reģistrācijas numurs 40003000642 juridiskā adrese aristida briāna iela 6 rīga lv 1001 tālāk tekstā sabiedrība izteikt sabiedrības akcionāriem akciju atpirkšanas piedāvājumu sakarā ar sabiedrības akciju izslēgšanu no regulētā tirgus tālāk tekstā piedāvājums
2334,all_events,DOWN,DOWN,12 nov 2024 12 10 cet nexans siège social 4 allée de l arche 92400 courbevoie france tél 33 0 1 78 15 00 00 www nexans com s a au capital de 43 753 380 euros r c s nanterre 393 525 852 id tva fr 74 393 525 852 déclaration des transactions sur actions propres période du 7 au 8 novembre 2024 emetteur nexans catégorie actions propres conformément à la réglementation relative aux rachats d actions nexans déclare ci après les transactions sur actions propres réalisées du 7 au 8 novembre 2024 ces transactions ont été réalisées dans le cadre du descriptif du programme de rachat publié le 25 mars 2024 sur le site de la société www nexans com et dans le cadre d un mandat exécuté par un prestataire de services d investissement nom de l émetteurcode identifiant de l émetteur code lei jour de la transactioncode identifiant de l instrument financiervolume total journ
6464,all_events,UP,,08 nov 2024 17 40 cet elis disclosure of trading in own shares occurred from november 4 to november 8 2024 saint cloud 8 november 2024 transactions occurred under the share buyback program approved by the shareholders general meeting of may 23 2024 aggregated presentation issuer name issuer code lei transaction date isin code daily total volume in number of shares daily weighted average price of shares acquired in euros platform mic code elis sa 969500uk71lce8may492 11 04 2024 fr0012435121 28 000 21 78 xpar total 28 000 21 78 the purpose of the own shares purchase operations carried out on november 4 2024 is to ensure the allocation of free shares to employees as part of the contribution to the elis for all 2024 international employee shareholding plan contacts nicolas burondirector of investor relations financing treasuryphone 33 0 1 75 49 98 30 nicolas buron elis com charline lefaucheuxinvestor relations phone 33 0 1 7
11196,all_events,UP,,press release uppsala november 6th 2024 senzime ab s publ interim report for january september 2024 is now available on the company s website www senzime com financial information july september 2024 net sales amounted to tsek 17 406 9 154 an increase of 90 percent currency adjusted net sales increased by 98 percent sales of disposable sensors amounted to tsek 12 473 4 644 an increase of 169 percent in the usa net sales increased to tsek 13 117 7 259 an increase of 81 percent sales of disposable sensors in the usa amounted to tsek 9 136 3 471 an increase of 163 percent the gross margin before depreciation amounted to 63 0 percent 69 4 operating costs amounted to tsek 38 362 32 841 operating profit before depreciation amounted to tsek 26 518 25 477 the result after financial items amounted to tsek 31 964 30 587 earnings per share amounted to sek 0 26 0 33 cash and cash equivalents as of 09 30 2024 amounted to tsek 50 241 69
12962,all_events,DOWN,,06 nov 2024 15 00 cet icade see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1295563_cp_droits_de_vote_31 10 2024 pdf icade les echos icade fr0000035081 icad euronext
5562,all_events,UP,,aktia bank plcstock exchange release 8 november 2024 at 10 00 a m aktia bank plc managers transactions karri varis person subject to the notification requirementname varis karriposition chief financial officerissuer aktia bank plclei 743700gc62jlhfbund16notification type initial notificationreference number 743700gc62jlhfbund16_20241106115439_209____________________________________________ transaction date 2024 11 06venue not applicableinstrument type shareisin fi4000058870nature of the transaction subscription transaction details 1 volume 747 unit price 8 36 eur aggregated transactions 1 volume 747 volume weighted average price 8 36 eur aktia bank plc further information oscar taimitarha director investor relations tel 358 40 562 2315 ir at aktia fi distribution nasdaq helsinki ltdmass mediawww aktia com aktia is a finnish asset manager bank and life insurer that has been creating wealth and wellbeing from one generation to the next for 200 years we s
5090,all_events,UP,,media release
12188,all_events,UP,,optomed plc company announcement november 13 2024 11 00 am eest share subscriptions based on stock options 2018c a total of 62 900 optomed plc s new shares has been subscribed for with the company s stock options 2018c on 25 october 2024 for subscriptions made with the stock options 2018c the entire subscription price of eur 220 150 00 will be entered in the reserve for invested unrestricted equity after the trade registration the total number of shares is 19 693 297 the shares subscribed for under the stock options 2018c have been registered in the trade register on 13 november 2024 as of which date the new shares will establish shareholder rights the shares will be traded on the main list of nasdaq helsinki ltd together with the old shares as of 14 november 2024 optomed plc further enquiries sakari knuutti cfo optomed plc sakari knuutti optomed com optomed in brief optomed is a finnish medical technology company and one of the leading providers of handheld fund
12745,all_events,DOWN,,13 nov 2024 08 00 cet romerike sparebank hovedtrekk i 3 kvartal resultatfremgang fra fjoråret økte renteinntekter og normaliserte driftskostnader styrker forholdstallet ki økning i utlånsvekst til privatkunder og marginal vekst i utlån til næringskunder første grønne obligasjonslån utstedt god soliditet gir rom for videre utlånsvekst ncr har tildelt banken en a rating etter kvartalsslutt banken har hittil i år et resultat før skatt på 199 1 millioner kroner 158 1 millioner kroner resultat etter skatt per 30 september gir en egenkapitalavkastning p a justert for fondsobligasjon på 9 4 prosent 8 3 prosent kostnad inntektsforhold ki siste 12 måneder er 42 3 prosent en bedring sammenliknet mot fjorårets 47 0 prosent ved utgangen av 3 kvartal er konsolidert ren kjernekapitaldekning 18 7 prosent 18 7 prosent ned fra 20 0 prosent per 31 12 2023 banken er godt kapitalisert banken har en 12 måneders vekst i brutto utlån inklude
4455,all_events,DOWN,,08 nov 2024 07 00 cet vgp press releaseregulated information inside information 8 november 2024 7 00 am antwerp belgium vgp nv vgp or the group today published its trading update for the first ten months of 24 reporting a record of new and renewed leases 64 9 million of new and renewed leases signed during the first ten months of 24 a ytd record of which 19 2 million was signed during the past 4 months bringing the annualised committed leases for the first ten months to 394 3 million1 43 5 million compared to 31 december 2023 which is 12 ytd in addition vgp has formally agreed terms on multiple new leases since 31 october 24 amounting to over 16 million in rental income thereby increasing the annualised committed leases to above 410 million to date 16 ytd 36 projects under construction representing 886 000 sqm of which 27 projects totalling 558 000 sqm started up during the year and 65 4 million in additional annual r
11960,all_events,UP,,media release
8897,all_events,UP,,brisbane calif may 09 2024 globe newswire annexon inc nasdaq annx a biopharmaceutical company advancing a late stage clinical platform of novel therapies for people living with devastating classical complement mediated neuroinflammatory diseases of the body brain and eye today announced that douglas love president and chief executive officer will present at the bank of america health care conference on tuesday may 14 2024 at 8 40 a m pt
9716,all_events,UP,,04 oct 2024 07 40 cest deutsche pfandbriefbank deutsche pfandbriefbank ag deutsche pfandbriefbank ag release according to article 40 section 1 of the wphg the german securities trading act with the objective of europe wide distribution 04 10 2024 07 40 cet cest dissemination of a voting rights announcement transmitted by eqs news a service of eqs group ag the issuer is solely responsible for the content of this announcement notification of major holdings 1 details of issuer name deutsche pfandbriefbank ag street parkring 28 postal code 85748 city garchinggermany legal entity identifier lei dzz47b9a52zj6lt6vv95 2 reason for notification x acquisition disposal of shares with voting rights acquisition disposal of instruments change of breakdown of voting rights other reason 3 details of person subject to the notification obligation legal entity the goldman sachs group inc city of registered office country wilmington de united sta
1621,all_events,DOWN,UP,toronto jan 16 2024 globe newswire revive therapeutics ltd revive or the company otcqb rvvtf cse rvv frankfurt 31r a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders today announced an update on the company s project evaluating bucillamine as a potential treatment for nerve agent exposure with defence r d canada suffield research centre drdc an agency of the canadian department of national defence the company and the drdc have finalized the research protocol and expect the project to be completed by the end of q2 2024
6438,all_events,UP,,communiqué de presse du 30 septembre 2024 relatif au depôt d une offre publique d achat
12247,all_events,DOWN,,estonian based deep tech company elmo has once again pushed the boundaries of remote vehicle technology setting a new public streets cross border teledriving record over two days elmo s teledriver stationed at the shift conference in zadar croatia remotely controlled an electric vehicle located at nokia s hq in espoo finland covering an impressive distance of 2500km this achievement marks a significant leap forward in the teledriving sector showcasing the potential of cross border operations it also highlights elmo s advanced remote vehicle technology solidifying the company s position as a global frontrunner in the field revolutionizing teledriving with quality network on demand connectivity what makes this event even more remarkable is the taken technical challenge of operating the vehicle in an area with poor network quality in espoo thanks to nokia s network as code quality network on demand api call the teledrivable e car s connectivity was prioritiz
4192,all_events,UP,,13 nov 2024 07 30 cet north energy asa north energy asa north energy or company recorded a comprehensive income of nok 37 1 million in the third quarter of 2024 compared to a comprehensive loss of nok 1 3 million in the same quarter last year the income reported this quarter is mostly driven by income from associated companies a positive change in fair value of financial investments partly offset by operational expenses at the end of the third quarter 2024 north energy s net asset value nav was nok 591 3 million representing an increase of nok 2 6 million 0 from last quarter and adjusted for dividends paid nok 163 8 million from the same quarter last year the report for the third quarter 2024 is attached and available on the company s website www northenergy no disclosure regulation this information is subject to the disclosure requirements pursuant to section 5 12 the norwegian securities trading act contacts rune damm cfo 47
9266,all_events,DOWN,,18 nov 2024 08 32 cet inin group as results of share exchange offer directed to all shareholders in inin group qben infra indends to proceed with listing of its shares on nasdaq first north premier growth market not for release publication or distribution in whole or in part directly or indirectly into or within the australia belarus canada hong kong india japan new zealand russia singapore south africa switzerland the united states or any other jurisdiction in which the distribution or release would be unlawful 18 november 2024 reference is made to the stock exchange announcements dated 4 and 12 november 2024 regarding the voluntary share exchange offer directed to all shareholders in inin group as qben infra ab has announced the outcome of its voluntary share exchange offer to acquire all the outstanding shares in inin group corresponding to approximately 86 per cent of the outstanding shares in inin group and the intention to proceed with the
12234,all_events,UP,,november 13 2024 06 59 et source pandora a s pandora a s pandora a s has been notified of transactions in the pandora a s share by persons discharging managerial responsibilities and or closely associated persons alexander lacik chief executive officer of pandora a s has reported the sale of 10 000 shares at a total consideration of dkk 10 762 768 and now holds a total of 247 205 shares in the company towards pandora a s alexander lacik has motivated his transaction as pertaining to his fulfilment of certain tax obligations arising from vested shares allotted to him under applicable long term incentive plan schemes about pandorapandora is the world s largest jewellery brand the company designs manufactures and markets hand finished jewellery made from high quality materials at accessible price points pandora jewellery is sold in more than 100 countries through 6 700 points of sale including more than 2 600 concept stores headquart
5748,all_events,DOWN,,november 08 2024 07 28 et source chemometec a s chemometec a s announcement no 284 8 november 2024 notification of managers transactions chemometec a s has received the enclosed notification pursuant to article 19 of eu regulation no 596 2014 of transactions related to shares in chemometec a s made by persons discharging managerial responsibilities in chemometec a s and or persons closely associated with them see the transactions of the vice chair of chemometec s board of directors martin glensbjerg in the attached pdf document for further information please contact kim nicolajsen cfotelephone 45 48 13 10 20 about chemometec a s chemometec develops manufactures and markets instruments for cell counting and a wide range of other measurements chemometec s instruments are marketed to the pharmaceutical biotech and agricultural industries worldwide chemometec was founded in 1997 and is listed on nasdaq omx copenhagen for further in
10915,all_events,DOWN,,malvern pa aug 02 2024 globe newswire ocugen inc nasdaq ocgn a biotechnology company focused on discovering developing and commercializing novel gene and cell therapies and vaccines today announced the closing of its previously announced underwritten public offering of 30 434 783 shares of its common stock each share of common stock was sold at a price to the public of 1 15 per share the gross proceeds to the company from the offering were approximately 35 million before deducting underwriting discounts and commissions and estimated offering expenses payable by the company the company intends to use the net proceeds from this offering for general corporate purposes capital expenditures working capital and general and administrative expenses the offering was led by a premier mutual fund along with participation from leading life sciences investors
5146,all_events,UP,,06 nov 2024 13 27 cet fertiberia corporate s l u se vedlegg på www newsweb no more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631411_interests 2024 11 06 pdf fertiberia corporate s l u oslo børs newspoint fertiberia corpora 24 28 frn eur floor c no0013219477 oslo børs
9870,all_events,DOWN,,november 18 2024 12 36 et source nilfisk holding a s nilfisk holding a s rising cleaning standards globally increases the demand for more efficient and hygienic cleaning solutions floor mopping is not an exception nilfisk dryft helps users deliver a more hygienic cleaning standard even in smaller spaces and in a faster time nilfisk discovered a need in the market to support cleaning staff with cleaning solutions for smaller spaces cleaning standards and working requirements have changed over time and a demand for easy to use solutions that offer improved ergonomics enhancing the comfort for the user and providing a more efficient cleaning experience that is why nilfisk is introducing the new nilfisk dryft a micro scrubber designed to help achieve the highest cleaning standards in small spaces the nilfisk dryft is an excellent extension of our portfolio it is an easily manoeuvrable micro scrubber dryer that cleans the hardest to rea
4387,all_events,DOWN,,media release
1323,all_events,UP,DOWN,til orientering er der dags dato indkaldt til ekstraordinær generalforsamling den 10 december 2024 hos foreningens forvalter hvor dagsordenen omhandler en indstilling om navneændring fra investeringsforvaltningsselskabet sebinvest a s til wealth fund partners a s samt en bestyrelsesændring de foreslåede ændringer hos foreningens forvalter har ingen praktisk påvirkning for dig som investor i kapitalforeningen wealth invest for mere information henvises til forvalters hjemmeside https seb dk virksomheder og institutioner sebinvest for eventuelle spørgsmål kan lise bøgelund jensen direktør i foreningens forvalter kontaktes på telefon 33 28 28 28
1107,all_events,DOWN,DOWN,under the base prospectus for bonds approved by the bank of lithuania on 25 november 2019 hereinafter the prospectus auga group ab hereinafter the company issued bonds with a total nominal value of eur 20 000 000 among other provisions the prospectus stipulates financial covenants including i an interest coverage ratio of no less than 2 and ii a consolidated equity to asset ratio of no less than hereinafter the financial covenants
1739,all_events,UP,DOWN,suominen corporation interim report on november 6 2024 at 9 30 a m eet suominen corporation s interim report for january 1 september 30 2024 profitability affected by operational issues outlook unchanged key figures in this interim report figures shown in brackets refer to the comparison period of the previous year if not otherwise stated july september 2024 in brief net sales increased by from the corresponding period of 2023 and were eur 111 6 million 106 4 comparable ebitda decreased to eur 3 3 million 5 2 cash flow from operations was eur 2 6 million 8 0 january september 2024 in brief net sales increased by from the corresponding period of 2023 and were eur 343 8 million 335 9 comparable ebitda increased to eur 12 8 million 10 5 cash flow from operations was eur 2 6 million 17 6 outlook for 2024 suominen expects that its comparable ebitda earnings before interest taxes depreciation and amortization in 2024 will increase from 2023 in 2
7370,all_events,UP,,longeveron announces exercise of warrants for 4 4 million gross proceeds
12549,all_events,DOWN,,07 nov 2024 21 41 cet stolt nielsen limited stolt nielsen limited board declares interim dividend of 1 25 per common share london november 7 2024 stolt nielsen limited oslo børs sni announced today that the company s board of directors approved an interim dividend payment of 1 25 per common share payable on december 4 2024 to shareholders of record as of november 22 2024 the shares will trade ex dividend on and after november 21 2024 for additional information please contact jens f grüner hegge chief financial officer u k 44 0 20 7611 8985 j gruner hegge stolt com mailto j gruner hegge stolt com ellie davison head of corporate communications u k 44 0 20 7611 8926 e davison stolt com mailto e davison stolt com about stolt nielsen limited stolt nielsen snl or the company is a long term investor and manager of businesses focused on opportunities in logistics distribution and aquaculture the stolt nielsen portfolio consists o
7301,all_events,DOWN,,media release
9791,all_events,UP,,vestas wind systems a s aarhus 8 november 2024 company announcement no 18 2024 in accordance with article 19 3 of the eu market abuse regulation vestas wind systems a s is required to disclose information regarding trading in vestas wind systems a s shares and securities by executives and persons closely associated with an executive the statement is based on a report which vestas wind systems a s has received from one of the executives see appendix contact details vestas wind systems a s denmark daniel patterson vice president investor relations tel 45 2669 2725 frederik holm jacobsen senior specialist investor relations tel 45 2835 3365 attachments 241108_18_company_announcement pdf
6790,all_events,DOWN,,south san francisco calif feb 29 2024 globe newswire akero therapeutics inc nasdaq akro a clinical stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need today reported fourth quarter and full year financial results for the period ending december 31 2023
2608,all_events,UP,,13 nov 2024 07 30 cet vente unique com volume d affaires global annuel record de 233 2 m en progression de 15 sur un an chiffre d affaires de 178 7 m 10 dans la trajectoire de croissance historique à deux chiffres du groupe et conforme à l objectif annoncé nouvel exercice de croissance rentable comme promis avec une marge d ebitda ajustée 1 annuelle attendue toujours exemplaire à plus de paris le 13 novembre 2024 le groupe vente unique com expert de la vente en ligne de mobilier et aménagement de la maison en europe annonce son chiffre d affaires non audité du 4ème trimestre période du 1er juillet 2024 au 30 septembre 2024 et de l exercice 2023 2024 période du 1er octobre 2023 au 30 septembre 2024 normes ifrs en k t4 2023 t4 2024 variation t4 2023 2024 2023 2024 variation 2023 2024 volume d affaires global 2 55 170 60 682 10 201 740 233 239 15 chiffre d affaires 43 341 46 103 6 162 254 178 655 10 dont e comm
5701,all_events,DOWN,,oslo norway 31 october 2024 the shares in tgs asa will be traded ex dividend nok 1 53 usd 0 14 as from today 31 october 2024
2882,all_events,DOWN,,media release
5195,all_events,DOWN,,telefonkonferenz und webcast sind für den 4 november 2024 um 14 00 uhr mez 8 00 uhr u s eastern standard time geplant
8947,all_events,DOWN,,06 nov 2024 22 08 cet borr drilling limited hamilton bermuda november 6 2024 borr drilling limited nyse and ose borr today announces that the company s board of directors has approved a cash distribution of paid in capital of us 0 02 per share for the third quarter of 2024 note to shareholders registered in euronext vps the norwegian central security depository due to implementation of the central securities depository regulation csdr in norway please note the information regarding the payment date for the shares registered in euronext vps below effective as of may 28 2024 the new york stock exchange nyse settles its trades on a t 1 basis while the oslo stock exchange ose continues to settle its trades on a t 2 basis as a result there will be different ex dividend dates between the two exchanges as set out below key information distribution amount 0 02 per share declared currency usd dividends payable to shares registered with eu
11110,all_events,UP,,media release
895,all_events,UP,DOWN,media release
3021,all_events,UP,,lánasjóður sveitarfélaga var með skuldabréfaútboð í flokkunum lss 39 0303 og lss151155 þann 10 október 2024 uppgjör viðskipta fer fram 15 október 2024 alls bárust tilboð í lss 39 0303 að nafnvirði isk 2 320 000 000 á bilinu 3 3 ákveðið var að taka tilboðum að nafnvirði isk 1 400 000 000 á ávöxtunarkröfunni 3 útistandandi fyrir voru isk 30 502 600 000 að meðtöldum eigin bréfum lánasjóðsins vegna viðskiptavaktar isk 500 000 000 heildarstærð flokksins er nú isk 31 902 600 000 alls bárust tilboð í lss151155 að nafnvirði isk 1 650 000 000 á bilinu 3 3 ákveðið var að taka tilboðum að nafnvirði isk 900 000 000 á ávöxtunarkröfunni 3 útistandandi fyrir voru isk 32 455 000 000 að meðtöldum eigin bréfum lánasjóðsins vegna viðskiptavaktar isk 440 000 000 heildarstærð flokksins er nú isk 33 355 000 000 nánari upplýsingar veitir óttar guðjónsson framkvæmdastjóri ottar lanasjodur is s 515 4949
2968,all_events,UP,,châtillon france 4 septembre 2024 22 30 cet
10086,all_events,UP,,november 15 2024 10 15 et source baltic horizon fund northern horizon capital baltic horizon fund northern horizon capital baltic horizon fondi fond osaku puhasväärtus nav 2024 aasta oktoobri lõpu seisuga on 0 7080 eurot osaku kohta 30 september 2024 0 7099 fondi kogu puhasväärtus on 101 6 miljonit eurot 30 september 2024 101 9 eurot epra nrv 2024 aasta oktoobri lõpu seisuga on 0 7493 eurot osaku kohta fond teenis 2024 aasta oktoobris konsolideeritud puhast renditulu 1 0 miljonit eurot 30 september 2024 1 0 miljonit eurot 2024 aasta oktoobri lõpus moodustas fondi konsolideeritud raha ja raha ekvivalendid 7 3 miljonit eurot 30 september 2024 10 0 miljonit eurot 31 oktoober 2024 seisuga fondi konsolideeritud varade kogumaht on 255 6 miljonit eurot 30 september 2024 256 8 miljonit eurot oktoobris tasus fond 1 2 miljonit eurot ennetähtaegselt pangalaenu ning investeeris ligikaudu 0 5 miljonit eurot et kohanda
11442,all_events,UP,,media release
9480,all_events,DOWN,,media release
3379,all_events,UP,,06 nov 2024 12 57 cet sparebank 1 nord norge det er fastsatt ny obligasjonsrente for no0013062299 ny obligasjonsrente i renteperioden 08 11 2024 10 02 2025 er 6 81 ticker nong116 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631402_559c6e905d3a4e2db54d3143b5da3a9d pdf sparebank 1 nord norge oslo børs newspoint sparebank 1 nord norge spb 1 nord norge 19 25 1 spb 1 nord norge 19 24 frn spb 1 nord norge 20 25 frn spb 1 nord norge 20 26 frn c spb 1 nord norge 21 27 frn c spb 1 nord norge 21 28 frn c spb 1 nord norge 21 32 frn c sub spb 1 nord norge 22 perp frn c hybrid spb 1 nord norge 22 25 frn spb 1 nord norge 23 perp frn c hybrid spb 1 nord norge 23 33 frn c sub spb 1 nord norge 23 33 ad
8689,all_events,UP,,invl baltic real estate hereinafter the issuer submits the received notifications on the acquisition and on the disposal of voting rights a purchase sale transaction within the invalda invl group additional information the issuer publishes an updated list of shareholders holding or controlling more than of the issuer s share capital and or voting rights according to information as of 6 november 2024 1 according to the article 16 item 1 of the law on securities of the republic of lithuania alvydas banys is considered to hold the voting rights of the controlled company ljb property uab the person authorized to provide additional information real estate fund manager of management company vytautas bakšinskas e mail vytautas baksinskas invl com attachments attachments notification of a person on the acquisition of voting rights_invalda invl_2024 11 pdf notification of a person on the disposal of voting rights_invl life_2024 11 pdf
9469,all_events,UP,,media release
12437,all_events,UP,,media release
11554,all_events,DOWN,,media release
10772,all_events,DOWN,,06 nov 2024 17 40 cet beneteau see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1295705_241106_beneteau_pr_revenue_q32024 pdf beneteau les echos beneteau fr0000035164 ben euronext
7207,all_events,UP,,november 13 2024 06 00 et source norsk hydro norsk hydro please see below information about transactions made under the share buyback program for norsk hydro asa announcement date of the share buyback program september 11 2024 end date of the share buyback program february 28 2025 overview of transactions prior to the share buyback program norsk hydro asa owned a total of 14 082 505 own shares following the above listed transactions norsk hydro asa owns a total of 22 972 411 shares corresponding to 1 of norsk hydro asa s share capital attachment an overview of all the completed transactions under the program for the dates specified above is attached to this notification and available on www newsweb no investor contact martine rambøl hagen head of investor relations 47 91708918 martine rambol hagen hydro com this is information that norsk hydro asa is obliged to make public pursuant to the eu market abuse regulation and subj
6086,all_events,DOWN,,06 nov 2024 07 00 cet lexibook linguistic elect sys ce communiqué ne constitue pas une offre d acquisition et n est pas destiné à être diffusé dans les juridictions où l offre ne serait pas autorisée communique de presse en date du 6 novembre 2024 relatif a la mise a disposition de la note d information et du document autres informations relatif aux caractéristiques juridiques financières et comptables de la société doodle dans le cadre de l offre publique d achat visant les actions de la société lexibook initiee par la societe doodle agissant de concert avec la société lawrence rosen llc et la famille le cottier conséilee par gilbert dupont groupe société générale presentee par societe generale prix de l offre 4 euros par action lexibook duree de l offre 25 jours de négociation le calendrier de la présente offre publique d achat l offre sera déterminé par l autorité des marchés financiers l amf conformément aux dispositions de son règlement génér
9802,all_events,DOWN,,media release
1142,all_events,DOWN,DOWN,los angeles oct 11 2023 globe newswire renovaro biosciences inc nasdaq renb renovaro a biotechnology corporation focusing on cell gene and immunotherapy has announced that avram miller will join its board of directors beyond this board position mr miller will also take on an advisory role contributing to the company s strategy and business development efforts renovaro biosciences has recently signed a definitive agreement to combine with gedicube a uk based medical ai company specializing in early detection and remissions of cancer and expedited drug discovery renovaro press release gedicube press release gedicube intends to rebrand as renovaro ai
10191,all_events,DOWN,,12 nov 2024 00 31 cet arctic fish holding as arctic fish holding as afish announces that stein ove tveiten ceo has informed the company s board of directors of his decision to step down from his role serving as ceo of arctic fish has been an incredible journey over the past seven years i ve had the privilege of working with a fantastic team and witnessing rapid and substantial growth for both the company and the industry as a whole it has been an honor to serve in this role and i believe arctic fish and iceland are uniquely positioned for continued growth and sustainable development said tveiten the chairman of the board øyvind oaland commented stein ove has dedicated a lot of efforts and time into arctic fish and is handing over a company with solid volume development and great future growth projections we are highly appreciative of his contribution the board of directors will commence the recruitment process for a new ceo tveiten will continu
5967,all_events,DOWN,,11 nov 2024 13 55 cet flekkefjord sparebank det er fastsatt ny obligasjonsrente for no0013311977 ny obligasjonsrente i renteperioden 13 11 2024 13 02 2025 er 5 37 ticker ffsb18 pro esg den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631841_d00e86c3959845f0af53e57940ae7753 pdf flekkefjord sparebank oslo børs newspoint flekkefjord spb 21 25 frn flekkefjord spb 22 26 frn flekkefjord spb 23 33 frn c sub flekkefjord spb 23 28 frn flekkefjord spb 23 perp adj c hybrid flekkefjord spb 24 27 frn flekkefjord sparebank no0011091316 no0012612235 no0012917592 no0013019042 no0013024083 no0013119263 no0013311977 no0013209858 ffsb nordic alternative bond market euronext growth
12565,all_events,DOWN,,vilnius lithuania 2024 10 07 08 00 cest for more information please visit full investor calendar https nasdaqbaltic com statistics en calendar nasdaq baltic issuer services 370 525 31459 vilnius 371 672 12431 riga 372 640 8800 tallinn https www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative markets first north operated by nasdaq companies in the baltic states i e nasdaq tallinn as nasdaq riga as and ab nasdaq vilnius
3834,all_events,DOWN,,15 nov 2024 08 47 cet beerenberg as bergen november 15th 2024 beerenberg reports revenue growth in q3 2024 compared to last year the ebitda margin ended at 9 in the quarter compared to 7 in the same quarter last year 3q 2024 financial highlights revenue nok 802 million ebitda nok 72 million ebitda margin 9 order intake nok 100 million order backlog nok 9 7 billion another quarter with high demand for our services it s a good basis for developing our business in the future says ceo arild apelthun in beerenberg the results will be available at www beerenberg com and published on www newsweb no for further information please contact harald haldorsen cfo tel 47 982 34 834 e mail harhal beerenberg com about beerenberg as beerenberg has delivered cost efficient solutions to a wide range of industrial enterprises for more than 40 years beerenberg is on
5605,all_events,UP,,18 nov 2024 08 00 cet induct as induct as er på veg ut av en krevende omstillingsprosess hvor vi har frigjort ressurser til å ekspandere i nye markeder vi er på veg inn i sverige med en av våre største suksesser tilskuddsportalen vi kommer også snart med gode nyheter fra satsingen i storbritannia vi har evne til å lykkes med de nye offensive planene fordi vi over to år har gjennomført en betydelig omstilling med kostnadskutt og tydelige prioriteringer i hva vi skal satse på i de markedene vi satser i disse endringene har vært nødvendige for å sikre aksjonærverdier kostnadskutt handler blant annet om å redusere antall ansatte og avvikle avtaler med eksterne konsulenter dette er prosesser som kan skape følelser og konflikter derfor ble nedbemanningen gjennomført i tråd med gode råd og faglig veiledning fra advokater i abelia som er spesialister på denne type juss alle enkeltsakene ble håndtert helt og holdent etter reglene som gjelder og det er ikke påvis
12004,all_events,DOWN,,in the course of the intra group reorganisation of as infortar on 7 november 2024 as tallink grupp transferred 34 000 shares of as tallink takso with a nominal value of 6 3 euros representing of the share capital to as infortar following the transaction as infortar will hold of the shares in as tallink takso the transaction is not treated as a transaction beyond everyday economic activities or a transaction of a significant importance transaction is between related parties but does not have a significant impact on the activities of as infortar or as tallink grupp anneli simminvestorsuhete juht as tallink gruppsadama 510111 tallinnphone 372 56157170e mail anneli simm tallink ee
653,all_events,UP,DOWN,new york june 28 2024 globe newswire eyenovia inc eyenovia or the company nasdaq eyen a commercial stage ophthalmic company announced today that it has entered into a securities purchase agreement with an institutional investor and its current largest stockholder providing for the purchase and sale of 7 575 757 shares of common stock and warrants to purchase up to 7 575 757 shares of common stock the offering the combined offering price for each share of common stock and accompanying warrant is 0 66
9276,all_events,DOWN,,science 37 stockholders to receive 5 75 per share in cash science 37 stockholders to receive 5 75 per share in cash
6051,all_events,UP,,2024 11 14 aac clyde space ab publ today the aos collaborative announces successful two way vdes communications through the satellite ymir 1 the satellite built and operated by aac clyde space has transmitted and received vdes messages from across the globe this communications milestone marks a pivotal movement towards connecting everything maritime and strengthening the communication and navigation infrastructure within the maritime domain providing for a safe secure and green global communication network ymir 1 is part of the collaborative aos project between aac clyde space saab and orbcomm unlike its predecessor satellite ais automatic identification system satellite based vdes offers bidirectional communication this means that vessels can not only receive information but also send data and messages to other ships and shore stations using vdes enabled satellites vdes creates the ability to create a global maritime communication and navigation network enabling shi
3988,all_events,DOWN,,08 nov 2024 10 11 cet proximar seafood as proximar seafood as invites to a presentation of its its financial results for the third quarter of 2024 the results will be presented through a webcast on friday 15th november 2024 at 09 00 cest date friday 15th november 2024 time 09 00 cest language english link https events webcast no proximar 2024 proximar q3 2024 presenters ceo joachim nielsen and cfo ole christian willumsen the report will be published 15th november 2024 and will be available at https proximarseafood com a recorded version of the presentation will also be available after the stream written questions can be submitted during the webcast for more information please contact joachim nielsen ceo 81 70 2811 9898 jn proximar com ole chr willumsen cfo 47 48 21 34 29 ocw proximar com about proximar seafood proximar seafood is a norwegian land based salmon farming company with its first production facility and production at the foot
6537,all_events,UP,,media release
11689,all_events,UP,,media release
11851,all_events,UP,,media release
1086,all_events,DOWN,DOWN,18 nov 2024 09 31 cet tgs asa oslo norway 18 th november 2024 following a series of fixed income investor meetings as previously communicated tgs asa tgs or the company a global leader in energy data and intelligence announces the launch of an offering the offering of senior secured notes with an expected aggregate principal amount of 550 million and maturity in 2030 the notes in connection with the offering the company also expects to enter into a senior secured credit facilities agreement the proceeds from which together with proceeds from the offering and cash on hand is expected to be used to redeem the entire outstanding amount of the 13 senior secured bonds due 2027 issued by petroleum geo services as the 2027 bonds and to repay the company s other existing debt financing this announcement does not constitute a notice of redemption under the indenture governing the 2027 bonds in addition to
3146,all_events,UP,,14 nov 2024 17 45 cet akwel efficient automotive solutions déclarations relatives au nombre total de droits de vote et d actions composant le capital de la société prévues par l article l 233 8 ii du code de commerce et l article 223 16 du règlement général de l autorité des marchés financiers date nombre d actions nombre de droits de vote théoriques nombre de droits de vote exerçables 1 31 10 2024 26 550 240 45 204 932 45 198 888 1 en raison d actions auto détenues akwel 975 route des burgondes01410 champfromier france tel 33 4 50 56 98 98 www akwel automotive com akwel s a à directoire et conseil de surveillance au capital de 21 392 832 euros 344 844 998 r c s bourg en bressesiège social 975 route des burgondes 01410 champfromier france pièce jointe 2024 10 31_akwel_declarationmensuelle_nbactiondroitsdevote efficient automotive solutions déclarations relatives au nombre total de droits de vote et d actions composant le capital
9271,all_events,DOWN,,07 nov 2024 18 45 cet sbm offshore n v amsterdam november 7 2024 sbm offshore and exxonmobil guyana ltd an affiliate of exxon mobil corporation have completed the transaction related to the purchase of fpso prosperity ahead of the maximum lease term which would have expired in november 2025 the purchase allows exxonmobil guyana to assume ownership of the unit while sbm offshore will continue to operate and maintain the fpso up to 2033 the transaction comprises a total cash consideration of c us 1 23 billion the net cash proceeds will primarily be used for the full repayment of the us 0 98 billion project financing and as such will decrease sbm offshore s net debt position the fpso prosperity has been on hire since november 2023 and has and will continue to be operated through the integrated operations and maintenance model combining sbm offshore and exxonmobil s expertise and experience delivering outstanding operational performance the impact of the transact
9966,all_events,DOWN,,12 nov 2024 19 12 cet sats asa 12 november 2024 canica as has today sold 13 172 428 shares in sats asa the company representing approximately 6 of the share capital in the company at a price of nok 22 30 per share for a total transaction size of approximately nok 294 million the transaction following completion of the transaction canica as no longer holds any shares in the company abg sundal collier asa and carnegie as acted as joint bookrunners in connection with the transaction this disclosure is made pursuant to section 4 2 of the norwegian securities trading act more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sats asa oslo børs newspoint sats no0010863285 sats oslo børs
2576,all_events,UP,DOWN,14 nov 2024 10 00 cet wolters kluwer n v press release share buyback transaction details november 7 november 13 2024 alphen aan den rijn november 14 2024 wolters kluwer euronext wkl a global leader in professional information software solutions and services today reports that it has repurchased 120 200 of its own ordinary shares in the period from november 7 2024 up to and including november 13 2024 for 19 3 million and at an average share price of 160 45 these repurchases are part of the share buyback program announced on february 21 2024 under which we intend to repurchase shares for 1 billion during 2024 the cumulative amounts repurchased in the year to date under this program are as follows share buyback 2024 periodcumulative shares repurchased in period total consideration million average share price 2024 to date 6 010 256890 1148 09 for the period starting may 2 2024 up to and including december
2628,all_events,UP,,02 oct 2024 08 00 cest michelin michelin et cie gle 23 place des carmes déchaux 63000 clermont ferrand information about securities repurchasing programregulated informationissuer social denomination michelin lei 549300sosi58j6viw052 types of securities ordinary shares code isin fr 0000121261date october 02th 2024 issuer nameissuer codetransactiondateisin codedaily total volume in number of actions daily weighted average price of shares acquiredplatformcompagnie générale des etablissements michelin549300sosi58j6viw05202 10 2024fr001400aj45171 51635 4114 eurosgré à grécompagnie générale des etablissements michelin549300sosi58j6viw05202 10 2024fr001400aj4550 96735 4114 eurosgré à gréissuer nameissuer codepsinameissuer codetransaction date isin code unit pricecurrencyquantity boughtplatformtransaction reference numberbuyback objectivecompagnie générale des etablissements michelin549300sosi58j6viw052natixiskx1wk48mpd4y2ncuiz6302 10 2024fr001400aj4535 4114euro171 5
8262,all_events,DOWN,,lexington mass oct 07 2024 globe newswire t2 biosystems inc nasdaq ttoo the company a leader in the rapid detection of sepsis causing pathogens and antibiotic resistance genes today announced that it has entered into a multi year exclusive u s agreement with cardinal health nyse cah under the agreement cardinal health will have exclusive rights to sell t2 biosystems fda cleared direct from blood diagnostics for the rapid detection of sepsis causing pathogens including the t2dx instrument the t2bacteria panel and the t2candida panel
720,all_events,UP,DOWN,attachments 11137287 pdf alma media 13 11 trades xlsx
11799,all_events,UP,,paris and cambridge mass may 28 2024 globe newswire nanobiotix euronext nano nasdaq nbtx the company a late clinical stage biotechnology company pioneering nanoparticle based therapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases today announced the presentation of updated data from the completed dose escalation part and first data from the ongoing expansion part of study 1100 a us phase 1 study evaluating nbtxr3 followed by anti pd 1 in patients with recurrent or metastatic head and neck cancer n 68 at the 2024 annual meeting of the american society for clinical oncology the data will be presented by study 1100 coordinating investigator colette shen md phd during a poster presentation session that begins at 10 00 am edt 4 00 pm cest on sunday june 2nd 2024
7841,all_events,UP,,november 06 2024 11 30 et source kalmar corporation kalmar corporation attachment
7883,all_events,UP,,19 nov 2024 20 47 cet danone danone french société anonyme with a capital of 169 888 497 75 registered office 17 boulevard haussmann 75009 paris registered with the paris commerce and company registry under number 552 032 534 information on the total number of voting rights and shares in compliance with article l 233 8 ii of the french commercial code and with article 223 16 of the general regulation of the financial markets authority amf autorité des marchés financiers datetotal number of sharestotal number of voting rights31 10 2024679 553 991total number of theoretical voting rights 1 699 095 232total number of exercisable voting rights 2 663 690 530 1 the total number of theoretical voting rights or gross voting rights is used as the basis for calculating the crossing of shareholding thresholds in accordance with article 223 11 of the amf general regulation this number is calculated on the basis of all shares to which voting rights are attached
3698,all_events,DOWN,,media release
12236,all_events,DOWN,,12 nov 2024 10 17 cet la francaise des jeux regulatory news la française des jeux fdj un leader européen des jeux d argent et de hasard va rencontrer des investisseurs ces prochains jours en vue de lancer sous réserve des conditions de marché sa première émission obligataire fdj rappelle que le 7 novembre moody s lui a attribué la note de crédit long terme baa1 perspective stable d un montant total de 1 5 milliard d euros réparti en 3 tranches de maturité 6 9 et 12 ans l émission obligataire sera utilisée pour refinancer la plus grande partie du crédit relais de 2 milliards d euros tiré le 7 octobre pour financer l acquisition des titres kindred pour près de 2 5 milliards d euros ces obligations seront cotées sur le marché règlementé euronext à paris par ailleurs fdj finalise la mise en place d un crédit de 400 millions d euros syndiqué auprès de banques françaises et internationales de premier rang amortissable sur 5 ans ce financement
5893,all_events,UP,,18 10 2024 17 00 01 eest suomen hypoteekkiyhdistys inside information in the half year interim report published on 9 august 2024 the operating profit of the mortgage society of finland group for 2024 was expected to be clearly higher than operating profit for 2023 the expectation contained uncertainties due to the development in economy and interest rates as well as uncertainties related to the war in ukraine and crisis in the middle east according to a new expectation the mortgage society of finland group expects its operating profit for year 2024 to be on the same level or slightly higher than operating profit for 2023 the expectation contains considerable uncertainties due to development in economy and interest rates war in ukraine crisis in the middle east and unstable world situation the expectation has been updated to be in line with changed interest rate anticipations the operating profit for the year 2023 was 8 5 million euros the mortgage society of finlan
12452,all_events,UP,,08 nov 2024 08 00 cet kbc groep kbc group 8 november 2024 information regarding the traditional annual capital increase reserved for staff following information regarding the traditional annual capital increase of kbc group nv reserved for staff is available on www kbc com corporate governance leadership board of directors information in the table special reports of the board only in dutch report of the board and related statutory auditors report concerning the disapplication of the preferential subscription right kbc group 8 november 2024 information regarding the traditional annual capital increase reserved for staff following information regarding the traditional annual capital increase of kbc group nv reserved for staff is available on www kbc com corporate governance leadership board of directors information in the table special reports of the board only in dutch report of the board and related statutory auditors report concerning the d
311,all_events,DOWN,DOWN,november 13 2024 01 59 et source svitzer group a s svitzer group a s today svitzer group a s svitzer has published its q3 2024 trading statement showing continued solid financial performance q3 2024 highlights q3 2023 in brackets svitzer s financial outlook for 2024 is unchanged compared to the interim report for the first six months of 2024 that was released on 14 august 2024 svitzer ceo kasper friis nilaus comments we are pleased to report continued solid financial results and performance across our global operations in the third quarter of the year with revenue growth in constant exchange rates of 9 and adjusted ebitda 12 higher than in the same period last year as in the previous quarters the positive performance was driven by a combination of tariff increases special operation jobs and new operations that have commenced since the same period last year in the quarter we succeeded in progressing and renewing contr
385,all_events,UP,DOWN,media release
99,all_events,DOWN,UP,media release
7696,all_events,UP,,certara has appointed rona anhalt as chief human resources officer and daniel corcoran as general counsel
8243,all_events,UP,,16 oct 2024 08 30 cest sparebank 1 smn sparebank 1 smn has in recent years built up norway s most complete finance centre physically and digitally the core concept has been to make all financial services available to customers under one and the same roof the organisation is now being revamped to achieve further synergies and greater power in its development work since 2020 both eiendomsmegler 1 midt norge and sparebank 1 regnskapshuset smn have been integrated into the wider business in order to generate increased synergies and a more attractive customer offering the heads of these companies have in the past four years been part of the group management team by offering everything from accounting and estate agency services to insurance saving investment and banking services under the same roof we cater both to people and firms where they are this also makes us an attractive employer our bank has the broadest customer offering among banks in norway and th
9918,all_events,UP,,12 nov 2024 08 30 cet nanobiotix transfert du sponsoring de l étude mondiale de phase 3 nanoray 312 sur le cancer de la tête et du cou pour les états unis une étape clé dans la préparation de la soumission réglementaire potentielle de nbtxr3 ajout de leaders experts de l industrie auprès du conseil de surveillance pour renforcer la perspective de la stratégie de croissance à long terme de l entreprise mise à jour du programme nbtxr3 concernant les études sur le cancer du pancréas et le cancer du poumon avec md anderson prévue respectivement au quatrième trimestre 2024 et au premier semestre 2025 communication sur l expansion du portefeuille de produits pour inclure la plateforme disruptive de nanothérapie curadigm attendue au quatrième trimestre 2024 53 2 millions d euros de trésorerie et équivalents de trésorerie au 30 septembre 2024 visibilité de trésorerie jusqu au quatrième trimestre 2025 paris et cambridge mass 12 nov 2024 globe newswire nanobiotix euro
6862,all_events,DOWN,,13 nov 2024 07 30 cet vente unique com record annual gross merchandise volume of 233 2m up 15 year on year revenues of 178 7m 10 in line with the group s historic double digit growth trajectory and in line with the announced target another financial year of profitable growth as promised with an adjusted annual ebitda 1 margin expected to remain exemplary at over paris 13 november 2024 the vente unique com group an expert in online sales of furniture and home furnishings in europe announces its unaudited revenues figures for the 4th quarter period from 1 july 2024 to 30 september 2024 and the 2023 2024 financial year period from 1 october 2023 to 30 september 2024 ifrs in k q4 2023 q4 2024 variation q4 2023 2024 2023 2024 variation 2023 2024 gross merchandise volume 2 55 170 60 682 10 201 740 233 239 15 revenues 43 341 46 103 6 162 254 178 655 10 e commerce 3 42 120 45 785 8 155 519 176 095 13 logistic
12881,all_events,UP,,the lithuanian government eurobonds auction of additional offers will be held on 2024 11 25 auction participants can submit competitive and non competitive bids the competitive bids shall be submitted in the order books of the vse new issue yield market whereas the non competitive bids shall be placed in the order books of the vse new issue yield non market the parameters of the emission to be issued shall be the following with the written consent of the ministry of finance this amount may be increased by one additional amount up to a maximum of eur 5 000 000 for one of the auction participants the securities shall be redeemed by paying to their holders the total amount of par value the paid up securities shall be admitted to the regulated market to the debt securities list of the nasdaq vilnius ab nasdaq baltic transaction services 370 5 253 14 54 www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative
5826,all_events,UP,,02 oct 2024 08 00 cest michelin michelin et cie gle 23 place des carmes déchaux 63000 clermont ferrand informations sur les opérations réalisées dans le cadre d un programme de rachat d actions hors contrat de liquiditéinformation réglementée dénomination sociale de l émetteur michelin lei 549300sosi58j6viw052référence de l instrument financier actions ordinaires code isin fr 0000121261date 02 octobre 2024 nom de l émetteurcode identifiant de l émetteurjour de la transactioncode identifiant de l instrument financiervolume total journalier en nombre d actions prix pondéré moyen journalier d acquisition des actionsmarchécompagnie générale des etablissements michelin549300sosi58j6viw05202 10 2024fr001400aj45171 51635 4114 eurosgré à grécompagnie générale des etablissements michelin549300sosi58j6viw05202 10 2024fr001400aj4550 96735 4114 eurosgré à grénom de l émetteur code identifiant nom du psi code identifiant psi jour heure de la transaction code identif
5466,all_events,DOWN,,15 nov 2024 13 45 cet høland og setskog sparebank det er fastsatt ny obligasjonsrente for no0011074577 ny obligasjonsrente i renteperioden 19 11 2024 19 02 2025 er 5 27 ticker hspg39 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632404_c893a759bf27411084da8bed252b56bb pdf høland og setskog sparebank oslo børs newspoint høland og setskog sparebank høland og setskog spb 20 25 frn holand og setskog spb 21 26 frn holand og setsk spb 21 perp frn c hybrid holand og setskog spb 21 31 frn c sub holand og setskog spb 22 25 frn holand og setskog spb 23 26 frn holand og setskog spb 23 28 frn høland og setskog spb 24 34 frn c sub høland og setsk spb 24 perp frn c hybrid høland og setskog spb 24 27 frn h
1599,all_events,DOWN,DOWN,11 nov 2024 13 03 cet sonae sgps s a 1130295sonae sgpspagamento juros cupao no 3 pdf sonae sgps sa euronext sonae ptson0am0001 son euronext
6444,all_events,UP,,media release
11752,all_events,UP,,november 18 2024 05 01 et source ensurge micropower asa ensurge micropower asa oslo 18 november 2024 reference is made to the announcement by ensurge micropower asa the company on 10 november 2024 regarding conversion of a convertible loan in the amount of nok 1 500 000 convertible loan plus accrued interest and the resulting issuance of a total of 3 003 131 new shares in the company the share capital increase has now been duly registered in the register of business enterprises following the share capital increase the company s share capital is nok 350 114 738 50 divided into 700 229 477 shares each share having a par value of nok 0 50 about ensurge micropower ensurge is energizing innovation tm with the first ultrathin flexible reliable and fundamentally safe solid state lithium microbattery for the 1 to 100 milliampere hour mah class of wearable devices connected sensors and beyond the innovative ensurge microbat
2357,all_events,DOWN,DOWN,portland maine april 09 2024 globe newswire immucell corporation nasdaq iccc immucell or the company a growing animal health company that develops manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle today announced preliminary unaudited sales results for the first quarter of 2024 which ended march 31 2024
8953,all_events,UP,,the general meeting of admirals group as has appointed juri kartakov as a new member of the supervisory board of the company effective from 01 10 2024 juri kartakov has been associated with the admirals group since 2009 having previously also served on the supervisory board of the company years 2009 2010 2014 2016 2017 2018 and on the subsidiary admiral markets as management years 2009 2014 and supervisory boards years 2015 2017 besides admirals group he is a management board member in finwizard oü and fwiz international oü the supervisory board of admirals group as shall operate from 01 10 2024 in the following composition anatolie mihalcenco dmitri lauš priit rohumaa olga senjuškina and juri kartakov additional information alexander tsikhilov chairman of the management board of admirals group as alexander tsikhilov admirals com 372 6309 300 https www admirals group
5013,all_events,UP,,media release
11620,all_events,UP,,07 nov 2024 18 00 cet waga energy s a waga energy le smd3 et waga energy lancent un projet de production de biométhane en dordogne 07 nov 2024 18 00 cet cest information réglementaire transmise par eqs group le contenu de ce communiqué est de la responsabilité de l émetteur le smd3 et waga energy lancent un projet de production de biométhane à saint laurent des hommes en dordogne le syndicat mixte départemental des déchets de la dordogne responsable de la collecte du transport et du traitement des déchets en dordogne a signé un contrat avec waga energy spécialiste de la production de biométhane sur les sites de stockage des déchets afin de produire du biométhane sur le site de saint laurent des hommes dans le cadre de ce contrat waga energy va construire sur l installation de stockage de déchets non dangereux isdnd de saint laurent des hommes une unité d épuration utilisant sa technologie brevetée wagabox pour valoriser sous forme de biométhane
63,all_events,DOWN,DOWN,08 nov 2024 06 30 cet lerøy seafood group asa lerøy seafood group asa will present its results for q3 2024 on 14 november 2024 at continental hotel stortingsgaten 24 26 oslo at 08 00 cet the presentation will be held in norwegian followed by a q a session delicious seafood will be served from 07 45 cet you may alternatively follow the norwegian presentation and submit questions through a live broadcast available on https www leroyseafood com no investor the quarterly report and presentation will be published at 06 30 cet a recording of the presentation in english will be available from 12 00 cet on http www leroyseafood com en investor this information is subject to the disclosure requirements pursuant to section 5 12 the norwegian securities trading act more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site lerøy seafood group asa oslo børs newspoint lerøy seafood group leroy seafo
7110,all_events,UP,,november 14 2024 02 30 et source aino health ab publ aino health ab publ yet another finnish public organization the city of savonlinna has chosen aino s saas platform as part of a strong initiative to build a more sustainable work environment to manage staffing needs and secure the competence supply to be a more attractive employer the agreement includes a total of 1100 employees and the aino saas platform is in production use from the fourth quarter of 2024 as a public employer we should always aim for a holistic and systematic approach to our employes wellbeing engagement and motivation with the aino platform our supervisors will finally have the right tools to be both systematic responsive and proactive says virve silvennoinen hr director city of savonlinna to see the expansion of our platform in the public sector is such a great validation and fantastic proof for our digital toolbox where people mean the most our sy
5508,all_events,DOWN,,the consolidated revenues of bercman technologies as hereinafter bercman for the third quarter of 2024 amounted to eur 326 567 compared to q3 2023 eur 403 272 mart suurkask ceo of bercman the third quarter sales results were affected by administrative delays on the client side in large key projects related to procurement procedures and tender projects as well as a slight slowdown in client development activities we are pleased to note that the defence sector has shown resilience amid broader economic challenges with companies in this field maintaining a steady demand for innovative solutions our development team has been fully supportive in assisting these companies with product development in the third quarter development services were exported not only to serve estonian clients but also to markets in norway sweden finland singapore and switzerland the focus on strategic projects particularly in the defence sector increased the share of defence indus
47,all_events,UP,DOWN,jupiter fla march 28 2024 globe newswire dyadic international inc dyadic we us our or the company nasdaq dyai a biotechnology company focused on the efficient large scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non pharmaceutical applications including food nutrition and wellness today announced that michael tarnok is stepping down as chairman of dyadic s board of directors the board and that current member of the board patrick lucy has been appointed to succeed him in each case effective immediately mr tarnok will continue to serve as a director through the end of his current term which will end at the company s annual meeting in june 2025 at which time he expects to retire in addition dr barry buckland announced that he is retiring and therefore will not stand for re election at the company s annual meeting in june 2024 the board has decided not to fill the vacancy due to dr buckland s retirement which will result in a reduction of the size of the board from seven to six members finally joseph hazelton has been appointed chief operating officer effective immediately and will oversee the day to day operations of the company
2252,all_events,UP,DOWN,vilvi group which consists of vilkyškių pieninė ab modest ab kelmės pieninė ab kelmės pienas uab pieno logistika ab and baltic dairy board sia consolidated sales for september 2024 amounted to 22 81 million eur 28 increase comparing to september 2023 the sales of the group for period january september 2024 amounted to 181 37 million eur 17 increase comparing to the same period last year vilija milaseviciute economics and finance directorphone 370 441 55 102 email vilija milaseviciute vilvi eu
8534,all_events,DOWN,,this message has been corrected click here to view the corrected message vilnius lithuania 2024 10 16 12 41 cest omx baltic benchmark fund share price on october 15 2024 13 1336 eur omx baltic benchmark fund number of shares issued on october 15 2024 0 units omx baltic benchmark fund number of shares redeemed on october 15 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of october 15 2024 125 362 units nter asset management
12197,all_events,DOWN,,06 nov 2024 07 00 cet lexibook linguistic elect sys ce communiqué ne constitue pas une offre d acquisition et n est pas destiné à être diffusé dans les juridictions où l offre ne serait pas autorisée communique de presse en date du 6 novembre 2024 relatif a la mise a disposition de la note d information et du document autres informations relatif aux caractéristiques juridiques financières et comptables de la société doodle dans le cadre de l offre publique d achat visant les actions de la société lexibook initiee par la societe doodle agissant de concert avec la société lawrence rosen llc et la famille le cottier conséilee par gilbert dupont groupe société générale presentee par societe generale prix de l offre 4 euros par action lexibook duree de l offre 25 jours de négociation le calendrier de la présente offre publique d achat l offre sera déterminé par l autorité des marchés financiers l amf conformément aux dispositions de son règlement génér
8944,all_events,UP,,copenhagen denmark 19 november 2024 fluoguide a s fluoguide or the company is pleased to announce publication of the first clinical data on fg001 a novel imaging agent tested in patients undergoing surgery for head and neck cancer the data has been published in theranostics a prestigious journal with a high impact factor of 12 4 the article is entitled optical molecular imaging in oral and oropharyngeal squamous cell carcinoma using a novel upar targeting near infrared imaging agent fg001 icg glu glu ae105 an explorative phase ii clinical trial and identified with doi 10 7150 thno 100042 fg001 is designed to enhance surgical accuracy by illuminating cancer cells intraoperatively using fluorescent light it selectively binds to the upar receptor widely expressed in most solid cancer types the use of fg001 is expected to reduce the incidence of local recurrence after surgery and surgical complications ultimately improving treatment outcomes for patients while also
12404,all_events,UP,,06 nov 2024 07 00 cet credit agricole s a très bon trimestre confirmation de la cible de résultat pour 2024 données publiées et sous jacentes casa et gca t3 2024 crédit agricole s a groupe crédit agricole publié sous jacent publié sous jacent revenus 6 487 m 2 t3 t3 6 484 m 7 t3 t3 9 213 m 0 t3 t3 9 210 m 4 t3 t3 charges 3 689 m 9 t3 t3 3 654 m 8 t3 t3 5 590 m 6 t3 t3 5 556 m 5 t3 t3 résultat brut d exploitation 2 799 m 5 t3 t3 2 830 m 5 t3 t3 3 623 m 9 t3 t3 3 654 m 2 t3 t3 coût du risque 433 m 0 t3 t3 433 m 0 t3 t3 801 m 15 t3 t3 801 m 15 t3 t3 rnpg 1 666 m 4 t3 t3 1 686 m 10 t3 t3 2 080 m 12 t3 t3 2 100 m 1 t3 t3 coex 56 3 6 pp t3 t3 56 0 6 pp t3 t3 60 3 7 pp t3 t3 60 0 8
7964,all_events,UP,,november 15 2024 09 30 et source baltic horizon fund northern horizon capital baltic horizon fund northern horizon capital 15 novembril 2024 a toimus baltic horizoni korraldatud veebiseminar kus fondijuht tarmo karotam andis ülevaate 2024 a kolmanda kvartali aruande tulemustest baltic horizon fond tänab kõiki osalejaid veebiseminari salvestus on huvilistele kättesaadav siit ning esitlus siit lisainformatsiooni saamiseks palume ühendust võtta tarmo karotam baltic horizon fond fondijuht e mail tarmo karotam nh cap com www baltichorizon com baltic horizon fond on registreeritud lepinguline avalik kinnine kinnisvarafond mida valitseb alternatiivfondivalitseja northern horizon capital as avaldamine globenewswire nasdaq tallinn nasdaq stockholm www baltichorizon com saamaks börsiteateid ning uudiseid baltic horizon fondilt tema projektide plaanide ja muu kohta registreeruge aadressil www baltichorizon com samuti on teil võimalik
4549,all_events,DOWN,,partial response and stable disease reported in combination cohort and durable stable disease observed in monotherapy cohorts
12495,all_events,UP,,media release
9609,all_events,UP,,media release
9515,all_events,DOWN,,19 nov 2024 10 43 cet jæren sparebank jæren sparebank har i dag utstedt et nytt senior obligasjonslån obligasjonen har flytende rente og løpetid på 5 25 år lånebeløp er nok 300 000 000 og kupongen er 3 måneders nibor 0 93 oppgjørsdato er 21 november 2024 seb var tilrettelegger av transaksjonen kontaktperson direktør økonomi og finans klas stølsnes mobil 916 96 150 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site jæren sparebank oslo børs newspoint jæren sparebank jæren spb 20 25 frn jaeren spb 21 27 frn jaeren spb 21 26 frn jaeren spb 21 31 frn c sub jaeren spb 21 24 frn jaeren spb 23 28 frn jaeren spb 23 perp frn c hybrid jaeren spb 23 33 frn c sub jæren spb 24 29 frn no0010359433 no0010872989 no0010891369 no0010932544 no0010932536 no0011017808 no0011086928 no0012804188 no0012866674 no0012927443 no0012989971 no0013320051 jaren oslo børs nordic alternative
7921,all_events,DOWN,,media release
3482,all_events,DOWN,,south san francisco calif june 08 2024 globe newswire akero therapeutics inc nasdaq akro a clinical stage biotechnology company developing transformational treatments for patients with serious metabolic disorders marked by high unmet medical need today announced two presentations featuring its lead product candidate efruxifermin efx at the european association for the study of the liver easl congress 2024 in milan italy the presentations will also be available on akero s website following the meeting
4540,all_events,DOWN,,06 nov 2024 19 45 cet scor se communiqué de presse06 novembre 2024 n 16 projet d offre publique sur mrm ajustement de prix pour lire cette information dans son intégralité veuillez confirmer que vous avez lu et compris la clause de non responsabilité sur le site web de scor ici scor un réassureur mondial de premier plan réassureur mondial de premier plan scor offre à ses clients une gamme innovante et diversifiée de solutions et de services de réassurance et d assurance pour le contrôle et la gestion des risques fidèle à sa devise l art et la science du risque le groupe met son expertise reconnue au sein du secteur et ses solutions financières de pointe au service du bien être et de la résilience des populations le groupe a enregistré 19 4 milliards d euros de primes en 2023 représenté à travers 35 bureaux dans le monde il est au service de ses clients dans près de 160 pays pour plus d informations rendez vous sur www scor com relatio
9303,all_events,UP,,13 nov 2024 16 10 cet andino inversiones global s a aig press release aih q3 2024 consolidated results pdf andino global euronext andino inversiones global s a es0105744009 mlaig euronext access
3068,all_events,DOWN,,media release
12477,all_events,UP,,needham mass may 22 2024 globe newswire candel therapeutics inc candel or the company nasdaq cadl a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer today announced that paul peter tak md phd fmedsci candel s president and chief executive officer will present a company overview at the jefferies global healthcare conference on wednesday june 5 2024 at 5 30 p m et
360,all_events,UP,DOWN,november 07 2024 06 31 et source parken sport entertainment a s parken sport entertainment a s koncernomsætningen udgjorde 1 061 9 mio kr pr 30 september 2024 hvilket er en fremgang på 57 2 mio kr i forhold til samme periode sidste år primært resultat før amortiseringer og transferaktiviteter udgjorde 65 6 mio kr pr 30 september 2024 mod 87 8 mio kr i samme periode sidste år resultat af transferaktiviteter udgjorde 201 3 mio kr pr 30 september 2024 mod 81 1 mio kr i samme periode sidste år resultat før skat udgjorde 294 1 mio kr pr 30 september 2024 mod 132 6 mio kr på samme tidspunkt sidste år periodens samlede resultat udgjorde 229 4 mio kr pr 30 september 2024 mod 103 4 mio kr i samme periode sidste år udviklingen kan bl a henføres til den positive udvikling i transferaktivitet salg af feriehuse i lalandia og den positive effekt af omlægning af hovedparten af koncernens realkreditlån i forhold til sa
6762,all_events,UP,,portland maine june 21 2023 globe newswire immucell corporation nasdaq iccc immucell or the company a growing animal health company that develops manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle today announced that bryan k gathagan has been appointed to its board of directors
4617,all_events,DOWN,,media release
4083,all_events,DOWN,,07 nov 2024 18 10 cet rexel rexel déclaration relative au nombre total d actions et de droits de vote au titre de l article l 233 8 ii du code de commerce et l article 223 16 du règlement général de l autorité des marchés financiers datenombre d actionsnombre de droits de vote 31 10 2024 298 233 069 nombre de droits de vote théoriques 1 298 233 069 nombre de droits de vote exerçables 2 296 658 211 1 nombre de droits de vote incluant les actions auto détenues privées de droits de vote 2 nombre de droits de vote déduction faite des actions auto détenues privées de droits de vote pièce jointe déclaration relative au nombre total d actions et de droits de vote rexel déclaration relative au nombre total d actions et de droits de vote au titre de l article l 233 8 ii du code de commerce et l article 223 16 du règlement général de l autorité des marchés financiers pièce jointe rexel globenewswire rexel fr0010451203 rxl euronext
1983,all_events,DOWN,DOWN,november 14 2024 12 10 et source clean motion ab clean motion ab elfordonstillverkaren clean motion ab presenterar sin delårsredogörelse för januari september 2024 bolaget redovisar en försäljning på 612 3 107 tsek och ett rörelseresultat på 7 188 4 309 tsek exklusive avskrivningar ebitda på 7 371 3 354 tsek ulf rask tf vd kommenterar bästa aktieägare jag vill börja med att tacka för förtroendet ni visade genom att delta i höstens företrädesemission vi hade naturligtvis hoppats på ett större deltagande men utfallet ger ändå bolaget utrymme att genomföra den lagda strategin dock i lägre takt för bolagets ledning har företrädesemissionen naturligtvis tagit en stor del av tiden men vi har ändå lyckats driva på bolagets utveckling inom samtliga områden min personliga höjdpunkt är iaa mässan i frankfurt som resulterade i flera bra leads både på försäljnings och leverantörssidan samt marknadssamarbetet med valeo för den fransk
12474,all_events,UP,,brisbane calif sept 16 2024 globe newswire annexon inc nasdaq annx a biopharmaceutical company advancing novel complement therapies for neuroinflammatory diseases of the body brain and eye today announced that it has granted inducement to six new non executive employees under the terms of the 2022 employment inducement award plan the equity awards were approved on september 13 2024 in accordance with nasdaq listing rule 5635 c 4
7224,all_events,DOWN,,10 oct 2024 07 00 cest fagron s a regulated information inside informationnazareth belgium rotterdam the netherlands 10 october 2024 7 00 am cet fagron reports outstanding third quarter 2024 performance with 12 revenue growth and reaffirms full year outlook fagron the leading global player in pharmaceutical compounding today publishes its quarterly results for the period ending 30 september 2024 key highlights continued topline momentum with 12 reported revenue growth 15 at cer and 12 organic growth at cer delivering 214 5 millionstrong organic growth across all regions and segments underscoring the strength of our structural growth driversglobal operational excellence initiatives remain a key contributor to revenue developmentthree strategic acquisitions signed across all regions and segments purifarma b e brazil ritedose cs north america eurootc b e germany maintain fy 2024 revenue outlook of 850 870 million and improvement i
4303,all_events,UP,,media release
10825,all_events,DOWN,,media release
7276,all_events,DOWN,,first patient in platinum resistant high grade serous ovarian cancer cohort was dosed on optimized dose and schedule with istisociclib kb 0742 expect data update in 1h 2025
1965,all_events,DOWN,UP,10 oct 2024 07 00 cest bw lpg limited singapore 10 october 2024 bw lpg limited bw lpg or the company ose ticker code bwlpg ol nyse ticker code bwlp today provides an update on its product services bw product services q3 2024 segment performance for the quarter ended 30 september 2024 bw product services reported an estimated gross profit of approximately usd 71 million this gross profit was mainly a result of usd 86 million of unrealised marked to market value of open cargo contracts and hedging transactions realised trading gains of usd 16 million offset by hedging loss of usd 31 million on the realised positions the open cargo value is reflected in the overall trading book value and will be gradually revalued and realised in the next 12 months as per standard methodology after general and administrative expenses and income taxes bw product services reported an estimated net profit of approximately usd 60 million for the quarter the a
2859,all_events,UP,,media release
8273,all_events,UP,,media release
11713,all_events,UP,,arcutis today announced the signing of a co promotion agreement with kowa pharmaceuticals america inc
2609,all_events,DOWN,,11 oct 2024 16 30 cest agilyx asa this filing includes the required director responsibility statement no changes to the first half 2024 financial statements have been made more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 629479_agilyx asa h1 2024 report incl director responsibility final pdf agilyx asa oslo børs newspoint agilyx asa no0010872468 aglx oslo børs
3312,all_events,UP,,net asset value and the latour share industrial operations the third quarter industrial operations january september the group investment portfolio events after the reporting period 1 the calculation of the net asset value on 5 november was based on the value of the investment portfolio at 5 30 p m on 5 november and the same values as on 30 september were used for the unlisted portfolio comments from the ceo the third quarter saw continued positive growth for latour s industrial operations despite the current economic downturn demand is relatively robust although the picture varies across segments and geographic regions demand has been relatively positive for several of our operations in both the third quarter and the first nine months of the year although the situation remains somewhat subdued for the construction and real estate markets the outlook is relatively positive for our three business areas with most exposure in these markets swegon and bemsiq are reporting a rise
10430,all_events,UP,,media release
9236,all_events,DOWN,,redwood city calif feb 23 2024 globe newswire jasper therapeutics inc nasdaq jspr jasper a biotechnology company focused on development of briquilimab a novel antibody therapy targeting c kit cd117 in mast cell driven diseases such as chronic spontaneous urticaria csu and chronic inducible urticaria cindu is presenting results from three preclinical studies evaluating briquilimab at the 2024 american academy of allergy asthma immunology aaaai annual meeting being held february 23 26 in washington d c one study will be featured in an oral presentation and two studies in poster presentations
3409,all_events,DOWN,,media release
8970,all_events,UP,,management to host conference call and webcast at 4 30 pm et on that day
5359,all_events,DOWN,,media release
8641,all_events,UP,,11 nov 2024 18 43 cet shell plc transaction in own shares 11 november 2024 shell plc the company announces that on 11 november 2024 it purchased the following number of shares for cancellation aggregated information on shares purchased according to trading venue date of purchasenumber of shares purchasedhighest price paid lowest price paid volume weighted average price paid per sharevenuecurrency11 11 2024851 000 25 7900 25 4500 25 6149lsegbp11 11 2024 0 0000 0 0000 0 0000chi x cxe gbp11 11 2024 0 0000 0 0000 0 0000bats bxe gbp11 11 2024512 000 31 4650 31 1350 31 3083xamseur11 11 2024 0 0000 0 0000 0 0000cboe dxeeur11 11 2024 0 0000 0 0000 0 0000tqexeur these share purchases form part of the on and off market limbs of the company s existing share buy back programme previously announced on 31 october 2024 in respect of this programme citigroup global markets limited will make trading decisions in relation to the securi
11555,all_events,UP,,media release
10354,all_events,UP,,maha energy ab publ maha or the company will publish the interim report for the third quarter 2024 on tuesday 19 november 2024 at approximately 7 30 cet the company hereby invites all interested parties to a live webcasted presentation on the same day at 14 00 cet kjetil solbraekke ceo and roberto marchiori cfo will present the report and recent developments the webcast will be held in english and will be broadcasted live an on demand version will also be available on maha s website questions to the presenters can be emailed in advance to the company at info maha energy com or be made directly on the day of the presentation in the youtube comments questions field link to webcast https youtube com live d7tldj1ed5k feature share contactskjetil solbraekke ceo phone 46 8 611 05 11 e mail info maha energy comroberto marchiori cfo phone 46 8 611 05 11 e mail info maha energy comjakob sintring head of ir phone 46 8 611 05 11 jakob sintring maha energy co
11268,all_events,UP,,november 18 2024 07 45 et source ålandsbanken ålandsbanken bank of åland plcother information disclosed according to the rules of the exchange18 11 2024 14 45 eet notification of an application for the delisting of a security in a regulated market the bank of åland has filed an application to nasdaq helsinki for the delisting of the below mentioned securities eur denominated covered bond issue in conjunction with submitting the delisting application the issued amount of the below mentioned securities has been reduced to zero name of issue covered bond due 2024isin code fi4000490677issue amount eur 400 000 000 for more information please contact peter wiklöf managing director and chief executive phone 358 0 40 512 7505
7709,all_events,DOWN,,12 nov 2024 17 35 cet eurazeo see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1297231_declarationamf1erau8novembre2024 pdf eurazeo les echos eurazeo se fr0000121121 rf euronext
6826,all_events,DOWN,,the environmental court of appeal announced today that the court will not grant leave to appeal regarding the appeal of the environmental permit for viscaria the court also dismissed the appeal from a private individual if today s decision is not appealed the judgment regarding the environmental permit will become final on december 5 2024 we are very pleased that the court has decided not to grant leave to appeal we can now continue our preparations to reopen the viscaria copper mine with full force says jörgen olsson ceo of viscaria the ruling from may 6 2024 was appealed by the gabna sámi village three private individuals and viscaria the laevas sámi village and the county administrative board of norrbotten also appealed the ruling but later withdrew their appeals this information is information that gruvaktiebolaget viscaria is obliged to make public pursuant to the eu market abuse regulation the information was submitted for publication through the agency of the c
11973,all_events,DOWN,,15 nov 2024 16 02 cet ørland sparebank vedlagt følger regnskapsrapport for 3 kvartal 2024 som er vedtatt av bankens styre 14 11 2024 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632439_kvartalsrapport 3 kvartal 2024 pdf ørland sparebank oslo børs newspoint ørland spb 20 25 frn orland spb 22 27 frn orland spb 22 26 frn orland spb 23 28 frn orland spb 23 26 frn orland spb 24 29 frn ørland spb 24 29 frn ørland spb 24 27 frn no0010873524 no0010890940 no0012520529 no0012694241 no0012939125 no0013019729 no0013162685 no0013314708 no0013355230 nordic alternative bond market
7640,all_events,DOWN,,on 13 november 2024 malene lunddal hansen was elected to the management board in coloplast finance b v replacing hea vinskov malene lunddal hansen is senior director for tax compliance in the coloplast group the management board in coloplast finance b v hereafter consists of henrik deneke anton mikkelsen and malene lunddal hansen attachment attachments 07_2024_change_in_management_board pdf
8028,all_events,UP,,media release
8798,all_events,DOWN,,november 08 2024 08 45 et source nokia oyj nokia oyj nokia corporationmanagers transactions8 november 2024 at 15 45 eetnokia corporation managers transactions fisk transaction notification under article 19 of eu market abuse regulation ____________________________________________person subject to the notification requirementname fisk louise position other senior manager issuer nokia corporationlei 549300a0jprwg1ki7u06notification type initial notificationreference number 84277 4 4____________________________________________ transaction date 2024 11 07 venue nasdaq helsinki ltd xhel instrument type share isin fi0009000681 nature of the transaction acquisition transaction details 1 volume 117 unit price 4 27670 aggregated transactions 1 volume 117 volume weighted average price 4 27670 about nokiaat nokia we create technology that helps the world act together as a b2b technology innovation leader we are pioneeri
9054,all_events,DOWN,,16 oct 2024 07 30 cest bourse direct hausse du chiffre d affaires consolidé de 14 croissance du nombre d ouvertures de comptes client de plus de sur les 9 premiers mois 2024 au 30 septembre 2024 le chiffre d affaires consolidé cumulé s inscrit en hausse de 14 à 57 1 millions d euros comparé à la même période en 2023 bourse direct enregistre un chiffre d affaires individuel en hausse de 12 sur les 9 premiers mois de l année 2024 à 50 7 millions d euros contre 44 9 millions d euros en 2023 avec 3 4 millions d ordres exécutés en hausse de 0 par rapport au neuf premiers mois 2023 le recrutement de nouveaux comptes est en croissance de plus de sur les 9 premiers mois de l année 2024 bourse direct enregistre plus de 340 000 comptes à fin septembre l activité professionnelle d exoe enregistre une hausse de 32 de son chiffre d affaires par rapport à 2023 à 6 4 millions d euros la situation financière de bourse direct n a pas connu de changement si
3680,all_events,UP,,attachments 10027149 pdf alma media 2 10 trades xlsx
4411,all_events,DOWN,,on 14 november 2024 the u s centers for medicare medicaid services cms issued a final local coverage determination lcd 1 policy regarding skin substitute grafts cellular and tissue based products for the treatment of diabetic foot ulcers dfus and venous leg ulcers vlus in the medicare population the final lcd policy confirms the introduction of a technical qualification and a clinical efficacy qualification proposed in a draft lcd policy2 earlier this year the final decision also introduces two separate lists for covered products for dfus and covered products for vlus in addition the application limit has been expanded from 4 to 8 and the duration of treatment has been increased from 12 to 16 weeks in the final policy the implementation date of the final policy is set to 12 february 2025 based on the final evaluation kerecis is included on the final list of covered products for dfus however kerecis has not been included on the covered list for vlus sales related t
2390,all_events,UP,DOWN,topline results expected in q3 2025 topline results expected in q3 2025
7219,all_events,DOWN,,zug switzerland oct 21 2024 globe newswire oculis holding ag nasdaq ocs oculis a global biopharmaceutical company purposefully driven to save sight and improve eye care today announces the acceleration of patient enrollment for both phase 3 diamond trials of ocs 01 eye drops in dme and expansion of the diamond program committees with globally renowned retina experts
3447,all_events,DOWN,,in october 2024 icelandair transported 409 thousand passengers a increase compared to october 2023 during the month traveled to iceland from iceland via iceland and within iceland there has been a positive pickup in travel to iceland after a few months of softened demand load factor was 84 one of the highest in october and on time performance was 84 up by 4 2 ppt compared to last year year to date icelandair has transported more than four million passengers an increase compared to last year bogi nils bogason president and ceo of icelandair i am very pleased to see the increase in travel to iceland and once again seeing the flexibility of our route network in action offering us the possibility of switching focus between markets in line with demand the market from iceland was also strong increasing by i am proud of our continued outstanding on time performance and high load factor as well as ongoing great feedback from our customers
5145,all_events,UP,,vancouver british columbia aug 14 2023 globe newswire mydecine innovations group otc mycof fse 0nfa mydecine or the company a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and ptsd announces the financial results for the six months ended june 30 2023
2303,all_events,DOWN,DOWN,phase 3 mantra trial completed enrollment five months ahead of previous guidance
10437,all_events,UP,,new york may 30 2024 globe newswire tiziana life sciences ltd nasdaq tlsa tiziana or the company a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery today announced that howard l weiner m d chairman of tiziana s scientific advisory board and co director of the ann romney center for neurologic diseases at brigham and women s hospital a founding member of mass general brigham healthcare system is being honored with the prestigious giants of ms award for his outstanding contributions in the area of multiple sclerosis ms research the award ceremony will take place on may 30 2024 at the consortium of multiple sclerosis centers annual meeting being held in nashville tennessee
4333,all_events,UP,,media release
3297,all_events,DOWN,,se vedlagte
4746,all_events,UP,,media release
9448,all_events,DOWN,,11 nov 2024 09 03 cet nordic technology group as reference is made to the n otc announcement published by condalign as on 18 october 2024 and on 4 november 2024 regarding that condalign need to secure additional funding to finance the current business to facilitate continued strategic discussions condalign has initiated an application period for a convertible loan to raise a minimum of nok 6m the convertible loan can be converted into existing preference shares at a conversion price of nok 8 00 per preference share the transaction is directed at 1 existing shareholders in the company as of 15 october 2024 as registered in the vps on 17 october 2024 in reliance on applicable prospectus exemptions who have not expressly informed the company that they will not subscribe for the convertible loan tranche 1 and 2 an institutional offering directed towards qualified investors in accordance with applicable prospectus exemptions tranche 2 the extended applicati
8021,all_events,UP,,the shareholders of arctic minerals ab publ reg no 556569 3602 are convened to the extraordinary general meeting to be held on 9 december 2024 at 11 00 cet at advokatfirman schjødt hamngatan 27 in stockholm the entrance to the meeting and registration will open at 10 30 cet right to participate shareholders who wish to participate in the extraordinary general meeting must both be registered in the share register maintained by euroclear sweden ab on 29 november 2024 and also notify the company of their intention to attend the meeting no later than on 3 december 2024 shareholders with nominee registered shares must temporarily register their shares in their own name with euroclear sweden to attend the meeting such registration must be completed by 3 december 2024 and should be requested well in advance of this date to the nominee of the shares notification to attend notification to attend the extraordinary general meeting shall be submitted in writing to the address arctic m
9036,all_events,UP,,08 nov 2024 13 11 cet itera asa board member and primary insider gyrid ingerø has today acquired 22 000 shares in itera asa at nok 9 44 per share following the transaction ms ingerø has 60 000 shares in itera asa more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631720_krt 1500 gyrid ingerø 081124 pdf itera asa oslo børs newspoint itera no0010001118 itera oslo børs
8355,all_events,UP,,toronto dec 18 2023 globe newswire revive therapeutics ltd revive or the company otcqb rvvtf cse rvv frankfurt 31r a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders is pleased to announce that it has signed a collaboration agreement with attwill medical solutions lp ams for the clinical and commercial development of the company s next generation lyophilized formulation of bucillamine
9867,all_events,DOWN,,media release
6834,all_events,UP,,media release
9104,all_events,UP,,19 nov 2024 17 45 cet air liquide l regulatory news air liquide paris ai annonce la nomination de david prinselaar en tant que directeur de la direction industrielle du groupe et membre du comité exécutif d air liquide à compter du 2 décembre 2024 air liquide annonce également que pascal vinet directeur général adjoint prendra sa retraite à la fin de l année de double nationalité néerlandaise et française david prinselaar dispose d une expérience des opérations la chaîne d approvisionnement et la transformation des entreprises après avoir obtenu un diplôme d ingénieur en ingénierie électromécanique à l ucl en belgique david a débuté sa carrière d ingénieur en malaisie il a ensuite travaillé pendant cinq ans dans le domaine du conseil en gestion pour celerant au sein de leur bureau de londres en 2005 il a rejoint reckitt où plusieurs fonctions de direction internationale l ont amené à travailler en europe amérique du nord et amérique du sud penda
1498,all_events,DOWN,UP,07 nov 2024 17 45 cet klepierre communiqué réglementé information relative au nombre total de droits de vote et d actions composant le capital de klépierre sa au 31 octobre 2024 1 paris le 7 novembre 2024 nombre d actions au 31 octobre 2024 date31 10 2024nom de la sociétéklépierremarché de cotationeuronext paris compartiment a code mnémoniquelisymbolesepa li li fp loim paisinfr0000121964nombre total d actions286 861 172nombre total de droits de vote nombre de droits de vote théoriques 2 286 861 172nombre de droits de vote exerçables 3 285 819 074 contactsrelations investisseurs paul logerot group head of investor relations and financial communication 33 0 7 50 66 05 63 paul logerot klepierre comhugo martins investor relations manager 33 0 7 72 11 63 24 hugo martins klepierre comtanguy phelippeau investor relations manager 33 0 7 72 09 29 57 tanguy phelippeau klepierre com à propos de klépierre klépierre la principale foncière spécialisée en centr
921,all_events,UP,UP,11 nov 2024 07 00 cet tgs asa oslo norway 11 november 2024 tgs a leading provider of energy data and intelligence is pleased to announce award of the company s first 3d streamer contract for the 2025 northwest europe summer season acquisition is scheduled to commence in may with a total duration of approximately 35 days kristian johansen ceo of tgs commented we are very pleased to secure our first streamer contract job for the 2025 summer season award of this program underscores our strong position in northwest europe we are experiencing higher bidding activity for this region compared to recent years and while most of our streamer acquisition programs in northwest europe were multi client in 2024 this trend will likely be reversed in 2025 with an overweight of contract work the planned activity increase in the northwest europe region mirrors the global demand increase we experience for our services scheduled for first half 2025 we look forward to su
9214,all_events,UP,,palo alto calif july 01 2024 globe newswire scilex holding company nasdaq sclx scilex or the company an innovative revenue generating company focused on acquiring developing and commercializing non opioid pain management products for the treatment of acute and chronic pain today provided certain preliminary unaudited financial results for the month ended june 30 2024 and quarter ended june 30 2024
12592,all_events,UP,,13 nov 2024 17 45 cet cenergy holdings sa 20241113 cenergy holdings cpw capacity expansionen pdf cenergy holdings euronext cenergy be0974303357 cener euronext
4501,all_events,UP,,09 oct 2024 18 00 cest voyageurs du monde voyageurs du monde voyageurs du monde activité soutenue au premier semestre 09 oct 2024 18 00 cet cest information réglementaire transmise par eqs group le contenu de ce communiqué est de la responsabilité de l émetteur communiqué paris le 9 octobre 2024 activité soutenue au premier semestre données consolidées en m publiées s1 2024 s1 2023 var 24 23 chiffre d affaires 289 0 261 2 10 6 marge brute du ca 93 1 32 2 82 2 31 5 13 2 charges d exploitation 88 8 77 9 14 0 ebitda 9 6 8 4 13 8 résultat d exploitation ebit 6 0 5 3 12 9 résultat net part du groupe 5 5 5 9 7 3 ebitda équivalent de l excédent brut d exploitation résultat d exploitation ebit après dotat
6604,all_events,DOWN,,highlights of q3 2024 results
5095,all_events,DOWN,,media release
8084,all_events,DOWN,,oü brem avarii and as baltplast informed aktsiaseltsi silvano fashion group sfg about a significant change in their holdings on october 21 2024 as baltplast transferred 2 000 000 sfg shares to oü brem avari as of october 21 2024 oü brem avarii owns 2 000 000 sfg shares which represents 5 of sfg s voting shares before the significant change in ownership oü brem avarii did not own a share in sfg as of october 21 2024 as baltplast owns 7 835 931 sfg shares which represents 21 of sfg s voting shares before the significant change in ownership as baltplast owned 9 827 413 sfg shares which represented 27 of all sfg voting shares as silvano fashion groupmember of the boardphone 372 6845 000email info silvanofashon com
763,all_events,UP,UP,07 nov 2024 18 00 cet equasens villers lès nancy 7 november 2024 6 00 p m cet press release 2024 nine month revenue 158 2 million return to growth in q3 0 revenue m 2023reported basis 2024reported basis change reported basis ségur2024 ségur2023 external growth change like for like basis q1 56 2 53 3 2 9 5 0 3 1 4 2 0 3 8 6 q2 56 4 54 7 1 7 3 0 3 1 2 1 7 2 6 4 q3 50 1 50 2 0 1 0 0 2 0 3 1 8 1 5 3 total 162 7 158 2 4 5 2 0 9 2 9 5 5 7 9 4 at september 30 2024 equasens group reported year to date revenue of 158 2m down 2 on a reported basis from one year earlier and 4 like for like improved momentum in q3 both on a reported and like for like basis with renewed growth by all divisions except axigate link which has been growing since the beginning of the year stable contributions from acquisitions up 3 in the quarter operating highli
6109,all_events,UP,,citycon oyj managers transactions 8 november 2024 at 16 40 hrs person subject to the notification requirement name gazit europe netherlands b v position closely associated person x legal person person discharging managerial responsibilities in issuer name chaim katzman position member of the board issuer citycon oyj lei 549300p8n0p6kdgtj206 notification type initial notification reference number 83980 4 4 ____________________________________________ transaction date 2024 11 05 outside a trading venue instrument type share isin fi4000369947 nature of transaction pledging transaction details 1 volume 19723221 unit price 0 n a aggregated transactions 1 volume 19723221 volume weighted average price 0 n a citycon oyj for further information please contact sakari järvelä cfo puh 358 50 387 8180 sakari jarvela citycon com
181,all_events,UP,UP,november 08 2024 08 45 et source nokia oyj nokia oyj nokia oyjjohtohenkilöiden liiketoimet8 11 2024 klo 15 45nokia oyj johtohenkilöiden liiketoimet sahgal markkinoiden väärinkäyttöasetuksen 19 artiklan mukainen ilmoitus liiketoimesta ilmoitusvelvollinennimi sahgal raghav asema muu ylin johto liikkeeseenlaskija nokia corporationlei 549300a0jprwg1ki7u06ilmoituksen luonne ensimmäinen ilmoitusviitenumero 84292 4 4 liiketoimen päivämäärä 2024 11 07kauppapaikka nasdaq helsinki ltd xhel instrumenttityyppi osakeisin fi0009000681liiketoimen luonne hankinta liiketoimien yksityiskohtaiset tiedot 1 volyymi 2645 yksikköhinta 4 27670 liiketoimien yhdistetyt tiedot 1 volyymi 2645 keskihinta 4 27670 tietoja nokiasta nokia luo teknologiaa joka auttaa maailmaa toimimaan yhdessä b2b teknologia ja innovaatiojohtajana olemme tulevaisuuden aistivien ajattelevien ja älykkäiden verkkoratkaisujen edelläkävijä johtoasemamme pohjautuu osa
5950,all_events,DOWN,,portland maine aug 10 2023 globe newswire immucell corporation nasdaq iccc immucell or the company a growing animal health company that develops manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle today announced its unaudited financial results for the quarter ended june 30 2023
1414,all_events,UP,DOWN,warrington pa may 07 2024 globe newswire windtree therapeutics inc windtree or the company nasdaqcm wint a biotechnology company focused on advancing early and late stage innovative therapies for critical conditions and diseases today announced it has received a bid price compliance letter from the nasdaq stock market llc nasdaq informing windtree that it has regained compliance with the minimum bid price requirement under nasdaq listing rule 5550 a 2 for continued listing on the nasdaq capital market
9813,all_events,UP,,18 nov 2024 08 38 cet ecit as oslo børs has received an application from ecit as for the delisting of the company s b shares from euronext growth oslo more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site ecit as oslo børs newspoint ecit as b aksjer no0010939804 ecit euronext growth
5613,all_events,DOWN,,12 nov 2024 07 00 cet flex lng ltd november 12 2024 hamilton bermuda please find enclosed the presentation of flex lng ltd s third quarter 2024 results which will be presented in a live video webcast today at 15 00 cet 09 00 a m est in order to watch the webcast use the following link third quarter 2024 earnings presentation https events webcast no flexlng iqchf6pfryokoohpdu6c sgmwgl0jqih t ed3vysfb a q a session will be held after the webcast information on how to submit questions will be given at the beginning of the session in conjunction with the quarterly results we have published a short teaser with the highlights of the second quarter the video can be accessed through the following link youtube link https www youtube com watch v mnpbgdes3ok the short video and the third quarter 2024 presentation can also be accessed on our website www flexlng com for further information please contact mr knut traaholt chief financial officer of
9466,all_events,UP,,vilnius lithuania 2024 11 07 10 57 cet omx baltic benchmark fund share price on november 06 2024 12 9297 eur omx baltic benchmark fund number of shares issued on november 06 2024 0 units omx baltic benchmark fund number of shares redeemed on november 06 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of november 06 2024 125 362 units nter asset management
12581,all_events,UP,,media release
487,all_events,DOWN,DOWN,needham mass nov 07 2024 globe newswire candel therapeutics inc candel or the company nasdaq cadl a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer today announced that paul peter tak md phd fmedsci candel s president and chief executive officer will present at the jefferies london healthcare conference 2024 being held on november 19 21 2024
10648,all_events,UP,,in8bio doses first patient in phase 2 clinical trial of inb 400 in newly diagnosed glioblastoma
11573,all_events,DOWN,,19 nov 2024 13 47 cet ovh groupe see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1298867_2024_11_19__ovhcloud__mise__disposition_deu_fy24 pdf ovh les echos ovh fr0014005hj9 ovh euronext
2267,all_events,UP,DOWN,media release
11301,all_events,DOWN,,media release
5524,all_events,DOWN,,in view of the upcoming entry into force of the polish act of november 6th 2024 on top up tax levied on constituent entities of multinational and domestic groups the act the management board of kruk s a the company announces that the company will fall within the scope of the act after meeting the revenue condition set out therein i e after its consolidated revenue in any two of the four consecutive fiscal years immediately preceding the tested fiscal year reaches eur 750 million or more the company estimates that the kruk group s consolidated revenue may reach the eur 750 million threshold in 2025 and 2026 at the earliest in such a case provided that the effective tax rate in the relevant jurisdiction computed in accordance with the act is lower than the kruk group would be required to pay top up tax for the first time for the fiscal year 2027 if other statutory conditions are met the kruk group may benefit from the safe harbour rules provided for in the act whi
35,all_events,UP,UP,media release
1562,all_events,DOWN,UP,reykjavik iceland and london aug 15 2024 globe newswire alvotech nasdaq alvo a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and advanz pharma a uk headquartered global pharmaceutical company with a strategic focus on specialty hospital and rare disease medicines in europe today announced that the european medicines agency ema has accepted a marketing authorization application for avt06 alvotech s proposed biosimilar to eylea aflibercept the process to obtain marketing authorization could be completed in the third quarter of 2025
741,all_events,DOWN,DOWN,november 07 2024 01 00 et source merko ehitus as merko ehitus as commentary from management merko ehitus revenue for the 9 months of 2024 was eur 379 million and net profit was eur 44 8 million third quarter revenue was eur 175 million net profit eur 27 3 million sales of construction services made up about of the 9 month revenue according to the management of merko ehitus the construction of some projects was accelerated at the request of the clients which increased current construction volumes helped reduce costs and increase efficiency as a result merko ended the 9 months with a stronger result than planned group companies reached the home stretch for several large and complex projects including the largest construction project in merko s history arter quarter with close to of its 150 million euro volume now completed one of the arter buildings is finished interior works on the second building are being completed and
290,all_events,DOWN,DOWN,יופיטר פלורידה ונס ציונה ישראל feb 23 2024 globe newswire dyadic international inc דיאדיק או החברה נאסד ק dyai חברת ביוטכנולוגיה גלובלית המתמחה בפלטפורמות מיקרוביאליות מתקדמות לפיתוח חלבונים וייצור ביולוגי ומתן מענה לצרכים קליניים והמכון למחקר ביולוגי iibr הודיעו כי קידמו את שיתוף הפעולה עם המכון למחקר ביולוגי iibr והזרוע המסחרית שלו life science research israel lsri כדי להתמקד בפתרונות מתפתחים למחלות שותפות זו נועדה למנף את המומחיות של dyadic בפלטפורמות מיקרוביאליות לייצור ביולוגי של חלבונים בקנה מידה גמיש ואת יכולות גילוי הנוגדנים והאנטיגנים של המכון כדי לפתח ולייצר פתרונות חדשניים לטיפול במחלות מתפתחות ובאיומים ביולוגיים פוטנציאליים באמצעות שיתוף פעולה זה שני הצדדים פועלים לפיתוח טיפולים וחיסונים יעילים למאבק באתגרי הבריאות העולמיים מתוך כוונה למסחור עתידי נכון להיום המסגרת אינה מחייבת וכפופה לביצוע הסכם מחייב שיידון על ידי הצדדים באמצעות יוזמות שיתוף פעולה של רישוי חוץ
937,all_events,DOWN,DOWN,media release
12365,all_events,UP,,alvotech nasdaq alvo a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and advanz pharma a uk headquartered global pharmaceutical company with a strategic focus on specialty hospital and rare disease medicines in europe today announced that the european medicines agency ema has accepted a marketing authorization application for avt06 alvotech s proposed biosimilar to eylea aflibercept the process to obtain marketing authorization could be completed in the third quarter of 2025
12053,all_events,DOWN,,november 15 2024 06 20 et source pro kapital grupp pro kapital grupp prolongation of term in office of chairman of the management board of as pro kapital grupp as pro kapital grupp hereinafter pro kapital informs that on 15th of november 2024 the supervisory council of pro kapital has decided to prolong the term of office of the chairman of the management board of pro kapital edoardo axel preatoni from 1st of january 2025 until 31st of december 2029 a longer term than 3 years is allowed by the law and by the articles of association of pro kapital edoardo axel preatoni has been the management board member of pro kapital since 2016 as pro kapital grupp management board will continue with two members edoardo axel preatoni and neringa rasimavičienė edoardo axel preatonimember of the management boardphone 372 614 4920e mail prokapital prokapital ee
2688,all_events,UP,,19 nov 2024 13 12 cet koninklijke vopak n v avtl filed draft red herring prospectus with securities and exchange board of india19 november 2024 rotterdam the netherlands following the publication of the press release dated 29 october 2024 and the press release dated 9 july 2024 avtl has now filed the draft red herring prospectus with the securities and exchange board of india sebi the formal approval process with sebi is expected to take several months avtl is the largest indian third party owner and operator of tank storage terminals for liquified petroleum gas and liquid products in terms of storage capacity as of june 30 2024 source crisil report avtl owns and operates a network of tank storage terminals having an aggregate storage capacity of approximately 1 50 million cubic meters for liquid products and 70 800 metric tons of static capacity for lpg as of june 30 2024 about royal vopakroyal vopak helps the world flow forward at ports around the world
4972,all_events,DOWN,,13 nov 2024 08 30 cet romerike sparebank se vedlagte innkalling more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632032_innkalling til informasjonsmøte i representantskapet 27 11 2024 pdf romerike sparebank oslo børs newspoint lillestrøm spb 19 24 frn blaker spb 20 perp frn c hybrid lillestrøm spb 20 25 frn blaker spb 20 25 frn lillestrøm spb 20 26 frn lillestrom spb 21 31 frn c sub romerike spb 22 27 frn romerike spb 22 28 frn romerike spb 22 26 frn romerike spb 23 28 frn romerike spb 23 29 frn romerike spb 23 27 frn romerike spb 23 26 frn romerike spb 24 perp frn c hybrid romerike spb 24 35 frn c sub romerike spb 24 29 frn romerike sparebank no0010868862 no0010874126 no0010890809 no0010904949 no0010907199 no0011036774 no0012756552 no0012780040 no0012780032 no0012860917 no0012942608 no0012942590 no0013017665 no0013183616 no0013331314 no0013351163
2615,all_events,DOWN,,arctic minerals ab publ arctic minerals or the company is pleased to announce that it has established an advisory committee to the board of the company arctic minerals holds multiple advanced exploration projects within the nordic region including the hennes bay and swan lake projects in sweden the bidjovagge project in norway and the tavast and kuusi projects in finland the advisory committee is comprised of lars eric aaro duncan large and erik lundstam all prominent highly experienced and well regarded european based businessman and technical experts with extensive resources sector and broader industry networks in europe and the nordics in particular the advisory committee will substantially strengthen arctic minerals position in the nordics with the committee members collective corporate technical and operating expertise plus extensive business and government networks greatly assisting the company as it focuses on rapidly advancing its strong project portfolio
1039,all_events,DOWN,DOWN,12 nov 2024 08 10 cet tonner drones s a tonner drones management to become reference shareholder schiltigheim november 12th 2024 08 00 tonner drones the company is pleased to announce that its management aims to become a reference shareholder of the company after publishing the half year figures and several subsequent publications management wants to use this period in which insiders are allowed to trade to execute purchase transactions in their own company share capital ceo d m van den ouden will initially aim to obtain a interest i e 12m shares through buying shares in and off the market the company s ceo and president of the board has committed himself to the success of the company he has invested substantially to stabilize the company s debt and has waived his managements fee for 2025 becoming one of the reference shareholders is a next step to show his commitment i m satisfied about the developments and the progress we were able to make within t
7677,all_events,DOWN,,media release
7222,all_events,UP,,cambridge mass march 18 2024 globe newswire intellia therapeutics inc nasdaq ntla a leading clinical stage gene editing company focused on revolutionizing medicine with crispr based therapies today announced the first patient dosed in the global pivotal phase 3 magnitude trial of ntla 2001 ntla 2001 is an investigational in vivo crispr based therapy designed as a single dose treatment to inactivate the ttr gene and thereby prevent the production of ttr protein for the treatment of transthyretin attr amyloidosis the magnitude trial is evaluating the efficacy and safety of ntla 2001 in patients with attr amyloidosis with cardiomyopathy
6153,all_events,DOWN,,media release
3776,all_events,UP,,media release
2128,all_events,UP,UP,07 nov 2024 18 00 cet jcdecaux se information trimestrielle du 3ème trimestre 2024 paris le 7 novembre 2024 jcdecaux se euronext paris dec numéro un mondial de la communication extérieure a publié ce jour la présente information trimestrielle pour le 3ème trimestre 2024 faits marquants du 3ème trimestre 2024 evolution du portefeuille de contrats asie pacifique en juillet jcdecaux se a annoncé que jcdecaux macao joint venture entre jcdecaux 80 du capital et hn group 20 du capital a renouvelé son contrat publicitaire exclusif avec l aéroport international de macao pour une durée de 10 ans à l issue d un appel d offres effectif depuis le 1er juillet 2024 ce nouveau contrat renforce la présence de jcdecaux à macao europe en septembre jcdecaux se a annoncé avoir remporté le contrat publicitaire emblématique des abribus de londres à la suite d un appel d offres organisé par transport for london tfl
9757,all_events,UP,,11 nov 2024 08 10 cet dnb asset management as dnb obx has been redeemed with 1 700 000 shares at price nok 124 334770 as of 11 11 2024 total outstanding shares will after the issue be 11 850 000 kind regards for dnb asset management as helene eklund analyst dnb asset management as more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site dnb asset management as oslo børs newspoint dnb obx no0010257801 obxd oslo børs
8203,all_events,DOWN,,18 nov 2024 12 00 cet toulouse 31 cse reg cr agr mut caisse régionale de crédit agricole mutuel toulouse 31 siège social 6 7 place jeanne d arc 31000 toulouse siren 776 916 207 rcs toulouse société coopérative à capital variable créée le 18 janvier 1901 régie par le livre v du code monétaire et financier établissement de crédit agréé en qualité de banque mutualiste ou coopérative société de courtage d assurances garantie financière et assurance de responsabilité civile professionnelle conformes aux articles l 512 6 et l 512 7 du code des assurances programme de rachat des certificats coopératifs d investissement autorisé par l assemblée générale du 28 mars 2024 déclaration des transactions sur certificats coopératifs d investissement propres réalisées du 11 11 2024 au 15 11 2024 présentation agrégée par jour et par marché nom de l émetteurcode identifiant de l émetteurjour de la transactioncode identifiant de l instrument financiervolume total journalier e
12662,all_events,DOWN,,november 19 2024 11 30 et source orion oyj orion oyj orion oyj sijoittajauutinen 19 11 2024 klo 18 30 orion ja alligator bioscience muuttavat kahta bispesifistä vasta ainetta koskevaa sopimustaan orion oyj ja alligator bioscience ab ovat sopineet lisenssisopimuksen muutoksesta jolla aiemmin rojaltivelvoitteen sisältänyt lisenssi muutetaan ikuiseksi täysin maksetuksi ja rojaltittomaksi lisenssiksi orionille lisenssisopimus koskee kahta bispesifistä vasta ainetta joita yhtiöt ovat menestyksekkäästi yhdessä kehittäneet hyödyntäen alligatorin vasta aineiden kehitykseen tarkoitettua ruby alustaa orion jatkaa näiden myöhäisessä pre kliinisessä kehitysvaiheessa olevien vasta aineiden kehitystä ilman velvoitetta maksaa alligatorille mitään etappimaksuja tai rojalteja sopimuksen muutoksen yhteydessä orion maksaa alligatorille 3 5 miljoonan euron kertamaksun yhteyshenkilö tuukka
10521,all_events,DOWN,,clinical laserthermia systems ab cls or the company has received additional guarantee commitments from external investors of approximately sek 5 8 million meaning that the total amount of guarantee commitments the so called top down guarantee amounts to a total of sek 11 2 million corresponding to approximately of the proceeds of approximately sek 22 4 million that the company can contribute through full exercise of the warrants of series to 7 b issue proceeds subscription undertakings and guarantee commitments the company announces that it has increased the amount of top down guarantee commitments from previously approximately sek 5 4 million to a total of approximately sek 11 2 million corresponding to a total of approximately 50 percent of the issue proceeds subscription commitments from existing owners already amount to approximately sek 3 3 million corresponding to approximately 14 6 percent of the issue proceeds neither the subscription undertakings no
2980,all_events,DOWN,,media release
6858,all_events,DOWN,,media release
2589,all_events,DOWN,DOWN,correction total demand and issued amount are corrected íslandsbanki hf has concluded an offering of senior preferred bond series isb 36 1114 gb for a total of isk 4 000m total demand amounted to isk 5 600m at a yield ranging from 3 to 4 offers in the amount of isk 4 000m were accepted at a yield of 3 the bonds are expected to be admitted to trading on nasdaq iceland on 14 november 2024 the transaction was managed by íslandsbanki s fixed income sales for further information please contact investor relations bjarney anna bjarnadóttir ir islandsbanki ispublic relations edda hermannsdóttir pr islandsbanki is mar legendthis announcement is released by íslandsbanki hf and contains information that qualified or may have qualified as inside information for the purposes of article 7 of the market abuse regulation eu 596 2014 mar for the purposes of mar and article 2 of commission implementing regulation eu 2016 1055 this announcement is made by ellert hlöðver
8629,all_events,UP,,symetri a company in division design management announces today that it has acquired ctc software the usa based company addresses the growing demand for efficient and automated bim workflows by creating add ins and tools on top of the autodesk platform ctc software has net sales of sek 40 million and an ebita margin representative for a proprietary software business symetri creates and provides technology solutions and services for design engineering construction and manufacturing businesses the acquisition of ctc software strengthens symetri s own technology portfolio which will further improve its customers ability to deliver high quality projects faster and with greater accuracy founded in 1997 and based in minnesota usa ctc software is known for its suite of add ins and tools for autodesk revit and autodesk civil 3d users its tools have more than 40 000 users such as architects engineers and construction aec professionals its flagship products including bim pro
11827,all_events,DOWN,,michael j finney ph d to continue as chairman of the board of directors
5767,all_events,UP,,media release
1722,all_events,UP,DOWN,media release
3079,all_events,UP,,media release
3425,all_events,UP,,as latvijas gāze ir saņēmusi latvijas bankas paziņojumu
3393,all_events,UP,,boston dec 22 2023 globe newswire elicio therapeutics inc nasdaq eltx elicio therapeutics or elicio a clinical stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer announced today that it has entered into a subscription agreement to sell 1 213 000 shares of its common stock at a purchase price of 5 81 per share in a private placement to gkcc llc gkcc llc is an entity controlled by a member of elicio s board of directors gross proceeds of the private placement are expected to be approximately 7 0 million before deducting expenses the private placement is expected to close on december 22 2023 subject to the satisfaction of customary closing conditions
11934,all_events,UP,,west lafayette ind nov 01 2023 globe newswire inotiv inc nasdaq notv a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services today announced that robert leasure jr president and chief executive officer and beth taylor chief financial officer will participate in multiple upcoming investor conferences throughout november 2023
6286,all_events,DOWN,,more than 100 patients enrolled in ongoing shield ii phase 3 trial of d plex100 for the prevention of abdominal colorectal surgical site infections
6213,all_events,UP,,14 nov 2024 07 00 cet thales see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1297651_pr_2024_thales_capital_markets_day_14_november_2024 pdf thales les echos thales fr0000121329 fr0000121329 ho 4ho euronext
12382,all_events,UP,,an important milestone has recently been achieved in the centennial flats solar and battery storage project located in arizona us which was sold by eolus in 2022 as a result of the owner s decision to start construction of the project eolus has received a payment of usd 64 7 million the milestone payment is estimated to have a positive effect on eolus s operating profit of usd 51 million in the fourth quarter based on current information eolus total revenues from the project is expected to be usd 116 9 million of which eolus now has collected usd 110 0 million the remaining usd 6 9 million will be paid at commercial operation start which is planned for 2026 the project will have an aggregate capacity of 500 mwac solar photovoltaic generation and 267 mw battery storage capacity i am excited to see the owner making investment decision for the centennial flats project this is a proof of the great appetite for investments in renewable energy and battery energy storage projec
4288,all_events,DOWN,,new grant from the bill melinda gates foundation supports the phase 1 development of vir 1388 an investigational hiv t cell vaccine based on a novel vector
12348,all_events,DOWN,,media release
2308,all_events,DOWN,DOWN,15 nov 2024 07 00 cet sanofi la fda a accepté l examen de la sbla pour le dupixent dans le traitement de l urticaire chronique spontanée la nouvelle demande comprend de nouvelles données pivots qui confirment que dupixent réduit considérablement les démangeaisons et l activité de l urticaireplus de 300 000 personnes aux états unis sont atteintes d urticaire chronique spontanée ucs insuffisamment contrôlée par des antihistaminiquesla décision de la fda attendue d ici le 18 avril 2025 s il est approuvé dupixent serait la première thérapie ciblée pour l ucs en une décennie paris et tarrytown ny le 15 novembre 2024 l agence fédérale américaine des produits alimentaires et médicamenteux us food and drug administration fda a accepté d examiner la nouvelle demande de licence supplémentaire de produits biologiques supplemental biologicals license application sbla pour dupixent dupilumab dans le traitement de patients adultes et pédiatriques âgés de 12 ans et plus a
12619,all_events,DOWN,,not for dissemination in the united states or for distribution to u s newswire services and does not constitute an offer of the securities described herein
9544,all_events,UP,,media release
10630,all_events,DOWN,,south san francisco calif nov 02 2023 globe newswire harpoon therapeutics inc nasdaq harp a clinical stage immunotherapy company developing novel t cell engagers today announced abstract acceptance and upcoming oral presentation of the results from the completed dose escalation portion of the phase 1 study of hpn217 in patients with relapsed refractory multiple myeloma the oral presentation will take place at the upcoming 65th american society of hematology ash annual meeting and exposition being held december 9 12 2023 in san diego
930,all_events,DOWN,DOWN,missing
6662,all_events,UP,,media release
7780,all_events,UP,,top line data from vega 3 phase 3 trial expected in first half of 2025
4081,all_events,UP,,planegg martinsried august 28 2024 medigene ag medigene or the company fse mdg1 prime standard an oncology platform company focused on the research and development of t cell receptor tcr guided therapies for the treatment of cancer will be presenting at the the annual german fall conference to be held in frankfurt from september 2 3 2024 as well as at the h c wainwright 26th annual global investment conference from september 9 11 2024 in new york and at the baader investment conference from september 23 26 2024 in munich
8638,all_events,UP,,rekstrarafgangur eykst milli ára tillaga að fjárhagsáætlun 2025 var lögð fyrir bæjarstjórn hafnarfjarðar til fyrri umræðu í dag miðvikudaginn 6 nóvember áætlaður rekstrarafgangur a og b hluta sveitarfélagsins nemur 1 246 milljón króna á árinu 2025 gert er ráð fyrir að veltufé frá rekstri verði 5 af heildartekjum eða 3 111 milljónir króna áætlun gerir ráð fyrir að rekstur a hluta fyrir afskriftir og fjármagnsliði verði jákvæður um 3 564 milljónir króna og afkoma a hluta verði jákvæð um 314 milljónir króna áætlað er að heildartekjur fyrir a og b hluta verði um 52 7 milljarðar króna árið 2025 og að áætluð rekstrargjöld fyrir fjármagnsliði verði um 47 1 milljarður króna fjárhagsleg staða hafnarfjarðarbæjar er traust og skuldaviðmið skv reglugerð 520 2012 áætlað í lok næsta árs útsvarsprósenta á árinu 2025 verður áfram 14 og álagningarprósenta fasteignaskatts og tengdra gjalda óbreytt á milli ára helstu tölur úr fjárhagsáætlun 2025 rekstur bæjarsjóðs hafnar
10708,all_events,DOWN,,media release
2865,all_events,UP,,08 nov 2024 17 52 cet saint gobain compagnie de see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1296561_capital_ddv_31oct2024_fr pdf saint gobain les echos saint gobain saint gobain fr0000125007 fr0000125007 sgo 4sgo euronext
5872,all_events,UP,,redwood city calif april 24 2024 globe newswire coherus biosciences inc coherus nasdaq chrs today announced the first presentation of clinical data for chs 114 a highly selective cytolytic anti ccr8 antibody at the upcoming asco annual meeting which will be held from may 31 to june 4 2024 at mccormick place in chicago
9060,all_events,DOWN,,la jolla calif nov 19 2023 globe newswire medicinova inc a biopharmaceutical company traded on the nasdaq global market nasdaq mnov and the standard market of the tokyo stock exchange code number 4875 today announced that medicinova s collaborator justin lathia phd co director of the brain tumor research and therapeutic development center of excellence at cleveland clinic lerner research institute and professor department of molecular medicine at cleveland clinic lerner college of medicine of case western reserve university and patrick wen director at the center for neuro oncology at dana farber cancer institute professor of neurology harvard medical school presented new data and results of a phase 2 clinical trial of mn 166 ibudilast in glioblastoma gbm patients at the 28th annual meeting of the society for neuro oncology sno held november 15 19 2023 in vancouver canada the presentation also included data from preclinical studies which evaluated the combination of mn 166 ibudilast and anti pd1 or anti pd l1 therapy in gbm models
2982,all_events,UP,,chs 114 shown to have an acceptable safety profile with no dose limiting toxicities dlts in heavily pretreated patients with solid tumors
2127,all_events,DOWN,DOWN,12 nov 2024 19 35 cet totalenergies se regulatory news on 12 november 2024 totalenergies se the company paris tte lse tte nyse tte announced an invitation to the qualifying holders of its outstanding 2 500 000 000 undated non call 10 year deeply subordinated fixed rate resettable notes with a first call date on 26 february 2025 issued on 26 february 2015 isin xs1195202822 all of which are currently outstanding and admitted to trading on euronext paris the notes to tender their notes for purchase by the company for cash up to the maximum acceptance amount as defined herein subject to the conditions described in the tender offer memorandum dated 12 november 2024 the tender offer memorandum prepared by the company such invitation the tender offer the company now announces the maximum acceptance amount for the tender offer the tender offer is being made on the terms and subject to the satisfaction or waiver of the financing condit
9926,all_events,UP,,13 nov 2024 17 00 cet sodexo regulated information issy les moulineaux november 13 2024 disclosure of transactions in own shares carried out from november 4 to november 8 2024 sodexo purchased treasury shares outside of its liquidity contract within the framework of its share buyback program as authorized by the shareholders meeting held on december 15 2023 these shares have been acquired to honor obligations related to free shares award plans information on these transactions are the following trading dateleiisinvolume in number of shares weighted average purchase price in euros market04 11 2024969500agkr3prjg4wd05fr000012122014 88580 3259xpar04 11 2024969500agkr3prjg4wd05fr000012122018 51480 2322ceux04 11 2024969500agkr3prjg4wd05fr00001212202 72880 2311tqex04 11 2024969500agkr3prjg4wd05fr00001212201 65680 3276aqeu05 11 2024969500agkr3prjg4wd05fr00001212209 38081 1744xpar05 11 2024969500agkr3prjg4wd05fr000012122010 06081 2303ceux05 11 2024969500agkr3prjg4wd05fr
7396,all_events,UP,,aktia bank plcstock exchange release6 november 2024 at 7 50 a m aktia s financial calendar and annual general meeting in 2025 financial statement release 2024 aktia bank plc publishes its financial statement release for 2024 on wednesday 12 february 2025 annual report 2024 aktia bank plc s annual report 2024 will be published on thursday 13 march 2025 annual general meeting of shareholders 2025 aktia bank plc s annual general meeting of shareholders is planned to be held on thursday 3 april 2025 interim reports 2025 interim report january march 2025 wednesday 7 may 2025half year report january june 2025 tuesday 5 august 2025interim report january september 2025 thursday 6 november 2025 aktia bank plc for more information oscar taimitarha director investor relations tel 358 40 562 2315 distribution nasdaq helsinki ltdmass mediawww aktia com aktia is a finnish asset manager bank and life insurer that has been creating wealth and wellbeing from one generation to the next for
10843,all_events,UP,,18 nov 2024 15 41 cet nordic unmanned asa 18 11 2024 15 41 26 cet nordic unmanned non regulatory press releases nordic unmanned publishes q3 2024 on the 19th november 2024 at 07 00 am the q3 2024 will also be presented in a webcast on the same day at 09 00 am to join the webcast please register on https attendee gotowebinar com register 1746704406470118486 contacts stig h christiansen ceo nordic unmanned asa 47 478 07 813 shc nordicunmanned com tarjei lode cfo nordic unmanned asa 47 46937008 tl nordicunmanned com about nordic unmanned nordic unmanned is a leading european manufacturer oem and certified operator of unmanned aircraft systems uas we are serving large corporations government agencies and security customers by offering systems solutions and flight services for environmentally friendly delivery of productivity improvements and time critical actionable data insights and logistics services our solutions and s
1634,all_events,UP,UP,eften united property fund hereinafter the fund earned 134 thousand euros in net profit in the third quarter of 2024 2023 third quarter 16 thousand euros in net loss the fund s revenues increased from 38 thousand euros to 176 thousand euros during the year during the 9 months of 2024 the fund earned 535 thousand euros in net profit 2023 9 months 87 thousand euros net loss
9527,all_events,UP,,media release
12512,all_events,UP,,bagsværd denmark 18 november 2024 on 11 november 2024 novo nordisk initiated a share repurchase programme in accordance with article 5 of regulation no 596 2014 of the european parliament and council of 16 april 2014 mar and the commission delegated regulation eu 2016 1052 of 8 march 2016 the safe harbour rules this programme is part of the overall share repurchase programme of up to dkk 20 billion to be executed during a 12 month period beginning 6 february 2024 under the programme initiated 11 november 2024 novo nordisk will repurchase b shares for an amount up to dkk 3 136 206 122 30 in the period from 11 november 2024 to 3 february 2025 since the announcement of the programme the following transactions have been made the details for each transaction made under the share repurchase programme are published on novonordisk com transactions related to novo nordisk s incentive programmes have resulted in a net transfer from novo nordisk of 828 b shares in the period f
647,all_events,UP,DOWN,redwood city calif may 23 2024 globe newswire coherus biosciences inc coherus nasdaq chrs today announced that senior management will present at the upcoming td cowen 5th annual oncology innovation virtual summit insights for asco eha on wednesday may 29 2024 at 12 00 p m eastern daylight time 9 00 a m pacific daylight time the presentation will be accessible via webcast through a link on the investor events and presentations section of the coherus website https investors coherus com events presentations this webcast will be available for replay until june 26 2024
12793,all_events,UP,,november 15 2024 15 00 et source innofactor oyj innofactor oyj innofactor oyj pörssitiedote 15 11 2024 klo 22 00 innofactor oyj on 15 11 2024 vastaanottanut onni bidco oy ltä arvopaperimarkkinalain 9 luvun 5 n mukaisen ilmoituksen jonka mukaan onni bidco oy n suora omistus innofactorin osakkeista nousi yli 90 n rajan onni bidco oy n osuus ilmoituksen mukaan tiedot omistus ja ääniosuudesta liputusrajan saavuttamisen tai rikkoutumisen jälkeen a osakkeet ja äänet b aml n 9 luvun 6 a ssä tarkoitetut rahoitusvälineet koko määräysvaltaketju ylintä määräysvaltaa käyttävästä luonnollisesta henkilöstä tai oikeushenkilöstä alkaen jonka kautta osakkeita äänioikeuksia tai rahoitusvälineitä hallitaan lisäksi onni bidco oy n ilmoituksen mukaan onni bidco oy on 15 11 2024 tehdyillä kaupoilla hankkinut yhteensä 3 648 829 innofactor oyj n osaketta onni bidco oy ja osakekaupat tehnyt välittäjä ovat so
8349,all_events,UP,,media release
7271,all_events,DOWN,,20 nov 2024 07 00 cet stmicroelectronics n v pr no c3296c stmicroelectronics présente son modèle financier pour 2027 2028 et sa trajectoire vers son ambition 2030 définition d un modèle financier intermédiaire chiffre d affaires d environ 18 milliards de dollars et marge d exploitation de 22 24 en 2027 2028réitération de l ambition d un chiffre d affaires à 20 milliards de dollars et du modèle financier associé dont l atteinte est désormais prévue d ici 2030 genève le 20 novembre 2024 stmicroelectronics nyse stm un leader mondial des semiconducteurs dont les clients couvrent toute la gamme des applications électroniques tient ce jour son capital markets day à paris dans le cadre d une stratégie inchangée st réitère son ambition d un chiffre d affaires de 20 milliards de dollars et au delà ainsi que du modèle financier associé dont l atteinte est désormais prévue d ici 2030 st définit également un modèle financier intermédiaire avec un chiffre d affaires
5379,all_events,UP,,boca raton florida april 25 2024 globe newswire inmune bio inc nasdaq inmb the company a clinical stage immunology company focused on developing treatments that harness the patient s innate immune system to fight disease today announced today that it has entered into definitive agreements for the sale and purchase of 986 000 shares of its common stock and warrants to purchase up to an aggregate of 986 000 shares of its common stock at an offering price of 9 84 per share of common stock and accompanying warrant the warrants include an acceleration clause upon positive top line data in the company s phase 2 alzheimer s disease program as further described below the offering was priced at the market under nasdaq rules based on the average of the previous 5 days closing prices or 9 84 per share which includes 0 125 per warrant the warrants terminate on the earlier of 1 the two 2 year anniversary of the initial exercise date of the warrant or 2 thirty 30 trading days following the reporting of positive top line data emacc in the phase 2 alzheimer s program of xpro1595 the termination date the gross proceeds of this offering are approximately 9 7 million before deducting placement agent fees and expenses the closing of the offering is expected to occur on or about april 29 2024 subject to the satisfaction of customary closing conditions
2788,all_events,DOWN,,örnsköldsvik sweden 14 november 2024 clavister a leader in european cyber security for mission critical applications today announced a new distribution partnership with seabix ag a dätwyler it infra ag company to provide integrated ict and cybersecurity solutions seabix will serve as clavister s distributor in switzerland offering comprehensive firewall solutions to support the digital sovereignty of european companies and institutions the partnership will initially focus on seamlessly integrating clavister s firewall solutions into seabix s io platform for managed security services with a strong end customer focus on the public sector and telecom industries this collaboration will commence in switzerland with plans for further expansion into other european markets this synergy will enable swiss partners and businesses to easily access top tier cybersecurity solutions originating from europe which is crucial in the current politically charged environment where protecti
1408,all_events,DOWN,DOWN,november 13 2024 15 30 et source nokia oyj nokia oyj nokia oyjpörssitiedote13 11 2024 klo 22 30 nokia oyj omien osakkeiden takaisinosto 13 11 2024 espoo nokia oyj lei 549300a0jprwg1ki7u06 on 13 11 2024 hankkinut omia osakkeitaan isin fi0009000681 omistukseensa seuraavasti kahden desimaalin tarkkuuteen pyöristettynä nokia ilmoitti 25 tammikuuta 2024 että yhtiön hallitus on käynnistämässä osakkeidensa takaisinosto ohjelman palauttaakseen yhtiön osakkeenomistajille enintään 600 miljoonaa euroa vaiheittain kahden vuoden kuluessa takaisinosto ohjelman ensimmäinen vaihe aloitettiin 20 maaliskuuta 2024 19 heinäkuuta 2024 nokia päätti nopeuttaa takaisinostoja korottamalla vuoden 2024 aikana ostettavien osakkeiden lukumäärää korotetut takaisinostot noudattaen euroopan parlamentin ja neuvoston antamaa markkinoiden väärinkäyttöasetusta eu 596 2014 mar euroopan komission delegoitua asetusta eu 2016 1052 ja nokian varsinaisen yhtiök
2742,all_events,DOWN,,south san francisco calif and san diego july 05 2024 globe newswire oric pharmaceuticals inc nasdaq oric a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance today announced that on july 1 2024 the grant date oric granted a total of 34 000 non qualified stock options and 5 600 restricted stock units to three new non executive employees who began their employment with oric in june 2024
7037,all_events,DOWN,,redwood city calif may 30 2024 globe newswire jasper therapeutics inc nasdaq jspr jasper a clinical stage biotechnology company focused on development of briquilimab a novel antibody therapy targeting c kit cd117 to address mast cell driven diseases such as chronic spontaneous urticaria csu chronic inducible urticaria cindu and asthma today announced presentations of data from its preclinical and healthy volunteer studies of briquilimab as well as trial in progress presentations from its beacon and spotlight clinical studies at the european academy of allergy and clinical immunology eaaci congress 2024 taking place may 31 june 3 in valencia spain
5743,all_events,UP,,mainz biomed awarded poster of distinction at digestive disease week positioning the company for its planned fda trial
1213,all_events,DOWN,DOWN,dallas sept 26 2024 globe newswire taysha gene therapies inc nasdaq tsha taysha or the company a clinical stage biotechnology company focused on advancing adeno associated virus aav based gene therapies for severe monogenic diseases of the central nervous system cns today announced that it will present previously disclosed clinical data on its tsha 102 program in evaluation for rett syndrome during an oral presentation at the upcoming 9th world rett syndrome congress taking place in queensland australia from october 2 5 2024
9558,all_events,DOWN,,san carlos calif april 02 2024 globe newswire vaxcyte inc nasdaq pcvx a clinical stage vaccine innovation company engineering high fidelity vaccines to protect humankind from the consequences of bacterial diseases announced today that company management will participate in a fireside chat at the 23rd annual needham virtual healthcare conference on tuesday april 9 at 12 45 p m et 9 45 a m pt
6535,all_events,DOWN,,media release
353,all_events,DOWN,UP,company to demonstrate mydcombi and avenova and share data for clobetasol propionate ophthalmic suspension 0 at the american society of cataract and refractive surgery ascrs annual meeting april 5 8 in boston
7118,all_events,UP,,mainz deutschland 13 november 2024 globe newswire biontech se nasdaq bntx biontech und biotheus biotheus gaben heute den abschluss einer vereinbarung bekannt im rahmen derer biontech biotheus übernehmen wird biotheus ist ein biotechnologie unternehmen in der klinischen phase das sich der entdeckung und entwicklung innovativer antikörper widmet um den ungedeckten medizinischen bedarf von patientinnen und patienten mit krebs oder entzündlichen erkrankungen zu adressieren
1732,all_events,UP,UP,media release
8293,all_events,DOWN,,12 nov 2024 07 30 cet veritas bureau communiqué de presse paris 12 novembre 2024 bureau veritas continue de renforcer ses capacités dans le secteur de l énergie et des énergies renouvelables grâce à l acquisition de versatec energy b v bureau veritas leader mondial de l industrie des essais de l inspection et de la certification tic annonce aujourd hui l acquisition de versatec energy b v une société de conseil technique indépendante spécialisée dans l industrie de l énergie offshore et onshore cette acquisition s inscrit dans la stratégie leap 28 de créer une nouvelle place forte dans le segment des énergies renouvelables en forte croissance cette transaction souligne l engagement du groupe en matière de transition énergétique et consolide sa position d acteur clé pour bâtir un secteur de l énergie durable et sûr bureau veritas contribue à l efficacité du secteur de l énergie en fournissant à ses clients énergétiques des solutions de bout en bout réponda
2290,all_events,DOWN,UP,november 08 2024 08 45 et source nokia oyj nokia oyj nokia oyjjohtohenkilöiden liiketoimet8 11 2024 klo 15 45nokia oyj johtohenkilöiden liiketoimet fisk markkinoiden väärinkäyttöasetuksen 19 artiklan mukainen ilmoitus liiketoimesta ____________________________________________ilmoitusvelvollinennimi fisk louiseasema muu ylin johto liikkeeseenlaskija nokia corporationlei 549300a0jprwg1ki7u06ilmoituksen luonne ensimmäinen ilmoitusviitenumero 84277 4 4____________________________________________ liiketoimen päivämäärä 2024 11 07 kauppapaikka nasdaq helsinki ltd xhel instrumenttityyppi osake isin fi0009000681 liiketoimen luonne hankinta liiketoimien yksityiskohtaiset tiedot 1 volyymi 117 yksikköhinta 4 27670 liiketoimien yhdistetyt tiedot 1 volyymi 117 keskihinta 4 27670 nokianokia luo teknologiaa joka auttaa maailmaa toimimaan yhdessä b2b teknologia ja innovaatiojohtajana olemme tulevaisuuden aistivien ajat
12913,all_events,DOWN,,media release
7017,all_events,DOWN,,arcutis today reported financial results for the quarter ended september 30 2024 and provided a business update
2662,all_events,DOWN,,media release
6634,all_events,UP,,media release
11224,all_events,DOWN,,jupiter fla march 26 2024 globe newswire dyadic international inc dyadic or the company nasdaq dyai a global biotechnology company focused on building innovative microbial protein production platforms today announced the online publication of the manuscript filamentous fungus produced human monoclonal antibody provides protection against sars cov 2 in hamster and nonhuman primate models in nature communications springer nature an international journal publishing peer reviewed research in all fields of science and technology
8819,all_events,DOWN,,oslo norway 13 october 2023 pci biotech ose pcib today announced a research collaboration agreement with the aim to address critical pain points in the manufacturing of gene therapies
8740,all_events,UP,,06 nov 2024 22 21 cet borr drilling limited hamilton bermuda november 6 2024 borr drilling limited the company ose and nyse borr has today filed with u s securities and exchange commission its unaudited interim financial report for the three months and nine months ended september 30 2024 on form 6 k the report is attached to this release and can also be found on the company s website www borrdrilling com and the u s securities and exchange commission website www sec gov this information is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act questions should be directed to magnus vaaler cfo 44 1224 289208 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631457_borr_drilling_limited_q3_24_6k pdf borr drilling limited oslo børs newspoint borr drilling bmg1466r1732 borr oslo børs
7416,all_events,UP,,litgrid ab company code 302564383 registered office address karlo gustavo emilio manerheimo str 8 vilnius lithuania is publishing results of the company for the nine months of 2024 key financial indicators for 9 months of 2024 the adjustment of profitability ratios is made due to temporary regulatory deviations from the regulated profitability approved by the national energy regulatory council nerc the calculation of the adjusted ratios shall take into account the adjustment of the revenue for prior periods which has already been approved by the nerc decision for the purpose of setting the regulated prices for transmission services for the reference period and shall take into account the deviation between the profitability approved by the nerc for the reference period and the actual profitability which will be taken into account by the nerc for the purpose of setting the prices for transmission services for future periods attachments 1 financial results of the company
1358,all_events,DOWN,UP,06 nov 2024 18 00 cet deezer s a see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1295585_deezer_nosh_oct_2024_fr pdf deezer les echos deezer fr001400ayg6 deezr euronext
9606,all_events,UP,,malvern pa oct 02 2024 globe newswire ocugen inc ocugen or the company nasdaq ocgn a biotechnology company focused on discovering developing and commercializing novel gene and cell therapies and vaccines today announced that dr shankar musunuri chairman chief executive officer and co founder of ocugen will present at the 2024 cell gene meeting on the mesa being held october 7 9 2024 at the arizona biltmore in phoenix az
2777,all_events,UP,,conference call begins today at 10 00 a m eastern time
3646,all_events,DOWN,,19 nov 2024 18 00 cet theranexus sa présentation des résultats prometteurs de l essai de phase i ii de batten 1 par la fondation bbdf et theranexus lors du child neurology society annual meeting à san diego des signaux positifs sur l acuité visuelle chez des patients plus jeunes atteints de cln3 dans le cadre d un usage compassionnel lyon france austin texas états unis 19 novembre 2024 18h00 cet theranexus entreprise biopharmaceutique innovante dans le traitement des maladies rares et la fondation beyond batten bbdf ont présenté les résultats finaux et positifs de l essai de phase i ii évaluant batten 1 chez six jeunes adultes atteints de la maladie de batten cln3 après 18 mois de traitement lors du congrès annuel de la société de neurologie pédiatrique qui s est tenu du 11 au 14 novembre à san diego aux états unis cette présentation a souligné le profil de sécurité solide du miglustat chez les patients atteints de cln3 et a mis en exergue les données d
8594,all_events,UP,,media release
5965,all_events,DOWN,,media release
11413,all_events,DOWN,,media release
173,all_events,UP,DOWN,media release
3274,all_events,DOWN,,november 20 2024 05 11 et source sildarvinnslan ltd sildarvinnslan ltd síldarvinnslan birtir uppgjör þriðja ársfjórðungs 2024 eftir lokun markaða á fimmtudaginn kemur 21 nóvember fjárfestakynning verður þann sama dag kl 1615 og verður hún eingöngu send út á vefstreymi vefstreymið má nálgast á https svn is fjarfestar streymi þar verður útbúinn sérstakur hlekkur áður en kynning hefst fjárfestum er velkomið að senda spurningar fyrir og á meðan á fundi stendur á netfangið fjarfestir svn is uppgjörsgögn verður hægt að nálgast á fjárfestasíðu síldarvinnslunnar www svn is fjarfestar upptaka verður einnig aðgengileg á fjárfestasíðunni að fundi loknum nánari upplýsingar veitir gunnþór ingvason í síma 470 7000 eða á fjarfestir svn is
10119,all_events,UP,,media release
379,all_events,UP,UP,sanoma corporation stock exchange release 18 november 2024 at 18 30 eet sanoma corporation acquisition of own shares 18 november 2024 nasdaq helsinki ltd the company holds a total of 169 664 of its own shares sanoma including the shares acquired on 18 november 2024 detailed information concerning the acquisition is attached to this stock exchange release on behalf of sanoma corporation skandinaviska enskilda banken ab publ helsinki branch antti salakka janne tiihonen additional information kaisa uurasmaa head of investor relations and sustainability tel 358 40 560 5601 sanoma sanoma is an innovative and agile learning and media company impacting the lives of millions every day our sustainability strategy is designed to maximise our positive brainprint on society and to minimise our environmental footprint we are committed to the un sustainable development goals and signatory to the un global compact our learning products and services enable teachers to
5464,all_events,UP,,company announcement copenhagen 11 november 2024 no 57 2024 transactions in connection with share buyback programmeiss a s a leading workplace experience and facility management company announced on 22 february 2024 a new share buyback programme see company announcement no 4 2024 the share buyback programme is executed in accordance regulation eu no 596 2014 of the european parliament and of the council of 16 april 2014 the market abuse regulation and the commission delegated regulation eu 2016 1052 of 8 march 2016 also referred to as the safe harbour regulation through the programme iss wishes to redistribute excess cash to shareholders the purpose of the share buy back programme is to i reduce the share capital and ii meet obligations arising from iss share based incentive programmes under the programme iss will repurchase shares for a maximum consideration of dkk 1 5 billion from 22 february 2024 to 19 february 2025 at the latest both days inclusive the s
5396,all_events,DOWN,,zug switzerland nov 13 2024 globe newswire oculis holding ag nasdaq ocs oculis a global biopharmaceutical company purposefully driven to save sight and improve eye care today announced that oculis management will be present at the stifel 2024 healthcare conference being held on november 18 19 2024 at the lotte new york palace hotel in new york ny sylvia cheung chief financial officer of oculis will participate in a fireside chat on november 18 2024 at 3 35 pm et a live webcast of the fireside chat will be available here the company will be available for one on one meetings during the conference interested investors should contact their stifel representative to request meetings a link to access the fireside chat when available will be posted to oculis website on the events presentation page under the investors media section ends about oculis oculis is a global biopharmaceutical company nasdaq ocs xice ocs purposefully driven to save sight an
7558,all_events,DOWN,,media release
2876,all_events,DOWN,,06 nov 2024 19 45 cet scor se communiqué de presse06 novembre 2024 n 16 projet d offre publique sur mrm ajustement de prix pour lire cette information dans son intégralité veuillez confirmer que vous avez lu et compris la clause de non responsabilité sur le site web de scor ici scor un réassureur mondial de premier plan réassureur mondial de premier plan scor offre à ses clients une gamme innovante et diversifiée de solutions et de services de réassurance et d assurance pour le contrôle et la gestion des risques fidèle à sa devise l art et la science du risque le groupe met son expertise reconnue au sein du secteur et ses solutions financières de pointe au service du bien être et de la résilience des populations le groupe a enregistré 19 4 milliards d euros de primes en 2023 représenté à travers 35 bureaux dans le monde il est au service de ses clients dans près de 160 pays pour plus d informations rendez vous sur www scor com relatio
2932,all_events,DOWN,,media release
3857,all_events,DOWN,,november 20 2024 01 00 et source kaldvik as kaldvik as kaldvik as kldvk reports operating income in q3 amounted to eurm 24 5 eurm 2 1 while the operating profit before fair value adjustment of biomass and production tax was eurm 2 1 eurm 0 3 harvest amounted to 3 798 tonnes in q3 2024 193 tonnes web cast will be at 11 00 cet 10 00 icelandic time on 20 november 2024 on the following link on teams https t ly 4yb_c attached is the presentation and report for q3 2024 kaldvik 20 november 2024 contacts robert robertsson cfo of kaldvik as 354 843 0086 mobile this information is subject to the disclosure requirements pursuant to section 5 12 the norwegian securities trading act attachments
3784,all_events,UP,,dallas july 01 2024 globe newswire spectral ai inc nasdaq mdai spectral ai or the company an artificial intelligence ai company focused on medical diagnostics for faster and more accurate treatment decisions in wound care today announced its inclusion in the russell microcap index following the annual russell reconstitution which took effect after the market close on june 28 2024 the reconstituted russell microcap index will commence trading on july 1 2024
5399,all_events,DOWN,,19 nov 2024 13 43 cet lokotech group as følgende primærinnsider i lokotech group as har kjøpt aksjer i lokotech group as yngve b johansen kjøpte 19 november 2024 100 000 aksjer til en snittkurs på nok 0 99 per aksje kjøpet ble foretatt av black monday holding as etter denne transaksjonen eier yngve b johansen styreleder for lokotech group as og nærstående direkte og indirekte 2 817 831 aksjer i lokotech group as denne informasjonen blir offentliggjort i henhold til eus markedsmisbruksforordning og er underlagt offentliggjøringskravene i henhold til verdipapirhandelloven 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site lokotech group as oslo børs newspoint lokotech group as no0010921299 loko euronext growth
9129,all_events,UP,,media release
4779,all_events,UP,,malvern pa may 20 2024 globe newswire ocugen inc ocugen or the company nasdaq ocgn a biotechnology company focused on discovering developing and commercializing novel gene and cell therapies and vaccines today announced that arun upadhyay phd chief scientific officer head of research development ocugen will speak at the international society for cell gene therapy isct annual meeting being held may 29 june 1 2024 in vancouver canada
9180,all_events,UP,,naimish patel m d appointed to chief medical officer
10292,all_events,DOWN,,media release
3206,all_events,DOWN,,conformément aux articles l 233 8 ii du code de commerce et 223 16 du règlement général de l autorité des marchés financiers
2477,all_events,DOWN,DOWN,media release
12080,all_events,UP,,09 oct 2024 19 20 cest plásticos compuestos s a 20241009 oir operaciones por directivos pdf kompuestos euronext plasticos compuestos s a kompuestos es0105425005 alkom euronext growth
2684,all_events,UP,,enrollment for hpn217 bcma and hpn328 dll3 remain on track with data updates and selection of recommended phase 2 doses for both ongoing clinical programs planned in 2023
11153,all_events,DOWN,,pratteln switzerland october 1 2024 santhera pharmaceuticals six sann announces the positive outcome of the lionheart study confirming vamorolone s distinctive action also as a mineralocorticoid receptor antagonist setting it apart from other corticosteroids
993,all_events,DOWN,UP,media release
135,all_events,UP,DOWN,media release
1153,all_events,UP,DOWN,media release
5106,all_events,DOWN,,november 08 2024 11 30 et source sanoma oyj sanoma oyj sanoma oyj pörssitiedote 08 11 2024 klo 18 30 sanoma oyj omien osakkeiden hankinta 08 11 2024 nasdaq helsinki oy yhtiön hallussa on 08 11 2024 tehtyjen kauppojen jälkeen 126 991 omaa osaketta sanoma yksityiskohtaiset tiedot hankinnasta ovat tämän pörssitiedotteen liitteenä sanoma oyj n puolesta skandinaviska enskilda banken ab publ helsingin sivukonttori antti salakka janne tiihonen lisätietoja kaisa uurasmaa sijoittajasuhde ja yritysvastuujohtaja puh 040 560 5601 sanoma sanoma on innovatiivinen ja ketterä oppimisen ja median yhtiö jolla on vaikutus miljoonien ihmisten elämään joka päivä vastuullisuusstrategiamme avulla vahvistamme positiivista vaikutustamme yhteiskuntaan ja minimoimme ympäristöjalanjälkeämme olemme sitoutuneet yk n kestävän kehityksen periaatteisiin ja allekirjoittaneet yk n global compact aloitteen oppimisen tuot
9798,all_events,UP,,media release
6946,all_events,UP,,media release
9764,all_events,UP,,november 18 2024 11 30 et source kalmar corporation kalmar corporation attachment
12670,all_events,UP,,november 08 2024 01 00 et source martela corporation martela corporation martela corporation interim report 8 11 2024 at 08 00 a m the revenue and operating result for january september 2024 weakened compared to the corresponding period of the previous year new orders rose in the third quarter july september 2024 january september 2024 outlook outlook for 2024 martela group s full year 2024 revenue are anticipated to be approximately at the previous year s level and to reach eur 91 97 million in 2024 eur 94 4 million in 2023 the operating result is estimated to be slightly negative and the operating loss is estimated to be at the level of eur 0 0 1 8 million operating loss in 2023 was eur 2 4 million key figures eur million ville taipale ceo the first half of the year was marked by market uncertainty and weak economic development which was reflected in the company s low accumulation of new orders and revenue
7120,all_events,DOWN,,new york dec 14 2023 globe newswire tourmaline bio inc tourmaline nasdaq trml a late stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life altering immune and inflammatory diseases announced today that clay siegall phd has been appointed as chairman of the board
4608,all_events,UP,,the annual general meeting of coloplast a s will be held onthursday 5 december 2024 at 3 30 pm cetat the premises of coloplast a s holtedam 3 in humlebæk the aage louis hansen auditorium humlebæk denmark the notice of the annual general meeting is enclosed for further information please contact investors and analysts anders lonning skovgaard executive vice president cfo tel 45 4911 1111 aleksandra dimovska vice president investor relations tel 45 4911 1800 45 4911 2458 email dkadim coloplast com press and media peter mønster sr media relations manager tel 45 4911 2623 email dkpete coloplast com address coloplast a s holtedam 1 dk 3050 humlebaek denmark company reg cvr no 69749917 website www coloplast com this announcement is available in a danish and an english language version in the event of discrepancies the english version shall prevail coloplast was founded on passion ambition and commitment we were born from a nurse s wish to help her sister and t
8454,all_events,UP,,08 nov 2024 07 31 cet desert control as sandnes norway 8 november 2024 desert control as dsrt or the company a leader in soil and water conservation technology has signed an agreement through its u s subsidiary desert control americas inc with berkeley country club for the phased deployment of desert control s water conservation technology at the country club s prestigious golf course located in the berkeley hills above the community of el cerrito california this agreement subject to successful initial validation phases aims to implement desert control s water conservation technology across the entire 63 acre golf course this marks a significant milestone for desert control as its first commitment to a full course deployment in the united states the agreement s structure includes initial validation stages to ensure the technology s efficacy on berkeley country club s golf course based on successful outcomes full deployment is anticipated in t
8045,all_events,UP,,november 08 2024 09 00 et source as infortar as infortar in the course of the intra group reorganization of as infortar on 8 november 2024 as tallink grupp transferred 34 000 shares of as tallink takso with a nominal value of 6 3 euros representing of the share capital to as infortar following the transaction as infortar will hold of the shares in as tallink takso the transaction is not treated as a transaction beyond everyday economic activities or a transaction of a significant importance transaction is between related parties but does not have a significant impact on the activities of as infortar or as tallink grupp aktsiaselts infortar operates in seven countries the company s main fields of activity are maritime transport energy and real estate aktsiaselts infortar owns a 68 stake in aktsiaselts tallink grupp a stake in as eesti gaas and a versatile and modern real estate portfolio of approx 116 000 m2 in a
2236,all_events,UP,DOWN,vilnius riga tallinn nasdaq baltic market november 14 2024 nasdaq ndaq announces that bonds issued by engineering solutions group fern group managed by invl baltic sea growth fund have been admitted to trading on the nasdaq baltic first north market by nasdaq vilnius as of today november 14 fern group has successfully raised eur 8 million through a public bond offering for investors in lithuania latvia and estonia each bond has a nominal value of eur 1 000 and offers an annual coupon rate of with quarterly payments maturing in two years the bonds issued by fern group attracted 406 investors who subscribed to eur 9 5 million worth of bonds the offering was oversubscribed with most investors coming from lithuania while were from latvia and estonia šiaulių bankas was the organizer of the public bond issue while the law firm cobalt acted as legal advisor and is also the certified adviser for the company on the first north market the audit firm audifi
12286,all_events,DOWN,,15 nov 2024 07 00 cet standard supply as oslo norway 15 november 2024 please find enclosed the third quarter report for standard supply as standard supply ose stsu the third quarter dividend of nok 1 10 per share was paid on october 22nd resulting in total dividends paid of nok 1 2bn or 6 27 per share since the ipo in 2022 not adjusted for the share consolidation in the ratio 100 1 registered on 29th october following this payment the company will be left with a smaller cash position of usd 4 5 million and will continue to evaluate opportunities to maximize the remaining value of the company ends for further information please contact ceo espen l fjermestad at 47 95 20 44 93 chairman of the board martin nes at 47 92 01 48 14 standard supply com more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632318_2024 3q report stsu_final pdf standard supply as oslo børs new
8957,all_events,DOWN,,dallas sept 26 2024 globe newswire taysha gene therapies inc nasdaq tsha taysha or the company a clinical stage biotechnology company focused on advancing adeno associated virus aav based gene therapies for severe monogenic diseases of the central nervous system cns today announced that it will present previously disclosed clinical data on its tsha 102 program in evaluation for rett syndrome during an oral presentation at the upcoming 9th world rett syndrome congress taking place in queensland australia from october 2 5 2024
11724,all_events,UP,,media release
8005,all_events,DOWN,,november 07 2024 01 00 et source merko ehitus as merko ehitus as commentary from management merko ehitus revenue for the 9 months of 2024 was eur 379 million and net profit was eur 44 8 million third quarter revenue was eur 175 million net profit eur 27 3 million sales of construction services made up about of the 9 month revenue according to the management of merko ehitus the construction of some projects was accelerated at the request of the clients which increased current construction volumes helped reduce costs and increase efficiency as a result merko ended the 9 months with a stronger result than planned group companies reached the home stretch for several large and complex projects including the largest construction project in merko s history arter quarter with close to of its 150 million euro volume now completed one of the arter buildings is finished interior works on the second building are being completed and
3608,all_events,UP,,saint herblain france et schlieren zurich le 13 novembre 2024 valneva se nasdaq valn euronext paris vla société spécialisée dans les vaccins et limmatech biologics ag société de biotechnologies développant des vaccins pour la prévention de maladies potentiellement mortelles ont annoncé aujourd hui la vaccination du premier participant à l essai d infection contrôlée chez l homme ou chim de phase 2b du candidat vaccin shigella4v s4v ce candidat bioconjugué tétravalent contre la shigellose pour lequel valneva a obtenu une licence exclusive mondiale de limmatech1 est le plus avancé au monde
6310,all_events,UP,,liitteet ovaro_10 10_trades xlsx
3098,all_events,DOWN,,management to host conference call and webcast at 4 30 p m et management to host conference call and webcast at 4 30 p m et
12019,all_events,UP,,the shareholders of meko ab are hereby invited to the extraordinary general meeting on thursday 19 december 2024 at 12 30 cet at world trade center klarabergsviadukten 70 in stockholm registration for the meeting opens at 12 00 cet shareholders may also exercise their voting rights at the extraordinary general meeting by postal voting right to participate registration proxies etc shareholders who wish to participate in the meeting must notification of attendance in the meeting room shareholders who wish to attend the extraordinary general meeting in the meeting room must notify the company of this no later than 13 december 2024 either at www meko com by phone 46 0 8 402 90 47 or by mail to meko ab egm c o euroclear sweden ab box 191 101 23 stockholm sweden shareholders participating through a proxy or representative should send the power of attorney and or certificate of registration or equivalent authorization documents to the above address well in advance of t
6442,all_events,UP,,admiral markets as i nõukogu nimetas alates 01 11 2024 ühingu uueks juhatuse liikmeks aleksandr ljubovski aleksandri peamiseks vastutusvaldkonnaks jääb riskijuhtimine
2388,all_events,DOWN,UP,november 14 2024 07 57 et source gabriel holding a s gabriel holding a s offentliggørelsen af gabriel holding a s årsrapport for 2023 24 samt tidspunktet for afholdelse af koncernens generalforsamling udskydes som følge af udfordringer med regnskabsaflæggelsen i gabriel koncernens mexicanske datterselskab der er produktionsenhed for forretningsenheden furnmaster regnskabsaflæggelsen i det mexicanske datterselskab er ikke blevet gennemført som planlagt ledelsen af datterselskabets regnskabsafdeling fratrådte kort før regnskabsafslutningen hvilket har medført en tidskrævende proces med at analysere og opgøre pålidelige regnskabstal der er i processen konstateret usikkerhed vedrørende balancen herunder opgørelser af varelagre i datterselskabet ledelsen har derfor besluttet at gennemføre en struktureret og detaljeret gennemgang af grundlaget for regnskabsaflæggelsen i det mexicanske datterselskab med henblik på at opnå fuld sikkerhed for a
9281,all_events,DOWN,,18 nov 2024 07 57 cet pembroke olive downs pty ltd please see attached notice regarding an application received from the sedgman cpb joint venture more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632469_scjv matter to bondholders executed version 181124 pdf pembroke olive downs pty ltd oslo børs newspoint pembroke olive downs 21 28 10 00pct usd c no0011173536 nordic alternative bond market
2993,all_events,DOWN,,15 nov 2024 08 30 cet dolfines dolfinescpconstatation laugmentation capital pdf dolfines euronext dolfines fr001400sp13 aldol euronext growth
10918,all_events,UP,,06 nov 2024 18 45 cet fonciere lyonnaise societe regulatory news the boards of directors of inmobiliaria colonial and its 98 owned subsidiary société foncière lyonnaise paris fly have decided to examine in detail a proposal to merge sfl into colonial the potential merger would be part of the ongoing strategy to simplify the group s structure one of the pivotal stages of which was colonial s public exchange offer in august 2021 it would strengthen further cohesion between sfl and colonial which has been sfl s majority shareholder since 2004 for over twenty years the two companies have shared the deeply held belief that the key to creating long term value lies in developing prime urban assets and building a unique mixed use portfolio in paris madrid and barcelona the potential transaction would consist of merging société foncière lyonnaise into inmobiliaria colonial and exchanging all sfl shares tendered for newly issued inmobiliaria colonial shares
119,all_events,UP,UP,warrington pa april 18 2024 globe newswire windtree therapeutics inc nasdaq wint windtree or the company a biotechnology company focused on advancing early and late stage innovative therapies for critical conditions today announced that the company s board of directors has approved a 1 for 18 reverse stock split of its issued and outstanding common stock par value of 0 001 per share the reverse stock split the reverse stock split will become effective at 11 59 p m eastern time on april 19 2024 and the company s common stock will open for trading on the nasdaq capital market on a split adjusted basis under the symbol wint on april 22 2024 at such time the company s common stock will also commence trading under a new cusip number 97382d 501
4205,all_events,UP,,06 nov 2024 17 50 cet mastrad télécharger la pièce jointe cette publication dispose du service actusnews security master security master key nghpyjpsz2vhy2pqzpdmagfpbgiwmjlfmjaex2psk5eabzpjm2uva8qyznfpm2pr pour contrôler cette clé https www security master key com information réglementée rapports financiers et d audit annuels rapport annuel euronext growth euronext accesscommuniqué intégral et original au format pdf https www actusnews com news 88655 mastrad conso rapport cac cptes 30 06 2024 pdf information réglementée rapports financiers et d audit annuels rapport annuel euronext growth euronext access communiqué intégral et original au format pdf https www actusnews com news 88655 mastrad conso rapport cac cptes 30 06 2024 pdf 88655_fr0004155687 pdf mastrad actusnewswire mastrad fr0004155687 almas euronext growth
7066,all_events,DOWN,,saint herblain france 13 septembre 2024 valneva se nasdaq valn euronext paris vla valneva ou la société société spécialisée dans les vaccins annonce aujourd hui le succès de son augmentation de capital définie ci dessous pour un montant final de 61 180 000 euros
4829,all_events,DOWN,,july september 2024 january september 2024 key events during the third quarter key events after the third quarter comment from the ceo we see good opportunities to continue growing our business and strengthening profitability the improved profitability demonstrates that we are on the right track to build a stronger cavotec the markets we target are to an increasing extent driven by new regulations in the environmental field and the urgent need to reduce emissions this combined with our ability to further enhance our offer gives us good momentum to continue growing with both new and existing customers revenue increased 5 in the quarter to eur 44 1 million mainly as a result of a strong quarter for the industry segment with good sales of radio remote controls and services we continue to gain positive effects from our ongoing change programs and increased cost control as well as improved purchasing procedures ebit increased 76 to eur 3 0 million with an ebit margin that imp
1006,all_events,UP,DOWN,13 nov 2024 19 06 cet shelf drilling ltd press release shelf drilling board of directors approves share issue and grant of rsus dubai november 13 2024 reference is made to the announcement by shelf drilling ltd shelf drilling or the company ose shlf on november 8 2023 regarding the grant of 51 923 restricted stock units rsus to the then chairman of the board of directors and 17 308 rsus to each of the other non executive directors of the company under the company s 2017 long term incentive plan the rsus will vest on november 14 2024 subject to each director s continued service with the company in order to settle the rsus the company s board of directors has resolved to issue a total of 155 771 new common shares each with a par value of usd 0 01 following the share issue the issued share capital of the company will be usd 2 558 985 75 divided into 255 898 575 common shares each with a par value of usd 0 01 the authorised share capital
4281,all_events,UP,,rockville md aug 16 2024 globe newswire theriva biologics inc nyse american tovx a diversified clinical stage company developing therapeutics designed to treat diseases in areas of high unmet need announced today a reverse stock split of its issued and outstanding common stock par value 0 001 per share at a ratio of one 1 share of common stock for every twenty five 25 shares of common stock effective as of 12 01 a m eastern time on august 26 2024 the effective date the company s common stock will begin trading on a split adjusted basis when the market opens on august 26 2024 the reverse stock split was authorized by the company s board of directors on august 15 2024 pursuant to the laws of the state of nevada the company s state of incorporation the company s board of directors has the authority to effect a reverse stock split without shareholder approval if the number of authorized shares of common stock and the number of outstanding shares of common stock are proportionally reduced the company will file a certificate of change to its articles of incorporation as amended with the secretary of state of nevada to effect the reverse stock split the company s common stock will continue to trade on the nyse american under the stock ticker tovx but will trade under the new cusip number 87164u 508
9291,all_events,DOWN,,media release
11623,all_events,UP,,boston april 30 2024 globe newswire x4 pharmaceuticals inc nasdaq xfor a company driven to improve the lives of people with rare diseases of the immune system today announced that it will be reporting financial results for the first quarter ended march 31 2024 and providing corporate updates on tuesday may 7 2024
11509,all_events,UP,,media release
8910,all_events,DOWN,,media release
1413,all_events,DOWN,DOWN,stockholm sweden november 6 2024 bioarctic ab publ nasdaq stockholm bioa b has presented the design of its proprietary braintransporter bt platform at the 16th annual protein antibody engineering summit pegs conference in barcelona spain the bt platform uses active transferrin receptor tfr mediated transport enabling up to 70 fold higher penetration of antibodies over the blood brain barrier without negative effects on hematological safety parameters during the 16th annual protein antibody engineering summit pegs europe conference dr per ola freskgård vp science technology at bioarctic presented for the first time the design of the proprietary bt platform as well as validation in preclinical models brain uptake of biotherapeutics such as antibodies and enzymes is severely limited by the blood brain barrier bbb primarily due to their size active transport across the bbb using one of the body s own delivery mechanisms aims to enable better drug u
5279,all_events,DOWN,,new york june 13 2024 globe newswire rezolute inc nasdaq rzlt rezolute or the company a late stage biopharmaceutical company committed to developing novel transformative therapies for serious rare diseases today announced that it is commencing an underwritten public offering of shares of its common stock or pre funded warrants to purchase its common stock in lieu thereof in addition the company intends to grant the underwriters an option for a period of 30 days to purchase up to an additional 15 percent of the number of shares of its common stock plus the shares of common stock underlying pre funded warrants sold in connection with the public offering the public offering is subject to market and other conditions and there can be no assurance as to whether or when the public offering may be completed or as to the actual size or terms of the public offering all of the shares in the public offering are being offered by the company
8494,all_events,DOWN,,paris and cambridge mass sept 18 2024 globe newswire nanobiotix euronext nano nasdaq nbtx the company a late clinical stage biotechnology company pioneering nanoparticle based approaches to expand treatment possibilities for patients with cancer and other major diseases provided an update on operational progress and announced its half year financial results for the six month period ended june 30 2024
8574,all_events,UP,,longeveron to present at the emerging growth virtual conference
1921,all_events,UP,DOWN,11 oct 2024 18 35 cest shelf drilling ltd press release shelf drilling ltd and shelf drilling north sea ltd completion of acquisition of shelf drilling north sea ltd dubai october 11 2024 reference is made to the stock exchange announcement as of september 16 2024 regarding an agreement and plan of merger the merger plan entered into between shelf drilling ltd shelf drilling an indirect subsidiary of shelf drilling mergersub and shelf drilling north sea ltd shelf drilling north sea whereby pursuant to the merger of mergersub with and into shelf drilling north sea shelf drilling north sea would become a wholly owned subsidiary of shelf drilling the merger reference is also made to the subsequent announcement as of september 18 2024 related to the notice for the special general meeting of shelf drilling north sea to approve the merger plan the statutory merger agreement as defined therein and the merger together
2495,all_events,UP,DOWN,media release
3852,all_events,DOWN,,06 nov 2024 07 00 cet ultimovacs asa oslo november 6 2024 ultimovacs asa ultimovacs ose ulti a clinical stage biotechnology company developing novel immunotherapies against cancer announces its third quarter 2024 results today conference call and webcast scheduled for november 6 2024 at 14 00 cet link to webcast here https channel royalcast com hegnarmedia hegnarmedia 20241106_6 third quarter 2024 business update highlights ultimovacs implemented cash preservation initiatives during the second quarter of 2024 during the third quarter of 2024 additional cash preservation opportunities have been identified which extend the anticipated cash runway through the first quarter of 2026 in august 2024 ultimovacs reported topline results from the phase ii focus trial in head and neck cancer the trial did not meet the primary endpoint of improved progress
2677,all_events,DOWN,,in accordance with articles l 233 8 ii of the french commercial code and 223 16 of the general regulation of the french financial markets authority autorité des marchés financiers
7541,all_events,DOWN,,mainz biomed partners with trusted health advisors to support u s go to market strategy for next generation early colorectal cancer diagnostic
8635,all_events,UP,,08 nov 2024 21 15 cet la francaise de l energie availability of the fy24 annual financial report pontpierre france november 8th 2024 fde euronext fde isin fr0013030152 a carbon negative energy producer has made available to the public and filed with the financial markets authority on november 8th 2024 its annual financial report for the year ended on june 30th 2024 the annual financial report can be accessed on the company s website at the following address https www francaisedelenergie fr en in the section shareholders regulated information financial reports next announcements general assembly for fy24 annual results december 18th 2024 reuters code fde pa bloomberg code fde fp press contact francaisedelenergie fr 33 0 3 87 04 34 51 investors relations ir francaisedelenergie fr 33 0 3 87 04 34 51 about la française de l énergie fde fde is an independent multi energy producer dedicated to making net zero happen as a specialis
3035,all_events,DOWN,,media release
9219,all_events,UP,,media release
5098,all_events,UP,,media release
4084,all_events,UP,,media release
5267,all_events,UP,,03 oct 2024 18 30 cest poxel accord avec orbimed pour monétiser une partie des redevances issues des ventes de twymeeg à hauteur de 50 millions de dollars sous la forme d un emprunt obligataire orbimed reçoit en contrepartie les redevances dont bénéficie poxel au titre des ventes de twymeeg réalisées par sumitomo pharma au japon pour un montant total de 100 millions de dollars le montant de l emprunt obligataire versé par orbimed sera utilisé pour réduire l endettement de la société vis à vis d ipf partners et des banques auprès desquelles poxel a contracté un prêt garanti par l état prêts pge et pour soutenir son plan stratégique dans les maladies rares en parallèle de la poursuite des discussions partenariales pour ses produits extension de l horizon de financement jusqu à fin 2025 suite à l accord de financement non dilutif avec orbimed en incluant le tirage résiduel intégral de la ligne de financement en fonds propres mise en place avec iris l équi
8871,all_events,UP,,cambridge mass aug 28 2024 globe newswire editas medicine inc nasdaq edit a clinical stage gene editing company today announced that management will participate in the following upcoming investor conferences to discuss the company and its programs including reni cel
3656,all_events,DOWN,,media release
2861,all_events,UP,,today on 7 november latvian fintech company delfingroup launched the listing of unsecured and subordinated bonds other than those previously offered to the public on the nasdaq first north alternative market these bonds which were previously only available to a limited number of investors in private placements will now be available in open trading delfingroup provides greater liquidity to existing and potential investors by listing its unsecured and subordinated bonds on the stock exchange the unsecured bonds isin lv0000860146 are issued in the amount of 15 million euros and bear interest at 3m euribor each bond has a nominal amount of 1000 euros and matures on 25 november 2026 the subordinated bonds isin lv0000802700 are issued in the amount of 5 million euros at an interest rate of 11 3m euribor and with a nominal value of 1000 euros per bond the maturity date of these bonds is 25 july 2028 with the listing of the new bonds investors will have access t
6733,all_events,DOWN,,media release
399,all_events,DOWN,DOWN,media release
4449,all_events,DOWN,,november 18 2024 01 30 et source sampo oyj sampo oyj sampo oyj pörssitiedote 18 11 2024 klo 8 30 sampo oyj n omien osakkeiden ostot 15 11 2024 sampo oyj y tunnus 0142213 3 lei 743700uf3rl386wida22 on hankkinut omia a osakkeitaan isin koodi fi4000552500 omistukseensa 15 11 2024 seuraavasti kahden desimaalin tarkkuuteen pyöristettynä sampo ilmoitti 17 6 2024 enintään 400 miljoonan euron suuruisen omien osakkeiden osto ohjelman käynnistämisestä markkinoiden väärinkäyttöasetuksen eu 596 2014 mar ja euroopan komission delegoidun asetuksen eu 2016 1052 mukaisesti sampo oyj n hallitus päätti 16 9 2024 kasvattaa omien osakkeiden osto ohjelmaa 475 miljoonaan euroon 18 6 2024 aloitetulla osto ohjelmalla on sammon varsinaisen yhtiökokouksen 25 4 2024 myöntämä valtuutus sammon omistuksessa on nyt ilmoitettujen transaktioiden jälkeen 10 808 319 sammon a osaketta mikä on 1 97 prosenttia sampo oyj n kaikista
3132,all_events,DOWN,,san carlos calif feb 02 2024 globe newswire vaxcyte inc nasdaq pcvx a clinical stage vaccine innovation company engineering high fidelity vaccines to protect humankind from the consequences of bacterial diseases announced today the closing of its previously announced underwritten public offering of 12 695 312 shares of common stock at a public offering price of 64 00 per share and pre funded warrants to purchase 781 250 shares of common stock at a public offering price of 63 999 per underlying share this includes the exercise in full by the underwriters of their option to purchase up to 1 757 812 additional shares of common stock at the public offering price per share less underwriting discounts and commissions the aggregate gross proceeds to vaxcyte from this offering were approximately 862 5 million before deducting underwriting discounts and commissions and other offering expenses payable by vaxcyte
1701,all_events,DOWN,UP,by a group internal transaction conchilia as a company in which kverva industrier as has an ownership interest of approximately has sold 267 600 shares in bewi asa to kverva industrier as at a price of nok 24 54 per share following this kverva industrier as owns 15 560 024 shares 8 in bewi asa in addition kverva as is a party to total return swap agreement with a third party under which kverva as has a financial exposure to 9 092 220 shares 4 in bewi asa resulting in kverva as having a total bewi asa exposure equal to 24 652 244 shares 12 kverva industrier as is a close associate of pernille skarstein christensen who is a board member in bewi asa please see further details in the attached notification of trade this announcement is made in accordance with article 19 of the eu market abuse regulation and sections 5 12 of the norwegian securities trading act attachments 241107 bewi_pdmr form kverva pdf
12920,all_events,DOWN,,media release
150,all_events,DOWN,DOWN,opgørelsen er baseret på samme regnskabspraksis som årsrapporten for 2023 opgørelsen er ikke revideret der tages forbehold for endelig opgørelse
3526,all_events,UP,,media release
10991,all_events,DOWN,,11 oct 2024 15 20 cest vivoryon therapeutics n v halle saale munich germany october 11 2024 vivoryon therapeutics n v euronext amsterdam vvy nl00150002q7 vivoryon a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins today announced that the company s abstract varoglutamstat increases glomerular filtration in elderly patients without signs of proteinuria and potentially offers a new approach to treat diabetic kidney disease dkd has been selected for a late breaking oral presentation at the american society of nephrology asn kidney week 2024 in san diego california held october 23 to 27 we are truly excited that our abstract has been selected for a late breaking oral presentation at the asn kidney week 2024 said frank weber m d ceo of vivoryon we are very much looking forward to sharing our results with the scientific and medic
8934,all_events,UP,,12 nov 2024 18 15 cet alpes proven csa reg cr mut caisse regionale de credit agricole mutuel alpes provence société coopérative à capital variable25 chemin des trois cyprès 13097 aix en provence cedex 2381 976 448 r c s aix en provence aix en provence le 12 novembre 2024 achats effectués dans les conditions de l article 5 du règlement abus de marché dans le cadre du programme de rachat des certificats coopératifs d investissement autorisé par l assemblée générale mixte des sociétaires du 26 mars 2024 le détail des transactions est disponible en annexe le crédit agricole alpes provence vous informe que le document est disponible sur son site internet http www ca alpesprovence fr et a été transmis à l autorité des marchés financiers nom de l émetteurcode identifiant de l émetteurjour de la transactioncode identifiant de l instrument financiervolume total journalier en nombre d actions prix pondéré moyen jour
11496,all_events,UP,,12 nov 2024 08 00 cet veidekke asa veidekke har signert avtale med tyresö kommune utenfor stockholm om å bygge en ny barnehage med plass til 160 barn i bollmora kontraktsverdien er cirka sek 125 millioner sentrale tyresö trenger flere permanente barnehageplasser i kommunal regi og nå har kommunen gitt veidekke oppdraget med å bygge ny barnehage ved siden av bergfotens skole tyresö er i stadig utvikling når vi bygger for samfunnet har vi mål om å ivareta alle tyresö verdiene og tenke bærekraftig menneskelig grønt og blått og med disse stikkordene for øye gleder vi oss nå til å starte byggingen av bergfotens barnehage sammen med veidekke her får innbyggerne i sentrale tyresö kort vei til barnas barnehage sier louise bergman avdelingssjef for strategi og prosjekt i tyresö kommune oppdraget er en utførelsesentreprise som omfatter barnehage med egen skolegård og tilhørende uteområder den skal bygges i henhold til kommunens ferdige konsept for barnehager
3658,all_events,DOWN,,media release
5479,all_events,UP,,13 nov 2024 15 57 cet skandia greenpower as lars gunnar abusdal cfo i skandia greenpower as har den 13 november 2024 kjøpt 130 076 aksjer i skandia greenpower as til gjennomsnittskurs nok 1 0973 per aksje etter denne transaksjonen eier abusdal 1 601 977 aksjer i selskapet denne opplysningen er informasjonspliktig etter markedsmisbruksforordningen mar artikkel 19 og verdipapirhandelloven 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site skandia greenpower as oslo børs newspoint skandia greenpower as no0010931207 skand euronext growth
4672,all_events,UP,,media release
12750,all_events,DOWN,,announcement no 243 11 november 2024 in connection with the announced share buy back program in norden a s motortramp continuously sells shares pro rata and the market is to be informed accordingly see the attached file and announcements nos 235 24 and 237 24 kind regards dampskibsselskabet norden a s martin badsted cfo for further information therese möllevinge head of investor relations tel 45 41 37 16 38 e mail thm norden com isabella zaugg hansen investor relations manager tel 45 27 62 90 96 e mail izh norden com attachments no 243 managers transactions etc pdf transactions by persons discharging managerial responsibilities and persons pdf
9982,all_events,UP,,operational and strategic highlights profitability growth operational milestones financial highlights and progress modestas sudnius the ceo of eleving group the third quarter of 2024 marks a transformative time for eleving group highlighted by our initial public offering ipo the largest in nasdaq riga s history and a milestone for a privately held company in the baltics we are deeply grateful to welcome over 4 500 new shareholders a balanced mix of institutional and retail investors from the baltics and beyond this ipo success has provided us with eur 29 mln which we will use to drive our plans to nearly double the business over the next three years in the immediate term we are focusing on using these proceeds to strengthen our balance sheet and optimize funding costs our diverse product portfolio remains a key driver of performance revenue from traditional loan products grew by 11 driven by strong portfolio expansion in romania and steady gains in georg
1945,all_events,DOWN,DOWN,november 19 2024 01 30 et source sampo plc sampo plc sampo plc stock exchange release 19 november 2024 at 8 30 am eet sampo plc s share buybacks 18 november 2024 on 18 november 2024 sampo plc business code 0142213 3 lei 743700uf3rl386wida22 has acquired its own a shares isin code fi4000552500 as follows rounded to two decimals on 17 june 2024 sampo announced a share buyback programme of up to a maximum of eur 400 million in compliance with the market abuse regulation eu 596 2014 mar and the commission delegated regulation eu 2016 1052 on 16 september 2024 the board of directors of sampo plc resolved to increase the share buyback programme to eur 475 million the programme which started on 18 june 2024 is based on the authorisation granted by sampo s annual general meeting on 25 april 2024 after the disclosed transactions the company owns in total 10 902 324 sampo a shares representing 1 98
8583,all_events,DOWN,,12 nov 2024 14 54 cet 4finance s a operational highlights online loan issuance volume was stable year on year in the period at 423 5 million compared with 423 8 million in the prior year period demand for credit remains strong in most markets particularly in the czech republic and spain new growth opportunities taking a deliberate step by step approach the uk joint venture ondal co uk and the mexican business kimbi mx progressing steadily showing gradual growth tbi bank loan issuance increased by to 832 8 million in the period compared to 652 3 million in 9m 2023 financial highlights interest income up year on year to 326 7 million in the period compared with 288 8 million in 9m 2023 cost to income ratio for the period was 41 an improvement from 44 in the prior year period cost discipline and operational efficiency remain a focus for the business adjusted ebitda was 116 2 million for the period up
4448,all_events,DOWN,,november 19 2024 01 56 et source avance gas holding ltd avance gas holding ltd bermuda november 19 2024 avance gas holding ltd ticker agas will on wednesday november 27 2024 release its unaudited results for the third quarter of 2024 in connection with the earnings release an audio webcast and conference call will be held at 14 00 cest the presentation and webcast link will be available from the investor relation section at avance gas website www avancegas com prior the presentation and available by using the following links webcast https edge media server com mmc p j6q2r66p conference call https register vevent com register bid9585c6a8c7a46fdaad8f2f978059a2d a q a session will be held after the conference call webcast for further queries please contact randi navdal bekkelund cfo telephone 47 23 11 40 00 email ir avancegas com about avance gas avance gas operates in the global market for transporting lique
6727,all_events,DOWN,,november 06 2024 02 00 et source aktia pankki oyj aktia pankki oyj aktia pankki oyjpörssitiedote6 11 2024 klo 9 00 aktia pankki oyj n suunnattu osakeanti osana pitkän aikavälin osakesäästöohjelmaa aktia pankki oyj on laskenut liikkeeseen yhteensä 105 167 uutta osaketta osana aktiauna osakesäästöohjelmaa 2024 2025 osakeanti perustuu varsinaisen yhtiökokouksen 3 4 2024 antamaan valtuutukseen konsernin kaikille työntekijöille avoimen aktiauna osakesäästöohjelman puitteissa osallistujalla on mahdollisuus säästää osa palkastaan ja säästösummalla hankkia aktia osakkeita alennettuun hintaan nk säästöosakkeita tarkemmat tiedot osakesäästöohjelmasta löytyvät aktian vuosi ja vastuullisuuskertomuksesta uudet osakkeet ovat osakesäästöohjelmassa ajanjaksolla 1 4 30 9 2024 kertyneillä osallistujien säästöillä merkittyjä säästöosakkeita osakkeiden merkintähinta on 8 36 euroa osake joka perustuu osakkeen vaihdolla painotettuun keskikurssiin nasdaq h
11812,all_events,UP,,media release
4102,all_events,DOWN,,media release
9169,all_events,UP,,media release
3837,all_events,DOWN,,18 nov 2024 18 00 cet eramet paris 18 november 2024 6 00 p m press release eramet purchase of own shares eramet announces the purchase of 9 900 of its own shares related to the allocation of bonus shares under the provisions of articles l 225 197 1 et seq and l 22 10 59 and l 22 10 60 of the french commercial code to cover the free allocation of shares to employees and corporate officer aggregated presentation per day and per market name of issuer identification code of issuer legal entity identifier day of transaction identification code of financial instrument aggregated daily volume in number of shares daily weighted average price of the purchased shares market mic code eramet 549300luh78pg2mp6n64 13 11 2024 fr0000131757 82 52 70 aqeu eramet 549300luh78pg2mp6n64 13 11 2024 fr0000131757 496 52 27 ceux eramet 549300luh78pg2mp6n64 13 11 2024 fr0000131757 109 53 01 tqex eramet 549300luh78pg2mp6n64 13 11 2024 fr0000131757 2
1744,all_events,UP,DOWN,06 nov 2024 08 00 cet nhoa mise à disposition de la note en réponse et des informations relatives aux caractéristiques notamment juridiques financières et comptables de nhoa s a regulatory news nhoa s a paris nhoa ne pas publier diffuser ou distribuer directement ou indirectement aux états unis d amérique ou dans tout autre pays dans lequel la distribution ou la diffusion du communiqué est interdite par la loi le communiqué ne constitue pas une offre d acquérir des titres le présent communiqué relatif à la mise à disposition de la note en réponse visée par l amf le 5 novembre 2024 et à la mise à disposition des informations relatives aux caractéristiques notamment juridiques financières et comptables de nhoa s a a été établi et diffusé par nhoa s a en application des dispositions des articles 231 27 3 et 231 28 i du règlement général de l amf le communiqué conformément aux dispositions de l article l 621 8 du code monétaire et f
3033,all_events,DOWN,,18 oct 2024 20 15 cest arctic bioscience as eggesbø eiendom as a legal person closely associated with a person discharging managerial responsibility in arctic bioscience has today sold 520 240 shares in arctic bioscience at an average price of nok 2 23 per share following the transaction eggesbø eiendom as holds 0 shares in arctic bioscience member of the board at arctic bioscience per magne eggesbø is the chairman of the board and ceo of eggesbø eiendom as and owns of the company please refer to the attached notification of trading for further details this information is subject to the disclosure requirements pursuant to regulation eu 596 2014 mar article 19 and the norwegian securities trading act 5 12 for more information please contact jone r slinning cfo phone 47 948 75 469 e mail jone arctic bioscience com about arctic bioscience arctic bioscience is a biotech company developing and commercializing pharmaceutical and nutraceutica
8332,all_events,DOWN,,media release
8979,all_events,UP,,uab atsinaujinančios energetikos investicijos the company publishes its factsheet providing information about the company s investment portfolio key events business strategy operating segments and financial indicators as of 30 september 2024 2024 q3 key events solar development in poland wind projects in lithuania hybrid projects contact person for further information grėtė bukauskaitė manager of the investment company grete bukauskaite lordslb lt www lordslb lt aei_green_bonds attachment attachments aei investor report 2024q3 en pdf
6590,all_events,DOWN,,preclinical findings show exosome based therapeutic approach for the treatment of arginase 1 deficiency arg1 d
4075,all_events,UP,,eften real estate fund as registry code 12864036 address a lauteri 5 10114 tallinn announces a public offering of shares based on a decision of the fund s supervisory board dated november 11 2024 and informs about the planned listing and admission to trading of new shares on the regulated market organized by nasdaq tallinn as registry code 10359206 the supervisory board s decision is based on the resolution of the shareholders general meeting held on october 16 2024 share offering eften real estate fund as offers up to 1 000 000 new ordinary shares of the fund to all natural and legal persons in estonia latvia and lithuania in accordance with the public offering prospectus the fund reserves the right to upsize the offering by an additional 500 000 shares there is no minimum or maximum number of shares that can be subscribed to existing shareholders i e individuals who are entered in the fund s shareholders register as of the end of the nasdaq csd working day on no
518,all_events,UP,DOWN,18 nov 2024 18 36 cet aelis farma s a le cb1 ssi aef0217 a atteint avec succès les objectifs en matière de sécurité critère principal de pharmacocinétique critère secondaire et d efficacité critères secondaires et exploratoires de cette étude menée auprès de jeunes adultes avec une trisomie 21 syndrome de down pour lesquels les troubles cognitifs constituent un important besoin médical non satisfait aef0217 a été bien toléré et aucun problème de sécurité n a été identifié confirmant que le candidat médicament peut être utilisé sans risques identifiés auprès d une population plus fragile telle que les jeunes adultes avec une trisomie 21 après quatre semaines de traitement aef0217 a amélioré de façon significative plusieurs capacités comportementales importantes dans les domaines de la communication des aptitudes à la vie quotidienne et des interactions sociales telles que mesurées par l échelle de référence vineland adaptative behavior scale vabs
2270,all_events,DOWN,UP,marlborough mass april 05 2024 globe newswire akoya biosciences inc nasdaq akya the spatial biology company today announced it will highlight case studies featuring its spatial biology 2 0 solutions that enable unprecedented speed and scale for spatial biology studies at the american association for cancer research aacr 2024 annual meeting in san diego april 5 to 10 in addition the company will showcase new applications of its phenocode signature panels and preliminary data from the thermo fisher viewrna assays on akoya s platforms
468,all_events,UP,UP,san diego june 25 2024 globe newswire capricor therapeutics nasdaq capr a biotechnology company developing transformative cell and exosome based therapeutics for the treatment of rare diseases today announced that the u s food and drug administration fda has scheduled a pre bla biologics license application meeting with the company in the third quarter of 2024 for deramiocel cap 1002 for the treatment of duchenne muscular dystrophy dmd capricor s goal for this meeting will be to finalize its bla filing plans based on all currently available data as well as to work with the fda to outline the rolling bla submission timeline
8678,all_events,UP,,helstu atriði í afkomu þriðja ársfjórðungs
357,all_events,UP,UP,media release
6526,all_events,UP,,boston oct 01 2024 globe newswire x4 pharmaceuticals nasdaq xfor a company driven to improve the lives of people with rare diseases of the immune system today announced that effective on september 30 2024 the company issued inducement awards to new employees under the x4 pharmaceuticals inc 2019 inducement equity incentive plan the 2019 inducement plan the 2019 inducement plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of x4 the inducement awards consist of options to purchase an aggregate of 744 468 shares of x4 s common stock these stock awards were granted as an inducement material to the new employees entering into employment with x4 in accordance with nasdaq listing rule 5635 c 4 and were approved by x4 s compensation committee of the board of directors
5228,all_events,DOWN,,14 nov 2024 08 30 cet telenor asa as announced in the stock exchange release on 27 may 2024 telenor entered into an agreement with dnb asa to conduct buyback of telenor shares to be used in the company s share programmes in 2024 in the third tranche dnb asa was mandated to acquire shares for up to nok 8 900 000 between 11 and 15 november 2024 the third tranche of the share purchase has now been executed date aggregated daily volume number of shares vwap nok transaction value nok 12 november 2024 65 273 133 355 8 704 487 investor contact svp capital markets and investor relations frank maaø 47 91 67 40 45 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site telenor asa oslo børs newspoint telenor telenor asa 23 28 frn c telenor asa 23 30 4 c no0010063308 no0012935313 no0012935339 tel oslo børs
2145,all_events,DOWN,DOWN,vancouver british columbia may 16 2023 globe newswire mydecine innovations group neo myco otc mycof fse 0nfa mydecine or the company a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and ptsd announces the financial results for the three months ended march 31 2023
450,all_events,UP,UP,media release
10092,all_events,UP,,14 of 15 participants enrolled achieved a clinical response
5322,all_events,DOWN,,media release
5353,all_events,DOWN,,media release
10695,all_events,DOWN,,certara today unveiled its next generation coauthor regulatory writing software coauthor is an advanced writing platform designed for medical writers
4015,all_events,UP,,14 nov 2024 07 00 cet asml holding n v asml provides updated view on market opportunities at 2024 investor day meetingpositioned for significant growth in revenue and profitability in this decade veldhoven the netherlands november 14 2024 at its 2024 investor day today asml holding n v asml provides an update on its long term strategy as well as global market and technology trends confirming potential 2030 scenarios for annual revenue between approximately 44 billion and 60 billion with a gross margin of between approximately and we expect that our ability to scale euv technology into the next decade and extend our versatile holistic lithography portfolio positions asml well to contribute to and leverage the artificial intelligence ai opportunity and allows asml to deliver significant revenue and profitability growth says president and ceo christophe fouquet the long term outlook for the semiconductor industry remains promising given the ro
3559,all_events,UP,,06 nov 2024 18 00 cet cybergun cession engagée des activités civil pour une valorisation globale de plus de 10 meur croissance et retour à la rentabilité du pôle militaire arkania recherche de nouveaux partenaires pour verney carron afin de finaliser le retournement 6 novembre 2024 cybergun acteur mondial du tir de loisir publie son résultats semestriels 2024 non audités 1 arrêtés par la gérance et revus par le conseil de surveillance afin de donner une vision analytique de son activité et de sa performance économique cybergun ventile son chiffre d affaires et son résultat d exploitation en 3 pôles cession engagée des activités du pôle civil pour une valorisation globale de plus de 10 meur en keur non audité s1 2023 s1 2024 chiffre d affaires 17 193 11 843 résultat d exploitation 589 2 911 cybergun a engagé au cours du 1er semestre 2024 la cession de son pôle civil activité historique du groupe le processus a abouti à la signature d un accord
6290,all_events,UP,,generated net furoscix revenue of 3 8 million
2009,all_events,DOWN,DOWN,longeveron to attend cell gene meeting on the mesa to highlight its cellular therapy program in alzheimer s disease and cdmo facilities and services
4509,all_events,DOWN,,châtillon france october 22 2024
7289,all_events,DOWN,,november 08 2024 15 30 et source nokia oyj nokia oyj nokia oyjpörssitiedote8 11 2024 klo 22 30 nokia oyj omien osakkeiden takaisinosto 08 11 2024 espoo nokia oyj lei 549300a0jprwg1ki7u06 on 8 11 2024 hankkinut omia osakkeitaan isin fi0009000681 omistukseensa seuraavasti kahden desimaalin tarkkuuteen pyöristettynä nokia ilmoitti 25 tammikuuta 2024 että yhtiön hallitus on käynnistämässä osakkeidensa takaisinosto ohjelman palauttaakseen yhtiön osakkeenomistajille enintään 600 miljoonaa euroa vaiheittain kahden vuoden kuluessa takaisinosto ohjelman ensimmäinen vaihe aloitettiin 20 maaliskuuta 2024 19 heinäkuuta 2024 nokia päätti nopeuttaa takaisinostoja korottamalla vuoden 2024 aikana ostettavien osakkeiden lukumäärää korotetut takaisinostot noudattaen euroopan parlamentin ja neuvoston antamaa markkinoiden väärinkäyttöasetusta eu 596 2014 mar euroopan komission delegoitua asetusta eu 2016 1052 ja nokian varsinaisen yhtiökok
1662,all_events,UP,DOWN,media release
624,all_events,UP,UP,november 14 2024 01 32 et source nkt a s nkt a s investornyhed14 november 2024 offentliggørelse af finansiel kalender for 2025 kontakt investorerjacob johansen head of investor relations 45 2169 3591 jacob johansen nkt com presse louise westh naldal head of group communications 45 2982 0022 louise westh naldal nkt com vedhæftet fil
7959,all_events,UP,,zug switzerland and boston april 22 2024 globe newswire crispr therapeutics nasdaq crsp a biopharmaceutical company focused on creating transformative gene based medicines for serious diseases today announced an oral presentation highlighting the company s lipid nanoparticle lnp approach for ocular editing will be presented at the american society of gene cell therapy asgct 2024 annual meeting taking place may 7 11 2024 in baltimore md and virtually
6956,all_events,DOWN,,invl baltic real estate hereinafter the company hereby gives notification that on 08 october 2024 a real estate purchase and sale agreement was concluded with bohnenkamp sia legal entity code 40003506739 the agreement pertains to the sale of a 2 9 ha plot of land located at franču iela 1 stūnīši olaines pag olaines nov lv 2127 latvia which is owned by the company s subsidiary dommo gruppa sia along with a warehouse of 12 800 sq m situated on the land owned by dommo biznesa parks sia the value of the transaction is eur 7 45 million it is estimated to have a positive impact of eur 1 6 million on the company s 2024 results and its impact on the company s net asset value nav per share will be eur 0 20 the transaction is expected to be completed by december 2024 upon completion of the transaction the company will continue to manage 52 ha of land plots in latvia owned by the company s subsidiary dommo gruppa sia which are designated for further development or
8072,all_events,UP,,11 nov 2024 08 30 cet eam solar as currently the following companies are placed in recovery box barramundi group ltd since 09 09 2024 recovery box is a special compartment where oslo børs can place securities where the issuer is subject to circumstances that make pricing of the securities particularly uncertain recovery box is regulated in section 2 10 2 of oslo rule book ii oslo børs and euronext expand and section 3 8 2 of euronext growth oslo rule book part ii the relevant security will remain in the recovery box until the circumstances for the allocation to the recovery box are no longer present currently the following companies are placed in penalty bench solis bond company dac since 02 05 2024 alternus energy plc since 03 06 2024 barramundi group ltd since 03 06 2024 eam solar as since 06 09 2024 penalty bench is a special compartment where the securities of issuers that fail to comply with the rules are placed penalty bench is regulat
12910,all_events,UP,,burlington mass may 29 2024 globe newswire scpharmaceuticals inc nasdaq scph a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies advance patient care and reduce healthcare costs today announced that john tucker president chief executive officer will present at the jefferies global healthcare conference on wednesday june 5 at 5 00pm et mr tucker will also be meeting with investors that day
10775,all_events,UP,,media release
744,all_events,UP,UP,12 nov 2024 08 33 cet titan cement international s a tci share buyback en12112024 pdf titan cement international euronext titan cement be0974338700 titc euronext
12805,all_events,DOWN,,san carlos calif sept 11 2024 globe newswire vaxcyte inc nasdaq pcvx a clinical stage vaccine innovation company engineering high fidelity vaccines to protect humankind from the consequences of bacterial diseases announced today that company management will participate in a fireside chat at the 2024 cantor global healthcare conference on wednesday september 18 at 10 20 a m et 7 20 a m pt
5804,all_events,DOWN,,media release
8546,all_events,UP,,11 nov 2024 15 14 cet arcticzymes technologies asa tromsø 11 november 2024 olav lanes vp r d and applications has on 11 november purchased 5 000 shares in arcticzymes technologies asa for nok 13 90 per share following this transaction holds mr lanes 7 000 shares and 100 000 options in the company marit sjo lorentzen vp operations has on 11 november purchased 5 000 shares in arcticzymes technoloiges asa for nok 13 88 per share following this transaction holds mrs lorentzen 25 331 shares and 100 000 options in the company this information is subject to the disclosure requirements in articles 19 of the regulation eu 596 2014 the eu market abuse regulation and section 5 12 of the norwegian securities trading act for additional information please contact børge sørvoll cfo 4795290187 ir arcticzymes com about arcticzymes technologies asa arcticzymes technologies is a norwegian life sciences company focused on the development manufacturing and commercializ
3647,all_events,UP,,media release
1022,all_events,UP,UP,18 nov 2024 15 30 cet alstom bonjour veuillez trouver ci joint le rapport financier semestriel d alstom pour l exercice fiscal 2024 25 cordialement l équipe relations investisseurs d alstom pièce jointe rapport financier semestriel_fr_hy_sep24_vfinal bonjour veuillez trouver ci joint le rapport financier semestriel d alstom pour l exercice fiscal 2024 25 cordialement l équipe relations investisseurs d alstom pièce jointe alstom sa globenewswire alstom fr0010220475 fr0010220475 alo 4alo euronext
1984,all_events,UP,DOWN,18 nov 2024 13 50 cet trøndelag fylkeskommune det er fastsatt ny obligasjonsrente for no0012947557 ny obligasjonsrente i renteperioden 20 11 2024 20 02 2025 er 5 208 ticker trfy15 den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632536_a841bbc8160d49a0899e98b675a12410 pdf trøndelag fylkeskommune oslo børs newspoint trøndelag fylke 19 25 frn trondelag fylke 20 25 frn trondelag fylke 23 25 frn trondelag fylke 23 26 frn trondelag fylke 23 28 frn trøndelag fylke 24 26 frn trøndelag fylke 24 27 frn no0010868250 no0010915242 no0012922527 no0012947557 no0013096321 no0013177998 no0013183681 no0013276436 no0013329326 oslo børs
9210,all_events,UP,,san diego may 30 2024 globe newswire oncternal therapeutics inc nasdaq onct a clinical stage biopharmaceutical company focused on the development of novel oncology therapies today announced that enrollment has been completed and dosing initiated for the fifth dose cohort of its phase 1 2 study of onct 534 for the treatment of patients with metastatic castration resistant prostate cancer who are relapsed or refractory to approved androgen receptor pathway inhibitors arpi patients in the fifth cohort are receiving onct 534 the company s dual action androgen receptor inhibitor daari at a dose of 600 mg taken orally once each day the decision to proceed to this higher dose level was made by the study s safety review committee src after reviewing data from the fourth dose level of 300 mg onct 534 daily an initial update on onct 534 safety and efficacy based on prostate specific antigen psa levels from this study is expected in the third quarter of 2024 and will include data from this 600 mg dose cohort
3468,all_events,UP,,robit plc stock exchange release 19 november 2024 at 18 45 eet robit plc repurchase of own shares 19 november 2024 robit plc now holds a total of 93 387 shares including the shares repurchased on 19 november 2024 detailed information concerning the repurchase is attached to this stock exchange release on behalf of robit plc op corporate bank further information robit plc arto halonen group ceo 358 40 028 0717 arto halonen robitgroup com distribution nasdaq helsinki ltd key media www robitgroup com robit is the specialist focused on high quality drilling consumables for the mining and construction markets globally to help you drill even further faster robit strives to be the world s number one drilling consumables company through our proven high quality top hammer down the hole and geotechnical products and our expert services we deliver drilling cost savings to our customers robit has its own sales and service points in seven countries and an active network of distribut
6298,all_events,UP,,media release
11497,all_events,UP,,kineta has completed enrollment in the monotherapy cohorts of the phase 1 vista 101 clinical trial
12588,all_events,UP,,media release
4147,all_events,DOWN,,longeveron to attend cell gene meeting on the mesa to highlight its cellular therapy program in alzheimer s disease and cdmo facilities and services
4365,all_events,DOWN,,12 nov 2024 19 00 cet sodexo paris november 12 2024 with the acquisition of crh catering premier convenience solutions provider and one of the largest independent operators in the mid atlantic region sodexo is building on its food model transformation by expanding its inreach offerings and footprint in the fast growing 30 billion u s convenience market with crh catering sodexo is reinforcing its territorial presence in the east coast and broadening its multi channel offerings with additional micro markets vending office coffee pantry fresh food and on site food services crh catering s commissary will also accelerate strategic synergies between offsite production and convenience in key northeast and mid atlantic markets supporting sodexo s target to reach 500 million in revenue from inreach by end 2025 this new acquisition reflects sodexo s ambition to upgrade and scale its new food distribution models to address fast changing consumer needs and behavior
4807,all_events,DOWN,,november 19 2024 02 00 et source as infortar as infortar aktsiaselts infortar will pay the second installment of dividends for the 2023 financial year in the net amount 1 5 euros per share list of shareholders entitled to dividends will be recorded on 3 december 2024 at the end of the business day of the settlement system of the securities registrar record date consequently the day of change of the rights related to the shares ex date is 2 december 2024 from this date onwards individuals acquiring shares will not be entitled to receive dividends for the financial year 2023 on 12 december 2024 dividend shall be paid to the shareholders on 12 december 2024 by transfer to the bank account infortar operates in seven countries the company s main fields of activity are maritime transport energy and real estate infortar owns a 68 stake in tallink grupp a stake in eesti gaas and a versatile and modern real estate portfolio of ap
12279,all_events,DOWN,,18 nov 2024 11 04 cet fleury michon programme de rachat declaration des transactions sur actions propres societe fleury michon présentation agrégée par jour et par marché période 11 11 2024 au 15 11 2024 publication du 18 11 2024 nom de l émetteurcode identifiant de l émetteurjour de la transactioncode identifiant de l instrument financiervolume total journalier en nombre d actions prix pondéré moyen journalier d acquisition des actionsmarchéfleury michon96950009em1d72ngcv2711 11 2024fr0000074759 162 23 67407xparfleury michon96950009em1d72ngcv2712 11 2024fr0000074759 41 23 80xparfleury michon96950009em1d72ngcv2713 11 2024fr0000074759 48 23 90xparfleury michon96950009em1d72ngcv2714 11 2024fr0000074759 71 23 95775xparfleury michon96950009em1d72ngcv2715 11 2024fr0000074759 123 24 0813xpar détail transaction par transaction nom de l émetteurcode identifiantnom du psicode identifiant psijour heure de la transactioncode identifiant de l instrument financierprix unitaire unité
9258,all_events,UP,,kraig biocraft labs otcqb kblb kicks off new bam 1 hybrid spring production trials on track to meet expectations and timeline
6408,all_events,UP,,finansinspektionen har idag 16 oktober klockan 8 00 meddelat att styrelsen beslutat att tilldela marginalen bank en varning finansinspektionen har idag 16 oktober klockan 8 00 meddelat att styrelsen beslutat att tilldela marginalen bank en varning finansinspektionen undersöker regelmässigt olika marknadsaktörers riskhantering marginalen bank delar finansinspektionens grundläggande syn att det är viktigt att banker följer de regler som ytterst syftar till en sund och ansvarsfull hantering av de risker som bankverksamheten är förenad med vi ska nu gå igenom och analysera beslutet som vi erhöll klockan 8 00 idag säger ewa glennow vd i marginalen bank för ytterligare information kontakta haris serhatlic kommunikationschef 46 701 721 736 haris serhatlic marginalen se informationen i detta pressmeddelande är sådan som marginalen bank bankaktiebolag ska offentliggöra enligt eu s marknadsmissbruksförordning informationen lämnas för offentliggörande den 16 oktober 2024 kl
5268,all_events,DOWN,,media release
10163,all_events,UP,,media release
2452,all_events,UP,DOWN,09 oct 2024 18 05 cest lepermislibre lepermislibre mot clé s résultat trimestriel chiffre d affaires du 3ème trimestre 2024 09 oct 2024 18 05 cet cest communiqué de presse chiffre d affaires du 3ème trimestre 2024 après un trimestre ralenti lepermislibre se prépare à une reprise marquée par des initiatives stratégiques lyon le 9 octobre 2024 lepermislibre isin fr001400f2z1 mnémonique allpl le pionnier de l auto école en ligne en france publie son chiffre d affaires du 3ème trimestre 2024 en k normes comptables françaises 9 mois t3 2024 2023 var 2024 2023 var chiffre d affaires 10 362 12 856 3 015 4 218 dont candidats classiques 4 780 5 580 1 330 1 816 dont candidats cpf 5 549 7 257 1 674 2 395 autres 33 20 11 7 le chiffre d affaires du t3 2024 s élève
6650,all_events,DOWN,,certara today announced the launch of phoenix version 8 5 software the pharmaceutical industry s gold standard in pk pd modeling and simulation
2796,all_events,DOWN,,19 nov 2024 13 41 cet solis bond company dac technical extension of maturity date more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632623_solis bond company notice of a written resolution pdf solis bond company dac oslo børs newspoint solis bond company 21 24 frn eur floor c no0010914914 oslo børs
8509,all_events,UP,,malvern pa may 09 2024 globe newswire annovis bio inc nyse anvs annovis or the company a clinical stage drug platform company developing novel therapies for neurodegenerative diseases today announced successful completion of data cleaning for its phase iii study of buntanetap in patients with early parkinson s disease pd topline efficacy data is expected in june
2227,all_events,DOWN,DOWN,november 11 2024 12 30 et source ab novaturas ab novaturas on november 11th 2024 at 9 00 am ceo of ab novaturas mr kristijonas kaikaris and cfo mr darius undzėnas presented the company s consolidated financial results for the third quarter of 2024 to investors link to webinar record https www youtube com watch v o8128vfquey list pleolx3tanx_9ben29gisabm4b srjehj2 performance of novaturas group for 9m of 2024 eur 000 s about the companynovaturas group is the largest and the only charter flights local tour operator in the baltic states offering summer and winter trips to more than 30 destinations worldwide and more than 100 tours based on audited data in 2023 novaturas group recorded revenues of eur 208 3 million and served 259 000 passengers in lithuania latvia and estonia darius undzėnas cfo 370 678 05749 attachment
4705,all_events,UP,,farmington hills mich jan 24 2024 globe newswire ocuphire pharma inc nasdaq ocup a clinical stage ophthalmic biopharmaceutical company focused on developing and commercializing small molecule therapies for the treatment of retinal and refractive eye disorders today announced that the independent members of its board of directors approved equity awards under ocuphire s 2021 inducement plan as a material inducement to two new employees in connection with their employment with the company effective on january 18 2024 the equity awards were approved in accordance with nasdaq listing rule 5635 c 4 which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan
8522,all_events,DOWN,,fast track designation has the potential to accelerate lead asset imm 1 104 s path to u s fda submission for pancreatic ductal adenocarcinoma
177,all_events,DOWN,DOWN,media release
6319,all_events,UP,,12 nov 2024 07 30 cet veritas bureau press release paris november 12 2024 bureau veritas continues to build capabilities in the energy and renewables sector through the acquisition of versatec energy b v bureau veritas a global leader in testing inspection and certification services today announced the acquisition of versatec energy b v an independent and specialized technical advisory company for the offshore and onshore energy industry this acquisition is in line with the leap 28 strategy to create a new stronghold in the fast growing renewables segment underscoring the group s commitment to the energy transition and strengthening its position as a crucial player in shaping a sustainable and safe energy sector bureau veritas contributes to energy sector efficiency by providing power sector customers with end to end solutions to meet the immediate and future challenges of transitioning energy sources while developing and operating innovative renewable asse
3105,all_events,UP,,media release
1740,all_events,DOWN,DOWN,11 oct 2024 18 49 cest panoro energy asa oslo 11 october 2024 panoro energy asa panoro or the company ose pen initiated a share buyback program on may 23 2024 to repurchase up to nok 100 million in value of the company s common shares in open market transactions on the ose pursuant to an agreement with arctic securities as for the period from and including 7 october through 11 october 2024 panoro purchased a total of 15 000 shares at an average price of nok 28 6867 per share the transactions effected through the agreement with arctic comprise all the transactions effected by or on behalf of the company during the period transaction overview date trading volume weighted average total daily cumulative venue share price nok transaction value nok 10 11 oct
1178,all_events,UP,DOWN,media release
6392,all_events,UP,,06 nov 2024 09 42 cet veolia environnement regulatory news on the occasion of the smart city world expo congress of barcelona veolia paris vie is announcing a 30 million commitment to the axeleo greentech industry gti i fund aimed at accelerating the ecological transformation of industry in europe veolia has joined forces with bpifrance and crédit mutuel alliance fédérale for this 1st closing dedicated to financing the first factory of industrial startups for ecological transformation in europe this fund which aims to raise 250m will offer decisive support to around twenty companies developing innovative technologies in strategic sectors essential to ecological transformation in europe such as energy new renewable energies storage etc chemicals materials biomaterials plastics recycling etc agriculture food and mobility decarbonisation of air and sea transport etc in addition to its financial participation veolia will use its indu
6496,all_events,UP,,media release
247,all_events,DOWN,UP,as tallinna sadam hereinafter as tallinna sadam and jetgas oü hereinafter as jetgas signed an agreement for establishment of a liquefied methane terminal in muuga harbour according to the agreement jetgas will build a liquified methane terminal with up to five storage tanks in stages with a connecting pipeline to the quayline by 2030 at the latest the launch of the first stage of the terminal with the construction of one tank is planned for the end of 2027 the construction of the liquefied methane terminal is the result of a tender process initiated last spring the aim of which was to find new operators for vacant areas of muuga harbour the new terminal and cooperation with jetgas as a long term player in the energy products market will bring us additional vessel calls and cargo volumes and will create opportunities for the transport sector when switching to more environmentally friendly fuels valdo kalm the chairman of the management board of tallinna sadam welcomed
4605,all_events,DOWN,,02 oct 2024 07 45 cest smcp sa press release paris october 2nd 2024 ida simonsen is appointed as president and ceo of smcp north america smcp group is pleased to announce the appointment of ida simonsen as president and ceo for north america she will succeed to paul griffin who decided to pursue his career outside the group isabelle guichot ceo of smcp group said we are thrilled to welcome ida simonsen to the smcp family as president and ceo for north america ida s dynamic leadership extensive industry expertise and passion for people make her the perfect fit to lead our north american team she has a proven track record of successfully navigating transitions and driving growth and i am confident that she will inspire our teams and help us achieve new milestones in the region i join the entire smcp team in wishing her every success in her new role ida simonsen as president and ceo of smcp north america i am delighted to join smcp a key player in the acce
6878,all_events,UP,,company announcement no 16 2024 13 november 2024 wirtek s board of directors has today approved the interim report for q3 2024 below a summary the detailed report is attached to this announcement ceo michael aaen comments our energy business unit has made extraordinary strides this quarter representing of total revenue in q3 2024 with a remarkable growth rate of compared to q3 2023 this achievement underscores both the resilience and potential of our focus on clean and green energy in addition to continue growing our existing services business our ambition is to provide clients with innovative and scalable solutions the recent acquisitions of pragmasoft and seluxit are already proving instrumental in accelerating our progress in this area as we integrate specialised talent intellectual property and technology into our operations since acquiring seluxit in july this year we have signed three new contracts within just two months highlighting the strong marke
3909,all_events,UP,,media release
218,all_events,DOWN,DOWN,media release
5061,all_events,DOWN,,media release
1643,all_events,DOWN,DOWN,15 nov 2024 03 55 cet shelf drilling ltd press release shelf drilling primary insider notification dubai november 15 2024 reference is made to the announcement by shelf drilling ltd shelf drilling or the company ose shlf today regarding the issuance of a total of 155 771 new common shares in the company without any consideration as settlement of restricted stock units rsus under the company s 2017 long term incentive plan pursuant to which the following primary insiders or the sponsor firm they represent received common shares in the company as further specified in the attached forms of notification ernie danner director john k castle director david b pittaway director benjamin sebel director usama trabulsi director david williams director mei xianzhi director reference is also made to the announcement made by shelf drilling on november 13 2024 regarding the award of 33 716 new rsus to each of the non executive directors
10697,all_events,UP,,media release
12241,all_events,UP,,media release
8994,all_events,UP,,11 nov 2024 12 55 cet sparebank 1 helgeland forstanderskapet i sparebank 1 helgeland vedtok i vår å videreføre spareprogram for ansatte alle fast ansatte i banken kan delta i spareprogrammet og betingelsene er like for alle formålet med programmet er å motivere ansatte til å være medeiere i banken og samtidig øke interessen rundt bankens strategi og resultater ansatte som har meldt seg inn i spareordningen vil spare et årlig beløp på enten kroner 12 000 24 000 eller 36 000 etter et års eiertid vil banken tildele ansatte som ikke har solgt egenkapitalbevis kjøpt gjennom spareprogrammet for 2025 ett gratis egenkapitalbevis for hvert andre egenkapitalbevis kjøpt gjennom spareprogrammet for 2025 se tabell i vedlegg for en oversikt over primærinnsidere i sparebank 1 helgeland som har meldt seg inn i spareprogrammet beløpene som oppgis er totale sparebeløp for 2025 antall egenkapitalbevis tildelt og kjøpskurs for egenkapitalbevisene som blir solgt til den enkel
9573,all_events,UP,,november 06 2024 09 10 et source oma säästöpankki oyj oma säästöpankki oyj oma säästöpankki oyj pörssitiedote 6 11 2024 klo 16 10 sisäpiiritieto sisäpiiritieto osakkeenomistajien nimitystoimikunta ehdottaa viiden uuden jäsenen valintaa oma säästöpankki oyj n hallitukseen ja suosittaa ylimääräistä yhtiökokousta hallituksen valitsemiseksi osakkeenomistajien nimitystoimikunta joka edustaa viittä suurintaa osakkeenomistajaa suosittaa oma säästöpankki oyj n omasp tai yhtiö hallitusta kutsumaan ylimääräisen yhtiökokouksen koolle jo ennen kevään 2025 varsinaista yhtiökokousta ja ehdottaa omasp n seuraavalle yhtiökokoukselle hallituksen kokoonpanosta ja palkitsemisesta seuraavaa osakkeenomistajien nimitystoimikunnan ehdotus omasp n hallituksen jäsenten lukumäärästä ja kokoonpanosta hallituksen jäsenten lukumääräksi ehdotetaan vahvistettavan kahdeksan osakkeenomistajien nimitystoimikunta ehdottaa että hallituksen jäseniksi valitaan uudellee
11263,all_events,UP,,07 nov 2024 17 46 cet vinci xavier huillard has named nicolas notebaert as chief executive officer of concessions at vinci in his new role mr notebaert reports to pierre anjolras chief operating officer of vinci already in charge of the vinci concessions business line notably including vinci airports vinci highways vinci railways and several public private partnerships mr notebaert has thus been given responsibility for vinci autoroutes and vinci stadium as well this appointment clarifies the group s organisation and will strengthen synergies between vinci s concession companies as pierre coppey has resigned as chairman of the motorway concession companies that make up vinci autoroutes mr notebaert now also serves in that role born in 1970 mr notebaert is a graduate of the école polytechnique and the école nationale des ponts et chaussées and holds an mba he joined the vinci group in 2002 as head of the operations department at cofiroute and moved to vinci
11047,all_events,DOWN,,november 20 2024 06 14 et source corline biomedical ab corline biomedical ab corline biomedical ab corline meddelar att man tagit initiativ till omförhandling av avtalet med imperative care gällande chs för neurovaskulära applikationer avtalet är från och med nu icke exklusivt och omfattar enbart s k stent coil produkter därmed har corline rätt att erbjuda chs till andra kunder inom neurovaskulära applikationer samt ingå utvecklingsavtal och kommersiella avtal med dessa parter corline har inlett utvärderingar med två bolag inom området ett mindre europeiskt utvecklingsbolag för icad åderförkalkning i hjärnan samt ett etablerat amerikanskt bolag för aneurysmbehandling corline bedömer att potentialen för chs inom det neurovaskulära området uppgår till minst 150 msek i årlig intäkt corline tecknade i maj 2023 ett exklusivt avtal med imperative care för användning av chs för neurovaskulära applikationer i december 2023 redovisa
50,all_events,DOWN,UP,18 nov 2024 08 30 cet sparebanken vest det vises til børsmelding 8 november 2024 vedrørende tegning av egenkapitalbevis i sparebanken vests spareprogram for ansatte sparebanken vest har nå overført 257 025 egenkapitalbevis fra egen beholdning til de ansatte i henhold til tegning i spareprogrammet sparebanken vest har etter denne overførselen 55 652 egenkapitalbevis i gjenværende egenbeholdning kontaktperson i sparebanken vest direktør økonomi operations og investor relations brede borgen kristiansen tlf 479 06 402 og e post brede kristiansen spv no denne informasjonen er informasjonspliktig etter verdipapirhandelloven 5 12 jf 4 2 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sparebanken vest oslo børs newspoint sparebanken vest spb vest boligkredit as 24 29 frn c covd spb vest 19 25 2 spb vest 19 25 frn spb vest 20 perp frn c hybrid spb vest 20 26 adj c spb vest
1705,all_events,UP,DOWN,07 nov 2024 17 45 cet transgene s a compelling 24 1 month median follow up data presented at sitc 2024 showed that all patients treated with tg4050 after completion of an adjuvant standard of care remain disease free tg4050 induced specific and sustained immune responses a phase ii part is now enrolling patients internationally to build on this promising outcome strasbourg france tokyo japan november 7 2024 5 45 p m cet transgene euronext paris tng a biotech company that designs and develops virus based immunotherapies for the treatment of cancer and nec corporation nec tse 6701 a leader in it network and ai technologies today announced 24 1 month median follow up data from the ongoing randomized phase i trial of tg4050 in the adjuvant treatment of head and neck cancers the data will be presented in a poster at the society for immunotherapy of cancer sitc 2024 annual meeting on november 9 in houston tx tg4050 is an individualized immunotherapy
5908,all_events,UP,,the company s management will host a webcast and conference call on wednesday may 15 2024 after the close of financial markets
1650,all_events,UP,UP,sugar land texas nov 11 2024 prnewswire pursuant to section 30 of the danish capital markets act noble corporation plc noble cse noble nyse ne hereby announces the receipt of a major shareholder notification from first eagle investments management llc first eagle first eagle has notified noble on november 8 2024 that as of november 5 2024 the first eagle holdings of shares and voting rights in noble as well as other financial instruments according to section 39 2 1 of the danish capital markets act corresponded to 5 the total share capital and voting rights of noble resulting from 8 169 046 shares and voting rights according to section 38 of the danish capital markets act corresponding to 5 of the total share capital and voting rights of noble important information this announcement is for information purposes only and does not constitute or contain any invitation solicitation recommendation offer or advice to any person to subscribe for
6576,all_events,DOWN,,san diego jan 31 2024 globe newswire anaptysbio inc nasdaq anab a clinical stage biotechnology company focused on delivering innovative immunology therapeutics today announced that daniel faga president and chief executive officer will present at guggenheim s 6th annual biotechnology conference
7824,all_events,DOWN,,media release
5852,all_events,DOWN,,not for release publication or distribution directly or indirectly in or into the united states australia canada new zealand hong kong japan switzerland singapore south africa south korea great britain or any other jurisdiction in which the release publication or distribution of this press release would be unlawful be subject to legal restrictions or would require registration or other measures further restrictions apply see the section important information at the end of this press release today november 18 2024 is the last day of trading in subscription rights in the ongoing rights issue of sek 80 million in flat capital ab publ flat or the company the subscription period ends on november 21 2024 a teaser prospectus and other information on how current shareholders and new investors can participate are available on flats website under the section rights issue 2024 www flatcapital com en rights issue 2024 upon full subscription of the rights iss
6275,all_events,UP,,trial did not meet statistical significance on improvement in primary endpoints of progression free survival pfs or overall survival os trial did not meet statistical significance on improvement in primary endpoints of progression free survival pfs or overall survival os
3931,all_events,DOWN,,warrington pa oct 23 2024 globe newswire windtree therapeutics inc windtree or the company nasdaqcm wint a biotechnology company focused on advancing early and late stage innovative therapies for critical conditions and diseases today announced that the company has completed national phase filings of patent applications around the world including in the united states germany france italy japan and china
5886,all_events,UP,,07 nov 2024 17 45 cet akwel champfromier jeudi 07 novembre 2024 chiffre d affaires neuf mois en baisse de 5 2 akwel fr0000053027 akw éligible pea équipementier systémier pour l industrie automobile et poids lourd spécialiste du management des fluides des mécanismes et des pièces de structure des véhicules électriques a enregistré sur les neuf premiers mois de l année 2024 un chiffre d affaires consolidé publié de 757 7 m en retrait de 5 2 par rapport à la même période de 2023 chiffre d affaires consolidé du 1er janvier au 30 septembre 2024 en m non audité20242023variationvariation pcc 1 1er trimestre263 5274 6 4 0 3 3 2ème trimestre265 3271 2 2 2 2 2 3ème trimestre228 9253 1 9 6 9 2 total 9 mois757 7799 0 5 2 4 8 1 à périmètre et taux de change constants chiffre d affaires du troisième trimestre en baisse de 9 6 la tendance de baisse d activité observée depuis le début de l exercice 2024 s est confirmée et renforcée au
10856,all_events,UP,,18 nov 2024 19 13 cet norwegian block exchange as not for distribution or release directly or indirectly in or into the united states canada australia the hong kong special administrative region of the people s republic of china or japan or any other jurisdiction in which the distribution or release would be unlawful other restrictions are applicable please see the important notice at the end of this announcement norwegian block exchange as partially underwritten rights issue oslo norway 18 november 2024 the board of directors of norwegian block exchange as norwegian block exchange or the company announces the terms of a planned rights issue of shares the new shares with preferential subscription rights for existing shareholders to raise gross proceeds of up to nok 17 million the rights issue certain existing shareholders and external investors jointly the underwriters have undertaken to underwrite in aggregate nok 10 million of the rig
2310,all_events,DOWN,DOWN,06 nov 2024 18 06 cet care property invest today care property invest publishes its interim financial report third quarter 2024 the link to the full report can be found below today care property invest publishes its interim financial report third quarter 2024 the link to the full report can be found below interimreportfromtheboardofdirectors q3 2024 eng pdf care property inv euronext care property invest be0974273055 cpinv euronext
7514,all_events,UP,,withsecure corporation inside information 11 october 2024 17 30 eest inside information profit warning withsecure corporation lowers its 2024 elements cloud products and services arr elements cloud products and services revenue and total group revenue outlook withsecure corporation lowers its elements cloud products and services arr elements cloud products and services revenue and total group revenue outlook for 2024 the company now expects its annual recurring revenue arr for elements cloud products and services to grow by 6 14 from the previous year previous outlook 10 20 in the end of 2023 elements cloud arr was eur 78 4 million revenue for elements cloud products and services is expected to grow by 8 12 from previous year previous outlook 10 16 previous year revenue from elements cloud products and services was eur 76 1 million total group revenue growth outlook is expected to be 2 5 from previous year previous outlook 6 previous year reven
3469,all_events,UP,,conference call begins today at 11 00 a m eastern time
7865,all_events,UP,,attachments 10090081 pdf relais 9 10 trades xlsx
6377,all_events,DOWN,,media release
6032,all_events,UP,,media release
7090,all_events,UP,,19 nov 2024 13 51 cet farsund kommune det er fastsatt ny obligasjonsrente for no0013233775 ny obligasjonsrente i renteperioden 21 11 2024 21 02 2025 er 4 994 ticker farko08 den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632639_b567456e3f4e40f7a1dd868a4f20bb91 pdf farsund kommune oslo børs newspoint farsund komm 22 25 frn farsund komm 23 28 4 farsund komm 24 26 frn farsund komm 24 27 3 no0012472515 no0012517582 no0013019877 no0013233775 no0013335596 oslo børs
9073,all_events,DOWN,,media release
4871,all_events,UP,,tampa fla may 30 2024 globe newswire pacira biosciences inc nasdaq pcrx today announced that it will participate in an analyst led fireside chat at the 2024 jefferies global healthcare conference at 11 00 am et on thursday june 6 2024 in new york live audio of the event can be accessed by visiting the events page of the company s website at investor pacira com a replay of the webcast will also be available for two weeks following the event
8762,all_events,UP,,13 nov 2024 12 16 cet mauna kea technologies regulatory news mauna kea technologies euronext growth almkt inventeur de cellvizio la plateforme multidisciplinaire d endomicroscopie confocale laser par minisonde et par aiguille p ncle fait un point sur ses récents développements dans un contexte de forte volatilité de son titre sur euronext growth la société a fait des avancées significatives dans le domaine des intolérances alimentaires depuis la conférence ueg week 2024 avec un nombre important de marques d intérêt de la part des professionnels elle a depuis participé à d autres conférences dont la dgvs deutsche gesellschaft für gastroenterologie société allemande de gastroentérologie où l accueil a été tout aussi enthousiaste la société a d ailleurs officiellement démarré l initiation de son programme celltolerance dans un groupe de cliniques réputé à paris et en régions en formant d ores et déjà des nutritionnistes au programme aux etats unis
12857,all_events,UP,,media release
6167,all_events,DOWN,,media release
10373,all_events,UP,,south san francisco calif oct 21 2024 globe newswire akero therapeutics inc nasdaq akro a clinical stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need today announced an upcoming oral presentation and two late breaking poster presentations at the 75th annual american association for the study of liver diseases aasld the liver meeting 2024 taking place from november 15 19 2024 in san diego the presentations will highlight findings from the 96 week phase 2b harmony study evaluating the efficacy and safety of lead product candidate efruxifermin efx in patients with pre cirrhotic metabolic dysfunction associated steatohepatitis mash fibrosis stage 2 or 3 f2 f3 along with insights from an analysis using ai and digital based pathology
4250,all_events,UP,,12 nov 2024 12 52 cet lea bank asa reference is made to previous stock exchange announcements on august 21 2024 september 26 2024 and october 22 2024 regarding the merger between lea bank asa and lea bank ab as approved by the board of directors the general meeting and the norwegian financial supervisory authority fsa the merger was conditional upon amongst other required approvals from the swedish fsa finansinspektionen the swedish fsa has today granted the necessary approval for the merger between lea bank asa and lea bank ab tentative timeline for the merger is january 2 2025 lea bank ab holds a swedish banking license and will be the surviving entity in the merger this information is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act contact information oddbjørn berentsen ceo phone 47 22 99 14 00 email ir leabank no more information access the news on oslo bors newsweb site more in
4047,all_events,UP,,rebellion operations ab publ rebellion operations meddelar att dess indirekta moderbolag rebellion capital ab publ rebellion capital idag framgångsrikt har placerat seniora säkerställda obligationer om 600 miljoner kronor under ett ramverk om totalt 1 000 miljoner kronor med en löptid om tre och ett halvt år de nya obligationerna de nya obligationerna löper med en rörlig ränta om 3m stibor plus 7 75 procent per år och emitterades till par enligt ett pressmeddelande daterat 9 oktober 2024 meddelade rebellion operations att rebellion capital har erbjudit externa innehavare av obligationer 2022 2025 med isin se0017486509 emitterade av rebellion operations befintliga obligationer att återköpa samtliga av deras befintliga obligationer till ett pris om 100 80 procent av det nominella beloppet plus upplupen men obetald ränta återköpserbjudandet återköpserbjudandet lämnades på de villkor som anges i ett återköpsdokument daterat den 9 oktober 2024 återköpserbjudandet
12725,all_events,UP,,in the course of the intra group reorganization of as infortar on 8 november 2024 as tallink grupp transferred 34 000 shares of as tallink takso with a nominal value of 6 3 euros representing of the share capital to as infortar following the transaction as infortar will hold of the shares in as tallink takso the transaction is not treated as a transaction beyond everyday economic activities or a transaction of a significant importance transaction is between related parties but does not have a significant impact on the activities of as infortar or as tallink grupp aktsiaselts infortar operates in seven countries the company s main fields of activity are maritime transport energy and real estate aktsiaselts infortar owns a 68 stake in aktsiaselts tallink grupp a stake in as eesti gaas and a versatile and modern real estate portfolio of approx 116 000 m2 in addition to the three main areas of activity aktsiaselts infortar also operates in construction and
4602,all_events,DOWN,,cyprium received 4 5 million payment upon closing and remains eligible to receive royalties and up to 129 million in aggregate development and sales milestones
2058,all_events,UP,DOWN,19 nov 2024 14 13 cet stad kommune se vedlegg på www newsweb no more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632648_interests 2024 11 19 pdf stad kommune oslo børs newspoint stad komm 22 25 frn stad komm 23 26 frn stad komm 24 27 frn no0012627050 no0012994344 no0013359364 oslo børs
12401,all_events,UP,,tuhura has an exclusive right to negotiate to acquire kineta s kva12123 immuno oncology drug program
8466,all_events,DOWN,,san diego aug 08 2024 globe newswire biora therapeutics inc nasdaq bior the biotech company reimagining therapeutic delivery today announced it will report financial results and provide a corporate update for the second quarter ended june 30 2024 company management will host a webcast and conference call on monday august 12 2024 after the close of financial markets
10306,all_events,UP,,09 oct 2024 17 45 cest renault regie nat des usines disclosure of the total number of voting rights and shares provided pursuant to article l 233 8 ii of the french commercial code and the article 223 16 of the règlement général de l autorité des marchés financiers regulation of the french stock market authority company name of the issuer renault s a 122 122 bis avenue du général leclerc 92100 boulogne billancourt isin code fr0000131906 rno date total number of issued shares total number of voting rights september 30 2024 295 722 284 theoretical number of voting rights 1 401 104 945 exercisable number of voting rights 2 394 204 621 1 pursuant to article 223 11 of the règlement général de l autorité des marchés financiers number calculated on the basis of all shares to which voting rights are attached including shares for which voting rights have been suspended treasury shares liquidity contract etc 2
10502,all_events,UP,,18 nov 2024 08 30 cet af gruppen asa vito kongsvinger as related party to board member and primary insider in af gruppen asa erik veiby has today sold 40 000 shares in af gruppen asa at a price of 134 00 per share the shares were sold to etv invest as also a related party to erik veiby following these transactions vito kongsvinger as and etv invest as owns 1 871 676 and 40 000 shares respectively in af gruppen asa this information is subject to disclosure requirements set out in the market abuse regulation eu 596 2014 article 19 and the norwegian securities trading act section 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site af gruppen asa oslo børs newspoint af gruppen no0003078107 afg oslo børs
12922,all_events,UP,,november 06 2024 02 45 et source sampo oyj sampo oyj sampo oyj osavuosiraportti 6 11 2024 klo 9 45 sampo konsernin tulos tammi syyskuulta 2024 kasvua kertyi 10 prosenttia kiintein valuuttakurssein tammi syyskuussa 2024 mitä tuki vahva kehitys kaikilla liiketoiminta alueilla mutta erityisesti isossa britanniassa underwriting tulos kasvoi 955 miljoonaan euroon 882 ja yhdistetty kulusuhde oli 84 6 prosenttia 84 2 vahvan kasvun ja positiivisen alla olevan kehityksen myötä konsernin alla oleva yhdistetty kulusuhde parani 1 6 prosenttiyksikköä mitä tukivat positiiviset trendit pohjoismaissa ja isossa britanniassa tulos ennen veroja vahvistui 1 340 miljoonaan euroon 1 113 underwriting tuloksen nousun ja vahvojen sijoitustuottojen tukemina ja osakekohtainen operatiivinen tulos nousi 2 prosenttia 1 68 euroon 1 65 solvenssi ii vakavaraisuussuhde oli 177 prosenttia osinkokertymä huomioiden ja velkaisuusaste oli 26 8 prosent
2616,all_events,UP,,conference call and webcast today at 8 30 a m et conference call and webcast today at 8 30 a m et
12473,all_events,UP,,company to host conference call november 13 2024 at 4 30 p m et company to host conference call november 13 2024 at 4 30 p m et
1623,all_events,DOWN,UP,cambridge mass and menlo park calif feb 15 2024 globe newswire intellia therapeutics inc nasdaq ntla a leading clinical stage gene editing company focused on revolutionizing medicine with crispr based therapies and recode therapeutics a clinical stage genetic medicines company using tissue specific delivery to power the next wave of mrna and gene correction therapeutics today announced a strategic collaboration to develop novel genomic medicines for the treatment of cystic fibrosis cf cf is a genetic disease caused by mutations in the cftr gene leading to the accumulation of thick mucus in the lungs digestive systems and other organs cf can result in life threatening infections respiratory failure and other serious complications
586,all_events,DOWN,UP,arctic minerals ab publ arctic minerals or the company is pleased to announce that it has established an advisory committee to the board of the company arctic minerals holds multiple advanced exploration projects within the nordic region including the hennes bay and swan lake projects in sweden the bidjovagge project in norway and the tavast and kuusi projects in finland the advisory committee is comprised of lars eric aaro duncan large and erik lundstam all prominent highly experienced and well regarded european based businessman and technical experts with extensive resources sector and broader industry networks in europe and the nordics in particular the advisory committee will substantially strengthen arctic minerals position in the nordics with the committee members collective corporate technical and operating expertise plus extensive business and government networks greatly assisting the company as it focuses on rapidly advancing its strong project portfolio
396,all_events,DOWN,DOWN,16 oct 2024 07 30 cest boussard gavaudan holding ltd boussard gavaudan holding limited ordinary shares the directors of boussard gavaudan holding limited would like to announce the following information for the company close of business 15 oct 2024 estimated nav euro sharessterling sharesestimated nav 28 4129 25 5457estimated mtd return 0 19 0 21 estimated ytd return 3 14 3 97 estimated itd return 184 13 155 46 nav and returns are calculated net of management and performance fees market information euro sharesamsterdam aex london lse market close 27 40n apremium discount to estimated nav 3 56 n a sterling sharesamsterdam aex london lse market closen agbx 2 380 00premium discount to estimated navn a 6 83 transactions in own securities purchased into treasury ordinary shares euro sharessterling sharesnumber of sharesn an aaverage pricen an arange of pricen an a
4533,all_events,DOWN,,media release
9851,all_events,DOWN,,media release
1010,all_events,UP,DOWN,14 nov 2024 18 00 cet oxurion leuven belgium november 14 2024 06 00 pm cet oxurion nv euronext brussels oxur a biopharmaceutical company headquartered in leuven today announced that pursuant to belgian transparency legislation1 it has received a transparency notification as follows oxurion received a transparency notification on november 14 2024 from atlas special opportunities llc indicating that as of november 12 2024 it held 267 064 shares of the then outstanding 2 002 550 shares and therefore crossed under the threshold by virtue of the sale of voting securities see annex 1 in pdf file about oxurion oxurion euronext brussels oxur is engaged in developing next generation standard of care ophthalmic therapies for the treatment of retinal disease oxurion is based in leuven belgium more information is available at www oxurion com important information about forward looking statements certain statements in this press release may be conside
1579,all_events,DOWN,UP,media release
2614,all_events,UP,,08 nov 2024 09 01 cet bio uv group biouvcprse07112024fr pdf bio uv group euronext bio uv group fr0013345493 altuv euronext growth
12847,all_events,UP,,ad hoc mitteilung gemäss art 53 kr
6596,all_events,UP,,dear sirs sydbank share buyback programme transactions in week 46on 28 february 2024 sydbank announced a share buyback programme of dkk 1 200m the share buyback programme commenced on 4 march 2024 and will be completed by 31 january 2025 the purpose of the share buyback programme is to reduce the share capital of sydbank and the programme is executed in compliance with the provisions of regulation eu no 596 2014 of the european parliament and of the council of 16 april 2014 and commission delegated regulation eu 2016 1052 of 8 march 2016 collectively referred to as the safe harbour rules the following transactions have been made under the share buyback programme all transactions were made under isin dk 0010311471 and effected by danske bank a s on behalf of sydbank a s further information about the transactions cf article 5 of regulation eu no 596 2014 of the european parliament and of the council on market abuse and commission delegated regulation is available
10767,all_events,UP,,media release
8231,all_events,DOWN,,saint herblain france 13 septembre 2024 valneva se nasdaq valn euronext paris vla valneva ou la société société spécialisée dans les vaccins annonce aujourd hui le succès de son augmentation de capital définie ci dessous pour un montant final de 61 180 000 euros
3912,all_events,DOWN,,media release
2751,all_events,UP,,media release
8544,all_events,DOWN,,awarded additional 6 7 million to advance nexobrid as a non surgical field care solution r d project budget increased to 14 4 million awarded additional 6 7 million to advance nexobrid as a non surgical field care solution r d project budget increased to 14 4 million
4720,all_events,UP,,missing
3038,all_events,UP,,media release
5500,all_events,DOWN,,reference is made to the press release issued by 24sevenoffice group ab the group listed company or 24sevenoffice on 11 october 2024 announcing that the group listed company had entered into a memorandum of understanding regarding a potential sale of parts of its assets and subsidiaries 24sevenoffice a leader in cloud based enterprise software across the nordics is today announcing that the group listed company has entered into a definitive agreement with abacus bidco oy the purchaser the holding company of accountor software which is majority owned by funds managed by kkr a leading global investment firm for the sale of certain subsidiaries and assets of 24sevenoffice the transaction kkr acquired accountor software one of the leading providers of business software in finland and sweden earlier this year kkr will be the majority owner of both companies which will be combined to create one of the leading financial management and hr software businesses serving
10118,all_events,UP,,media release
251,all_events,UP,DOWN,08 nov 2024 08 00 cet texaf regulated information attachment communiqué 241108en_trimestriel_vfinale regulated information attachment communiqué 241108en_trimestriel_vfinale pdf texaf globenewswire texaf be0974263924 texf euronext
2109,all_events,UP,DOWN,media release
3060,all_events,DOWN,,media release
4301,all_events,UP,,november 06 2024 00 30 et source mowi asa mowi asa bergen 6 november 2024 mowi generated record high operating revenues of eur 1 44 billion in the third quarter which translated into an operational profit of eur 173 million this was yet another good quarter for mowi with our best ever seawater production and harvest volumes of 161 000 tonnes we ve never had more fish in the sea with biomass in sea up 4 year on year at quarter end mowi ceo ivan vindheim said mowi is well positioned to meet its harvest volume guidance for 2024 of a milestone 500 000 tonnes furthermore record high biomass in sea supports 2025 volume guidance of 520 000 tonnes the first step towards mowi s next milestone of harvesting 600 000 tonnes of salmon expected in 2029 520 000 tonnes in 2025 represents growth of 145 000 tonnes since 2018 equivalent to 4 cagr vs 2 average for the industry continued growth in mowi s farming operations will in turn l
9256,all_events,DOWN,,media release
10871,all_events,UP,,q3 2024 konzernumsatz von 502 mio bei tatsächlichen kursen bei konstanten wechselkursen cer verwässerter gewinn je aktie von 0 44 und bereinigter verwässerter gewinn je aktie von 0 57 konzernumsatz bei konstanten wechselkursen cer von 502 mio übertrifft prognose von mindestens 495 mio cer bereinigter verwässerter gewinn je aktie von 0 58 cer übertrifft prognose von mindestens 0 55 cer diagnostiklösungen sind mit cer wachstum die stärkste produktgruppe bereinigte operative marge steigt um 3 prozentpunkte auf 29 im vergleich zu 26 in q3 2023 free cashflow steigt in den ersten neun monaten 2024 im vergleich zum vorjahres zeitraum um auf 364 mio umsatzprognose für das geschäftsjahr 2024 von mindestens 1 985 mrd cer aufgrund solider trends im kerngeschäft bestätigt prognose für bereinigten verwässerten gewinn je aktie auf mindestens 2 19 cer erhöht
5861,all_events,UP,,06 nov 2024 18 00 cet aurea aurea société anonyme au capital de 11 264 260 80 siège social 3 avenue bertie albrecht 75008 paris562 122 226 rcs paris information mensuelle relative au nombre total de droits de vote et d actions composant le capital social article 223 16 du règlement général de l autorité des marchés financiers datenombre total d actions composant le capital socialnombre total de droits de vote31 octobre 20249 386 884droits de vote théoriques 1 16 306 178droits de vote réels 2 16 283 793 1 les droits de vote théoriques sont calculés sur la base de l ensemble des actions auxquelles sont attachés des droits de vote y compris les actions privées de droits de vote conformément à l article 223 11 du règlement général de l amf 2 les droits de vote réels correspondent au nombre total de droits de vote exerçables en assemblée générale ils sont calculés sur la base du nombre total de droits de vote attachés au nombre total d actions déductio
149,all_events,UP,DOWN,07 nov 2024 17 55 cet nrj group see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1296201_nrj_group__financial_information_q3_2024docx pdf nrj group les echos nrj group fr0000121691 nrg euronext
12065,all_events,UP,,turku finland and boston jan 25 2024 globe newswire faron pharmaceuticals ltd aim farn first north faron a clinical stage biopharmaceutical company pursuing a clever approach to reprogramming myeloid cells to activate anti tumor immunity in hematological and solid tumor microenvironments today provided details from its further analysis of data from the completed phase 1 part of the ongoing bexmab trial
2351,all_events,UP,DOWN,nordic iron ore ab has appointed magnus lundin as director of technology projects magnus lundin has extensive experience as a project manager and maintenance manager in the mining and steel industry magnus comes from the role of consultant manager at aenigma bergslagen combined with the role of project manager backfill and ventilation at boliden garpenberg previously magnus has held a number of important roles at outokumpu avesta the position of director of technology and projects reports to the company s ceo the role involves responsibility for and management of the operations of the company s technology and projects unit it feels very exciting to welcome magnus lundin with a broad background in the local mining and steel industry to nordic iron ore to lead the work of building up and establishing our project office and technical operations to be an important part in the company going forward towards a start of the mine construction towards the end of 2025 says ronne ham
6784,all_events,UP,,summarising the results of the operations of the company for the first nine months of the year sales of pre owned slightly pre owned and new goods amounted to 12 4 million euros which is more than in the first nine months of 2023 in the third quarter of 2024 sales reached 4 5 million euros an increase of compared to the same period last year in the third quarter we have made significant steps in the development of the convenience retail segment by opening two new banknote branches in vilnius lithuania and expanding our banknote xl network in latvia by opening branches of this concept in rēzekne and daugavpils in response to public demand for flexible and versatile shopping solutions we are also further developing our online shop in latvia and lithuania where more than 50 000 goods are available in one place with a guarantee of up to 24 months we continue to play an active role in the development of the circular economy promoting sustainable consumption and
11319,all_events,DOWN,,boston march 13 2024 globe newswire pepgen inc nasdaq pepg a clinical stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases today announced that management will participate in the following upcoming investor conferences
9659,all_events,DOWN,,boston jan 16 2024 globe newswire elicio therapeutics inc nasdaq eltx elicio therapeutics or elicio a clinical stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer today announced that robert connelly chief executive officer and christopher haqq m d ph d executive vice president head of research and development and chief medical officer will participate in a fireside chat at the b riley securities 4th annual oncology conference on january 18 2024 at 2 30 pm et
1807,all_events,UP,UP,financial commentary for the third quarter and nine months of 2024 sales revenue was 796 keur in 3q 2024 681 keur in 3q 2023 and 2 206 meur for the nine months of 2024 2 043 meur for 9 months of 2023 operating profit was 724 keur in 3q 2024 605 keur in 3q 2023 and 2 017 meur for the nine months of 2024 1 753 meur for 9 months of 2023 ebitda was was 724 keur in 3q 2024 605 keur in 3q 2023 and 2 017 meur for the nine months of 2024 1 753 meur for 9 months of 2023 net income was 350 keur in 3q 2024 209 keur in 3q 2023 and 746 keur for the nine months of 2024 649 keur for 9 months 2023 the higher operating and net profit in q3 2024 is mainly due to increased sales revenue during the reporting period the higher operating and net profit for the first nine months of 2024 is in addition to the above due to the higher cost of goods and services sold during the comparison period management board the management board of upp olaines oü has one member marko tali
200,all_events,DOWN,UP,data from an analysis of five nhp studies showed lumbar it administration led to widespread and consistent biodistribution of aav9 gene therapy vectors across brain and spinal cord regions
4412,all_events,UP,,06 nov 2024 10 36 cet volue asa oslo børs has decided to delist the shares of volue asa from trading on euronext oslo børs pursuant to rule book ii pkt 2 11 2 3 oslo børs has on 6 november 2024 made the following resolution the shares in volue asa will be delisted from euronext oslo børs as of 7 november 2024 the last day of trading will be 6 november 2024 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site volue asa oslo børs newspoint volue asa no0010894603 volue oslo børs
11149,all_events,DOWN,,10 oct 2024 18 00 cest horisont energi as sandnes norway 10 october 2024 horisont energi euronext hrgi is assessing additional co2 storage options to polaris as part of the work towards the concept select decision for the clean ammonia project barents blue recent development for co2 storages in the north sea has provided new alternatives and thus optionality for the barents blue project that were not available when the project was launched an alternative co2 storage in the north sea will reduce capital requirements both in the development and construction phase and project on project risks will be reduced this will allow barents blue to explore the commercial potential recognising that the opex is expected to increase because of the transportation cost from barents blue there are several licenses for co2 storage in the north sea that have stipulated a timeline in line with the barents blue milestones which also makes it relevant for us to consider these
9602,all_events,DOWN,,media release
3859,all_events,UP,,olaine 2024 10 15 01 06 cest to continue the company s growth and refinance the existing bonds lv0000860047 on october 14 2024 sia crosschem submitted documents to nasdaq csd for the registration of a new unsecured bond issue with the following characteristics notes issue will be structured as a private placement with eur 100 000 minimum investment see issue terms attached we highly value our investors and wish to continue our successful collaboration with them our goal is to refinance the existing 3 million bond issue and if necessary we are prepared to issue the full bond amount up to 5 million says ričards andersons chairman of the board at crosschem offer to existing investors from 15 october to 29 october 2024 noteholders of lv0000860047 notes with maturity 4 november 2024 who wish to continue investing in sia crosschem notes are offered the opportunity to exchange their existing lv0000860047 notes for the new ones noteholders of lv0000860047 not
8236,all_events,DOWN,,ms jones joins vaxcyte with over 20 years of experience leading people and culture strategies across multiple industries san carlos calif jan 16 2024 globe newswire vaxcyte inc nasdaq pcvx a clinical stage vaccine innovation company engineering high fidelity vaccines to protect humankind from the consequences of bacterial diseases today announced the appointment of whitney jones as chief people officer ms jones will lead vaxcyte s human resources strategy and operations including people and culture talent acquisition and management learning and development total rewards and employee engagement
749,all_events,DOWN,DOWN,this message has been corrected click here to view the corrected message from october 8th 2024 10 00 eest bigbank as bonds isin code ee3300004977 public offer subscription process is launched the last trading day of the subscription period is october 18th 2024 15 30 eest up to 3 000 bonds are being publicly offered to investors in estonia latvia and lithuania the offer price is 1 000 eur per bond which is equal to the nominal value of a bond the interest rate is 6 per annum payed quarterly and the maturity is 10 years the bonds will be registered in the nasdaq csd under the isin code ee3300004977 in case of over subscription bigbank has the right to increase the volume of the offering to a total of 8 000 bonds and the offering may also be decreased by the amount unsubscribed the subscription offer will be carried out using the stock exchange trading system and nasdaq csd offering via stock exchange trading system for investors in latvia and lithuan
1433,all_events,DOWN,DOWN,08 nov 2024 18 00 cet essilorluxottica nombre total de droits de vote et d actions composant le capital social au 31 octobre 2024 conformément à l article l 233 8 ii du code de commerce et aux articles 221 1 et 223 16 du règlement général de l amf paris france 8 novembre 2024 18h00 au 31 octobre 2024 le capital d essilorluxottica le leader mondial dans la conception la fabrication et la distribution de verres ophtalmiques de montures et de lunettes de soleil s établit comme indiqué ci dessous 31 octobre 2024nombre total d actions composant le capital457 322 5071nombre réel des droits de vote déduction faite des actions auto détenues 456 762 601nombre théorique des droits de vote y compris actions auto détenues 457 322 507 a noter les droits de vote font l objet d un plafonnement à 31 applicable à tout actionnaire conformément à une formule décrite à l article 23 des statuts d essilorluxottica2 pour plus d informations veuillez vous référer au pros
11660,all_events,UP,,media release
11321,all_events,UP,,media release
8196,all_events,UP,,media release
1328,all_events,DOWN,UP,november 12 2024 11 30 et source sanoma corp sanoma corp sanoma corporation stock exchange release 12 november 2024 at 18 30 eet sanoma corporation acquisition of own shares 12 november 2024 nasdaq helsinki ltd the company holds a total of 140 997 of its own shares sanoma including the shares acquired on 12 november 2024 detailed information concerning the acquisition is attached to this stock exchange release on behalf of sanoma corporation skandinaviska enskilda banken ab publ helsinki branch antti salakka janne tiihonen additional information kaisa uurasmaa head of investor relations and sustainability tel 358 40 560 5601 sanoma sanoma is an innovative and agile learning and media company impacting the lives of millions every day our sustainability strategy is designed to maximise our positive brainprint on society and to minimise our environmental footprint we are committed to the un sustainable development go
2848,all_events,DOWN,,newark calif nov 18 2022 globe newswire rain therapeutics inc nasdaqgs rain rain a late stage biotechnology company developing precision oncology therapeutics with a lead product candidate milademetan an oral small molecule inhibitor of the mdm2 p53 complex that reactivates p53 today announced that it will be participating in piper sandler s 34th annual healthcare conference being held november 29 december 1 2022 in new york
11828,all_events,DOWN,,financial commentary for the third quarter and nine months of 2024 sales revenue was 796 keur in 3q 2024 681 keur in 3q 2023 and 2 206 meur for the nine months of 2024 2 043 meur for 9 months of 2023 operating profit was 724 keur in 3q 2024 605 keur in 3q 2023 and 2 017 meur for the nine months of 2024 1 753 meur for 9 months of 2023 ebitda was was 724 keur in 3q 2024 605 keur in 3q 2023 and 2 017 meur for the nine months of 2024 1 753 meur for 9 months of 2023 net income was 350 keur in 3q 2024 209 keur in 3q 2023 and 746 keur for the nine months of 2024 649 keur for 9 months 2023 the higher operating and net profit in q3 2024 is mainly due to increased sales revenue during the reporting period the higher operating and net profit for the first nine months of 2024 is in addition to the above due to the higher cost of goods and services sold during the comparison period management board the management board of upp olaines oü has one member marko tali
83,all_events,DOWN,UP,on november 13 2024 the sole shareholder of maxima grupė uab uab vilniaus prekyba made a decision to extend the term of office of the current board for a new four year term the board of maxima grupė uab consists of manfredas dargužis jolanta bivainytė petar petrov pavlov lauryna šaltinė agnė voverė arūnas zimnickas and karolina zygmantaitė additional information maxima grupė uab manages the retail chains maxima in the baltic states stokrotka in poland t market in bulgaria and the online grocery store barbora which operates in the baltic states maxima grupė uab is part of the vilniaus prekyba group of companies vilniaus prekyba also manages investments in retail pharmacy catering service networks and real estate development and leasing companies in the baltic states sweden poland and bulgaria through other subsidiaries contact person lukas radžiūnas head of communication and corporate affairs lukas radziunas maximagrupe eu
10652,all_events,DOWN,,media release
3522,all_events,DOWN,,media release
3571,all_events,UP,,media release
12487,all_events,UP,,tallinn estonia 2024 11 18 14 16 cet nasdaq tallinn decided on november 18 2024 to change the grounds of the observation status applied for punktid technologies as pnktd isin kood ee3100089160 the observation status applied on august 5 2024 is removed as the reasons due to which the observation status was applied on ceased to exist observation status was applied due to the fact that punktid technologies as did not pay the fee within the time limit and in the amount specified by the exchange and the payment was overdue for more than six months the observation status applied to the company on july 1 2024 is still in force nasdaq baltic issuer services 372 640 8800 www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative markets first north operated by nasdaq companies in the baltic states i e nasdaq tallinn as nasdaq riga as and ab nasdaq vilnius
5681,all_events,UP,,nasdaq vilnius decided to apply observation status to sun investment group uab sigr130024fa isin kodas lt0000313256 the reason for the observation status is that the semi annual financial information for 2024 h1 has not been announced within 3 months after the end of the reporting period as stipulated by the rules of the first north in lithuania the purpose of applying observation status is to alert the market participants nasdaq baltic transaction services 370 5 253 14 54 www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative markets first north operated by nasdaq companies in the baltic states i e nasdaq tallinn as nasdaq riga as and ab nasdaq vilnius
1166,all_events,DOWN,DOWN,s p global ratings has revised the future perspective of jsc augstsprieguma tīkls credit rating from positive to stable due to the sovereign downgrade about jsc augstsprieguma tikls ast the latvian electrical power transmission system operator ensures uninterrupted and secure transmission of electricity throughout latvia its vision is to become the leading transmission system operator in the region through the efficient and successful implementation of development oriented changes ast has 68 shareholding in the capital of the operator of the natural gas transmission and storage system as conexus baltic grid further information līva jēgere head of communications ph 371 26151344 email liva jegere ast lv attachments ratingsdirect_researchupdatelatvianelectricitytransmissionoperatorastoutlookrevisedtostableonsovereigndowngradearatingaffirmed_59594161_oct 11 2024 cleaned pdf
11294,all_events,UP,,nors 2024 metų ab utenos trikotažas trečio ketvirčio pardavimai išlieka žemi tačiau nuo ketvirčio pabaigos pastebimas nuosaikus užsakymų ir gamybos apimčių didėjimas šiuo metu ab utenos trikotažas dirba pilnu pajėgumu tuo tarpu dėl didelio užimtumo dalis gamybos yra atliekama subrangoje panevėžio apygardos teismui patvirtinus restruktūrizavimo planą pradedamas plano vykdymas
3474,all_events,DOWN,,litgrid ab company code 302564383 registered office address karlo gustavo emilio manerheimo str 8 vilnius lithuania is publishing results of the company for the nine months of 2024 key financial indicators for 9 months of 2024 the adjustment of profitability ratios is made due to temporary regulatory deviations from the regulated profitability approved by the national energy regulatory council nerc the calculation of the adjusted ratios shall take into account the adjustment of the revenue for prior periods which has already been approved by the nerc decision for the purpose of setting the regulated prices for transmission services for the reference period and shall take into account the deviation between the profitability approved by the nerc for the reference period and the actual profitability which will be taken into account by the nerc for the purpose of setting the prices for transmission services for future periods attachments 1 financial results of the company
5666,all_events,DOWN,,06 nov 2024 09 02 cet hoteles bestprice s a hoteles bestprice celebra su investor day con el anuncio de nuevas estimaciones al alza de sus resultados a nivel de facturación y beneficios con una cifra de inversión que supera en estos meses los 13 millones de euros la cadena hotelera eleva sus previsiones de ingresos para el 2026 a 13 5 millones de euros con unos beneficios operativos esperados de 7 millones de euros excluyendo nuevas inversiones de capex y costes de estructura las inversiones se están desarrollando en los últimos 4 hoteles incorporados a su portfolio que ya suma 10 establecimientos hoteleros el grado de ejecución de las cifras de capex alcanza el asimismo la cadena hotelera dibuja un escenario de incorporación de nuevos establecimientos hoteleros en régimen de arrendamiento dentro de su plan estratégico bianual de 2026 de disponer de hasta 14 hoteles operativos una cifra de negocios que se elevaría a los 16 millones de euros y un beneficio de op
7754,all_events,UP,,11 nov 2024 08 00 cet egide s a communiqué de presse bollène 11 novembre 2024 8h00 cet résultats de l augmentation de capital avec maintien du dps des actionnaires par émission d actions à bons de souscription d actions pour un montant de 1 67 m demandes de souscription portant sur un total de 3 341 375 absa représentant un taux de souscription d environ 92 emission de 3 341 375 absa pour une augmentation de capital de 1 670 687 50 le groupe egide euronext growth paris isin fr0000072373 mnémo algid spécialiste mondial des boîtiers hermétiques et des solutions de dissipation thermique pour composants électroniques sensibles annonce ce jour le résultat de l augmentation de capital avec maintien du droit préférentiel de souscription des actionnaires dps par émission d actions à bons de souscription d actions absa décidée par le conseil d administration du 21 octobre 2024 et dont la période de souscription s est déroulée du 29 octobre au 6
10487,all_events,UP,,media release
429,all_events,DOWN,DOWN,media release
8968,all_events,UP,,media release
9627,all_events,UP,,se venligst vedlagte
12032,all_events,DOWN,,07 oct 2024 18 00 cest essilorluxottica third quarter 2024 revenueconference call invitation mr stefano grassi chief financial officer andmr giorgio iannella head of investor relations have the pleasure of inviting you to our third quarter 2024 revenue conference call on thursday october 17 2024 at 6 30 pm cest dial in telephone access if you wish to dial into the conference call please pre register at the following link to receive the personal credentials dial in numbers conference id and user id https aiti capitalaudiohub com essilorluxottica reg html if you encounter any issue in the pre registration phase you may contact ir essilorluxottica com providing your name and surname and the name of your company live webcast you can watch the presentation at the following link https streamstudio world television com 1217 2090 40578 en the press release will be published at 6 00 pm cest on the same day and the presentation slides will be made available pr
3684,all_events,DOWN,,toronto feb 01 2024 globe newswire revive therapeutics ltd revive or the company otcqb rvvtf cse rvv frankfurt 31r a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders announced today its initiative in bucillamine an oral thiol based drug with anti inflammatory and antiviral properties as a potential treatment for long covid the company aims to advance the clinical development of bucillamine by leveraging the published research and existing data from its previous phase 3 clinical trial the study and is preparing a clinical package that includes a proposed phase 2 3 clinical protocol for long covid to present to the fda and international health regulatory bodies
1061,all_events,UP,DOWN,as merko ehitus kontserni kuuluv sia merks mājas on käivitanud riias skanste linnaosas arena garden towersi korteriarendusprojekti esimese etapi 13 korruseline 84 korteriga maja aadressil arēnas iela 1 valmib 2026 aasta suvel
4043,all_events,UP,,15 oct 2024 22 05 cest sanofi informations relatives au nombre total de droits de vote et d actions prévues par l article l 233 8 ii du code de commerce et l article 223 16 du règlement général de l autorité des marchés financiers sanofisociété anonyme au capital de 2 537 214 304 siège social 46 avenue de la grande armée 75017 paris395 030 844 r c s paris date nombre d actions composant le capital nombre réel de droits de vote déduction faite des actions auto détenues nombre théorique de droits de vote y compris actions auto détenues 30 septembre 20241 268 914 3661 413 296 4971 428 630 140 en application de l article 223 11 du règlement général de l autorité des marchés financiers ces informations sont également disponibles sur le site internet de sanofi rubrique information réglementée https www sanofi com fr investisseurs action sanofi et adrs action sanofi droits de vote et actions direction des relations investisseurse mail investor relatio
1655,all_events,UP,DOWN,media release
8377,all_events,DOWN,,13 nov 2024 17 45 cet cenergy holdings sa 20241113 cenergy holdings cpw capacity expansionfr pdf cenergy holdings euronext cenergy be0974303357 cener euronext
7907,all_events,UP,,conference call and webcast to be held at 8 30 a m est
3708,all_events,UP,,media release
293,all_events,DOWN,DOWN,media release
4170,all_events,UP,,new york aug 13 2024 globe newswire eyenovia inc nasdaq eyen an ophthalmic technology company commercializing mydcombi tropicamide and phenylephrine hydrochloride ophthalmic spray 2 for mydriasis clobetasol propionate ophthalmic suspension 0 for postsurgical inflammation and pain and developing the optejet device for use both in connection with its own drug device therapeutic product for pediatric progressive myopia and dry eye as well as out licensing for additional indications today announced that the company will participate in the h c wainwright 4th annual ophthalmology virtual conference which is being held on thursday august 15th
4292,all_events,DOWN,,vilnius lithuania 2024 10 18 08 33 cest omx baltic benchmark fund share price on october 17 2024 13 1603 eur omx baltic benchmark fund number of shares issued on october 17 2024 0 units omx baltic benchmark fund number of shares redeemed on october 17 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of october 17 2024 125 362 units nter asset management
6517,all_events,DOWN,,04 oct 2024 07 30 cest codelab capital as oslo 4 october 2024 reference is made to the stock exchange announcement made by codelab capital as the company on 26 june 2024 regarding the successful placing of a private placement in the company raising gross proceeds of nok 40 million and a potential subsequent offering of up to 17 241 379 new shares the shares in the company have since 30 august 2024 traded below the subscription price in the private placement with volumes deemed substantial compared to the size of the potential subsequent offering consequently any shareholders wishing to reduce the dilutive effect of the private placement have had the opportunity to purchase shares in the company in the market at prices similar to or below what would have been the subscription price in the subsequent offering the board of directors of codelab has therefore decided not to proceed with the subsequent offering for further queries please contact ceo kristian ika
7676,all_events,DOWN,,media release
11436,all_events,UP,,second quarter fiscal 2024 revenue down 21 to 119 0 million year to date fiscal 2024 revenue down 7 to 254 5 million agreement in principle reached with the u s department of justice on related matter site optimization projects near completion conference call begins today at 4 30 pm et
3160,all_events,UP,,08 nov 2024 07 15 cet itera asa oslo 8th november 2024 itera reports a decline in revenue for the third quarter primarily due to a large customer downscale despite this challenge the company is beginning to see positive trends in demand and has during the quarter secured several large framework agreements of 500 mnok in estimated value additionally itera is expanding its presence by opening a new office in stavanger through a small acquisition itera reports operating revenue of nok 184 2 million nok 193 9 million for the third quarter of 2024 for the first nine months of 2024 operating revenue was nok 636 9 million nok 649 5 million revenue and profitability were negatively impacted by a global customer replacing a significant portion of itera s activities with a global supplier leading to a sudden reduction in volume that affected approximately 35 40 consultants the customer has however based on a comprehensive assessment decided to revert the a
7825,all_events,DOWN,,november 11 2024 02 58 et source sparekassen sjælland fyn a s sparekassen sjælland fyn a s selskabsmeddelelse nr 57 2024holbæk den 11 november 2024 aktietilbagekøb i sparekassen sjælland fyn transaktioner i uge 45 sparekassen sjælland fyn a s sparekassen offentliggjorde den 13 maj 2024 et tilbagekøbsprogram på 100 mio kr aktietilbagekøbsprogrammet startede den 13 maj 2024 og vil være afsluttet senest den 5 februar 2025 aktietilbagekøbsprogrammet sker med henblik på nedsættelse af aktiekapitalen i sparekassen og gennemføres efter bestemmelserne i europa parlamentets og rådets forordning eu nr 596 2014 af 16 april 2014 og eu kommissionens delegerede forordning eu 2016 1052 af 8 marts 2016 samlet kaldet safe harbour reglerne under aktietilbagekøbsprogrammet er gennemført følgende transaktioner alle transaktioner er foretaget i isin dk 0060670776 og gennemført af danske bank a s på vegne af sparekassen yderligere oplysninger
8593,all_events,UP,,radnor pa may 06 2024 globe newswire mineralys therapeutics inc nasdaq mlys a clinical stage biopharmaceutical company focused on developing medicines to target hypertension chronic kidney disease ckd and other diseases driven by dysregulated aldosterone today announced that management will be participating in a fireside chat at the bank of america securities health care conference being held in las vegas on may 14 16 2024
6495,all_events,UP,,november 12 2024 01 45 et source nordecon nordecon nordecon as ja eesti rahvusringhääling sõlmisid töövõtulepingu tallinnasse aadressile f r kreutzwaldi tn 14 gonsiori tn 21 rajatava eesti rahvusringhäälingu uue telemaja ehitamiseks uus telemaja on kuni kuue maapealse ning ühe maa aluse parkimiskorrusega multifunktsionaalne hoone kuhu on kompaktselt ja funktsionaalselt hästi toimivalt kokku pandud muuhulgas erineva suurusega stuudiod dekoratsioonide laoruumid ja töökojad eri tüüpi teletehnoloogilised struktuuriüksused ning bürooruumid hoone suletud netopind on kokku 17 000 m² lepinguliste tööde kogumaksumuseks on 40 1 miljonit eurot koos tellija reservi ja ilma käibemaksuta ning need kestavad 36 kuud riigihankel edukaks tunnistamise teade on varasemalt avaldatud 16 10 2024 nordeconi kontsern www nordecon com hõlmab ettevõtteid mis on keskendunud hoonete ja rajatiste ehitamise projektijuhtimisele ja peatöövõtule geograafiliselt te
3000,all_events,UP,,media release
7238,all_events,UP,,fondsbørsmeddelelse 22 2024
608,all_events,UP,UP,an open letter to shareholders regarding a reverse stock split
5181,all_events,DOWN,,media release
8628,all_events,DOWN,,media release
5635,all_events,UP,,06 nov 2024 18 00 cet covivio hotels see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1295729_20241031__covivio_hotels_droits_de_vote pdf covivio hotels les echos covivio hotels fr0000060303 covh euronext
6383,all_events,UP,,18 oct 2024 18 15 cest orange communiqué de presseparis le 18 octobre 2024 orange a finalisé son retrait volontaire du nyse et a déposé un certificat de désenregistrement auprès de la sec orange maintient un programme adr de niveau 1 orange annonce aujourd hui que le retrait volontaire de la cote des american depositary shares ads représentant ses actions ordinaires de la bourse de new york nyse est effectif la société a déposé un formulaire 15f auprès de la securities and exchange commission sec pour mettre fin à ses obligations de reporting en vertu du securities exchange act de 1934 tel que modifié exchange act concernant les ads et les actions ordinaires le désenregistrement devrait devenir effectif 90 jours après le dépôt du formulaire 15f le formulaire 15f et le désenregistrement concernent également les titres suivants émis par orange les obligations à 9 00 arrivant à échéance le 1er mars 2031 les obligations à 5 375 arrivant à éc
12928,all_events,DOWN,,tallinn estonia 2024 10 08 16 15 cest on october 8th 2024 the management board of nasdaq tallinn decided to approve the additional admission to trading application of as bercman technologies and to list its 12 742 additionally issued shares issued due to option s program realization on nasdaq baltic alternative market first north proceeding from the above the additional shares of as bercman technologies will be admitted to trading as of wednesday october 9th or on a date close to it thus altogether 1 464 007 shares of bercman technologies isin ee3100076407 will be traded under the trading code bercm on or about october 9th 2024 nasdaq baltic issuer services 372 640 8800 www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative markets first north operated by nasdaq companies in the baltic states i e nasdaq tallinn as nasdaq riga as and ab nasdaq vilnius
1953,all_events,UP,DOWN,miami jan 03 2024 globe newswire fortress biotech inc nasdaq fbio fortress or company an innovative biopharmaceutical company focused on efficiently acquiring developing and commercializing or monetizing promising therapeutic products and product candidates today announced the closing of its previously announced registered direct offering the company issued 3 303 305 shares of its common stock and warrants to purchase up to 3 303 305 shares of common stock at a combined offering price of 3 33 per share of common stock and accompanying warrant priced at the market under nasdaq rules the warrants have an exercise price of 3 21 per share are immediately exercisable and will expire five years following the date of issuance
1989,all_events,UP,UP,13 nov 2024 15 28 cet elopak asa financial calendar for elopak asa financial year 2024 02 04 2025 annual report 11 02 2025 quarterly report q4 financial year 2025 14 08 2025 half yearly report 14 05 2025 annual general meeting 07 05 2025 quarterly report q1 28 10 2025 quarterly report q3 this information is published pursuant to the requirements set out in the continuing obligations more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site elopak asa oslo børs newspoint elopak asa no0011002586 elo oslo børs
5746,all_events,DOWN,,florham park n j jan 04 2024 globe newswire celularity inc nasdaq celu the company a biotechnology company developing allogeneic cell therapies and advanced biomaterial products today confirmed that it has entered into an exclusive u s strategic commercialization agreement with biocellgraft inc biocellgraft under which celularity will manufacture advanced biomaterial products for biocellgraft which biocellgraft will distribute in the united states for use in multiple dental oral healthcare applications a copy of biocellgraft s announcement of the agreement can be accessed here https www prweb com releases biocellgraft finalizes commercialization agreement with celularity for the manufacture and distribution of products for therapeutic use in oral healthcare 302025082 html
9876,all_events,UP,,conference call and webcast to be held at 8 30 a m edt
7136,all_events,DOWN,,the lithuanian government eurobonds auction of additional offers will be held on 2024 10 28 auction participants can submit competitive and non competitive bids the competitive bids shall be submitted in the order books of the vse new issue yield market whereas the non competitive bids shall be placed in the order books of the vse new issue yield non market the parameters of the emission to be issued shall be the following with the written consent of the ministry of finance this amount may be increased by one additional amount up to a maximum of eur 5 000 000 for one of the auction participants the securities shall be redeemed by paying to their holders the total amount of par value the paid up securities shall be admitted to the regulated market to the debt securities list of the nasdaq vilnius ab nasdaq baltic transaction services 370 5 253 14 54 www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative
3721,all_events,DOWN,,addvise group s subsidiary mrc systems has received an order from orbitworks a company specialized in advanced technology based in united arab emirates the order is worth approximately usd 1 8 million the order involves design paneling and installation of a cleanroom and associated accessories delivery of the order is scheduled to be completed during q2 2025 for further information please contact staffan torstensson ceo 46 704 33 20 19 staffan torstensson addvisegroup se important information this information is information that addvise group ab is required to disclose under the eu market abuse regulation the information was submitted for publication on november 11 2024 at 11 20 cet about addvise group addvise is an international life science group operating a decentralised ownership model we develop and acquire high quality companies within the business areas lab and healthcare the group comprises more than 20 companies and generates annual revenues of close to s
9185,all_events,DOWN,,resultat du 1er semestre 2024
11217,all_events,UP,,new york aug 08 2024 globe newswire ovid therapeutics inc nasdaq ovid a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain conditions today announced the appointment of amanda banks m d as chief development officer dr banks will oversee ovid s clinical development medical and regulatory affairs functions as well as drive corporate development strategy and execution in partnership with the company s leadership team
8621,all_events,UP,,nokia corporationstock exchange release7 october 2024 at 22 30 eet nokia corporation repurchase of own shares on 07 10 2024 espoo finland on 7 october 2024 nokia corporation lei 549300a0jprwg1ki7u06 has acquired its own shares isin fi0009000681 as follows rounded to two decimals on 25 january 2024 nokia announced that its board of directors is initiating a share buyback program to return up to eur 600 million of cash to shareholders in tranches over a period of two years the first phase of the share buyback program started on 20 march 2024 on 19 july 2024 nokia decided to accelerate the share buybacks by increasing the number of shares to be repurchased during the year 2024 the post increase repurchases in compliance with the market abuse regulation eu 596 2014 mar the commission delegated regulation eu 2016 1052 and under the authorization granted by nokia s annual general meeting on 3 april 2024 started on 22 july 2024 and end by 31 december 2024 with a maximu
5040,all_events,DOWN,,15 nov 2024 15 04 cet hydrogenpro asa on september 27 2024 the european hydrogen bank introduced new terms where prospective projects will not be allowed to source more than 25 percent of electrolyser stacks covering surface treatment cell unit production and stack assembly from china this week the european commission shared a letter that further clarifies the regulations based on dialogue with investors and analysts hydrogenpro observes that this has created uncertainty and has led to misunderstandings of the complex supply chain involved in the production of electrolysers therefore hydrogenpro would like to clarify the following hydrogenpro fully complies with the european hydrogen bank s funding requirements for our european projects any necessary adjustments to our supply chain will be minimal jarle dragvik ceo of hydrogenpro asa comments we have thoroughly analyzed our supply chain based on the eu regulations which includes our electrode pr
1383,all_events,DOWN,UP,south san francisco calif oct 30 2024 globe newswire septerna inc nasdaq sepn a clinical stage biotechnology company pioneering a new era of g protein coupled receptor gpcr oral small molecule drug discovery today announced the closing of its upsized initial public offering ipo of 18 400 000 shares of its common stock at a public offering price of 18 00 per share which includes an additional 2 400 000 shares issued upon the full exercise by the underwriters of their option to purchase additional shares all of the shares were offered by septerna
9737,all_events,DOWN,,new york july 01 2024 globe newswire ovid therapeutics inc nasdaq ovid a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain conditions and graviton bioscience corporation a privately held clinical stage biotechnology company focused on developing rho associated coiled coil containing protein kinase 2 rock2 inhibitors and other innovative therapeutic compounds today announced the results from their phase 1 healthy volunteer study evaluating the safety tolerability and pharmacokinetic pk profile of multiple ascending doses of ov888 gv101 capsule ovid and graviton plan to progress to a phase 2 clinical study in cerebral cavernous malformations ccm later this year
7706,all_events,UP,,immunocore announces upcoming presentation and posters at asco 2024
2348,all_events,DOWN,DOWN,rockville md may 04 2023 globe newswire opgen inc nasdaq opgn opgen or the company a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease today announced the closing of its previously announced public offering of an aggregate of 4 495 825 shares of its common stock or pre funded warrants in lieu thereof and common stock purchase warrants to purchase up to 4 495 825 shares of common stock at a combined public offering price of 0 7785 per share or pre funded warrant in lieu thereof and accompanying warrant the warrants have an exercise price of 0 7785 per share will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the warrants and will expire five years from the date of stockholder approval
9232,all_events,DOWN,,media release
10756,all_events,DOWN,,media release
4770,all_events,UP,,november 07 2024 04 20 et source netcompany group a s netcompany group a s company announcement no 50 2024 7 november 2024 on 31 october 2024 netcompany group a s netcompany announced that a share buyback programme of up to dkk 250m and a maximum of 1 300 000 shares had been initiated with the purpose of adjusting netcompany s capital structure and meeting its obligations relating to share based incentive programmes the share buyback programme is executed in accordance with eu market abuse regulation eu regulation no 596 2014 of 16 april 2014 and the provisions of commission delegated regulation eu 2016 1052 of 8 march 2016 the safe harbour regulation the share buyback programme will end no later than 24 january 2024 transactions made under the share buyback programme will be announced through nasdaq copenhagen on a weekly basis the following transactions have been executed in the period 31 october 2024 to 6 nove
8331,all_events,UP,,november 15 2024 10 03 et source orkela uab orkela uab basic data about the company uab orkela hereinafter the company is a private limited liability company registered with the state enterprise centre of registers on 24 september 2015 legal address jogailos st 4 vilnius the company has no branches or representative offices the company s main activity is real estate development and construction the company owns a land plot and building complex in vilnius at vasario 16 st 1 the company is developing a lyceum and hotel complex next to the church and monastery of the apostles st philip and james the company expects to complete the project in 2024 highlights of three quarters of 2024 during three quarters of 2024 the company invested eur 5 84 million in the development of the project during this period the company incurred eur 298 6 thousand of costs related to the project development and eur 2 307 3 thousand of project fin
7456,all_events,UP,,flx475 treated patients exhibited significant changes in immune pathways likely to enhance an antitumor response
6096,all_events,UP,,media release
7793,all_events,DOWN,,media release
5372,all_events,UP,,media release
8949,all_events,UP,,media release
3528,all_events,DOWN,,media release
6703,all_events,UP,,media release
3461,all_events,DOWN,,08 nov 2024 08 00 cet texaf gereglementeerde informatie bijlage communique 241108nl_trimestriel_vfinale gereglementeerde informatie bijlage communique 241108nl_trimestriel_vfinale pdf texaf globenewswire texaf be0974263924 texf euronext
12551,all_events,DOWN,,november 07 2024 02 00 et source statkraft as statkraft as oslo norge 7 november 2024 statkraft leverte robuste underliggende resultater og rekordsterk energidisponering i tredje kvartal 2024 tross lavere kraftpriser i norden resultatet ble påvirket av netto finansposter på 3 4 milliarder kroner hovedsakelig på grunn av en svakere krone statkraft fortsetter å levere robuste underliggende resultater tross lavere priser og lavere vannkraftproduksjon i norge solid energidisponering ga rekordhøy prismargin i vår nordiske vannkraftportefølje og gjenspeiler den økte verdien av disse anleggene på grunn av høyt tilsig og langsiktig energidisponering er statkraft godt rustet til å møte økt etterspørsel og forventede høyere priser i vintersesongen sier konsernsjef birgitte ringstad vartdal i statkraft hun legger til i segmentene europa og internasjonal reflekterte resultatene fortsatt høyt tempo innen forretningsutvikling økt prod
1512,all_events,DOWN,DOWN,event to highlight results from the clinical trial of bt 600 an orally administered drug device combination in development for ulcerative colitis
1261,all_events,DOWN,UP,november 19 2024 02 30 et source aino health ab publ aino health ab publ aino health har informerats om att norberg partner sustainable group ab igår avyttrade st 98 748 884 aktier till två finska investmentbolag nexit iii ky har köpt 59 249 330 aktier och tenendum oy 39 499 554 aktier efter transaktionerna äger norberg partner sustainable group ab 0 procent av aktierna i aino health ab nexit iii ky 29 procent och tenendum oy 19 3 procent mer information om de nya ägarnanexit ventures oy är ett erfaret finskt riskkapitalbolag som under de senaste 25 åren har investerat i dussintals lovande unga teknikföretag och skapat internationella framgångssagor nexits investering gjordes från nexit iii ky fonden länk till deras hemsida www nexitventures comtenendum oy är en aktiv delägare i framför allt mjukvaru och it tjänsteföretag tenendum investerar i både noterade och onoterade bolag länk till deras hemsida www tenendum fi för mer info
9423,all_events,DOWN,,westlake village calif july 03 2024 globe newswire arcutis biotherapeutics inc nasdaq arqt a commercial stage biopharmaceutical company focused on developing meaningful innovations in immuno dermatology today reported the grant of an aggregate of 325 000 restricted stock units of arcutis common stock as well as options to purchase an aggregate of 55 000 shares of arcutis common stock to 43 newly hired employees these awards were approved by the compensation committee of arcutis board of directors and granted under the arcutis biotherapeutics inc 2022 inducement plan with a grant date of july 1 2024 as an inducement material to the new employees entering into employment with arcutis in accordance with nasdaq listing rule 5635 c 4
704,all_events,UP,UP,november 06 2024 11 00 et source kn energies kn energies on november 5 2024 ab kn energies hereinafter kn received a formal notice from independent board member edvinas katilius regarding his resignation from the position of board member of kn effective december 31 2024 december 31 2024 will be edvinas katilius last day in office as an independent board member head of communication milda ancevičėm ancevice kn lt 370 694 29855
8525,all_events,DOWN,,media release
8777,all_events,UP,,18 nov 2024 07 50 cet equinor asa the shares in equinor asa ose eqnr nyse eqnr will as from today be traded on oslo børs exclusive the second quarter 2024 cash dividend as detailed below ex date 18 november 2024 ordinary cash dividend amount 0 35 extraordinary cash dividend amount 0 35 announced currency usd this information is published in accordance with the requirements of the continuing obligations and is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site equinor asa oslo børs newspoint equinor statoil asa 13 33 4 no0010096985 no0010689615 eqnr oslo børs
2316,all_events,UP,DOWN,new york sept 27 2024 globe newswire eyenovia inc nasdaq eyen eyenovia or the company an ophthalmic technology company with two fda approved products and a late stage asset in development for the treatment of pediatric progressive myopia today announced it has entered into a securities purchase agreement with a healthcare focused institutional investor for the purchase and sale of 8 695 653 shares of its common stock or common stock equivalents in lieu thereof and warrants to purchase up to an aggregate of 8 695 653 shares of common stock in a registered direct offering at a combined offering price of 0 46 per share and accompanying warrant the warrants have an exercise price of 0 50 per share will be exercisable commencing six months from the date of issuance and will expire five years from the initial exercise date the closing of the offering is expected to take place on or about september 30 2024 subject to the satisfaction of customary closing conditions
6705,all_events,UP,,18 nov 2024 10 54 cet østfold energi as ratingbyrået scope ratings har offentliggjort sin årlige oppdatering av rating for østfold energi østfold energi har fått en rating på bbb stabil scope har også bekreftet ratingen for senior usikret gjeld på bbb og kortsiktig gjeldsrating på s 2 ratingen reflekterer østfold energis kostnadseffektive og miljøvennlige vannkraftproduksjon samt selskapets sterke finansielle nøkkeltall vi er fornøyd med å motta nok en sterk rating dette bekrefter at vi er et trygt og solid selskap med stabile utsikter det gir oss et godt grunnlag for å finansiere utbyggingen av mer fornybar energi og jobbe målrettet mot å nå målene i konsernstrategien sier trine iren bjørck berg direktør for finans økonomi og risiko i østfold energi vedlagt følger pressemelding fra scope ratings for fullstendig rapport se https www ostfoldenergi no om ostfold energi finansiell informasjon for mer informasjon kontakt trine berg direktør øk
6977,all_events,UP,,november 08 2024 15 30 et source nokia oyj nokia oyj nokia corporationstock exchange release8 november 2024 at 22 30 eet nokia corporation repurchase of own shares on 08 11 2024 espoo finland on 8 november 2024 nokia corporation lei 549300a0jprwg1ki7u06 has acquired its own shares isin fi0009000681 as follows rounded to two decimals on 25 january 2024 nokia announced that its board of directors is initiating a share buyback program to return up to eur 600 million of cash to shareholders in tranches over a period of two years the first phase of the share buyback program started on 20 march 2024 on 19 july 2024 nokia decided to accelerate the share buybacks by increasing the number of shares to be repurchased during the year 2024 the post increase repurchases in compliance with the market abuse regulation eu 596 2014 mar the commission delegated regulation eu 2016 1052 and under the authorization granted by nokia s annual
1593,all_events,UP,DOWN,redwood city calif nov 05 2024 globe newswire rezolute inc nasdaq rzlt rezolute or the company a late stage biopharmaceutical company dedicated to developing transformative therapies for rare diseases with serious unmet needs today announced that management will participate in the following investor conferences
10945,all_events,UP,,saab north america inc ett amerikanskt dotterbolag till saab har tagit emot ett föreläggande från usa s justitiedepartement u s department of justice usa s justitiedepartement har begärt information om den brasilianska regeringens köp av 36 stridsflygplan av typ gripen e f för landets flygvapen kontraktet signerades 2014 brasiliens upphandling av stridsflyg fx 2 programmet ägde rum mellan 2008 och 2014 och saab tilldelades kontraktet saab avser att följa begäran att lämna information och att samarbeta med usa s justitiedepartement i detta ärende myndigheter i både brasilien och sverige har tidigare utrett delar av den brasilianska upphandlingen av stridsflyg dessa utredningar avslutades utan att påvisa något felaktigt agerande av saab på grund av sekretess har saab inte möjlighet att kommunicera ytterligare avseende detta kontakt mattias rådström presschef 46 0 734 180 018 presscentre saabgroup com merton kaplan chef investerarrelationer 46 0 734 182 071 merton k
8169,all_events,DOWN,,media release
6724,all_events,DOWN,,november 15 2024 05 40 et source kn energies kn energies correction interim financial information for the 3 quarters of 2024 will be released on 18 november 2024 ab kn energies further kn informs that it plans to release financial information in 2024 according to the following schedule on 30 april 2024 the company convened an ordinary general meeting of shareholders tomas tumėnas chief financial officer 370 46 391772
8014,all_events,DOWN,,first patient dosed with imm 1 104 in combination with modified gemcitabine plus nab paclitaxel for first line treatment of pancreatic ductal adenocarcinoma pdac
7620,all_events,UP,,05 nov 2024 18 00 cet groupe airwell le groupe airwell euronext growth alair créateur d écosystèmes énergétiques intelligents publie son chiffre d affaires au terme des neuf mois d exercice 2024 normes françaises en m non auditées q3 2023 q3 2024 variation 9 mois 2023 9 mois 2024 variation france métropolitaine 7 4 4 2 43 22 8 20 2 11 dom tom 2 4 1 7 29 4 9 3 1 37 international 4 4 5 1 16 19 0 13 5 29 total 14 2 11 0 22 46 7 36 8 21 activité du 3ème trimestre groupe airwell réalise au 3ème trimestre un chiffre d affaires de 11 0 m en repli de 22 par rapport au 3ème trimestre 2023 la conjoncture défavorable de l immobilier continue de peser fortement sur l activité après les records atteints lors de l exercice précédent en termes de répartition sectorielle les ventes sont réalisées à sur le marché résidentiel et sur le tertiaire en france métropolitaine l activité est toujours impactée pa
10704,all_events,DOWN,,media release
5880,all_events,UP,,media release
6125,all_events,DOWN,,under the base prospectus for bonds approved by the bank of lithuania on 25 november 2019 hereinafter the prospectus auga group ab hereinafter the company issued bonds with a total nominal value of eur 20 000 000 among other provisions the prospectus stipulates financial covenants including i an interest coverage ratio of no less than 2 and ii a consolidated equity to asset ratio of no less than hereinafter the financial covenants
9344,all_events,UP,,media release
9781,all_events,DOWN,,first patient dosed with imm 1 104 in combination with modified gemcitabine plus nab paclitaxel for first line treatment of pancreatic ductal adenocarcinoma pdac
772,all_events,UP,UP,10 oct 2024 17 32 cest atlantic sapphire asa please see attachment on www newsweb no more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 629406_notification of major holdings atlantic sapphire asa 09 10 2024 oslo bors pdf atlantic sapphire asa oslo børs newspoint atlantic sapphire no0013249896 asa oslo børs
9842,all_events,DOWN,,media release
6485,all_events,DOWN,,the improved results presented at esmo and the collaboration agreement with eisai have strengthened fostrox s chances of becoming the first approved therapy in second line liver cancer july septemberfinancial summary for the quarter significant events during the quarter january septemberfinancial summary for the period events after the end of the period conference call for investors analysts and the mediathe interim report january september 2024 will be presented by medivir s ceo jens lindberg time wednesday november 6 2024 at 14 00 cet to access the webcast and find information about the teleconference please klick here the conference call will also be streamed via a link on the website www medivir com investors calendarthe presentation will be available on medivir s website after completion of the conference ceo s messagetoday there are no approved drugs for the second line treatment of advanced liver cancer at the esmo congress in barcelona in september
1043,all_events,DOWN,UP,zug switzerland aug 15 2024 globe newswire oculis holding ag nasdaq ocs oculis a global biopharmaceutical company purposefully driven to save sight and improve eye care today announced the appointment of dr sharon klier an executive leader with extensive experience in clinical development across early and late stage programs regulatory submissions and approvals to the role of chief development officer in this key role dr klier will oversee and provide strategic leadership across the clinical development and operations of oculis robust ophthalmology pipeline
9582,all_events,DOWN,,stockholm 4 november 2024 virtune en svensk reglerad kapitalförvaltare av kryptotillgångar meddelar idag lanseringen av virtune crypto altcoin index etp på nasdaq stockholm den största börsen i norden
5561,all_events,UP,,18 nov 2024 19 17 cet norwegian block exchange as not for distribution or release directly or indirectly in or into the united states canada australia the hong kong special administrative region of the people s republic of china or japan or any other jurisdiction in which the distribution or release would be unlawful other restrictions are applicable please see the important notice at the end of this announcement norwegian block exchange as key information relating to the preferential rights issue reference is made to the stock exchange announcement published by norwegian block exchange as the company earlier today on 18 november 2024 regarding the planned partly underwritten rights issue with preferential subscription rights for existing shareholders to raise gross proceeds of up to nok 17 million the rights issue date on which the terms and conditions of the preferential rights issue were announced 18 november 2024 last day including right 20
811,all_events,UP,UP,oslo 24 may 2023 pci biotech holding asa pci biotech or the company issue this notification on behalf of its chairman hans peter bøhn
1520,all_events,UP,UP,unblinded interim analysis to be conducted during the current quarter
1670,all_events,DOWN,UP,november 12 2024 01 32 et source flsmidth a s flsmidth a s company announcement no 11 2024 12 november 2024 copenhagen denmark highlights in q3 2024 group ceo mikko keto commented in the third quarter of 2024 we continued to see a stable and healthy mining service market and a relatively softer mining products market and we expect these conditions to continue into next year the mining business delivered an adjusted ebita margin of 13 and we continue to progress towards our 2026 financial target the long term market outlook remains encouraging among other things exemplified by the recently signed strategic cooperation agreement for a new copper concentrator production line in uzbekistan a clear testament to the strength of our full flowsheet offerings and to our proven global execution capabilities for cement the stable market conditions continue to provide good opportunities for the service business whereas we continue to
11457,all_events,DOWN,,boca raton florida sept 13 2024 globe newswire inmune bio inc nasdaq inmb the company or inmune bio a clinical stage inflammation and immunology company focused on developing treatments that harness a patient s innate immune system to fight disease today announced it has entered into securities purchase agreements with new and existing institutional investors and certain directors and officers and employees of the company the directors and officers and employees herein referred to as the insiders for the purchase and sale of 2 341 260 shares of its common stock and warrants to purchase up to an aggregate of 2 341 260 shares of common stock at a combined purchase price per share and accompanying warrant of 5 50 for the institutional investors and 6 50 per share and accompanying warrant for the insiders pursuant to a registered direct offering the warrants will be exercisable commencing six months from the date of issuance at a price of 6 40 per share and will expire five years from the initial exercise date the warrant term may be subject to acceleration following the satisfaction of certain conditions in the case of insiders that participated in the offering if the warrant termination date is on a blackout date then the insiders will have an additional 60 days from the termination of the blackout date to exercise the warrant
113,all_events,UP,UP,12 nov 2024 12 10 cet nexans head office 4 allée de l arche 92400 courbevoie france tel 33 0 1 78 15 00 00 www nexans com a french société anonyme with a share capital of 43 753 380 r c s nanterre 393 525 852 id vat fr 74 393 525 852 disclosure of trading in own shares from november 7 2024 to november 8 2024 issuer nexans category treasury shares pursuant to applicable law on share buybacks nexans declares the following purchases of its own shares from november 7 2024 to november 8 2024 the trades have been executed within the framework of the description of the buyback program published on march 25th 2024 on the company s website www nexans com by an investment firm pursuant to a mandate name of the issueridentity code of the issuerday of the transactionidentity code of total daily volume in number of shares daily weighted average purchase price of
7936,all_events,DOWN,,needham mass dec 12 2023 globe newswire candel therapeutics inc candel or the company nasdaq cadl a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer today announced that the u s food and drug administration fda granted fast track designation for its lead investigational adenovirus asset can 2409 plus prodrug valacyclovir for the treatment of patients with pancreatic ductal adenocarcinoma pdac to improve overall survival
1418,all_events,UP,DOWN,november 18 2024 03 00 et source huhtamäki oyj huhtamäki oyj huhtamäki oyj lehdistötiedote 18 11 2024 klo 10 00 huhtamäki toimii tänä vuonna slushin virallisena vastuullisuuskumppanina ja toimittaa kierrätettävät kupit tapahtumassa nautittaville juomille lisäksi huhtamäki järjestää työpajan sekä paneelikeskustelun yhdessä teollisuusteknologia alan pääomasijoitusyhtiö emerald technology venturesin kanssa maailman johtava startup tapahtuma slush järjestetään tänä vuonna helsingissä 20 21 marraskuuta 2024 tapahtuma kokoaa yhteen yli 10 000 startup yrittäjää sijoittajaa ja eri alojen johtavaa asiantuntijaa ympäri maailman olemme innoissamme yhteistyöstä slush edistää innovaatioita kestävää kehitystä sekä kasvua startupeissa ja teknologiayrityksissä yhteistyö on meille luonnollinen valinta sillä teollisuuden vastuullisuus sekä kiertotalouden edistäminen pakkausten osalta vaativat innovointia koko arvoketjussa eivätkä nämä haasteet ole
8401,all_events,UP,,saint herblain france and new york ny september 3 2024 valneva se nasdaq valn euronext paris vla and pfizer inc nyse pfe announced today positive immunogenicity and safety data from their vla15 221 phase 2 study following a second booster vaccination of their lyme disease vaccine candidate vla15 given one year after receiving the first booster dose the immune response and safety profile of vla15 one month after receiving the second booster dose were similar to those reported after receiving the first booster dose showing compatibility with the anticipated benefit of a booster vaccination prior to each lyme season there are currently no approved human vaccines for lyme disease and vla15 is the lyme disease vaccine candidate which has advanced the furthest along the clinical development timeline with two phase 3 trials in progress the centers for disease control and prevention cdc has estimated that approximately 476 000 people in the u s are diagnosed and treated for lyme disease each year and 129 000 cases are reported annually in europe 1 2
5470,all_events,DOWN,,18 nov 2024 08 30 cet af gruppen asa vito kongsvinger as nærstående selskap til styremedlem og primærinnsider i af gruppen asa erik veiby solgte i dag 40 000 aksjer i af gruppen asa til kurs 134 00 pr aksje aksjene ble solgt til etv invest as også et nærstående selskap til erik veiby etter transaksjonene eier vito kongsvinger as og etv invest as hhv 1 871 676 og 40 000 aksjer i af gruppen asa denne opplysningen er informasjonspliktig etter markedsmisbruksforordningen eu 596 2014 artikkel 19 og verdipapirhandelloven 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site af gruppen asa oslo børs newspoint af gruppen no0003078107 afg oslo børs
10052,all_events,UP,,16 million multiple draw facility to be used as a bridge to anticipated pharma partnership
6061,all_events,UP,,media release
4962,all_events,UP,,vilnius lithuania 2024 11 05 10 58 cet omx baltic benchmark fund share price on november 04 2024 12 9634 eur omx baltic benchmark fund number of shares issued on november 04 2024 0 units omx baltic benchmark fund number of shares redeemed on november 04 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of november 04 2024 125 362 units nter asset management
10935,all_events,DOWN,,06 nov 2024 22 08 cet borr drilling limited hamilton bermuda november 6 2024 borr drilling limited nyse and ose borr today announces that the company s board of directors has approved a cash distribution of paid in capital of us 0 02 per share for the third quarter of 2024 note to shareholders registered in euronext vps the norwegian central security depository due to implementation of the central securities depository regulation csdr in norway please note the information regarding the payment date for the shares registered in euronext vps below effective as of may 28 2024 the new york stock exchange nyse settles its trades on a t 1 basis while the oslo stock exchange ose continues to settle its trades on a t 2 basis as a result there will be different ex dividend dates between the two exchanges as set out below key information distribution amount 0 02 per share declared currency usd dividends payable to shares registered with eu
8696,all_events,UP,,neobo fastigheter ab publ has recruited ali ali as head of transactions he will join the company in february 2025 ali has many years of experience in real estate transactions and most recently from a role as senior business developer at rikshem ali holds a master of science in real estate economics from the royal institute of technology we are very pleased to have recruited ali and look forward to welcoming him to neobo in february we have an exciting time ahead and ali s experience from real estate transactions especially in the residential segment will be a valuable addition in the continued work to optimize and expand our real estate portfolio says ylva sarby westman ceo at neobo i am delighted to have had the opportunity to join neobo s dedicated team as head of transactions my task will be to identify and take advantage of the optimization and growth opportunities that exist in the market and within the portfolio i look forward to being part of the company s fut
6666,all_events,UP,,second rare disease program with rz358 in phase 3 development
7774,all_events,DOWN,,media release
12356,all_events,DOWN,,15 nov 2024 15 18 cet sparebanken vest boligkreditt sparebanken vest boligkreditt as rated aaa by moody s has issued sek 500m in a new frn covered bond with settlement date the 20th of november 2024 and maturity the 20th of november 2029 the coupon is 3 months stibor 0 42 percentage points p a isin xs2944441810 seb acted as manager contact john hopp ceo sparebanken vest boligkreditt tel 47 450 81 776 karoline opstad strand coo sparebanken vest boligkreditt tel 47 481 82 463 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sparebanken vest boligkreditt as oslo børs newspoint spb vest boligkredit as 12 27 adj covd spb vest boligkredit as 18 28 covd spb vest boligkredit as 20 25 frn covd spb vest boligkredit as 21 26 frn covd spb vest boligkreditt as 22 27 frn covd spb vest boligkredit as 23 28 frn covd spb vest boligkreditt as 23 28 frn covd spb vest boligkredit as
11165,all_events,DOWN,,on 13 november 2024 malene lunddal hansen was elected to the management board in coloplast finance b v replacing hea vinskov malene lunddal hansen is senior director for tax compliance in the coloplast group the management board in coloplast finance b v hereafter consists of henrik deneke anton mikkelsen and malene lunddal hansen attachment attachments 07_2024_change_in_management_board pdf
11293,all_events,DOWN,,november 12 2024 09 01 et source danske bank a s danske bank a s 12 november 2024 notification no 115 2024 transactions made by persons obliged to report transactions to the danish fsa and nasdaq copenhagen cf the eu market abuse regulation in connection with the share buy back program in danske bank a s apmh invest a s continuously sells shares pro rata for further details please find the attached templates for notifications and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them contact stefan singh kailay head of media relations tel 45 45 14 14 00 attachment
6961,all_events,UP,,14 nov 2024 06 30 cet lerøy seafood group asa q3 24 påvirket av lave laksepriser lerøy seafood group asa rapporterer i dag et konsolidert operasjonelt driftsresultat ebit på mnok 412 for tredje kvartal 2024 havbrukssegmentet leverte et operasjonell ebit på mnok 310 i kvartalet konsernsjef henning beltestad kommenterte resultatene for tredje kvartal er påvirket av lave priser på laks og ørret kombinert med høyt lusepress på grunn av historisk høye sjøtemperaturer i nord norge dette har på kort sikt ført til noe lavere vekst i sjø i deler av vår virksomhet vi forventer at slaktet volum i år vil bli 190 000 gwt inkludert 20 000 gwt fra scottish seafarms tidligere guiding var 193 500 gwt scottish seafarms har vist betydelig lønnsomhetsvekst i år noe som reflekterer en sterk utvikling i biologiske prestasjoner jeg er også fornøyd med å se en fortsatt utvikling i vårt segment for videreforedling og salg og distribusjon vap s
6347,all_events,DOWN,,media release
2998,all_events,UP,,10 oct 2024 18 00 cest oxurion atlas special opportunities llc has converted 6 convertible bonds in oxurion resulting in a eur 150 000 capital increase this is part of atlas special opportunities llc s eur 20 million capital commitment 1 that will allow oxurion to focus on developing innovative therapeutics to preserve the vision of elderly people targeting potential market opportunities of usd 3 6 billion leuven belgium 10 october 2024 06 00 pm cet in accordance with article 15 of the belgian act of may 2 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions oxurion nv euronext brussels oxur the company or oxurion announces the below information following the issuance of 452 841 new ordinary shares on october 8 2024 for a total amount of eur 150 000 pursuant to the capital commitment entered into with atlas special opportunities llc follow
5148,all_events,UP,,november 12 2024 11 30 et source kalmar corporation kalmar corporation attachment
6592,all_events,DOWN,,media release
5271,all_events,UP,,south san francisco calif june 11 2024 globe newswire akero therapeutics inc nasdaq akro a clinical stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need today announced initiation of the synchrony outcomes study a phase 3 trial evaluating the efficacy and safety of efruxifermin efx in patients with compensated cirrhosis fibrosis stage 4 f4 due to metabolic dysfunction associated steatohepatitis mash
9216,all_events,DOWN,,media release
9443,all_events,DOWN,,copenhagen 13 november 2024 notification and public disclosure of transactions by person discharging managerial responsibilities 1 information on the person discharging managerial responsibilities person closely associated a name thomas thomsen2 reason for the notificationa position title member of the board of directors employee electedb initial notification amendmentinitial notification3 details of the issuer emission allowance market participant auction platform auctioneer or auction monitora namescandinavian tobacco group a sb lei code5299003kg4js99trml674 details of the transaction s section to be repeated for i each type of instrument ii each type of transaction iii each date and iv each place where transactions have been conducted a description of the financial instrument type of instrumentidentification codeshares dk0060696300 stgb nature of the transaction purchase of sharesc price s and volume s d aggregated information aggregated volume price2
6984,all_events,UP,,vancouver british columbia sept 15 2023 globe newswire mydecine innovations group inc mydecine or the company neo myco otc mycof fse 0nfa a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and ptsd is pleased to announce that in connection with certain common share subscription agreements the subscription agreements entered into with third party investors collectively the investors dated september 15 2023 the company has filed a shelf prospectus supplement the prospectus supplement to the company s final short form base shelf prospectus the base shelf prospectus for the province of québec and amended and restated final short form base shelf prospectus for each of the provinces of canada dated january 28 2022 together the shelf prospectus
9410,all_events,DOWN,,adagene s ceo dr peter luo participating in sitc webinar on september 22 focused on essential role of treg depletion for anti ctla 4 therapies
3325,all_events,DOWN,,media release
7502,all_events,DOWN,,media release
1964,all_events,UP,UP,media release
2157,all_events,DOWN,DOWN,10 oct 2024 18 00 cest phaxiam therapeutics listing market euronext paris market segment c isin code fr001400k4b1 symbol phxm website www phaxiam com datetotal of shares composing the share capitaltotal of brut 1 voting rightstotal of net 2 voting rightsdecember 31 20236 075 1056 226 9826 226 733january 31 20246 075 1056 227 0026 226 753february 29 20246 075 1056 226 9516 226 702march 29 20246 075 1056 226 9386 226 689april 30 20246 075 1056 226 9326 226 683may 31 20246 075 1056 226 9896 226 740july 1 20249 980 66810 132 59710 132 348october 8 202410 013 71910 165 84810 165 599 1 gross voting rights number or theoretical voting rights is used as a basis for calculating the crossing of the threshold in accordance with article 223 11 of general regulation of autorité des marchés financiers this number is calculated on the basis of all shares carrying the single and double voting rights including shares without voting rights 2 without t
884,all_events,UP,DOWN,media release
3222,all_events,UP,,14 nov 2024 19 00 cet abionyx pharma chiffre d affaires consolidé de 3 4 m à fin septembre 2024 trésorerie de 4 1 m avant encaissement du cir d iris pharma 610k au 30 septembre 2024 retransmission en direct de l age le 28 novembre 2024 à 14h00 cet regulatory news abionyx pharma fr0012616852 abnx éligible pea pme société de biotechnologie de nouvelle génération dédiée à la découverte et au développement de thérapies innovantes basées sur l apolipoprotéine apoa i humaine recombinante fait le point aujourd hui sur son activité et la trésorerie et les équivalents de trésorerie au 30 septembre 2024 information financière sélectionnée ifrs m t3 2024 t3 2024 chiffre d affaires activité biotech 0 00 0 00 chiffre d affaires iris pharma 3 41 3 60 chiffre d affaires total 3 41 3 60 autres revenus et produits d exploitation 0 00 0 00 total revenus et produits d exploitat
10334,all_events,UP,,copenhagen denmark november 13 2024 evaxion biotech a s nasdaq evax evaxion a clinical stage techbio company specializing in developing ai immunology powered vaccines has as anticipated received a letter dated november 11 2024 with a delisting determination from nasdaq stock market llc nasdaq for failure to maintain stockholders equity of at least 2 5 million as required by nasdaq listing rule 5550 b 1
2974,all_events,UP,,19 nov 2024 18 00 cet teleperformance regulatory news teleperformance tp paris tep un leader mondial des services aux entreprises en solutions digitales a été classé 7e du palmarès world s best workplacestm 2024 établi par le magazine fortune et l institut great place to work tp figure ainsi sur la liste des meilleurs employeurs au monde pour la quatrième année consécutive pour figurer dans ce palmarès les entreprises doivent être reconnues comme des employeurs exceptionnels à l échelle mondiale et figurer dans au moins cinq listes régionales best workplaces en asie europe amérique latine afrique amérique du nord ou australie en 2023 ou début 2024 les 25 lauréats ont été sélectionnés à partir des réponses données par leurs employés à des enquêtes anonymes dans le monde entier les collaborateurs de tp qui ont participé à l enquête ont évalué les efforts du groupe pour créer des environnements de travail exceptionnels avec un impact positif sur
4536,all_events,DOWN,,media release
3844,all_events,UP,,copenhagen denmark sept 09 2024 globe newswire evaxion biotech a s nasdaq evax evaxion a clinical stage techbio company specializing in developing ai immunology powered vaccines announces new exciting clinical phase 2 data for its lead compound evx 01 the data show that 11 out of 16 patients had objective clinical responses equaling a overall response rate orr 15 out of the 16 patients had reduction of their tumors target lesions
7803,all_events,UP,,media release
11908,all_events,DOWN,,media release
12135,all_events,DOWN,,norwood mass nov 04 2024 globe newswire corbus pharmaceuticals holdings inc nasdaq crbp corbus or the company an oncology and obesity company with a diversified portfolio presents new pre clinical data at obesity week 2024 further characterizing crb 913 its highly peripherally restricted cb1 inverse agonist the data are being presented as a poster presentation titled induction and maintenance regimens with cb1 inverse agonist crb 913 and semaglutide in dio mice
9575,all_events,DOWN,,cooper brings decades of global pharmaceutical and biotechnology leadership experience
4764,all_events,UP,,november 11 2024 05 24 et source cbrain a s cbrain a s press release no 11 2024 scaling climate software solutions in california copenhagen november 11 2024 cbrain nasdaq cbrain has signed a contract with san mateo resource conservation district rcd to help accelerate adoption of climate smart agriculture csa practices through digitization this solution called the sustainable land initiative sli relies on cbrain s standard f2 climate software the goal is to empower conservationists to rapidly identify and quantify the value of csa practices and support landowners in adoption by connecting them with implementation and funding support cbrain configured and delivered the first f2 based sli solution in 2022 for the upper salinas las tablas rcd the agreement with san mateo rcd demonstrates how the f2 platform can be copied and adapted to other geographies and agencies at speed and scale it is planned that the f2 solution wil
5339,all_events,UP,,november 07 2024 02 00 et source akva group asa akva group asa strong financial performance driven by sea based akva group delivered high quarterly revenue in q3 2024 of mnok 1 011 817 adjusted for the gain of mnok 76 related to the observe transaction the revenue was mnok 936 and 14 higher compared to q3 2023 ebitda was mnok 199 in q3 2024 adjusted for the net gain of nok 71 related to the observe transaction ebitda was mnok 128 compared to mnok 78 in q3 2023 total order intake of mnok 803 600 in q3 2024 and order backlog was bnok 2 4 at the end of september 2024 completion of the acquisition of observe technologies at the start of q3 increasing ownership from 33 to awarded loi from cermaq early q4 related to ras contract for new post smolt facility in chile with estimated contract value of meur 30 the high activity is driven by the sea based business segment and continued positive momentum in the nordic market the
12174,all_events,DOWN,,announcement no 250 19 november 2024 in connection with the announced share buy back program in norden a s motortramp continuously sells shares pro rata and the market is to be informed accordingly see the attached file and announcements nos 235 24 and 237 24 kind regards dampskibsselskabet norden a s martin badsted cfo for further information therese möllevinge head of investor relations tel 45 41 37 16 38 e mail thm norden com isabella zaugg hansen investor relations manager tel 45 27 62 90 96 e mail izh norden com attachments no 250 managers transactions etc pdf transactions by persons discharging managerial responsibilities and persons pdf
3891,all_events,UP,,ab ignitis grupė hereinafter the group informs that pursuant to the methodology for determining the price caps for electricity transmission distribution and public supply services link in lithuanian and to the methodology for determining the regulated prices in the natural gas sector link in lithuanian on 17 october 2024 national energy regulatory council hereinafter nerc adopted the resolutions on the price caps for electricity distribution services of ab energijos skirstymo operatorius hereinafter eso for 2025 on the income cap for gas distribution service of eso for 2025 and on other regulatory components for 2025 hereinafter the resolutions link in lithuanian 1 regulated asset base rab at the beginning of the period according to the resolutions nerc established an allowed income level for eso s electricity distribution services for 2025 comprising eur 321 6 million which is 4 higher compared to the income level set for the year 2024 eur 309 1
3669,all_events,DOWN,,funding extends company s cash runway into second quarter 2025 which is beyond the anticipated timing for shield ii top line results if warrants are fully exercised
4783,all_events,DOWN,,media release
6187,all_events,DOWN,,07 nov 2024 22 10 cet genfit trésorerie et équivalents de trésorerie s élevant à 96 0 millions d euros au 30 septembre 202459 7 millions d euros de revenus des neuf premiers mois de 2024 dont 48 7 millions d euros de paiement d étape facturés en juin 2024 reçu en août 2024 lors de la première vente d iqirvo élafibranor d ipsen aux états unis pour le traitement de la cholangite biliaire primitive pbc lille france cambridge massachusetts états unis zurich suisse le 7 novembre 2024 genfit nasdaq et euronext gnft société biopharmaceutique de stade clinique avancé engagée dans l amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le pronostic vital annonce aujourd hui sa trésorerie au 30 septembre 2024 et son chiffre d affaires pour les neuf premiers mois de 20241 situation de trésorerie au 30 septembre 2024 la trésorerie et les équivalents de trésorerie de la société s élevaient à 96 0 millions d euros contre 61 6 m
2927,all_events,DOWN,,media release
4467,all_events,DOWN,,to nasdaq copenhagen a s corrections to final terms the english translation of the final terms of the bonds with isin code dk0009547804 published on 23 september 2024 have been updated section 15 coupon interest of the english translation has been updated from for the period until the first interest rate reset the interest rate is 3 p a to for the period until the first interest rate reset the interest rate is 3 p a nykredit realkredit a s s base prospectus dated 8 may 2024 with prospectus supplement dated 14 august 2024 and the relevant final bond terms are available for download in danish and english in the event of discrepancies between the original danish text and the english translation the danish text shall prevail the documents can be found on nykredit s website at nykredit com ir questions can be addressed to lars mossing madsen phone 45 44 55 11 66 or christian mauritzen phone 45 44 55 10 14 attachment attachments correction pdf
102,all_events,UP,DOWN,not for release distribution or publication in whole or in part directly or indirectly within or to the united states australia canada hong kong japan new zealand singapore south africa switzerland russia belarus or in any other jurisdiction where the release distribution or publication of this press release would be unlawful or would require registration or any other measures please refer to the important information at the end of this press release in august 2022 intellego entered into an agreement to acquire all shares in daro group for a total purchase price of gbp 6 5 million equivalent to approximately sek 81 million the acquisition the payment was to be made in various installments both through cash payments and payments with intellego shares as communicated via a press release on 23 august 2022 the sellers of daro group the sellers have asked to modify the payment structure and to receive a larger amount of intellego shares instead of cash through
7268,all_events,DOWN,,november 15 2024 06 20 et source pro kapital grupp pro kapital grupp as i pro kapital grupp juhatuse esimehe volituste pikendamine as pro kapital grupp edaspidi pro kapital teatab et pro kapitali nõukogu otsustas 15 11 2024 pikendada pro kapitali juhatuse esimehe edoardo axel preatoni volitusi alates 01 01 2025 kuni 31 12 2029 pikem ametiaeg kui 3 aastat on seaduse ja pro kapitali põhikirjaga lubatud edoardo axel preatoni on olnud pro kapitali juhatuse liige aastast 2016 as pro kapital grupp juhatus jätkab kaheliikmelisena edoardo axel preatoni ja neringa rasimavičienė edoardo axel preatonijuhatuse liigetel 614 4920email prokapital prokapital ee
12747,all_events,DOWN,,18 nov 2024 18 10 cet freelance com freelance com freelance com chiffre d affaires du 3ème trimestre 2024 18 nov 2024 18 10 cet cest information réglementaire transmise par eqs group le contenu de ce communiqué est de la responsabilité de l émetteur communiqué de presse 18 novembre 2024 chiffre d affaires 3ème trimestre 2024 242 6 m chiffre d affaires cumulé au 30 septembre 2024 759 7 m freelance com euronext growth paris fr0004187367 alfre leader de la relation entre les entreprises et leurs talents externes publie son chiffre d affaires consolidé au titre du 3ème trimestre 2024 période du 1er janvier au 30 septembre 2024 chiffre d affaires en m données non auditées 2024consolidé 2023consolidé variation 1er trimestre 258 2 208 5 2ème trimestre 258 8 210 9 3ème trimestre 242 6 198 6 cumulé au 30 09 2024 759 7 618 0 sur le 3ème trimestre le chiffre d affai
6436,all_events,UP,,interim report july 1 september 30 regulatory release 57 2024 flash highlights ceo letter positioning better collective for the next chapter of growthbetter collective has been on a strong path of growth for over two decades both financially as well as organizationally expanding the team significantly across many geographies our audience across our sports media network has surged from 7 million to over 400 million visits since 2018 a testament to the impact we ve made in the digital sports media arena in the pursuit of becoming the leading digital sports media group however sometimes in the pursuit of growth it s necessary to pause reassess and adapt to prepare for the next chapter of growth during q3 we have experienced changing dynamics in the us market which has changed the outlook further brazil has seen an increasing slowdown all year heading into the expected regulation the impact on q3 and the outlook led us to lower our financial targets for the year marking
1697,all_events,UP,DOWN,media release
11059,all_events,UP,,during the period november 4 8 2024 enea ab publ has repurchased in total 14 310 own shares isin se0009697220 within the framework of the authorization from the annual general meeting 2024 to repurchase own shares the purpose of the repurchase program is to enable the company to adapt its capital structure to its capital needs over time thereby contributing to increased shareholder value the intention is that the repurchased shares will be withdrawn by resolution at the upcoming annual general meetings the repurchases are part of the share buyback program of up to sek 100 million that was announced on may 7 2024 the program which runs during the period may 10 2024 up to and including the day before the annual general meeting 2025 is being carried out in accordance with the eu market abuse regulation mar and commission delegated regulation 2016 1052 the so called safe harbour regulation the shares have been repurchased as follows all the repurchases have been ca
1175,all_events,DOWN,DOWN,immunocore announces randomization of first patient in the global registrational phase 3 clinical trial testing brenetafusp for the treatment of first line advanced or metastatic cutaneous melanoma
10736,all_events,UP,,lemonsoft oyj company release november 14 2024 at 08 30 00 eet lemonsoft oyj share repurchase 13 11 2024 helsinki stock exchange trade date 13 11 2024bourse trade buy share lemonamount 57 sharesaverage price share 5 6825 eurtotal cost 323 90 eurfollowing shares repurchased on 13 11 2024the company now holds 3 713 shares on behalf of lemonsoft oyjlago kapital ltdmaj van dijk jani koskell further information alpo luostarinenceoalpo luostarinen lemonsoft fi 358 50 911 3507 mari erkkiläcfomari erkkila lemonsoft fi 358 40 768 1415 certified adviser aktia alexander corporate finance oy 358 50 520 4098 about us lemonsoft is a finnish software company that designs develops and sells erp software solutions to streamline its customers processes across different business lines and administration the extensive offering of software solutions and related services enables the company to provide its customers with holistic service the company s standardised and scalable softwa
1482,all_events,UP,DOWN,media release
434,all_events,UP,UP,november 11 2024 11 30 et source kalmar corporation kalmar corporation attachment
7852,all_events,DOWN,,16 oct 2024 00 08 cest jervois mining usa limited please see attached notice of the written resolution resolved today more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 629685_no0011041568_nb_20241015 1616402 1 pdf jervois mining usa limited oslo børs newspoint jervois mining usa li 21 26 12 usd c no0011041568 nordic alternative bond market
1880,all_events,UP,DOWN,14 nov 2024 17 45 cet touax communiqué de presse paris le 14 novembre 2024 17 h 45 votre solution de location au service des transports durables progression du niveau d activité à fin septembre volume d affaires de 121 5 millions d euros sur 9 mois 4 3 1hausse des ventes de matériels 3 9 millions d euros 9 2 progression de l activité de gestion 2 7 millions d euros 39 3 le total des produits retraités des activités2 à la fin du 3e trimestre 2024 s élève à 121 5 millions d euros 121 7 millions d euros à devises et périmètre constants3 contre 116 5 millions d euros à la même période en 2023 en progression de 5 0 millions d euros porté par les ventes de matériels détenus en propre et les commissions de syndication produits retraités des activitést1 2024 t2 2024 t3 2024 9 mois 2024 t1 2023 t2 2023 t3 2023 9 mois 2023 variation en milliers d euros chiffre d affaires locatif des matériels détenus en propre19 38118 10817 52455 01317 13917
1385,all_events,UP,UP,08 nov 2024 13 43 cet sparebank 1 sør norge asa aksjene sparebank 1 sør norge asa kjøpte 1 november og 4 november 2024 til bruk i bankens spareprogram for ansatte er videresolgt de ansatte i henhold til deres sparebeløp aksjene er solgt til kurs kr 146 1722 etter videresalget er bankens egen beholdning 88 829 aksjer primærinnsiderenes erverv av aksjer som deltakere i spareprogrammet er som angitt i vedlagt oppstilling denne opplysningen er informasjonspliktig etter verdipapirhandelloven 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631725_vedlegg til børsmelding primærinnsidere november 2024 pdf sparebank 1 sør norge asa oslo børs newspoint sparebank 1 sør norge asa spb 1 sr bank asa 19 25 1 spb 1 sr bank asa 20 26 1 30 per cent spb 1 sr bank asa 20 26 frn spb 1 sr bank asa 21 25 1 86pct spb 1 sr bank asa 21 25 frn spb 1 sr bank asa 22 28 4 60pct sp
3898,all_events,DOWN,,media release
8929,all_events,UP,,media release
7630,all_events,DOWN,,media release
8197,all_events,DOWN,,09 oct 2024 18 07 cest theon international plc theon completes the acquisition of harder digitalbloomberg theon na reuters theon as nicosia 9 october 2024 theon international plc theon has received approval from the german government for foreign direct investment fdi into harder digital group harder digital with effect from 7 october 2024 after receiving all official approvals the acquisition first announced in september will be performed through a cash injection of 34 million this investment will allow theon to vertically integrate by insourcing a critical component of the night vision value chain and gain access to a niche technology the first tranche totalling 10 million will take place in october and will be used to upgrade harder digital s production facilities and increase the capacity of gen iii image intensifier tubes iit manufacturing lines in germany harder digital was established in 1999 having its hq in woltersdorf germany and oper
10127,all_events,UP,,november 13 2024 07 06 et source coloplast finance b v coloplast finance b v on 13 november 2024 malene lunddal hansen was elected to the management board in coloplast finance b v replacing hea vinskov malene lunddal hansen is senior director for tax compliance in the coloplast group the management board in coloplast finance b v hereafter consists of henrik deneke anton mikkelsen and malene lunddal hansen attachment
4513,all_events,DOWN,,08 nov 2024 18 05 cet exmar pr text q3 2024 nl pdf exmar euronext exmar ord be0003808251 exm euronext
8888,all_events,UP,,research triangle park n c oct 24 2023 globe newswire science 37 holdings inc nasdaq snce the industry leading metasite today announced it will report third quarter 2023 financial results prior to the market open on tuesday november 7 2023
103,all_events,DOWN,UP,châtillon france le 23 septembre 2024 22 30 cest
2673,all_events,UP,,07 nov 2024 19 00 cet altareit see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1296249_10_nombre_dactions_et_de_droits_de_vote_au_31_10_2024 pdf altareit les echos altareit fr0000039216 areit euronext
9643,all_events,DOWN,,philogen new production facility in rosia has received the gmp certificate by competent authorities
1825,all_events,UP,UP,boston nov 09 2023 globe newswire elicio therapeutics inc nasdaq eltx elicio therapeutics or elicio a clinical stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer today reported financial results for the third quarter ended september 30 2023 and provided recent corporate and clinical updates
535,all_events,UP,DOWN,18 nov 2024 14 00 cet stmicroelectronics n v stmicroelectronics announces status ofcommon share repurchase program disclosure of transactions in own shares period from nov 11 2024 to nov 15 2024 amsterdam november 18 2024 stmicroelectronics n v the company or stmicroelectronics a global semiconductor leader serving customers across the spectrum of electronics applications announces full details of its common share repurchase program the program disclosed via a press release dated june 21 2024 the program was approved by a shareholder resolution dated may 22 2024 and by the supervisory board stmicroelectronics n v registered with the trade register under number 33194537 lei 213800z8nohikri42w10 announces the repurchase by a broker acting for the company on the regulated market of euronext paris in the period between nov 11 2024 to nov 15 2024 the period of 474 885 ordinary shares equal to 0 of its issued share capital at the
2439,all_events,UP,UP,13 nov 2024 17 00 cet sodexo information réglementée issy les moulineaux 13 novembre 2024 declaration des transactions sur actions propres realisees du 4 au 8 novembre 2024 sodexo a procédé à l acquisition d actions propres hors contrat de liquidité dans le cadre du programme de rachat d actions autorisé par son assemblée générale du 15 décembre 2023 ces acquisitions sont destinées à honorer des obligations liées à des plans d attribution gratuite d actions les informations agrégées sur ces opérations sont les suivantes jour de la transactionleicode isinvolume en nombre d actions prix pondéré moyen d acquisition en euros marché04 11 2024969500agkr3prjg4wd05fr000012122014 88580 3259xpar04 11 2024969500agkr3prjg4wd05fr000012122018 51480 2322ceux04 11 2024969500agkr3prjg4wd05fr00001212202 72880 2311tqex04 11 2024969500agkr3prjg4wd05fr00001212201 65680 3276aqeu05 11 2024969500agkr3prjg4wd05fr00001212209 38081 1744xpar05 11 2024969500agkr3prjg4wd05fr000012122010 06081 2
7465,all_events,DOWN,,record fourth quarter 2023 cguard eps revenue of 1 76 million increased 71 over fourth quarter 2022
3143,all_events,DOWN,,16 oct 2024 07 45 cest gimv see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1290787_241016_pr_udb_exit_eng pdf gimv les echos gimv be0003699130 gimb euronext
2375,all_events,UP,DOWN,media release
5400,all_events,DOWN,,new york oct 30 2024 globe newswire tiziana life sciences ltd nasdaq tlsa tiziana or the company a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate intranasal foralumab a fully human anti cd3 monoclonal antibody today announced positive results demonstrating the anti inflammatory potential of our anti cd3 antibody foralumab in combination with semaglutide a glp 1 agonist marketed by novo nordisk nyse nvo under the brand names ozempic and wegovy the data show that the combination of nasal anti cd3 plus semaglutide improves liver homeostasis and reduces inflammation in models of diet induced obesity dio providing a potential novel approach to combat obesity related inflammation and liver inflammation and dysfunction
5386,all_events,DOWN,,announcement no 239 6 november 2024 in connection with the announced share buy back program in norden a s motortramp continuously sells shares pro rata and the market is to be informed accordingly see the attached file and announcements nos 235 24 and 237 24 kind regards dampskibsselskabet norden a s martin badsted cfo for further information therese möllevinge head of investor relations tel 45 41 37 16 38 e mail thm norden com isabella zaugg hansen investor relations manager tel 45 27 62 90 96 e mail izh norden com attachments no 239 managers transactions etc pdf transactions by persons discharging managerial responsibilities and persons pdf
5071,all_events,UP,,06 nov 2024 17 00 cet cambi asa cambi s third quarter revenues were nok 278 million an increase over the same period in 2023 progress was made across several construction contracts and cambi continues to meet customer delivery timelines and expectations as of the quarter s end the order backlog stood at nok 1 324 million providing a strong foundation for revenue conversion in future quarters key highlights in nok million q3 2024 q3 2023 revenue 277 235 ebitda 68 70 order intake 117 983 order backlog 1 324 1 791 comment from cambi s ceo per lillebø cambi had a good third quarter as we continued to convert our backlog into revenue and fulfil customer commitments in both the technology and solutions segments we also launched a new visual identity and website in september and just this week a new investor portal to enhance engagement with our stakeholders globally i am confident in cambi s potential for continued growth and commend the tea
2184,all_events,DOWN,DOWN,09 oct 2024 20 42 cest aedifica nv sa please find below a press release from aedifica a public regulated real estate company under belgian law listed on euronext brussels and euronext amsterdam regarding a publication relating to a transparency notification attachments press release en communiqué de presse fr persbericht nl please find below a press release from aedifica a public regulated real estate company under belgian law listed on euronext brussels and euronext amsterdam regarding a publication relating to a transparency notification attachments aed_cp2024_en_transpanot_2024 10 09_bb pdf aed_cp2024_fr_transpanot_2024 10 09_bb pdf aed_cp2024_nl_transpanot_2024 10 09_bb pdf aedifica globenewswire aedifica be0003851681 aed euronext
9230,all_events,DOWN,,media release
12303,all_events,DOWN,,media release
10194,all_events,DOWN,,14 nov 2024 19 27 cet nordic aqua partners as not for release publication or distribution in whole or in part directly or indirectly in australia canada japan or the united states or any other jurisdiction in which the release publication or distribution would be unlawful this announcement does not constitute an offer of any of the securities described herein reference is made to the stock exchange notice from nordic aqua partners as the company on 6 november 2024 regarding the commencement of the subscription period the subscription period in the subsequent offering the subsequent offering consisting of up to 466 666 new shares the subsequent offer shares in the company at a subscription price of nok 75 per share the subscription period expired yesterday 13 november 2024 at 16 30 hours cet by the end of the subscription period the company had received valid subscriptions for 212 812 subsequent offer shares in the subsequent offering th
10840,all_events,DOWN,,13 nov 2024 18 14 cet noram drilling as oslo norway november 13 2024 noram drilling as the company or noram today reported unaudited results for the three and nine months ended september 30 2024 highlights reported revenues of musd 26 5 adjusted ebitda of musd 6 0 improved fleet utilization by 3 to 89 current revenue backlog of musd 26 6 as of november 13 2024 marty l jimmerson chief executive officer of noram drilling as commented during the third quarter rig counts in the us and permian were essentially flat the us rig market has been impacted by reduced drilling demand after substantial consolidation activity among operators continued production discipline being demonstrated by most e ps and near term uncertainties regarding global demand for oil on the other hand we expect the results of the recent us election to increase focus on us energy production and drilling demand should be positively impacted in the medium to long ter
2144,all_events,DOWN,UP,november 15 2024 05 40 et source kn energies kn energies patikslinimas 2024 m 3 ketvirčių tarpinė finansinė informacija bus skelbiama 2024 m lapkričio 18 d ab kn energies toliau kn informuoja kad 2024 metais veiklos rezultatus planuoja skelbti tokia tvarka 2024 m balandžio 30 d bendrovė surengė eilinį visuotinį akcininkų susirinkimą tomas tumėnas finansų direktorius tel 370 46 391772
6702,all_events,UP,,media release
1457,all_events,DOWN,DOWN,media release
33,all_events,DOWN,DOWN,08 nov 2024 10 30 cet lvmh moet hennessy vuitton se société européenne au capital de 150 042 510 eurossiège social 22 avenue montaigne 75008 paris775 670 417 rcs parisarticles l 233 8 ii du code de commerce et 223 16 du règlement général de l autorité des marchés financiers code isin fr0000121014 date nombre total d actions en circulation nombre total de droits de vote 31 octobre 2024 500 141 700 total brut de droits de vote 734 087 105 total net de droits de vote 733 154 253 total net nombre total de droits de vote attachés au nombre total d actions sous déduction des actions privées de droit de vote fait à paris le 8 novembre 2024 pièce jointe droits de vote au 31 octobre 2024 société européenne au capital de 150 042 510 eurossiège social 22 avenue montaigne 75008 paris775 670 417 rcs parisarticles l 233 8 ii du code de commerce et 223 16 du règlement général de l autorité des marchés financiers code isin fr0000121014 total net
4450,all_events,DOWN,,09 oct 2024 18 00 cest planisware s a availability of the 2024 half year financial report paris france october 9 2024 planisware a leading b2b provider of saas in the rapidly growing project economy market announces that it has made available to the public and filed with the autorité des marchés financiers its half year financial report as of june 30 2024 this report is available for consultation and downloading on www planisware com in the investor regulated information section the 2024 half year financial report includes the 2024 half year activity report the condensed consolidated interim financial statements 2024 the statutory auditors review report on the half year financial information for 2024 the declaration by the person responsible for the half year financial information for 2024 upcoming events october 23 2024 q3 revenue publication contact investor relationsbenoit d amécourtbenoit damecourt planisware com 33 6 75 51 41 47 about planisware
4890,all_events,UP,,18 nov 2024 20 37 cet gaussin situation au 18 novembre 2024 investisseursnombre total de bsa souscritsnombre de bsa en circulation avant exercicenombre de bsa exercésprix d exercice unitairenombre d actions souscritesnombre de bsa restants riverfort global opportunities pcc ltd3 500 0002 700 000500 0001 00 500 0002 200 000 ya ii pn ltd 3 500 0002 700 000500 0001 00 500 0002 200 000 total7 000 0005 400 0001 000 000 1 000 0004 400 000 voir le communiqué de presse publié par la société gaussin sa le 2 août 2023 situation au 18 novembre 2024 voir le communiqué de presse publié par la société gaussin sa le 2 août 2023 cp tableau suivi exercices bsa au 18 11 2024 pdf gaussin euronext gaussin fr0013495298 algau euronext growth
9029,all_events,DOWN,,media release
5453,all_events,DOWN,,media release
6627,all_events,DOWN,,rockaway n j april 30 2024 globe newswire electrocore inc the company nasdaq ecor a commercial stage bioelectronic medicine and wellness company today announced the results of its most recent truvaga plus consumer study conducted earlier this year based on a 30 day in home use test by an independent third party research firm truvaga plus helped its users improve sleep focus stress energy and mood
11658,all_events,DOWN,,november 11 2024 03 45 et source alm brand a s alm brand a s alm brand a s share buy back program transactions during 4 november 2024 8 november 2024on 15 august 2024 alm brand a s announced a share buy back program of up to dkk 150 million as described in company announcement no 40 2024 on 7 november 2024 alm brand a s announced an increase of the existing share buy back program by dkk 70 million to dkk 220 million with the intention of purchasing shares for the employee share scheme in 2025 additionally the program was extended until and including 31 january 2025 the program is carried out in accordance with the regulation no 596 2014 of the european parliament and council of 16 april 2014 mar and the commission delegated regulation eu 2016 1052 also referred to as the safe harbour regulations the following transactions were made under the share buy back program during week number 45 with the transactions stated above alm
373,all_events,UP,DOWN,call scheduled for study clinical leadership to discuss results and details on pivotal randomized trial call scheduled for study clinical leadership to discuss results and details on pivotal randomized trial
7216,all_events,DOWN,,media release
4104,all_events,UP,,media release
6577,all_events,DOWN,,white pearl technology group wptg demonstrated its hands on approach through an intensive three day visit to the group s african headquarters in johannesburg south africa from october 27 29 2024 the visit reinforced the board s commitment to understanding african market dynamics and supporting regional growth initiatives the board led by chairman sven otto littorin met with representatives of the group s businesses across seven african countries including south africa zimbabwe malawi lesotho tanzania ethiopia and egypt the programme balanced strategic review with direct client engagement enabling board members to assess operational excellence and market opportunities firsthand in depth business discussions at the local office provided valuable insights into regional performance and growth trajectories a highlight of the visit was the board meeting customers from across the continent and interacting with wptg staff at all levels from management through to support an
5935,all_events,UP,,09 oct 2024 18 00 cest claranova se regulatory news claranova euronext paris fr0013426004 cla annonce avoir obtenu le niveau gold pour son bilan carbone décerné par greenly une référence internationale en matière de mesure et de gestion des émissions de carbone ce classement place claranova dans le top 5 des entreprises évaluées et distingue le groupe en tant qu entreprise éco responsable grâce à la mise en place d un plan d actions pour réduire son empreinte carbone et à la réalisation d un bilan de gaz à effet de serre précis intégrant les scopes 1 2 et 3 claranova a vu son score greenly passé de c l an dernier niveau bronze à un score de a cette année le statut gold signifie que le groupe a montré un engagement solide dans la gestion de son impact environnemental en se fixant des objectifs chiffrés pour réduire ses émissions en quantifiant l impact de ses plans d action et en sensibilisant ses employés aux sujets environnementaux en parallèl
1085,all_events,DOWN,DOWN,media release
7649,all_events,DOWN,,november 12 2024 08 00 et source evaxion biotech evaxion biotech copenhagen denmark november 12 2024 evaxion biotech a s nasdaq evax evaxion a clinical stage techbio company specializing in developing ai immunology powered vaccines announces new positive preclinical data from its ongoing cytomegalovirus cmv vaccine program named evx v1 the data will be presented today at the 9th international conference on vaccines research development taking place in boston usa the data demonstrates that the antigens identified with evaxion s ai immunology platform effectively trigger targeted immune responses including induction of both cmv reactive b and t cells to further enhance vaccine effectiveness evaxion has additionally designed a proprietary prefusion gb antigen a well established cmv vaccine component known to offer partial virus neutralization new preclinical data confirms that evaxion s proprietary gb antigen successfu
11762,all_events,DOWN,,in the wptg q3 2024 earnings release published on november 11 2024 at 08 00 cet the q3 2024 financial report was not included as an attachment the q3 2024 financial report is now attached to this correction for the complete q3 2024 financial report please refer to the attached document contact ir manager ir whitepearltech com 46 707 340 804 marco marangoni ceo marco marangoni whitepearltech com 598 93 370 044 certified adviser amudova ab info amudova se 46 8 546 017 58 about wptg white pearl technology group ab listed on nasdaq first north growth market is a global technology company delivering digital transformation solutions across 30 countries through 28 subsidiaries with over 650 professionals wptg provides comprehensive technology services including cloud cybersecurity ai ml solutions and iot analytics attachments wptg q3 report 11 11 2024 pdf
10386,all_events,DOWN,,radnor pa jan 29 2024 globe newswire mineralys therapeutics inc nasdaq mlys a clinical stage biopharmaceutical company focused on developing medicines to target hypertension chronic kidney disease ckd and other diseases driven by abnormally elevated aldosterone today announced that chief executive officer jon congleton will be participating in a fireside chat at the guggenheim securities 6th annual biotechnology conference being held in new york city on february 7 8 2024
9553,all_events,DOWN,,november 12 2024 08 00 et source evaxion biotech evaxion biotech copenhagen denmark november 12 2024 evaxion biotech a s nasdaq evax evaxion a clinical stage techbio company specializing in developing ai immunology powered vaccines announces new positive preclinical data from its ongoing cytomegalovirus cmv vaccine program named evx v1 the data will be presented today at the 9th international conference on vaccines research development taking place in boston usa the data demonstrates that the antigens identified with evaxion s ai immunology platform effectively trigger targeted immune responses including induction of both cmv reactive b and t cells to further enhance vaccine effectiveness evaxion has additionally designed a proprietary prefusion gb antigen a well established cmv vaccine component known to offer partial virus neutralization new preclinical data confirms that evaxion s proprietary gb antigen successfu
4814,all_events,UP,,media release
6480,all_events,DOWN,,oma savings bank plc stock exchange release 6 november 2024 at 17 33 p m eet inside information correction insider information the shareholders nomination committee proposes the election of five new members to the board of directors of oma savings bank plc and recommends an extraordinary general meeting to elect the board correction this release corrects a release published on 6 11 2024 at 16 10 p m est the name of irma gillberg hjelt has been corrected in the content of the release in finnish and english and juha volotinen s job title at municipality finance plc has been corrected in the finnish release the shareholders nomination committee which represents the five largest shareholders recommends that the board of directors of oma savings bank plc omasp or the company convene an extraordinary general meeting already before the annual general meeting in spring 2025 and proposes the following to the next general meeting of omasp regarding the composition and remunerati
7387,all_events,UP,,media release
1002,all_events,DOWN,DOWN,15 nov 2024 17 45 cet bouygues bouygues telecom acquiert l opérateur virtuel la poste mobile et annonce la conclusion d un accord de distribution exclusif avec le groupe la poste paris le 15 novembre 2024 bouygues telecom annonce avoir finalisé aujourd hui avec le groupe la poste et sfr l acquisition de la poste telecom 1er opérateur virtuel du marché français qui opère sous la marque la poste mobile et un partenariat de distribution exclusif entre la poste telecom la poste et la banque postale cette opération permet à bouygues telecom de renforcer son parc d environ 2 4 millions de clients mobile et de s appuyer sur un réseau de distribution de la poste reconnue pour ses valeurs de confiance et de proximité avec ses 7000 bureaux de poste la poste telecom dont julien tétu est président devient une filiale du groupe bouygues telecom elle regroupe 400 collaborateurs et a réalisé un chiffre d affaires de plus de 300m en 2023 benoît torloting directeur général de b
9403,all_events,DOWN,,call scheduled for tuesday june 4 2024 at 8 30 a m et call scheduled for tuesday june 4 2024 at 8 30 a m et
8207,all_events,UP,,company maintains solid cash position of 158 9 million company maintains solid cash position of 158 9 million
2805,all_events,DOWN,,expects to complete enrollment of the 400 participant sentinel cohort for the covid 19 phase 2b study in november 2024
8371,all_events,DOWN,,certara has signed a definitive agreement to acquire chemaxon a leading provider of cheminformatics software
4948,all_events,UP,,media releasecopenhagen denmark november 5 2024
6567,all_events,DOWN,,19 nov 2024 14 13 cet atos se salon des maires et des collectivités locales 2024 la software république lance la commercialisation de son concept u1st vision une première dans les services mobiles centrés sur le citoyen et sur la santé avec des premières livraisons prévues fin 2025 le démonstrateur technologique u1st vision de la software république annonce une nouvelle ère passant des services de mobilité aux services en mobilité le concept de véhicule modulaire u1st vision et les solutions associées de planification et de suivi ont été conçus pour aider les acteurs publics et les prestataires de services privés à fournir de nouveaux services de proximité la software république essilorluxottica praesens withings et 12 autres contributeurs révèlent un premier cas d usage de cette plateforme de prestation de services avec le module health pop up qui déploie des services de santé décentralisés humanisés et sécurisés là et lorsque cela est nécessaire
2405,all_events,DOWN,DOWN,vaxcyte appoints john furey to board of directors
10039,all_events,DOWN,,this message has been corrected click here to view the corrected message vilnius lithuania 2024 10 11 09 51 cest omx baltic benchmark fund share price on october 10 2024 13 0152 eur omx baltic benchmark fund number of shares issued on october 10 2024 0 units omx baltic benchmark fund number of shares redeemed on october 10 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of october 10 2024 125 362 units nter asset management
1516,all_events,UP,DOWN,12 nov 2024 07 00 cet itera asa the shares in itera asa will be traded ex dividend of nok 0 20 as from today 12 november 2024 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site itera asa oslo børs newspoint itera no0010001118 itera oslo børs
5049,all_events,UP,,successfully delivered first development candidate to biogen 8 million payment earned
2858,all_events,UP,,15 nov 2024 07 00 cet horisont energi as sandnes norway 15 november 2024 horisont energi euronext hrgi continues to progress the project activities within carbon infrastructure carbon storage and clean ammonia at the same time moving forward as planned with the strategic review we are making progress in our core business areas with developments related to the gismarvik co2 hub including paid studies with emitters and licences and the submission of an eu funding application additionally we have filed a licence application for a new carbon storage site in the north sea the financial position remains a key focus area and we are working towards creating a successful outcome of the strategic review say bjørgulf haukelidsæter eidesen and leiv kallestad co ceos horisont energi highlights q3 2024 horisont energi has initiated a strategic review with its board of directors and major shareholders to explore several options for its project portfoli
3437,all_events,UP,,12 nov 2024 07 41 cet lleida net madrid november 12th the technological services company lleida net bme lln epa allln otcqx lleif has signed renewal contracts in colombia for 665 000 euros the contracts which have already come into effect represent a significant boost for the company in the south american country and a consolidation of its subsidiary in colombia in operation since 2018 both contracts correspond to the company s new line of saas services operating under the lleida net pki brand pki is the evolution of the valencian company indenova which lleida net bought in 2021 the first contract with the colombian ministry of finance and public credit is worth 443 000 euros the contract is valid for one year until october 2025 open to renewal the second contract is with the country s superintendencia de vigilancia y seguridad privada the body responsible for exercising control inspection and surveillance over the country s private security and su
9564,all_events,UP,,stjórn eikar fasteignafélags hf birtir greinargerð sína vegna yfirtökutilboðs langasjávar ehf til hluthafa eikar fasteignafélags þar sem hún setur fram rökstutt álit sitt á tilboðinu og skilmálum þess í greinargerðinni er m a fjallað um álit stjórnarinnar á framtíðaráformum tilboðsgjafa og hvaða áhrif hún telur að tilboðið geti haft á hagsmuni félagsins störf stjórnenda og starfsmanna þess sem og staðsetningu starfsstöðva félagsins lögum samkvæmt að teknu tilliti til þeirra upplýsinga og greininga er fram koma í greinargerðinni er það mat stjórnar að tilboðsverð tilboðgjafa sé of lágt þegar það er borið saman við vænt virði framtíðar sjóðstreymis og arðgreiðslna félagsins skorað er á hluthafa að kynna sér meðfylgjandi greinargerð stjórnar eikar fasteignafélags tilboðsyfirlit langasjávar og aðrar upplýsingar sem fram hafa komið af hálfu langasjávar í tengslum við yfirtökutilboðið viðhengi viðhengi greinarger stjornar eikar fasteignafelags hf vegna yfirtokutilbos langasjav
12373,all_events,DOWN,,media release
10362,all_events,UP,,new york july 30 2024 globe newswire ovid therapeutics inc nasdaq ovid a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by certain epilepsies and brain conditions today announced that management will participate in two upcoming investor conferences in august
11500,all_events,DOWN,,media release
9152,all_events,DOWN,,08 nov 2024 10 00 cet af gruppen asa af gruppen afg will release its 3rd quarter results 2024 on friday november 15 at 07 00 am cet the company will present the results the same day at 08 30 am cet at hotel continental in oslo breakfast will be served from 08 00 to attend the presentation please notify af gruppen by e mail to mads larsen afgruppen no or by phone 47 452 44 603 by wednesday november 13 location hotel continental address stortingsgata 24 26 oslo the presentation will be held in norwegian and may also be viewed by webcast please go to https channel royalcast com hegnarmedia hegnarmedia 20241115_2 to follow the presentation live the q3 2024 quarterly report will be available from november 15 at 07 00 am cet on www newsweb no and on af gruppen s website www afgruppen com more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site af gruppen asa oslo børs newspoint a
5186,all_events,DOWN,,cantargia ab publ hereby provides notification that the nomination committee nc has been appointed ahead of the 2025 annual general meeting agm and consists of arne lööw fjärde ap fonden daniel kristiansson alecta tjänstepension mats larsson första ap fonden and magnus persson chairman of the board the nomination committee has been appointed in accordance with the guidelines established at the 2023 agm as of september 30 2024 the nomination committee represents a total of 23 per cent of the shares in cantargia in accordance with the guideline arne lööw representing the largest shareholder will be the chairman of the nc the annual general meeting will be held on may 15 2025 at ideon gateway scheelevägen 27 in lund sweden the nomination committee s tasks for the agm are to propose a chairman for the agm members of the board of directors and chairman of the board of directors remuneration to the members and the chairman respectively and potential remunera
10379,all_events,DOWN,,partial response and stable disease reported in combination cohort and durable stable disease observed in monotherapy cohorts in the vista 101 trial
4233,all_events,DOWN,,needham mass april 11 2024 globe newswire candel therapeutics inc candel or the company nasdaq cadl a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer today announced that the u s food and drug administration fda has granted orphan drug designation to can 2409 candel s most advanced multimodal biological immunotherapy candidate for the treatment of pancreatic cancer
10501,all_events,DOWN,,11 nov 2024 14 03 cet havila shipping asa sammendrag fraktinntektene var nok 140 8 million i 3 kvartal en reduksjon på nok 28 9 million i forhold til tilsvarende periode i fjor og en reduksjon på nok 5 1 million sammenlignet med forrige kvartal gjennomsnittsraten på oppdrag er høyere dette kvartalet enn forrige kvartal men utnyttelsen er lavere som følge av klargjøring til ny kontrakt for to fartøy driftskostnadene var nok 81 2 million i 3 kvartal en reduksjon i forhold til 3 kvartal i fjor på nok 37 8 million og en økning i forhold til forrige kvartal på nok 6 7 million selskapet hadde et resultat før avskrivninger på nok 69 0 million i 3 kvartal 2024 mot nok 57 0 million i 3 kvartal 2023 det er ikke foretatt nedskrivninger eller reversering av tidligere nedskrivninger i tredje kvartal i tredje kvartal i fjor ble tidligere nedskrivninger reversert med nok 465 0 million verdijustering av selskapets gjeld utgjorde nok 30 5 million i tredje kvartal mot
2087,all_events,DOWN,UP,media release
6904,all_events,UP,,vilnius lithuania 2024 11 20 10 48 cet omx baltic benchmark fund share price on november 19 2024 12 7569 eur omx baltic benchmark fund number of shares issued on november 19 2024 0 units omx baltic benchmark fund number of shares redeemed on november 19 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of november 19 2024 125 362 units nter asset management
9706,all_events,DOWN,,18 nov 2024 08 30 cet metavisio s a a strategic alliance for french breakthrough innovation this joint venture to be headquartered in france represents a significant step toward a new era of decentralized applications and digital finance including the launch of the world s first web3 ready computers in 2025 the ambitions of this new entity compete with market leaders valued in billions of euros go public on the north american stock market to enhance visibility and reach integrate advanced cryptographic security devices designed to withstand quantum threats and deliver superior cybersecurity against future digital challenges dammarie les lys november 18 2024 metavisio thomson computing fr00140066x4 ticker altho and io finnet a pioneering american company specializing in web3 solutions announce the signing of a letter of intent loi to establish a new independent company the joint venture jv will be headquartered in france with ownership e
828,all_events,UP,UP,november 19 2024 02 00 et source equinor asa equinor asa please see below information about transactions made under the fourth tranche of the 2024 share buy back programme for equinor asa ose eqnr nyse eqnr ceux eqnro tqex eqnro date on which the fourth tranche of the 2024 programme was announced 24 october 2024 the duration of the fourth tranche of the 2024 programme 25 october to no later than 31 january 2025 further information on the tranche can be found in the stock market announcement on its commencement dated 24 october 2024 available here https newsweb oslobors no message 630240 from 11 november until 15 november 2024 equinor asa has purchased a total of 1 500 000 own shares at an average price of nok 254 1340 per share overview of transactions following the completion of the above transactions equinor asa owns a total of 53 759 167 own shares corresponding to 1 of equinor asa s share capital including shares un
6512,all_events,DOWN,,south san francisco calif jan 02 2024 globe newswire rapt therapeutics inc nasdaq rapt a clinical stage immunology based therapeutics company focused on discovering developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology today announced that brian wong m d ph d president and chief executive officer will present a company overview at the 42nd annual j p morgan healthcare conference on wednesday january 10 2024 at 9 00 a m pacific time
4802,all_events,DOWN,,november 13 2024 11 30 et source kalmar corporation kalmar corporation attachment
12156,all_events,UP,,snk01 phase i autologous clinical program demonstrated improvement in neuroinflammation and cognitive function in patients with alzheimer s disease expect to initiate phase i iia by year end
12788,all_events,DOWN,,today 16 october the shares of eleving group a baltic headquartered fintech group start trading on the nasdaq riga baltic main list and on the frankfurt stock exchange s prime standard as previously reported on 8 october eleving group completed the largest ever initial public offering ipo in latvia by a private capital company during the ipo eleving group raised eur 29 million and attracted 4 515 new shareholders all funds raised will be used to further develop the business eleving group saw high demand from both private and institutional investors institutional investors including funds and family offices from the baltics and western europe accounted for of the total number of shares issued while were made up of retail investors primarily from the baltic states measured by the volume of demand from retail investors in the baltic states investors from estonia were the most active with followed by investors from latvia and lithuania with and o
8722,all_events,DOWN,,anticipated 2024 milestones include present reni cel clinical data updates mid year and year end initiate the ruby clinical trial adolescent cohort establish in vivo preclinical proof of concept for an undisclosed indication and continue to sublicense foundational ip
11854,all_events,DOWN,,media release
5169,all_events,DOWN,,15 nov 2024 17 45 cet fnac darty press release ivry sur seine france november 15 2024 5 45 pm cest the release publication or distribution of this press release in whole or in part directly or indirectly is not permitted in or into the united states of america australia canada japan or any other country where such communication would violate the relevant applicable regulation voluntary public tender and exchange offer for all the shares of unieuro supplemental information on the procedure to comply with the obligation to purchase under art 108 par 2 of the cfa full cash alternative consideration equal to 11 67208 euro the procedure to comply with the obligation to purchase under art 108 par 2 of the cfa will start on 18 november 2024 and will end on 6 december 2024the payment of the consideration for the procedure to comply with the obligation to purchase under art 108 par 2 of the cfa will take place on 13 december 2024 notice pursuant to article 5
11887,all_events,UP,,12 nov 2024 16 07 cet broadpeak s a broadpeak sa broadpeak sa information mensuelle relative au nombre total des droits de vote et d actions composant le capital social 12 nov 2024 16 07 cet cest information réglementaire transmise par eqs group le contenu de ce communiqué est de la responsabilité de l émetteur information mensuelle relative au nombre total des droits de vote et d actions composant le capital social cesson sévigné france le 12 novembre 2024 broadpeak acteur de référence des solutions logicielles dédiées au streaming vidéo publie aujourd hui au titre de l article 223 16 du règlement général de l autorité des marchés financiers l information mensuelle relative au nombre total des droits de vote et d actions composant le capital social date d arrêté des informations nombre total d actions composant le capital nombre total de droits de vote au 01 11 2024 douze millions cinq cent quarante et un mille six cent quatre vingt six
2910,all_events,DOWN,,media release
2517,all_events,UP,DOWN,san diego april 24 2024 globe newswire cidara therapeutics inc nasdaq cdtx a biotechnology company using its proprietary cloudbreak platform to develop drug fc conjugate dfc immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases today announced that it has entered into an asset purchase agreement with its current partner mundipharma for the divestiture of rezafungin mundipharma currently has commercial rights to rezafungin outside the u s and japan mundipharma purchased the assets in consideration of its assumption of the ongoing obligation to conduct and fund the respect phase 3 clinical trial the costs of the rezafungin patent portfolio and cmc and regulatory obligations cidara estimates that it will achieve approximately 128 million in cost savings over the patent life of rezafungin comprised of approximately 67 million in clinical development expense including the cost of the potential upsizing of the respect trial and cmc costs over the next three years and an additional approximately 61 million in forecasted obligations through the expected patent life of rezafungin
10957,all_events,UP,,media release
2254,all_events,UP,DOWN,media release
8473,all_events,UP,,rockville md aug 07 2023 globe newswire opgen inc nasdaq opgn opgen a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease and opgen subsidiary ares genetics which strives to become a leader in bacterial genomics and ai powered prediction of antimicrobial resistance amr announced today a major feature upgrade for the arescloud platform that has been implemented with our healthcare clients to enhance genomic surveillance
6443,all_events,UP,,edward rebane has in depth understanding of banking sector focusing on digital and retail banking solutions and customer experience he has been working in banking sector for 14 years starting his career in seb bank in estonia in 2010 throughout his tenure he has held key leadership positions most recently overseeing digital banking and retail sales across the baltic region edward rebane has pursued advanced studies at five universities including university of oxford and the estonian business school his deep expertise in strategic planning and customer focused solutions makes him an ideal fit to lead citadele retail division and drive our next phase of growth rūta ežerskiene citadele ceo and chair of management board citadele has a clear vision ahead and edward rebane s appointment is one of the steps we are taking to achieve it we are a truly baltic bank and with edward rebane in our team we will further strengthen our presence in all baltic countries delivering our
3746,all_events,UP,,november 12 2024 05 51 et source salmar asa salmar asa salmar presenterer resultater for tredje kvartal 2024 mandag 18 november 2024 klokken 08 00 på hotel continental stortingsgaten 24 26 i oslo konsernsjef frode arntsen og cfo ulrik steinvik vil være til stede fra selskapet presentasjonen vil i tillegg være tilgjengelig via norsk webcast på selskapets hjemmeside www salmar no fra 08 00 det vil være mulig å sende inn spørsmål under presentasjonen engelsk webcast opptak vil være tilgjengelig fra 10 00 på www salmar no det vil bli arrangert to gruppekonferanser i etterkant av q3 presentasjonen en fysisk presentasjon som avholdes på norsk klokken 11 00 og en digital presentasjon på engelsk klokken 15 15 for å delta vennligst registrer deg via seb ca seb no resultatene offentliggjøres klokken 06 30 på selskapets hjemmeside www salmar no og på oslo børs nyhetssider www newsweb no for mer informasjon kontakt håkon husby ir ansvar
3031,all_events,DOWN,,san diego april 22 2024 globe newswire cidara therapeutics inc nasdaq cdtx the company a biotechnology company using its proprietary cloudbreak platform to develop drug fc conjugate dfc immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases today reported financial results for the fourth quarter and full year ended december 31 2023 and provided an update on its corporate activities and product pipeline
1373,all_events,DOWN,UP,13 nov 2024 03 36 cet hafnia limited financial calendar for hafnia limited financial year 2024 27 02 2025 annual report 27 11 2024 quarterly report q3 27 02 2025 quarterly report q4 this information is published pursuant to the requirements set out in the continuing obligations more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site hafnia limited oslo børs newspoint hafnia limited sgxz53070850 hafni oslo børs
5955,all_events,UP,,logro del objetivo de inscripción de 92 pacientes evaluables en virage el ensayo clínico de fase 2b de vcn 01 en pacientes con adenocarcinoma pancreático ductal metastásico
3316,all_events,UP,,kb 0742 cleared 80mg four days on three days off dosing schedule in dose escalation
4110,all_events,UP,,07 nov 2024 19 34 cet autostore holdings ltd nedre vats 7 november 2024 reference is made to the 2019 equity incentive plan of autostore holdings ltd autostore or the company ose auto in an exercise window opened in connection with the publication of the company s q3 2024 results option holders under the company s 2019 equity incentive plan have exercised a total of 275 997 options with a strike price of nok 3 91991 per option no primary insiders of the company have exercised any options in this exercise window all the option holders who exercised options have chosen to exercise their options with cash settlement by the company the company have sold a total of 176 870 option shares at a price of nok 10 9141 per option share to cash settle the exercised share options the company holds 68 845 285 treasury shares following the option exercise and the above mentioned sale of option shares following the exercise there are 66 769 718 vested and 475 9
1282,all_events,DOWN,UP,06 nov 2024 17 45 cet teleperformance points clés du t3 2024 chiffre d affaires du t3 2024 2 520 millions d euros en progression de 26 7 à données publiées et 3 0 à périmètre comparable chiffre d affaires des 9 premiers mois 2024 7 596 millions d euros en progression de 27 7 à données publiées et 2 1 à périmètre comparable croissance des activités core services d i b s dynamique soutenue sur l ensemble des régions du groupe particulièrement dans les secteurs des services financiers de la distribution et du e commerce de la technologie du voyage et de l hôtellerie de la santé et de l automobile croissance des activités services spécialisés poursuite d une excellente dynamique intégration de majorel conforme aux attentes une gouvernance renforcée regulatory news teleperformance paris tep un leader mondial des services aux entreprises en solutions digitales a enregistré au 3ème trimestre 2024 un chiffre d affa
676,all_events,DOWN,DOWN,november 08 2024 08 28 et source skako a s skako a s til nasdaq omx copenhagen a s globenewswire faaborg den 8 november 2024 selskabsmeddelelse nr 10 2024 opdatering af helårsforventninger for 2024 aktiviteten i den europæiske automobilindustri og bygge anlægsindustri var meget lav i 3 kvartal og forventes fortsat at være lav i 4 kvartal derfor havde skako i 3 kvartal et stort fokus på at vinde og forberede gennemførelsen af den store ordre på 150 mio kr til ocp i marokko jf omx 8 2024 der vil sikre meget stærk vækst og indtjening i 2025 og 2026 i forhold til 2024 tilsammen bidrog dette til et midlertidigt fald i omsætning og indtjening i 3 kvartal drevet af kundesegmentet minerals mens det vigtige kundesegment recycling fortsatte den solide vækst som følge af denne udvikling opdateres helår
1197,all_events,UP,DOWN,20 nov 2024 07 00 cet seacrest petroleo bermuda limi rio de janeiro brazil hamilton bermuda 20 november 2024 seacrest petroleo bermuda limited seacrest petroleo or the company today reported third quarter 2024 unaudited results the report and results presentation are attached hereto and can be found on the company website www seacrestpetroleo com during the third quarter we proved our ability to execute our drilling program within schedule and on budget with a single rig we drilled ten wells at a rate of approximately four per month several of these new infill wells have started producing achieving initial production rates in line with expectations our good drilling performance and reassuring well performance have de risked the core operating element of our strategy we have also made progress on our financial strategy to strengthen our capital structure since we reported second quarter results we raised usd 8 million in a convertible bond and in oc
12312,all_events,DOWN,,08 nov 2024 07 00 cet omda as oslo norway 08 november 2024 today omda as omda a leading provider of specialised software for healthcare and emergency response published its results for the third quarter of 2024 total revenue increased to 103 mnok compared to 100 mnok in q3 23 the company s long standing customer relationships remain a solid base with growth in recurring revenue representing of total sales in q3 24 omda delivered an ebitda of 22 mnok for the quarter resulting in a ebitda margin gross margin was stable at omda ceo sverre flatby is optimistic about the underlying trend recurring revenues are steadily increasing alongside the implementation of cost reduction strategies this combination provides confidence that margin improvements will continue into 2025 in q3 the south eastern norway regional health authority helse sør øst rhf awarded omda a contract for the implementation of a regional solution for oncology med
5008,all_events,UP,,media release
11522,all_events,DOWN,,media release
4754,all_events,UP,,media release
927,all_events,UP,UP,lemonsoft oyj company release november 19 2024 at 08 30 00 eet lemonsoft oyj share repurchase 18 11 2024 helsinki stock exchange trade date 18 11 2024bourse trade buy share lemonamount 317 sharesaverage price share 5 7965 eurtotal cost 1 837 50 eurfollowing shares repurchased on 18 11 2024the company now holds 4 640 shares on behalf of lemonsoft oyjlago kapital ltdmaj van dijk jani koskell further information alpo luostarinenceoalpo luostarinen lemonsoft fi 358 50 911 3507 mari erkkiläcfomari erkkila lemonsoft fi 358 40 768 1415 certified adviser aktia alexander corporate finance oy 358 50 520 4098 about us lemonsoft is a finnish software company that designs develops and sells erp software solutions to streamline its customers processes across different business lines and administration the extensive offering of software solutions and related services enables the company to provide its customers with holistic service the company s standardised and scalable soft
3542,all_events,UP,,carmel ind nov 15 2023 globe newswire mbx biosciences inc a clinical stage biopharmaceutical company developing precision endocrine peptide pep therapeutics to treat an array of endocrine disorders today announced that kent hawryluk president and chief executive officer will present at the piper sandler 35th annual healthcare conference on wednesday november 29th 2023 at 9 10 a m eastern time and will host 1 on 1 investor meetings
1157,all_events,UP,DOWN,13 nov 2024 13 59 cet aqua bio technology asa 13 11 2024 13 59 25 cet aqua bio technology asa additional regulated information required to be disclosed under the laws of a member state aqua bio technology asa abt or the company has today held an extraordinary general meeting all resolutions were made in accordance with the proposals set out in the notice for the extraordinary general meeting which means that the private placement and jetcarrier transaction announced on 17 october have been completed the minutes of the extraordinary general meeting are attached to this notice following the jetcarrier transaction abt owns all the shares in jetcarrier as which owns 100 of the shares in jetcarrier logistics as isebakkeveien 75 as jetcarrier solutions as xpanz as norlane as jetcarrier ab freightway ab and filial magnoas and represents a major logistic group in the nordics for further information please contact jan varming cfo telephone 47
221,all_events,DOWN,DOWN,07 nov 2024 17 45 cet rougier s a see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1296017_2024_10_rougier_droits_vote pdf rougier sa les echos rougier s a fr0000037640 alrgr euronext growth
10611,all_events,UP,,paris and cambridge mass sept 04 2024 globe newswire nanobiotix euronext nano nasdaq nbtx the company a late clinical stage biotechnology company pioneering nanoparticle based therapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases today announced the nominations of dr margaret a liu and ms anat naschitz as observers to its supervisory board
6177,all_events,UP,,12 nov 2024 17 55 cet opmobility see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1297119_opmobilitydeclarationdesdroitsvoteafinoctobre2024fr pdf opmobility les echos opmobility fr0000124570 opm euronext
7229,all_events,UP,,media release
5350,all_events,UP,,november 11 2024 04 30 et source danmarks nationalbank danmarks nationalbank de udbudte beviser har følgende fondskoder salget vil blive afregnet den 15 november 2024 til skæringsrenten for hver serie for bud på skæringsrenten kan der blive tale om pro rata tildeling sidste frist for bud er kl 10 15 på auktionsdagen
2019,all_events,UP,DOWN,xano har idag via dotterbolag tecknat avtal om försäljning av samtliga aktier i xano fastigheter ljungarum ab som äger industrifastigheten älgskytten 14 på ljungarums industriområde i jönköping förvärvare är nivika ett småländskt fastighetsbolag med syfte att långsiktigt äga förvalta och utveckla fastigheter och samtidigt skapa lönsam och hållbar värdetillväxt nivika bedriver verksamhet i jönköping värnamo och växjö samt på västkusten avyttringen får löpande liten effekt på xanos resultat och ställning köpeskillingen som erläggs kontant uppgår till 73 msek och medför en beräknad realisationsvinst om 65 msek i kvartal 4 tillträdesdagen är planerad till den 28 oktober 2024 försäljningen ger xano ökat kapitalutrymme och är ett led i det fortsatta arbetet med offensiv omställning genom investeringar i produktutveckling och innovationer samt via förvärv och etablering såväl i nya länder som inom nya marknadsnischer för ytterligare information kontakta lennart persson
11524,all_events,UP,,on friday 18 october 2024 at 9 am eet coop pank held an investor webinar where the chairman of the board margus rink and the chief financial officer paavo truu introduced the bank s unaudited financial results of third quarter of 2024 webinar was held in estonian language coop pank would like to thank all participants webinar recording is available here https youtu be 8scqcyf0aao coop pank s report for unaudited results of q3 2024 and the presentation is available here https view news eu nasdaq com view id b7ef39da9a44d08908473da7ebb7c38c0 lang en coop pank based on estonian capital is one of the five universal banks operating in estonia the number of clients using coop pank for their daily banking has reached 202 000 coop pank aims to put the synergy generated by the interaction of retail business and banking to good use and to bring everyday banking services closer to people s homes the strategic shareholder of the bank is the domestic retail chain coop
5608,all_events,DOWN,,u s launch underway for xolremdi mavorixafor in whim syndrome
1617,all_events,DOWN,DOWN,20 11 2024 08 30 00 eet loihde oyj company announcement loihde plc share repurchase 19 11 2024 helsinki stock exchange trade date 19 11 2024bourse trade buy share loihde amount 419 sharesaverage price share 10 5558 eurtotal cost 4 422 90 eur following shares repurchased on 19 11 2024the group now holds 27 110 shares on behalf of loihde plc lago kapital ltd maj van dijk jani koskell further information ceo samu konttinen media contact director of communications tiina nieminen tel 358 44 411 3480 email tiina nieminen loihde com attachments download announcement as pdf pdf loihde_sbb_trades_20241119 xlsx
457,all_events,UP,DOWN,arcutis today reported financial results for the quarter ended june 30 2024 and provided a business update
3013,all_events,UP,,please see attached company announcement no 11 2024 attachment attachments company announcement no 11 2024 pdf
2929,all_events,DOWN,,11 nov 2024 20 59 cet alternus energy group plc alternus energy group plc aeg or the company was informed today by its us legal counsel that sunrise has filed confessions of judgment with the fourth judicial district of the minnesota courts and sunrise have the right to take default judgment against aeg and its two indirect wholly owned subsidiaries alt us 03 llc and alt us 04 llc jointly and severally in the amount of 4 549 616 and an additional default judgment in the amount of 516 400 on december 31 2024 further information will be made available once aeg has assessed the implications of the filed confessions of judgment more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site alternus energy group plc oslo børs newspoint alternus energy group plc ie00blrprp89 alt euronext growth
9353,all_events,DOWN,,media release
333,all_events,DOWN,UP,new partnership adds 26 podcasts and 176 million global listens to acast each year november 14 2024 acast the world s largest independent podcast company today announced a new partnership with the ted audio collective under the terms of the deal acast is the exclusive ad sales hosting and distribution partner for the brand in all regions outside of australia and new zealand the ted brand is synonymous with excellence and is a known destination for the curious the addition of the entire ted audio collective to acast brings a massive and highly engaged global audience and importantly monetizable listens for advertisers around the world to connect with said acast ceo ross adams the ted audio collective is home to 26 hit podcasts across business tech health and wellness and a variety of other genres each year the network garners 176 million listens globally through popular titles such as ted talks daily how to be a better human ted business ted en español and more
7379,all_events,UP,,media release
9548,all_events,UP,,02 oct 2024 08 22 cest scana asa bergen 2 oktober 2024 det henvises til børsmelding fra scana asa ose scana 1 september 2024 scana asa har i dag mottatt en pressemelding fra mig finance namibia proprietary limited mig pressemeldingen fra mig er vedlagt den publiserte børsmeldingen i tillegg har psw technology as godkjent en utsettelse på 10 forskuddsbetaling for potensielt salg av capping stack til mig forskuddsbetalingen vil skje i løpet av oktober for mer informasjon kontakt pål selvik konsernsjef scana asa 47 970 46 502 scana i korte trekk scana er en aktiv industriell eier av teknologi og tjenester til både energi og offshore bransjen med en industriell historie som strekker seg tilbake til starten av 1900 tallet har scana utviklet seg til å bli ledende innen teknologi og innovasjon innenfor flere nisjer denne reisen har gitt en unik posisjon til å forme morgendagens løsninger drevet av lang industriell erfaring kombinert med kvali
6508,all_events,UP,,media release
979,all_events,UP,DOWN,12 nov 2024 18 07 cet gbl groupe bruxelles lambert 20241112 transactions gbl shares pdf gbl euronext gbl be0003797140 gblb euronext
5822,all_events,DOWN,,fondia plc company release 19 11 2024 at 6 45 p m eet fondia acquisition of own shares 19 11 2024 fondia plc first north finland date 19 11 2024 exchange transactions buy share class fondia amount shares 270 average price share eur 5 839074 total price eur 1576 55 the shares held by fondia plc on 19 11 2024 202 274 shares on behalf of fondia plc op corporate bank fondia in brief fondia solves the legal needs of companies by combining the best services from internal legal departments and law firms fondia operates in finland sweden estonia and lithuania and the group s net sales in 2023 were eur 26 1 million fondia employs around 190 people www fondia com distribution nasdaq helsinki ltd key media attachments fondia trades_1911 xlsx
9875,all_events,DOWN,,media release
10903,all_events,DOWN,,sydney australia oct 29 2024 globe newswire immutep limited asx imm nasdaq immp immutep or the company a clinical stage biotechnology company developing novel lag 3 immunotherapies for cancer and autoimmune disease provides an update on its activities for the quarter ended 30 september 2024 q1 fy25
9355,all_events,UP,,november 20 2024 03 08 et source avance gas holding ltd avance gas holding ltd hamilton bermuda november 20 2024 avance gas holding ltd avance gas or company ose agas refer to the announcement on august 15 2024 to sell its vlgc fleet to bw lpg ltd buyer for 1 050 million on november 1 2024 the company announced the first vlgc delivery and today avance gas announce the second vlgc delivery the 2022 built dual fuel ship avance capella avance capella was under a sale leaseback agreement which has been successfully novated to the buyer as a part of the transaction outstanding lease obligation of 64 4 million have been novated to bw lpg in connection with the delivery 2 1 million shares in bw lpg were issued by the buyer to avance gas additionally the company also received net cash proceeds of 15 million following the delivery avance gas owns 3 45 million shares in bw lpg corresponding to a 2 ownership share
4480,all_events,DOWN,,16 oct 2024 07 00 cest euroapi s a communiqué de presse paris le 16 octobre 2024 olivier falut a été nommé directeur financier d euroapi à compter du 17 octobre 2024 et sera membre du comité exécutif il succède à evelyne nguyen qui restera au sein de la société jusqu à la fin octobre afin d assurer la transition je suis très heureux d accueillir olivier un directeur financier chevronné doté d une très grande expérience du secteur industriel son rôle sera déterminant dans la mise en place de notre projet de transformation focus 27 a indiqué ludwig de mot directeur général d euroapi l ensemble de l entreprise et le conseil d administration se joignent à moi pour exprimer notre gratitude à evelyne pour avoir mené à bien sa mission consistant à assurer le financement de notre plan stratégique olivier falut apporte à euroapi près de 30 ans d expérience en management et en finance dans le secteur industriel au cours de sa carrière il a occupé différ
6088,all_events,DOWN,,media release
5337,all_events,UP,,04 oct 2024 07 03 cest deep value driller as oslo 4 october 2024 reference is made to the stock exchange notice by deep value driller as dvd earlier today as set out in the notice the board of directors has resolved to distribute a dividend in the amount of nok 1 00 per share in total approximately nok 86 4 million the dates relevant to the proposed dividend distribution are set out below dividend amount nok 1 00 per share announced currency nok last day including right 7 october 2024 ex date 8 october 2024 record date 9 october 2024 payment date on or about 11 october 2024 date of approval 4 october 2024 the distribution shall constitute repayment of paid in capital by the shareholders of dvd this information is published in accordance with the requirements of the euronext growth oslo rule book part ii more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site deep value driller as o
3193,all_events,UP,,media release
4106,all_events,DOWN,,13 nov 2024 07 00 cet innate pharma jonathan dickinson appointed chief executive officer and chairman of the executive board encouraging initial fda feedback received on lacutamab regulatory pathway lacutamab health related quality of life and translational data to be presented at the upcoming ash annual meeting iph4502 a nectin 4 adc received fda clearance of the ind to be developed in solid tumors preclinical data for proprietary tetra specific nk cell engager iph6501 and novel adc iph4502 presented at sitc cash position of 96 4 million1 as of september 30 2024 anticipated cash runway to end of 2025 conference call to be held today at 2 00 p m cet 8 00 a m et regulatory news innate pharma sa euronext paris iph nasdaq ipha innate or the company today announced its business update and financial results for the first nine months of 2024 i m honored to join innate pharma at such a pivotal moment in its evolution s
12458,all_events,UP,,oslo norway 4 may 2023 the annual general meeting of pci biotech holding asa will be held at the company s office at oslo cancer cluster innovation park on 25 may 2023 at 10 00am cest
6302,all_events,UP,,18 nov 2024 10 37 cet nrc group asa reference is made to the stock exchange announcement made by nrc group asa the company on 8 november 2024 regarding the final result of a subsequent offering of 20 000 000 new shares the offer shares at a subscription price of nok 2 50 per share the subsequent offering the share capital increase pertaining to the issuance of the offer shares has now been registered with the norwegian register of business enterprises the company s new registered share capital is nok 172 954 549 divided on 172 954 549 shares each with a nominal value of nok 1 00 the offer shares are tradable on euronext oslo børs from the time of publication of this stock exchange announcement this information is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site nrc group asa
9225,all_events,UP,,alvotech nasdaq alvo mun senda út tilkynningu með uppgjöri fyrir fyrstu níu mánuði ársins 2024 eftir lokun markaða í bandaríkjunum miðvikudaginn 13 nóvember nk þá mun alvotech halda kynningarfund um niðurstöðuna fyrir fjárfesta í beinu streymi fimmtudaginn 14 nóvember nk kl 13 00 að íslenskum tíma
2619,all_events,DOWN,,november 11 2024 04 42 et source sydbank a s sydbank a s storaktionærmeddelelse sydbank a s med henvisning til 31 i lov om kapitalmarkeder oplyses at sydbank a s den 8 november 2024 gennem direkte og indirekte besiddelser råder over 2 732 283 aktier i sydbank a s svarende til 5 af det samlede antal aktier i sydbank a s bankens besiddelse af egne aktier kan for hovedparten henføres til bankens aktietilbagekøbsprogram på 1 200 mio kr aktietilbagekøbsprogrammet blev igangsat den 28 februar 2024 og afsluttes senest den 31 januar 2025 aktietilbagekøbsprogrammet er nærmere beskrevet i selskabsmeddelelse 03 2024 venlig hilsen sydbank a s vedhæftet fil
5936,all_events,UP,,10 oct 2024 17 40 cest lanson bcc see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1289871_lansonbcc_pub_droit_de_vote_au_30092024 pdf lanson bcc les echos lanson bcc fr0004027068 allan euronext growth
11968,all_events,DOWN,,media release
6729,all_events,DOWN,,the subscription period for divio technologies ab s divio or the company rights issue of shares the rights issue concluded on november 12 2024 the board of directors of the company has today november 14 2024 based on the authorization from the annual general meeting on june 7 2024 resolved to carry out a directed issue of series b shares to honor the guarantee agreements entered into in connection with the rights issue the directed issue under the same authorization and in accordance with the information included in the announcement of the rights issue on october 18 2024 the board has also resolved to carry out a directed share issue of approximately sek 2 million to an investment fund focusing on growth companies the second directed issue the directed issuein connection with the rights issue the guarantors participating in guarantee tranche 3 were offered the option to receive their guarantee compensation either as a cash payment amounting to 15 percent o
724,all_events,DOWN,UP,media release
5050,all_events,DOWN,,irvine calif may 13 2024 globe newswire biomerica inc nasdaq bmra the company a global provider of advanced medical diagnostic and therapeutic products today announced the initiation of a pilot program for its infoods ibs product with a large 1 100 member physician group this pilot launch will commence in june 2024
11434,all_events,DOWN,,the general meeting of shareholders held on 31 october 2024 approved the allocation of the profit of ab akola group which included a pay out of dividends 0 03 euro shall be paid for each ordinary registered share dividends shall be paid out to persons who were the shareholders of ab akola group at the end of the dividend record day 15 november 2024
9967,all_events,DOWN,,08 nov 2024 15 18 cet nykode therapeutics asa oslo norway november 8 2024 norda asa has today acquired 5 000 000 shares in nykode therapeutics asa at an average price of nok 1 9172 per share christian åbyholm is chairman of the board of norda asa and is a member of the board of directors and primary insider in nykode therapeutics asa following the transaction norda asa holds 12 996 755 shares in nykode therapeutics asa for further details please see the attached form more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631746_20241108 attachment pdf nykode therapeutics asa oslo børs newspoint nykode therapeutics asa no0010714785 nykd oslo børs
10644,all_events,DOWN,,san diego sept 18 2023 globe newswire anaptysbio inc nasdaq anab a clinical stage biotechnology company focused on delivering innovative immunology therapeutics today announced it has appointed john orwin chairman of the anaptysbio board of directors
795,all_events,DOWN,UP,media release
5349,all_events,DOWN,,this message has been corrected click here to view the corrected message vilnius lithuania 2024 10 03 08 39 cest omx baltic benchmark fund share price on october 02 2024 12 6921 eur omx baltic benchmark fund number of shares issued on october 02 2024 0 units omx baltic benchmark fund number of shares redeemed on october 02 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of october 02 2024 125 362 units nter asset management
70,all_events,DOWN,DOWN,warrington pa nov 09 2023 globe newswire windtree therapeutics inc windtree or the company nasdaqcm wint a biotechnology company focused on advancing late stage interventions for cardiovascular disorders today reported financial results for the third quarter ended september 30 2023 and provided key business updates
1491,all_events,DOWN,UP,media release
839,all_events,UP,DOWN,nightingale health plc press release 6 november 2024 at 09 45 a m eet nightingale health a pioneer in disease risk detection and preventative health has appointed internationally recognised expert in medicine dr charles alessi as chief medical officer of nightingale health uk dr charles alessi is a physician with more than 35 years of experience in all aspects of policy and clinical practice in the united kingdom northern ireland and globally alessi s experience includes key positions in some of the world leading organisations in the industry such as acting as a member of the world health organisation s expert panels in neurosciences and dementia risk deduction global chief clinical officer at healthcare information and management systems society himss senior advisor to public health england and chairman of national association of primary care napc in the uk he is also currently advising the chief executive of the international association of public health instit
6684,all_events,DOWN,,13 nov 2024 09 53 cet sparebank 1 nordmøre finansiell kalender for sparebank 1 nordmøre regnskapsår 2024 25 03 2025 årsrapport 08 04 2025 ordinær generalforsamling 14 11 2024 kvartalsrapport q3 12 02 2025 kvartalsrapport q4 regnskapsår 2025 15 08 2025 halvårsrapport 25 03 2026 årsrapport 08 04 2026 ordinær generalforsamling 09 05 2025 kvartalsrapport q1 31 10 2025 kvartalsrapport q3 11 02 2026 kvartalsrapport q4 denne informasjonen offentliggjøres i henhold til kravene i løpende forpliktelser more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sparebank 1 nordmøre oslo børs newspoint sparebank 1 nordmøre spb 1 nordvest 20 25 frn surnadal spb 20 25 frn spb 1 nordvest 20 26 1 spb 1 nordvest 21 perp frn c hybrid spb 1 nordvest 21 31 frn c sub spb 1 nordvest 21 28 frn spb 1 nordvest 21 26 frn spb 1 nordmore 21 26 frn spb 1 nordmore 21 31 2 52pct spb
5843,all_events,UP,,first patient randomized in serenity at home trial of bxcl501 for acute treatment of agitation associated with bipolar disorders or schizophrenia
455,all_events,DOWN,DOWN,not for release distribution or publication directly or indirectly in or into the united states australia belarus hong kong japan canada new zealand russia switzerland singapore south africa south korea or any other jurisdiction where the release distribution or publication of this press release would be unlawful or require additional registration or other measures during the third quarter of 2023 wyld networks ab wyld networks or the company entered a loan agreement and conducted a directed issue and a rights issue in connection with the transactions wyld networks issued in total 3 839 998 warrants of series to5 one 1 warrant of series to5 entitles the holder to subscribe for 12 42 new shares in the company in the event that the number of warrants does not entitle the subscriber to a whole number of shares the number of shares shall be rounded down to the nearest whole number the exercise price for the warrants of series to5 amounts to 70 percent of the
1393,all_events,DOWN,UP,15 nov 2024 13 46 cet ørland sparebank det er fastsatt ny obligasjonsrente for no0013162685 ny obligasjonsrente i renteperioden 19 11 2024 19 02 2025 er 5 74 ticker orlsb27 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632414_f31ad4cf605340cf91ba399960f37321 pdf ørland sparebank oslo børs newspoint ørland spb 20 25 frn orland spb 22 27 frn orland spb 22 26 frn orland spb 23 28 frn orland spb 23 26 frn orland spb 24 29 frn ørland spb 24 29 frn ørland spb 24 27 frn no0010873524 no0010890940 no0012520529 no0012694241 no0012939125 no0013019729 no0013162685 no0013314708 no0013355230 nordic alternative bond market
11152,all_events,DOWN,,november 14 2024 00 30 et source lerøy seafood group asa lerøy seafood group asa q3 2024 affected by low prices lerøy seafood group asa today announced a consolidated operational ebit of mnok 412 for the third quarter of 2024 the farming segment reported an operational ebit of mnok 310 ceo henning beltestad commented the third quarter results reflect the impact of weaker prices for salmon and trout coupled with historically high seawater temperatures in northern norway which have intensified sea lice challenges in the short term this has slightly moderated growth in certain parts of our operations we expect the total harvest volume this year to end at 190 000 gwt previous guidance 193 500 gwt including 20 000 gwt from scottish seafarms scottish seafarms has shown substantial year over year profit growth underscoring strong biological performance i am also pleased to see the continued positive development in our value added proc
12960,all_events,UP,,media release
2183,all_events,UP,UP,media release
11986,all_events,UP,,media release
8122,all_events,DOWN,,media release
11024,all_events,UP,,aktsiaselts modera registrikood 11383889 aadress mõisa tn 4 13522 tallinn eesti edaspidi selts juhatus avaldas 30 oktoobril 2024 ajalehes õhtuleht vastavalt äriseadustiku le 2991 seltsi aktsionäridele otsuste eelnõud aktsionäride otsuste vastuvõtmiseks üldkoosolekut kokku kutsumata hääletamiseks õigustatud aktsionäride ring määrati kindlaks seisuga seitse päeva enne hääletamise tähtaega st 31 oktoobril 2024 nasdaq csd se arveldussüsteemi tööpäeva lõpu seisuga seltsil on kokku 1750 aktsionäri kellele kuulub kokku 1 972 489 aktsiat aktsionäridele määratud tähtaeg oma seisukohtade esitamiseks oli 7 november 2024 hiljemalt kell 23 59 eesti aja järgi oma hääle andis 10 aktsionäri kellele kuuluvad aktsiad esindavad kokku 1 184 599 häält mis moodustab kokku 60 aktsiatega määratud häältest seltsi aktsionärid võtsid 7 novembril 2024 üldkoosolekut kokku kutsumata äs s 2991 sätestatud korras vastu järgmised otsused valida seltsi uueks nõukogu liikme
1427,all_events,DOWN,UP,18 nov 2024 06 30 cet salmar asa operational ebit for norway was nok 1 082 million in the third quarter of 2024 the harvest volume was 56 400 tonnes and operational ebit per kg was nok 19 2 operational ebit for the group was nok 1 041 million in the third quarter of 2024 the harvest volume was 60 300 tonnes and operational ebit per kg was nok 17 3 the farming segments in norway were affected by biological challenges during the quarter and volume expectations for 2024 have been reduced sales and industry reported historically strong results where the efficient and flexible operational setup along with the contract share positively impacted the results salmar aker ocean completed the harvest of the remaining volume in 2024 and the production cycles for both ocean farm 1 and arctic offshore farming are well underway with planned harvesting in 2025 icelandic salmon continued to be affected by low volum
11308,all_events,UP,,mainz biomed provides half year 2024 corporate update industry leading clinical data position the company for fda premarket approval study
11388,all_events,UP,,in october 2024 as tallink grupp transported 479 232 passengers which is a 1 increase compared to october 2023 the number of cargo units decreased by 10 compared to the same period a year ago and was 24 346 units the number of passenger vehicles decreased by 5 to 59 530 vehicles in the same comparison
12722,all_events,DOWN,,media release
6058,all_events,UP,,media release
683,all_events,DOWN,DOWN,initiated dosing of oric 944 in combinations with nubeqa darolutamide and erleada apalutamide in the ongoing phase 1b trial for prostate cancer
4629,all_events,DOWN,,needham mass nov 14 2024 globe newswire candel therapeutics inc candel or the company nasdaq cadl a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer today reported financial results for the third quarter ended september 30 2024 and provided a corporate update
12540,all_events,DOWN,,15 nov 2024 08 32 cet axactor asa moody s investors service moody s has announced to downgrade axactor asa s corporate family rating cfr to b3 from b2 and its senior unsecured ratings to caa2 from caa1 moody s states in a press release dated 14 november 2024 that the rationale for the downgrade is axactor s weakened financial performance in the currently challenging macroeconomic environment for debt purchasers characterized by reduced collections and further exacerbated by the increased cost of funding the rating action concludes the review initiated on 17 may 2024 the full press release from moody s is enclosed for further information please contact kyrre svae chief of strategy ir axactor tel 47 478 39 405 e mail kyrre svae axactor com more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632351_rating_action moodys ratings downgrades 14nov2024 pr_498630 pdf axacto
7550,all_events,UP,,13 nov 2024 10 51 cet aperam s a aperam s a key word s miscellaneous designated person notification 13 nov 2024 10 51 cet cest designated person notification luxembourg 13 november 2024 10 30 cet with reference to article 19 3 of regulation eu no 596 2014 of the european parliament and of the council of 16 april 2014 on market abuse market abuse regulations aperam announces that one notification of share transactions by a designated person i e directors or executive officers is available in the luxembourg stock exchange s electronic database oam on www bourse lu and on aperam s web site www aperam com under investors news contact managers transactions link about aperam aperam is a global player in stainless electrical specialty steel and recycling with customers in over 40 countries the business is organized in four primary reportable segments stainless electrical steel services solutions alloys s
7932,all_events,UP,,november 19 2024 02 30 et source sutntib invl baltic real estate sutntib invl baltic real estate 2024 m lapkričio 19 d įvykusio specialiosios uždarojo tipo nekilnojamojo turto investicinės bendrovės sutntib invl baltic real estate toliau bendrovė neeilinio visuotinio akcininkų susirinkimo toliau susirinkimas sprendimai 1 supažindinimas su invl baltic real estate investicinio komiteto rekomendacija dėl naujos įstatų redakcijos 1 1 akcininkai buvo supažindinti su invl baltic real estate investicinio komiteto rekomendacija dėl naujos įstatų redakcijos šiuo darbotvarkės klausimu sprendimas nepriimamas 2 dėl invl baltic real estate dalyvavimo reorganizavime 2 1 vadovaujantis lietuvos respublikos civilinio kodekso 2 97 straipsnio 3 dalimi invl baltic real estate dalyvauja reorganizavime jungimo būdu kurio metu prie veiklą tęsiančios invl baltic real estate prijungiama veiklą be likvidavimo procedūros baigianti du
2536,all_events,UP,DOWN,initiated phase 3 synchrony outcomes trial of lead candidate efruxifermin efx in patients with compensated cirrhosis f4 due to mash
8346,all_events,DOWN,,partial response and stable disease reported in combination cohort and durable stable disease observed in monotherapy cohortsno dose limiting toxicities observed at any dose levelcleared fifth of six monotherapy cohorts and second of four combination cohortskineta is actively exploring strategic alternatives to maximize value for all stakeholders
4782,all_events,UP,,12 nov 2024 23 05 cet kongsberg gruppen asa kongsberg defence aerospace kongsberg har signert en anskaffelseskontrakt med us navy for levering av naval strike missile nsm til us navy and fleet marine force over en femårsperiode fastpriskontrakten er verdt 10 milliarder kroner denne kontrakten inkluderer opsjoner som dersom de utøves vil bringe totalverdien av kontrakten til ca 12 milliarder kroner dette er den største missilkontrakten i kongsbergs historie og en viktig milepæl for oss vi er glade for at usa har valgt kongsberg som industripartner og ser frem til fortsatt samarbeid for å støtte amerikansk forsvarsevne og skape verdier i norge og usa sier geir håøy konsernsjef i kongsberg nsm er sentral i marinens over the horizon weapons system program og blir installert på deres littoral combat ships og constellation klasse fregatter kongsberg leverer også nsm til us marine corps nmesis program navy marine expeditionary ship interdiction system
7322,all_events,DOWN,,ahead of novedo s annual general meeting on may 15 2025 mikael ericson fredrik holmström and marc cameras have been appointed members of the nomination committee according to the current instructions for the nomination committee novedo s nomination committee will consist of members appointed by the three largest shareholders in the company based on voting rights as recorded in the share register maintained by euroclear sweden ab as of september 30th of the year preceding the annual general meeting if any of the three largest shareholders choose not to appoint a representative to the nomination committee the right to appoint will be passed to the shareholder with the subsequent largest shareholding in the company the member representing the largest shareholder will be designated as the chairman of the nomination committee unless the committee unanimously decides to appoint someone else the chairman of the board of directors of novedo will be responsible for convening the nomi
3221,all_events,DOWN,,vilnius lithuania 2024 11 06 14 42 cet sun investment group invites investors to join the investor webinar scheduled on the 8 november 2024 at 10 00 am in english eest baltic time during the call sun investement group issuer ceo deividas varabauskas and orion securities issue organizer head of corporate finance mykantas urba will present bond issue details and answer investor questions 8 november 2024 at 10 00 am in english register here key bond issue details the existing bondholders of sun investment group uab bonds isin lt0000313256 issued in 2023 will be able to exchange these bonds to newly issued ones through the nasdaq csd securities exchange offer for more information and full documentation click here attachments 2024106_sun investment group investor webinar en_2 pdf
4739,all_events,UP,,media release
2020,all_events,DOWN,DOWN,06 nov 2024 11 19 cet askøy kommune oslo børs has received an application for isin no0013392340 to be admitted to stock exchange listing the market abuse regulation mar applies from the time the application has been made including the issuer s disclosure obligation on inside information more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site askøy kommune oslo børs newspoint askøy komm 20 25 frn askoy komm 23 26 frn askøy komm 24 27 frn no0010901143 no0013066340 no0013260315 oslo børs
6462,all_events,DOWN,,november 19 2024 02 30 et source invl baltic real estate invl baltic real estate the resolutions of the general extraordinary shareholders meeting hereinafter the meeting of special closed ended type real estate investment company invl baltic real estate hereinafter the company that was held on 19 november 2024 1 presentation of the recommendation of invl baltic real estate investment committee regarding the new wording of the articles of association 1 1 shareholders of invl baltic real estate were presented with the company s investment committee s recommendation on the new wording of the articles of association there is no voting on this issue of agenda 2 regarding invl baltic real estate participation in the reorganisation 2 1 pursuant to article 2 97 3 of the civil code of the republic of lithuania invl baltic real estate participates in the reorganisation by way of merger whereby the company terminating the activity wi
9248,all_events,UP,,media release
12105,all_events,UP,,14 nov 2024 08 00 cet skue sparebank utsteder skue sparebank isin for obligasjonslånet no0012451931 dato for innfrielse 15 11 2024 beløp som innfris 50 millioner kroner utestående beløp etter innfrielse 152 millioner kroner innløsningskurs 100 125 innfrielsene gjøres som nedkvittering i vps denne opplysningen er informasjonspliktig etter verdipapirhandelloven 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site skue sparebank oslo børs newspoint skue sparebank skue spb 20 25 frn skue spb 21 31 frn c sub skue spb 21 26 frn skue spb 21 perp frn c hybrid skue spb 22 25 frn skue spb 22 27 frn skue spb 22 perp adj c hybrid skue spb 22 28 frn skue spb 23 perp frn c hybrid skue spb 23 27 frn skue spb 23 28 frn skue spb 24 29 frn skue spb 24 27 frn no0006001809 no0010873565 no0010875461 no0010935505 no0010977200 no0011031296 no0011031304 no0011100778 no001245193
2177,all_events,UP,UP,14 nov 2024 11 33 cet sogn sparebank sogn sparebank kvartalsrapport q3 2024 1 samandrag sogn sparebank legg fram eit driftsresultat før tap på 107 7 mill kroner pr 30 09 2024 driftsresultatet er 19 0 mill kroner betre enn 3 kvartal 2023 banken har pr 30 09 2024 kostnadsført nedskrivingar på utlån og garantiar med 1 4 mill kroner banken rapporterer eit totalresultatet pr 30 09 2024 på 70 5 mill kroner 2 q3 2024 forholdstal resultat før tap 107 7 mnok resultat etter skatt 70 5 mnok eigenkapitalavkastning 9 66 rentenetto 139 5 mnok kostnadar i forhold til inntekter 41 1 rein kjernekapitaldekning 22 8 forteneste pr eigenkapitalbevis 17 04 nok utlånsvekst siste 12 mnd 3 04 innskotsvekst siste 12 mnd 2 3 hovudrapport sjå vedlegg for komplett delårsrapport og rekneskap q3 2024 4 kontaktpersonar ass banksjef gunnar skahjem tlf 91374994 adm banksjef mads arnfinn indrehus tlf 90950615 sogn sparebank e
6454,all_events,UP,,yavne israel oct 08 2024 globe newswire mediwound ltd nasdaq mdwd a global leader in next generation enzymatic therapeutics for tissue repair today announced that chief executive officer ofer gonen will take part in a fireside chat during the 2024 maxim healthcare virtual summit the fireside chat hosted by michael okunewitch senior biotechnology analyst at maxim will take place on wednesday october 16 2024 at 9 30 a m et
12280,all_events,UP,,media release
11685,all_events,UP,,06 nov 2024 06 45 cet nexity press release montrouge 6 november 2024 crédit agricole immobilier announces the closing of the acquisitionof nexity property managementand becomes the leader of property management in france crédit agricole immobilier is pleased to announce that it has completed the acquisition of nexity property management a nexity subsidiary specialised in commercial and residential asset management with this transaction announced on 25 july 2024 crédit agricole immobilier becomes the leader in institutional property management in france 1 the acquisition of nexity property management brings additional expertise to crédit agricole immobilier ranging from advisory services to accounting and technical rental management supervision of works shopping malls management etc in addition nexity property management s powerful network of over 30 branches and offices across france comes as an addition to strengthens crédit agricole immobilier s own presence
3441,all_events,DOWN,,on track to announce topline data in q1 2025
2201,all_events,UP,DOWN,media release
6162,all_events,UP,,media release
6018,all_events,UP,,november 15 2024 06 38 et source borregaard borregaard 15 november 2024 borregaard asa borregaard ose ticker brg borregaard intends to repurchase up to 200 000 shares of its outstanding common stock the shares will be used for employee incentive programmes borregaard s board of directors was given authority by the shareholders at the ordinary general meeting held on 11 april 2024 to repurchase up to ten percent of the outstanding shares according to the proxy the highest price to be paid is nok 400 00 per share the repurchase of shares will be conducted in a period from 18th november up to and including 20th december 2024 at the latest the maximum daily volume to be purchased during the above mentioned period is 15 628 shares this limit corresponds to of the average daily turnover in october 2024 all shares will be purchased in a regulated market borregaard has appointed sparebank 1 markets as to carry out the repurchase pro
9383,all_events,DOWN,,although there were no huge positive development leaps in the operating environment there were still signs of renewed optimism in the residential property market during the third quarter we signed 32 contracts under the law of obligation sales contract 2024 q2 47 2023 q3 21 and during the first 9 months of the year we signed a total of 95 sales contracts 2023 40 most of the new sales during the quarter came from the regati development which is under construction and also the sales of previously completed apartments of luuslangi development liven s market share of new sales in tallinn and the surrounding area is estimated to have been around in the first 9 months of 2024 up from the 6 estimate of the previous two years
11808,all_events,UP,,november 12 2024 08 50 et source landsbankinn hf landsbankinn hf s p global ratings has today affirmed the credit rating of landsbankinn and revised the outlook from stable to positive the credit rating of the bank is bbb a 2 with positive outlook in s p s announcement it is stated that the positive outlook reflects potential uplift of the credit rating due to increased loss absorbing capacity if the bank continues its issuance of alac eligible debt beyond s p s threshold of of risk weighted assets as calculated in accordance with s p s methodology in the rationale for the decision s p highlights that landsbankinn was the first icelandic bank to issue senior non preferred bond and thereby proving sound market access and investor appetite for the issuance further information can be found in s p s announcement available on the bank s website https www landsbankinn is en the bank investor relations credit rating
9895,all_events,DOWN,,media release
1114,all_events,DOWN,UP,12 nov 2024 07 30 cet onward medical eindhoven the netherlands nov 12 2024 globe newswire onward medical n v euronext onwd the medical technology company creating innovative spinal cord stimulation therapies to restore movement function and independence in people with spinal cord injury sci today announces that it will host a webcast to discuss its q3 2024 business highlights the webcast will be held on november 26 2024 at 2 00pm cet 08 00am et it will be hosted by ceo dave marver who will discuss highlights from q3 2024 and provide a business update to join the webcast via zoom please register using this link participants may also join by phone 32 2 290 9360 belgium 33 1 7095 0350 france 49 69 3807 9884 germany 31 20 794 0854 netherlands 41 22 591 0156 switzerland 44 203 481 5240 united kingdom 1 346 248 7799 us additional telephone numbers available meeting id 834 0031 2222 a recording of the webcast will be available o
1575,all_events,UP,DOWN,media release
3963,all_events,DOWN,,san diego april 03 2024 globe newswire biora therapeutics inc nasdaq bior the biotech company that is reimagining therapeutic delivery today announced the closing of its previously announced registered direct offering of an aggregate of 5 454 548 shares of the company s common stock at an offering price of 1 10 per share of common stock and concurrent private placement of unregistered warrants to purchase up to 5 454 548 shares of common stock the warrants have an exercise price of 1 10 per share will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the warrants and will expire five years from the date of stockholder approval
5665,all_events,UP,,media release
6778,all_events,DOWN,,14 nov 2024 18 00 cet spineway press release ecully november 14 2024 6 p m spineway a week dedicated to medical excellence with more than 20 surgeons trained the spineway group a specialist in innovative implants for the treatment of severe spine disorders organized a week of training dedicated to medical education from november 4 to 8 2024 through practical sessions in the operating room and on anatomical specimens in the laboratory this intensive program trained over 20 international surgeons in the use of the group s esp cervical and lumbar prostheses these events also enabled the group s distributors to provide ongoing training and support for their users the week began with a costa rican surgeon being trained in the operating room by pr lazennec hôpital de la pitié salpêtrière ap hp paris on cervical prosthesis cp esp and lumbar prosthesis lp esp this was followed by a training session with two indonesian surgeons led by pr r
8826,all_events,DOWN,,new data show istisociclib kb 0742 triggered cell death in preclinical ovarian cancer models of platinum and parp inhibitor parpi resistance
3887,all_events,DOWN,,se venligst vedlagte vedhæftede filer vedlagte filer notifikation af transaktioner nci 03102024 pdf notifikation af transaktioner nci 04102024 pdf notifikation af transaktioner nci 07102024 pdf selskabsmeddelelse 28_2024 ledende medarbejderes transaktioner pdf
6137,all_events,UP,,24 07 2024 jsc latvijas gāze has received a notification from the bank of latvia that
3307,all_events,UP,,on 4 october 2024 the board of telia lietuva ab hereinafter telia lietuva or the company elected board member hannu matti mäkinen as a new member and chair of the audit committee previous chair of the company s audit committee agneta wallmark has resigned from the board and the audit committee as of 20 september 2024 agneta s resignation is aligned with her forthcoming retirement and departure from telia company ab as representative of telia company ab that owns 88 15 per cent of telia lietuva s shares and votes hannu matti mäkinen is member of the board of telia lietuva from april 2018 he is also a member of the remuneration committee at telia company hannu matti mäkinen holds a position of chief legal counsel for telia asset management three members of the board compose the audit committee of telia lietuva whereof two leda iržikevičienė and mindaugas glodas are independent members of the board at present there 5 members of the board three representing telia
8455,all_events,UP,,media release
101,all_events,UP,DOWN,vaisala oyjpörssitiedote1 11 2024 klo 10 20
12548,all_events,DOWN,,12 11 2024 10 00 00 eet digital workforce services oyj company announcement company announcement november 12 2024 at 10am eet share subscriptions based on stock options 2020 a total of 12 975 digital workforce services plc s new shares has been subscribed for with the company s stock options 2020 on 30 september 2024 for subscriptions made with the stock options 2020 the entire subscription price of eur 8 650 00 will be entered in the reserve for invested unrestricted equity after the trade registration the total number of shares is 11 281 818 the shares subscribed for under the stock options 2020 have been registered in the trade register on 12 november 2024 as of which date the new shares will establish shareholder rights the shares will be traded on the first north growth market finland marketplace maintained by nasdaq helsinki oy together with the old shares as of 13 november 2024 for further information please contact jussi vasama ceo digital workforce serv
11085,all_events,DOWN,,media release
2150,all_events,DOWN,DOWN,media release
1355,all_events,UP,UP,19 nov 2024 10 08 cet totalenergies se regulatory news totalenergies paris tte lse tte nyse tte and oil india limited oil signed a cooperation agreement to carry out methane emissions detection and measurement campaigns using totalenergies pioneer ausea1 technology at oil sites in india state owned enterprise oil recently joined the oil and gas decarbonization charter ogdc a global industry initiative launched at cop28 co chaired by totalenergies ceo the ogdc s ambition is to work towards net zero operations by 2050 as well as near zero upstream methane emissions and zero routine flaring by 2030 moreover ogdc members are committed to measuring and publicly reporting progress in line with the ogdc s principle of sharing good practices totalenergies makes this technology available to other operators among the signatories as an effective and recognized tool to detect measure and eventually abate methane emissions on their own assets ause
4794,all_events,UP,,bagsværd denmark 13 november 2024 this company announcement discloses the data of the transaction s made in novo nordisk shares by the company s board members executives and their associated persons in accordance with article 19 of regulation no 596 2014 on market abuse the company s board members executives and their associated persons have given novo nordisk power of attorney on their behalf to publish trading in novo nordisk shares by the company s board members executives and their associated persons please find below a statement of such trading in shares issued by novo nordisk novo nordisk is a leading global healthcare company founded in 1923 and headquartered in denmark our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes we do so by pioneering scientific breakthroughs expanding access to our medicines and working to prevent and ultimately cure disease novo nordisk employs about 72 000 people in 80 countries and
9896,all_events,UP,,media release
1208,all_events,DOWN,DOWN,13 nov 2024 16 35 cet ayfie international as oslo november 13 2024 reference is made to the stock exchange announcement by ayfie international as ayfie or the company on 30 october 2024 regarding a successfully completed private placement of new shares in the company the private placement skandinaviska enskilda banken ab publ was appointed as manager for the private placement the manager please see the attached forms for information regarding the conditional allocations of shares in the private placement made to primary insiders and their close associates this information is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act for further information please contact olav gram degnes cfo ir tel 47 906 25 168 e mail olav degnes ayfie com about ayfie ayfie is a leading innovator in search solutions and artificial intelligence ai offering a powerful ai driven search product
747,all_events,DOWN,DOWN,spatial biology 2 0 solutions enable discovery and translational workflows at an unprecedented speed and scale
1766,all_events,UP,UP,02 oct 2024 07 45 cest smcp sa communiqué paris le 2 octobre 2024 ida simonsen est nommée présidente directrice générale de smcp amérique du nord le groupe smcp a le plaisir d annoncer la nomination d ida simonsen au poste de présidente directrice générale de la région amérique du nord elle succède à paul griffin qui a décidé de poursuivre sa carrière en dehors du groupe isabelle guichot directeur général du groupe smcp a déclaré nous sommes ravis d accueillir ida simonsen au sein de la famille smcp en tant que présidente directrice générale de la région amérique du nord son leadership sa profonde expertise du secteur et son engagement envers les relations humaines font d elle la candidate idéale pour diriger notre équipe nord américaine ida a su démontrer son talent tant dans la gestion des transitions stratégiques que dans la conduite de la croissance et je suis convaincue qu elle saura inspirer nos équipes et nous aider à atteindre de nouveaux objectifs d
6270,all_events,UP,,media release
3679,all_events,UP,,media release
6070,all_events,DOWN,,ratos is acquiring kb gruppen s minority holding in the norwegian infrastructure maintenance company presis infra with this transaction ratos has strengthened its holding from 72 to the remaining minority share is held by company management ratos acquired a majority holding in presis infra in 2021 as a platform investment in the expansive future industry of infrastructure maintenance since the acquisition the company has continued to deliver a very positive performance resulting in a doubling of sales in three years net sales amounts to nok 3 437m ltm as of the end of the third quarter of 2024 which is an increase of compared to the corresponding period in 2021 nok 1 696m the purchase price for the minority holding of is nok 895m and has been determined based on the terms of the shareowner agreement between ratos and kb gruppen 10 9x ebita ltm as of the end of the third quarter of 2024 in 2023 presis infra established a presence in sweden and its perf
6848,all_events,UP,,18 nov 2024 15 31 cet alstom communiqué de mise à disposition du rapport financier semestriel au 30 septembre 2024 18 novembre 2024 alstom annonce ce jour avoir mis à la disposition du public et déposé auprès de l autorité des marchés financiers son rapport financier semestriel au 30 septembre 2024 le rapport financier semestriel peut être consulté sur le site internet d alstom à l adresse www alstom com fr dans la rubrique finance information réglementée à propos d alstom alstom contribue par ses engagements à un futur décarboné en développant et favorisant des solutions de mobilité durables et innovantes appréciées des passagers qu il s agisse de trains à grande vitesse de métros de monorails de trams de systèmes intégrés de services sur mesure d infrastructures de solutions de signalisation ou de mobilité numérique alstom offre à ses divers clients le portefeuille le plus large du secteur présent dans 64 pays et fort de plus de 84 700 employés de 1
9549,all_events,DOWN,,toronto feb 01 2024 globe newswire revive therapeutics ltd revive or the company otcqb rvvtf cse rvv frankfurt 31r a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders announced today its initiative in bucillamine an oral thiol based drug with anti inflammatory and antiviral properties as a potential treatment for long covid the company aims to advance the clinical development of bucillamine by leveraging the published research and existing data from its previous phase 3 clinical trial the study and is preparing a clinical package that includes a proposed phase 2 3 clinical protocol for long covid to present to the fda and international health regulatory bodies
7748,all_events,DOWN,,immunocore converts phase 2 3 tebe am clinical trial into registrational phase 3 trial evaluating kimmtrak for previously treated advanced cutaneous melanoma
6224,all_events,DOWN,,06 nov 2024 17 45 cet carmila provided pursuant to article l 233 8 ii of the code de commerce french commercial code and article 223 16 of the règlement général de l autorité des marchés financiers general regulation of the french financial market authority regulatory news carmila paris carm date total number of issued shares number of real voting rights excluding treasury shares theoretical number of voting rights including treasury shares 31 october 2024 141 594 500 141 417 620 141 594 500 pursuant to article 223 11 of the règlement général de l autorité des marchés financiers carmila french société anonyme with a share capital of 849 567 000 registered office 25 rue d astorg 75008 paris france registered at the paris commercial and companies registry under number 381 844 471 view source version on businesswire com https www businesswire com news home 20241106018019 en carmila provide
10255,all_events,DOWN,,06 nov 2024 07 00 cet xxl asa oslo 6 november 2024 xxl continued to see sales recovery quarter over quarter but delivered negative year over year growth of 7 per cent in the third quarter of 2024 total operating revenue amounted to nok 1 8 billion nok 2 0 billion the nordic sporting goods market persisted to be challenging in q3 2024 after ten consecutive quarters with negative growth especially in norway and finland xxl is experiencing initial recovery in sweden impacted by three interest rate cuts so far this year ebitda amounted to nok 5 million nok 35 million mainly driven by the negative sales growth hampering scale in operations xxl has continued to prioritize strict liquidity and inventory control resulting in a reduction of inventory of 13 per cent in value but only 3 per cent in number of pieces lower inventory has a negative impact on the availability of products and on the topline development consequently xxl is in the process of secur
9194,all_events,UP,,media release
7905,all_events,UP,,sampo plc managers transactions 2 october 2024 at 3 00 pm eest sampo plc managers transactions svensson sampo plc business code 0142213 3 has received the following notification under article 19 of the market abuse regulation shares have been acquired in accordance with terms and conditions of the long term incentive scheme 2020 1 2 ____________________________________________ person subject to the notification requirement name klas svenssonposition other senior managerissuer sampo plclei 743700uf3rl386wida22notification type initial notificationreference number 80001 5 8____________________________________________ transaction date 2024 09 30venue nasdaq helsinki ltd xhel instrument type shareisin fi4000552500nature of transaction receipt of a share based incentive transaction details 1 volume 483 unit price 41 9316 eur aggregated transactions 1 volume 483 volume weighted average price 41 9316 eur____________________________________________ transactio
9931,all_events,DOWN,,redwood city calif june 17 2024 globe newswire jasper therapeutics inc nasdaq jspr jasper a biotechnology company focused on development of briquilimab a novel antibody therapy targeting c kit cd117 to address mast cell driven diseases such as chronic spontaneous urticaria csu chronic inducible urticaria cindu and asthma today announced today announced that its management will present at the oppenheimer novel targets in immunology summit to be held on monday june 24 2024 in new york city
10858,all_events,UP,,media release
1483,all_events,UP,DOWN,from october 8th 2024 10 00 eest bigbank as bonds isin code ee3300004977 public offer subscription process is launched the last trading day of the subscription period is october 18th 2024 15 30 eest up to 3 000 bonds are being publicly offered to investors in estonia latvia and lithuania the offer price is 1 000 eur per bond which is equal to the nominal value of a bond the interest rate is 6 per annum payed quarterly and the maturity is 10 years the bonds will be registered in the nasdaq csd under the isin code ee3300004977 in case of over subscription bigbank has the right to increase the volume of the offering to a total of 8 000 bonds and the offering may also be decreased by the amount unsubscribed the subscription offer will be carried out using the stock exchange trading system and nasdaq csd offering via stock exchange trading system for investors in latvia and lithuania market tse equity auctions genium inet trading system order book bigbbo
11009,all_events,DOWN,,in view of the upcoming entry into force of the polish act of november 6th 2024 on top up tax levied on constituent entities of multinational and domestic groups the act the management board of kruk s a the company announces that the company will fall within the scope of the act after meeting the revenue condition set out therein i e after its consolidated revenue in any two of the four consecutive fiscal years immediately preceding the tested fiscal year reaches eur 750 million or more the company estimates that the kruk group s consolidated revenue may reach the eur 750 million threshold in 2025 and 2026 at the earliest in such a case provided that the effective tax rate in the relevant jurisdiction computed in accordance with the act is lower than the kruk group would be required to pay top up tax for the first time for the fiscal year 2027 if other statutory conditions are met the kruk group may benefit from the safe harbour rules provided for in the act whi
9239,all_events,UP,,media release
10692,all_events,UP,,cambridge mass may 14 2024 globe newswire editas medicine inc nasdaq edit a clinical stage gene editing company today announced that two abstracts including one oral presentation and one poster presentation detailing clinical data from the ruby and edithal trials of renizgamglogene autogedtemcel reni cel have been accepted for presentation at the european hematology association eha hybrid congress being held june 13 16 2024 in madrid spain and via livestream
9191,all_events,DOWN,,hilbert capital the asset management division of hilbert group ab nasdaq hilb b has reached a significant milestone achieving its 2024 assets under management aum target of 300 million sek 3 3 billion a target that was set in 2022 hilbert group ceo niclas sandström comments our pipeline looks promising and the market environment has improved substantially positioning us well for continued growth in 2025 we will provide new short and long term targets including profitability goals at the end of this month with the release of our q3 report for additional information on hilbert please contact niclas sandströmceo hilbert group abphone 46 8 502 353 00email ir hilbert group about us hilbert group is a quantitative investment company specializing in algorithmic trading strategies in digital asset markets hilbert group is a swedish public company and is committed to providing operational infrastructure risk management and corporate governance that meets the ever i
533,all_events,DOWN,DOWN,november 06 2024 00 30 et source mowi asa mowi asa bergen 6 november 2024 mowi rapporterte rekordhøye inntekter på 1 44 milliarder euro og et operasjonelt driftsresultat på 173 millioner euro i tredje kvartal dette var nok et kvartal med nye rekorder for mowi med vår beste produksjon i sjø og høyeste slaktevolumer noensinne på totalt 161 000 tonn laks vi har heller aldri hatt mer fisk stående i sjø opp 4 fra samme tid i fjor sier konsernsjef i mowi ivan vindheim mowi ligger derfor godt an til å nå sitt mål om å slakte 500 000 tonn laks i 2024 som er en milepæl for selskapet neste år forventer mowi å slakte 520 000 tonn som er første steg mot neste milepæl på 600 000 tonn som selskapet forventer å nå i 2029 520 000 tonn representerer en vekst på 145 000 tonn siden 2018 som tilsvarer en årlig vekst på 4 mot 2 i snitt for næringen dette fører også til vekst innen selskapets to andre segmenter videreforedling og fôrprod
2215,all_events,UP,UP,media release
4352,all_events,UP,,spar nord bank expects to announce the financial statements on the following dates
10058,all_events,UP,,zug switzerland oct 02 2024 globe newswire oculis holding ag nasdaq ocs oculis a global biopharmaceutical company purposefully driven to save sight and improve eye care today announced the appointment of daniel s char to the role of chief legal officer leading oculis legal compliance and corporate governance functions mr char brings over 35 years of success in global legal leadership experience at both large and smaller biotech companies
12443,all_events,DOWN,,media release
1602,all_events,DOWN,DOWN,iceland seafood will publish its interim consolidated financial statements for q3 and 9m 2024 after the markets close on november 20th 2024 on the same day at 4 30 pm the company will host an online meeting for investors and market participants where management will present and discuss the results the meeting will only be streamed online participants in the online meeting can send questions in writing before and during the meeting to the email investors icelandseafood com a link to the webcast and the investor presentation is here below https vimeo com event 4726268 embed c2efa9c7e6
10943,all_events,UP,,media release
10760,all_events,UP,,tel aviv israel and new york may 03 2022 globe newswire vbl therapeutics nasdaq vblt a late clinical stage biotechnology company focused on developing first in class therapeutics for difficult to treat malignant solid tumors and immune or inflammatory indications today announced that the company will present new data on its novel monocyte targeting technology and lead candidate vb 601 at immunology2022tm being held in portland or on may 6 10 2022 in addition dror harats m d chief executive officer of vbl therapeutics will discuss the vb 601 program at the lifesci immunology inflammation symposium being held virtually on may 11 2022 prof harats will also provide a keynote presentation at the biomed israel 2022 conference on may 12 2022 and a corporate overview at the h c wainwright global investment conference taking place may 23 may 26 2022
4838,all_events,DOWN,,the consolidated revenues of bercman technologies as hereinafter bercman for the third quarter of 2024 amounted to eur 326 567 compared to q3 2023 eur 403 272 mart suurkask ceo of bercman the third quarter sales results were affected by administrative delays on the client side in large key projects related to procurement procedures and tender projects as well as a slight slowdown in client development activities we are pleased to note that the defence sector has shown resilience amid broader economic challenges with companies in this field maintaining a steady demand for innovative solutions our development team has been fully supportive in assisting these companies with product development in the third quarter development services were exported not only to serve estonian clients but also to markets in norway sweden finland singapore and switzerland the focus on strategic projects particularly in the defence sector increased the share of defence indus
3378,all_events,DOWN,,november 07 2024 01 00 et source inbank inbank inbanki 2024 aasta kolmanda kvartali konsolideeritud puhaskasum oli 3 1 miljonit eurot mis on aastatagusega võrreldes enam aasta esimese üheksa kuu kasum ulatus 10 8 miljoni euroni mis on rohkem kui aasta tagasi omakapitali tootlus oli kolmandas kvartalis 8 ja aasta üheksa esimese kuu jooksul 10 tulemusi kommenteerib inbanki juhatuse esimees priit põldoja inbanki finantstulemused olid ka kolmandas kvartalis head ja tulud kasvasid stabiilselt võrreldes eelmise aastaga kasvas kolmandas kvartalis inbanki puhas intressitulu ja kogutulu kuna inbank kasutab intressimäära riskide maandamiseks finantsinstrumente avaldas kolmanda kvartali tuludele negatiivset mõju nende instrumentide õiglase väärtuse allahindlus 1 2 miljoni euro võrra aasta esimese kahe kvartali jooksul teenis ettevõte samadest instrumentidest kasumit autode finantseerimises saavutasime jätkuvalt v
5140,all_events,DOWN,,toronto march 19 2024 globe newswire revive therapeutics ltd revive or the company otcqb rvvtf cse rvv frankfurt 31r a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders announced today that the fda advised the company to submit a type c meeting request to discuss evaluating a proposed phase 2 clinical study of bucillamine an oral thiol based drug with anti inflammatory and antiviral properties as a potential treatment for long covid the company expects to submit the type c meeting request by next week
8559,all_events,UP,,a nomination committee consisting of shareholder representatives and the chairman of the board of directors has been established for acarix ab publ in accordance with the principles adopted by the annual general meeting held on may 14 2024 members of the nomination committee are the nomination committee is assigned to prepare proposals regarding chairman of the annual general meeting board of directors chairman of the board of directors auditor as well as board remuneration and fee to the auditor the nomination committee represents approximately 11 percent of the total voting rights of acarix ab based on the ownership structure as of october 31 2024 shareholders wishing to submit a proposal to the nomination committee may do so by sending an e mail to valberedning acarix com the annual general meeting agm 2025 in acarix will be held on may 15 of 2025 in stockholm shareholders who wish to submit proposals for the agm 2025 can send such requests in writing to acarix ab
11944,all_events,DOWN,,media release
19,all_events,UP,DOWN,15 nov 2024 08 00 cet sparebanken sør not for distribution or release in whole or in part directly or indirectly in or into usa australia canada japan hong kong switzerland or singapore or any other jurisdiction in which the distribution or release would be unlawful except as permitted under applicable securities law reference is made to the stock exchange announcement dated 28 november 2023 regarding the successful bookbuilding and sale of existing equity capital certificates offer eccs in sparebanken sør carried out by sparebankstiftelsen sparebanken sør the foundation the offering the offering consisted of i an institutional offering ii a retail offering to the public in norway and iii an employee offering investors allocated eccs in the retail offering have under specific terms the right to receive bonus eccs bonus eccs as described in the prospectus for the offering dated 20 november 2023 and in the stock exchange annou
8790,all_events,DOWN,,media release
9001,all_events,UP,,science 37 s metasite and patient recruitment solutions together dramatically boost patient enrollment in a phase 3 asthma clinical trial
5006,all_events,UP,,adelaide australia and cambridge mass may 20 2024 globe newswire bionomics limited nasdaq bnox bionomics or company a clinical stage biotechnology company developing novel first in class allosteric ion channel modulators to treat patients suffering from serious central nervous system cns disorders with high unmet medical need today announced that spyridon spyros papapetropoulos m d phd president and chief executive officer of bionomics will be giving an oral presentation and presenting two posters about bnc210 as a potential treatment for social anxiety disorder and post traumatic stress disorder ptsd at the 2024 american society of clinical psychopharmacology ascp annual meeting taking place may 28 31 in miami beach florida details of the presentations are as follows
3015,all_events,DOWN,,carmel ind sept 12 2024 globe newswire mbx biosciences inc nasdaq mbx mbx biosciences a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders today announced the pricing of its initial public offering of 10 200 000 shares of its common stock at a price to the public of 16 00 per share the gross proceeds to mbx biosciences from the offering before deducting the underwriting discounts and commissions and offering expenses are expected to be 163 2 million all of the shares are being offered by mbx biosciences in addition mbx biosciences has granted the underwriters a 30 day option to buy an additional 1 530 000 shares of its common stock at the initial public offering price less underwriting discounts and commissions
10937,all_events,DOWN,,media release
5597,all_events,DOWN,,media release
8358,all_events,UP,,sydney june 20 2024 globe newswire radiopharm theranostics limited asx rad radiopharm or the company a developer of diagnostic and therapeutic radiopharmaceutical products has entered into strategic agreements with lantheus holdings inc lnth nasdaq a leading radiopharmaceutical focused company and its affiliates lantheus lantheus has agreed to make an initial equity investment of a 7 5 million us 4 99 million and will have an option to invest a further a 7 5 million us 5 million within 6 months on the same terms additionally radiopharm has agreed to transfer two of its early preclinical assets to lantheus for a 3 0 million us 2 0 million pursuant to a separate transfer and development agreement
12371,all_events,UP,,media release
11180,all_events,DOWN,,november 11 2024 02 45 et source ab invalda invl ab invalda invl pirmaujančios turto valdymo grupės baltijos šalyse invalda invl bendrovės invl asset management šių metų rugsėjį įsteigtas informuotiems investuotojams skirtas uždaro tipo fondas invl partner power opportunities fund iš investuotojų pritraukė 24 71 mln jav dolerių į fondą investavo 71 investuotojas invl partner power opportunities fund investicinius vienetus baltijos šalyse platino finansų maklerio įmonė invl financial advisors veikianti su prekės ženklu invl šeimos biuras dar kartą įsitikinome kad tokios pasaulinio lygio investicinės galimybės yra itin laukiamos mūsų regiono investuotojų prieiga prie šio fondo ne tik padeda investuotojams diversifikuoti portfelius ir siekti ilgalaikio kapitalo augimo bet ir leidžia prisidėti prie teigiamų pokyčių energetikos ir infrastruktūros sektoriuose globaliu mastu sako invl šeimos biuro vadovė asta jovaišienė
4921,all_events,UP,,advancing tranquility and serenity program plans for two pivotal phase 3 trials to expand bxcl501 market potential in acute treatment of agitation
3473,all_events,UP,,media release
11608,all_events,DOWN,,12 nov 2024 22 05 cet okeanis eco tankers corp athens greece november 12 2024 okeanis eco tankers corp the company or oet nyse eco ose oet has been notified of the following transactions on november 12 2024 iraklis sbarounis chief financial officer of the company purchased 2 110 shares of the company on nyse at a price of usd 23 25 per share and 125 shares of the company on ose at a price of nok 259 00 per share following these transactions iraklis sbarounis holds a total of 8 470 shares in the company a primary insider notification is enclosed contacts company iraklis sbarounis cfo tel 30 210 480 4200 ir okeanisecotankers com investor relations media contact nicolas bornozis president capital link inc 230 park avenue suite 1540 new york n y 10169 tel 1 212 661 7566 okeanisecotankers capitallink com about oet oet is a leading international tanker company providing seaborne transportation of crude oil and ref
321,all_events,DOWN,DOWN,media release
12505,all_events,UP,,media release
10687,all_events,UP,,july september 2024 january september 2024 for more information please contact patrik andersson ceo 46 0 76 148 44 44 helena claesson cfo 46 0 70 676 07 50 this information is such information that garo ab is obligated to publish in accordance with the eu market abuse regulation the information was published by the abovementioned contact persons on november 15 2024 at 8 30 cet garo ab publ corp reg no 556071 7772 is a company that develops manufactures and markets innovative products and systems for the electrical installations market under its own brand garo s customer offering is to provide complete solutions in the product areas of electrical distribution products e mobility project business temporary power with a focus on electrical safety user friendliness and sustainability garo was founded in 1939 has its head office in gnosjö and is today an international company with operations in several countries the company s production units in sweden
10103,all_events,DOWN,,media release
12810,all_events,DOWN,,media release
12184,all_events,UP,,la jolla calif oct 23 2024 globe newswire medicinova inc a biopharmaceutical company traded on the nasdaq global market nasdaq mnov and the standard market of the tokyo stock exchange code number 4875 today announced the lead principal investigator of this clinical trial björn oskarsson md faan presented the update of an ongoing phase 2 3 clinical trial of mn 166 ibudilast in amyotrophic lateral sclerosis als patients at the 2024 annual neals meeting being held virtually on oct 21 24 2024
7104,all_events,UP,,ad hoc announcement pursuant to art 53 lr
8876,all_events,DOWN,,highlights of q3 2024 results
7944,all_events,UP,,redeye interviewed richard paxman regarding the q3 report https redeye 3 wistia com medias 1jj555wy60 contacts richard paxman ceo tel 44 7968 020641 email richard paxmanscalpcooling com www paxman se about us the paxman scalp cooling system has been developed by the paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy the concept behind the system came when the mother of four sue paxman experienced first hand the trauma of chemotherapy induced hair loss with close to 5 000 systems delivered in to hospitals clinics and treatment centres around the world paxman is the leading supplier of scalp cooling technology paxman s scalp cooling cap is made from lightweight biocompatible silicone that is soft and flexible providing a snug yet comfortable fit during treatment paxman ab publ has its headquarters in karlshamn sweden with subsidiaries in huddersfield uk houston texas us and toronto ontario ca the paxman share is listed on
7051,all_events,UP,,selskabet annoncerede i selskabsmeddelelse 13 2024 at man havde indledt en proces med at gennemføre et identitetsskifte med nasdaq for fortsat at kunne bevare sin status som børsnoteret selskab
8271,all_events,DOWN,,november 20 2024 06 37 et source investeringsforeningen gudme raaschou investeringsforeningen gudme raaschou opdateret prospekt for investeringsforeningen gudme raaschou offentliggøres dags dato prospektet er opdateret med kommende benchmarkændringer i afdelingerne european high yield us high yield og emerging markets debt som træder i kraft pr 1 januar 2025 herudover er prospektet opdateret med præciseringer af enkelte afdelingers aktivitetsbaserede eksklusioner samt foreningens finanskalender for 2025 prospektet er vedhæftet og kan også findes på foreningens hjemmeside www lsinvest dk henvendelser vedrørende denne meddelelse bedes rettet til undertegnede på telefon 38 14 66 00 med venlig hilsen niels erik eberharddirektør vedhæftet fil
5996,all_events,UP,,sydney australia oct 09 2023 globe newswire radiopharm theranostics asx rad a developer of a world class platform of radiopharmaceutical products for both diagnostic and therapeutic uses is pleased to announce it has been granted human research ethics committee hrec approval to commence its first in human phase i study in australia for the company s therapy for patients with pdl1 positive non small cell lung cancer nsclc
2543,all_events,DOWN,DOWN,westlake village calif nov 04 2024 globe newswire arcutis biotherapeutics inc nasdaq arqt a commercial stage biopharmaceutical company focused on developing meaningful innovations in immuno dermatology today reported the grant of an aggregate of 50 000 restricted stock units of arcutis common stock as well as options to purchase an aggregate of 50 000 shares of arcutis common stock to five newly hired employees these awards were approved by the compensation committee of arcutis board of directors and granted under the arcutis biotherapeutics inc 2022 inducement plan with a grant date of november 1 2024 as an inducement material to the new employees entering into employment with arcutis in accordance with nasdaq listing rule 5635 c 4
6498,all_events,UP,,clinical data for wholly owned anti ctla 4 franchise show best in class safety profiles for unmasked and masked candidates unlocking the full therapeutic benefit of anti ctla 4 in combination with anti pd 1 and beyond
2264,all_events,UP,DOWN,advanced phase 3 chaperone study of micropine as a treatment of pediatric progressive myopia with preparations for interim analysis this quarter
11158,all_events,UP,,november 06 2024 10 31 et source the republic of iceland government debt management the republic of iceland government debt management on the auction date between 10 30 am and 11 00 am the government debt management will auction treasury bonds in the series with the isin numbers and with the maturity dates according to the table above payments for the treasury bonds must be received by the central bank before 14 00 on the settlement date and the bonds will be delivered in electronic form on the same day article 6 of the general terms of auction for treasury bonds applies for the right to purchase an additional further reference is made to the description of the treasury bond and the general terms of auction for treasury bonds on the government debt management website for additional information please contact oddgeir gunnarsson government debt management at 354 569 9635
4351,all_events,DOWN,,18 nov 2024 18 08 cet gbl groupe bruxelles lambert 20241118 transacties aandelen pdf gbl euronext gbl be0003797140 gblb euronext
11147,all_events,UP,,09 oct 2024 18 00 cest spartoo regulatory news spartoo code isin fr00140043y1 mnémonique alspt un des leaders de la vente d articles de mode en ligne en europe est fier de passer le cap des 10 ans de soutien à la première ong africaine de développement de la santé en afrique amref health africa faisant ainsi perdurer ses engagements en matière de santé publique avec la mise en place d une opération spéciale au profit d amref en vigueur du 7 au 27 octobre boris saragaglia co fondateur et président directeur général de spartoo déclare nous sommes particulièrement ravis de fêter les 10 ans de notre collaboration avec l ong africaine et leader de la santé publique qu est amref health africa france ce partenariat fait profondément écho aux valeurs de spartoo qui depuis 2011 s engage en faveur de causes qui lui sont chères telles que l accès à l éducation et les problématiques de santé publique des engagements à l œuvre dans de nombreuses initiati
263,all_events,DOWN,UP,07 oct 2024 19 00 cest crossject communiqué de presse information relative au nombre total de droits de vote et d actions composant le capital social dijon le 7 octobre 2024 crossject isin fr0011716265 mnémo alcj specialty pharma qui développe et commercialisera prochainement un portefeuille de médicaments dédiés aux situations d urgence publie conformément aux articles 223 16 du règlement général de l amf et l 233 8 ii du code de commerce le nombre total de droits de vote et d actions composant son capital social au 30 septembre 2024 datenombre d actions composant le capitalsocial 1 nombre de droits de vote théoriquesnombre de droits de vote exerçables 2 30 septembre 202441 281 09450 938 34550 807 876 1 pour mémoire 41 281 094 actions à fin août 2024 2 le nombre de droits de vote exerçables est calculé sur la base de l ensemble des actions moins celles privées de droit de vote au 30 septembre 2024 la société détenait 87 789 de ses propres actions
1346,all_events,UP,UP,media release
10146,all_events,UP,,media release
2546,all_events,UP,UP,media release
10129,all_events,UP,,malvern pa april 29 2024 globe newswire annovis bio inc nyse anvs annovis or the company a clinical stage drug platform company developing novel therapies for neurodegenerative diseases such as alzheimer s ad and parkinson s disease pd today announced the data from its phase ii iii alzheimer study of buntanetap in mild to moderate ad patients based on these data the company plans to conduct a pivotal phase iii trial in biomarker positive early ad patients
4447,all_events,UP,,media release
9680,all_events,DOWN,,cambridge mass july 24 2024 globe newswire intellia therapeutics inc nasdaq ntla a leading clinical stage gene editing company focused on revolutionizing medicine with crispr based therapies today announced that it awarded inducement grants on july 22 2024 to its executive vice president and chief financial officer edward dulac under intellia s 2024 inducement plan as a material inducement to employment
5113,all_events,UP,,13 nov 2024 13 48 cet sparebank 1 østlandet det er fastsatt ny obligasjonsrente for no0013311944 ny obligasjonsrente i renteperioden 15 11 2024 17 02 2025 er 5 73 ticker spol89 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632078_ee38c21a3db145da90e70f6c2754e050 pdf sparebank 1 østlandet oslo børs newspoint sparebank 1 østlandet bank 1 oslo akershus as 16 26 2 spb 1 østlandet 17 27 2 spb 1 østlandet 17 27 2 spb 1 østlandet 18 33 2 spb 1 østlandet 19 25 2 spb 1 østlandet 20 25 frn spb 1 østlandet 20 25 2 spb 1 østlandet 20 26 frn c spb 1 østlandet 20 perp frn c hybrid spb 1 ostlandet 21 28 2 pct spb 1 ostlandet 21 perp frn c hybrid spb 1 ostlandet 21 28 2 25pct
4580,all_events,DOWN,,09 oct 2024 18 00 cest orapi communique du 9 octobre 2024 depot d un projet d offre publique de retrait suvie d un retrait obligatoire visant les actions ordinaires de la société initiée par présentée par etablissements présentateurs et garants communique relatif au depot d un projet de note d information etabli par groupe paredes orapi prix de l offre publique de retrait 6 50 euros par action ordinaire orapi duree de l offre publique de retrait 10 jours de négociation le calendrier de l offre publique de retrait sera déterminé par l autorité des marchés financiers amf conformément aux dispositions de son règlement général le présent communiqué le communiqué a été établi et est diffusé en application de l article 231 16 du règlement général de l amf le projet d offre publique de retrait suivie d un retrait obligatoire et le projet de note d information déposé ce jour auprès de l amf le projet de note d information restent soumis à l examen de l amf a
11432,all_events,DOWN,,media release
7033,all_events,DOWN,,media release
10022,all_events,UP,,media release
473,all_events,DOWN,DOWN,november 18 2024 03 30 et source alm brand a s alm brand a s aktietilbagekøbsprogram i alm brand a s transaktioner 11 november 2024 15 november 2024alm brand a s offentliggjorde i selskabsmeddelelse nr 40 2024 et aktietilbagekøbsprogram på op til 150 mio kr aktietilbagekøbsprogrammet blev igangsat den 15 august 2024 den 7 november 2024 offentliggjorde alm brand a s en forhøjelse af det eksisterende aktietilbagekøbsprogram med 70 mio kr til 220 mio kr med henblik på køb af aktier til aktieløn for medarbejdere i 2025 programmet blev samtidigt forlænget indtil og inklusive d 31 januar 2025 aktietilbagekøbsprogrammet sker i henhold til europa parlamentets og rådets forordning nr 596 2014 af 16 april 2014 mar og kommissionens delegerede forordning eu 2016 1052 også kaldet safe harbour reglerne under aktietilbagekøbsprogrammet er der i uge 46 gennemført følgende transaktioner efter de ovenfor nævnte transaktioner ej
10200,all_events,DOWN,,152 0 million cash runway into the second half of 2026
2271,all_events,UP,DOWN,media release
3975,all_events,UP,,in terms of articles 41 and 42 of the articles of association of the company notice is hereby given that that an extraordinary general meeting the meeting of kambi group plc company number c 49768 the company will be held on friday 20 december 2024 at 11 00 cet at kambi hälsingegatan 38 113 43 stockholm sweden to consider the following agenda the registration of shareholders starts at 10 30 cet right to attendance and voting shareholders right to appoint a proxy agenda 1 opening of the meeting2 election of chair of the meeting3 drawing up and approval of the voting list4 approval of the agenda5 determination that the meeting has been duly convened6 election of two persons to approve the minutes special business extraordinary resolution 7 whereas the board of directors is proposing certain amendments to the current memorandum and articles of association of the company and whereas a marked up version of the memorandum and articles of association showing all the
12245,all_events,UP,,media release
9145,all_events,DOWN,,novel immunotherapy approach targets soluble tumor necrosis factor to overcome resistance and enhance therapeutic outcome in high risk breast cancer
8225,all_events,UP,,05 nov 2024 18 00 cet maat pharma fin du recrutement dans l essai clinique européen ares de phase 3 qui a pour objectif d évaluer l efficacité et la sécurité de maat013 dans le traitement de la maladie aiguë du greffon contre l hôte les principaux résultats sont attendus en janvier 2025 première évaluation de sécurité positive par le dsmb dans le cadre de l essai européen de phase 2b phoebus avec une recommandation du dsmb de poursuivre l essai sans modification au 30 septembre 2024 la position de trésorerie et des équivalents de trésorerie s élevait à 27 millions d euros1 un chiffre d affaires de 0 6 million d euros au t3 2024 contre 0 4 million d euros au t3 2023 cette tendance reflète directement la demande croissante de la communauté médicale pour le candidat médicament maat013 nomination d éric soyer au poste de directeur financier et transition de sian crouzet au poste de directrice de cabinet après 8 ans en tant que directrice financière r
7058,all_events,DOWN,,november 14 2024announcement no 22 bioporto announces interim results and business update for the third quarter and nine months of fiscal 2024 revenue growth and strategic execution copenhagen denmark november 14 2024 globe newswire bioporto a s cvr no 17500317 bioporto or company cph biopor an in vitro diagnostics company focused on empowering the early detection of acute kidney injury aki today announced interim financial results for the first nine months of 2024 and business progress for the third quarter of 2024 strategic and operational highlights from third quarter ended september 30 2024 financial highlights for the period ended september 30 2024for the nine months ended september 30 2024 for the third quarter ended september 30 2024 events after the reporting period peter mørch eriksen bioporto s group chief executive officer ceo commented the level of activity was very high in the third quarter of 2024 commercially we expanded our team secur
2856,all_events,UP,,18 nov 2024 14 11 cet atos se paris france november 18 2024 eviden the atos group business leading in advanced computing today announces the launch of qaptiva hpc an innovative software tailored for high performance computing hpc environments with qaptiva hpc research centers and organizations can now easily enhance large scale simulation performance by implementing quantum computing emulation on their current hpc architecture without integrating any additional hardware qaptiva hpc stands out in the market by managing large scale simulations within a distributed environment that utilizes multiple clusters this unique software offers a comprehensive environment capable of running large scale simulations with high speed and a high number of qubits on distributed nodes located in hpc clusters it is currently utilized in the france hybrid hpc quantum initiative where it has successfully achieved emulations of up to 43 qubits using the dedicated computing res
6071,all_events,DOWN,,attachments 11158544 pdf alma media 15 11 trades xlsx
7508,all_events,UP,,06 nov 2024 08 30 cet umicore umicore deelt details over kostenmaatregelen en pauzeert de bouw van haar batterijmaterialenfabriek in canada umicore deelt details over de verwachte kostenmaatregelen die een impact hebben op haar personeelsbestand in battery materials en andere specifieke domeinen in het kader van de strategische evaluatie van haar battery materials activiteiten heeft umicore beslist om de bouw van haar batterijmaterialenfabriek in loyalist ontario canada te blijven pauzeren de strategische evaluatie wordt voortgezet en verdere conclusies zullen uiterlijk op de komende capital markets day worden meegedeeld een belangrijk onderdeel van de lopende strategische evaluatie van umicore s battery materials activiteiten is het maximaal benutten van de bestaande fabrieken alvorens verder uit te breiden umicore heeft nu besloten om de bouw van haar nieuwe fabriek voor batterijmaterialen in loyalist te blijven pauzeren umicore wil ondertussen een solide kerntea
3355,all_events,DOWN,,cambridge mass and rostock germany and berlin april 02 2024 globe newswire centogene n v nasdaq cntg centogene we or the company the essential life science partner for data driven answers in rare and neurodegenerative diseases today announced that it received a notification letter dated march 27 2024 from the nasdaq stock market llc listing qualifications department indicating that the company was not in compliance with the minimum bid price requirement set forth in rule 5450 a 1 of the nasdaq listing rules since the closing bid price for the company s common shares listed on nasdaq was below us 1 00 for 30 consecutive business days from february 12 through march 26 2024 nasdaq rule 5450 a 1 requires the shares to maintain a minimum bid price of us 1 00 per share and nasdaq rule 5810 c 3 a provides that failure to meet such a requirement exists when the bid price of the shares is below us 1 00 for a period of 30 consecutive business days
12527,all_events,DOWN,,nokia corporationstock exchange release12 november 2024 at 22 30 eet nokia corporation repurchase of own shares on 12 11 2024 espoo finland on 12 november 2024 nokia corporation lei 549300a0jprwg1ki7u06 has acquired its own shares isin fi0009000681 as follows rounded to two decimals on 25 january 2024 nokia announced that its board of directors is initiating a share buyback program to return up to eur 600 million of cash to shareholders in tranches over a period of two years the first phase of the share buyback program started on 20 march 2024 on 19 july 2024 nokia decided to accelerate the share buybacks by increasing the number of shares to be repurchased during the year 2024 the post increase repurchases in compliance with the market abuse regulation eu 596 2014 mar the commission delegated regulation eu 2016 1052 and under the authorization granted by nokia s annual general meeting on 3 april 2024 started on 22 july 2024 and end by 31 december 2024 with a ma
10447,all_events,DOWN,,la jolla calif nov 11 2024 globe newswire medicinova inc a biopharmaceutical company traded on the nasdaq global market nasdaq mnov and the standard market of the tokyo stock exchange code number 4875 today announced that it was notified by sanofi that the sanofi novartis litigation was settled accordingly medicinova is entitled to receive a certain amount of monetary damages through this settlement further details will be provided as they become available
9993,all_events,DOWN,,novel immunotherapy approach targets soluble tumor necrosis factor to overcome resistance and enhance therapeutic outcome in high risk breast cancer
3204,all_events,DOWN,,communiqué de presse information réglementée27 novembre 2023 1 00 edt 7 00 cet
10894,all_events,UP,,the board of directors has today approved the interim report for the period 1 january 30 september 2024
3545,all_events,UP,,management to host conference call and webcast at 4 30 p m et management to host conference call and webcast at 4 30 p m et
8171,all_events,DOWN,,media release
6699,all_events,DOWN,,media release
6520,all_events,DOWN,,góður rekstur skilar sterku sjóðstreymi og hagnaði
7363,all_events,DOWN,,san diego april 22 2024 globe newswire cidara therapeutics inc nasdaq cdtx the company a biotechnology company using its proprietary cloudbreak platform to develop drug fc conjugate dfc immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases today reported financial results for the fourth quarter and full year ended december 31 2023 and provided an update on its corporate activities and product pipeline
10978,all_events,DOWN,,07 nov 2024 18 07 cet marie brizard wine and spirits declaration mensuelle relative au nombre total de droits de vote et d actions article l233 8ii du code de commerce et 223 16 du reglement general de l autorite des marches financiers charenton le pont le 7 novembre 2024 marie brizard wine spirits code isin 0000060873 situation au nombre total d actions composant le capital socialnombre total de droits de votes31 octobre 2024111 989 823nombre de droits de vote théoriques 1 138 376 398nombre de droits de vote exerçables 2 138 266 718 présence dans les statuts de marie brizard wine spirits sa d une clause imposant une obligation d information de franchissement de seuil statutaire complémentaire de celle relative aux seuils légaux oui 1 y compris actions auto détenues 2 déduction faite des actions auto détenues pièce jointe declaration mensuelle octobre 2024 declaration mensuelle relative au nombre total de droits de vote et d actions art
2459,all_events,UP,DOWN,18 nov 2024 19 00 cet patrimoine et commerce patrimoine et commerce patrimoine et commerce déclaration des transactions sur actions propres hors contrat de liquidité réalisées du 11 novembre 2024 au 15 novembre 2024 18 nov 2024 19 00 cet cest information réglementaire transmise par eqs group le contenu de ce communiqué est de la responsabilité de l émetteur déclaration des transactions sur actions propres hors contrat de liquidité réalisées du 11 novembre 2024 au 15 novembre 2024 le 18 novembre 2024 nom de l émetteur code identifiant de l émetteur jour de la transaction code identifiant de l instrument financier volume total journalier en nombre d actions prix pondéré moyen journalier d acquisition des actions marché patrimoine et commerce 969500c2c11l0ptgrh11 2024 11 11 fr0011027135 133 20 600000 xpar patrimoine et commerce 969500c2c11l0ptgrh11 2024 11 12 fr0011027135 77 20 400000 xpar patrimoine et commerce 96
1683,all_events,DOWN,DOWN,media release
5117,all_events,DOWN,,media release
3024,all_events,UP,,media release
3822,all_events,DOWN,,media release
5153,all_events,DOWN,,13 nov 2024 07 00 cet abn amro bank n v abn amro rapporteert nettowinst van eur 690 miljoen in q3 2024 13 november 2024 key messages derde kwartaal sterke kwartaalresultaten nettowinst van eur 690 miljoen en een rendement op eigen vermogen van 11 gedreven door verbeterde netto rentebaten sterke inkomsten uit provisies en een netto vrijval van kredietvoorzieningen aanhoudende groei van de hypotheekportefeuille ondersteund door een toenemend aantal nieuwe klanten groeide onze hypotheekportefeuille met eur 1 6 miljardverbeterde netto rentebaten we profiteerden van betere treasury resultaten gedreven door de gunstige renteomgeving toename inkomsten uit provisies groei van sinds begin van het jaar in vergelijking met dezelfde periode vorig jaar gedreven door goede resultaten in alle client units kosten blijven onder controle kosten namen zoals verwacht toe door de start van onze nieuwe cao en het opschalen van capaciteit solide kredietkwaliteit met een netto v
5118,all_events,DOWN,,conference call to be held tuesday august 6 2024 at 8 30 am et conference call to be held tuesday august 6 2024 at 8 30 am et
9669,all_events,DOWN,,rockaway n j july 31 2024 globe newswire electrocore inc nasdaq ecor a commercial stage bioelectronic medicine and wellness company today announced that it will report financial results for the second quarter ended june 30 2024 after the close of the market on wednesday august 7 2024 management will host a conference call and webcast at 4 30 pm edt to discuss the financial results and answer questions
850,all_events,DOWN,DOWN,kraig labs otcqb kblb confirmed the exceptional strength and toughness of its commercially produced recombinant spider silk
1453,all_events,UP,DOWN,warrington pa aug 20 2024 globe newswire windtree therapeutics inc windtree or the company nasdaqcm wint a biotechnology company focused on advancing early and late stage innovative therapies for critical conditions today reported financial results for the second quarter ended june 30 2024 and provided key business updates
4600,all_events,UP,,media release
6412,all_events,UP,,november 18 2024 04 00 et source danske bank a s danske bank a s aktietilbagekøb i danske bank transaktioner i uge 46 den 2 februar 2024 offentliggjorde danske bank a s et aktietilbagekøbsprogram for samlet 5 5 mia kr med maksimalt 70 mio aktier i perioden fra 5 februar 2024 til senest 31 januar 2025 som beskrevet i selskabsmeddelelse nr 2 2024 programmet bliver udført i henhold til europa parlamentets og rådets forordning eu nr 596 2014 af 16 april 2014 samt kommissionens delegerede forordning eu 2016 1052 af 8 marts 2016 også kaldet safe harbour reglerne under aktietilbagekøbsprogrammet er der i uge 46 foretaget følgende transaktioner med ovenstående transaktioner svarer det samlede akkumulerede antal egne aktier under aktietilbagekøbsprogrammet til 2 61 af danske bank a s aktiekapital transaktionsdata vedrørende aktietilbagekøb i detaljeret form for hver transaktion vedhæftes i overensstemmelse med kommissionens dele
12051,all_events,DOWN,,during 4 november 2024 and 8 november 2024 truecaller ab publ lei code 549300teyf1fa5g5gk26 has repurchased in total 50 000 own b shares isin se0016787071 corresponding to 0 of outstanding capital as part of the share buyback programme initiated by the board of directors since the start of the programme in the end of may almost 3 7 million b shares has been repurchased which corresponds to 1 of the outstanding capital the share buybacks form part of the share buyback programme announced by truecaller on 28 may 2024 the share buyback programme will run between 28 may up until the 2025 agm which will be held in may 2025 and is carried out in accordance emittentregelverket on the annual general meeting 2024 the board was authorized to buy back b shares up until the annual general meeting in 2025 the new authorization means that buybacks may be made so that the company s shareholding does not exceed ten 10 percent of the total number of shares in the company
10333,all_events,UP,,15 nov 2024 08 44 cet odfjell drilling ltd the shares in odfjell drilling ltd ose odl will be traded ex dividend 0 06 usd per share corresponding to nok 0 6698 for the third quarter of 2024 as of today 15 november 2024 for further queries please contact james crothers investor relations officer 44 0 7495 067 684 44 0 7393 766 446 jchu odfjelldrilling com london united kingdom 15 november 2024 odfjell drilling ltd this information is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632354_odl q3 ex dividend 2024 pdf odfjell drilling ltd oslo børs newspoint odfjell drilling bmg671801022 odl oslo børs
2629,all_events,UP,,14 nov 2024 18 57 cet stainless tankers asa stainless tankers mandatory notification of trade christmas common investments limited a close associate of the chair of the board of directors ted kalborg has today 14 november 2024 purchased 25 000 shares in stainless tankers asa please see the enclosed form for further details about the transaction about stainless tankers asa www stainlesstankers com stainless tankers asa is a shipping company specialized in providing seaborne transportation of chemical cargoes worldwide the company provides investors with pure play stainless steel chemical tanker exposure in an investor friendly structure through its fleet of nine stainless steel vessels each with an approximate total carrying capacity of 20 000dwt the fleet is managed by tufton management limited with a primary focus on maximizing earnings and distributing excess operating cashflow to shareholders about tufton tufton is a leading investment manage
10223,all_events,DOWN,,missing
7046,all_events,UP,,11 nov 2024 10 00 cet danske bank a s company announcement no 50 2024 group communications bernstorffsgade 40 dk 1577 københavn v tel 45 45 14 00 00 11 november 2024 danske bank share buy back programme transactions in week 45 on 2 february 2024 danske bank a s announced a share buy back programme for a total of dkk 5 5 billion with a maximum of 70 million shares in the period from 5 february 2024 to 31 january 2025 at the latest as described in company announcement no 2 2024 the programme is being carried out under regulation eu no 596 2014 of the european parliament and of the council of 16 april 2014 and the commission s delegated regulation eu 2016 1052 of 8 march 2016 also referred to as the safe harbour rules the following transactions were made under the s
4089,all_events,UP,,07 nov 2024 17 55 cet nrj group see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1296199_nrj_group__information_financire_t3_2024 pdf nrj group les echos nrj group fr0000121691 nrg euronext
967,all_events,DOWN,DOWN,media release
1236,all_events,UP,DOWN,06 nov 2024 15 35 cet bluenord asa please see attachment on www newsweb no more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631425_bluenord asa notification td 05 11 2024 pdf bluenord asa oslo børs newspoint bluenord asa nore asa 19 27 8 usd step c sub conv no0010379266 no0010851520 bnor oslo børs
3111,all_events,UP,,06 nov 2024 07 00 cet aker asa the net asset value nav of aker asa and holding companies aker was nok 57 0 billion at the end of the third quarter 2024 compared to nok 63 9 billion at the end of the second quarter 2024 aker s board of directors has approved to pay an additional cash dividend of nok 35 50 per share for a total of nok 2 6 billion in the fourth quarter bringing the total dividend to nok 3 8 billion or nok 51 per share for the full year aker ended the third quarter with a more streamlined and cash generative investment portfolio this enables us to pay an additional nok 35 50 per share in cash dividend furthermore for the first time the aker s board is adjusting the dividend policy upward to 4 of nav annually despite a decrease in our net asset value this quarter primarily due to lower oil prices these actions reflect how we are playing to our strengths including active ownership and transactional capabilities to drive value cre
1783,all_events,UP,UP,06 nov 2024 16 38 cet credit agricole s a raison sociale de l émetteur crédit agricole s a sa au capital de 9 123 093 081 eurosimmatriculée sous le n 784 608 416 r c s nanterresiège social montrouge 92120 12 place des etats unis informations relatives au nombre total de droits de vote et d actions prévues par l article l 233 8 ii du code de commerce et l article 223 16 du règlement général de l autorité des marchés financiers date nombre d actions nombre total dedroits de vote 31 octobre 2024 3 041 031 027 nombre de droits de vote théoriques 3 041 031 027 nombre de droits de vote exerçables 3 025 355 679 nombre de droits de vote exerçables nombre de droits de vote théoriques actions privées de droits de vote auto détention pièce jointe déclaration des droits de vote octobre 2024 raison sociale de l émetteur crédit agricole s a sa au capital de 9 123 093 081 eurosimmatriculée sous le n 784 608 416 r c s nanterresiège s
95,all_events,DOWN,UP,alvotech nasdaq alvo tekur þátt í 22 árlegri heilbrigðisráðstefnu fjárfestingabankans morgans stanleys í new york
5362,all_events,UP,,12 nov 2024 17 45 cet verimatrix company honored for its excellence in app shielding technology that arms developers with the proactive protections needed to repel today s attacks regulatory news verimatrix euronext paris vmx the leader in powering the modern connected world with people centered security today announced it was named a winner of the editor s choice award for mobile app security in cyber defense magazine s cdm top infosec innovators awards continually honored with industry accolades recognizing the app shielding innovations within its verimatrix xtd enterprise suite the company provides some of the world s most discerning mobile app developers with the latest security technologies to consistently protect their app centric businesses verimatrix xtd stands as the go to security solution for organizations looking to proactively protect vital mobile apps from today s wide range of threats such as supply chain attacks screen overlays appli
7180,all_events,DOWN,,november 15 2024 06 31 et source sp group a s sp group a s sp group realiserede i de 3 første kvartaler 2024 en omsætning på dkk 2 194 9 mio mod dkk 1 953 2 mio i samme periode sidste år hvilket svarer til en stigning på 12 4 ebitda steg 38 1 til dkk 447 3 mio mod dkk 323 9 mio i samme periode sidste år og resultatet før skat steg 82 9 til dkk 254 2 mio større salg af egne varemærker er årsag til den forbedrede indtjening forventninger til 2024 som offentliggjort i selskabsmeddelelse nr 11 2024 præciseres der forventes nu en vækst i omsætningen på 10 16 tidligere 8 18 med en ebitda margin på 19 21 og en ebt margin på 11 13 se vedhæftede selskabsmeddelelse vedhæftet fil
8655,all_events,DOWN,,attachments 11158544 pdf alma media 15 11 trades xlsx
7080,all_events,UP,,07 nov 2024 18 10 cet rexel rexel déclaration relative au nombre total d actions et de droits de vote au titre de l article l 233 8 ii du code de commerce et l article 223 16 du règlement général de l autorité des marchés financiers datenombre d actionsnombre de droits de vote 31 10 2024 298 233 069 nombre de droits de vote théoriques 1 298 233 069 nombre de droits de vote exerçables 2 296 658 211 1 nombre de droits de vote incluant les actions auto détenues privées de droits de vote 2 nombre de droits de vote déduction faite des actions auto détenues privées de droits de vote pièce jointe déclaration relative au nombre total d actions et de droits de vote rexel déclaration relative au nombre total d actions et de droits de vote au titre de l article l 233 8 ii du code de commerce et l article 223 16 du règlement général de l autorité des marchés financiers pièce jointe rexel globenewswire rexel fr0010451203 rxl euronext
59,all_events,UP,UP,media release
2874,all_events,DOWN,,adelaide australia and cambridge mass sept 03 2024 globe newswire bionomics limited nasdaq bnox bionomics or company a clinical stage biotechnology company developing novel first in class allosteric ion channel modulators to treat patients suffering from serious central nervous system cns disorders with high unmet medical need today announced that it will be participating and presenting at the h c wainwright 26th annual global investment conference being held september 9 11 2024 virtually and in person at the lotte new york palace hotel in new york ny
11736,all_events,DOWN,,bigbank as registry code 10183757 address riia tn 2 tartu 51004 bigbank hereby announces a public offering of its unsecured subordinated bonds offering and informs about the approval of prospectus supplement no 2 by the estonian financial supervision and resolution authority fsa to the base prospectus registered on 13 november 2023 the base prospectus its earlier supplement no 1 and supplement no 2 approved by fsa for this offering hereinafter collectively referred to as the prospectus the offering is a third series of the bigbank unsecured subordinated bond programme programme described in the prospectus the offering is conducted on the basis of the prospectus which has been supplemented and includes supplement no 1 supplement 1 approved by the fsa on 13 may 2024 and supplement no 2 supplement 2 approved by the fsa on 7 october 2024 both of which have been disclosed on the date of this announcement on the web pages of bigbank https investor bigba
10157,all_events,DOWN,,zug switzerland nov 13 2024 globe newswire oculis holding ag nasdaq ocs oculis a global biopharmaceutical company purposefully driven to save sight and improve eye care today announced that oculis management will be present at the stifel 2024 healthcare conference being held on november 18 19 2024 at the lotte new york palace hotel in new york ny sylvia cheung chief financial officer of oculis will participate in a fireside chat on november 18 2024 at 3 35 pm et a live webcast of the fireside chat will be available here the company will be available for one on one meetings during the conference interested investors should contact their stifel representative to request meetings a link to access the fireside chat when available will be posted to oculis website on the events presentation page under the investors media section ends about oculis oculis is a global biopharmaceutical company nasdaq ocs xice ocs purposefully driven to save sight an
6975,all_events,UP,,vancouver british columbia sept 19 2023 globe newswire mydecine innovations group inc mydecine or the company neo myco otc mycof fse 0nfa a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and ptsd is pleased to announce that further to the company s news release dated september 15 2023 the company has closed its previously announced offering by way of prospectus supplement the offering pursuant to the offering the company issued 18 7500 000 common shares of the company each a share at a price of 0 20 per share for aggregate gross proceeds of 3 7500 000
3492,all_events,DOWN,,petach tikva israel jan 31 2024 globe newswire polypid ltd nasdaq pypd polypid or the company a late stage biopharma company aiming to improve surgical outcomes today announced that it will report its fourth quarter and full year 2023 financial results and operational highlights before the open of the u s financial markets on wednesday february 14 2024 the company will host a conference call and webcast at 8 30 am eastern time to discuss the results and provide an update on business operations
1121,all_events,UP,UP,olvi plc interim report 16 october 2024 at 9 am olvi group s interim report january september 2024 profitability improved in line with targets july september 2024 january september 2024 near term outlook for 2024 changed on 14 october 2024 olvi group s adjusted operating result for the 2024 financial year is expected to be eur 78 84 million previously eur 74 80 million the group s key figures 7 9 2024 7 9 2023 change 1 9 2024 1 9 2023 change 1 12 2023 sales volume mltr 272 6 264 1 3 2 775 7 773 1 0 3 975 8 net sales meur 184 9 171 1 8 1 510 0 495 9 2 8 630 6 gross profit meur 78 5 64 3 22 2 208 4 185 0 12 7 235 6 of net sales 42 5 37 6 40 9 37 3 37 4 adjusted operating result meur 29 8 20 5 45 4 72 0 59 3 21 5 67 1 of net sales 16 1 12 0 14 1 12 0 10 6 items affecting the comparability of the operating result meur 0 0 0 0 0 0 12 2 12 2 operating result meur 29 8 20 5 45 4 72 0 47 1 52 9 54 9 of net sales 16 1 1
9962,all_events,DOWN,,13 nov 2024 13 48 cet sparebank 1 sør norge asa det er fastsatt ny obligasjonsrente for no0012839028 ny obligasjonsrente i renteperioden 15 11 2024 17 02 2025 er 6 63 ticker sb1no55 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632069_2c0a5546a15d45e4b9e26e8b47776f2f pdf sparebank 1 sør norge asa oslo børs newspoint sparebank 1 sør norge asa spb 1 sr bank asa 19 25 1 spb 1 sr bank asa 20 26 1 30 per cent spb 1 sr bank asa 20 26 frn spb 1 sr bank asa 21 25 1 86pct spb 1 sr bank asa 21 25 frn spb 1 sr bank asa 22 28 4 60pct spb 1 bv 17 27 2 spb telemark 18 28 3 spb 1 sr bank asa 19 perp frn c hybrid spb 1 bv 19 25 frn spb 1 bv 19 25 2 spb telemark 19 25 2 spb telemark 20
10207,all_events,UP,,uppsala sweden november 19 2024 the potency drug developer dicot pharma which recently initiated a phase 2a clinical trial and was listed on nasdaq first north is intensifying its focus on future commercialization one measure is strengthening the management team with the appointment of a chief business officer the international business development expert håkan wickholm has been recruited for the cbo role he brings extensive global experience from business development and multi commercial roles within astrazeneca such as regional business development director for europe the middle east and africa nordic vice president of mature brands and local products and ceo in the gulf states håkan has also held several ceo and cbo positions in smaller development companies including lytix biopharma it is gratifying to announce this addition which reflects our strong focus on business development and future commercialization håkan s many years of experience from the global arena
461,all_events,UP,UP,media release
4129,all_events,DOWN,,8 november 2024 notification no 112 2024 transactions made by persons obliged to report transactions to the danish fsa and nasdaq copenhagen cf the eu market abuse regulation in connection with the share buy back program in danske bank a s apmh invest a s continuously sells shares pro rata for further details please find the attached templates for notifications and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them contact stefan singh kailay head of media relations tel 45 45 14 14 00 attachment attachments apmh invest as sale 2024 11 07 pdf
8701,all_events,DOWN,,jed latkin to transition to ceo jed latkin to transition to ceo
10155,all_events,UP,,media release
11523,all_events,DOWN,,please see attached company announcement no 10 2024 attachment attachments company announcement no 10 2024 pdf
10154,all_events,DOWN,,10 oct 2024 18 00 cest lebon compagnie middle office emetteur tél 01 53 48 80 10 fax 01 49 74 32 77 34318 cic fr compagnie lebon date d arrêté 30 09 2024 article 223 16 du règlement général de l amf actions du capital 1 173 000 droits de vote théoriques 1 2 154 323 actions privées de droits de vote autodétention au nominatif 2 36 623 autodétention au porteur 3 0 autres 4 0 à compléter par la société droits de vote exerçables 2 117 700 1 2 3 4 pour information nombre de comptes courants nominatifs 2 077 pièce jointe ddv compagnie lebon au 30 09 2024 middle office emetteur tél 01 53 48 80 10 fax 01 49 74 32 77 34318 cic fr compagnie lebon date d arrêté 30 09 2024 article 223 16 du règlement général de l amf actions du capital 1 173 000 droits de vote théoriques 1 2 154 323 actions privées de droits de vote autodétention au nominatif 2 36 623 autodétention au porteur 3 0 autres 4 0 à compléter
3424,all_events,UP,,15 nov 2024 10 47 cet sparebank 1 lom og skjåk sparebank 1 lom og skjåk har i dag lagt ut eit nytt obligasjonslån på nok 100 millionar med flytande rente kupongrenta tilsvarar 3 mnd nibor 1 02 prosentpoeng p a og oppgjersdato er 27 november 2024 seb var tilretteleggar av transaksjonen kontaktperson i sparebank 1 lom og skjåk svein garmo økonomiansvarleg tlf 47 909 37 456 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sparebank 1 lom og skjåk oslo børs newspoint spb 1 lom og skjaak 21 26 frn spb 1 lom og skjaak 22 25 frn spb 1 lom og skjak 22 26 frn spb 1 lom og skjaak 23 27 frn spb 1 lom og skjak 24 29 frn spb 1 lom og skjåk 24 34 adj c sub spb 1 lom og skjåk 24 28 frn no0010921042 no0012569443 no0012692617 no0013035188 no0013119214 no0013254854 no0013361147 nordic alternative bond market
7038,all_events,UP,,this message has been corrected click here to view the corrected message vilnius lithuania 2024 10 08 08 28 cest omx baltic benchmark fund share price on october 07 2024 12 7116 eur omx baltic benchmark fund number of shares issued on october 07 2024 0 units omx baltic benchmark fund number of shares redeemed on october 07 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of october 07 2024 125 362 units nter asset management
9511,all_events,UP,,media release
12165,all_events,UP,,media release
4680,all_events,UP,,eften united property fund invests 2 5 million euros ca of fund aum in eften real estate fund 5 aimed at institutional investors the latter acquires kristiine shopping centre in tallinn kristiine keskus is one of the best known shopping centers in estonia with 45 300 square meters of leasable area on two floors opened in 1999 the center underwent renovation in 2019 around 120 trade and service tenants and eateries operate in the kristiine center the center s anchor tenants are prisma h m sportland reserved rademar apollo o learys new yorker and jysk the transaction is expected to be completed before the 2024 year end and is dependent on a positive decision from the competition authority after the transaction the eften united property fund is basically fully invested as the investment is to another fund managed by the eften capital as the eften united property fund does not charge a management fee on the investment in line with its fund terms and conditions kri
1978,all_events,DOWN,DOWN,this message has been corrected click here to view the corrected message vilnius lithuania 2024 10 09 08 27 cest omx baltic benchmark fund share price on october 08 2024 12 7909 eur omx baltic benchmark fund number of shares issued on october 08 2024 0 units omx baltic benchmark fund number of shares redeemed on october 08 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of october 08 2024 125 362 units nter asset management
327,all_events,UP,DOWN,san diego sept 30 2024 globe newswire biora therapeutics inc nasdaq bior the biotech company reimagining therapeutic delivery today announced an upcoming poster presentation at the american college of gastroenterology acg annual scientific meeting which will be held in philadelphia october 25 30 2024
1053,all_events,UP,UP,of evaluable participants at month 6 achieved target absolute neutrophil count anc increase with once daily oral mavorixafor stable dose g csf as of the interim analysis data cut off date
7407,all_events,DOWN,,paris et cambridge mass 12 nov 2024 globe newswire nanobiotix euronext nano nasdaq nbtx la société société française de biotechnologie en phase de développement clinique avancé pionnière des approches fondées sur les nanoparticules pour élargir les possibilités de traitement des patients atteints de cancer ou d autres maladies fait aujourd hui le point sur ses activités et publie ses résultats financiers pour le troisième trimestre 2024
4093,all_events,DOWN,,results to be announced at 8 00 a m eastern time conference call to begin at 8 30 a m eastern time
12935,all_events,UP,,13 nov 2024 08 49 cet paratus energy services ltd finansiell kalender for paratus energy services ltd regnskapsår 2024 29 11 2024 kvartalsrapport q3 selskapet har oppdatert dato for publisering av sitt q3 2024 rapport denne informasjonen offentliggjøres i henhold til kravene i løpende forpliktelser more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site paratus energy services ltd oslo børs newspoint paratus energy services ltd bmg6904d1083 plsv oslo børs
1217,all_events,UP,DOWN,conference call today at 11 00 a m et
3154,all_events,DOWN,,the members of the nomination committee for nordisk bergteknik s annual general meeting on thursday may 15 2025 have now been appointed according to the instruction and rules of procedure for the nomination committee the committee must consist of four members the nomination committee shall include members selected by each of the three largest shareholders in terms of voting rights that wish to participate in the committee as of the last banking day in august together with the chairman of the board the three largest shareholders by number of votes also refers to known shareholder groups the nomination committee ahead of the 2025 annual general meeting has the following composition the term of office for members of the nomination committee shall run until a new nomination committee is appointed the shareholders who appointed the members of the nomination committee represented approximately 40 percent of the outstanding votes in nordisk bergteknik as of 30 august 2024 th
613,all_events,DOWN,UP,brisbane calif may 16 2024 globe newswire annexon inc nasdaq annx a clinical stage biopharmaceutical company developing a new class of complement based medicines for people living with devastating inflammatory related diseases today announced that it has granted inducement to two new non executive employees under the terms of the 2022 employment inducement award plan the equity awards were approved on may 11 2024 in accordance with nasdaq listing rule 5635 c 4
7937,all_events,DOWN,,13 nov 2024 08 30 cet kmc properties asa reference is made to the stock exchange announcements made by kmc properties asa the company on 12 november 2024 regarding the minutes from the extraordinary general meeting in which the general meeting adopted a resolution to distribute dividend in kind to the shareholders of the company as of 12 november 2024 as registered in euronext securities oslo vps on 14 november 2024 and the updated key information relating to the dividend in kind the shares of the company will be traded ex dividend on the oslo stock exchange from today 13 november 2024 for more information please contact christian linge former cfo in the company tel 47 466 37 648 email christian linge kmcp no this information is published in accordance with the requirements of the continuing obligations more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site kmc properties asa
5404,all_events,DOWN,,saint herblain france et schlieren zurich le 16 octobre 2024 valneva se nasdaq valn euronext paris vla société spécialisée dans les vaccins et limmatech biologics ag société de biotechnologie développant des vaccins pour la prévention des maladies potentiellement mortelles ont annoncé que l agence de santé américaine food and drug administration fda a accordé le statut fast track à shigella4v s4v candidat vaccin bioconjugué tétravalent contre la shigellose le plus avancé au monde pour lequel valneva a obtenu une licence exclusive mondiale de limmatech
14,all_events,DOWN,DOWN,media release
6243,all_events,DOWN,,06 nov 2024 07 00 cet lexibook linguistic elect sys communique de presse en date du 6 novembre 2024 relatif a la mise a disposition de la note d information en reponse et du document incluant les informations relatives aux caractéristiques notamment juridiques financières et comptables etablis par lexibook dans le cadre de l offre publique d achat visant les actions de la societe lexibook initiee par la societe doodle agissant de concert avec la société lawrence rosen llc et la famille le cottier conséilee par gilbert dupont groupe société générale presentee par societe generale amfle présent communiqué le communiqué établi par la société lexibook est diffusé conformément aux dispositions des articles 231 27 3 et 231 28 du règlement général de l autorité des marchés financiers l amf en application de l article l 621 8 du code monétaire et financier et de l article 231 26 de son règlement général l amf a en application de la décision de conformité prise
4508,all_events,UP,,reiterates full year 2023 financial guidance reiterates full year 2023 financial guidance
10480,all_events,UP,,media release
3689,all_events,UP,,november 18 2024 02 50 et source as tallinna sadam as tallinna sadam as tallinna sadam edaspidi tallinna sadam ja jetgas oü edaspidi jetgas sõlmisid lepingu veeldatud metaani terminali rajamiseks muuga sadamasse lepingu kohaselt ehitab jetgas etapiviisiliselt hiljemalt aastaks 2030 kuni viie mahutiga veeldatud metaani terminali koos kailiini ühendava torustikuga terminali esimese etapi käivitamine koos ühe mahuti rajamisega on planeeritud 2027 aasta lõpuks veeldatud metaani terminali rajamine on kevadel korraldatud konkursi tulemus mille eesmärk oli leida muuga sadama vabadele aladele uusi operaatoreid uus terminal ja koostöö jetgasi kui pikaajalise tegijaga energiatoodete turul toob meile täiendavaid laevakülastusi ja kaubamahtusid ning loob võimalusi transpordisektorile keskkonnasõbralikematele kütustele üleminekul tervitas uue kaubaoperaatori lisandumist tallinna sadama juhatuse esimees valdo kalm jetgasi juhatuse esimees
1688,all_events,DOWN,DOWN,media release
611,all_events,UP,UP,20 nov 2024 04 46 cet orinoquia real estate socimi s orinoquia capital management s l an entity related to orinoquia real estate socimi s a the company has purchased shares of the company according to the details attached orinoquia capital management s l an entity related to orinoquia real estate socimi s a the company has purchased shares of the company according to the details attached relevant information related party share purchase delfino 35000 acciones pdf orinoquia real estate socimi s a euronext orinoquia real estate socimi s a es0105534004 mlorq euronext access
7632,all_events,DOWN,,south san francisco calif june 08 2024 globe newswire akero therapeutics inc nasdaq akro a clinical stage biotechnology company developing transformational treatments for patients with serious metabolic disorders marked by high unmet medical need today announced two presentations featuring its lead product candidate efruxifermin efx at the european association for the study of the liver easl congress 2024 in milan italy the presentations will also be available on akero s website following the meeting
3881,all_events,UP,,selskabet har afholdt ekstraordinær generalforsamling den 21 oktober 2024 kl 10 00 på selskabets adresse lyskær 8a 2730 herlev med følgende dagsorden
8459,all_events,DOWN,,preclinical findings show exosome based therapeutic approach for the treatment of arginase 1 deficiency arg1 d
1950,all_events,DOWN,DOWN,media release
12328,all_events,DOWN,,12 nov 2024 12 10 cet nexans siège social 4 allée de l arche 92400 courbevoie france tél 33 0 1 78 15 00 00 www nexans com s a au capital de 43 753 380 euros r c s nanterre 393 525 852 id tva fr 74 393 525 852 déclaration des transactions sur actions propres période du 7 au 8 novembre 2024 emetteur nexans catégorie actions propres conformément à la réglementation relative aux rachats d actions nexans déclare ci après les transactions sur actions propres réalisées du 7 au 8 novembre 2024 ces transactions ont été réalisées dans le cadre du descriptif du programme de rachat publié le 25 mars 2024 sur le site de la société www nexans com et dans le cadre d un mandat exécuté par un prestataire de services d investissement nom de l émetteurcode identifiant de l émetteur code lei jour de la transactioncode identifiant de l instrument financiervolume total journ
8276,all_events,UP,,aktietilbagekøbsprogram i alm brand a s
7303,all_events,UP,,15 nov 2024 07 00 cet aegon ltd the hague november 15 2024 please click here to access all 3q 2024 trading update related documents eur 336 million operating capital generation before holding funding and operating expenses full year 2024 guidance raised to around eur 1 2 billion from around eur 1 1 billion previouslycapital ratios of the main units remain above their respective operating levelsplanned new eur 150 million share buyback program announced completion expected in the first half of 2025 the program includes neutralization of shares issued for share based compensation plans cash capital at holding of eur 1 5 billion as of september 30 2024 expect to reach mid point of the target range eur 1 0 billion by the end of 2026 completed program to purchase institutionally owned universal life policies terminated policies negatively impacted us rbc ratio by points expect points benefit in 4q 2024 after equity funding repayment operating capital gen
7434,all_events,DOWN,,zug sviss aug 27 2024 globe newswire oculis holding ag nasdaq ocs xice ocs oculis eða félagið alþjóðlegt líftæknifyrirtæki sem hefur það að markmiði að þróa augnlyf sem bæta sjón í alvarlegum augnsjúkdómum birti í dag uppgjör fyrir ársfjórðunginn sem lauk 30 júní og kynnti nýlega áfanga í rekstri félagsins
8602,all_events,UP,,miami sept 04 2024 globe newswire fortress biotech inc nasdaq fbio fortress an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long term value for shareholders through product revenue equity holdings and dividend and royalty revenue today announced that lindsay a rosenwald m d chairman president and chief executive officer will present a corporate overview at the h c wainwright 26th annual global investment conference the presentation will be available for on demand viewing by conference attendees starting on september 9 2024 at 7 00 a m et the company will also attend one on one meetings during the conference
1935,all_events,DOWN,UP,media release
1372,all_events,UP,UP,14 nov 2024 17 40 cet elis augmentation de capital réservée aux salariés elis for all 2024 saint cloud le 14 novembre 2024 la période de souscription à l augmentation de capital réservée aux salariés d elis s est achevée le 3 octobre 2024 4 des salariés établis dans 18 pays du groupe ont fait le choix de participer soit directement soit via le fcpe d elis à cette opération pour une souscription globale de plus de 10 6 millions d euros mise en œuvre par le conseil de surveillance d elis des 14 décembre 2023 et 24 juillet 2024 et par le directoire du 25 juillet 2024 sur la base des délégations consenties par l assemblée générale extraordinaire du 23 mai 2024 l augmentation de capital permettait aux salariés du groupe d investir dans l action elis à un prix unitaire de 14 73 euros correspondant à la moyenne des cours d ouverture de l action du 19 août au 13 septembre 2024 décotée de et en bénéficiant d un abondement d elis égal à une action offerte pour
5800,all_events,UP,,press release 11 november 2024 between 4 november 2024 and 8 november 2024 h m hennes mauritz ab publ lei code 529900o5rr7r39frdm42 has repurchased in total 706 140 own b shares isin se0000106270 as part of the share buyback programme initiated by the board of directors the share buybacks form part of the sek 1 billion share buyback programme that h m announced on 26 september 2024 the share buyback programme which runs between 26 september 2024 and no later than 26 november 2024 is being carried out in accordance with regulation eu no 596 2014 on market abuse the market abuse regulation mar and commission delegated regulation eu 2016 1052 the so called safe harbour regulation h m b shares have been repurchased as follows date aggregated daily volume number of shares weighted average share price per day sek total daily transaction value sek 4 november 2024 141 611 161 6472 22 891 021 64 5 november 2024 133 725 162 2112 21 691 692 72 6 november 2024
3418,all_events,DOWN,,ad hoc announcement pursuant to art 53 lr
10718,all_events,DOWN,,sampo oyj pörssitiedote 4 11 2024 klo 8 30
2342,all_events,DOWN,DOWN,media release
970,all_events,UP,UP,as previously disclosed inter alia in 2024 first half financial results report on 30 august 2024 the company plans to raise additional capital in 2024 to support operations and marketing activities for the upcoming years the company has begun meeting with selected potential investors and the presentation used in those meetings is attached to this announcement for further information please contact investor relations stefán þór björnssonstefanbjo solidclouds com attachments investor presentation november 2024 pdf update on solid clouds financing pdf
10548,all_events,UP,,interim management statement covering q1 2024 25 the board of directors of rovsing a s has today reviewed and approved the interim management statement for the first quarter 1 july 2024 30 september 2024 of the financial year 2024 25 q1 highlights further information hjalti pall thorvardarson ceo tel 45 53 39 18 88 email hpt rovsing dk attachments attachments announcement373_interim_management_statement_q1_2024 25_final pdf selskabsmeddelelse373_kvartalsmeddelelse_q1_2024 25_final dk pdf
4553,all_events,UP,,14 nov 2024 17 45 cet bonduelle bonduelle siège social la woestyne 59173 renescure francesociété en commandite par actions au capital de 57 102 699 50 eurosrcs dunkerque 447 250 044 villeneuve d ascq le 14 novembre 2024 communiqué assemblée générale mixte du 5 décembre 2024 modalités de mise à disposition des documents préparatoires les actionnaires de la société sont invités à participer à l assemblée générale mixte qui se tiendra le 5 décembre 2024 à 17 heures au siège administratif de la société sis rue nicolas appert 59650 villeneuve d ascq france l avis préalable comportant l ordre du jour et les projets de résolutions a été publié au bulletin des annonces légales obligatoires ci après balo n 129 du 25 octobre 2024 et l avis de convocation sera publié au balo et dans un journal d annonces légales le 18 novembre 2024 l intégralité des projets de résolutions de l assemblée générale mixte est exposé dans le livret des actionnaires lequel est mis e
8877,all_events,UP,,07 nov 2024 17 55 cet credit agricole s a montrouge le 7 novembre 2024 achèvement du programme de rachat d actions crédit agricole s a le programme de rachat d actions de crédit agricole s a qui a débuté le 1er octobre 2024 a été entièrement achevé le 6 novembre 2024 au 6 novembre 2024 15 128 677 actions crédit agricole s a ont été achetées sur instruction irrévocable donnée à un prestataire de services d investissement indépendant pour un prix d achat global de 208 465 605 euros cette instruction irrévocable a donc pris fin à la même date comme annoncé précédemment cette opération vise à compenser l effet dilutif de l augmentation de capital 2024 réservée aux salariés et les actions achetées dans le cadre de ce programme de rachat d actions seront annulées l impact de cette opération sur le ratio cet1 de crédit agricole s a est de 5 points de base et 3 points de base sur celui du groupe crédit agricole l exécution du contrat de liquidité existant avec k
3873,all_events,DOWN,,18 oct 2024 17 45 cest odiot holding report de la tenue de l assemblée générale annuelle d approbation des comptes de l exercice clos le 31 décembre 2023 paris le 18 10 2024 à 17h45 odiot holding euronext access fr0004152700 mlodt actionnaire de référence de l orfèvre odiot annonce qu elle a présenté le 16 octobre 2024 une requête auprès de monsieur le président du tribunal de commerce de paris afin d obtenir la prorogation jusqu au 31 décembre 2024 du délai dans lequel pourra être tenue l assemblée générale ordinaire de la société à laquelle seront présentés et soumis les comptes de l exercice clos le 31 décembre 2023 cette demande de prorogation au 31 décembre 2024 est justifiée par les motifs suivants la société a au cours de l exercice clos le 31 décembre 2023 rencontré des difficultés dans son organisation interne notamment liées à des départs de salariés occupant des postes clefs en matière comptable et à des dysfonctionnements du système informatique c
8383,all_events,UP,,gaithersburg md oct 24 2023 globe newswire neximmune inc nasdaq nexi announces the extension of the research partnership between neximmune yale and jdrf to explore the use of neximmune s aim nanoparticles in combination with an anti cd3 mab to tolerize deplete or modulate diabetes antigen specific t cells the extension includes an additional 300 000 grant funded by jdrf to yale as a part of its cures research portfolio which includes therapies for the prevention of type 1 diabetes t1d
12133,all_events,DOWN,,on 9 february 2024 dfds a s dfds announced the initiation of a share buyback programme to be executed in accordance with eu market abuse regulation eu regulation no 596 2014 of 16 april 2014 and the provisions of commission delegated regulation eu 2016 1052 of 8 march 2016 the safe harbour rules
10025,all_events,DOWN,,grab as informs its shareholders that in connection with its activities in canada it has decided to recall board member lauri kiivit and appoint a new board member reio orasmäe who will focus on the company s expansion into the canadian market and the management of related projects this change aligns with the company s strategy and aims to enhance operations in the new target market disclosure information in accordance with nasdaq requirements grab as will promptly inform of all significant further steps related to this initiative grab2go is an estonian technology company whose innovative solutions are transforming the operations of convenience stores and pharmacies at the core of the grab2go solution is the reduction of daily business expenses focusing on challenges such as labour shortages high operating costs and inefficient logistics additionally the company addresses issues such as food waste reduction lower rental costs real time data utilization and the impl
2664,all_events,DOWN,,emrosi approved by fda on november 4 for the treatment of inflammatory lesions of rosacea in adults
1237,all_events,UP,DOWN,kesko investor news 14 11 2024 at 8 00 kesko s sales increased by 6 in october or by 2 in comparable terms kesko s sales grew by 6 in october sales grew in all divisions in grocery trade sales increased especially in kespro s foodservice business in building and technical trade sales in building and home improvement trade increased thanks to the davidsen acquisition in car trade sales increased in all business areas the number of delivery days was up by one in all divisions in october says jorma rauhala kesko s president and ceo sales in the grocery trade division totalled 565 6 million in october up by 2 sales to k group grocery stores increased by 2 sales in k citymarket s home and speciality goods trade non food decreased kespro s sales increased by 5 sales in the building and technical trade division totalled 438 5 million in october up by 11 or by 1 in comparable terms sales in building and home improvement trade increased by 25 0
3187,all_events,UP,,05 nov 2024 18 00 cet sodexo information réglementée issy les moulineaux 5 novembre 2024 declaration des transactions sur actions propres realisees du 28 octobre 2024 au 1er novembre 2024 sodexo a procédé à l acquisition d actions propres hors contrat de liquidité dans le cadre du programme de rachat d actions autorisé par son assemblée générale du 15 décembre 2023 ces acquisitions sont destinées à honorer des obligations liées à des plans d attribution gratuite d actions les informations agrégées sur ces opérations sont les suivantes jour de la transactionleicode isinvolume en nombre d actions prix pondéré moyen d acquisition en euros marché28 10 2024969500agkr3prjg4wd05fr000012122014 60580 9265xpar28 10 2024969500agkr3prjg4wd05fr000012122014 30680 9126ceux28 10 2024969500agkr3prjg4wd05fr00001212202 77880 8474tqex28 10 2024969500agkr3prjg4wd05fr00001212202 61880 8036aqeu29 10 2024969500agkr3prjg4wd05fr000012122023 68980 6207xpar29 10 2024969500agkr3prjg4wd05fr0000
12027,all_events,DOWN,,media release
12839,all_events,UP,,14 nov 2024 09 00 cet romerike sparebank romerike sparebank med rating a stable fra nordic credit rating ncr har mandatert sparebank 1 markets som tilrettelegger for å undersøke muligheten for utvidelse av utestående grønt obligasjonslån eventuelt å utstede nye grønne obligasjonslån med flytende rente avhengig av markedsforhold forventet løpetid vil være inntil 6 år lillestrøm 14 november 2024 kontaktperson torunn merete holtet banksjef cfo økonomi og finans tlf 976 24 350 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site romerike sparebank oslo børs newspoint blaker spb 20 perp frn c hybrid lillestrøm spb 20 25 frn blaker spb 20 25 frn lillestrøm spb 20 26 frn lillestrom spb 21 31 frn c sub romerike spb 22 27 frn romerike spb 22 28 frn romerike spb 22 26 frn romerike spb 23 28 frn romerike spb 23 29 frn romerike spb 23 27 frn romerike spb 23 26 frn romerike spb 2
5544,all_events,DOWN,,dallas sept 26 2024 globe newswire taysha gene therapies inc nasdaq tsha taysha or the company a clinical stage biotechnology company focused on advancing adeno associated virus aav based gene therapies for severe monogenic diseases of the central nervous system cns today announced that it will present previously disclosed clinical data on its tsha 102 program in evaluation for rett syndrome during an oral presentation at the upcoming 9th world rett syndrome congress taking place in queensland australia from october 2 5 2024
4792,all_events,DOWN,,media release
10448,all_events,DOWN,,media release
11198,all_events,UP,,november 15 2024 08 26 et source strategic investments a s strategic investments a s bestyrelsen for strategic investments a s har i dag opdateret selskabets forventninger til resultatet for 2024 der forventes nu et resultat svarende til et afkast i intervallet til selskabet forventede tidligere et resultat for 2024 svarende til et afkast på til selskabets langsigtede resultatmålsætning er uforandret et årligt afkast på 10 de justerede resultatforventninger for 2024 har baggrund i et fortsat vanskeligt markeds miljø for mange small cap investeringer præget af lav likviditet store spreads og lav investorinteresse endvidere må vi konstatere at det for flere af vore større aktieposter tager længere tid end hidtil forventet for potentialet i investeringscasen at materialisere sig investmentcasen vurderes dog gennemgående fortsat at være intakt men forsinket spørgsmål vedrørende denne meddelelse kan rettes til selskab
12558,all_events,UP,,advance htn trial of lorundrostat for the treatment of uhtn or rhtn is anticipated to deliver topline data in q4 2024
2444,all_events,UP,UP,07 nov 2024 18 00 cet bonduelle bonduelle head office la woestyne 59173 renescure francebonduelle a french s c a partnership limited by shares with a capital of 57 102 699 50 eurosregistered under number 447 250 044 dunkerque commercial and companies register quarter 1 fy 2024 2025 sales july 1 september 30 2024 stability of sales and growth in branded products over quarter 1 sales and current operating income annual targets confirmed the bonduelle group sales for quarter 1 of fy 2024 2025 july 1 september 30 2024 amounted to 567 2 million euros thus almost stable at 0 on a like for like basis and 0 on reported figures compared to quarter 1 of the previous fiscal year beyond stable sales over the period the group s branded products at the heart of the transform to win transition program presented on october 7 posted growth of 2 on a like for like basis and 2 on reported figures the impact of exchange rates between main cur
5038,all_events,DOWN,,det meddeles hermed at hvidbjerg bank a s har modtaget meddelelse fra sparekassen danmark om ændring i deres aktiebeholdning i hvidbjerg bank a s sparekassen danmark har solgt nominelt 243 262 aktier i banken svarende til 14 af bankens udstedte kapital og dermed afhændet deres beholdning af aktier i hvidbjerg bank a s
11214,all_events,DOWN,,media release
4442,all_events,DOWN,,media release
1923,all_events,UP,DOWN,jupiter fla june 28 2024 globe newswire dyadic international inc dyadic nasdaq dyai announced today that they have entered into a development and commercialization partnership with proliant health and biologicals phb a leading supplier of purified proteins for the diagnostic nutrition and cell culture markets
3128,all_events,DOWN,,november 13 2024 12 11 et source sýn hf sýn hf skýr fókus á kjarnastarfsemi og rekstrarbata árshlutareikningur samstæðu sýnar hf fyrir fyrstu níu mánuði ársins 2024 var samþykktur á stjórnarfundi þann 13 nóvember 2024 rekstrarhagnaður ebit á þriðja ársfjórðungi 3f var 363 m kr samanborið við 590 m kr á fyrra ári hagnaður eftir skatta á 3f nam 17 m kr samanborið við 321 m kr hagnað á sama tímabili árið 2023 skýrist þessi munur helst af minni tekjum af iot þjónustu hærra kostnaðarverði og hærri afskriftum sýningarrétta sem voru lægri á sama tíma í fyrra vegna endursamninga við birgja þann 1 október var undirritaður kaupsamningur við hexatronic um hluta af starfsemi endor ehf dótturfyrirtæki sýnar hf viðmiðunardagur viðskiptanna var 20 september en hluti kaupverðsins var greiddur í byrjun október skipurit sýnar tók breytingum 1 nóvember tveir nýir stjórnendur taka sæti í framkvæmdastjórn en unnið er að ráðningu í stöð
4217,all_events,UP,,attachments 10078877 pdf relais 7 10 trades xlsx
2124,all_events,UP,UP,oslo norway 23 august 2024 pci biotech ose pcib invites to a webcast presentation of the company s first half 2024 interim report on wednesday 28 august 2024 08 30am 09 00am cest local time
6421,all_events,DOWN,,12 nov 2024 11 40 cet citycon treasury b v citycon oyj stock exchange release 12 november 2024 at 12 40 hrs citycon oyj s extraordinary general meeting took place today 12 november 2024 the extraordinary general meeting was held without a meeting venue using remote connection in real time in accordance with section 11 of the articles of association of the company and chapter 5 section 16 subsection 3 of the finnish limited liability companies act the general meeting approved all the proposals made by the board of directors to the general meeting the number of members of the board of directors was resolved to be ten mr eero sihvonen was elected as new member of the board of directors for a term that will continue until the close of the next annual general meeting other current members of the board of directors continue in their position until the close of the next annual general meeting the personal details of the new member of the board of directors are
1769,all_events,DOWN,DOWN,as part of the asset innovation partnership led by diamyd medical the leading healthcare foundation organizes a conference on november 26 2024 in stockholm sweden on the future of type 1 diabetes screening and treatment the conference is co sponsored by sanofi the event gathers key stakeholders including patient organizations healthcare professionals researchers and regulators to explore the practical implementation of precision and preventive medicine in type 1 diabetes care the conference will feature a keynote lecture by prof chantal mathieu president of the european association for the study of diabetes easd and leading expert in diabetes care who will discuss ongoing screening initiatives and guidelines in europe additionally two panel discussions will bring together patient and professional organizations clinicians regulators and policymakers these discussions will center on the ethical regulatory and policy requirements needed to integrate new screeni
11575,all_events,DOWN,,13 nov 2024 17 20 cet å energi as å energi as med rating a stable fra scope har i dag utstedt ett nytt grønt usikret obligasjonslån på nok 300 millioner med en kupongrente på 3 måneder nibor 0 p a og forfallsdato 28 februar 2028 lånet vil søkes notert på oslo børs å energi as har også utvidet følgende grønne usikrede obligasjonslån nok 250 millioner i isin no0013251843 med forfallsdato 5 september 2029 etter utvidelsen er utestående beløp nok 700 millioner nok 250 millioner i isin no0013251850 med forfallsdato 5 september 2029 etter utvidelsen er utestaånde beløp nok 900 millioner nok 400 millioner i isin no0013013920 med forfallsdato 19 september 2030 etter utvidelsen er utestående beløp nok 900 millioner oppgjørsdato for alle lånene er 27 november 2024 seb var tilrettelegger av transaksjonen for ytterligere informasjon vennligst kontakt stein johnsgård finanssjef 47 95 29 82 30 stein johnsgard aenergi no more information ac
10389,all_events,UP,,november 06 2024 01 30 et source sampo plc sampo plc sampo plc stock exchange release 6 november 2024 at 8 30 am eet sampo plc s share buybacks 5 november 2024 on 5 november 2024 sampo plc business code 0142213 3 lei 743700uf3rl386wida22 has acquired its own a shares isin code fi4000552500 as follows rounded to two decimals on 17 june 2024 sampo announced a share buyback programme of up to a maximum of eur 400 million in compliance with the market abuse regulation eu 596 2014 mar and the commission delegated regulation eu 2016 1052 on 16 september 2024 the board of directors of sampo plc resolved to increase the share buyback programme to eur 475 million the programme which started on 18 june 2024 is based on the authorisation granted by sampo s annual general meeting on 25 april 2024 after the disclosed transactions the company owns in total 10 055 400 sampo a shares representing 1 83 per
708,all_events,DOWN,DOWN,media release
6180,all_events,UP,,13 nov 2024 08 00 cet nordic aqua partners as not for release publication or distribution directly or indirectly in canada japan australia or the united states or any other jurisdiction in which such release publication or distribution would be unlawful this announcement does not constitute an offer of any of the securities described herein reference is made to the stock exchange notice from nordic aqua partners as the company on 6 november 2024 regarding the commencement of the subscription period the subscription period in the subsequent offering the subsequent offering consisting of up to 466 666 new shares the subsequent offer shares in the company at a subscription price of nok 75 per share the subscription period will expire today 13 november 2024 at 16 30 hours cet correctly completed subscription forms must be received by the managers as defined below or in the case of online subscriptions be registered by the expiry of the
3208,all_events,DOWN,,november 07 2024 01 00 et source inbank inbank inbanki 2024 aasta kolmanda kvartali konsolideeritud puhaskasum oli 3 1 miljonit eurot mis on aastatagusega võrreldes enam aasta esimese üheksa kuu kasum ulatus 10 8 miljoni euroni mis on rohkem kui aasta tagasi omakapitali tootlus oli kolmandas kvartalis 8 ja aasta üheksa esimese kuu jooksul 10 tulemusi kommenteerib inbanki juhatuse esimees priit põldoja inbanki finantstulemused olid ka kolmandas kvartalis head ja tulud kasvasid stabiilselt võrreldes eelmise aastaga kasvas kolmandas kvartalis inbanki puhas intressitulu ja kogutulu kuna inbank kasutab intressimäära riskide maandamiseks finantsinstrumente avaldas kolmanda kvartali tuludele negatiivset mõju nende instrumentide õiglase väärtuse allahindlus 1 2 miljoni euro võrra aasta esimese kahe kvartali jooksul teenis ettevõte samadest instrumentidest kasumit autode finantseerimises saavutasime jätkuvalt v
8626,all_events,UP,,media release
10629,all_events,DOWN,,marlborough mass jan 07 2024 globe newswire akoya biosciences inc nasdaq akya akoya the spatial biology company today announced preliminary unaudited revenue for the fourth quarter and full year ended december 31 2023 and projected year end 2023 cash cash equivalents and restricted cash balance which remain subject to quarter end closing adjustments and are also unaudited
8288,all_events,UP,,not for release distribution or publication in whole or in part directly or indirectly in or into the united states of america australia canada new zealand hong kong japan switzerland singapore south africa south korea russia belarus or any other jurisdiction in which the release distribution or publication would be unlawful or require registration or any other measures beyond what is required under swedish law active biotech ab s publ active biotech or the company rights issue with pre emptive rights for active biotech s shareholders has been oversubscribed the rights issue due to strong demand the board of directors has resolved to exercise the over allotment option through the rights issue and the over allotment option active biotech will receive proceeds amounting to approximately sek 43 4 million before transaction costs with this funding in place we will concentrate on the clinical programs with tasquinimod in myelofibrosis as well as finding a
12251,all_events,UP,,rockville md april 25 2024 globe newswire theriva biologics nyse american tovx a diversified clinical stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need today announced that based on the strength of the science and its relevance virage the phase 2b randomized open label placebo controlled multicenter clinical trial of systemically administered vcn 01 in combination with standard of care soc chemotherapy gemcitabine nab paclitaxel as a first line therapy for patients with newly diagnosed metastatic pancreatic ductal adenocarcinoma pdac has been accepted for presentation as a trial in progress poster at the 2024 american society of clinical oncology asco annual meeting being held in chicago il from may 31 june 4
10190,all_events,UP,,14 nov 2024 17 05 cet ecit as company announcement no 272 oslo 14 november 2024 following completion of the compulsory acquisition by ecit bidco as formerly known as olympus bidco as of all shares in ecit as not already owned by ecit bidco as as announced earlier today an extraordinary general meeting of ecit as has today resolved to apply for a delisting of the class b shares in ecit as from euronext growth oslo accordingly ecit as will promptly apply for a delisting of its class b shares from euronext growth oslo please find attached the minutes from the extraordinary general meeting for further information please contact mads skovgaard group cfo mskovgaard ecit com 45 2780 4942 about ecit founded in 2013 ecit supports a large customer base with accounting payroll and it services ecit has a proven model for acquisitions combining proximity to customers local entrepreneurship and the strength of a larger international group ecit has a full
3017,all_events,UP,,saint herblain france 12 septembre 2024 valneva se nasdaq valn euronext paris vla valneva ou la société société spécialisée dans les vaccins annonce aujourd hui sous réserve des conditions de marché son intention de procéder à l émission d environ 22 6 millions de nouvelles actions ordinaires les actions nouvelles au prix de 2 66 par action nouvelle par voie d un processus de construction accélérée d un livre d ordres qui débute immédiatement l augmentation de capital
5431,all_events,UP,,06 nov 2024 18 12 cet broadpeak s a broadpeak sa broadpeak publishes third quarter 2024 revenue 06 nov 2024 18 12 cet cest dissemination of a french regulatory news transmitted by eqs group the issuer is solely responsible for the content of this announcement broadpeak publishes third quarter 2024 revenue revenue of 8 7m over the period up 10 at the end of september group revenue totalled 25 8m 0 growth of 8 in the biggest contributors to revenue over 9 months licenses services maintenance saas good visibility for year end thanks to orders already confirmed annual targets and ambitions for 2027 confirmed cesson sévigné france 6 november 2024 broadpeak isin fr001400ajz7 ticker albpk a leading provider of video streaming software solutions is reporting its third quarter and 9 month 2024 revenue revenue in k 9m 2023 9m 2024 change q3 2023 q3 2024 change emea 11 055 12 074 9
4279,all_events,UP,,media release
12919,all_events,UP,,irvine calif aug 25 2023 globe newswire biomerica inc nasdaq bmra the company a global provider of advanced medical products today reported its fiscal 2023 financial results
424,all_events,UP,UP,media release
554,all_events,DOWN,DOWN,lexington mass sept 20 2024 globe newswire t2 biosystems inc nasdaq ttoo the company a leader in the rapid detection of sepsis causing pathogens and antibiotic resistance genes today announced that it has successfully defended against an opposition filed against a key patent for its direct from whole blood detection method in the european union
944,all_events,UP,DOWN,18 november 2024 šiauliai this announcement contains information on transactions of the acquisition of own shares of ab šiaulių bankas the bank carried during the period specified below under the bank s own share buy back programme announced on 31 october 2024 the period during which the acquisition of the bank s own shares under the programme was carried out 04 11 2024 15 11 2024 period covered by this periodic report 11 11 2024 15 11 2024 other information additional information tomas varenbergas head of investment management division tomas varenbergas sb lt attachment attachments additional detailed information about transactions pdf
5761,all_events,UP,,gabab pam selection of drug candidates under indivior collaboration expected by end of q2 2024
6479,all_events,DOWN,,zug switzerland aug 15 2024 globe newswire oculis holding ag nasdaq ocs oculis a global biopharmaceutical company purposefully driven to save sight and improve eye care today announced the appointment of dr sharon klier an executive leader with extensive experience in clinical development across early and late stage programs regulatory submissions and approvals to the role of chief development officer in this key role dr klier will oversee and provide strategic leadership across the clinical development and operations of oculis robust ophthalmology pipeline
4985,all_events,UP,,15 nov 2024 13 45 cet romerike sparebank det er fastsatt ny obligasjonsrente for no0010907199 ny obligasjonsrente i renteperioden 19 11 2024 19 02 2025 er 5 42 ticker romer31 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632399_11a65ed4e6fd465dba6eb28771e82d98 pdf romerike sparebank oslo børs newspoint blaker spb 20 perp frn c hybrid lillestrøm spb 20 25 frn blaker spb 20 25 frn lillestrøm spb 20 26 frn lillestrom spb 21 31 frn c sub romerike spb 22 27 frn romerike spb 22 28 frn romerike spb 22 26 frn romerike spb 23 28 frn romerike spb 23 29 frn romerike spb 23 27 frn romerike spb 23 26 frn romerike spb 24 perp frn c hybrid romerike spb 24 35 frn c sub romerike spb 24 29 frn romerike sp
7530,all_events,DOWN,,12 nov 2024 18 00 cet medesis pharma s a see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1297211_medesispharma_cp_res_s1_2024 pdf medesis pharma les echos medesis pharma s a fr0010844464 almdp euronext growth
5595,all_events,DOWN,,media release
7308,all_events,UP,,minesto leading ocean energy developer is part of the official swedish business delegation to united nation climate change conference cop29 taking place in baku azerbaijan on energy day on 15 november minesto will host a session on the role and importance of innovation in tackling climate change mr daniel westlén state secretary to swedish minister for climate and the environment will take part in the session on 15 november friday at 11 00 11 40 utc 4 baku local time minesto will host a programme session titled towards the era of electricity do we have enough tools in the toolbox a discussion on the role and importance of innovation to tackle climate change in the swedish pavilion at cop29 mr daniel westlén state secretary to the swedish minister for climate and the environment romina pourmokhtari will take part in the session dr martin edlund ceo of minesto and isabella gustafsson ismodes research programme manager industry at swedish energy agency wil
9182,all_events,DOWN,,the bank of latvia has approved the base prospectus of the secured bond issue of as longo group the largest used car retailer in the baltic region in the first tranche it is planned to raise up to eur 10 million both retail and professional investors are invited to invest in group s bonds with a fixed interest rate of and a maturity of three years the subscription period will start on november 11 and end on november 25 as longo group historical performance demonstrates longo s capacity for growth the company has strategically invested in all necessary business processes that support the scaling of its operations the next steps include significantly expanding the passenger car inventory widening and strengthening the physical presence in existing markets says edgars cērps founder and the member of the management board at as longo group the capital raised from as longo group bond offering is aimed at refinancing existing liabilities as well as additional investment
7540,all_events,DOWN,,immunocore announces clinical trial collaboration and supply agreement with bristol myers squibb to evaluate imc f106c prame hla a02 in combination with nivolumab in its registrational phase 3 first line advanced cutaneous melanoma trial
9758,all_events,DOWN,,06 nov 2024 09 10 cet navamedic asa oslo 6 november 2024 building on the successful product launch of eroxon in norway and sweden earlier this year navamedic asa ose nava a nordic pharma company and reliable provider of high quality products to hospitals and pharmacies is now launching eroxon across pharmacies in finland eroxon will be the first clinically proven over the counter topical treatment for the treatment of erectile dysfunction in men in finland eroxon is part of navamedic s increasingly growing consumer health category since the product launched in norway in february 2024 eroxon has already become one of the top performing products within this category and it is expected to continue driving further growth the product launch in finland marks the third launch this year and will be followed by a launch in denmark in 2025 the finnish market for erectile dysfunction has significant potential a recent study 1 concluded that 37
5444,all_events,DOWN,,13 nov 2024 18 00 cet carbios 2024 11 13 cpcapital carbios octobre 2024 pdf carbios euronext carbios fr0011648716 alcrb euronext growth
7505,all_events,DOWN,,media release
12692,all_events,DOWN,,media release
11462,all_events,DOWN,,yonkers n y june 27 2023 globe newswire contrafect corporation nasdaq cfrx a clinical stage biotechnology company focused on the discovery and development of direct lytic agents dlas including lysins and amurin peptides as new medical modalities for the treatment of life threatening antibiotic resistant infections announces today that it has entered into a warrant exercise agreement with an existing accredited investor to exercise certain outstanding warrants to purchase an aggregate of 7 0 million shares of the company s common stock in consideration for the immediate exercise of the existing warrants for cash the exercising holder received new unregistered warrants to purchase an aggregate of 7 0 million shares of the company s common stock in connection with the exercise the company also agreed to reduce the exercise price of such existing warrants to 1 36 which is equal to the most recent closing price of the company s common stock on the nasdaq capital market prior to the execution of the warrant exercise agreement
8233,all_events,DOWN,,november 14 2024 03 01 et source investeringsforeningen maj invest investeringsforeningen maj invest i forlængelse af fondsbørsmeddelelsen af 1 juli 2024 vedrørende investeringsforeningen maj invests deltagelse i forligsaftale i o w bunker a s ansvarssagen kan det nu meddeles at størrelsen på investorernes forligsbeløb ekskl omkostninger er fastlagt der er hensat et mindre beløb til omkostninger som er fratrukket forligsbeløbet udbetalingen af forligsbeløbet til afdeling danske aktier kl med andelsklasserne danske aktier isin dk0060005171 og danske aktier w isin dk0060825487 har medført en positiv påvirkning af de to andelsklassers indre værdi offentliggjort dags dato som angivet nedenfor med venlig hilsen investeringsforeningen maj invest v investeringsforvaltningsselskabet sebinvest a s attachment
12733,all_events,UP,,media release
2318,all_events,UP,DOWN,pharmacokinetic and tissue data confirm navicap platform delivers topically through the entire colon with lower systemic concentrations as desired
5465,all_events,UP,,04 oct 2024 07 05 cest shelf drilling ltd and shelf drilling north sea ltd key dates for completion of merger dubai 4 october 2024 reference is made to the stock exchange announcement as of 16 september 2024 regarding an agreement and plan of merger entered into between shelf drilling ltd shelf drilling an indirect subsidiary of shelf drilling mergersub and shelf drilling north sea ltd shelf drilling north sea whereby pursuant to the contemplated merger of mergersub with and into shelf drilling north sea shelf drilling north sea will become a wholly owned subsidiary of shelf drilling the proposed merger reference is also made to the subsequent announcement related to the notice for the special general meeting in shelf drilling north sea to approve the proposed merger it is currently expected that completion of the proposed merger will occur on 11 october 2024 key dates and information for the completion of the proposed merger wil
3006,all_events,DOWN,,samkvæmt útboðsdagatali lánasjóðs sveitarfélaga var áætlað að halda skuldabréfaútboð miðvikudaginn 6 nóvember 2024 í ljósi rúmrar lausafjárstöðu hefur verið ákveðið að fella útboðið niður
6740,all_events,UP,,adelaide australia and cambridge mass aug 23 2023 globe newswire bionomics limited nasdaq bnox asx bno bionomics or company a clinical stage biotechnology company developing novel first in class allosteric ion channel modulators to treat patients suffering from serious central nervous system cns disorders with high unmet medical need today announced that the last patient last visit has been completed in its phase 2 attune study in ptsd and disclosed timing of the end of phase 2 eoph2 meeting to review advancing bnc210 into phase 3 program in patients with sad
6691,all_events,UP,,oral presentation of study shows intranasal foralumab attenuates microglial activation and disease progression in multiple sclerosis ms patients with pira as measured by changes in pet scans oral presentation of study shows intranasal foralumab attenuates microglial activation and disease progression in multiple sclerosis ms patients with pira as measured by changes in pet scans
68,all_events,UP,UP,stockholm sweden november 7 2024 maximum entertainment ab nasdaq maxent b today announced the highly anticipated early access release of maximum football on steam we are thrilled to share one of our flagship owned ip titles bringing a unique gaming experience straight to football fans everywhere said philippe cohen ceo of maximum entertainment maximum football assembles all of the features football fans have been asking for over the last decade into one free to play model entirely built around community feedback the game brings a variety of single and multiplayer modes bringing some of football fans most requested features including physics based gameplay and unparalleled levels of customization all built into a free to play model beyond early access more will come when 1 0 hits pc playstation and xbox in 2025 view today s launch trailer https youtu be rf15cjmbu9w the game is available to play now for free https store steampowered com app 1691280 maxi
8492,all_events,DOWN,,12 nov 2024 10 44 cet tinn sparebank kvartalsrapport for q3 er godkjent av styret i tinn sparebank 12 11 2024 kontaktperson marit våle telefon 97 11 05 05 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631920_kvartalsrapport q3 2024 tinn sparebank pdf tinn sparebank oslo børs newspoint tinn spb 22 perp frn c hybrid tinn spb 23 26 frn tinn spb 23 33 frn c sub tinn spb 24 27 frn no0012692625 no0012898719 no0012918129 no0013229757 nordic alternative bond market
11624,all_events,DOWN,,11 nov 2024 08 30 cet ørskog sparebank ørskog sparebank oppnådde eit resultat etter tap og skatt på 31 1 mill kr pr 30 09 24 dette er 4 5 mill kr betre enn pr 30 09 2023 banken sine totale utlån inkludert eika boligkreditt syner det siste året ein auke på 4 79 rentenettoen ligg stabilt på 2 37 den underliggande bankdrifta er solid og banken sin marknadsposisjon er sterk banken sin balanse syner ei rein kjernekapitaldekning på 18 61 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631798_3 kv 2024 pdf ørskog sparebank oslo børs newspoint ørskog spb 20 30 frn c sub orskog spb 21 26 frn orskog spb 21 25 frn orskog spb 22 perp frn c hybrid orskog spb 22 25 frn orskog spb 23 28 frn ørskog spb 24 29 frn ørskog spb 24 27 frn no0010891666 no0010932528 no0011025751 no0011125577 no0012639535 no0012719170 no0013038919 no0013209825 no0013363820 nordic alte
1351,all_events,DOWN,DOWN,07 nov 2024 18 00 cet roctool roctool roctool information mensuelle relative au nombre total de droits de vote et actions composant le capital social 07 nov 2024 18 00 cet cest information réglementaire transmise par eqs group le contenu de ce communiqué est de la responsabilité de l émetteur communiqué de presse jeudi 07 novembre 2024 information mensuelle relative au nombre total de droits de vote et actions composant le capital social article 223 16 du règlement général de l autorité des marchés financiers place de cotation euronext growth paris mnémonique alroc éligible pea pme code isin fr0010523167 site web www roctool com date nombre total d actions composant le capital social nombre total de droits de vote 31 août 2024 6 801 186 7 719 741 contacts relations investisseurs presse aelyon advisors jerome gacoin valentine boivin 33 1 75 77 54 65 roctool aelium fr fichier pdf dépôt régle
3693,all_events,UP,,media release
7234,all_events,UP,,media release
12711,all_events,DOWN,,november 11 2024 02 00 et source tallink grupp tallink grupp person subject to the notification requirementname nõgene paavoposition chairman of the management board of as tallink grupp issuer as tallink grupp lei 529900qrmwakkr3l9w75 notification type initial notification _____________________________________ transaction date 08 11 2024venue nasdaq omx tallinninstrument type shareisin ee3100004466nature of the transaction acquisition transaction details 1 volume 13 932 unit price 0 598 eur 2 volume 4 788 unit price 0 599 eur 3 volume 1 280 unit price 0 600 eur aggregated transactions 3 volume 20 000 volume weighted average price 0 598 eur anneli simminvestor relations manager as tallink gruppsadama 510111 tallinn phone 372 56157170e mail anneli simm tallink ee
2522,all_events,UP,DOWN,mainz biomed reports full year 2023 financial results
2701,all_events,UP,,science 37 emerges as the only clinical trial site to be recognized as a leader in decentralized clinical trials science 37 emerges as the only clinical trial site to be recognized as a leader in decentralized clinical trials
2991,all_events,DOWN,,g1 therapeutics announces inducement grants under nasdaq listing rule 5635 c 4
6860,all_events,DOWN,,november 12 2024 03 00 et source huhtamäki oyj huhtamäki oyj huhtamäki oyj press release 12 11 2024 at 10 00 huhtamaki signed a eur 450 million sustainability linked syndicated revolving credit facility huhtamäki oyj has signed a eur 450 million sustainability linked syndicated multi currency revolving credit facility loan agreement rcf with a maturity of five 5 years the rcf refinances an existing eur 400 million sustainability linked syndicated revolving credit facility signed in january 2021 and will be used for general corporate purposes of the group the rcf has two one year extension options at the discretion of the lenders the mandated lead arrangers and bookrunners of the rcf are citi nordea bank abp skandinaviska enskilda banken ab publ bnp paribas commerzbank aktiengesellschaft danske bank a s dbs bank ltd london branch j p morgan se landesbank hessen thüringen girozentrale op corporate bank plc raiffeisen bank
732,all_events,UP,DOWN,alvotech nasdaq alvo og samstarfsaðili þess alþjóðlega lyfjafyrirtækið advanz pharma tilkynntu í dag að lyfjastofnun evrópu ema hafi samþykkt að taka til umsagnar umsókn um markaðsleyfi fyrir avt05 sem er fyrirhuguð líftæknilyfjahliðstæða alvotech við simponi golimumab sem notað er til meðferðar við ýmsum þrálátum bólgusjúkdómum þetta er talin vera fyrsta umsókn um markaðsleyfi fyrir fyrirhugaða líftæknilyfjahliðstæðu við simponi sem tikynnt hefur verið um alþjóðlega markaðsleyfi í evrópu gæti legið fyrir á síðasta ársfjórðungi 2025
245,all_events,UP,UP,06 nov 2024 10 47 cet hipay group cp hipay ca q3 2024 fr rev04112024 pdf hipay group euronext hipay group fr0012821916 alhyp euronext growth
9455,all_events,DOWN,,02 oct 2024 07 00 cest essilorluxottica essilorluxottica complete l acquisizione diuna quota di maggioranza in heidelberg engineering parigi francia e heidelberg germania 2 ottobre 2024 ore 7 00 essilorluxottica leader globale nel settore dell ottica ha completato l acquisizione precedentemente annunciata di una partecipazione dell di heidelberg engineering azienda tedesca specializzata in soluzioni diagnostiche tecnologie chirurgiche digitali e soluzioni it per l oftalmologia clinica l operazione è stata autorizzata dalle autorità antitrust competenti allegato scarica il comunicato stampa essilorluxottica complete l acquisizione diuna quota di maggioranza in heidelberg engineering parigi francia e heidelberg germania 2 ottobre 2024 ore 7 00 essilorluxottica leader globale nel settore dell ottica ha completato l acquisizione precedentemente annunciata di una partecipazione dell di heidelberg engineering azienda tedesca specializza
3872,all_events,UP,,q2 2024 net sales of 496 million actual rates constant exchange rates cer net loss per share of 0 83 but adjusted diluted eps of 0 55 net sales at cer of 502 million ahead of outlook for at least 495 million cer and adjusted diluted eps of 0 55 cer ahead of 0 52 cer outlook 28 adj operating income margin up 1 percentage point from 27 in q2 2023 q2 2024 free cash flow up to 129 million vs q2 2023 fy 2024 outlook updated after solid h1 2024 results ahead of outlook updated net sales outlook of at least 1 985 billion cer reflects solid core business trends and neumodx decision adj diluted eps outlook increased to at least 2 16 cer q2 2024 net sales of 496 million actual rates constant exchange rates cer net loss per share of 0 83 but adjusted diluted eps of 0 55 net sales at cer of 502 million ahead of outlook for at least 495 million cer and adjusted diluted eps of 0 55 cer ahead of 0 52 cer outlook 28 adj operating income margin up 1 percentage point from 27 in q2 2023 q2 2024 free cash flow up to 129 million vs q2 2023 fy 2024 outlook updated after solid h1 2024 results ahead of outlook updated net sales outlook of at least 1 985 billion cer reflects solid core business trends and neumodx decision adj diluted eps outlook increased to at least 2 16 cer
1665,all_events,DOWN,UP,record quarterly revenues driven by yoy growth of rx gammacore in the va dod and increase in truvaga sales
8750,all_events,DOWN,,gigasun s chinese subsidiary has entered into an agreement with a food industry company in hubei province the agreement covers the installation of a solar power plant with a capacity of approximately 2 5 megawatts mw the plant is expected to generate annual revenues of approximately sek 1 25 million from electricity sales which amounts to a total of approximately sek 25 million during the 20 year contract period all electricity produced will be sold directly to the grid the investment in the plant which will be owned by gigasun s wholly owned subsidiary in china amounts to approximately sek 10 7 million construction is scheduled to start in the first quarter of 2025 the plant is estimated to reduce carbon dioxide emissions by about 1 300 tonnes annually the project is located in hubei province and is profitable without any subsidies max metelius ceo of gigasun comments despite fierce competition and challenges in the chinese economy gigasun continues to secure profita
2002,all_events,UP,DOWN,15 nov 2024 17 45 cet fnac darty communiqué de presseivry sur seine france 15 novembre 2024 17h45 cest la diffusion la publication ou la distribution de ce communiqué de presse en tout ou en partie directement ou indirectement n est pas autorisée aux états unis d amérique en australie au canada au japon ou dans tout autre pays ou une telle communication violerait la règlementation applicable en la matière offre publique d achat mixte volontaire portant sur l ensemble des actions d unieuro informations complémentaires concernant la procédure de conformité à l obligation d achat visée à l article 108 paragraphe 2 du cfa la contrepartie alternative intégralement en numéraire s élève à 11 67208 eurosla procédure de conformité à l obligation d achat visée à l article 108 paragraphe 2 du cfa commencera le 18 novembre 2024 et prendra fin le 6 décembre 2024le paiement de la contrepartie due dans le cadre de la procédure de conformité à l obligation d achat visée à
7442,all_events,DOWN,,immuneering to participate in the 23rd annual needham virtual healthcare conference
11612,all_events,UP,,media release
5858,all_events,DOWN,,media release
6104,all_events,UP,,05 nov 2024 18 00 cet m r m information relative au nombre total de droits de vote et d actions composant le capital conformément aux dispositions de l article l233 8 ii du code de commerce et de l article 223 16 du règlement général de l autorité des marchés financiers situation au 31 octobre 2024 datenombre d actions composant le capital socialnombre de droits de vote brutsnombre de droits de vote exerçables31 octobre 20243 209 5323 209 5323 200 974 présence dans les statuts d une clause imposant une obligation de déclaration de franchissement de seuil complémentaire de celle ayant trait aux seuils légaux oui extrait de l article 8 des statuts toute personne physique ou morale qui viendrait à franchir à la hausse ou à la baisse un seuil de détention de capital ou de droits de vote dans la société égal à 2 5 ou à un multiple de ce seuil soit les seuils de détention de 2 5 5 7 5 etc doit obligatoirement déclarer à la société dans les quinze jours de c
673,all_events,DOWN,DOWN,la jolla calif nov 14 2024 globe newswire medicinova inc a biopharmaceutical company traded on the nasdaq global market nasdaq mnov and the standard market of the tokyo stock exchange code number 4875 announces that it has received a notice of allowance from the u s patent and trademark office uspto for a pending patent application for mn 001 tipelukast to cover method to decrease triglyceride synthesis in a liver of a subject the allowed claims cover a groundbreaking method for decreasing triglyceride synthesis in the liver by administering mn 001 tipelukast or its metabolite or pharmaceutically acceptable salt this method is particularly beneficial for subjects diagnosed with insulin resistance pre diabetes or diabetes once issued this patent is expected to expire no earlier than may 26 2042
6523,all_events,DOWN,,november 08 2024 09 30 et source litgrid ab litgrid ab litgrid ab juridinio asmens kodas 302564383 registruotos buveinės adresas karlo gustavo emilio manerheimo g 8 vilnius skelbia 2024 m 9 mėnesių rezultatus pagrindiniai 2024 m devynių mėnesių finansiniai rodikliai pelningumo rodiklių perskaičiavimas atliekamas dėl laikinų reguliacinių nuokrypių nuo valstybinės energetikos reguliavimo tarybos vert patvirtinto reguliuojamo pelningumo apskaičiuojant koreguotus rodiklius įvertinama pajamų dėl praėjusių laikotarpių korekcija kuri vert sprendimu jau yra patvirtinta nustatant ataskaitinio periodo perdavimo paslaugų reguliuojamas kainas bei įvertinamas ataskaitinio periodo vert patvirtinto reguliuojamo ir faktinio pelningumo nuokrypis kuris bus įvertintas vert nustatant perdavimo kainas būsimiems periodams pridedama 1 2024 m 9 mėnesių finansinės ataskaitos 2 pranešimas žiniasklaidai daugiau informacijos jurga eivaitė komunika
5120,all_events,UP,,11 nov 2024 21 50 cet pioneer property group asa an extraordinary general meeting of pioneer property group asa the company will be held on 03 december 2024 at 09 00 hours cet the extraordinary general meeting will be held at the company s offices located at rådhusgata 23 0158 oslo norway the notice of the extraordinary general meeting is attached hereto the notice and other relevant documents are also available on the company s website www pioneerproperty no the board of directors of the company has proposed that the share capital of the company be reduced through i the redemption of 3 284 048 ordinary shares against distribution of a redemption amount of nok 47 220 per ordinary share to the holders of the redeemed shares and ii the redemption of 500 000 preference shares held in treasury by the company as further described in the attached notice this announcement is subject to disclosure under section 5 12 of the norwegian securities act and the
1730,all_events,DOWN,DOWN,media release
3984,all_events,UP,,tel aviv israel and miami jan 31 2024 globe newswire inspiremd inc nasdaq nspr developer of the cguard embolic prevention carotid stent system eps for the prevention of stroke today announced that it has received ce mark recertification under the european union s new medical device regulation mdr regulatory framework mdr replaced the previous mdd framework which had governed the approval and marketing of medical devices in the eu until may of 2021
3798,all_events,UP,,11 oct 2024 17 45 cest acticor biotech 27 patients recruited in the phase 2b liberate study evaluating glenzocimab in the treatment of st elevation myocardial infarction stemi preparation of a new phase 2 study gloria evaluating glenzocimab in angioplasty for stemi regulatory news acticor biotech fr0014005oj5 alact a clinical stage biopharmaceutical company developing glenzocimab an innovative drug for the treatment of cardiovascular emergencies today provides an update on its clinical developments evaluating glenzocimab in the treatment of myocardial infarction gilles avenard chief executive officer and founder of acticor biotech comments myocardial infarction remains a major cause of death worldwide accounting for 7 to 9 million deaths per year of which 30 to are caused by st elevation myocardial infarction stemi this severe type of heart attack caused by the complete blockage of a coronary artery results in significant damage t
2487,all_events,UP,DOWN,november 07 2024 05 30 et source flyplay hf flyplay hf play airlines transported 138 155 passengers in october 2024 down from 154 479 in october the previous year this aligns with play s strategy of gradually reducing its transatlantic capacity which is reflected in the october traffic figures in line with this shift the airline achieved an 85 load factor in october 2024 the highest for the month of october in play s history up from last year play s on time performance also improved reaching 91 in october 2024 compared to 85 last year among the passengers 33 were traveling from iceland 39 to iceland and 27 were connecting passengers via this reflects play s increased focus on its local market with a growth in passengers flying from iceland rising from 43 872 in october 2023 to 46 143 in october 2024 passengers flying to iceland increased by from 52 368 in october 2023 to 54 018 in october 2024 p
8991,all_events,DOWN,,media release
4622,all_events,DOWN,,02 oct 2024 22 30 cest golden ocean group limited reference is made to the announcement by the board of directors in golden ocean group limited ose nasdaq gogl dated 4 october 2022 and 3 october 2023 regarding the establishment and renewal of a share buy back program the company has repurchased a total of 1 507 328 shares under the program for a total consideration of 11 629 758 a total of 741 900 shares have been repurchased at average price of 7 84 per share at nasdaq and 765 428 shares have been repurchased at an average price of nok 81 2 at oslo stock exchange the board of directors of golden ocean group limited has on 2 october 2024 resolved to extend the existing share buy back program with a further 12 months and the following main terms maximum usd 100 million to purchase up to an aggregate of 10 000 000 of the company s common shares with 1 507 328 shares repurchased for usd 11 629 758 as of the date hereof a period from and includ
3082,all_events,DOWN,,zug switzerland oct 21 2024 globe newswire oculis holding ag nasdaq ocs oculis a global biopharmaceutical company purposefully driven to save sight and improve eye care today announces the acceleration of patient enrollment for both phase 3 diamond trials of ocs 01 eye drops in dme and expansion of the diamond program committees with globally renowned retina experts
10506,all_events,UP,,13 nov 2024 07 00 cet carmat franchissement du cap des 30 transplantations cardiaques après support d aeson intérêt marqué de la communauté médicale pour aeson plus de 100 experts européens partageront leur expérience lors du premier aeson european user meeting organisé fin novembre regulatory news carmat fr0010907956 alcar éligible pea pme concepteur et développeur du cœur artificiel total le plus avancé au monde la société ou carmat visant à offrir une alternative thérapeutique aux malades souffrant d insuffisance cardiaque biventriculaire avancée fait un point d étape sur la montée en puissance du cœur artificiel aeson en tant que pont à la transplantation en europe adoption croissante d aeson en tant que solution de pont à la transplantation en europe a fin octobre 2024 30 patients avaient bénéficié avec succès d une greffe cardiaque après avoir été sous support du cœur artificiel aeson ce qui confirme la capacité du d
6020,all_events,UP,,adelaide australia and cambridge mass sept 14 2023 globe newswire bionomics limited nasdaq bnox bionomics or company a clinical stage biotechnology company developing novel first in class allosteric ion channel modulators to treat patients suffering from serious central nervous system cns disorders with high unmet medical need today announced an update on the company s α7 nicotinic acetylcholine receptor nachr positive allosteric modulator pam collaboration with msd known as merck co inc rahway nj usa in the us and canada data for mk 4334 a novel clinical candidate developed by msd and derived from bionomics original α7 nachr pam candidate bnc375 was recently presented at the society for chemical industry sci and royal society of chemistry rsc 22nd medicinal chemistry symposium held in cambridge uk september 10 13 2023
2325,all_events,DOWN,DOWN,07 nov 2024 17 45 cet transgene s a compelling 24 1 month median follow up data presented at sitc 2024 showed that all patients treated with tg4050 after completion of an adjuvant standard of care remain disease free tg4050 induced specific and sustained immune responses a phase ii part is now enrolling patients internationally to build on this promising outcome strasbourg france tokyo japan november 7 2024 5 45 p m cet transgene euronext paris tng a biotech company that designs and develops virus based immunotherapies for the treatment of cancer and nec corporation nec tse 6701 a leader in it network and ai technologies today announced 24 1 month median follow up data from the ongoing randomized phase i trial of tg4050 in the adjuvant treatment of head and neck cancers the data will be presented in a poster at the society for immunotherapy of cancer sitc 2024 annual meeting on november 9 in houston tx tg4050 is an individualized immunotherapy
8839,all_events,DOWN,,19 nov 2024 19 13 cet synergie acquisition des actions de l actionnaire minoritaire de synergie italia synergie acquiert la part minoritaire de synergie italia et poursuit son développement sur ce marché stratégique synergie annonce l acquisition de la participation de l actionnaire minoritaire de synergie italia et renforce ainsi sa position sur le marché italien du recrutement et des solutions rh cette acquisition marque une étape importante dans notre développement international en intégrant pleinement synergie italia nous consolidons notre présence en italie et renforçons notre capacité à répondre aux besoins spécifiques du marché local cette prise de participation à est le résultat d une croissance organique forte sur ce marché et représente un succès majeur pour notre groupe synergie italia est désormais encore mieux positionnée pour capitaliser sur les opportunités de croissance en italie et continuer à innover dans le domaine des ressources humaines sur ce
7328,all_events,DOWN,,zug sviss aug 27 2024 globe newswire oculis holding ag nasdaq ocs xice ocs oculis eða félagið alþjóðlegt líftæknifyrirtæki sem hefur það að markmiði að þróa augnlyf sem bæta sjón í alvarlegum augnsjúkdómum birti í dag uppgjör fyrir ársfjórðunginn sem lauk 30 júní og kynnti nýlega áfanga í rekstri félagsins
9621,all_events,DOWN,,parsippany n j oct 30 2024 globe newswire pacira biosciences inc nasdaq pcrx today announced that it will report its third quarter financial results after the close of the u s markets on wednesday november 6 2024 following the release the company will host a live conference call and webcast at 4 30 p m et
5576,all_events,UP,,02 oct 2024 19 00 cest precia 20241002 cp cession cit pdf precia euronext precia fr0014004ec4 alpm euronext growth
11069,all_events,DOWN,,media release
8158,all_events,UP,,12 nov 2024 12 20 cet golar lng limited attached is a copy of our q3 2024 results a webcast presentation will be held at 2pm cet today tuesday november 12 2024 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631933_interim results for the period ended september 30 2024 pdf golar lng limited oslo børs newspoint golar lng limited 21 25 7 00pct usd c no0011123432 oslo børs
1743,all_events,UP,UP,15 nov 2024 14 11 cet scatec asa se vedlegg på www newsweb no more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632418_interests 2024 11 15 pdf scatec asa oslo børs newspoint scatec asa scatec asa 21 25 frn eur c scatec asa 23 27 frn c scatec asa 24 28 frn floor c no0010715139 no0010931181 no0012837030 no0013144964 scatc oslo børs
5762,all_events,DOWN,,media release
812,all_events,UP,UP,media release
8450,all_events,DOWN,,media release
5020,all_events,DOWN,,thunderful group ab publ thunderful or the group announces today the implementation of a strategic restructuring program within its publishing segment the program aimed to increase the focus on third party game publishing while reducing investments in internal game projects the program will lead to workforce reductions and the discontinuation of some internal game projects in short the program will mean thunderful s management and board of directors have continued to assess the group s business capabilities and capital structure and after careful consideration have decided to implement this strategic restructuring program in the publishing segment the shift will entail a greater focus on third party game publishing and a reduction in investments in internally developed projects this newly announced program follows the cost saving measures introduced earlier this year as well as the divestment of the group s distribution business to manage previously incurred net de
12890,all_events,UP,,florham park n j jan 18 2024 globe newswire celularity inc nasdaq celu has posted a letter to shareholders from robert j hariri m d ph d chairman ceo and founder which is included below and can also be accessed here
8620,all_events,DOWN,,15 nov 2024 08 00 cet s d standard etc plc reference is made to the announcement by s d standard etc plc on 7 november 2024 with key information regarding a cash dividend of nok 0 20 per share the shares of the company are trading exclusive of the right to receive the cash dividend as of today as described below issuer s d standard etc plc ex date 15 november 2024 dividend per share nok 0 20 announced currency nok for further information please contact general manager evangelia panagide at 357 99 77 11 16 chairman of the board martin nes at 47 92 01 48 14 the information is published in accordance with the requirements of euronext oslo rule book ii and is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site s d standard etc plc oslo børs newspoint s d standard etc plc cy0
2992,all_events,UP,,12 nov 2024 08 22 cet oci n v q3 2024 trading update pdf oci nv euronext oci n v nl0010558797 oci euronext
6386,all_events,DOWN,,05 nov 2024 18 00 cet getlink se regulatory news getlink se paris get presenter corporate name getlink se société européenne rcs paris 483 385 142 37 39 rue de la bienfaisance 75008 paris number of ordinary shares in issue 1 550 000 000 number of voting rights theoretical 2 3 785 003 809 date 31 october 2024 total number of exercisable voting rights at 31 october 2024 and not including the shares for which voting rights have been suspended 776 417 661 1 the share capital is divided into 550 000 000 ordinary shares of a nominal value of 0 40 2 theoretical number calculated on the basis of all shares including the shares for which voting rights have been suspended 3 a double voting right is set out for ordinary shares under article 11 of the company s by laws to all fully paid up ordinary shares which can be shown to have been held by the same shareholder in registered fo
11455,all_events,UP,,media release
6417,all_events,UP,,media release
7573,all_events,UP,,november 19 2024 11 30 et source sanoma oyj sanoma oyj sanoma oyj pörssitiedote 19 11 2024 klo 18 30 sanoma oyj omien osakkeiden hankinta 19 11 2024 nasdaq helsinki oy yhtiön hallussa on 19 11 2024 tehtyjen kauppojen jälkeen 174 146 omaa osaketta sanoma yksityiskohtaiset tiedot hankinnasta ovat tämän pörssitiedotteen liitteenä sanoma oyj n puolesta skandinaviska enskilda banken ab publ helsingin sivukonttori antti salakka janne tiihonen lisätietoja kaisa uurasmaa sijoittajasuhde ja yritysvastuujohtaja puh 040 560 5601 sanoma sanoma on innovatiivinen ja ketterä oppimisen ja median yhtiö jolla on vaikutus miljoonien ihmisten elämään joka päivä vastuullisuusstrategiamme avulla vahvistamme positiivista vaikutustamme yhteiskuntaan ja minimoimme ympäristöjalanjälkeämme olemme sitoutuneet yk n kestävän kehityksen periaatteisiin ja allekirjoittaneet yk n global compact aloitteen oppimisen tuotteemme ja palvelumme autta
10440,all_events,DOWN,,izafe group ab publ izafe announces today that it has received a new confirmed order for an additional 1 000 dosell units from its exclusive distributor in the netherlands tccn this strategically important order has a value of approximately sek 3 million deliveries will be split into two batches 750 units in 2024 and the remaining 250 in the first half of 2025 laying the foundation for stable licensing revenue of up to sek 400 000 per month during 2025 this order ensures that tccn retains its exclusivity in the dutch market in accordance with previously communicated terms once this order and previous ones are fully implemented they are expected to generate recurring revenue of approximately sek 400 000 per month in 2025 the order strengthens izafe s cash flow and builds a long term revenue model clearly affirming dosell s strong position as a leading solution in medication dispensing and a vital tool for the digitalization of the healthcare sector since the beginnin
12031,all_events,UP,,gaithersburg md may 15 2023 globe newswire neximmune inc nasdaq nexi a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen specific t cells in oncology autoimmune and infectious diseases today reported financial results for the first quarter 2023
10688,all_events,DOWN,,stockholm sweden november 8 2024 bioarctic ab s publ nasdaq stockholm bioa b partner eisai today updated their revenue outlook for leqembi for their 2024 fiscal year fy which runs from april 2024 through march 2025 eisai now expects leqembi sales to total jpy 42 5 billion approximately sek 3 billion for the period down from jpy 56 5 billion announced in may this would generate approximately sek 300 m in royalty to bioarctic in the same period leqembi sales for the first half of eisai s fy2024 amounted to jpy 16 3 billion resulting in sek 112 4 m in royalty to bioarctic eisai serves as the lead of leqembi development and regulatory submissions globally with both eisai and biogen co commercializing and co promoting the product and eisai having final decision making authority bioarctic has the right to commercialize lecanemab in the nordic region pending european approval and eisai and bioarctic are currently preparing for a joint commercialization in the region b
2483,all_events,UP,DOWN,statistically significant week 96 results from the phase 2b harmony study of efx in patients with pre cirrhotic mash reported during the first quarter of 2024 phase 3 synchrony histology and synchrony real world studies in patients with pre cirrhotic mash f2 f3 continue to enroll synchrony outcomes study in patients with compensated cirrhosis due to mash f4 on track to be initiated in second quarter of 2024
10680,all_events,DOWN,,on november 4 2024 the nasdaq tallinn stock exchange listing and surveillance committee decided to terminate the trading of elmo rent as shares on the first north list effective from november 6 2024 this decision is based on various regulatory non compliance issues including deadlines with which we have faced challenges in ensuring compliance we recognize that this decision may raise questions and concerns among our shareholders and partners who have supported our efforts and growth elmo rent as deeply values the support of its shareholders and partners and we are confident that this step will allow us to focus on further developing the company and creating new investment opportunities e g venture capital investors who do not invest in publicly listed companies we kindly ask shareholders to send their contact details to investor elmorent ee so that we can keep you informed of important developments provide regular reports and maintain close communication with you
114,all_events,UP,DOWN,media release
8943,all_events,UP,,media release
5477,all_events,UP,,november 13 2024 16 05 et source alvotech alvotech iceland germany india u s iceland germany india u s alvotech nasdaq alvo or the company a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide today reported unaudited financial results for the first nine months of 2024 and provided a summary of recent corporate highlights we are delighted by the results in the quarter and the first nine months of 2024 the third quarter marked our second consecutive quarter with positive adjusted ebitda and operating profit not only did we see growth in product revenue compared to the previous quarter but we also experienced a more than doubling of product gross margins primarily due to improved utilization and scale at our manufacturing site said robert wessman chairman and ceo of alvotech we are also plea
5785,all_events,UP,,media release
230,all_events,UP,UP,11 nov 2024 11 49 cet oslo kommune oslo børs har mottatt søknad om børsnotering av isin no0013378877 markedsmisbruksforordningen mar gjelder fra søknadstidspunktet herunder låntagers informasjonsplikt om innsideinformasjon more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site oslo kommune oslo børs newspoint oslo komm 15 30 2 oslo komm 15 25 2 oslo komm 17 27 2 oslo komm 17 27 2 oslo komm 18 28 2 oslo komm 18 26 frn oslo komm 19 29 2 oslo komm 19 34 2 oslo komm 20 28 1 oslo komm 20 30 1 5 per cent oslo komm 20 26 1 20 per cent oslo komm 21 30 2 25 pct oslo komm 21 31 2 22pct oslo komm 21 29 2 17pct oslo komm 21 26 frn oslo komm 22 27 frn oslo komm 22 29 4 45pct oslo komm 22 32 4 45pct oslo komm 22 28 4 26pct oslo komm 23 33 3 70pct oslo komm 23 32 3 50pct oslo komm 23 28 4 oslo komm 23 31 4 oslo komm 24 34 4 oslo komm 24 29 3 9
5896,all_events,UP,,media release
5183,all_events,DOWN,,moonlake immunotherapeutics presents positive 12 week data from the phase 2 mira trial with nanobody sonelokimab for hidradenitis suppurativa at the european academy of dermatology and venereology congress
6913,all_events,UP,,19 nov 2024 17 45 cet vinci nanterre 19 november 2024 vinci autoroutes and vinci airports traffic in october 2024 i change in vinci autoroutes intercity networks traffic october ytd at the end of october 10 months change 2024 2023 change 2024 2023 vinci autoroutes 0 0 light vehicles 0 0 heavy vehicles 4 0 traffic was particularly buoyant in october for heavy vehicles which benefited from one additional working day compared with last year across all vehicle categories the contraction in traffic year to date has been reduced to 0 ii change in vinci airports passenger traffic1 october ytd at the end of october 10 months change 2024 2023 change 2024 2019 change 2024 2023 change 2024 2019 vinci airports 6 8 8 3 portugal ana 2 4 united kingdom 4 2 7 2 france
8960,all_events,DOWN,,media release
6649,all_events,UP,,today 12 november 2024 the subscription period begins in opticept technologies ab s publ opticept or the company rights issue of shares announced on 18 october 2024 the rights issue the subscription period runs until november 26 2024 please note that some banks and nominees may have an earlier deadline for subscription in the rights issue shareholders should therefore check with their bank or nominee whether they have an earlier response date for subscription of shares the rights issue in briefon october 18 2024 the board of directors of opticept communicated the rights issue in accordance with the following main terms and conditions prospectuscomplete terms and conditions for the rights issue and other information about the company are set out in the eu growth prospectus the prospectus published on 8 november 2024 the prospectus and subscription forms are available on the company s website www opticept se and on aqurat fondkommission s website www aq
214,all_events,UP,DOWN,management to host conference call and webcast at 4 30 p m et management to host conference call and webcast at 4 30 p m et
10152,all_events,UP,,media release
3433,all_events,DOWN,,latvia s transmission system operator jcs augstsprieguma tīkls ast has signed two agreements with the central finance and contracting agency cfla for the 73 24 million funding from the european union s eu recovery and resilience fund repowereu plan within the framework of the eu supported energy sector transformation ast will invest in the development of the electricity transmission network and the synchronisation of the baltic states with continental europe with the increase of equipment and material prices in the energy sector due to russia s invasion of ukraine the repowereu funding is a significant support for implementing ast transmission network investment projects these projects will contribute to achieving latvia s climate goals increasing the share of renewable energy and improving the security of the transmission network and electricity supply in the baltic region emphasized arnis daugulis a member of ast management board 60 34 million of the allo
2791,all_events,UP,,the u s food and drug administration fda granted orphan drug designation to pgn edodm1 for the treatment of myotonic dystrophy type 1 dm1 the u s food and drug administration fda granted orphan drug designation to pgn edodm1 for the treatment of myotonic dystrophy type 1 dm1
5514,all_events,UP,,11 nov 2024 08 12 cet dnb asset management as dnb obx er pr 11 11 2024 innløst med 1 700 000 andeler til kurs nok 124 334770 totalt utestående andeler vil etter innløsningen være 11 450 000 med vennlig hilsen for dnb asset management as helene eklund analyst dnb asset management as more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site dnb asset management as oslo børs newspoint dnb obx no0010257801 obxd oslo børs
696,all_events,UP,UP,attachments 10111330 pdf alma media 11 10 trades xlsx
10924,all_events,UP,,november 18 2024 06 23 et source djurslands bank a s djurslands bank a s fondsbørsmeddelelse 25 2024 djurslands bank offentliggjorde den 16 august 2024 et aktietilbagekøbsprogram på 35 mio kr dog med maksimalt 76 100 aktier aktietilbagekøbsprogrammet startede den 1 september 2024 og vil være afsluttet senest den 31 august 2025 aktietilbagekøbsprogrammet sker med henblik på nedsættelse af aktiekapitalen i banken med op til 25 mio kr samt etablering af medarbejderaktieordning med op til 10 mio kr programmet gennemføres i overensstemmelse med artikel 5 i eu kommissionens forordning nr 596 2014 af 16 april 2014 og eu kommissionens delegerede forordning nr 2016 1052 af 8 marts 2016 der tilsammen udgør safe harbour reguleringen under aktietilbagekøbsprogrammet er gennemført følgende transaktioner alle transaktioner er foretaget i isin dk0060136273 og gennemført af danske bank a s på vegne af banken yderligere oplysninger om tr
6991,all_events,DOWN,,media release
8430,all_events,UP,,san carlos calif may 01 2024 globe newswire iovance biotherapeutics inc nasdaq iova a biotechnology company focused on innovating developing and delivering novel polyclonal tumor infiltrating lymphocyte til therapies for patients with cancer will report its first quarter 2024 financial results on thursday may 9 2024 management will host a conference call and live audio webcast to discuss these results and provide a corporate update at 4 30 p m et
8765,all_events,DOWN,,media release
9959,all_events,DOWN,,november 07 2024 02 00 et source ignitis grupe ignitis grupe ab ignitis grupė hereinafter the group announces its financial calendar for 2025 including the dates of the general meetings of shareholders in addition the group expects to announce the strategic plan 2025 2028 in q2 2025 the group expects to announce its financial results at around 9 00 am vilnius 7 00 am london time on the above mentioned dates upon its publication the group will organize earnings calls for investors and analysts the group will inform about each earnings call separately through the stock exchanges the owners of global depositary receipts representing the group s ordinary registered shares hereinafter gdr should consider the specifics of gdr regulation market differences and consult with gdr issuer the bank of new york mellon link its authorized party or their securities manager regarding the timing of the right to receive dividends and
3065,all_events,DOWN,,06 nov 2024 18 00 cet cybergun télécharger la pièce jointe cette publication dispose du service actusnews security master security master key mzlsycznajedm5ycajttbwzmamzpxwwvl5xiywiemjmwb3grnjhozpwwznfpm2lt pour contrôler cette clé https www security master key com information réglementée rapports financiers et d audit semestriels examens réduits rapport semestriel euronext growth euronext accesscommuniqué intégral et original au format pdf https www actusnews com news 88647 2024 06_cyb_rapport financier semestriel 2024_v def pdf information réglementée rapports financiers et d audit semestriels examens réduits rapport semestriel euronext growth euronext access communiqué intégral et original au format pdf https www actusnews com news 88647 2024 06_cyb_rapport financier semestriel 2024_v def pdf 88647_fr0014004qr6 pdf cybergun actusnewswire cybergun fr0014004qr6 alcyb euronext growth
10143,all_events,UP,,new york aug 23 2024 globe newswire eyenovia inc eyenovia or the company nasdaq eyen a commercial stage ophthalmic company announced today the closing of its public offering of 12 850 000 shares of common stock at a price per share of 0 40 the offering
10295,all_events,DOWN,,eurobio scientific ouverture de l offre publique d achat jusqu au 27 novembre
5817,all_events,DOWN,,stockholm 15 november 2024 safello the leading cryptocurrency exchange in the nordics announces the election of åsa leander skålén to the board of directors of safello ab with extensive experience in both legal and compliance roles within the financial sector åsa brings invaluable insights as safello advances its regulatory roadmap including the upcoming markets in crypto assets mica application process åsa leander skålén has worked as a lawyer since 2003 serving in both business law firms and as in house legal counsel and compliance officer in 2013 she founded realjuridik i sverige ab a consultancy firm offering legal compliance and regulatory services to financial institutions across both traditional finance and the blockchain and crypto markets her expertise spans commercial contracts corporate law financial regulations and compliance complemented by her work as a lecturer in financial ethics regulations and compliance her knowledge of blockchain technology
10132,all_events,DOWN,,jupiter fla march 26 2024 globe newswire dyadic international inc dyadic or the company nasdaq dyai a global biotechnology company focused on building innovative microbial protein production platforms today announced the online publication of the manuscript filamentous fungus produced human monoclonal antibody provides protection against sars cov 2 in hamster and nonhuman primate models in nature communications springer nature an international journal publishing peer reviewed research in all fields of science and technology
3495,all_events,UP,,media release
9241,all_events,UP,,04 oct 2024 08 00 cest xplora technologies as as of september 30 2024 xplora technologies has 326k subscriptions a increase from september 2023 226k this quarter s highlight 66k new subscriptions gross premium services has surpassed 60k subscriptions we expect our churn rate to be consistent with historic numbers but now churning from a higher subscription base we expect a more moderate net growth in subscriptions note subscriptions encompass connectivity plans mobile subscriptions premium services b2b service revenues and service fees for xplora smartwatches without xplora mobile subscriptions nordics xplora has seasonal changes especially related to back to school and the festive season the net growth in the subscription base will therefore fluctuate throughout the year for further information please contact sten kirkbak ceo 47 92203710 sten kirkbak xplora com knut stålen cfo 47 92043458 knut stalen xplora com about
736,all_events,UP,DOWN,media release
12485,all_events,UP,,santa ana calif oct 11 2023 globe newswire nkgen biotech inc nasdaq nkgn nkgen or the company a clinical stage biotechnology company focused on the development and commercialization of innovative autologous allogeneic and car nk natural killer cell therapeutics today announced an upcoming poster presentation on an interim report of a phase i study of snk01 in patients with alzheimer s disease at the xxvi world congress of neurology wcn annual meeting to be held in montreal qc canada and online between october 15 19 2023
4191,all_events,DOWN,,san diego feb 05 2024 globe newswire ars pharmaceuticals inc nasdaq spry a biopharmaceutical company dedicated to empowering at risk patients and caregivers to better protect patients from severe allergic reactions that could lead to anaphylaxis today announced that new clinical data including efficacy outcomes supporting neffy epinephrine nasal spray will be presented during the 2024 american academy of allergy asthma and immunology aaaai the meeting will be held february 23 26 2024 in washington dc
3601,all_events,UP,,media release
10733,all_events,UP,,14 nov 2024 10 00 cet eutelsat communications l élargissement d un partenariat existant permettra aux entreprises et aux communautés d afrique australe de bénéficier de services de connectivité à haut débit et à faible latence le nouvel accord souligne les efforts déployés pour doter les régions mal desservies d un accès fiable à l internet regulatory news eutelsat group isin fr0010221234 euronext paris london stock exchange etl annonce la signature d un nouvel accord pluriannuel avec q kon acteur majeur dans la fourniture de solutions et de services satellitaires afin d étendre les services satellitaires en orbite terrestre basse leo à l ensemble de l afrique subsaharienne ce nouvel accord permettra d accélérer le déploiement de services de connectivité à haut débit et à faible latence pour les entreprises et les communautés situées dans les zones mal desservies du continent africain notamment en afrique australe l accord élargi qui vie
11681,all_events,DOWN,,tampa fla may 08 2024 globe newswire pacira biosciences inc nasdaq pcrx today announced that it intends to offer subject to market and other conditions 250 0 million aggregate principal amount of convertible senior notes due 2029 the notes in a private placement to qualified institutional buyers pursuant to rule 144a under the securities act of 1933 as amended the securities act pacira also intends to grant the initial purchasers of the notes an option to purchase for settlement within a period of 13 days from and including the date the notes are first issued up to an additional 37 5 million aggregate principal amount of notes
11166,all_events,DOWN,,first half sales performance in line with full year 2024 guidance
12649,all_events,DOWN,,media release
8972,all_events,DOWN,,12 nov 2024 08 00 cet beerenberg as not for release publication or distribution in whole or in part directly or indirectly into or within canada australia new zealand south africa hong kong japan or any other jurisdiction in which the release publication or distribution would be unlawful 12 november 2024 reference is made to the announcement made on 4 september 2024 by beerenberg as beerenberg or the company and altrad investment authority s a s altrad or the offeror regarding the issuance of an offer document the offer document and the start of the offer period the offer period for the board recommended unregulated voluntary cash offer to acquire all outstanding shares in the company the shares not already owned by the offeror the offer reference is also made to the announcement on 31 october 2024 where the offeror announced the final extension of the offer period the waiver of the minimum acceptance closing condition and a
11359,all_events,UP,,media release
3703,all_events,DOWN,,media release
7095,all_events,DOWN,,media release
8855,all_events,DOWN,,this announcement does not constitute or form part of any offer invitation to sell or issue or any solicitation of an offer to purchase or subscribe for any securities of akcinė bendrovė šiaulių bankas šiaulių bankas has successfully placed eur 50 million issue of fixed rate reset perpetual additional tier 1 temporary write down notes the annual fixed rate coupon on the notes up to the reset date will be 8 75 the nearest reset date is set after 5 years settlement will take place on 17 october 2024 it is intended to list the notes on the global exchange market multilateral trading facility operated by euronext dublin the notes have been allocated to almost 20 institutional and professional investors mostly from uk we have made another significant step for both the bank and the lithuanian capital market being the first issuer in the country to issue at1 notes we are grateful to our international investors who consistently show confidence in the bank s prospects this is
31,all_events,UP,DOWN,media release
11305,all_events,UP,,14 nov 2024 07 17 cet scor se communiqué de presse14 novembre 2024 n 17 résultats du troisième trimestre 2024 revue 2024 des hypothèses l h achevée ratio de solvabilité groupe de 203 bonne performance sous jacente du groupe au t3 2024 reflétant une très forte performance de p c avec un ratio combiné de 88 3 au t3 2024 et permettant le maintien d une politique de provisionnement disciplinéeune tendance positive de la performance sous jacente de l h avec un résultat des activités d assurance l h l h insurance service result 1 de eur 81 millions ajusté des éléments non récurrents2 ou de eur 210 millions sur une base publiéetaux de rendement courant des investissements élevé à 3 5 au t3 2024 ratio de solvabilité estimé du groupe de 203 3 au 30 septembre 2024 dans la plage de solvabilité optimale de 185 220 avec un impact additionnel négligeable de l achèvement de la revue des hypothèses l h et la mise en place d une solution de
1981,all_events,DOWN,UP,06 nov 2024 07 02 cet multiconsult asa multiconsult ose multi will today host its capital markets day at hotel continental starting at 09 15 cet the company will at the capital markets day present an update on its strategic ambitions sustainability and financial targets please find presentation attached multiconsult hereby invites you to the presentations and all participants are invited to attend in person programme and link to the webcast can be found below participants will have the opportunity to submit questions online throughout the webcast session prior to the presentation the company will present third quarter results 08 30 cet programme 08 15 doors open 08 30third quarter result 2024 09 15 10 30 capital markets day light lunch will be served around 10 30 capital markets day presentation 6 november 09 15 cet live webcast https channel royalcast com landingpage hegnarmedia 20241106_9 the presentations will be held in english by grethe
9923,all_events,UP,,waltham mass may 13 2024 globe newswire checkpoint therapeutics inc checkpoint nasdaq ckpt a clinical stage immunotherapy and targeted oncology company today announced that james oliviero president and chief executive officer will participate in a fireside chat at the h c wainwright 2nd annual bioconnect investor conference at nasdaq taking place on monday may 20 2024 at 12 30 p m et checkpoint will also attend in person one on one meetings during the conference
3635,all_events,UP,,geneva switzerland january 9 2024 addex therapeutics six and nasdaq adxn a clinical stage pharmaceutical company pioneering allosteric modulation based drug discovery and development today announced that dr robert lütjens head of discovery biology will present at the swiss equities baader conference being held in bad ragaz switzerland january 10 12 2024
4707,all_events,UP,,media release
8506,all_events,UP,,instalco today announced that it has entered into an agreement to invest in the german installation group fabri ag fabri the investment is made in newly issued shares and represents a minority stake of 24 per cent of the voting rights and capital in fabri after the capital increase the transaction is done to capitalise on the growth opportunities identified in the german installation market together with a local partner and with a long term plan to become the majority owner the consideration for the minority investment amounts to approximately eur 15 million of which approximately eur 13 million is to be paid in newly issued instalco shares and approximately eur 2 million is to be paid in cash fabri based in nuremberg currently employs 400 people in 12 subsidiaries across germany with an annual turnover of approximately eur 70 million the company is acquisition driven with a decentralised model and subsidiaries with specialist expertise in areas such as electricity heating
9603,all_events,DOWN,,06 nov 2024 09 42 cet veolia environnement regulatory news a l occasion du smart city world expo congress de barcelone veolia paris vie annonce un engagement à hauteur de 30m dans le fonds axeleo greentech industry gti i pour accélérer la transformation écologique industrielle en europe veolia s engage aux côtés de bpifrance et le crédit mutuel alliance fédérale pour ce 1er closing dédié au financement de la première usine des startups industrielles de la transformation écologique en europe ce fonds qui vise à lever 250 m offrira un soutien décisif à une vingtaine d entreprises qui développent des technologies innovantes dans des secteurs stratégiques essentiels à la transformation écologique en europe tels que l énergie nouvelles énergies renouvelables stockage etc la chimie les matériaux biomatériaux recyclage des plastiques etc l agriculture l alimentation et la mobilité décarbonation du transport aérien et du transport maritime etc
8513,all_events,UP,,media release
8193,all_events,UP,,13 nov 2024 08 50 cet ayfie international as oslo november 13 2024 ayfie international as ayfie ose aix has signed an agreement with total betong as a nationwide general contractor with projects along the entire norwegian coastline the agreement entails that total betong will install ayfie s complete platform including ayfie locator and ayfie personal assistant ai enabling all employees to use ai securely and directly on their data total betong is renowned for its expertise in aquaculture and concrete work and they develop and deliver all types of construction and infrastructure projects with projects ranging from finnmark in the north to kristiansand in the south they have a significant presence in norway among their prestigious projects are the world s largest land based aquaculture facility in rjukan and state of the art smolt facilities in salten from 2019 to 2023 total betong increased its revenue from 390 mnok to 1 16 billion nok while the t
8451,all_events,DOWN,,certara today unveiled its next generation coauthor regulatory writing software coauthor is an advanced writing platform designed for medical writers
7559,all_events,DOWN,,19 nov 2024 07 30 cet matvareexpressen as matvareexpressen satt ny omsetningsrekord i september 2024 3 kvartal som helhet hadde en omsetning på 91 1 millioner kroner mot 77 0 millioner kroner for samme kvartal i 2023 for resten av 2024 ser vi frem til å ta nye steg matvareexpressen fortsetter den gode organiske veksten antall kunder øker videre vi opprettholder målet om å nå en omsetning på over 400 millioner kroner i 2024 matvareexpressen får rekordomsetning i 4 kvartal 2024 3 kvartal 2024 hadde matvareexpressen as samlede inntekter på 91 132 992 kroner ebitda på 1 858 195 kroner et negativt resultat før skatt på 1 677 284 kroner 3 kvartal 2023 var tilsvarende tall samlede inntekter på 77 042 927 kroner ebitda på 2 098 604 kroner et resultat før skatt på 221 107 kroner for nærmere informasjon kontakt cfo gunnar gullaksen på gunnar gullaksen mve no matvareexpressen as er en inno
11582,all_events,UP,,media release
483,all_events,UP,UP,mdxhealth to present fourth quarter and full year 2023 financial results and corporate update on march 6
3958,all_events,DOWN,,media release
11564,all_events,UP,,media release
12776,all_events,DOWN,,media release
7894,all_events,DOWN,,achieved quarterly revenue growth compared to the prior year period achieved quarterly revenue growth compared to the prior year period
12951,all_events,DOWN,,november 11 2024 03 00 et source nokia oyj nokia oyj press releasenokia and fibertime expand broadband access across south africa s underserved communities 11 november 2024capetown south africa nokia today announced that fibertime will deploy its fiber solution to rapidly expand broadband access to underserved regions of south africa fibertime will quickly connect the next 1 5 million customers leveraging nokia s lightspan fx optical line terminals olts and wi fi 6 enabled optical network terminals onts nokia s technologies are key to enabling fibertime s flagship product r5 a day for uncapped unthrottled internet currently less than of south africans have access to high speed broadband leaving many reliant on costly mobile plans that are up to 70 times more expensive per gigabit than fiber through nokia s fiber solution fibertime will unlock a new wave of affordable reliable pay as you go broadband empowering local com
2820,all_events,DOWN,,management report real estate development in 2024 we are continuing the construction and sales activities of the last stage of kalaranna 8 tallinn the final stage consists of 4 residential buildings with 146 apartments and 4 commercial units which upon completion brings the total count of the buildings to 12 in q3 we are continuing with internal finishing works of the buildings and as per current conditions we are meeting the schedule deadlines we expect to deliver the first units from the first two buildings by the end of 2024 and complete the remaining two buildings by the first quarter of 2025 with respect to sales in kalaranna as of the publishing of this report we have reached ca threshold in presales and signed reservations we deem this a success in today s challenging market especially so when our location warrants above average pricing in kristiine city we have continued the sales and construction activities of our new project uus kindrali by the end of q
11179,all_events,UP,,media release
10126,all_events,UP,,irvine calif aug 29 2024 globe newswire biomerica inc nasdaq bmra today reported its financial results for the fiscal year ended may 31 2024 the company achieved a modest increase in net sales to 5 4 million compared to 5 3 million in the prior year this growth was primarily driven by strong demand for ez detect colorectal screening tests and aware breast self exam products in the middle east including the united arab emirates
8756,all_events,UP,,media release
8394,all_events,DOWN,,west lafayette ind jan 29 2024 globe newswire inotiv inc nasdaq notv the company or inotiv a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services today announced that it will issue its financial results for the fiscal 2024 first quarter ended december 31 2023 on wednesday february 7 2024 after the close of the stock market the company will host a conference call that same day at 4 30 p m eastern time to discuss the results
11285,all_events,DOWN,,san diego march 07 2024 globe newswire ars pharmaceuticals inc nasdaq spry a biopharmaceutical company dedicated to empowering at risk patients and caregivers to better protect patients from severe allergic reactions that could lead to anaphylaxis today hosted an investor event highlighting neffy epinephrine nasal spray an investigational new drug for the treatment of type i allergic reactions the event included presentations by members of the ars pharma management team and by two distinguished allergists dr jonathan spergel m d ph d and dr thomas b casale m d
5128,all_events,DOWN,,the management board of as ekspress grupp registry code 10004677 official address narva mnt 13 tallinn 10151 proposes to the shareholders to adopt resolutions without convening a meeting in accordance to 2991 of the commercial code the shareholders have the possibility to vote by e mail using a voting ballot which is added this notice on the website of nasdaq baltic stock exchange https nasdaqbaltic com as well as of ekspress grupp homepage http egrupp ee en the filled in and signed ballot and the documents enabling identification of the shareholder and proof the right of representation shall be sent by e mail at egrupp egrupp ee by no later than 31 october 2024 at 9 00 estonian time in accordance with the procedure specified below if a shareholder does not give notice of whether he is in favour of or opposed to the resolution during this term it shall be deemed that the shareholder has voted against the resolution the circle of shareholders entitled to adopt the
10561,all_events,UP,,08 nov 2024 07 20 cet itera asa utbyttebeløp 0 20 per aksje annonsert valuta nok siste dag inklusive 11 november 2024 ex dato 12 november 2024 record date eierregisterdato 13 november 2024 betalingsdato 6 desember 2024 vedtaksdato 7 november 2024 denne informasjonen offentliggjøres i henhold til kravene i løpende forpliktelser for mer informasjon bent hammer cfo 47 982 15 497 bent hammer itera com more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site itera asa oslo børs newspoint itera no0010001118 itera oslo børs
9683,all_events,UP,,18 nov 2024 07 00 cet lexibook linguistic elect sys chiffre d affaires lexibook s1 24 25 24 6m vs 22 2m 2 4m resultat d exploitation 2 5m 1 1m vs s1 23 24 en raison de depenses publicitaires accrues 1 2m et de changements de methode de comptabilisation de certaines provisions resultat net en retrait à 2 4m vs 3 1m en 23 24 sur le semestre le chiffre d affaires europe hors france est inchangé par rapport à la même période de l exercice précédent le chiffre d affaires france ressort en hausse de vs s1 23 24 le chiffre d affaires sur le reste du monde est en forte hausse notamment grâce à la croissance des ventes aux etats unis les revenus des produits sous licence progressent de les produits hors licence progressent aussi de les ventes de produits sous licence représentent les 2 3 du chiffre d affaires total une proportion cohérente avec les ventes de l exercice fiscal 2023 2024
5152,all_events,UP,,media release
4123,all_events,DOWN,,stockholm sweden november 6 2024 bioarctic ab publ nasdaq stockholm bioa b will publish the company s third quarter report for july september 2024 on thursday november 14 2024 at 08 00 a m cet in conjunction to the report bioarctic invites investors analysts and media to an audiocast with teleconference in english on november 14 at 09 30 cet where gunilla osswald ceo and anders martin löf cfo will present and comment on the third quarter report followed by a q a session if you wish to participate via webcast please use the link below via the webcast you will be able to ask written questions webcast https ir financialhearings com bioarctic q3 report 2024 register if you wish to participate via teleconference please register on the link below after registration you will be provided with phone numbers and a conference id to access the conference you can ask questions verbally via the teleconference https conference financialhearings com teleconf
11725,all_events,UP,,media release
299,all_events,UP,UP,g1 therapeutics and pepper bio announce global excluding asia pac license agreement for lerociclib
4786,all_events,DOWN,,13 nov 2024 18 12 cet atenor 2024 11 13 trading update q3 2024 pdf atenor euronext atenor be0003837540 ateb euronext
12422,all_events,DOWN,,tourmaline will be focused on advancing tour006 its differentiated anti il 6 antibody to treat thyroid eye disease ted atherosclerotic cardiovascular disease ascvd and other diseases
8644,all_events,UP,,stayble therapeutics ab stayble or the company announces positive results from the company s clinical phase 1b study in lumbar disc herniation ldh the study met its primary safety and tolerability endpoint additionally sta363 treated patients showed a statistically significant reduction in disc volume compared to placebo treated patients the study met its primary endpoint with an established favorable safety profile only a few adverse events ae and no sustained serious adverse events sae related to sta363 were recorded during the study data show a statistically significant volume decreasing effect compared to placebo already after 1 month with a maximum reached after 3 months with a sustained decrease at the 6 month follow up these results correlate with previously generated data from the phase 2b sta363 study in degenerative disc disease and add valuable insights regarding the onset of volume changes moreover the sta363 induced disc volume reduction is similar
2512,all_events,UP,DOWN,palo alto calif sept 05 2024 globe newswire scilex holding company nasdaq sclx scilex or company an innovative revenue generating company focused on acquiring developing and commercializing non opioid pain management products for the treatment of acute and chronic pain today announced the acceptance of a presentation at the 2024 american college of rheumatology convergence conference to be held at the walter e washington convention center in washington d c on november 14 19 2024
11695,all_events,DOWN,,06 nov 2024 17 51 cet byggma asa financial calendar for byggma asa financial year 2024 30 04 2025 annual report 07 11 2024 quarterly report q3 27 02 2025 quarterly report q4 financial year 2025 27 08 2025 half yearly report 27 05 2025 annual general meeting 15 05 2025 quarterly report q1 07 11 2025 quarterly report q3 this information is published pursuant to the requirements set out in the continuing obligations more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site byggma asa oslo børs newspoint byggma no0003087603 bma oslo børs
4046,all_events,DOWN,,11 nov 2024 11 30 cet norconsult asa sandvika 11 november 2024 ose norco nils morten huseby chair of the board in norconsult asa the company has today 11 november 2024 purchased 5 300 shares in the company at an average price per share of nok 39 following the transaction nils morten huseby holds a total number of 57 931 shares in the company for further information please contact investors elin spieler head of treasury and ir manager ir norconsult com this information is subject to the disclosure requirements in the market abuse regulation article 19 and section 5 12 of the norwegian securities trading act about norconsult norconsult is a leading pan nordic interdisciplinary consulting firm combining engineering architecture and digital expertise across projects of all sizes for private and public customers in infrastructure energy and industry buildings and architecture headquartered in sandvika norway norconsult s delivery model is
668,all_events,DOWN,DOWN,15 nov 2024 10 50 cet regulatory news the board of directors of somaïr met on 12 november 2024 and approved a motion to introduce protective measures which are essential for preserving the cash required to pay salaries and maintain the safety and integrity of industrial sites the board is requesting a temporary halt to expenditure related to mining and processing ore until such time as it resumes the export and sale of its products at this meeting of the board orano reaffirmed its commitment to somaïr employees by voting for a proposal to direct its remaining available cash reserves towards the payment of salaries and the upkeep of industrial sites vital functions for as long as possible the administrators representing sopamin left the meeting room during that vote choosing to abstain today somaïr is stifled by the debts accumulated by its shareholder sopamin and by its inability to export and obtain proceeds from the sale of its products even though
8908,all_events,DOWN,,châtillon france october 18 2024
6114,all_events,DOWN,,media release
6529,all_events,UP,,november 15 2024 02 30 et source aino health ab publ aino health ab publ aino avslöjar de främsta orsakerna till frånvaro på arbetet januari september 2024 juli september 2024 under det tredje kvartalet har vi fortsatt att stärka vår marknadsposition genom att säkra nya affärer och utöka vårt nätverk av kunder marknadsaktiviteten har varit lovande och vi ser en tydlig efterfrågan på våra tjänster och lösningar genom att kombinera vår expertis med våra partnerskap har vi kunnat skapa nya möjligheter för tillväxt och framgång antalet användare var oförändrat på grund av säsongsmässiga variationer i antalet anställda i våra kundorganisationer vi förväntar oss en ökning av antalet användare i takt med att nytecknade avtal implementeras och våra säsongsvarierade kunder går in i sin högsäsong för det kommande året ser vi möjlighet till tillväxt inom omsättning resultat och kassaflöde drivet av både de nya affärer vi redan har säkrat
2474,all_events,DOWN,DOWN,pursuant to section 30 of the danish capital markets act novonesis hereby announces that blackrock inc has notified novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments per november 11 2024 blackrock inc has adjusted its holding of shares to an equivalent of 23 180 630 shares corresponding to 4 previously 5 of the total share capital attached to shares the combined total of share capital attached to shares and share capital through financial instruments is 5 previously 5 attachments attachments 2024_46_major_shareholders_announcement pdf novozymes b 11 nov 2024 final pdf
10932,all_events,DOWN,,media release
3080,all_events,UP,,12 nov 2024 07 30 cet exosens s a communiqué de pressemérignac france 12 novembre 2024 laurent sfaxi est nommé directeur des relations investisseurs d exosens exosens annonce la nomination de laurent sfaxi en tant que directeur des relations investisseurs au sein de la direction financière du groupe dirigée par quynh boi demey cfo il s agit d une fonction créée à la suite de l introduction en bourse d exosens en juin 2024 m sfaxi qui dispose de plus de 20 ans d expérience dans le domaine de la communication financière et des relations investisseurs apportera ainsi son expertise dans ce poste stratégique pour renforcer les liens d exosens avec les actionnaires les analystes financiers et les investisseurs du groupe nous sommes ravis d accueillir laurent au sein d exosens son expérience et son expertise sont des atouts majeurs pour accompagner les ambitions de croissance de notre groupe dans sa nouvelle phase de développement la présence de laurent est do
10279,all_events,UP,,missing
303,all_events,UP,DOWN,redwood city calif aug 27 2024 globe newswire rezolute inc nasdaq rzlt rezolute or the company a late stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism hi today announced that management will participate in the following investor conferences
6874,all_events,DOWN,,this message has been corrected click here to view the corrected message vilnius lithuania 2024 10 16 12 41 cest omx baltic benchmark fund share price on october 15 2024 13 1336 eur omx baltic benchmark fund number of shares issued on october 15 2024 0 units omx baltic benchmark fund number of shares redeemed on october 15 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of october 15 2024 125 362 units nter asset management
8864,all_events,DOWN,,tallinn estonia 2024 10 17 10 40 cest nasdaq tallinn decided on october 17 2024 to apply an additional reason for applied observation status to silvano fashion group shares sfg1t isin code ee3100001751 based on the clause 3 5 4 7 of chapter supervision of the rules and regulations supervision rules based on the clause 3 8 2 of requirements for issuers chapter of the rules and regulations the issuer is obligated to immediately disclose information about all precepts issued by supervisory authorities concerning them on october 7 the estonian financial supervision and resolution authority issued a precept to as silvano fashion group about which the issuer has not disclosed a market announcement despite the exchange s demand the observation statuses applied to the company on may 7 2024 and march 1 2022 are also still in force the purpose of applying observation status is to alert the market participants nasdaq baltic issuer services 372 640 88
1018,all_events,DOWN,DOWN,november 18 2024 05 57 et source pandora a s pandora a s on 7 february 2024 pandora announced a new share buyback programme cf company announcement no 843 the share buyback programme is executed in accordance with regulation eu no 596 2014 of the european parliament and of the council of 16 april 2014 on market abuse market abuse regulation the purpose of the programme is to reduce pandora s share capital and to meet obligations arising from company incentive programmes under the programme pandora will repurchase shares for an aggregate maximum amount of dkk 4 0 billion from 8 february 2024 until 31 january 2025 at the latest both days inclusive the first tranche of dkk 1 3 billion concluded on 11 june 2024 while the second tranche of dkk 1 3 billion was completed on 27 september 20
3404,all_events,UP,,media release
7601,all_events,UP,,19 nov 2024 20 47 cet danone danone société anonyme à conseil d administration au capital de 169 888 497 75 siège social 17 boulevard haussmann 75009 paris 552 032 534 r c s paris informations relatives au nombre total de droits de vote et d actions prévues par l article l 233 8 ii du code de commerce et l article 223 16 du règlement général de l autorité des marchés financiers datenombre d actionsnombre total de droits de vote31 10 2024679 553 991nombre de droits de vote théoriques 1 699 095 232nombre de droit de votes exerçables 2 663 690 530 1 le nombre de droits de vote théoriques ou droits de vote bruts sert de base de calcul pour les franchissements de seuils conformément à l article 223 11 du règlement général de l amf ce nombre est calculé sur la base de l ensemble des actions auxquelles sont attachés des droits de vote y compris les actions privées de droit de vote 2 le nombre de droits de vote exerçables ou droits de vote nets
12516,all_events,UP,,media release
8617,all_events,UP,,diagonal bio today announces that the nomination committee has been appointed in preparation for the annual general meeting agm on may 20 2025 according to the instruction for the nomination committee adopted by the agm in 2024 the nomination committee for the diagonal bios agm 2025 shall consist of four members representing the three largest shareholders on september 30th together with the chairman of the board if a shareholder does not exercise its right to appoint a member entitlement to appoint a member of the nomination committee transfers to the shareholder who is the next largest shareholder in terms of voting rights based on the above the nomination committee for the agm 2025 has been established to consist of the following persons the company shall publish the names of the nomination committee members at least six months before the annual general meeting if within two months of the annual general meeting a shareholder s voting power exceeds that of the shar
9307,all_events,UP,,san carlos calif march 22 2024 globe newswire iovance biotherapeutics inc nasdaq iova iovance or the company a biotechnology company focused on innovating developing and delivering novel polyclonal tumor infiltrating lymphocyte til therapies for patients with cancer today announced that on march 22 2024 the date of grant the company approved the grant of inducement stock options covering an aggregate of 97 700 shares of iovance s common stock to twenty new non executive employees
7991,all_events,UP,,lund november 13 2024 active biotech nasdaq stockholm acti today announced that the us patent office uspto has issued a notice of allowance for active biotech s patent application related to methods of treating eye diseases associated with excessive vascularization using laquinimod the patent which was filed under application no 17 939 109 will provide protection and market exclusivity in this field of use until 2040 this us patent is a result of our continued work with our laquinimod patent portfolio to optimize protection for its use in eye diseases with high medical need said active biotech s ceo helén tuvesson the patent covers the medical use of laquinimod for treatment of sight threatening eye disorders e g wet age related macular degeneration wet amd corneal neovascularization choroidal neovascularization proliferative diabetic retinopathy retinopathy of prematurity and ischemic retinopathy in the eu active biotech has already been granted patent right
5504,all_events,DOWN,,expects to complete enrollment of the 400 participant sentinel cohort for the covid 19 phase 2b study in november 2024
11913,all_events,UP,,12 nov 2024 17 45 cet lagardere s a see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1297213_rachat_dactions_cp_hebdomadaire__041124_au_081124__fr pdf lagardere les echos lagardere sa fr0000130213 mmb euronext
11065,all_events,UP,,06 nov 2024 12 58 cet sparebank 1 helgeland det er fastsatt ny obligasjonsrente for no0013176628 ny obligasjonsrente i renteperioden 08 11 2024 10 02 2025 er 5 68 ticker helg60 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631405_43f9b26898d842e6b9c4f9a1a120f470 pdf sparebank 1 helgeland oslo børs newspoint sparebank 1 helgeland helgeland spb 20 25 frn spb 1 helgeland 21 26 1 88 pct spb 1 helgeland 21 perp frn c hybrid spb 1 helgeland 21 26 frn spb 1 helgeland 21 27 frn spb 1 helgeland 23 33 frn c sub spb 1 helgeland 23 34 frn sub spb 1 helgeland 23 28 5 spb 1 helgeland 24 29 frn spb 1 helgeland 24 30 frn spb 1 helgeland 24 35 adj c sub no0010029804 no0010890973 no0011013104 no001109
9375,all_events,DOWN,,needham mass april 11 2024 globe newswire candel therapeutics inc candel or the company nasdaq cadl a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer today announced that the u s food and drug administration fda has granted orphan drug designation to can 2409 candel s most advanced multimodal biological immunotherapy candidate for the treatment of pancreatic cancer
4630,all_events,UP,,media release
6329,all_events,UP,,18 nov 2024 17 52 cet vinci nanterre november 18th 2024 disclosure of transactions in own shares from november 11th to november 15th 2024 within the framework of the authorization granted by the general meeting of vinci sa of april 09 2024 to trade in its shares and in accordance with the regulations relating to share buybacks vinci sa lei 213800wfq334r8uxug83 declares the purchases of treasury shares below fr0000125486 carried out from november 11th to november 15th 2024 i aggregate presentation by day and by market issuer s namedate of transactionidentifying code of financial instrumentaggregated daily volume in number of shares daily weighted average price of the purchased shares in euromarket mic code vinci11 11 2024fr000012548659 477101 43086xparvinci11 11 2024fr000012548631 354101 43106ceuxvinci11 11 2024fr000012548612 234101 39919tqexvinci12 11 2024fr000012548692 179100 95238xparvinci12 11 2024fr000012548644 091101 05492ceuxvinc
1791,all_events,DOWN,DOWN,06 nov 2024 08 33 cet credit agricole assurances release paris november 6th 2024 steady growth across all our business lines 9m 2024 key figures total revenue1 of 32 8 billion euros up 18 2net inflows of 4 2 billion euros of which 1 1 billion on the general accountcontribution to crédit agricole s a s net income group share2 of 1 466 million euros up 11 2 these new interim results confirm the momentum already seen in the 1st half of last year in all our business lines both in france and internationally these results are driven by the commitment of crédit agricole assurances teams and our partner banks a commitment to serving our customers that is currently particularly expressed through the handling of the damages caused by storms kirk and leslie in an uncertain economic and geopolitical environment these results illustrate the increased need for protection expressed by our customers as reflected in the i
3706,all_events,DOWN,,single infusion of anx005 30 mg kg met primary endpoint delivering a highly statistically significant and clinically meaningful 2 4 fold improvement in gbs ds vs placebo at week 8 p 0 0058
2054,all_events,UP,DOWN,november 15 2024 01 35 et source ab novaturas ab novaturas baltijos šalių turizmo rinkos lyderė novaturo grupė spalio mėnesį uždirbo 26 1 mln eurų pajamų o tai 5 proc daugiau nei 2023 m spalį kai jos siekė 24 9 mln eurų bendrovė aptarnavo 28 tūkst klientų o pernai tokiu metu 30 tūkstančių pajamų augimą lėmė sėkmingai įvykdyta kelionių krypčių diversifikacija didėję išankstiniai pardavimai ir skrydžių į tolimuosius kraštus apimtys be to spalį bendrovei pavyko užtikrinti teigiamus finansinius rezultatus daugelyje siūlomų krypčių bei pasiekti itin aukštą lėktuvų užpildymo procentą iš viso 2024 m sausio spalio mėn bendrovė fiksuoja 178 5 mln eurų pajamų ir 220 tūkst klientų atitinkamu laikotarpiu 2023 m pajamos siekė 191 7 mln eurų o klientų skaičius 240 tūkstančių pirmaisiais rudens mėnesiais stebime teigiamą tendenciją kaip jau skelbėme rugsėjis buvo pelningas o spalis antras iš eilės efektyvus bei finan
4851,all_events,UP,,attachments 11147919 pdf alma media 14 11 trades xlsx
12267,all_events,DOWN,,07 nov 2024 18 00 cet bonduelle bonduelle siège social la woestyne 59173 renescure francebonduelle sca société en commandite par actions au capital de 57 102 699 50 eurosrcs dunkerque 447 250 044 chiffre d affaires du 1er trimestre 2024 2025 1er juillet 30 septembre 2024 stabilité du chiffre d affaires et croissance des activités à marques sur le 1er trimestre confirmation de l objectif annuel de chiffre d affaires et de résultat opérationnel courant le chiffre d affaires du 1er trimestre de l exercice 2024 2025 du groupe bonduelle du 1er juillet au 30 septembre 2024 s établit à 567 2 millions d euros soit une quasi stabilité à 0 4 en données comparables et 0 2 en données publiées par rapport au 1er trimestre de l exercice précédent au delà de la stabilité du chiffre d affaires sur la période les activités à marques du groupe au cœur du programme de transformation transform to win présenté le 7 octobre dernier affichent une croissance de
6876,all_events,DOWN,,media release
11440,all_events,UP,,november 11 2024 16 57 et source det østasiatiske kompagni a s det østasiatiske kompagni a s københavn 11 november 2024 i henhold til artikel 19 i eu regulativ nr 596 2014 af 16 april 2014 skal det østasiatiske kompagni a s indberette oplysninger om ledende medarbejderes og disses nærtståendes transaktioner med det østasiatiske kompagni a s aktier og tilknyttede værdipapirer detaljer fremgår af vedhæftede med venlig hilsen det østasiatiske kompagni a s for yderligere informationkresten m valdal ceo telefon 45 8233 4044 e mail investorinformation eac dk vedhæftet fil
11329,all_events,UP,,november 07 2024 01 00 et source merko ehitus as merko ehitus as juhtkonna kommentaar merko ehituse 2024 aasta 9 kuu müügitulu oli 379 miljonit eurot ja puhaskasum 44 8 miljonit eurot kolmanda kvartali müügitulu oli 175 miljonit ja puhaskasum 27 3 miljonit eurot ehitusteenuste müük moodustas 9 kuu müügitulust pea merko ehituse juhtkonna sõnul kiirendati tellijate soovil mõne objekti ehitust mis suurendas jooksvalt kontserni ehitusmahtusid aitas vähendada kulusid ja tõsta efektiivsust sellest tulenevalt lõpetas merko 9 kuud kavandatust tugevama tulemusega kontserni ettevõtted jõudsid lõpusirgele mitme suure ja keerulise objektiga sealhulgas merko ajaloo suurima ehitusobjekti arteri kvartaliga mille 150 miljoni euro suurusest mahust on ligi valmis arteri üks hoone on valmis teise sisetööd on lõpusirgel ning kõrgeimas hoones sisetööd jätkuvad merko ehituse juhtkonna sõnul on kontserni ettevõtted olnud konservatiivsed kulude pr
9199,all_events,UP,,media release
1068,all_events,DOWN,DOWN,november 19 2024 01 30 et source sampo oyj sampo oyj sampo oyj pörssitiedote 19 11 2024 klo 8 30 sampo oyj n omien osakkeiden ostot 18 11 2024 sampo oyj y tunnus 0142213 3 lei 743700uf3rl386wida22 on hankkinut omia a osakkeitaan isin koodi fi4000552500 omistukseensa 18 11 2024 seuraavasti kahden desimaalin tarkkuuteen pyöristettynä sampo ilmoitti 17 6 2024 enintään 400 miljoonan euron suuruisen omien osakkeiden osto ohjelman käynnistämisestä markkinoiden väärinkäyttöasetuksen eu 596 2014 mar ja euroopan komission delegoidun asetuksen eu 2016 1052 mukaisesti sampo oyj n hallitus päätti 16 9 2024 kasvattaa omien osakkeiden osto ohjelmaa 475 miljoonaan euroon 18 6 2024 aloitetulla osto ohjelmalla on sammon varsinaisen yhtiökokouksen 25 4 2024 myöntämä valtuutus sammon omistuksessa on nyt ilmoitettujen transaktioiden jälkeen 10 902 324 sammon a osaketta mikä on 1 98 prosenttia sampo oyj n kaikista
8151,all_events,UP,,santa ana calif aug 22 2024 globe newswire nkgen biotech inc nasdaq nkgn nkgen or the company today announced it received a standard notice the notice on august 20 2024 from the listing qualifications department of the nasdaq stock market nasdaq stating that the company is not in compliance with nasdaq listing rule 5250 c 1 the rule because it had not timely filed its quarterly report on form 10 q for the period ended june 30 2024 the form 10 q with the securities and exchange commission the sec on or before august 19 2024 the extended period provided for the filing under rule 12b 25 b of the securities exchange act of 1934 as amended the delay is in part due to the recent change in the company s independent registered public accounting firm and its valuation firm the notice indicated that the company has 60 calendar days or until october 21 2024 to submit a plan to regain compliance and that nasdaq can grant an exception of up to 180 calendar days from the form 10 q due date or until february 18 2025 to regain compliance the notice from nasdaq has no immediate effect on the listing or trading of the company s common stock on the nasdaq global market
9803,all_events,UP,,8 november 2024 lund sweden the board of directors of dug foodtech ab publ dug foodtech or the company has today november 8 by virtue of authorization granted by the extraordinary general meeting on october 15 2024 resolved on a directed set off issue of 20 595 384 shares at a subscription price of sek 0 34 per share the set off issue of the issued shares 19 536 561 shares are directed to lenders and 1 058 823 shares to a guarantor in the recently completed rights issue for which the company announced the outcome on november 6 the rights issue payment will be made through set off against the company s debt consisting of the respective loan amounts of the lenders totaling approximately sek 6 6 million and the guarantor s claim for guarantee compensation of sek 0 36 million the subscription price in the set off issue corresponds to the subscription price in the rights issue the purpose of the set off issue and the reason for deviating from shareholders
5218,all_events,DOWN,,media release
7917,all_events,UP,,dallas oct 14 2024 globe newswire spectral ai inc nasdaq mdai spectral ai or the company an artificial intelligence ai company focused on medical diagnostics for faster and more accurate treatment decisions in wound care today announced that the company s founder dr j michael dimaio has been named chairman of the board of directors
8317,all_events,UP,,norwood mass nov 12 2024 globe newswire corbus pharmaceuticals holdings inc nasdaq crbp corbus or the company today announced that yuval cohen ph d chief executive officer of corbus will participate in a fireside chat and one on one investor meetings at the jefferies london healthcare conference to be held november 19 21 2024 in london uk
12510,all_events,DOWN,,new york june 28 2024 globe newswire tiziana life sciences ltd nasdaq tlsa tiziana or the company a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to active neuroinflammatory processes today announced that it had received non dilutive funding of 3 4 million and issued a corporate update video available here
11709,all_events,DOWN,,this message has been corrected click here to view the corrected message from october 7th 2024 10 00 eest as citadele banka bonds offer subscription process is launched the subscription process closing date is october 10th 2024 15 30 eest up to 3 500 bonds are being offered to qualified investors in latvia and estonia as well as elsewhere in the eea the price of one security is fixed at eur 10 000 or of the nominal amount of the security note the minimum investment amount is eur 100 000 10 bonds the interest rate of the bonds is 5 per cent per annum the bonds are registered in the nasdaq csd under the isin code lv0000804334 the subscription offer will be carried out using the stock exchange trading system market rse equities ipo genium inet trading system order book lv0000804334 cblbbond the auction period during which the order collection will take place is october 7th 2024 from 10 00 until 16 00 october 8th october 9th 2024 from
12740,all_events,UP,,media release
7444,all_events,UP,,media release
2055,all_events,DOWN,DOWN,media release
11169,all_events,UP,,radnor pa nov 05 2024 globe newswire mineralys therapeutics inc nasdaq mlys a clinical stage biopharmaceutical company focused on developing medicines to target hypertension chronic kidney disease ckd and other diseases driven by dysregulated aldosterone today announced that management will be participating in fireside chats at three upcoming investor conferences
7628,all_events,UP,,18 nov 2024 07 00 cet ipsen ipsen met en avant 3 nouvelles présentations ainsi que 8 abstracts dans le cadre de son portefeuille de maladies cholestatiques rares du foie au congrès 2024 de l aasld paris france le 18 novembre 2024 ipsen euronext ipn adr ipsey annonce aujourd hui la présentation de données lors du congrès de l american association for the study of liver diseases aasld évaluant l efficacité et le profil de tolérance à long terme de bylvay chez les patients traités dans le cadre de deux études d extension ouvertes de phase iii avec un abstract comportant de nouvelles données n 5045 sur pedfic 2 dans la cholestase intrahépatique familiale progressive cifp et une présentation orale sur assert ext n 50 dans le syndrome d alagille sag des données révélant une efficacité soutenue et une amélioration des mesures de la taille du poids et du sommeil ont été observées chez les patients traités par bylvay pendant au moins 72 semaines dans les deu
4122,all_events,UP,,evaluating a number of opportunities to diversify pipeline in precision oncology
5044,all_events,UP,,interim results in mss crc suggest that safebody precision masking technology enables a new standard for anti ctla 4 therapy at higher more frequent and repeat doses by overcoming longtime safety limited efficacy challenges with this proven immunotherapy target
12633,all_events,DOWN,,november 07 2024 03 33 et source sveriges riksbank sveriges riksbank pre announcement of certificate auction tender monetary policy meeting 2024 11 06 auction periods commencing 2024 11 13 fixed rate 2 75 valid until next monetary policy meeting deposit rate 2 65 lending rate 2 85
2984,all_events,DOWN,,aktia bank plcstock exchange release 8 november 2024 at 10 00 a m aktia bank plc managers transactions anssi huhta person subject to the notification requirementname huhta anssiposition other senior managerissuer aktia bank plclei 743700gc62jlhfbund16notification type initial notificationreference number 743700gc62jlhfbund16_20241106115439_210____________________________________________ transaction date 2024 11 06venue not applicableinstrument type shareisin fi4000058870nature of the transaction subscription transaction details 1 volume 2 067 unit price 8 36 eur aggregated transactions 1 volume 2 067 volume weighted average price 8 36 eur aktia bank plc further information oscar taimitarha director investor relations tel 358 40 562 2315 ir at aktia fi distribution nasdaq helsinki ltdmass mediawww aktia com aktia is a finnish asset manager bank and life insurer that has been creating wealth and wellbeing from one generation to the next for 200 years we
11899,all_events,UP,,san carlos calif march 04 2024 globe newswire iovance biotherapeutics inc nasdaq iova a commercial biotechnology company focused on innovating developing and delivering novel polyclonal tumor infiltrating lymphocyte til therapies for patients with cancer today announced that the u s food and drug administration fda lifted a partial clinical hold placed on the registrational iov lun 202 trial investigating ln 145 til cell therapy in non small cell lung cancer nsclc in collaboration with the fda and an independent data monitoring committee iovance developed additional safety measures and monitoring upon reviewing this proposal the fda has cleared iovance to resume patient enrollment in iov lun 202
12179,all_events,DOWN,,sampo plc managers transactions 8 november 2024 at 12 30 pm eet sampo plc managers transactions mäkinen sampo plc business code 0142213 3 has received the following notification under article 19 of the market abuse regulation shares have been acquired in accordance with the decision of sampo s annual general meeting on 25 april 2024 ____________________________________________ person subject to the notification requirement name antti mäkinen position member of the board deputy member issuer sampo plc lei 743700uf3rl386wida22 notification type initial notification reference number 84082 7 7 ____________________________________________ transaction date 2024 11 07 venue nasdaq helsinki ltd xhel instrument type share isin fi4000552500 nature of transaction receipt of a share based incentive transaction details 1 volume 1 540 unit price 40 35 eur aggregated transactions 1 volume 1 540 volume weighted average price 40 35 eur ______________________________
8625,all_events,DOWN,,15 nov 2024 08 15 cet af gruppen asa vedlagt følger presentasjonen som holdes via webcast 15 november 2024 kl 08 30 link til webcast https channel royalcast com hegnarmedia hegnarmedia 20241115_2 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632344_afg q3 24 no pdf af gruppen asa oslo børs newspoint af gruppen no0003078107 afg oslo børs
4655,all_events,DOWN,,15 nov 2024 17 45 cet renault regie nat des usines communiqué de presse15 novembre 2024 information sur la date de la prochaine assemblée générale des actionnaires de renault s a boulogne billancourt 15 novembre 2024 renault s a informe ses actionnaires que la prochaine assemblée générale annuelle des actionnaires est prévue le mercredi 30 avril 2025 cette date sera confirmée par le conseil d administration de la société qui en février 2025 convoquera cette assemblée générale le calendrier complet des prochaines publications financières de la société est disponible sur son site internet https www renaultgroup com renault grouprelations investisseursphilippine de schonenphilippine de schonen renault com 33 0 6 13 45 68 39 renault group relations mediasvalérie gillot 33 6 83 92 92 96valerie gillot renault comrié yamane 33 6 03 16 35 20rie yamane renault com à propos de renault group renault group est aux avant postes d une mobilité qui se réinvente fort d
10587,all_events,UP,,19 nov 2024 07 00 cet axactor asa oslo 19 november 2024 axactor asa axactor ose acr has entered into an accretive eur 83 million sale of npl portfolios in spain in parallel the company announces an anticipated negative revaluation of the remaining portfolios for the fourth quarter 2024 axactor has entered into a binding agreement to sell npl portfolios for a total of eur 83 million representing a premium over book value the transaction represents approximately of axactor s total npl portfolio and the proceeds from the transaction will be used to reduce debt the positive impact on cash metrics such as cash ebitda is significant supporting covenant compliance for at least the next four quarters we believe this transaction demonstrates axactor s commitment to enhancing financial stability while navigating challenging market conditions this strategic sale not only supports covenant compliance but also provides flexibility to manage our portfolio
3819,all_events,DOWN,,farmington hills mich feb 23 2024 globe newswire ocuphire pharma inc nasdaq ocup ocuphire a clinical stage ophthalmic biopharmaceutical company focused on developing and commercializing small molecule therapies for the treatment of retinal and refractive eye disorders today announced that george magrath m d m b a m s ceo of ocuphire will be presenting a company overview at the bio ceo investor conference being held february 26 27 2024 in new york city company management will also be participating in one on one meetings throughout the conference
6839,all_events,UP,,10 oct 2024 08 00 cest poujoulat informations relatives au nombre total de droits de vote et d actions au 30 septembre 2024 informations relatives au nombre total de droits de vote et d actions prévues par l article l 223 8 ii du code de commerce et l article 222 12 5 du règlement général de l autorité des marchés financiers date nombre d actions composant le capital nombre de droits de vote droit exerçable droit théorique 31 01 2024 7 836 000 12 983 809 12 992 812 29 02 2024 7 836 000 12 982 778 12 991 912 31 03 2024 7 836 000 12 983 581 12 991 912 30 04 2024 7 836 000 12 983 125 12 991 912 31 05 2024 7 836 000 12 981 951 12 991 062 30 06 2024 7 836 000 13 004 278 13 013 766 31 07 2024 7 836 000 13 004 505 13 013 566 31 08 2024 7 836 000 13 004 491 13 013 658 30 09 2024 7 836 000 13 003 192 13
11288,all_events,DOWN,,lexington mass aug 01 2024 globe newswire t2 biosystems inc nasdaq ttoo a leader in the rapid detection of sepsis causing pathogens and antibiotic resistance genes today announced plans to participate in two upcoming investor conferences in august 2024
2122,all_events,UP,DOWN,14 nov 2024 17 38 cet neoen s a see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1298003_cp_2024_11_14_neoen_cre_solaire_vf pdf neoen sa les echos neoen fr0011675362 neoen euronext
5601,all_events,UP,,san francisco june 29 2023 globe newswire vir biotechnology inc nasdaq vir today announced the appointment of sasha damouni ellis as executive vice president and chief corporate affairs officer effective july 10 2023 ms damouni ellis will be responsible for the company s strategic approach to corporate communications government affairs investor relations and patient advocacy as well as for establishing vir s corporate social responsibility and environmental social and governance efforts she will report to vir s chief executive officer marianne de backer m sc ph d mba and will join the company s executive management team
9893,all_events,UP,,west lafayette ind aug 28 2024 globe newswire inotiv inc nasdaq notv a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services announced today that robert leasure jr inotiv s president and chief executive officer and beth taylor chief financial officer will participate in the 8th annual lake street best ideas growth conference on thursday september 12 2024 in new york city
4429,all_events,UP,,november 11 2024 03 00 et source ekspress grupp ekspress grupp argo virkebau the chairman of the management board and ceo of as delfi meedia the subsidiary of as ekspress grupp will leave the company at his own request on december 31 2024 argo virkebau has been working as ceo and the chairman of the management board at delfi meedia since 2018 the supervisory board of as delfi meedia is thankful to argo virkebau for his long term contribution to the management and growth of the media company the supervisory board of as delfi meedia has elected erik heinsaar the long time ceo of as õhtuleht kirjastus as a new member of the management board until december 31 2027 erik heinsaar will be acting as a ceo of as delfi meedia starting from january 1 2025 the management board of as delfi meedia will be as follows erik heinsaar chairman of the board piret põldoja sander maasik tarvo ulejev erle laak sepp and urmo soonvald the supe
4462,all_events,UP,,18 nov 2024 14 26 cet amundi physical metal plc amundi physical metals plc glda amundi physical metals plc final terms 18 nov 2024 14 26 cet cest final terms final terms dated 15 november 2024 amundi physical metals plc etc securities of amundi physical gold etc issued under its secured precious metal linked etc securities programme the etc securities issue of 50 000 00 etc securities being tranche 617 of amundi physical gold etc specified in these final terms part a contractual terms terms used herein shall be deemed to be defined as such for the purposes of the conditions set forth in the base prospectus dated 20 may 2019 as supplemented by the supplement to the base prospectus dated 4 march 2020 this document constitutes the final terms of the etc securities described herein for the purposes of article 8 4 of the prospectus regulation regulation eu 2017 1129 the prospectus regulation and must be read in conjunction with the base prospectu
420,all_events,UP,DOWN,generated 1q 2024 net furoscix revenue of 6 1 million despite an estimated impact to doses filled resulting from the change healthcare cyberattack
3954,all_events,DOWN,,as prfoods announces that aavo kokk has submitted his resignation from the position of a member of the supervisory board of as prfoods effective from october 21 2024 aavo kokk will also step dwown as the chairman of the audit committee the company would like to express their gratitude to aavo for his dedication and contributions during his tenure kristjan kotkasas prfoodsmember of the management boardinvestor prfoods eewww prfoods ee
12429,all_events,DOWN,,media release
10171,all_events,UP,,company is on track with ongoing repeat dose study under allergen induced allergic rhinitis conditions requested by u s fda with topline data expected in q1 2024
1047,all_events,UP,DOWN,19 nov 2024 10 03 cet lokotech group as powerpool mining sl convened a board meeting today during which the board of directors approved an expanded mandate for the ceo to take on greater price exposure risk through tactical allocation between cryptocurrencies for the entity s free funds the decision was driven by several key factors november is projected to set a record monthly performance for the pools operation the past week saw a new daily net revenue record of 130 945 nok current market conditions including high price volatility price discrepancies across exchanges record hash rates all time high cryptocurrency prices and significant user growth make tactical allocation between select coins particularly attractive the company will not inform the market until a new daily record beats the previous record by a large margin readers are reminded that daily net revenue fluctuates and that a record daily revenue should not be read as an indication
856,all_events,UP,UP,achieved increase in total revenue compared to prior year period achieved increase in total revenue compared to prior year period
8493,all_events,DOWN,,media release
6170,all_events,DOWN,,14 nov 2024 10 40 cet spotlio as 14 11 2024 10 40 18 cet spotlio as additional regulated information required to be disclosed under the laws of a member state oslo 14 november 2024 an extraordinary general meeting of spotlio as was held on 14 november 2024 at 10 00 cet please find the minutes of the meeting attached disclosure regulation this information is subject to the disclosure requirements pursuant to euronext growth oslo rule book part ii item 3 10 1 no 8 and item 3 15 5 contacts albert ferrando ceo spotlio as 34 932 20 35 45 albert ferrando spotlio com james price cfo spotlio as 34 972 001 021 james price spotlio com about spotlio as spotlio as is a trailblazing force in destination digital technology offering tailor made solutions from apps to e commerce and almost everything in between that redefine the way consumers interact with resorts parks and attractions with a decade long legacy of excellence spotlio
1669,all_events,UP,UP,vilnius lithuania 2024 11 12 11 03 cet omx baltic benchmark fund share price on november 11 2024 12 8744 eur omx baltic benchmark fund number of shares issued on november 11 2024 0 units omx baltic benchmark fund number of shares redeemed on november 11 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of november 11 2024 125 362 units nter asset management
9961,all_events,UP,,kesko corporation stock exchange release 11 11 2024 at 16 30 kesko corporation has on 11 november 2024 received a notification pursuant to chapter 9 section 10 of the finnish securities markets act from blackrock inc according to the notification on 8 november 2024 blackrock inc s holding in kesko corporation including holding through financial instruments fell below the threshold of five 5 per cent of shares according to the notification of blackrock inc kesko corporation s share capital is divided into a shares and b shares the total number of shares is 400 079 008 of which 126 948 028 31 are a shares and 273 130 980 68 are b shares the total amount of own b shares held by the company is 2 122 600 the full chain of controlled undertakings through which the voting rights and or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity is presented in the enclosed attachment further information
2564,all_events,DOWN,DOWN,12 nov 2024 10 20 cet sparebank 1 østfold akershus nordic credit rating har den 12 november 2024 bekreftet sparebank 1 østfold akershus rating på a med stable outlook rapporten finnes på hjemmesiden til nordic credit rating https nordiccreditrating com issuer sparebank 1 ostfold akershus for mer informasjon kontakt viseadm dir lillian e lundberg 480 44 469 finanssjef henry tvete 918 40 809 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sparebank 1 østfold akershus oslo børs newspoint sparebank 1 østfold akershus spb 1 østfold akershus 20 25 2 spb 1 østfold akershus 20 25 frn spb 1 østfold akershus 20 26 1 spb 1 ostfold akershus 21 28 1 73 pct spb 1 ostfold akershus 21 31 1 95 pct spb 1 ostfold akershus 21 25 frn spb 1 ostfold akershus 22 27 3 93pct spb 1 ostfold akershus 22 28 frn spb 1 ostfold akershus 23 30 4 spb 1 ostfold akers 23 33 frn step c sub spb
11795,all_events,DOWN,,november 11 2024 04 42 et source sydbank a s sydbank a s storaktionærmeddelelse sydbank a s med henvisning til 31 i lov om kapitalmarkeder oplyses at sydbank a s den 8 november 2024 gennem direkte og indirekte besiddelser råder over 2 732 283 aktier i sydbank a s svarende til 5 af det samlede antal aktier i sydbank a s bankens besiddelse af egne aktier kan for hovedparten henføres til bankens aktietilbagekøbsprogram på 1 200 mio kr aktietilbagekøbsprogrammet blev igangsat den 28 februar 2024 og afsluttes senest den 31 januar 2025 aktietilbagekøbsprogrammet er nærmere beskrevet i selskabsmeddelelse 03 2024 venlig hilsen sydbank a s vedhæftet fil
10886,all_events,DOWN,,november 20 2024 02 46 et source investeringsforeningen bankinvest investeringsforeningen bankinvest på grund af lokale børslukkedage i underliggende markeder anmodes om suspension af nedenstående afdelinger hvis der er spørgsmål kontakt da chef for fund valuation trade processing peter akstrup telefon 77 30 90 31 med venlig hilsenbi management a s martin fjordlund smidtdirektør
7593,all_events,UP,,08 nov 2024 13 44 cet lyse as det er fastsatt ny obligasjonsrente for no0010929342 ny obligasjonsrente i renteperioden 12 11 2024 12 02 2025 er 5 47 ticker lyse24 den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631731_a2966a8b81184fd985e9349bca3e325d pdf lyse as oslo børs newspoint lyse as 15 25 3 lyse as 16 26 3 lyse as 17 27 3 lyse as 17 32 2 lyse as 17 29 3 075pct lyse as 20 27 frn lyse as 20 28 1 73 per cent lyse as 21 31 frn lyse as 21 25 1 635 lyse as 21 26 frn lyse as 22 28 frn lyse as 22 28 4 85pct lyse as 22 30 4 52pct lyse as 23 33 4 lyse as 23 35 4 lyse as 23 29 5 lyse as 23 28 frn lyse as 23 29 5 lyse as 23 31 5 lyse as 24 27 frn lyse as 24
8414,all_events,UP,,the government securities auction of additional offers will be held on 2024 11 18 auction participants can submit competitive and non competitive bids the competitive bids shall be submitted in the order books of the vse new issue yield market whereas the non competitive bids shall be placed in the order books of the vse new issue yield non market the parameters of the emission to be issued shall be the following with the written consent of the ministry of finance this amount may be increased by one additional amount up to a maximum of eur 5 000 000 for one of the auction participants the securities shall be redeemed by paying to their holders the total amount of par value the paid up securities shall be admitted to the regulated market to the debt securities list of the nasdaq vilnius ab nasdaq baltic transaction services 370 5 253 14 54 www nasdaqbaltic com
5547,all_events,DOWN,,digitalist group plc oy managers transactions person subject to the notification requirement name wilhelm rosenlew position member of the board deputy member issuer digitalist group plc oy lei 743700al68pux6jms644 notification type initial notification reference number 84921 5 4 transaction date 2024 11 12 venue nasdaq helsinki ltd xhel instrument type share isin fi0009008007 6 7nature of transaction disposal transaction details 1 volume 440000 unit price 0 0182 eur 2 volume 40000 unit price 0 0186 eur 3 volume 40000 unit price 0 0182 eur aggregated transactions 3 volume 520000 volume weighted average price 0 01823 eur additional information digitalist group plc ceo magnus leijonborg tel 46 76 315 8422 magnus leijonborg digitalistgroup com chairman of the board esa matikainen tel 358 40 506 0080 esa matikainen digitalistgroup com distribution nasdaq helsinki ltd major media https digitalist global
9948,all_events,UP,,tel aviv israel and new york may 31 2022 globe newswire vbl therapeutics nasdaq vblt vbl a late clinical stage biotechnology company developing first in class therapeutics for difficult to treat malignant solid tumors and immune or inflammatory indications today announced that dror harats m d chief executive officer of vbl therapeutics will present a corporate overview and participate in investor meetings at the upcoming jefferies healthcare conference being held in new york on june 8 10 2022
1139,all_events,UP,DOWN,sydney australia march 28 2023 globe newswire radiopharm theranostics asx rad radiopharm or the company a developer of radiopharmaceutical products for both diagnostic and therapeutic uses is pleased to announce that the company will participate in jefferies inaugural radiopharma innovation summit being held in new york city on april 3rd 2023 riccardo canevari chief executive officer and managing director of radiopharm theranostics and vittorio puppo chief operating officer will be available for 1x1 meetings
2771,all_events,UP,,adelaide australia and cambridge mass july 25 2023 globe newswire bionomics limited asx bno nasdaq bnox bionomics or the company a clinical stage biotechnology company developing novel first in class allosteric ion channel modulators to treat patients suffering from serious central nervous system cns disorders with high unmet medical need today announced that it has submitted a formal request to the australian securities exchange asx to be removed from the official list of the asx in keeping with the company s ongoing transformation to a u s focused organization the main consequence of an asx delisting for shareholders is that from the time the proposed asx delisting is scheduled to take effect on august 28 2023 bionomics shares will no longer be quoted or traded on the asx and will only be tradable in the form of american depositary shares on the nasdaq global market nasdaq under the symbol bnox
4639,all_events,DOWN,,15 nov 2024 17 45 cet bouygues bouygues telecom acquiert l opérateur virtuel la poste mobile et annonce la conclusion d un accord de distribution exclusif avec le groupe la poste paris le 15 novembre 2024 bouygues telecom annonce avoir finalisé aujourd hui avec le groupe la poste et sfr l acquisition de la poste telecom 1er opérateur virtuel du marché français qui opère sous la marque la poste mobile et un partenariat de distribution exclusif entre la poste telecom la poste et la banque postale cette opération permet à bouygues telecom de renforcer son parc d environ 2 4 millions de clients mobile et de s appuyer sur un réseau de distribution de la poste reconnue pour ses valeurs de confiance et de proximité avec ses 7000 bureaux de poste la poste telecom dont julien tétu est président devient une filiale du groupe bouygues telecom elle regroupe 400 collaborateurs et a réalisé un chiffre d affaires de plus de 300m en 2023 benoît torloting directeur général de b
4058,all_events,DOWN,,media release
5438,all_events,UP,,media release
4919,all_events,DOWN,,san diego aug 01 2024 globe newswire bioatla inc nasdaq bcab a global clinical stage biotechnology company focused on the development of conditionally active biologic cab antibody therapeutics for the treatment of solid tumors today announced that it plans to host a conference call and webcast on thursday august 8 2024 at 4 30 p m et to discuss its financial results for the second quarter ended june 30 2024 and provide business highlights
8634,all_events,DOWN,,to the nasdaq copenhagen prepayments ck93 pursuant to s 24 of the danish capital markets act totalkredit a s hereby publishes prepayment data ck93 as at 15 november 2024 in the attached file furthermore the data will be distributed in the usual way through nasdaq copenhagen data on nykredit and totalkredit bonds is also available by isin code in excel format on https www nykredit com en gb investor relations financial reporting prepayments for further information about data format and contents please refer to the nasdaq website questions may be addressed to morten bækmand nielsen head of investor relations tel 45 44 55 15 21 yours sincerelytotalkredit a s attachments attachments eordindftk xml prepayments totalkredit a_s_18 11 2024 pdf
107,all_events,DOWN,DOWN,november 15 2024 09 30 et source baltic horizon fund northern horizon capital baltic horizon fund northern horizon capital on the 15th of november 2024 baltic horizon held an investor webinar where fund manager tarmo karotam introduced the results of q3 2024 baltic horizon fund would like to thank all participants webinar recording is available here presentation is available here for additional information please contact tarmo karotam baltic horizon fund manager e mail tarmo karotam nh cap com www baltichorizon com baltic horizon fund is a registered contractual public closed end real estate fund managed by alternative investment fund manager license holder northern horizon capital as both the fund and the management company are supervised by the estonian financial supervision authority distribution nasdaq globenewswire www baltichorizon com to receive nasdaq announcements and news from baltic horizon fund about its projects pl
8730,all_events,UP,,16 oct 2024 07 45 cest gimv see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1290791_241016_pr_udb_exit_nl pdf gimv les echos gimv be0003699130 gimb euronext
367,all_events,UP,DOWN,media release
5494,all_events,DOWN,,media release
10550,all_events,DOWN,,san diego july 11 2024 globe newswire oncternal therapeutics inc nasdaq onct a clinical stage biopharmaceutical company focused on the development of novel oncology therapies today announced that james breitmeyer m d ph d oncternal s president and chief executive officer will present at the jonestrading healthcare seaside summit being held july 14 16 2024 in san diego california
11391,all_events,UP,,13 nov 2024 13 48 cet porsgrunn kommune det er fastsatt ny obligasjonsrente for no0013233148 ny obligasjonsrente i renteperioden 15 11 2024 17 02 2025 er 4 988 ticker poko11 den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632077_e62605685fc949fb984c937bf4bca057 pdf porsgrunn kommune oslo børs newspoint porsgrunn komm 19 29 1 porsgrunn komm 22 26 frn porsgrunn komm 24 26 frn no0010860935 no0012740283 no0013233148 oslo børs
10069,all_events,DOWN,,07 nov 2024 17 45 cet transgene s a tg4050 données prometteuses de phase i présentées au sitc 2024 confirmant une preuve de principe clinique en situation adjuvante du cancer de la tête et du cou visibilité financière confirmée jusqu au quatrième trimestre 2025 strasbourg france le 7 novembre 2024 17h45 transgene euronext paris tng société de biotechnologie qui conçoit et développe des immunothérapies reposant sur des vecteurs viraux contre les cancers publie aujourd hui un point sur ses activités et sa situation financière au 30 septembre 2024 faits marquants et prochaines annonces tg4050 vaccin thérapeutique individualisé contre le cancer transgene et nec présenteront de nouvelles données prometteuses de l essai de phase i de tg4050 son vaccin individualisé reposant sur des néoantigènes voir le communiqué de presse ici au sitc le 9 novembre 2024 ces données apportent une solide preuve de principe clinique pour le candidat phare de transgene dans l
2798,all_events,UP,,selskabet har opnået følgende resultat for første kvartal 2024
3445,all_events,DOWN,,media release
7103,all_events,UP,,advancing two pivotal phase 3 trials of bxcl501 for acute treatment of agitation associated with bipolar disorders schizophrenia and alzheimer s dementia
3595,all_events,DOWN,,rockville md april 23 2024 globe newswire opgen inc nasdaq opgn opgen or the company announced today that it received a notice from the nasdaq stock market llc nasdaq indicating that the company was not in compliance with nasdaq listing rule 5250 c 1 due to the company not filing its annual report on form 10 k for the fiscal year ended december 31 2023 the form 10 k nasdaq listing rule 5250 c 1 requires listed companies to timely file all periodic reports with the securities and exchange commission the sec the company previously filed a form 12b 25 with the sec disclosing that it was unable to file the form 10 k by april 1 2024 without unreasonable effort or expense
8773,all_events,DOWN,,alvotech nasdaq alvo a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide today announced the closing of its previously announced senior secured first lien term loan facility the facility the closing has allowed alvotech to refinance outstanding debt obligations reduce the cost of capital and improve its overall debt maturity profile
217,all_events,UP,DOWN,media release
3978,all_events,DOWN,,media release
7716,all_events,UP,,bestyrelsen har i dag godkendt delårsrapport for perioden 1 januar 30 september 2024
1626,all_events,UP,UP,media release
4165,all_events,UP,,media release
6081,all_events,DOWN,,la jolla calif may 14 2024 globe newswire medicinova inc a biopharmaceutical company traded on the nasdaq global market nasdaq mnov and the standard market of the tokyo stock exchange code number 4875 today announced that it has received a notice of allowance from the u s patent and trademark office for a pending patent application which covers mn 166 ibudilast for the treatment of chlorine induced acute respiratory distress syndrome ards
9372,all_events,DOWN,,media release
3519,all_events,DOWN,,copenhagen denmark sept 09 2024 globe newswire evaxion biotech a s nasdaq evax evaxion a clinical stage techbio company specializing in developing ai immunology powered vaccines announces new pre clinical data demonstrating the ability of its novel evx b2 mrna gonorrhea vaccine candidate in eliminating gonorrhea bacteria by triggering a targeted immune response
510,all_events,DOWN,DOWN,all ruby patients with 5 months follow up have achieved a normal hemoglobin level and a fetal hemoglobin level of
700,all_events,DOWN,DOWN,i henhold til vedtægternes pkt 4 5 indkaldes hermed til ekstraordinær generalforsamling i orphazyme a s til afholdelse den 21 oktober 2024 kl 10 00 på selskabets adresse hos visionhouse lyskær 8a 2730 herlev med følgende dagsorden
169,all_events,DOWN,DOWN,media release
10823,all_events,UP,,san diego may 30 2024 globe newswire cidara therapeutics inc nasdaq cdtx a biotechnology company using its proprietary cloudbreak platform to develop drug fc conjugate dfc immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases today announced the company will be presenting a poster at the american society for microbiology asm microbe 2024 conference to be held june 13 17 2024 at the georgia world congress center in atlanta georgia
6504,all_events,UP,,stockholm sweden november 18 2024 modus therapeutics holding ab modus announces that it has received approval from the relevant authorities in italy for its planned phase iia clinical trial with sevuparin as previously communicated the planned phase iia study will be conducted in two parts part 1 aims to establish dosage levels and safety of sevuparin through single doses in 25 30 patients with varying degrees of kidney failure part 1 will also include a small reference group of healthy volunteers and may also provide an opportunity to assess early effects on hepcidin in a relevant patient population part 2 the so called proof of concept segment will evaluate the effects of repeated dosing of sevuparin based on the dose levels established in part i focusing on endpoints related to anemia hepcidin kidney status and relevant biomarkers in patients with more severe chronic kidney disease and anemia it is expected to recruit 25 30 patients bringing the total study e
1277,all_events,DOWN,UP,kidney morphology improved in all three patients with protein re expression consistent with disease regression in its phase 2 open label clinical trial of elx 02 for the treatment of alport syndrome
573,all_events,DOWN,DOWN,media release
12030,all_events,DOWN,,media release
39,all_events,UP,UP,06 nov 2024 16 48 cet photocure asa oslo norway 6 november 2024 photocure asa photocure pho ose will announce the third quarter 2024 financial results on wednesday 13 november 2024 at 08 00 cet and will present a live webcast at 14 00 cet the same day the quarterly report and presentation will be published at 08 00 cet and will be publicly available at www photocure com the investor presentation will be streamed live and be hosted by dan schneider ceo and erik dahl cfo the presentation will be held in english and questions can be submitted throughout the event the presentation is scheduled to conclude at 14 45 cet the streaming event is available through https channel royalcast com landingpage hegnarmedia 20241113_5 https eur01 safelinks protection outlook com url https 3a 2f 2fchannel royalcast com 2fland i ngpage 2fhegnarmedia 2f20241113_ 2f data 7c 7cth 40photocure no 7c6812ef56 2 bdd4e35b74108dcd96c 7c0986794f1d6f488980bd853c0715
4049,all_events,UP,,november 14 2024 01 00 et source norbit asa norbit asa trondheim 14 november 2024 norbit delivered continued growth in the third quarter reporting revenues of nok 371 9 million the reported ebit result was nok 53 7 million and nok 60 1 million when adjusting for transaction costs relating to the innomar acquisition the third quarter was another eventful quarter for us at norbit we saw growth across both oceans and pir while connectivity achieved increased profits despite rescheduled orders from a major european client says per jørgen weisethaunet ceo of norbit over the last two months the oceans segment has received orders for a total of nok 100 million for guardpoint underwater surveillance sonars with deliveries expected during the fourth quarter of 2024 and first quarter of 2025 the connectivity segment announced an agreement with toll4europe for supply of a new innovative gnss on board unit currently under development the i
9861,all_events,UP,,06 nov 2024 08 00 cet capsol technologies asa capsol technologies asa capsol and sumitomo shi fw sfw announce a carbon capture demonstration campaign at swedish mälarenergi s combined heat and power bio chp plant in västerås sweden the demonstration unit will commence operations in november 2024 as part of a rental agreement between sfw and capsol mälarenergi and sfw have signed an agreement under which sfw will provide a mobile carbon capture demonstration facility and mälarenergi will host the corresponding operation activities at their biomass plant in västerås sweden the mobile carbon capture unit delivered by capsol is based on the hot potassium carbonate hpc process incorporating the patented eop heat recovery technology by capsol the demonstration campaign will provide valuable data on the performance of the technical solution for mälarenergi s specific flue gas conditions that can be used in optimizing the planned full scale capture plant at
11412,all_events,UP,,november 18 2024 04 40 et source dlr kredit a s dlr kredit a s i medfør af kapitalmarkedsloven 24 oplyser dlr kredit hermed om ekstraordinære indfrielser pr fredag den 15 november 2024 oplysningerne fremgår af vedhæftede fil denne meddelelse er offentliggjort med henblik på opfyldelse af transparensdirektivets krav om offentliggørelse oplysningerne vil endvidere på sædvanlig måde blive formidlet via nasdaq copenhagen spørgsmål kan rettes til head of rating ir jakob kongsgaard olsson tlf nr 33 42 07 06 med venlig hilsen dlr kredit a s vedhæftet fil
2189,all_events,UP,DOWN,tethys oil s share of the production before government take from blocks 3 4 onshore the sultanate of oman in october 2024 amounted to 251 170 barrels of oil corresponding to 8 102 barrels of oil per day the official selling price osp for oman export blend crude oil for the month of october 2024 was usd 77 54 per barrel the osp as published by sultanate of oman s ministry of energy and minerals is the benchmark price for tethys oil s monthly oil sales excluding trading and quality adjustments tethys oil ab through its wholly owned subsidiary tethys oil block 3 4 ltd has a 30 percent interest in blocks 3 4 partners are mitsui e p middle east b v with 20 percent and the operator cc energy development s a l oman branch holding the remaining 50 percent for further information please contact magnus nordin managing director phone 46 8 505 947 00petter hjertstedt cfo phone 46 8 505 947 00ir tethysoil com tethys oil ab publ tethys oil is an oil exploration and prod
6192,all_events,DOWN,,media release
932,all_events,UP,UP,media release
2884,all_events,DOWN,,rockville md aug 03 2023 globe newswire opgen inc nasdaq opgn opgen or the company a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease reported today that its german subsidiary curetis gmbh has signed an extended and continued research and development r d collaboration agreement with find following the successful completion of the feasibility phase of the collaboration and having met all milestones on time and within budgets the parties now plan to collaborate on first phases of product development of an antimicrobial resistance amr cartridge from blood culture that is tailored to the needs of low and middle income countries lmics in terms of panel design and coverage of specific genetic variants of bacterial strains and their amr markers in such countries as well as ensuring attractive cost profile and pricing models that allow for access to such rapid testing in lmics
3546,all_events,DOWN,,october 02 2024 11 00 et source first watch restaurant group inc first watch restaurant group inc bradenton fla oct 02 2024 globe newswire first watch the leading daytime dining restaurant serving breakfast brunch and lunch has been named the 1 most loved workplace in america by newsweek and the best practice institute this is the third consecutive year first watch has been recognized on the list a demonstration of the company s focus on championing its you first culture for its more than 14 000 employees to be named the most loved workplace in america is an incredible honor because it s all about our employees and they mean the world to us said laura sorensen chief people officer at first watch our people are our purpose which is why we continue to invest in their quality of life with important benefits and programs our you first vision is to create amazing opportunities for our people and we take that
10720,all_events,DOWN,,meðfylgjandi má finna staðfestingu kpmg ehf á skýrslum haga hf um fjárhagslegar kvaðir í tengslum við skuldabréfaútgáfu haga 021029 haga 181024 haga 120926 1 og haga161127 útreikningar og staðfesting fjárhagslegra skilyrða skal fara fram í tengslum við nýja útgáfu skuldabréfaflokka og í kjölfar birtingar hálfsárs og ársreiknings félagsins hálfsársuppgjör haga var birt þann 17 október sl
7007,all_events,UP,,november 06 2024 02 00 et source arco vara arco vara tallinna linnavalitsus võttis vastu arco vara tütarfirmale kodulahe kvartal oü le kuuluva aadressil soodi 6 asuva 1 42 ha suuruse kinnistu detailplaneeringu kehtestatud detailplaneeringuga kooskõlas on arendajal soov ehitada hoonetekompleks mis on maa alt ühendatud kuid visuaalselt kolmest majast koosnev kodulahe järgmine etapp kus on kokku 62 korterit ning 4 äripinda kinnistu paldiski maantee poolne hoone tuleb 5 korruseline merepoolsed osad jäävad neljakordseteks arco vara juht kristina mustoneni kommentaar detailplaneeringu protsessi alustamisest kehtestamiseni kulus 3 aastat mis on detailplaneeringute maastikul kiire tempo täname kõiki protsessi kaasatuid inimesi nende panuse eest nüüd kus detailplaneering on kehtestatud töötame selle nimel et hankida võimalikult kiiresti ehitusluba loodame et meie eeltöö on piisav ning saame juba lähikuudel ehitustöödega alustada kuna
6791,all_events,UP,,zimmer biomet har meddelat bactiguard att de säger upp licensavtalet som signerades 2022 som omfattar fler produktkategorier inom ortopedi den angivna orsaken är att processen relaterad till amerikanska regulatoriska myndigheter us food and drug administration fda har blivit mer komplex och tagit längre tid än zimmer biomets ursprungliga förväntan uppsägningen kommer inte att påverka bactiguard negativt finansiellt för 2024 bactiguard är i dialog med teamet på zimmer biomet för att utreda ytterligare detaljer och vilken påverkan uppsägningen har och kommer att återkomma när mer information finns tillgänglig partnerskapet med zimmer biomet avseende trauma produkter relaterade till avtalet som signerades 2019 gäller fortsatt denna information är sådan information som bactiguard holding ab publ är skyldigt att offentliggöra enligt eu s marknadsmissbruksförordning informationen lämnades genom nedanstående kontaktpersoners försorg för offentliggörande 2024 10 02 kl 10 40 cet
3118,all_events,DOWN,,jupiter fla sept 23 2024 globe newswire dyadic international inc dyadic we us our or the company nasdaq dyai a biotechnology company focused on the efficient large scale manufacture of proteins for use in non pharmaceutical applications including food nutrition and wellness as well as animal and human health therapeutics and vaccines today provided an update on business progress and announced its attendance at the bioprocess international conference in boston september 23 26 2024
346,all_events,DOWN,UP,november 06 2024 05 43 et source hexagon purus asa hexagon purus asa oslo norway 6 november 2024 dionysos as has today purchased a total of 82 500 shares in hexagon purus asa hexagon purus at an average price of nok 5 9739 per share dionysos as is a company controlled by jon erik engeset board member of hexagon purus and ceo of hexagon composites asa following the transaction dionysos as holds 242 360 shares in hexagon purus and the total shareholding in hexagon purus of jon erik engeset and his close associates is 301 973 shares for additional information please contact salman alam cfo hexagon purus telephone 47 476 12 713 salman alam hexagonpurus com mathias meidell director investor relations hexagon purustelephone 47 909 82 242 mathias meidell hexagonpurus com about hexagon purus hexagon purus enables zero emission mobility for a cleaner energy future the company is a world leading provider of hydrogen type 4
8118,all_events,DOWN,,media release
5333,all_events,DOWN,,19 nov 2024 13 28 cet iante investments socimi s a certificate gsm capitalincrease 1124 iante pdf iante investments euronext iante investments es0105479002 mlint euronext access
7925,all_events,DOWN,,media release
2631,all_events,UP,,05 nov 2024 18 00 cet facephi biometria s a communication operations of members of the board communication operations of members of the board nov 05 24 ng nod euronext pdf facephi euronext facephi es0105029005 alphi euronext growth
5900,all_events,UP,,media release
1586,all_events,DOWN,UP,testing in advanced animal model planned in q4 for smaller 00 size biojet device with largest capacity of any ingestible injectable
8278,all_events,UP,,play airlines carried 144 746 passengers in september 2024 a 14 decrease compared to last year when 163 784 passengers were flown however the load factor increased rising from 85 in september 2023 to 87 this year of the passengers flying with play in september 28 were departing from iceland 35 were flying to iceland and 35 were connecting passengers via the number of passengers flying from iceland increased by compared to last year in 2023 play had nearly 38 thousand passengers departing from iceland while in 2024 this figure grew to nearly 41 thousand marking significant growth in the local market the load factor for north american destinations reached 89 an all time high for a single month additionally the load factor for eu city destinations rose by play s on time performance in september was 90 surpassing last year s otp of 85 new destinations and sabre launch in september play launched ticket sales for scheduled flights to
6965,all_events,DOWN,,18 oct 2024 17 00 cest contextvision ab aktieägarna i contextvision ab publ org nr 556377 8900 kallas till extra bolagsstämma onsdagen den 20 november 2024 kl 11 00 i bolagets lokaler holländargatan 13 stockholm deltagande och anmälan mm aktieägare som vill delta i stämman med rösträtt skall dels vara upptagen som aktieägare i den av euroclear sweden ab framställda aktieboken avseende förhållandena tisdagen den 12 november 2024 tillfällig registrering för aktieägare registrerade vid norska verdipapirsentralen vps görs hos dnb bank asa se nedan dels skriftligen ha anmält sig till bolaget senast torsdagen den 14 november 2024 via e post ir contextvision com eller post holländargatan 13 111 36 stockholm vid anmälan ska anges namn person eller organisationsnummer adress telefonnummer samt aktieinnehav om en aktieägare företräds genom ombud ska en skriftlig och daterad fullmakt utfärdas för ombudet fullmaktsformulär finns tillgängligt p
4974,all_events,UP,,media release
2714,all_events,DOWN,,media release
1402,all_events,UP,DOWN,05 nov 2024 18 00 cet soitec in bernin on november 5 2024 information relating to the total number of voting rights and shares forming the share capital article l 233 8 ii of the french commercial code and article 223 16 of the general regulation of the french financial markets authority amf corporate name and address of the company soitecparc technologique des fontaines chemin des franques 38190 bernin france statement date total number of shares forming the share capital total number of voting rights 10 31 2024 35 726 462 1 number of theoretical gross voting rights 2 45 644 165 number of exercisable net voting rights 3 45 585 773 35 726 462 ordinary shares of 2 00 par value each listed on the euronext paris regulated market under isin code fr0013227113 and the mnemonic soi the total number of theoretical voting rights or gross voting rights is used as the basis for calculating the crossing of shareholding threshold
5001,all_events,DOWN,,la jolla calif march 12 2024 globe newswire medicinova inc a biopharmaceutical company traded on the nasdaq global market nasdaq mnov and the standard market of the tokyo stock exchange code number 4875 today announced that medicinova s collaborator perenlei enkhbaatar md phd faha professor department of anesthesiology director translational intensive care unit charles robert allen professor in anesthesiology university of texas medical branch presented new data and results of a nonclinical study evaluating mn 166 ibudilast in a chlorine gas induced acute lung injury ciali model at the society of toxicology sot 63rd annual meeting and toxexpo in salt lake city utah
10897,all_events,DOWN,,la jolla calif june 05 2024 globe newswire medicinova inc a biopharmaceutical company traded on the nasdaq global market nasdaq mnov and the standard market of the tokyo stock exchange code number 4875 today announced that it has received a notice of allowance from the u s patent and trademark office for a pending patent application which covers mn 166 ibudilast for the prevention of metastasis in various cancers including pancreatic cancer lung cancer breast cancer colorectal cancer melanoma and ovarian cancer
5684,all_events,UP,,media release
5719,all_events,DOWN,,14 nov 2024 08 50 cet vår energi asa sandnes norway 14 november 2024 vår energi asa ose var confirms a commercial oil and gas discovery in the equinor operated rhombi well in the fram licence in the north sea the preliminary estimate of shows gross recoverable resources of between 13 28 million barrels of oil equivalent mmboe the discovery was made in two different structural segments in sognefjord and fensfjord formations with fair to very good reservoir characteristics the preliminary estimate of gross recoverable resources of the discovery are between 13 28 million barrels of oil equivalent the licensees regard the discovery to be commercially viable and will consider a tie in to existing infrastructure vår energi s coo torger rød said we congratulate equinor for their safe and successful drilling operation which again proves the potential in the highly prolific fram area its close proximity to existing infrastructure provides further opportunit
6948,all_events,DOWN,,generated first quarter 2024 cguard eps revenue of 1 51 million an increase of 22 over the first quarter of 2023
3299,all_events,DOWN,,the annual general meeting hereinafter the meeting of ab akola group hereinafter the company was held on 31 october 2024 on the day the meeting is convened the total number of the company s shares is 167 170 481 and the number of shares granting voting rights is 166 508 509 the own shares in the amount of 661 972 acquired by the company do not grant voting rights in total 25 company s shareholders who owned shares of the company at the end of the accounting day of the meeting 24 october 2024 participated in the meeting having 138 965 128 share votes which amounted to 83 46 percent of the total number of the company s share votes 22 duly filled general voting ballots were presented before the meeting the board member and cfo of the company mažvydas šileika deputizing company s ceo participated in the meeting the quorum existed decisions of the meeting 1 presentation of the company s audit committee activity report presented no voting 2 presentation of the independent auditor s report presented no voting 3 presentation of the consolidated annual report of the company for the financial year 2023 2024 presented no voting 4 approval of the company s remuneration report approve the company s remuneration report results of voting for 138 965 128 votes including 138 885 287 share votes of shareholders who voted in advance against 0 did not vote 0 5 approval of the consolidated and the company s set of financial statements for the financial year ended 30 june 2024 approve the consolidated and the company s set of financial statements for the financial year ended 30 june 2024 results of voting for 138 965 128 votes including 138 885 287 share votes of shareholders who voted in advance against 0 did not vote 0 6 approval of the distribution of the company s profit loss approve the distribution of the company s profit loss
2301,all_events,UP,DOWN,media release
971,all_events,DOWN,DOWN,châtillon france november 6 2024
12817,all_events,UP,,08 nov 2024 18 00 cet adocia regulatory news pursuant to the provisions of article l 233 8 ii of the french code de commerce and article 223 16 of the french stock market authorities autorité des marchés financiers or amf charter adocia sa paris adoc a french société anonyme corporation 115 avenue lacassagne 69003 lyon euronext paris fr0011184241 adoc a clinical stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity releases its total number of outstanding shares as well as its voting rights as of october 31st 2024 month date total number of outstanding shares total number of theoretical voting rights 1 total number of exercisable voting rights 2 october 10 31 2024 15 471 638 17 596 509 17 588 846 225 000 new shares have been issued over the month in connection with the paceo financing line w
10046,all_events,DOWN,,november 14 2024 16 15 et source frontline plc frontline plc frontline plc the company announces that its 2024 annual general meeting will be held on december 12 2024 a copy of the notice of annual general meeting and associated information including the company s annual report on form 20 f for 2023 can be found on our website at www frontlineplc cy and attached to this press release november 14 2024limassol cyprus this information is subject to the disclosure requirements pursuant to section 5 12 the norwegian securities trading act attachments
7911,all_events,UP,,18 oct 2024 17 45 cest winfarm communique de presse loudéac le 18 octobre 2024 modalites de mise à disposition du rapport financier semestriel 2024 winfarm code isin fr0014000p11 mnémonique alwf n 1 français de la vente à distance pour le monde agricole annonce que son rapport financier semestriel 2024 a été déposé auprès de l autorité des marchés financiers amf le 18 octobre 2024 ce document est disponible sur le site de la société à l adresse www winfarm group com et sur le site de l amf www amf france org il est également tenu à disposition au siège social de la société zone industrielle de très le bois 22600 loudéac le rapport financier semestriel peut être consulté sur le site internet de la société à l adresse suivante https www winfarm group com investisseurs a propos de winfarm fondé à loudéac au cœur de la bretagne au début des années 90 le groupe winfarm est aujourd hui le premier acteur français proposant aux marchés de l agricultur
11181,all_events,DOWN,,media release
1201,all_events,DOWN,UP,vancouver british columbia aug 30 2023 globe newswire mydecine innovations group inc neo myco otc mycof fse 0nfa mydecine or the company is pleased to announce that it has made an application and received conditional approval to list its common shares on the canadian securities exchange the cse subject to fulfilling customary cse requirements the company anticipates that trading will commence immediately upon receipt of voluntarily delisting approval from the neo exchange with a trading date to be provided in due course the company s trading symbol myco will remain the same
3026,all_events,DOWN,,november 14 2024 13 32 et source nilfisk holding a s nilfisk holding a s nilfisk ceo jon sintorn comments on the q3 results after strong momentum to start the third quarter a demand slowdown in the americas negatively impacted the professional business and our overall results for the quarter business performance in the us was below expectations this was partially offset by continued strong organic growth in emea and positive contributions from our consumer and specialty businesses we are assessing the challenges and will look for structural efficiency improvements across the group nilfisk will announce its financial outlook for 2025 and provide an update in connection with the 2024 annual report in february 2025 financial highlights financial outlook for 2024the financial outlook as updated in company announcement no 22 of october 24 2024 remains unchanged organic revenue growth is expected to be between and previousl
4189,all_events,DOWN,,media release
10369,all_events,UP,,san diego sept 19 2024 globe newswire cidara therapeutics inc nasdaq cdtx a biotechnology company using its proprietary cloudbreak platform to develop drug fc conjugate dfc immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases today announced the appointment of rick bright ph d philip krause m d mario barro ph d and frederick g hayden m d facp to its scientific advisory board sab
5045,all_events,UP,,06 nov 2024 08 30 cet acticor biotech regulatory news acticor biotech fr0014005oj5 alact société de biopharmaceutique au stade clinique spécialisée dans le développement de médicaments innovants pour le traitement des urgences cardiovasculaires et notamment les maladies thrombotiques aigues fait aujourd hui le point sur la procédure de redressement judiciaire en cours afin de permettre à la société de poursuivre ses recherches de nouveaux investisseurs ou partenaires pour soutenir son nouveau plan de développement dans le stemi l infarctus du myocarde avec élévation du segment st l administrateur judiciaire avait accordé mi octobre 2024 une prorogation jusqu au 5 novembre 2024 de l appel d offres publié le 13 septembre en vue d un plan de continuation ou de cession a ce jour l administrateur judiciaire n a reçu aucune proposition d un repreneur la société poursuit donc la recherche d une solution pour soutenir le développement du glenzocimab dans le s
3691,all_events,DOWN,,pharmaceutical and academic veteran brings significant innovative technology and development expertise launching new cellular therapies pharmaceutical and academic veteran brings significant innovative technology and development expertise launching new cellular therapies
3090,all_events,UP,,08 nov 2024 12 03 cet bewi asa by a group internal transaction conchilia as a company in which kverva industrier as has an ownership interest of approximately has sold 267 600 shares in bewi asa to kverva industrier as at a price of nok 24 54 per share following this kverva industrier as owns 15 560 024 shares 8 in bewi asa in addition kverva as is a party to total return swap agreement with a third party under which kverva as has a financial exposure to 9 092 220 shares 4 in bewi asa resulting in kverva as having a total bewi asa exposure equal to 24 652 244 shares 12 kverva industrier as is a close associate of pernille skarstein christensen who is a board member in bewi asa please see further details in the attached notification of trade this announcement is made in accordance with article 19 of the eu market abuse regulation and sections 5 12 of the norwegian securities trading act more information access the news on oslo bors ne
5837,all_events,UP,,innovative design enables five minute pegfilgrastim cbqv delivery time
4747,all_events,DOWN,,15 nov 2024 17 45 cet renault regie nat des usines communiqué de presse15 novembre 2024 information sur la date de la prochaine assemblée générale des actionnaires de renault s a boulogne billancourt 15 novembre 2024 renault s a informe ses actionnaires que la prochaine assemblée générale annuelle des actionnaires est prévue le mercredi 30 avril 2025 cette date sera confirmée par le conseil d administration de la société qui en février 2025 convoquera cette assemblée générale le calendrier complet des prochaines publications financières de la société est disponible sur son site internet https www renaultgroup com renault grouprelations investisseursphilippine de schonenphilippine de schonen renault com 33 0 6 13 45 68 39 renault group relations mediasvalérie gillot 33 6 83 92 92 96valerie gillot renault comrié yamane 33 6 03 16 35 20rie yamane renault com à propos de renault group renault group est aux avant postes d une mobilité qui se réinvente fort d
7377,all_events,DOWN,,rockaway n j july 31 2024 globe newswire electrocore inc nasdaq ecor a commercial stage bioelectronic medicine and wellness company today announced that it will report financial results for the second quarter ended june 30 2024 after the close of the market on wednesday august 7 2024 management will host a conference call and webcast at 4 30 pm edt to discuss the financial results and answer questions
8009,all_events,DOWN,,media release
4202,all_events,DOWN,,media release
12391,all_events,UP,,fondia plc company release 14 11 2024 at 6 45 p m eet fondia acquisition of own shares 14 11 2024 fondia plc first north finland date 14 11 2024 exchange transactions buy share class fondia amount shares 277 average price share eur 6 05 total price eur 1675 85 the shares held by fondia plc on 14 11 2024 201 570 shares on behalf of fondia plc op corporate bank fondia in brief fondia solves the legal needs of companies by combining the best services from internal legal departments and law firms fondia operates in finland sweden estonia and lithuania and the group s net sales in 2023 were eur 26 1 million fondia employs around 190 people www fondia com distribution nasdaq helsinki ltd key media attachments fondia trades_1411 xlsx
4498,all_events,UP,,spectral ai s deepview system designed to provide equity in burn care access while optimizing healthcare resources spectral ai s deepview system designed to provide equity in burn care access while optimizing healthcare resources
9616,all_events,UP,,media release
3833,all_events,DOWN,,media release
6832,all_events,UP,,07 nov 2024 18 00 cet bonduelle bonduelle siège social la woestyne 59173 renescure francebonduelle sca société en commandite par actions au capital de 57 102 699 50 eurosrcs dunkerque 447 250 044 chiffre d affaires du 1er trimestre 2024 2025 1er juillet 30 septembre 2024 stabilité du chiffre d affaires et croissance des activités à marques sur le 1er trimestre confirmation de l objectif annuel de chiffre d affaires et de résultat opérationnel courant le chiffre d affaires du 1er trimestre de l exercice 2024 2025 du groupe bonduelle du 1er juillet au 30 septembre 2024 s établit à 567 2 millions d euros soit une quasi stabilité à 0 4 en données comparables et 0 2 en données publiées par rapport au 1er trimestre de l exercice précédent au delà de la stabilité du chiffre d affaires sur la période les activités à marques du groupe au cœur du programme de transformation transform to win présenté le 7 octobre dernier affichent une croissance de
12726,all_events,UP,,west lafayette ind nov 07 2024 globe newswire inotiv inc nasdaq notv the company or inotiv a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services today announced that robert leasure jr president and chief executive officer will present at the upcoming jefferies london global healthcare conference beth taylor chief financial officer will participate at the upcoming 15th annual craig hallum alpha select conference
6013,all_events,UP,,12 nov 2024 17 45 cet fnac darty comunicato stampaivry sur seine francia 15 novembre 2024 5 45 cest è vietata la divulgazione la pubblicazione o la distribuzione del presente comunicato in tutto o in parte in o verso gli stati uniti d america l australia il canada il giappone o qualsiasi altro paese in cui tale comunicazione violerebbe la normativa applicabile risultati finali della riapertura dei termini fnac darty e ruby si assicurano il 91 del capitale sociale di unieuro le cui azioni saranno revocate dalla quotazione risultati definitivi della riapertura dei termini 19 del capitale sociale di unieuro portato in adesione il quale sommato al 71 già detenuto dagli offerenti rappresenta il 91 del capitale sociale di unieuroil pagamento del corrispettivo della riapertura dei termini avrà luogo il 15 novembre 2024 la procedura per l adempimento dell obbligo di acquisto ai sensi dell art 108 comma 2 del tuf avrà luogo successivamente comunica
5802,all_events,UP,,12 nov 2024 16 30 cet sparebank 1 smn not for release publication or distribution in whole or in part directly or indirectly in or into the united states australia canada hong kong japan or any jurisdiction in which such release publication or distribution would be unlawful this announcement is not an offer of securities and the securities referred to herein may not be offered or sold in the united states absent registration except pursuant to an exemption from or in a transaction not subject to the registration requirements of the u s securities act any public offering of such securities to be made in the united states will be made by means of a prospectus that may be obtained from the company which would contain detailed information about the company and management as well as financial statements there will be no public offering of the securities in the united states sparebankstiftinga søre sunnmøre selger har engasjert arctic securities as og s
12637,all_events,DOWN,,08 nov 2024 12 47 cet hofseth biocare asa financial calendar for hofseth biocare asa financial year 2024 11 04 2025 annual report 08 11 2024 quarterly report q3 14 02 2025 quarterly report q4 financial year 2025 22 08 2025 half yearly report 23 05 2025 annual general meeting 16 05 2025 quarterly report q1 07 11 2025 quarterly report q3 13 02 2026 quarterly report q4 this information is published pursuant to the requirements set out in the continuing obligations more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site hofseth biocare asa oslo børs newspoint hofseth biocare no0010598683 hbc oslo børs
4688,all_events,DOWN,,biologics license application bla for hav accepted by fda
11890,all_events,UP,,media release
2034,all_events,UP,UP,media release
1595,all_events,DOWN,UP,missing
3827,all_events,DOWN,,today landsbankinn concluded a covered bond auction where one series was offered for sale a total of 13 bids for isk 4 040m were received in the series lbank cbi 30 at 3 3 yield bids in the amount of isk 3 740m were accepted in the series at 3 yield following the tap issuance the total amount issued in the series will be isk 42 900m a total of 10 bids for isk 1 680m were received in the series lbank cb 29 at 7 7 yield bids in the amount of isk 1 120m were accepted in the series at 7 yield following the tap issuance the total amount issued in the series will be isk 14 100m settlement date will be 13 november 2024 arion banki islandsbanki and kvika act as market makers for covered bonds issued by landsbankinn covered bonds issued by landsbankinn are rated a with stable outlook by s p global ratings the covered bonds are issued in accordance with a license from the financial supervisory authority fme with reference to act no 11 2008 and fme s ru
8267,all_events,DOWN,,media release
12502,all_events,UP,,conference call and webcast scheduled for tuesday november 26 2024 at 8 30 a m eastern time conference call and webcast scheduled for tuesday november 26 2024 at 8 30 a m eastern time
3643,all_events,UP,,mainz germany november 13 2024 globe newswire biontech se nasdaq bntx biontech and biotheus biotheus today announced the signing of a definitive agreement for the acquisition of biotheus a clinical stage biotechnology company dedicated to the discovery and development of novel antibodies to address unmet medical needs of patients with oncological or inflammatory diseases
8090,all_events,DOWN,,qiagen führt über 100 neue laborvalidierte qiacuity digitale pcr assays für krebsforschung vererbte genetische störungen überwachung von infektionskrankheiten und weitere anwendungen ein qiacuitys digitale pcr ermöglicht den präzisen und sensitiven nachweis gering verbreiteter pathogene erkennt kopienzahl variationen und identifiziert seltene mutationen portfolioerweiterung und partnerschaften unterstützen den zunehmende einsatz von qiacuity in zahlreichen anwendungsbereichen qiagen führt über 100 neue laborvalidierte qiacuity digitale pcr assays für krebsforschung vererbte genetische störungen überwachung von infektionskrankheiten und weitere anwendungen ein qiacuitys digitale pcr ermöglicht den präzisen und sensitiven nachweis gering verbreiteter pathogene erkennt kopienzahl variationen und identifiziert seltene mutationen portfolioerweiterung und partnerschaften unterstützen den zunehmende einsatz von qiacuity in zahlreichen anwendungsbereichen
7356,all_events,DOWN,,consortium includes top universities hospitals and industry partners led by the francis crick institute and the royal marsden nhs foundation trust
5405,all_events,UP,,media release
10941,all_events,DOWN,,media release
10282,all_events,UP,,14 nov 2024 07 45 cet agfa gevaert n v november 14 2024 7 45 a m cet regulated information agfa announces plan to adjust the cost base of its traditional film activities to the reality in the market mortsel belgium november 14 2024 7 45 a m cet agfa today announced a plan to adjust the cost base of its traditional film activities to the reality in the market the company has the intention to thoroughly reorganize all aspects of the film related activities with the goal of achieving savings of 50 million euro by the end of 2027 on november 14 the intention to reorganize the film related business was presented to the social partners in belgium at an extraordinary works council meeting if the intended plan would be executed this would impact up to 530 employees in belgium blue collar employees white collar employees as well as management positions would be affected its implementation would run over a three year perio
1350,all_events,DOWN,UP,media release
10319,all_events,UP,,meko s nomination committee proposes the election of jörn werner and marie björklund as new members of the company s board of directors the proposal will be presented at an extraordinary general meeting on december 19 2024 after the 2024 annual general meeting board member michael løve stepped down at his own request to fully focus on his role as ceo of the danish energy company ok as a result the nomination committee began work to find a replacement leading to a proposal that strengthens the board s competence through two new members with solid industrial and financial backgrounds considered to match meko s operations and strategy jörn werner born 1961 is a successful leader with extensive experience in the independent automotive aftermarket as well as in adjacent business areas such as trade and industry he has among other roles served as ceo of ceconomy ag formerly metro ag one of europe s largest companies in consumer electronics he has also been ceo of a t u grou
1327,all_events,DOWN,DOWN,06 nov 2024 15 13 cet sparebanken sør boligkreditt sparebanken sør boligkreditt as has repurchased nok 460 million in sorb30 no0010882632 with settlement 06 11 2024 kristiansand 6 november 2024 contacts sparebanken sør boligkreditt as marianne lofthus ceo 47 905 14 183 geir are kårvik head of treasury 47 934 96 044 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sparebanken sør boligkreditt as oslo børs newspoint sør boligkreditt as 13 28 4 covd spb sør boligkreditt as 18 25 frn covd spb sør boligkreditt as 20 24 frn covd spb sør boligkreditt as 21 27 frn c covd spb sor boligkreditt as 22 27 frn covd no0010670409 no0010832637 no0010882632 no0011002529 no0012535824 oslo børs
9090,all_events,DOWN,,november 15 2024 02 00 et source karolinska development ab publ karolinska development ab publ stockholm 15 november 2024 karolinska development ab nasdaq stockholm kdev today publishes its interim report january september 2024 the full report is available on the company s website research progress is an important element and one that generates value in our portfolio companies so it s particularly pleasing when a so newly added company such as boost pharma delivers strong data at an early stage in the process we now have an investment portfolio in which several of our portfolio companies have achieved a degree of maturity that offers considerable potential for realizing increases in value through exits over the coming years says viktor drvota ceo karolinska development significant events during the third quarter significant post period events financial update the interim report for karolinska development ab for the peri
9919,all_events,DOWN,,15 nov 2024 08 51 cet teco 2030 asa with reference to the announcements from teco 2030 asa on 14 11 2024 oslo børs has decided to place the company in recovery box recovery box is a special compartment where oslo børs can place securities when the issuer is subject to circumstances that make pricing of the securities particularly uncertain recovery box is regulated in section 3 8 2 of euronext growth oslo rule book part ii the relevant security will remain in the recovery box until the circumstances for the allocation to the recovery box are no longer present more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site teco 2030 asa oslo børs newspoint teco 2030 no0010887516 teco euronext growth
9920,all_events,UP,,06 nov 2024 08 00 cet nhoa availability of the response document note en réponse and of the information relating in particular to the legal financial and accounting characteristics of nhoa s a regulatory news nhoa s a paris nhoa this document is an unofficial english language translation of the legal press release communiqué normé relating to the availability of the response document approved visa by the french autorité des marchés financiers on november 5 2024 and of the information relating in particular to the legal financial and accounting characteristics of nhoa s a and is provided for information purposes only in the event of any discrepancies between this unofficial english language translation and the official french document the official french document shall prevail not for publication dissemination or distribution directly or indirectly in the united states of america or any other jurisdiction in which the distribution or dissemi
8642,all_events,DOWN,,moonlake immunotherapeutics reports full year 2023 financial results recent business highlights and announces an r d day on march 10
11226,all_events,DOWN,,boca raton florida sept 03 2024 globe newswire inmune bio inc nasdaq inmb the company a clinical stage inflammation and immunology company focused on developing treatments that harness a patient s innate immune system to fight disease today announced that management will participate in the following investor conferences in september and october 2024
8388,all_events,DOWN,,during the period september 30 october 4 2024 enea ab publ has repurchased in total 5 864 own shares isin se0009697220 within the framework of the authorization from the annual general meeting 2024 to repurchase own shares the purpose of the repurchase program is to enable the company to adapt its capital structure to its capital needs over time thereby contributing to increased shareholder value the intention is that the repurchased shares will be withdrawn by resolution at upcoming annual general meetings the repurchases are part of the share buyback program of up to sek 100 million that was announced on may 7 2024 the program which runs during the period may 10 2024 up to and including the day before the annual general meeting 2025 is being carried out in accordance with the eu market abuse regulation mar and commission delegated regulation 2016 1052 the so called safe harbour regulation the shares have been repurchased as follows all the repurchases have be
210,all_events,UP,UP,newly issued patents extend exclusivity of ublituximab through 2042 newly issued patents extend exclusivity of ublituximab through 2042
10740,all_events,DOWN,,14 nov 2024 07 45 cet agfa gevaert n v gereglementeerde informatie 14 11 2024 7 45 uur cet de agfa gevaert groep in het derde kwartaal van 2024 stabiele omzet aangepaste ebitda van 15 miljoen euro de agfa gevaert groep noteerde een omzetgroei met dubbele cijfers en een sterke rendabiliteitsverbetering in digital printing and chemicals alsook een aanzienlijke toename van de order intake in healthcare it met een groot aandeel van cloud gebaseerde contracten en netto nieuwe klantencontracten dit werd gecompenseerd door een versnelde achteruitgang in de markt voor traditionele filmproducten het besparingsprogramma van 50 miljoen euro dat de kostenbasis moet afstemmen op de versnelde marktgedreven achteruitgang van de filmgerelateerde activiteiten is in volle voorbereiding de besparingen zullen in de tweede helft van 2025 zichtbaar worden en het volledige potentieel zal in 2027 worden gerealiseerd
5076,all_events,UP,,tourmaline bio announces formation of cardiovascular scientific advisory board
651,all_events,DOWN,DOWN,media release
12824,all_events,UP,,bi boligejendomme a s i likvidation har afholdt ekstraordinær generalforsamling mandag den 4 november 2024
6433,all_events,UP,,11 nov 2024 15 15 cet sparebanken møre sparebanken møre refers to the stock exchange announcement published on 25 october 2024 i a regarding notice of order from the norwegian fsa the notice states among other things that the decision can be appealed within three weeks of receiving the order sparebanken møre has applied for an extended appeal deadline in order to have sufficient time to assess the question of whether the decision should be appealed in a letter from the norwegian fsa dated 11 november 2024 sparebanken møre has been granted an extension of the appeal deadline to 6 december 2024 contact persons trond lars nydal ceo tlf 47 951 79 977 john arne winsnes cfo tlf 47 462 80 999 runar sandanger senior economist tlf 47 950 43 660 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sparebanken møre oslo børs newspoint sparebanken møre spb møre 20 25 1 spb mo
8959,all_events,DOWN,,san diego nov 07 2024 globe newswire biora therapeutics inc nasdaq bior the biotech company reimagining therapeutic delivery today announced it will report financial results and provide a corporate update for the third quarter ended september 30 2024 company management will host a webcast and conference call on thursday november 14 2024 after the close of financial markets
9144,all_events,DOWN,,san diego sept 09 2024 globe newswire bioatla inc nasdaq bcab a global clinical stage biotechnology company focused on the development of conditionally active biologic cab antibody therapeutics for the treatment of solid tumors today announced a poster presentation at the upcoming 2024 european society for medical oncology esmo annual meeting to be held in barcelona spain from september 13 17 2024
6883,all_events,DOWN,,18 nov 2024 08 32 cet inin group as results of share exchange offer directed to all shareholders in inin group qben infra indends to proceed with listing of its shares on nasdaq first north premier growth market not for release publication or distribution in whole or in part directly or indirectly into or within the australia belarus canada hong kong india japan new zealand russia singapore south africa switzerland the united states or any other jurisdiction in which the distribution or release would be unlawful 18 november 2024 reference is made to the stock exchange announcements dated 4 and 12 november 2024 regarding the voluntary share exchange offer directed to all shareholders in inin group as qben infra ab has announced the outcome of its voluntary share exchange offer to acquire all the outstanding shares in inin group corresponding to approximately 86 per cent of the outstanding shares in inin group and the intention to proceed with the
7532,all_events,UP,,media release
7724,all_events,UP,,marlborough mass aug 05 2024 globe newswire akoya biosciences inc nasdaq akya akoya the spatial biology company today announced its financial results for the second quarter ending june 30 2024
8671,all_events,UP,,november 14 2024 01 30 et source sampo plc sampo plc sampo plc stock exchange release 14 november 2024 at 8 30 am eet sampo plc s share buybacks 13 november 2024 on 13 november 2024 sampo plc business code 0142213 3 lei 743700uf3rl386wida22 has acquired its own a shares isin code fi4000552500 as follows rounded to two decimals on 17 june 2024 sampo announced a share buyback programme of up to a maximum of eur 400 million in compliance with the market abuse regulation eu 596 2014 mar and the commission delegated regulation eu 2016 1052 on 16 september 2024 the board of directors of sampo plc resolved to increase the share buyback programme to eur 475 million the programme which started on 18 june 2024 is based on the authorisation granted by sampo s annual general meeting on 25 april 2024 after the disclosed transactions the company owns in total 10 620 010 sampo a shares representing 1 93
2218,all_events,UP,DOWN,10 oct 2024 17 55 cest veritas bureau regulated information neuilly sur seine france october 10 2024 information on number of shares and voting rights as stipulated by article 223 16 of the general regulations of the french financial markets authority amf issuer bureau veritas datenumber of shares 1 number of voting rights30 09 2024454 033 034 theoretical number of voting rights 584 082 063 number of exercisable voting rights 578 525 878 1 including the new shares issued in euroclear as a result of the exercise of stock options since january 1 2024 if any bureau veritashead officetel 33 0 1 55 24 70 00société anonymeimmeuble newtimefax 33 0 1 55 24 70 01 limited liability corporation 40 52 boulevard du parcwww bureauveritas comshare capital of eur 54 464 582 4092200 neuilly sur seine rcs nanterre 775 690 621france attachment bureau veritas number of shares and voting rights as of 09 30 2024 reg
4193,all_events,DOWN,,08 nov 2024 18 30 cet umicore déclarations de transparence par bank of america corp conformément à l article 14 1 de la loi du 2 mai 2007 relative à la publicité des participations importantes umicore a récemment été informée par bank of america corp qu elle a franchi à la baisse le 4 novembre 2024 le seuil réglementaire de des instruments financiers équivalents et qu elle a franchi à la baisse le 5 novembre 2024 le seuil réglementaire de des droits de vote directs et des instruments financiers équivalents la détention totale de droits de vote directs et d instruments financiers équivalents de bank of america s élève désormais à 2 résumé de la transaction date de franchissement du seuildate de la notificationdroits de vote directs après la transaction instruments financiers assimilés après la transactiontotal4 novembre 20245 novembre 20240 35 2 73 3 08 5 novembre 20246 novembre 20240 22 2 72 2 94 notifications de bank of america corp l
11094,all_events,UP,,18 nov 2024 15 30 cet alstom to whom it may concern please find enclosed alstom s half year financial report 2024 25 regards the alstom investor relations team attachment half year financial report_eng_hy_sep24_vfinal to whom it may concern please find enclosed alstom s half year financial report 2024 25 regards the alstom investor relations team attachment alstom sa globenewswire alstom fr0010220475 fr0010220475 alo 4alo euronext
4767,all_events,DOWN,,enclosed is the trading statement of skel fjárfestingafélag hf for the third quarter of 2024
7072,all_events,UP,,06 nov 2024 15 55 cet nordea eiendomskreditt as oslo børs har mottatt søknad om børsnotering av isin no0013389460 markedsmisbruksforordningen mar gjelder fra søknadstidspunktet herunder låntagers informasjonsplikt om innsideinformasjon more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site nordea eiendomskreditt as oslo børs newspoint nordea eiendomskredi as 10 25 4 covd nordea eiendomskre as 19 26 2 covd nordea eiendomskredi as 20 25 frn covd nordea eiendomskredi as 21 26 frn covd nordea eiendomskre as 22 30 2 covd nordea eiendomskreditt as 22 27 frn covd nordea eiendomskreditt as 22 29 4 00pct nordea eiendomskredi as 23 28 frn covd nordea eiendomskredi as 23 25 frn c covd nordea eiendomskredi as 23 28 frn c covd nordea eiendomskredi as 24 29 frn c covd gjensidige bank boligkred as 13 25 covd no0010593064 no0010852650 no0010873334 no0010893282 no0010981301 no00
2380,all_events,UP,DOWN,media release
8520,all_events,UP,,07 nov 2024 18 30 cet fleury michon fleury michon communiqué financier fleury michon annonce la cession de l activité plateaux repas située en ile de france cette activité représentait environ du chiffre d affaires du groupe pouzauges le 7 novembre 2024 à 18h00 fleury michon annonce la signature d un protocole de cession de l activité plateaux repas à la société kumo spécialiste des produits ultra frais destinés aux acteurs de la grande distribution et du catering restauration collective cette transaction marque la volonté de fleury michon de concentrer son développement sur son cœur de métier en gms et sur le développement des activités catering aérien conformément à sa stratégie déployée depuis 2021 cette activité représentait un chiffre d affaires d environ 13 millions d euros moins de du ca du groupe et un résultat d exploitation négatif le goodwill de ces activités est intégralement déprécié au 31 décembre 2023 la cession intègre les activités de
8779,all_events,DOWN,,18 nov 2024 17 45 cet streamwide cp sw sa calendrier com fi 2025 pdf streamwide euronext streamwide fr0010528059 alstw euronext growth
1470,all_events,UP,DOWN,media release
484,all_events,UP,DOWN,media release
6820,all_events,DOWN,,liitteet ovaro_9 10_trades xlsx
9311,all_events,UP,,konecranes plc managers transactions sami piittisjärvi ____________________________________________ person subject to the notification requirement name piittisjärvi sami position member of the board deputy member issuer konecranes plc lei 549300ef0cdeqzbma096 notification type initial notification reference number 549300ef0cdeqzbma096_20241111140410_439 ____________________________________________ transaction date 2024 11 08 venue xhel instrument type share isin fi0009005870 nature of the transaction acquisition transaction details 1 volume 4 unit price 64 1102 eur aggregated transactions 1 volume 4 volume weighted average price 64 1102 eur the share acquisition is part of the konecranes employee share savings program essp konecranes plc kiira fröberg vice president investor relations further information kiira fröberg vice president investor relations tel 358 0 20 427 2050 konecranes is a global leader in material handling solutions serving a b
2174,all_events,UP,UP,media release
398,all_events,DOWN,DOWN,radnor pa march 13 2024 globe newswire mineralys therapeutics inc nasdaq mlys a clinical stage biopharmaceutical company focused on developing medicines to target hypertension chronic kidney disease ckd and other diseases driven by abnormally elevated aldosterone today announced it will report its financial results from the fourth quarter and full year ended december 31 2023 before the financial markets open on thursday march 21 2024
5058,all_events,UP,,media release
7436,all_events,DOWN,,09 oct 2024 18 00 cest phaxiam therapeutics a phase 2 study sponsored by assistance publique hôpitaux de paris ap hp as part of the hospital based clinical research program phrc evaluation of the efficacy of a local treatment with phaxiam s anti s aureus phages added to the standard treatment by surgery and antibiotics 80 patients to be enrolled in 27 french clinical centersvalidation of the study protocol by the ansm expected in h1 2025 lyon france october 9 2024 06 00pm cest phaxiam therapeutics euronext phxm fr0011471135 a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections today announces the validation as part of the french hospital clinical research program phrc of a new instigator sponsored trial ist phagoscarpa in extra cavitary vascular grafts implant infections caused by staphylococcus aureus s aureus the number of vascular prostheses is increasing every year and vascular graft
908,all_events,UP,DOWN,company announcement inside information
4687,all_events,UP,,in september 2017 at an extraordinary general meeting balco adopted an instruction regarding the appointment of the nomination committee applicable until the general meeting resolves otherwise pursuant to this instruction the company shall have a nomination committee comprising one representative for each of the four principal shareholders in terms of votes based on the information received from euroclear sweden ab on the last banking day in august 2024 as well as the chairman of the board convener the nomination committee has now been appointed and comprises the following members carl mikael lindholm appointed by family hamrin chairman of the nomination committee annica nordin appointed by skandrenting ab adam hansson appointed by lannebo kapitalförvaltning magnus sjöqvist appointed by swedbank robur fonder ingalill berglund balco s chairman of the board the nominat
7990,all_events,UP,,portland maine jan 08 2024 globe newswire immucell corporation nasdaq iccc immucell or the company a growing animal health company that develops manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle today announced preliminary unaudited sales results for the fourth quarter of 2023 which ended december 31 2023
592,all_events,DOWN,DOWN,15 nov 2024 07 00 cet sanofi la fda a accepté l examen de la sbla pour le dupixent dans le traitement de l urticaire chronique spontanée la nouvelle demande comprend de nouvelles données pivots qui confirment que dupixent réduit considérablement les démangeaisons et l activité de l urticaireplus de 300 000 personnes aux états unis sont atteintes d urticaire chronique spontanée ucs insuffisamment contrôlée par des antihistaminiquesla décision de la fda attendue d ici le 18 avril 2025 s il est approuvé dupixent serait la première thérapie ciblée pour l ucs en une décennie paris et tarrytown ny le 15 novembre 2024 l agence fédérale américaine des produits alimentaires et médicamenteux us food and drug administration fda a accepté d examiner la nouvelle demande de licence supplémentaire de produits biologiques supplemental biologicals license application sbla pour dupixent dupilumab dans le traitement de patients adultes et pédiatriques âgés de 12 ans et plus a
1250,all_events,DOWN,UP,october 02 2024 11 02 et source faruqi faruqi llp faruqi faruqi llp faruqi faruqi llp securities litigation partner james josh wilson encourages investors who suffered losses exceeding 75 000 in orthofix to contact him directly to discuss their options if you suffered losses exceeding 75 000 in orthofix between october 11 2022 and september 12 2023 and would like to discuss your legal rights call faruqi faruqi partner josh wilson directly at 877 247 4292 or 212 983 9330 ext 1310 you may also click here for additional information new york oct 02 2024 globe newswire faruqi faruqi llp a leading national securities law firm is investigating potential claims against orthofix medical inc orthofix or the company nasdaq ofix and reminds investors of the october 21 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the company faruqi faruq
9630,all_events,DOWN,,november 20 2024 01 00 et source kaldvik as kaldvik as kaldvik as kldvk reports operating income in q3 amounted to eurm 24 5 eurm 2 1 while the operating profit before fair value adjustment of biomass and production tax was eurm 2 1 eurm 0 3 harvest amounted to 3 798 tonnes in q3 2024 193 tonnes web cast will be at 11 00 cet 10 00 icelandic time on 20 november 2024 on the following link on teams https t ly 4yb_c attached is the presentation and report for q3 2024 kaldvik 20 november 2024 contacts robert robertsson cfo of kaldvik as 354 843 0086 mobile this information is subject to the disclosure requirements pursuant to section 5 12 the norwegian securities trading act attachments
9300,all_events,UP,,cambridge mass nov 07 2024 globe newswire intellia therapeutics inc nasdaq ntla a leading clinical stage gene editing company focused on revolutionizing medicine with crispr based therapies today reported operational highlights and financial results for the third quarter ended september 30 2024
3372,all_events,DOWN,,november 14 2024 09 00 et source telia lietuva telia lietuva we hereby inform that telia lietuva ab financial results in 2025 will be released according to the following annual general meeting of shareholders is planned to be held on 28 april 2025 88 15 per cent of telia lietuva shares are owned by telecommunication company telia company ab sweden telia lietuva shares are listed on nasdaq vilnius stock exchange ticker tel1l the shares of telia company are listed on nasdaq stockholm and nasdaq helsinki stock exchanges darius džiaugyshead of investor relationstel 370 5 236 78 78 e mail darius dziaugys telia lt
10533,all_events,DOWN,,10 oct 2024 08 30 cest cegedim boulogne billancourt france le 10 octobre 2024 le management de la qualité du circuit des dmi et leur traçabilité sont au cœur des enjeux réglementaires d un établissement de santé cegedim business services acteur majeur de la transformation digitale et phast expert en interopérabilité sémantique annoncent un partenariat pour répondre à ces nouvelles exigences sedistock va désormais s appuyer sur le catalogue d interopérabilité ciodm pour renforcer la traçabilité des dispositifs médicaux à l hôpital un partenariat pour renforcer l interopérabilité des applications sur le circuit informatisé des dmi fluidifier les échanges d informations sur le circuit des dmi est un enjeu primordial au regard des exigences croissantes en matière de traçabilité c est précisément l objectif de ce partenariat sedistock de cegedim business services la solution de gestion des dispositifs médicaux actuellement déployée dans divers services hospitali
8481,all_events,UP,,18 nov 2024 09 30 cet argeo asa asker 18 november 2024 argeo asa will present its q3 2024 results on thursday 21 november 2024 at 11 00 cet argeo asa has the pleasure of inviting investors analysts and media to a livestreamed presentation of the results on thursday 21 november 2024 at 11 00 cet the presentation will be broadcasted live at www argeo no webcast viewers may submit written questions during and after the presentations presenters ceo trond figenschou crantz cfo odd erik rudshaug for further information trond figenschou crantz ceo trond crantz argeo no 47 976 37 273 about argeo asa argeo is a comprehensive subsea service provider operating across three major sectors oil gas marine minerals and renewables the company offers a unique package that integrates robust vessels state of the art autonomous underwater vehicles auvs advanced sensors digital imaging technology and an intuitive digital platform designed to collect a
12887,all_events,UP,,media release
8797,all_events,UP,,on october 14 2024 ipas indexo received notification on loss of a significant holding from legal entity saggis oü of the company s capital shares are owned by sandu huban detailed information is included in the attached document about indexo indexo is a financial services group that includes pension management companies and indexo bank indexo an investment management company licensed by the bank of latvia offers modern 2nd and 3rd pillar pension plans in latvia and is one of the fastest growing pension managers in the baltics with over 138 thousand customers and more than 1 25 billion euros under management meanwhile indexo bank is a credit institution licensed by the european central bank which will provide a full range of convenient and advantageous banking services to latvian residents and within the next 6 9 months also to latvian companies indexo is founded and based in latvia and is listed on the nasdaq riga stock exchange with nearly 6
8514,all_events,UP,,se vedhæftede
11804,all_events,DOWN,,12 nov 2024 17 45 cet fnac darty press releaseivry sur seine france november 12 2024 5 45 pm cest the release publication or distribution of this press release in whole or in part directly or indirectly is not permitted in or into the united states of america australia canada japan or any other country where such communication would violate the relevant applicable regulation final results of the reopening of the tender period fnac darty and ruby secure 91 of the share capital of unieuro which will be delisted final results of the reopening of the tender period 19 of unieuro s share capital tendered which cumulated to the 71 already owned by offerors represents 91 of unieuro s share capitalthe payment of the consideration for the reopening of the tender period will take place on 15 november 2024 the procedure for the fulfillment of the obligation to purchase under art 108 par 2 of the cfa will take place thereafter notice pursuant to art
12802,all_events,UP,,durham n c sept 26 2024 globe newswire humacyte inc nasdaq huma a clinical stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale today announced it will host a virtual kol event on monday september 30 2024 at 8 00 am et to register click here
9193,all_events,DOWN,,16 oct 2024 07 45 cest gimv see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1290787_241016_pr_udb_exit_eng pdf gimv les echos gimv be0003699130 gimb euronext
5792,all_events,UP,,13 nov 2024 13 47 cet bjugn sparebank det er fastsatt ny obligasjonsrente for no0012494576 ny obligasjonsrente i renteperioden 15 11 2024 17 02 2025 er 5 49 ticker bjsp06 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632064_b94e0b2a5df94351ae5572e7bcaeb5fb pdf bjugn sparebank oslo børs newspoint bjugn spb 22 25 frn bjugn spb 23 26 frn bjugn spb 24 27 frn bjugn spb 24 28 frn no0012494576 no0012921545 no0013229153 no0013233130 nordic alternative bond market
7325,all_events,UP,,media release
764,all_events,DOWN,DOWN,to nasdaq copenhagen a s corrections to final terms the english translation of the final terms of the bonds with isin code dk0009547804 published on 23 september 2024 have been updated section 15 coupon interest of the english translation has been updated from for the period until the first interest rate reset the interest rate is 3 p a to for the period until the first interest rate reset the interest rate is 3 p a nykredit realkredit a s s base prospectus dated 8 may 2024 with prospectus supplement dated 14 august 2024 and the relevant final bond terms are available for download in danish and english in the event of discrepancies between the original danish text and the english translation the danish text shall prevail the documents can be found on nykredit s website at nykredit com ir questions can be addressed to lars mossing madsen phone 45 44 55 11 66 or christian mauritzen phone 45 44 55 10 14 attachment attachments correction pdf
11154,all_events,DOWN,,media release
582,all_events,DOWN,DOWN,14 nov 2024 12 00 cet latecoere regulatory news this press release features multimedia view the full release here https www businesswire com news home 20241114231672 en andré hubert roussel new ceo of latecoere photo latecoere arnaud späni latecoere paris lat a tier 1 supplier to major international aircraft manufacturers announces that the board of directors on the recommendation of the nominations remuneration and csr committee appointed andré hubert roussel as the company s new chief executive officer effective today andré hubert roussel is an experienced and respected leader in the aerospace and defence industry with a reputation for building strong teams and running complex engineering and manufacturing organizations he brings over 20 years of experience in the aerospace and defence industry having most recently served as the ceo of arianegroup the prime contractor for ariane satellite launchers and the french nuclear deterrence mis
12860,all_events,UP,,g1 therapeutics provides update on phase 3 preserve 2 trial in patients receiving trilaciclib prior to first line chemotherapy in metastatic triple negativ
10744,all_events,UP,,media release
6682,all_events,UP,,12 11 2024 at 18 30 united bankers plc acquisition of own shares 12 11 2024 the shares held by united bankers plc on 12 11 2024 on behalf of united bankers plc skandinaviska enskilda banken ab publ helsinki branch antti salakka janne tiihonen for more information please contact patrick anderson ceo united bankers plce mail patrick anderson unitedbankers fiphone 358 400 244 544 358 9 25 380 236 www unitedbankers fi attachments ub sbb 12112024 xlsx
2948,all_events,UP,,media release
8992,all_events,UP,,missing
3910,all_events,DOWN,,media release
1844,all_events,DOWN,DOWN,radnor pa jan 04 2024 globe newswire mineralys therapeutics inc nasdaq mlys a clinical stage biopharmaceutical company focused on developing medicines to target hypertension chronic kidney disease ckd and other diseases driven by abnormally elevated aldosterone today announced the appointment of minji kim ph d as chief business officer adam levy will remain in his role as chief financial officer
11256,all_events,UP,,tom johnstone declines re election as chair of the board of husqvarna ab he will remain as board chair until the next annual general meeting to be held on april 29 2025 the nomination committee intends to propose the election of torbjörn lööf as new chair of the husqvarna ab board tom johnstone has served as the chair of the board of husqvarna ab since 2015 and has been a member of the board since 2006 torbjörn lööf has been part of husqvarna s board of directors since 2023 and was elected deputy chair of the board at the board s statutory board meeting held in connection with the 2024 annual general meeting today i have informed the nomination committee of husqvarna ab of my intention to step down in conjunction with the 2025 annual general meeting it has been an honor to serve as the chair of husqvarna ab and i am proud of the achievements of the group and the management team during these years my announcement today is part of a planned transition to new leadership that
4561,all_events,DOWN,,19 nov 2024 10 15 cet idex biometrics asa oslo norway and seoul south korea 19 november 2024 idex biometrics has entered into a commercial development agreement with south korean smart card manufacturer cellfie global formerly ick to design manufacture and market biometric metal and pvc cards for bank and fintech launches in usa europe and asia this gives idex biometrics full coverage across all four card manufacturers in south korea representing a production capacity in excess of 100 million smart cards annually and with world leading metal card manufacturing capabilities cellfie global has a strong customer base in mainly usa and europe markets representing of the 40 million annual metal card shipments cellfie global s leading metal cards provide a unique sensory experience that is driven by card weight card sound card technology and a unique design perspective bringing a different metal card solution to banks and fintechs globally we are exc
9994,all_events,UP,,after seven years the transformation to growth is completed we enter the next phase of kinnevik with a strong financial position and with a growth focused portfolio consisting of a high performing core and several exciting earlier stage companies with the potential to create significant outcomes during the quarter we continued to execute on our strategic priorities investing more capital into our core company spring health and our newer venture aira valuations in the core companies grew on the back of strong growth and improving margins but a full write down of our remaining villagemd investment and the weaker dollar weighed on our net asset value georgi ganev ceo of kinnevik key events investment activities financial position key events after the end of the quarter a conference call will be held today at 10 00 cest to present the results link to the webcast listen only https edge media server com mmc p gwm7t83x those who wish to ask questions during the conference ca
8587,all_events,DOWN,,media release
12118,all_events,UP,,jerusalem march 20 2024 globe newswire entera bio ltd nasdaq entx entera or the company a leader in the development of orally delivered peptides announced today positive pharmacokinetic results from its collaborative research combining a proprietary long acting glp 2 agonist developed by opko health inc nasdaq opk or opko with entera s proprietary n tab technology
2924,all_events,UP,,kraig labs otcqb kblb launched its third and largest production cycle of the 2024 spider silk production season
4111,all_events,UP,,12 nov 2024 13 58 cet tinn sparebank det er fastsatt ny obligasjonsrente for no0013229757 ny obligasjonsrente i renteperioden 14 11 2024 14 02 2025 er 5 42 ticker tnsb21 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631955_35905d6391b946869b25a7184d6df4c7 pdf tinn sparebank oslo børs newspoint tinn spb 22 perp frn c hybrid tinn spb 23 26 frn tinn spb 23 33 frn c sub tinn spb 24 27 frn no0012692625 no0012898719 no0012918129 no0013229757 nordic alternative bond market
7297,all_events,DOWN,,november 15 2024 05 40 et source kn energies kn energies correction interim financial information for the 3 quarters of 2024 will be released on 18 november 2024 ab kn energies further kn informs that it plans to release financial information in 2024 according to the following schedule on 30 april 2024 the company convened an ordinary general meeting of shareholders tomas tumėnas chief financial officer 370 46 391772
4898,all_events,UP,,missing
2320,all_events,DOWN,UP,14 nov 2024 19 27 cet nordic aqua partners as not for release publication or distribution in whole or in part directly or indirectly in australia canada japan or the united states or any other jurisdiction in which the release publication or distribution would be unlawful this announcement does not constitute an offer of any of the securities described herein reference is made to the stock exchange notice from nordic aqua partners as the company on 6 november 2024 regarding the commencement of the subscription period the subscription period in the subsequent offering the subsequent offering consisting of up to 466 666 new shares the subsequent offer shares in the company at a subscription price of nok 75 per share the subscription period expired yesterday 13 november 2024 at 16 30 hours cet by the end of the subscription period the company had received valid subscriptions for 212 812 subsequent offer shares in the subsequent offering th
12764,all_events,DOWN,,new data show istisociclib kb 0742 triggered cell death in preclinical ovarian cancer models of platinum and parp inhibitor parpi resistance
7447,all_events,UP,,biovascular pancreas bvp product candidate is under development as a potential treatment for type 1 diabetes
10063,all_events,UP,,portfolioerweiterung stärkt qiagens marktführerschaft bei automatisierten lösungen für nicht invasive flüssigbiopsie in kombination mit kompletten workflows aktualisiertes ccfdna kit mit urinbasiertem protokoll für die verwendung auf ez1 und ez2 instrumenten verbessert flüssigbiopsie workflows in der krebsforschung neue qiasymphony dsp circulating dna und maxi kits liefern hochwertige cfdna für downstream anwendungen portfolioerweiterung stärkt qiagens marktführerschaft bei automatisierten lösungen für nicht invasive flüssigbiopsie in kombination mit kompletten workflows aktualisiertes ccfdna kit mit urinbasiertem protokoll für die verwendung auf ez1 und ez2 instrumenten verbessert flüssigbiopsie workflows in der krebsforschung neue qiasymphony dsp circulating dna und maxi kits liefern hochwertige cfdna für downstream anwendungen
5382,all_events,DOWN,,daniel bonn rosén has been appointed as head of treasury at neobo with operational responsibility for the company s financial operations he started his new role on november 1st daniel started at neobo as a treasury analyst at the beginning of 2024 and has gradually assumed operational responsibility for the financial area within the company daniel has many years of experience from both treasury operations and capital raising in the real estate industry as head of treasury daniel will lead the operational work within neobo s financial operations with a focus on further developing neobo s financial strategy ensuring financing needs and interest cost development and working for continued good relations with lenders daniel has taken on the operational responsibility for our financial operations in an excellent way and will play a key role in our continued work to further strengthen our financial position for neobo as an employer it is particularly gratifying that we can recruit
11202,all_events,DOWN,,media release
11499,all_events,DOWN,,newark calif nov 09 2023 globe newswire rain oncology inc nasdaqgs rain rain today reported financial results for the third quarter ended september 30 2023 along with an update on the company s key developments and business operations
7383,all_events,DOWN,,south san francisco calif and san diego nov 01 2024 globe newswire oric pharmaceuticals inc nasdaq oric a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance today announced that on november 1 2024 the grant date oric granted a total of 61 800 non qualified stock options and 10 400 restricted stock units to two new non executive employees who began their employment with oric in october 2024
10879,all_events,UP,,kancera ab publ today announces the decision to focus its business on developing the company s fractalkine blocking candidate drugs kand567 and kand145 to treat cardiovascular diseases initially with focus on treatment of st elevation myocardial infarction stemi the decision is based on an overall assessment of the previously reported positive phase iia results in the fractal study the opportunity for market approval and the market potential and payers willingness to pay for an approved product the company has developed a high level development plan up until market approval which includes a phase iib study as a next step following with the decision regarding strategic direction together with the assessment that the primary study objective can be met with the existing number of patients the company will close the patient recruitment in the ongoing kandova study in ovarian cancer we see significant opportunities for our candidate drugs in both cardiovascular diseases and c
5532,all_events,UP,,media release
9187,all_events,DOWN,,15 nov 2024 17 45 cet lotus bakeries pb20241115vervreemdingeigenaandelen pdf pr20241115disposaloftreasuryshares pdf lotus bakeries euronext lotus bakeries be0003604155 lotb euronext
9315,all_events,DOWN,,media release
10283,all_events,UP,,media release
7719,all_events,DOWN,,13 nov 2024 22 10 cet genfit programme pbc sous licence ipsen ipsen présentera de nouvelles données sur elafibranor à l aasld liver meeting 2024lancement commercial d iqirvo elafibranor 1 conforme aux attentes retours encourageants des prestataires de soins de santé et des organismes payeurs aux états unisapprobation du remboursement par le nice au royaume uni et premières ventes remboursées en allemagne en octobre 2024prochain paiement d étape de 26 5 millions d euros par ipsen dépendant de l obtention d une troisième décision de fixation de prix de remboursement en europe les avancées scientifiques dans le domaine de l aclf seront illustrées lors de l aasld liver meeting 2024 par 4 posters présentant de nouvelles données précliniques au cours duquel genfit organisera 3 événements rassemblant des acteurs clés du domaine les résultats de l étude de phase 2 unveil it évaluant vs 01 dans l aclf sont désormais attendus pour le deuxième semestre 2025 le protocole
12203,all_events,UP,,08 nov 2024 08 15 cet bekaert s a mise à jour relative au contrat de liquidité période allant du 31 octobre 2024 au 6 novembre 2024 contrat de liquiditédans le cadre du contrat de liquidité reconduit avec kepler cheuvreux annoncé le 25 juin 2024 bekaert annonce aujourd hui que kepler cheuvreux a acheté 7 600 actions pour le compte de bekaert durant la période comprise entre le 31 octobre 2024 et le 6 novembre 2024 sur euronext bruxelles au cours de la même période kepler cheuvreux a vendu 5 904 actions pour le compte de bekaert sur euronext bruxelles les tableaux ci dessous donnent un aperçu des transactions effectuées dans le cadre du contrat de liquidité au cours de la période comprise entre le 31 octobre 2024 et le 6 novembre 2024 achat d actions datenombre d actionsprix moyen prix le plus élevé prix le plus bas montant total 31 octobre 20242 10033 2933 4033 2069 9091 novembre 202441433 3633 4033 2413 8114 novembre 20241 38633 1833 3033 0845 9875 novem
1275,all_events,DOWN,DOWN,november 08 2024 05 30 et source sampo oyj sampo oyj sampo oyj johdon liiketoimet 8 11 2024 klo 12 30 sampo oyj johdon liiketoimet rauramo sampo oyj y tunnus 0142213 3 on vastaanottanut seuraavan markkinoiden väärinkäyttöasetuksen 19 artiklan mukaisen ilmoituksen osakkeet on hankittu sammon yhtiökokouksen 25 4 2024 tekemän päätöksen mukaisesti ____________________________________________ ilmoitusvelvollinen nimi markus rauramoasema hallituksen jäsen varajäsenliikkeeseenlaskija sampo oyjlei 743700uf3rl386wida22ilmoituksen luonne ensimmäinen ilmoitusviitenumero 84096 7 6____________________________________________ liiketoimen päivämäärä 2024 11 07kauppapaikka nasdaq helsinki ltd xhel instrumenttityyppi osakeisin fi4000552500liiketoimen luonne osakepalkkion vastaanottaminen liiketoimien yksityiskohtaiset tiedot 1 volyymi 694 yksikköhinta 40 35 eur liiketoimien yhdistetyt tiedot 1 volyymi 694 keskihinta 40 35 eur______
12223,all_events,UP,,media release
2769,all_events,DOWN,,media release
2559,all_events,DOWN,DOWN,media release
6108,all_events,DOWN,,media release
2323,all_events,DOWN,UP,immuneering to present at the jefferies global healthcare conference
4842,all_events,DOWN,,november 18 2024 03 50 et source heimar hf heimar hf in week 46 heimar hf heimar purchased 4 000 000 own shares at a total purchase price of 137 700 000 isk as follows the transactions are in accordance with heimar s buyback program which was announced on october 16 2024 according to the program the buybacks will amount to a maximum of isk 500 000 000 in total and the program will remain in effect until that limit is reached but no later than the company s 2025 annual general meeting heimar owned 27 312 500 shares prior to the above transaction and following these purchases now holds 31 312 500 shares or approximately 1 of the company s issued shares with a total purchase price of isk 995 400 000 the execution of the buyback program will comply with the icelandic public limited companies act no 2 1995 article 5 of the european parliament and council regulation eu no 596 2014 on market abuse as referred to in the
2996,all_events,UP,,media release
8539,all_events,DOWN,,13 nov 2024 18 00 cet lectra déclaration mensuelle du nombre total d actions et de droits de vote composant le capital social au 31 octobre 2024 cette déclaration est établie en application de l article l 233 8 ii du code de commerce et de l article 223 11 du règlement général de l autorité des marchés financiers amf date d arrêté des informations 31 octobre 2024 nombre total d actions composant le capital social 37 956 271 total brut 1 des droits de vote 38 148 421 total net 2 des droits de vote 38 113 734 1 conformément au deuxième alinéa de l article 223 11 du règlement général de l amf le nombre total brut de droits de vote est calculé sur la base de l ensemble des actions auxquelles sont attachés des droits de vote y compris les actions privées de droit de vote 2 le total net est égal au total brut diminué des actions privées de droit de vote actions détenues en propre en dehors des seuils prévus par la loi il n y a pas d obligation statutaire
2450,all_events,UP,DOWN,topline results to include biopsy results for the phase 2 clinical study evaluating elx 02 for the potential treatment of alport syndrome expected in first half of 2023 meaningful protein reduction has been observed in one patient to date
12888,all_events,DOWN,,media release
2531,all_events,DOWN,DOWN,media release
1369,all_events,DOWN,UP,media release
740,all_events,UP,DOWN,media release
10345,all_events,UP,,05 nov 2024 18 23 cet care property invest care property invest announces having received a transparency notification dated 4 november 2024 from blackrock inc read the press release in english care property invest announces having received a transparency notification dated 4 november 2024 from blackrock inc read the press release in english pressrelease publicationofatransparencynotification blackrock 20241101 eng pdf care property inv euronext care property invest be0974273055 cpinv euronext
6836,all_events,UP,,media release
1188,all_events,UP,UP,november 07 2024 11 30 et source kalmar oyj kalmar oyj liite
11502,all_events,UP,,tiziana life sciences announces platform presentation of new quantitative pet imaging data on foralumab at the american academy of neurology
1570,all_events,DOWN,DOWN,19 nov 2024 18 15 cet volta finance ltd volta finance limited vta vtas october 2024 monthly reportnot for release distribution or publication in whole or part in or into the united states guernsey november 19th 2024 axa im has published the volta finance limited the company or volta finance or volta monthly report for october 2024 the full report is attached to this release and will be available on volta s website shortly www voltafinance com performance and portfolio activity dear investors volta finance recorded a net performance of 4 in october bringing the year to date return to 18 this performance was primarily achieved via our clo equity exposure that generated strong distributions while prices remained broadly flat in terms of market activity it felt like october displayed evidences of a transition month placed in between a very busy post summer run and the us presidential elections the month was far from being non eventful though
3599,all_events,DOWN,,media release
11656,all_events,DOWN,,15 nov 2024 08 16 cet mutares se co kgaa sixteenth acquisition in 2024 mutares signed an agreement to acquire vr road logistics from vr group further strengthening mutares presence in finland after recent successful acquisition of palmia and redo new platform investment for the goods services segment revenues of ca eur 80 million in 2023 provider of road logistics services wide service coverage in finland with a focus on industrial customers please see attached pdf to view the full announcement more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632346_20241114_fox_ _mux_signing_final_en_ _v2 pdf mutares se co kgaa oslo børs newspoint mutares se co k 23 27 frn eur floor c no0012530965 nordic alternative bond market
7067,all_events,DOWN,,05 nov 2024 22 01 cet galapagos new phase 1 2 data support the potential of our car t cell therapy candidates glpg5101 and glpg5201 in addressing unmet needs for patients with poor prognoses our innovative decentralized cell therapy manufacturing platform delivers fresh fit cells within a median vein to vein time of seven days with potentially encouraging patient outcomes three abstracts including one oral presentation for glpg5101 in relapsed refractory non hodgkin lymphoma and a company showcase will spotlight our cutting edge cell therapy innovations in blood cancers and solid tumors mechelen belgium november 5 2024 22 01 cet galapagos nv euronext nasdaq glpg today announced that it will present new data from its car t and tcr t cell therapy pipeline at the 66th american society of hematology ash annual meeting and exposition in san diego ca 7 10 december 2024 three abstracts including one oral presentation will feature new data from our prop
9234,all_events,DOWN,,media release
11920,all_events,UP,,18 oct 2024 18 00 cest tme pharma la dernière analyse des données cliniques de nox a12 présentée à l esmo 2024 révèle un bénéfice de survie statistiquement significatif pour la combinaison nox a12 bevacizumab radiothérapie chez les patients atteints de glioblastome validant ainsi son potentiel de bénéfices cliniques sans précédent pour les patients echanges en cours avec partenaires industriels stratégiques potentiels et des institutions gouvernementales afin de licencier nox a12 et obtenir un soutien non dilutif pour le prochain essai clinique activités et discussions en cours pour externaliser le développement du nox e36 qui présente un fort potentiel dans de nombreuses indications ophtalmologiques horizon de trésorerie prolongé d un mois porté à janvier 2025 regulatory news tme pharma n v euronext growth paris altme société de biotechnologie au stade clinique spécialisée dans le développement de nouvelles thérapies pour le traitement du c
3942,all_events,DOWN,,07 nov 2024 18 07 cet marie brizard wine and spirits declaration mensuelle relative au nombre total de droits de vote et d actions article l233 8ii du code de commerce et 223 16 du reglement general de l autorite des marches financiers charenton le pont le 7 novembre 2024 marie brizard wine spirits code isin 0000060873 situation au nombre total d actions composant le capital socialnombre total de droits de votes31 octobre 2024111 989 823nombre de droits de vote théoriques 1 138 376 398nombre de droits de vote exerçables 2 138 266 718 présence dans les statuts de marie brizard wine spirits sa d une clause imposant une obligation d information de franchissement de seuil statutaire complémentaire de celle relative aux seuils légaux oui 1 y compris actions auto détenues 2 déduction faite des actions auto détenues pièce jointe declaration mensuelle octobre 2024 declaration mensuelle relative au nombre total de droits de vote et d actions art
10523,all_events,DOWN,,u s launch underway for xolremdi mavorixafor in whim syndrome
2119,all_events,DOWN,DOWN,12 nov 2024 07 30 cet veritas bureau communiqué de presse paris 12 novembre 2024 bureau veritas continue de renforcer ses capacités dans le secteur de l énergie et des énergies renouvelables grâce à l acquisition de versatec energy b v bureau veritas leader mondial de l industrie des essais de l inspection et de la certification tic annonce aujourd hui l acquisition de versatec energy b v une société de conseil technique indépendante spécialisée dans l industrie de l énergie offshore et onshore cette acquisition s inscrit dans la stratégie leap 28 de créer une nouvelle place forte dans le segment des énergies renouvelables en forte croissance cette transaction souligne l engagement du groupe en matière de transition énergétique et consolide sa position d acteur clé pour bâtir un secteur de l énergie durable et sûr bureau veritas contribue à l efficacité du secteur de l énergie en fournissant à ses clients énergétiques des solutions de bout en bout réponda
9118,all_events,DOWN,,media release
11052,all_events,UP,,on june 19 2024 savelend group ab savelend group announced the initiation of a strategic review regarding the billing platform segment whose operations are conducted within the wholly owned subsidiary billecta ab billecta the aim of the review is to maximize savelend groups future potential and optimize shareholder value the ongoing review has led to discussions with multiple interested parties regarding the acquisition of all shares in billecta as part of this process savelend group has entered into a non binding letter of intent and is now in a due diligence process with a potential buyer the goal is for the transaction to be completed before the end of the year as part of the deal with the potential buyer the intention is for parts of billecta s management and board to invest and for the staff to be offered the opportunity to invest in a minority stake in the company that intends to acquire all shares in billecta savelend groups board has not set a timeline for
4929,all_events,DOWN,,media release
12859,all_events,UP,,stora enso oyj stock exchange release 6 november 2024 at 13 30 eet stora enso oyj received a notification pursuant to chapter 9 section 5 of the securities market act from blackrock inc on 5 november 2024 on 5 november 2024 blackrock s holding in stora enso s shares decreased below the 5 percent threshold of shares and voting rights total of 7 a of shares and voting rights through financial instruments total of 7 b total of both in 7 a 7 b resulting situation on the date on which threshold was crossed or reached 4 shares below voting rights 0 shares below voting rights 5 shares below voting rights position of previous notification if applicable 5 shares below voting rights 0 shares below voting rights 5 shares below voting rights a shares and voting rights class type of shares isin code if possible number of shares and voting rights of shares and voting rights direct sma 9 5 indirect sma 9 6 and 9 7 direct s
3265,all_events,DOWN,,media release
11365,all_events,UP,,media release
10606,all_events,UP,,media release
10712,all_events,UP,,november 15 2024 06 35 et source pro kapital grupp pro kapital grupp in 2025 as pro kapital grupp will disclose its consolidated financial results on the following dates ann kristin kuusikcfo 372 614 4920prokapital prokapital ee
3573,all_events,UP,,mj foundation fundacja rodzinna a company related to mateusz juroszek board member and primary insider of gentoo media inc gentoo has today acquired 9 139 shares in gentoo at a price of sek 24 30 per share after this transaction close associates of mateusz juroszek hold 24 036 905 shares in gentoo this information is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act about gentoo media gentoo media is a market leading affiliate connecting operators and players in the online gambling and sports betting industry gentoo media offers an array of igaming affiliate solutions such as paid marketing expertise and quality traffic through our prominent industry sites including askgamblers time2play casinotopsonline wsn and casinomeister in 2024 gentoo media formerly gig media became gentoo media inc following a legal split separating the media and platform and sportsbook business in gaming innovation group gig into two in
12017,all_events,UP,,13 nov 2024 07 00 cet borgestad asa highlights borgestad groups profit before tax at mnok 44 1 for q3 24 compared to mnok 29 4 in q3 23 ebit margin at 7 4 percent for höganäs borgestad group ltm 24 compared to adjusted ebit at 3 2 percent ltm 23 agora bytom delivered an ebitda of mnok 10 3 in q3 24 compared to an ebitda of mnok 8 0 in q3 23 borgestad asa strengthened its team with the addition of bendik persch andersen as head of m a corporate development and investor relations borgestad asa s report and presentation for third quarter of 2024 is attached hereto the contact person is pål feen larsen ceo borgestad asa 47 48 84 53 33 or bendik persch andersen head of m a corporate development and investor relations in borgestad asa 47 98 83 67 27 this information is subject to disclosure requirements pursuant to the securities trading act 5 12 about borgestad www borgestad no borgestad asa ose bor is an investment company focused on rea
2069,all_events,UP,DOWN,19 nov 2024 17 46 cet warehouses estates belgium see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1298857_web_compresse_20241119_wteam pdf warehouse estates belgium s a les echos warehouses estates belgium w e b be0003734481 web euronext
9189,all_events,DOWN,,12 nov 2024 08 30 cet compagnie du bois sauvage see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1296665_2024_11_12_cbs_rap_en pdf compagnie bois sauvage les echos cie bois sauvage be0003592038 comb euronext
9140,all_events,UP,,15 nov 2024 13 46 cet sparebanken møre det er fastsatt ny obligasjonsrente for no0012526286 ny obligasjonsrente i renteperioden 19 11 2024 19 02 2025 er 8 19 ticker morg56 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632409_2e7902809f1f4a39ad86f7be018df020 pdf sparebanken møre oslo børs newspoint sparebanken møre spb møre 20 25 1 spb more 21 27 frn c spb more 22 28 frn spb more 22 32 frn c sub spb more 22 perp frn c hybrid spb more 23 33 frn c sub spb more 23 26 frn spb more 23 27 5 spb more 23 27 frn spb more 23 27 5 spb more 23 29 5 spb møre 24 perp adj c hybrid spb møre 24 29 frn no0012483207 no0010904907 no0010917933 no0012422916 no0012490012 no0012526286 no0012
4609,all_events,UP,,november 15 2024 08 05 et source pro kapital grupp pro kapital grupp 2025 aastal avaldab as pro kapital grupp oma konsolideeritud majandustulemused järgnevatel kuupäevadel ann kristin kuusikfinantsjuht 372 614 4920prokapital prokapital ee
1606,all_events,UP,DOWN,12 nov 2024 17 45 cet imerys see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1297111_imerys12november2024informationsharecapitalandvotingrightsasof31october2024 pdf imerys les echos imerys fr0000120859 nk euronext
4026,all_events,DOWN,,new york june 11 2024 globe newswire tiziana life sciences ltd nasdaq tlsa tiziana or the company a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery today announced it has received acceptance of its submission for intranasal foralumab to receive fast track designation approval for the treatment of non active secondary progressive multiple sclerosis na spms to the u s food and drug administration fda
7320,all_events,UP,,07 nov 2024 18 00 cet jcdecaux se information trimestrielle du 3ème trimestre 2024 paris le 7 novembre 2024 jcdecaux se euronext paris dec numéro un mondial de la communication extérieure a publié ce jour la présente information trimestrielle pour le 3ème trimestre 2024 faits marquants du 3ème trimestre 2024 evolution du portefeuille de contrats asie pacifique en juillet jcdecaux se a annoncé que jcdecaux macao joint venture entre jcdecaux 80 du capital et hn group 20 du capital a renouvelé son contrat publicitaire exclusif avec l aéroport international de macao pour une durée de 10 ans à l issue d un appel d offres effectif depuis le 1er juillet 2024 ce nouveau contrat renforce la présence de jcdecaux à macao europe en septembre jcdecaux se a annoncé avoir remporté le contrat publicitaire emblématique des abribus de londres à la suite d un appel d offres organisé par transport for london tfl
2473,all_events,UP,UP,media release
4336,all_events,UP,,mainz biomed to present results of colorectal cancer screening study eaarly detect at digestive disease week 2024 in washington d c
10925,all_events,DOWN,,13 nov 2024 08 00 cet romerike sparebank hovedtrekk i 3 kvartal resultatfremgang fra fjoråret økte renteinntekter og normaliserte driftskostnader styrker forholdstallet ki økning i utlånsvekst til privatkunder og marginal vekst i utlån til næringskunder første grønne obligasjonslån utstedt god soliditet gir rom for videre utlånsvekst ncr har tildelt banken en a rating etter kvartalsslutt banken har hittil i år et resultat før skatt på 199 1 millioner kroner 158 1 millioner kroner resultat etter skatt per 30 september gir en egenkapitalavkastning p a justert for fondsobligasjon på 9 4 prosent 8 3 prosent kostnad inntektsforhold ki siste 12 måneder er 42 3 prosent en bedring sammenliknet mot fjorårets 47 0 prosent ved utgangen av 3 kvartal er konsolidert ren kjernekapitaldekning 18 7 prosent 18 7 prosent ned fra 20 0 prosent per 31 12 2023 banken er godt kapitalisert banken har en 12 måneders vekst i brutto utlån inklude
9414,all_events,DOWN,,zug switzerland oct 21 2024 globe newswire oculis holding ag nasdaq ocs oculis a global biopharmaceutical company purposefully driven to save sight and improve eye care today announces the acceleration of patient enrollment for both phase 3 diamond trials of ocs 01 eye drops in dme and expansion of the diamond program committees with globally renowned retina experts
8101,all_events,UP,,new agreement expands collaboration with astrazeneca beyond oncology including complex chronic diseases qiagen s syndromic testing platform qiastat dx enables specialty care providers to make fast decisions about patients eligibility for investigational precision medicines new agreement expands collaboration with astrazeneca beyond oncology including complex chronic diseases qiagen s syndromic testing platform qiastat dx enables specialty care providers to make fast decisions about patients eligibility for investigational precision medicines
2085,all_events,UP,DOWN,conformément aux articles l 233 8 ii du code de commerce et 223 16 du règlement général
248,all_events,UP,DOWN,19 nov 2024 07 30 cet nicox s a communiqué de pressenicox annonce la publication de la partie adaptive de l étude clinique de phase 3 mont blanc sur ncx 470 une partie adaptative est un outil de design d étude clinique utile qui a permis d identifier la dose optimale de ncx 470 dans l étude mont blanc la première étude de phase 3 de ncx 470les deux doses de la solution ophtalmique ncx 470 évaluées 0 065 et 0 1 ont réduit la pression intraoculaire davantage que le comparateur latanoprost solution ophtalmique 0 005 la concentration de 0 1 de ncx 470 a été retenue pour la suite de l étude mont blanc ainsi que pour l étude denali en cours cette sélection a été réalisée sur la base d une réduction plus importante de la pression intraoculaire par rapport à la concentration de 0 065 et sur la base d un bon profil de sécurité 18 novembre 2024 publication à 7h30sophia antipolis francenicox sa euronext growth paris fr0013018124 alcox éligible pea pme une soc
2582,all_events,DOWN,UP,missing
9402,all_events,UP,,best in class anti ctla 4 candidates designed for more than 30 fold increase in therapeutic index addressing patient populations where ctla 4 mediated treg depletion is essential for efficacy
10997,all_events,DOWN,,media release
562,all_events,DOWN,DOWN,18 nov 2024 17 45 cet lagardere s a see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1298525_rachat_dactions_cp_hebdomadaire__111124_au_151124__fr pdf lagardere les echos lagardere sa fr0000130213 mmb euronext
2456,all_events,DOWN,DOWN,media release
7406,all_events,UP,,november 07 2024 01 00 et source dno asa dno asa oslo 7 november 2024 dno asa the norwegian oil and gas operator today announced that pursuant to the authorization granted at the annual general meeting held on 6 june 2024 the board of directors has approved a dividend payment of nok 0 3125 per share to be made on or about 22 november 2024 to all shareholders of record as of 15 november 2024 dno shares will be traded ex dividend as of 14 november 2024 for further information please contact media media dno noinvestors investor relations dno no dno asa is a norwegian oil and gas operator active in the middle east the north sea and west africa founded in 1971 and listed on the oslo stock exchange the company holds stakes in onshore and offshore licenses at various stages of exploration development and production in the kurdistan region of iraq norway the united kingdom côte d ivoire netherlands and yemen this information
8074,all_events,UP,,innofactor plc stock exchange release november 15 2024 at 22 00 eest innofactor plc has on november 15 2024 received a notification from onni bidco under chapter 9 section 5 of the finnish securities markets act according to which onni bidco oy s direct holding in innofactor s shares increased above the 90 percent threshold total positions of onni bidco oy according to the notification notified details of the resulting situation on the date on which the threshold was crossed or reached a shares and voting rights b financial instruments according to sma 9 6a full chain of controlled undertakings through which the voting rights and or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity further according to onni bidco oy s notification onni bidco oy has acquired a total of 3 648 829 shares of innofactor plc through transactions made on november 15 2024 onni bidco oy and the broker wh
7886,all_events,DOWN,,media release
11563,all_events,UP,,media release
914,all_events,DOWN,DOWN,media release
8114,all_events,UP,,media release
10866,all_events,DOWN,,media release
5851,all_events,UP,,11 oct 2024 18 08 cest alpes compagnie des see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1290173_cda__cp_compo_ca pdf compagnie des alpes les echos alpes compagnie fr0000053324 cda euronext
5653,all_events,UP,,november 18 2024 03 15 et source investeringsforeningen bankinvest investeringsforeningen bankinvest opdateret prospekt for investeringsforeningen bankinvest offentliggøres dags dato der er fore taget følgende opdateringer i prospektet og prospektets bilag vedr bæredygtighedsrelaterede oplysninger prospektet er vedhæftet denne fondsbørsmeddelelse og kan endvidere downloades på bankinvest dk eller rekvireres ved henvendelse til bi management a s bredgade 40 1260 københavn k tlf 77 30 90 00 henvendelser vedrørende denne meddelelse kan rettes til direktør martin fjordlund smidt på tlf 77 30 90 00 med venlig hilsenbi management a s martin fjordlund smidtdirektør vedhæftet fil
12378,all_events,DOWN,,media release
4382,all_events,UP,,media release
9858,all_events,UP,,media release
8710,all_events,UP,,media release
11325,all_events,DOWN,,15 nov 2024 06 30 cet desert control as sandnes norway 15 november 2024 desert control as dsrt announces its third quarter report and interim financial results for the fiscal period ending 30 september 2024 desert control continued its positive momentum in the third quarter of 2024 achieving milestones in market expansion pilot progress and initiation of licensing revenues in the middle east the quarter saw strong results from pilots in agriculture and landscaping supporting negotiations for larger commercial projects in the united states growing traction in the middle east further strengthens the foundation for sustainable growth under the company s royalty based licensed operator model operational highlights solid pilot results strengthen validation and support negotiations for larger contracts in the united states landscaping success in the u s landscaping pilots in california achieved over irrigation savings with some clients reporting wa
862,all_events,UP,DOWN,kraig labs otcqb kblb successfully completed its fourth 2024 production cycle with record setting performance across nearly every tracked metric
12192,all_events,UP,,malvern pa may 06 2024 globe newswire annovis bio inc nyse anvs annovis or the company a clinical stage drug platform company developing novel therapies for neurodegenerative diseases announced that maria maccecchini founder president and ceo of annovis issued a letter to stockholders providing a review of phase ii iii data from its alzheimer s study and sharing next steps
9486,all_events,UP,,18 nov 2024 08 30 cet barramundi group ltd currently the following companies are placed in recovery box barramundi group ltd since 09 09 2024 teco 2030 asa since 15 11 2024 recovery box is a special compartment where oslo børs can place securities where the issuer is subject to circumstances that make pricing of the securities particularly uncertain recovery box is regulated in section 2 10 2 of oslo rule book ii oslo børs and euronext expand and section 3 8 2 of euronext growth oslo rule book part ii the relevant security will remain in the recovery box until the circumstances for the allocation to the recovery box are no longer present currently the following companies are placed in penalty bench solis bond company dac since 02 05 2024 alternus energy plc since 03 06 2024 barramundi group ltd since 03 06 2024 eam solar as since 06 09 2024 penalty bench is a special compartment where the securities of issuers that fail to comply with the ru
6697,all_events,DOWN,,s p global ratings has revised the future perspective of jsc augstsprieguma tīkls credit rating from positive to stable due to the sovereign downgrade about jsc augstsprieguma tikls ast the latvian electrical power transmission system operator ensures uninterrupted and secure transmission of electricity throughout latvia its vision is to become the leading transmission system operator in the region through the efficient and successful implementation of development oriented changes ast has 68 shareholding in the capital of the operator of the natural gas transmission and storage system as conexus baltic grid further information līva jēgere head of communications ph 371 26151344 email liva jegere ast lv attachments ratingsdirect_researchupdatelatvianelectricitytransmissionoperatorastoutlookrevisedtostableonsovereigndowngradearatingaffirmed_59594161_oct 11 2024 cleaned pdf
4682,all_events,UP,,media release
12655,all_events,DOWN,,tourmaline bio to present at upcoming investor conferences
11937,all_events,UP,,media release
1320,all_events,DOWN,DOWN,media release
5834,all_events,DOWN,,company release nanoform finland plc november 19 2024 20 45 finnish time 19 45 swedish time nanoform finland plc manager s transactions albert hæggström helsinki finland manager s transaction related to nanoform finland plc s member of the board and cfo albert hæggström s purchase of nanoform finland plc shares nanoform finland oyj managers transactions ____________________________________________ person subject to the notification requirement name albert haeggström position member of the board deputy member issuer nanoform finland oyj lei 743700jjo2nu8lbs1592 notification type initial notification reference number 85422 5 4 ____________________________________________ transaction date 2024 11 19 venue first north growth market finland fsme instrument type share isin fi4000330972 nature of transaction acquisition transaction details 1 volume 18812 unit price 1 168 eur aggregated transactions 1 volume 18812 volume weighted average price 1 168 eur
6050,all_events,UP,,20 nov 2024 07 30 cet borr drilling limited hamilton bermuda november 20 2024 borr drilling limited borr drilling or the company nyse ose borr initiated a share repurchase program on november 12 2024 to repurchase usd 10 million of the company s common shares in open market transactions the first tranche on the ose and nyse until no later than november 30 2024 pursuant to an agreement with dnb markets a part of dnb bank asa dnb markets this was the initial step under the board of directors authorized commitment to repurchase 20 million worth of shares before the end of 2024 for the period from and including november 12 2024 through the last day of the repurchase program november 18 2024 the company purchased a total of 2 466 281 shares at an average price of usd 4 055 per share equal to a total of usd 9 999 789 as a result borr drilling hereby announces that the first tranche of the share repurchase program initiated on 12 november
1496,all_events,DOWN,UP,results of dose escalation portion from phase 1b 2 trials of adg126 in combination with anti pd 1 therapies including confirmed clinical responses pave way for dose expansion in specific tumors
3508,all_events,UP,,09 oct 2024 18 00 cest exclusive networks sa modalities of participation in the shareholders general meeting regulatory news the shareholders of exclusive networks sa paris exn are invited to the ordinary general shareholders meeting to be held on 31 october 2024 at 2 30 p m cet at the company s registered office 20 quai du point du jour 92100 boulogne billancourt france the documents referred to in the article r 225 73 of the french commercial code are available on the company s website under general meetings at the following address https ir exclusive networks com agm the preliminary notice of meeting was published in the bulletin des annonces légales obligatoires of 23 september 2024 n 115 https www journal officiel gouv fr pages balo that contains the agenda and the draft text of the resolutions due to be submitted to a shareholder vote the terms and conditions to participate and vote to this general shareholders meeting are detailed
1747,all_events,UP,DOWN,06 nov 2024 12 21 cet bluenord asa oslo 6 november 2024 bluenord asa bluenord or the company has today announced its preliminary production figures for october 2024 the company had a preliminary production in october of net 23 4 mboepd from dan gorm and halfdan of this 0 3 mboepd of gas was consumed on tyra during the ongoing commissioning work such that the net export production figure was 23 1 mboepd net to bluenord production from the tyra hub was temporarily halted in october in connection with the upcoming restart of the facilities the production from halfdan and gorm was lower in october compared to previous months as planned compressor maintenance was successfully completed during the month on halfdan certain wells were temporarily closed due to the ongoing well optimization campaign wrom the increased production from the skjold gas acceleration sgpap caused temporary restrictions on production due to capacity constraints the company rei
180,all_events,UP,DOWN,02 oct 2024 08 22 cest scana asa bergen 2 october 2024 reference is made to the announcement by scana asa ose scana on 1 september 2024 scana asa has today received a press release from mig finance namibia proprietary limited mig the press release from mig is attached to the published stock exchange notice in addition psw technology as has accepted a postponement of the 10 prepayment for potential sale of capping stack to mig the prepayment is to be made during october for more information please contact pål selvik ceo scana asa 47 970 46 502 scana in brief scana is an active industrial owner of technology and services to both the energy and offshore industries with an industrial history dating back to the early 1900s scana has evolved to become a leader in technology and innovation this journey has provided a unique position to shape solutions for tomorrow driven by extensive industrial experience combined with quality and value crea
4007,all_events,DOWN,,18 nov 2024 14 02 cet solis bond company dac se vedlegg på www newsweb no more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632546_interests 2024 11 18 pdf solis bond company dac oslo børs newspoint solis bond company 21 24 frn eur floor c no0010914914 oslo børs
7707,all_events,DOWN,,radnor pa oct 28 2024 globe newswire certara inc nasdaq cert a global leader in model informed drug development today announced that company management will participate in the stephens annual investment conference
9980,all_events,UP,,jupiter fla and nes ziona israel feb 23 2024 globe newswire dyadic international inc dyadic or the company nasdaq dyai a global biotechnology company specializing in advanced microbial platforms for protein development and bioproduction and meeting clinical needs and israel institute for biological research iibr announced it has advanced its collaboration with the israel institute for biological research iibr and its commercial arm life science research israel lsri to target emerging disease solutions this partnership aims to leverage dyadic s expertise in microbial platforms for flexible scale protein bioproduction and the iibr s antibodies and antigens discovery capabilities to develop and manufacture innovative solutions for addressing emerging diseases and potential bio threats through this collaboration both parties are working towards the development of effective treatments and vaccines to combat global health challenges with the intention of future commercialization to date the framework is non binding and subject to the execution of a binding agreement to be negotiated by the parties through collaborative out licensing initiatives
8993,all_events,DOWN,,12 nov 2024 09 26 cet agder sparebank utsteder agder sparebank isin for obligasjonslånet no0011204349 dato for innfrielse 29 10 2024 beløp som innfris mnok 30 innløsningskurs 100 095 dato for innfrielse 30 10 2024 beløp som innfris mnok 25 innløsningskurs 100 093 dato for innfrielse 13 11 2024 beløp som innfris mnok 45 innløsningskurs 100 064 utestående beløp etter innfrielse mnok 0 innfrielsen er gjort som nedkvittering i vps denne opplysningen er informasjonspliktig etter verdipapirhandelloven 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site agder sparebank oslo børs newspoint østre agder spb 20 perp frn c hybrid østre agder spb 20 25 frn ostre agder spb 21 31 frn c sub ostre agder spb 22 25 frn agder spb 22 27 frn agder spb 22 26 frn agder spb 23 28 frn agder spb 22 25 frn agder spb 23 33 frn c sub agder spb 24 29 frn agder spb 24 28 frn no0010886385
3717,all_events,UP,,13 nov 2024 08 22 cet måsøval as financial calendar for måsøval as financial year 2024 10 04 2025 annual report 19 11 2024 quarterly report q3 25 02 2025 quarterly report q4 financial year 2025 19 08 2025 half yearly report 05 06 2025 annual general meeting 22 05 2025 quarterly report q1 18 11 2025 quarterly report q3 this information is published pursuant to the requirements set out in the continuing obligations more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site måsøval as oslo børs newspoint måsøval as no0010974983 mas euronext growth
1057,all_events,UP,UP,media release
8774,all_events,UP,,media release
7680,all_events,DOWN,,alisa bank plc manager transactions 19 11 2024 at 10 40 eet person subject to the notification requirement name sh ventures oy position member of the board deputy member x legal person 1 person discharging managerial responsibilities in issuer name sami honkonen position member of the board issuer alisa pankki oyj lei 743700vk1nb8hrgtqh74 notification type initial notification reference number 85045 6 4 transaction date 2024 11 15 venue nasdaq helsinki ltd xhel instrument type share isin fi4000170915 nature of transaction acquisition transaction details 1 volume 411 235 unit price 0 189 eur aggregated transactions 1 volume 411 235 volume weighted average price 0 189 eur further information juha saari interim ceo alisa bank plc juha saari alisapankki fi tel 358 40 672 0595 alisa bank in brief alisa bank plc is a financial technology company that provides seamless banking services through digital channels we serve sme customers deposit customers se
3478,all_events,DOWN,,needham mass may 30 2024 globe newswire candel therapeutics inc candel or the company nasdaq cadl a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer today announced that the u s food and drug administration fda has granted orphan drug designation to can 3110 a next generation oncolytic viral immunotherapy for the treatment of recurrent high grade glioma rhgg glioblastoma gbm is the most common and aggressive form of high grade glioma
1399,all_events,UP,DOWN,nightingale health plc company release 8 november 2024 at 5 00 p m eet the annual general meeting of nightingale health plc was held on 8 november 2024 the meeting was held as a fully virtual remote meeting in accordance with chapter 5 section 16 subsection 3 of the finnish companies act the general meeting adopted the financial statements and the consolidated financial statements discharged the members of the board of directors and the ceo from liability and approved in an advisory vote the remuneration report of the governing bodies for the financial period of 1 july 2023 30 june 2024 use of profit shown on the balance sheet and the payment of dividend the general meeting resolved that based on the balance sheet adopted for the financial period of 1 july 2023 30 june 2024 no dividend is paid and that the loss of the financial period is recorded in retained earnings board of directors the number of members of the board of directors was confirmed to be six 6 antti kangas
1799,all_events,DOWN,DOWN,heimar reports a profit of isk 5 6 billion in the first nine months of the year ebitda rises by 7 key highlights of the nine month results halldór benjamín þorbergsson ceo of heimar our operations are performing well and in line with plans we are experiencing strong demand for commercial real estate especially in heimar s core areas rental revenue growth is at 7 for the first nine months of the year equating to approximately 1 real revenue growth heimar has made substantial investments in updating its property portfolio alongside acquiring new assets over recent years and this is now reflected in the company s results these investments have laid the foundation for the 7 rental income growth in the first nine months of the year the company has also explored opportunities to divest certain assets with its total property square footage reduced by nearly since the end of 2022 through strategic sales so far this year the company has sold properties for isk
7688,all_events,UP,,kambi group plc company registration number c49768 having its registered address situated at avenue 77 complex a4 triq in negozju zone 3 central business district birkirkara cbd3010 malta the company held an extraordinary general meeting on the 18 november 2024 at kambi hälsingegatan 38 113 43 stockholm sweden the meeting two resolutions were presented to the meeting namely i resolution a being an ordinary resolution and ii resolution b being an extraordinary resolution resolution a was approved and accordingly the cancellation on or after the 26 november 2024 of 1 374 678 ordinary b shares having a nominal value of 0 003 each that the company holds in itself pursuant to article 106 6 of the companies act chapter 386 of the laws of malta was approved the extraordinary resolution namely resolution b obtained one majority of two required in terms of article 135 1 of the companies act chapter 386 of the laws of malta the companies act and i
12590,all_events,UP,,media release
2554,all_events,DOWN,DOWN,media release
8064,all_events,UP,,06 nov 2024 12 21 cet nhoa regulatory news nhoa s a paris nhoa this document is an unofficial english language translation of the legal press release communiqué normé relating to the availability of the offer document approved visa by the french autorité des marchés financiers on november 5 2024 and of the information relating in particular to the legal financial and accounting characteristics of taiwan cement europe holdings b v and is provided for information purposes only in the event of any discrepancies between this unofficial english language translation and the official french document the official french document shall prevail not for publication dissemination or distribution directly or indirectly in the united states of america or any other jurisdiction in which the distribution or dissemination of this press release is unlawful this press release does not constitute an offer to purchase any securities press release dated novem
5963,all_events,UP,,media release
3069,all_events,DOWN,,media release
12602,all_events,UP,,20 nov 2024 07 30 cet thor medical asa 20 11 2024 07 30 01 cet thor medical asa ikke informasjonspliktige pressemeldinger thor medical a leading emerging supplier of alpha emitters for next generation precision cancer treatment is pleased to invite investors and other interested parties to a capital markets update on monday 25 november 2024 this is a reminder to enable you to save the date in your calendar please reach out to request 1 on 1 meetings with management see details below thor medical s ceo jasper kurth and cfo brede ellingsæter will present an updated investor presentation and will be accompanied by emanuele ostuni ceo of artbio keynote speaker for thor medical s capital markets update is professor jane sosabowski bsc hons msc phd from the centre for cancer biomarkers and biotherapeutics barts cancer institute queen mary university of london professor sosabowski will provide a perspective on treatment with upcoming targeted alpha th
5860,all_events,DOWN,,at an extraordinary general meeting in prostatype genomics ab publ prostatype or the company on october 22 2024 it was decided to implement a consolidation a reverse split of shares 1 1 000 meaning that one thousand 1 000 shares were combined into one 1 new share as previously communicated the record date for the combination of shares was 1 november 2024 which means that the share price reflects the effect of the combination of shares from this date the new isin code for the company s share progen is hereafter se0023261532 recalculation of warrant of series to 4due to the consolidation of shares a recalculation takes place in accordance with the terms of the company s warrants of series to 4 regarding the subscription price and number of shares that each warrant gives the right to subscribe for with the aim of neutralizing the effect of the consolidation of shares other terms for the warrants of series to 4 remain unchanged such as the time for exercisin
11067,all_events,UP,,longeveron raises 4 4 million in gross proceeds from warrant exercise transaction to fund development of its cellular therapy lomecel b
1210,all_events,UP,DOWN,media release
10305,all_events,UP,,12 november 2024 swedbank changes the previously communicated date for the annual general meeting 2025 swedbank s annual general meeting 2025 will be held in stockholm on wednesday 26 march 2025 contact charlotte nilsson media relations manager tel 46 76 534 66 12 swedbank empowers the many people and businesses to create a better future our vision is a financially sound and sustainable society swedbank group is the leading bank with over 7 million retail customers and 550 000 corporate customers in our four home markets sweden estonia latvia and lithuania swedbank group is also present in other nordic countries the u s and china together we make your financial life easier find out more www swedbank com
6594,all_events,DOWN,,prolongation of term in office of chairman of the management board of as pro kapital grupp as pro kapital grupp hereinafter pro kapital informs that on 15th of november 2024 the supervisory council of pro kapital has decided to prolong the term of office of the chairman of the management board of pro kapital edoardo axel preatoni from 1st of january 2025 until 31st of december 2029 a longer term than 3 years is allowed by the law and by the articles of association of pro kapital edoardo axel preatoni has been the management board member of pro kapital since 2016 as pro kapital grupp management board will continue with two members edoardo axel preatoni and neringa rasimavičienė edoardo axel preatonimember of the management boardphone 372 614 4920e mail prokapital prokapital ee
4718,all_events,DOWN,,media release
9309,all_events,UP,,media release
900,all_events,UP,DOWN,zug switzerland june 10 2024 globe newswire oculis holding ag nasdaq ocs oculis a global biopharmaceutical company purposefully driven to save sight and improve eye care today announced positive topline results from its phase 2b relief trial with licaminlimab a novel anti tnfα biologic eye drop with an established dual anti inflammatory and anti apoptotic mechanism of action in patients with dry eye disease ded
10162,all_events,UP,,06 nov 2024 18 00 cet selectirente informations relatives au nombre total de droits de vote et d actions articles l 233 8 ii du code de commerce et 223 16 du règlement général de l autorité des marchés financiers date nombre total d actions composant le capital social nombre total de droits de vote théoriques 1 exerçables 2 31 octobre 2024 4 172 938 4 172 938 4 164 033 1 les droits de vote théoriques correspondent au nombre total de droits de vote attachés à l ensemble des actions y compris celles privées du droit de vote article 223 11 du règlement général de l amf 2 les droits de vote exerçables correspondent au nombre total de droits de vote exerçables en assemblées générales ils sont calculés sur la base du nombre total de droits de vote attachés au nombre total d actions déduction faite des actions privées de droit de vote autodétention contacts dany abi azar directeur administratif et financier selectirente gestion 33 0 1 69 87 02 0
12041,all_events,DOWN,,16 oct 2024 07 45 cest gimv see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1290787_241016_pr_udb_exit_eng pdf gimv les echos gimv be0003699130 gimb euronext
4367,all_events,UP,,13 nov 2024 08 00 cet haugesund sparebank det vises til børsmelding 3 september 2024 om tapsavsetninger i tysnes sparebank fusjonsprosessen pågår fortsatt men det vil ta noe mer tid enn opprinnelig forutsatt å fremforhandle et bytteforhold som ivaretar interessene for eierne i tysnes sparebank og haugesund sparebank på en tilfredsstillende måte reforhandlingen av bytteforholdet og andre deler av fusjonsavtalen følger de avtalte prinsippene i fusjonsavtalen partene forventer at gjennomføring av sammenslåingen skjer i løpet av andre eller tredje kvartal 2025 kontaktpersoner haugesund sparebank banksjef bente haraldson syre tlf 907 65 432 styreleder john erik hagen tlf 909 47 630 tysnes sparebank banksjef dag sandstå tlf 900 89 084 styreleder bente raknes tlf 452 52 954 informasjon om fremtidsrettede uttalelser denne meldingen inneholder fremtidsrettede uttalelser og reflekterer bankens nåværende syn på kommende hendelser de fremtidsrettede u
9173,all_events,UP,,06 nov 2024 18 12 cet broadpeak s a broadpeak sa broadpeak publie son chiffre d affaires du troisième trimestre 2024 06 nov 2024 18 12 cet cest information réglementaire transmise par eqs group le contenu de ce communiqué est de la responsabilité de l émetteur broadpeak publie son chiffre d affaires du troisième trimestre 2024 les ventes atteignent 8 7 m sur la période en progression de 10 à fin septembre le chiffre d affaires du groupe ressort à 25 8 m 0 hausse de 8 3 sur 9 mois des activités les plus contributives licences services maintenance saas bonne visibilité pour la fin de l année grâce aux commandes déjà confirmées maintien des objectifs annuels et des ambitions à horizon 2027 cesson sévigné france le 6 novembre 2024 broadpeak code isin fr001400ajz7 code mnémonique albpk acteur de référence des solutions logicielles dédiées au streaming vidéo publie son activité au titre du troisième trim
4438,all_events,UP,,15 nov 2024 17 45 cet renault regie nat des usines press releasenovember 15 2024 information on the date of the next annual general meeting of renault s a boulogne billancourt november 15 2024 renault s a informs its shareholders that the next annual general meeting is scheduled on wednesday april 30th 2025 this date will be confirmed by the company s board of directors which in february 2025 will convene this annual general meeting the schedule of the company s upcoming financial publications is available on the website https www renaultgroup com en renault groupinvestor relations philippine de schonenphilippine de schonen renault com 33 0 6 13 45 68 39 renault group press contactvalérie gillot 33 6 83 92 92 96valerie gillot renault comrié yamane 33 6 03 16 35 20rie yamane renault com about renault group renault group is at the forefront of a mobility that is reinventing itself strengthened by its alliance with nissan and mitsubishi motors and its
2813,all_events,UP,,08 nov 2024 08 00 cet nexans nexans signe un accord en vue de la cession d amercable à mattr _communiqué de presse_ nexans annonce la conclusion d un accord en vue de la cession de sa filiale nord américaine amercable à mattr pour un montant de 280 millions de dollars us sous réserve des conditions suspensives règlementaires habituelles cette transaction marque un nouveau jalon dans la mise en œuvre de la stratégie de nexans qui vise à repositionner le groupe en pure player de l électrification paris france le 8 novembre 2024 nexans nex fp leader de la transition énergétique mondiale annonce aujourd hui la conclusion d un accord en vue de la cession à mattr matr to d amercable producteur majeur nord américain de câbles d alimentation d instrumentation et de contrôle pour les environnements hostiles pour une valeur d entreprise établie à 280 millions de dollars us depuis sa création en 1922 amercable fabrique des câbles électriques spécifiquement conçus p
2287,all_events,UP,UP,13 nov 2024 16 30 cet sparebank 1 nord norge sparebank 1 nord norge rated aa3 stable by moody s has today issued a new perpetual additional tier 1 bond of nok 200 million the coupon is equal to 3 months nibor 2 80 percentage points p a settlement date is 21 november 2024 the additional tier 1 bond issue has a first time call option for the issuer on 21 february 2030 subject to an approval from the financial supervisory authority of norway if required the new issue is approved by the bank s supervisory board and the bonds will be applied for listing on nordic abm dnb markets acted as sole arranger of the transaction tromsø 13 november 2024 contact person sparebank 1 nord norge ronny løvberg sørensen head of treasury 47 971 05 220 this information is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act more information access the news on oslo bors newsweb site more information access the news on
12803,all_events,UP,,november 18 2024 16 00 et source golden ocean group limited golden ocean group limited golden ocean group limited the company will publish its financial results for the third quarter of 2024 on wednesday november 27 2024 in connection with the release a conference call and webcast will be held as described below conference call and webcasta conference call will be held at 2 30 p m cet 8 30 a m new york time on wednesday november 27 2024 the presentation will be available for download from the investor relations section at www goldenocean bm under presentations prior to the conference call webcast in order to listen to the presentation you may do one of the following a webcastvisit the investor relations section of the company s website at www goldenocean bm and click on the link to webcast or access directly via the webcast link below gogl q3 2024 webcast b conference callparticipants will need to register online pr
6387,all_events,UP,,06 nov 2024 17 40 cet neurones press informationheading 3rd quarter 2024 revenues nanterre november 6 2024 after trading organic growth up 10 in 3rd quarter 2024 not audited in millions of euros 20232024growthof which organic3rd quarter revenues177196 7 11 10 total as at the end september545 7599 1 9 8 achievements neurones posted double digit organic growth in the 3rd quarter the most notable advances continue to be in data digital projects cybersecurity sovereign and secure cloud secnumcloud total turnover is down 3 points 14 vs 17 a year ago over the entire nine month period operating profit amounted to 9 of revenues outlook for 2024 neurones confirms its forecasts made at the beginning of the year around 800 million in revenues and 9 in operating profit not audited and after inclusion of 0 of expenses related to bonus shares about neuroneswith 7 100 experts and ranking among the french leaders in con
4983,all_events,UP,,media release
1434,all_events,DOWN,DOWN,árshlutareikningur eikar fasteignafélags hf fyrir tímabilið 1 janúar til 30 september 2024 var samþykktur af stjórn og forstjóra félagsins þann 31 október 2024
6321,all_events,UP,,06 nov 2024 10 47 cet hipay group cp hipay ca q3 2024 rev04112024 pdf hipay group euronext hipay group fr0012821916 alhyp euronext growth
92,all_events,DOWN,UP,november 13 2024 04 00 et source reykjavíkurborg reykjavíkurborg í dag miðvikudaginn 13 nóvember efnir reykjavíkurborg til útboðs í samræmi við útgáfuáætlun 2024 á skuldabréfaflokknum rvk 44 1 heimild til lántöku á árinu er 16 500 m kr en þetta er sjöunda útboð ársins rvk 44 1 ber fasta 3 verðtryggða vexti og greiðir jafnar greiðslur á sex mánaða fresti með lokagjalddaga 21 maí 2044 heildarstærð rvk 44 1 fyrir þetta útboð nemur alls 4 130 m kr að nafnvirði gert er ráð fyrir að viðskiptavakt hefjist með flokkinn við fyrsta útboð eftir að nafnverð útgáfu nemur 6 000 m kr útboðið verður með hollenskri aðferð þar sem öll skuldabréf verða seld á hæstu ávöxtunarkröfu sem tekið verður reykjavíkurborg áskilur sér rétt til að taka hvaða tilboði sem er að hluta eða í heild eða hafna öllum niðurstöður útboðsins verða birtar opinberlega eigi síðar en næsta virka dag eftir útboð áætlaður uppgjörsdagur er þriðjudagurinn 19 nóvember nk
12147,all_events,UP,,media release
3107,all_events,UP,,media release
2447,all_events,DOWN,DOWN,missing
8976,all_events,UP,,media release
11495,all_events,UP,,media release
4671,all_events,DOWN,,complete pre tcrα deficiency found to be very rare partial form more common than expected complete pre tcrα deficiency found to be very rare partial form more common than expected
1839,all_events,UP,UP,november 08 2024 07 28 et source chemometec a s chemometec a s meddelelse nr 284 8 november 2024 indberetning af ledende medarbejderes transaktioner chemometec a s har i henhold til artikel 19 i forordning eu nr 596 2014 modtaget nedenstående indberetning om transaktioner i chemometec a s aktier udført af personer med ledelsesansvar og eller personer der er nært knyttet til dem se indberetning af næstformand for bestyrelsen martin glensbjergs transaktioner i vedhæftede pdf dokument yderligere oplysninger kan fås ved henvendelse til kim nicolajsen cfo telefon 45 48 13 10 20 om chemometec a s chemometec udvikler producerer og markedsfører instrumenter til celletælling og en lang række andre målinger chemometecs instrumenter markedsføres globalt inden for blandt andet farma biotek og landbrug chemometec blev etableret i 1997 og er børsnoteret på nasdaq copenhagen se også www chemometec com vedhæftet fil
10713,all_events,UP,,18 nov 2024 10 15 cet danske bank a s notice of substitution more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632503_notice to noteholders re substitution_final pdf danske bank a s oslo børs newspoint danske bank a s 20 25 frn covd danske bank a s 21 26 frn step covd danske bank a s 22 27 frn covd danske bank a s 10 25 adj c covd danske bank a s 18 25 adj c covd danske bank a s 23 28 frn covd danske bank a s 23 29 frn covd no0010885353 no0011017725 no0012757675 no0012767831 no0010589880 no0010830003 no0013012559 no0013091801 oslo børs
12624,all_events,DOWN,,12 nov 2024 08 00 cet ing groep n v progress on share buyback programme ing announced today that as part of our 2 0 billion share buyback programme announced on 31 october 2024 in total 7 704 055 shares were repurchased during the week of 4 november 2024 up to and including 8 november 2024 the shares were repurchased at an average price of 15 35 or a total amount of 118 240 205 76 for detailed information on the daily repurchased shares individual share purchase transactions and weekly reports see share buy back programme in line with the purpose of the programme to reduce the share capital of ing the total number of shares repurchased under this programme to date is 11 720 329 ordinary shares at an average price of 15 45 for a total consideration of 181 038 327 77 to date approximately 9 of the maximum total value of the share buyback programme has been completed note for editors for more on ing please visit www ing com frequent news updates can be f
2344,all_events,DOWN,DOWN,bagsværd denmark 8 november 2024 this company announcement discloses the data of the transaction s made in novo nordisk shares by the company s board members executives and their associated persons in accordance with article 19 of regulation no 596 2014 on market abuse the company s board members executives and their associated persons have reported the transactions to novo nordisk and have given novo nordisk power of attorney on their behalf to publish trading in novo nordisk shares by the company s board members executives and their associated persons please find below a statement of such trading in shares issued by novo nordisk novo nordisk is a leading global healthcare company founded in 1923 and headquartered in denmark our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes we do so by pioneering scientific breakthroughs expanding access to our medicines and working to prevent and ultimately cure disease novo nordi
5556,all_events,DOWN,,conference call to be held tomorrow wednesday may 1 2024 at 8 30 am et conference call to be held tomorrow wednesday may 1 2024 at 8 30 am et
11747,all_events,UP,,media release
12555,all_events,UP,,06 nov 2024 08 30 cet umicore umicore shares details on cost saving measures and pauses construction of its battery materials plant in canada umicore shares details on the anticipated cost saving measures affecting its workforce in battery materials and other select areas as part of the strategic review of its battery materials business umicore has decided to continue to pause construction of its battery materials plant in loyalist ontario canada the strategic review continues and further outcomes will be communicated latest at the upcoming capital markets day a key part of umicore s ongoing strategic review of its battery materials business is to maximize capacity utilization of existing plants prior to any further expansion umicore has now decided to continue to pause the construction of a new battery materials plant in loyalist in the meantime umicore intends to retain a solid core team on site at umicore s local office in loyalist the decision of
4397,all_events,DOWN,,media release
12694,all_events,DOWN,,rockville md aug 03 2023 globe newswire opgen inc nasdaq opgn opgen or the company a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease reported today that its german subsidiary curetis gmbh has signed an extended and continued research and development r d collaboration agreement with find following the successful completion of the feasibility phase of the collaboration and having met all milestones on time and within budgets the parties now plan to collaborate on first phases of product development of an antimicrobial resistance amr cartridge from blood culture that is tailored to the needs of low and middle income countries lmics in terms of panel design and coverage of specific genetic variants of bacterial strains and their amr markers in such countries as well as ensuring attractive cost profile and pricing models that allow for access to such rapid testing in lmics
2407,all_events,UP,DOWN,media release
1084,all_events,UP,DOWN,15 nov 2024 12 58 cet everfuel a s herning denmark 15 november 2024 reference is made to the previous stock exchange announcement on 15 november 2024 where faro bidco aps announced the unconditional date of its unregulated recommended voluntary cash offer the offer to the shareholders of everfuel a s everfuel as further described therein and in the offer document dated 2 september 2024 the offer document all terms not defined herein shall have the meaning ascribed to such terms in the offer document as set out in the announcement regarding the offer becoming unconditional and sections 1 7 and 1 21 of the offer document the termination warrants shall now be considered irrevocably lapsed in consideration each holder of termination warrants will as settlement for the termination warrants receive an agreed cash amount corresponding to dkk 0 75 per termination warrant in connection therewith everfuel has today received information about the following
12927,all_events,DOWN,,06 nov 2024 07 50 cet altera shuttle tankers llc westhill united kingdom 6 november 2024 altera infrastructure holdings l l c a wholly owned subsidiary of altera infrastructure l p has entered into an agreement to sell all the membership interests in altera shuttle tankers l l c ast to maistros shiptrade limited a company affiliated with the angelicoussis group the transaction altera shuttle tankers l l c is a leading shuttle tanker provider owning and operating 18 shuttle tankers in brazil canada and the north sea the angelicoussis group is one of the world s largest privately owned shipping groups with 144 vessels on the water and 23 vessels including three shuttle tankers on order dating back to 1947 the group has a long family legacy providing best in class shipping services to the lng tanker and dry bulk markets completion of the transaction is conditional upon receipt of relevant regulatory approvals subject to receipt of such ap
6545,all_events,UP,,needham mass may 14 2024 globe newswire candel therapeutics inc candel or the company nasdaq cadl a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer today reported financial results for the first quarter ended march 31 2024 and provided a corporate update
8650,all_events,DOWN,,15 nov 2024 07 00 cet rana gruber asa the shares in rana gruber asa will be traded ex dividend of nok 1 45 as of today 15 november this information is subject of the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act contact ceo gunnar moe 47 941 47 650 gunnar moe ranagruber no cfo erlend høyen 47 902 02 741 erlend hoyen ranagruber no rana gruber is a norwegian iron ore producer established in 1964 with operations based on more than 200 years of mining experience the company s products are based on natural mineral resources which are processed and exported to customers worldwide key customers include steel producers and participants in the chemical industry the company has about 370 employees and a production capacity of 1 8 million metric tons of iron ore concentrates more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site rana gruber asa oslo børs
428,all_events,DOWN,DOWN,19 nov 2024 14 05 cet ivar iks se vedlegg på www newsweb no more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632645_interests 2024 11 19 pdf ivar iks oslo børs newspoint ivar iks 24 26 frn no0013233908 nordic alternative bond market
3434,all_events,UP,,media release
9644,all_events,UP,,marlborough mass oct 28 2024 globe newswire akoya biosciences inc nasdaq akya akoya the spatial biology company today announced that it will release financial results for the third quarter of 2024 after the market closes on thursday november 14 2024 company management will host a conference call to discuss financial results at 5 00 p m et
10493,all_events,UP,,07 nov 2024 18 40 cet esker s a formulaire type de déclaration des programmes de rachats ce formulaire constitue l annexe 3 de l instruction amf n 2005 06 relative aux modalités de déclaration des programmes de rachat des actions propres et des opérations de stabilisation dénomination sociale de l émetteur esker sa nature des titres nom du titre caractéristiques adp cci esker date de début du programme01 07 24 tableau de declaration mensuelle des operations realisees par un emetteur sur ses propres titres opérations du mois de octobre 2024 i informations cumulees capital autodétenu de manière directe et indirecte à la date du descriptif en titres en pourcentage 6083311 solde au 30 06 2024 date de la dernière déclaration 143877 2 nombre de titres achetés dans le mois 0 nombre de titres vendus dans le mois 0 nombre de titres transférés 1 dans le mois nombre de titres an
8971,all_events,DOWN,,18 nov 2024 16 05 cet schibsted asa 18 11 2024 16 05 09 cet schibsted non regulatory press releases schibsted asa schibsted marketplaces will publish all presentation materials for its capital markets day on tuesday 19 november 2024 at 07 00 cet presentations will start at 13 00 cet and will last including q a until approximately 17 00 cet the event will also be streamed live from 13 00 cet at https channel royalcast com hegnarmedia hegnarmedia 20241119_6 for the q a participants following the event online can send in written questions via slido link https www sli do event code 1011554 location for the event port olímpic barcelona detailed address espai mestral sala d actes port olímpic moll de mestral s n sant martí 08005 barcelona to get there search the address espai mestral sala d actes port olímpic on google maps or follow the description below the venue is just in the middle of port olímpic on the seafront on the
12106,all_events,UP,,november 07 2024 01 35 et source dfds a s dfds a s ferry freight total volumes in october 2024 were 10 above 2023 and up 5 adjusted for the addition of strait of gibraltar routes in 2024 and closure of the calais tilbury route in 2023 north sea channel and baltic sea volumes were all above 2023 following solid growth on most routes mediterranean volumes were in october also above 2023 for the last twelve months 2024 23 the total transported freight lane metres increased 6 to 41 0m from 38 5m in 2023 22 the increase was 3 adjusted for the addition of strait of gibraltar routes and the calais tilbury route closure ferry passenger the number of passengers in october 2024 was 33 above 2023 and down 1 adjusted for the addition of the strait of gibraltar routes the adjusted decrease was due to smaller variances across routes the number of cars was 16 above 2023 and down 10 adjusted for strait of gibraltar for
8515,all_events,DOWN,,durham n c march 18 2024 globe newswire humacyte inc nasdaq huma a clinical stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale will release its financial results for the fourth quarter and year ended december 31 2023 on friday march 22 2024 management will host a webcast and conference call at 8 00 a m et to provide a corporate and financial update
8688,all_events,DOWN,,19 nov 2024 08 00 cet ikonisys s a regulatory news ikonisys sa euronext growth paris aliko une entreprise spécialisée dans la détection précoce et précise des cancers grâce à une solution unique et entièrement automatisée pour les laboratoires d analyses médicales l émetteur annonce aujourd hui avoir réalisé une augmentation de capital de 200 k par le biais d un placement privé cette opération s inscrit dans la continuité des augmentations de capital réalisées récemment visant à renforcer la solidité financière de la société et à diversifier sa structure actionnariale le produit net de l émission d un montant de 200 k contribuera au financement du fonds de roulement cadre juridique de l augmentation de capital la mise en œuvre de cette augmentation de capital réalisée avec suppression du droit préférentiel de souscription des actionnaires par voie de placement privé a été approuvée par le conseil d administration de l emetteur lors de
1396,all_events,DOWN,UP,media release
1430,all_events,DOWN,DOWN,14 nov 2024 08 30 cet telenor asa as announced in the stock exchange release on 27 may 2024 telenor entered into an agreement with dnb asa to conduct buyback of telenor shares to be used in the company s share programmes in 2024 in the third tranche dnb asa was mandated to acquire shares for up to nok 8 900 000 between 11 and 15 november 2024 the third tranche of the share purchase has now been executed date aggregated daily volume number of shares vwap nok transaction value nok 12 november 2024 65 273 133 355 8 704 487 investor contact svp capital markets and investor relations frank maaø 47 91 67 40 45 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site telenor asa oslo børs newspoint telenor telenor asa 23 28 frn c telenor asa 23 30 4 c no0010063308 no0012935313 no0012935339 tel oslo børs
5294,all_events,DOWN,,november 11 2024 02 00 et source tallink grupp tallink grupp person subject to the notification requirementname nõgene paavoposition chairman of the management board of as tallink grupp issuer as tallink grupp lei 529900qrmwakkr3l9w75 notification type initial notification _____________________________________ transaction date 08 11 2024venue nasdaq omx tallinninstrument type shareisin ee3100004466nature of the transaction acquisition transaction details 1 volume 13 932 unit price 0 598 eur 2 volume 4 788 unit price 0 599 eur 3 volume 1 280 unit price 0 600 eur aggregated transactions 3 volume 20 000 volume weighted average price 0 598 eur anneli simminvestor relations manager as tallink gruppsadama 510111 tallinn phone 372 56157170e mail anneli simm tallink ee
2766,all_events,DOWN,,izafe group ab publ izafe announces today that it has received a new confirmed order for an additional 1 000 dosell units from its exclusive distributor in the netherlands tccn this strategically important order has a value of approximately sek 3 million deliveries will be split into two batches 750 units in 2024 and the remaining 250 in the first half of 2025 laying the foundation for stable licensing revenue of up to sek 400 000 per month during 2025 this order ensures that tccn retains its exclusivity in the dutch market in accordance with previously communicated terms once this order and previous ones are fully implemented they are expected to generate recurring revenue of approximately sek 400 000 per month in 2025 the order strengthens izafe s cash flow and builds a long term revenue model clearly affirming dosell s strong position as a leading solution in medication dispensing and a vital tool for the digitalization of the healthcare sector since the beginnin
408,all_events,UP,DOWN,media release
5664,all_events,UP,,arcutis today announced the enrollment of the last subject in the phase 1b study evaluating arq 255 for the treatment of alopecia areata
11939,all_events,UP,,boca raton florida sept 30 2024 globe newswire inmune bio inc nasdaq inmb the company a clinical stage inflammation and immunology company targeting microglial activation and neuroinflammation as a cause of alzheimer s disease ad announced today that it closed enrollment for its phase 2 trial on friday 27 september this global blinded randomized phase 2 trial the ad02 trial is focused on patients with early ad and biomarkers of elevated neuroinflammation
1608,all_events,DOWN,DOWN,media release
9456,all_events,DOWN,,selskabsmeddelelse 32 2024 18 oktober 2024 bestyrelsesmedlemmers direktørers eller nærtstående personers handel med orphazyme aktier se venligst vedlagte vedhæftede filer vedlagte filer notifikation af transaktioner mhi 16102024 pdf selskabsmeddelelse 32_ bestyrelsesmedlemmers direktrers eller nrtstaende personers handel med orphazyme aktier _ pdf
5384,all_events,UP,,advance htn trial is approximately enrolled trial is anticipated to deliver topline data in q1 2025
5219,all_events,UP,,media release
1768,all_events,UP,UP,kh group plc stock exchange release 4 november 2024 at 11 30 am eet
3753,all_events,DOWN,,media release
8499,all_events,DOWN,,mdxhealth to present third quarter 2024 financial resultsand corporate update on november 6
7746,all_events,UP,,malvern pa oct 28 2024 globe newswire ocugen inc ocugen or the company nasdaq ocgn a biotechnology company focused on discovering developing and commercializing novel gene and cell therapies biologics and vaccines today announced that it will host an in person clinical showcase on tuesday november 12 2024 the event will take place from 10 a m noon et at the nasdaq marketsite in times square new york city
7733,all_events,DOWN,,12 november 2024 astrazeneca invests 3 5 billion in r d and manufacturing in the united states astrazeneca today announces 3 5 billion of capital investment in the united states focused on expanding the company s research and manufacturing footprint by the end of 2026 this includes 2 billion of new investment creating more than a thousand new high skilled jobs contributing to the growth of the us economy astrazeneca s expanding footprint in the us includes among others pascal soriot chief executive officer astrazeneca said our multibillion dollar investment reflects the attractiveness of the business environment together with the quality of talent and innovation capabilities here in the united states by expanding our r d and manufacturing footprint we aim to enhance the development of cutting edge therapies and support the united states leadership in healthcare innovation delivering growth ambition 2030 these us investments are the first of a series of important step
7773,all_events,DOWN,,media release
11358,all_events,DOWN,,november 08 2024 08 45 et source nokia oyj nokia oyj nokia oyjjohtohenkilöiden liiketoimet8 11 2024 klo 15 45nokia oyj johtohenkilöiden liiketoimet fisk markkinoiden väärinkäyttöasetuksen 19 artiklan mukainen ilmoitus liiketoimesta ____________________________________________ilmoitusvelvollinennimi fisk louiseasema muu ylin johto liikkeeseenlaskija nokia corporationlei 549300a0jprwg1ki7u06ilmoituksen luonne ensimmäinen ilmoitusviitenumero 84277 4 4____________________________________________ liiketoimen päivämäärä 2024 11 07 kauppapaikka nasdaq helsinki ltd xhel instrumenttityyppi osake isin fi0009000681 liiketoimen luonne hankinta liiketoimien yksityiskohtaiset tiedot 1 volyymi 117 yksikköhinta 4 27670 liiketoimien yhdistetyt tiedot 1 volyymi 117 keskihinta 4 27670 nokianokia luo teknologiaa joka auttaa maailmaa toimimaan yhdessä b2b teknologia ja innovaatiojohtajana olemme tulevaisuuden aistivien ajat
7744,all_events,UP,,single infusion of anx005 demonstrated significant improvements across multiple functional and prognostic measures that expedited recovery in gbs patients
4139,all_events,UP,,media release
10460,all_events,DOWN,,media release
7584,all_events,DOWN,,marlborough mass april 05 2024 globe newswire akoya biosciences inc nasdaq akya the spatial biology company today announced it will highlight case studies featuring its spatial biology 2 0 solutions that enable unprecedented speed and scale for spatial biology studies at the american association for cancer research aacr 2024 annual meeting in san diego april 5 to 10 in addition the company will showcase new applications of its phenocode signature panels and preliminary data from the thermo fisher viewrna assays on akoya s platforms
12511,all_events,UP,,media release
4246,all_events,DOWN,,hilbert capital the asset management division of hilbert group ab nasdaq hilb b has reached a significant milestone achieving its 2024 assets under management aum target of 300 million sek 3 3 billion a target that was set in 2022 hilbert group ceo niclas sandström comments our pipeline looks promising and the market environment has improved substantially positioning us well for continued growth in 2025 we will provide new short and long term targets including profitability goals at the end of this month with the release of our q3 report for additional information on hilbert please contact niclas sandströmceo hilbert group abphone 46 8 502 353 00email ir hilbert group about us hilbert group is a quantitative investment company specializing in algorithmic trading strategies in digital asset markets hilbert group is a swedish public company and is committed to providing operational infrastructure risk management and corporate governance that meets the ever i
833,all_events,UP,UP,18 nov 2024 11 18 cet brie picardie crcam caisse régionale de crédit agricole mutuel brie picardie société coopérative à capital variable agréée en tant qu établissement de crédit siège social 500 rue saint fuscien 80095 amiens cedex 3 rcs amiens 487 625 436rachats réalisés dans les conditions de l article 5 du règlement mar présentation agrégée par jour et par marché nom de l émetteurcode identifiant de l émetteurjour de la transactioncode identifiant de l instrument financierdevisevolume total journalier en nombre d actions prix unitairemarché mic code credit agricole brie picardie969500fyexw795npjo792024 11 11fr0010483768eur241418 553359xparcredit agricole brie picardie969500fyexw795npjo792024 11 12fr0010483768eur688918 560581xparcredit agricole brie picardie969500fyexw795npjo792024 11 13fr0010483768eur378918 608489xparcredit agricole brie picardie969500fyexw795npjo792024 11 14fr0010483768eur94518 570434xparcredit agricole b
11269,all_events,UP,,arcutis today announced the fda has accepted its snda for zoryve roflumilast foam 0 for scalp and body psoriasis
5272,all_events,UP,,san diego march 21 2024 globe newswire capricor therapeutics nasdaq capr a biotechnology company developing transformative cell and exosome based therapeutics for the treatment and prevention of rare diseases today announced that the company is scheduled to present at two upcoming investor conferences
4924,all_events,UP,,media release
6775,all_events,DOWN,,19 nov 2024 13 50 cet protector forsikring asa det er fastsatt ny obligasjonsrente for no0012442278 ny obligasjonsrente i renteperioden 21 11 2024 21 02 2025 er 7 45 ticker protct07 den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632629_162b5b39a2d54eda9a6b69afc16a6562 pdf protector forsikring asa oslo børs newspoint protector forsikring protector forsi asa 20 50 frn c sub protector forsi asa 21 perp frn c hybrid protector forsikring asa 22 52 frn c sub no0010209331 no0010914443 no0011170045 no0012442278 prot oslo børs
5912,all_events,UP,,12 nov 2024 14 17 cet sparebank 1 østlandet se vedlegg på www newsweb no more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631963_interests 2024 11 12 pdf sparebank 1 østlandet oslo børs newspoint sparebank 1 østlandet bank 1 oslo akershus as 16 26 2 spb 1 østlandet 17 27 2 spb 1 østlandet 17 27 2 spb 1 østlandet 18 33 2 spb 1 østlandet 19 25 2 spb 1 østlandet 20 25 frn spb 1 østlandet 20 25 2 spb 1 østlandet 20 26 frn c spb 1 østlandet 20 perp frn c hybrid spb 1 ostlandet 21 28 2 pct spb 1 ostlandet 21 perp frn c hybrid spb 1 ostlandet 21 28 2 25pct spb 1 ostlandet 21 31 2 4275pct spb 1 ostlandet 21 26 2 00 pct spb 1 ostlandet 22 27 frn spb 1 ostlandet 22 26 2 spb 1 ostlandet 22 27 4 50pct spb 1 ostlandet 22 33 adj c sub spb 1 ostlandet 23 28 4 spb 1 ostlandet 23 28 frn spb 1 ostlandet 23 33 frn c sub spb 1 ostlandet 23 2
6786,all_events,DOWN,,aktia bank plcstock exchange release 8 november 2024 at 10 00 a m aktia bank plc managers transactions anssi huhta person subject to the notification requirementname huhta anssiposition other senior managerissuer aktia bank plclei 743700gc62jlhfbund16notification type initial notificationreference number 743700gc62jlhfbund16_20241106115439_210____________________________________________ transaction date 2024 11 06venue not applicableinstrument type shareisin fi4000058870nature of the transaction subscription transaction details 1 volume 2 067 unit price 8 36 eur aggregated transactions 1 volume 2 067 volume weighted average price 8 36 eur aktia bank plc further information oscar taimitarha director investor relations tel 358 40 562 2315 ir at aktia fi distribution nasdaq helsinki ltdmass mediawww aktia com aktia is a finnish asset manager bank and life insurer that has been creating wealth and wellbeing from one generation to the next for 200 years we
2021,all_events,UP,DOWN,solna sweden november 11 2024 vivesto ab an oncology focused development company today announced that the drug candidate paccal vet was confirmed as intended for a limited market by the european medicines agency for treatment of splenic hemangiosarcoma hsa following splenectomy in dogs the classification may give the opportunity for a faster regulatory route to approval in the eu if approved paccal vet would be protected from generic competition for 10 years in eu limited market classification is the eu equivalent to the us mums classification which vivesto received for paccal vet in 2023 and is designated for products for the treatment or prevention of diseases that occur infrequently in the eu the benefits comprise potentially reduced data requirements and enhanced regulatory assistance limited market classification and the eligibility to be authorized with a reduced clinical data package is similar to the us conditional approval i e a file based on safety data an
11705,all_events,DOWN,,media release
3070,all_events,UP,,vilnius lithuania 2024 11 08 12 21 cet on the 8th of november 2024 sun investment group held an investor call during the call sun investment group issuer ceo deividas varabauskas and orion securities issue organizer head of corporate finance mykantas urba presented bond issue details and answered investor questions the recording of the investor call is available in the following link presentation can be downloaded here key bond issue details the existing bondholders of sun investment group uab bonds isin lt0000313256 issued in 2023 will be able to exchange these bonds to newly issued ones through the nasdaq csd securities exchange offer for more information and full documentation click here
1368,all_events,UP,DOWN,neo finance ab the company and a partner are establishing an investment portfolio of eur 2 4 million in consumer loans and a special purpose vehicle spv has been set up with neo finance ab as its sole shareholder to manage this portfolio this strategic decision will allow for faster funding of customer loans and more efficient deployment of funds to retail investors on the platform the company s share of the investment in the agreement amounts to eur 360 thousand the cooperation period with the partner is foreseen for 3 years during which the spv will acquire the investment portfolio formed by the company in order to ensure the fulfilment of its obligations to the partner the spv has undertaken to pledge the entire investment portfolio and the shares owned by the spv the parties agreed that in the event that the partner s receivables under the contract are insufficient to cover the shortfall following the realisation of the investment portfolio the company undertak
1421,all_events,UP,DOWN,18 nov 2024 15 10 cet first phosphate corp mot clé s autres first phosphate annonce son inscription au marché otcqb et l éligibilité dtc aux états unis 18 nov 2024 15 10 cet cest saguenay quebec newsfile corp 18 novembre 2024 first phosphate corp cse phos otcqb frspf fse kd0 first phosphate ou la société a le plaisir d annoncer que ses actions ordinaires ont commencé à être négociées aujourd hui sur le marché otcqb venture market otcqb sous le symbole boursier frspf la société est également heureuse d annoncer que ses actions ordinaires sont désormais éligibles pour le règlement et la compensation électroniques aux états unis par l intermédiaire de la depository trust company dtc l otcqb est un marché de premier plan pour les entreprises américaines et internationales en phase de démarrage ou en développement reconnu comme un marché public établi par la commission des valeurs mobilières des états unis sec et
10898,all_events,UP,,company announcment no 19 2024 søborg november 13 2024 notice to extraordinary general meeting in konsolidator a s notice is hereby given to shareholders in konsolidator a s konsolidator of an extraordinary general meeting which is scheduled for november 28 2024 at 15 00 at vandtårnsvej 83a 2 dk 2860 søborg as mentioned in company announcement no 18 2024 the chairman of the board of directors jesper eigen møller has decided to resign and the board of directors proposes that the general meeting elect michael moesgaard andersen to replace jesper eigen møller at the extraordinary general meeting the board of directors will also report on the financial situation of the company and the measures that have been or will be taken due to the negative equity which was reported in the half year report for 2024 cf company announcement no 14 2024 shareholders not able to attend the general meeting will be able to follow the live webcast of the general meeting by a link whic
4237,all_events,DOWN,,12 nov 2024 18 48 cet ikonisys s a regulatory news ikonisys sa paris aliko le groupe ikonisys renouvelle son accord en tant que représentant autorisé et importateur européen de la technologie d immunohistochimie en temps réel certifiée ce ivd de novodiax pour les diagnostics oncologiques et la sécurité des transplantations d organes ikonisys sa euronext growth paris aliko une entreprise spécialisée dans la détection précoce et précise des cancers grâce à une solution unique et entièrement automatisée pour les laboratoires d analyses médicales est heureuse d annoncer le renouvellement du contrat d hospitex en tant que représentant autorisé et importateur européen pour novodiax novodiax société américaine spécialisée en immunohistochimie est le fournisseur exclusif de dispositifs médicaux ce ivd ihc diagnostics in vitro et immunohistochimie pour les diagnostics oncologiques en temps réel sur des échantillons de tissus grâce à sa plateforme inn
10045,all_events,DOWN,,15 nov 2024 07 00 cet sanofi dupixent sbla accepted for fda review for the treatment of chronic spontaneous urticaria resubmission includes new pivotal data which confirm dupixent significantly reduced itch and hive activitymore than 300 000 people in the us suffer from chronic spontaneous urticaria csu that is inadequately controlled by antihistaminesfda decision expected by april 18 2025 if approved dupixent would be the first targeted therapy for csu in a decade paris and tarrytown ny november 15 2024 the us food and drug administration fda has accepted for review the resubmission of the supplemental biologics license application sbla for dupixent dupilumab to treat adults and pediatric patients aged 12 years and older with chronic spontaneous urticaria csu whose disease is not adequately controlled with h1 antihistamine treatment the target action date for the fda decision is april 18 2025 the resubmitted sbla is supported by data from the multi stu
819,all_events,UP,UP,06 nov 2024 15 00 cet icade see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1295565_pr_icade_number_of_voting_rights_and_shares_31 10 2024 pdf icade les echos icade fr0000035081 icad euronext
4403,all_events,UP,,06 nov 2024 18 16 cet amg critical materials n v amsterdam 6 november 2024 regulated information amg critical materials n v amg euronext amsterdam amg reports third quarter 2024 revenue of 356 million a decrease versus the third quarter of 2023 amg achieved an adjusted ebitda of 40 million supported by an exceptionally strong performance by the amg technologies segment showing an increase of compared to the same period in 2023 dr heinz schimmelbusch chairman of the management board and ceo said ebitda continued on a steady growth trend in the third quarter of 2024 during which we achieved 40 million of ebitda amg technologies delivered a strong performance compared to the third quarter last year with excellent results in a growing market amg engineering secured 131 million in order intake and had a record high order backlog as of september 30 2024 of 367 million this result continues to demonstrate the earnings power of our divers
9531,all_events,DOWN,,november 11 2024 04 30 et source dfds a s dfds a s den 9 februar 2024 meddelte dfds a s dfds iværksættelsen af et aktietilbage købsprogram til gennemførsel i henhold til eus markedsmisbrugsforordning eu forordning nr 596 2014 af 16 april 2014 samt eu kommissionens delegerede forordning eu nr 2016 1052 af 8 marts 2016 safe harbour reglerne under programmet vil dfds tilbagekøbe egne aktier for op til dkk 431 mio i perioden fra 12 februar 2024 til 31 december 2024 der vil maksimalt blive tilbagekøbt 3 400 000 aktier disse begrænsninger omfatter såvel aktier købt under safe harbour reglerne som aktier købt fra lauritzen fonden holding aps på en pro rata basis i forhold til aktier købt under programmet i henhold til en separat aftale med dfds udenfor safe harbour reglerne handler i perioden 4 8 november de følgende handler er gennemført under aktietilbagekøbsprogrammet i perioden mandag 4 november 2024 til fredag 8 novemb
8973,all_events,UP,,aktsiaselts modera teavitab et nõukogu liikme robin jan georg bade volitused on lõppenud alates 6 juulist 2024 volituste lõppemisest teavitamine viibis seoses äriregistri olevate kannete ebatäpsusega nimelt on äriregistris märgitud nõukogu liikme volituste algusajaks ekslikult kuupäev mil nõukogu liige lahkus nõukogu esimehe positsioonilt mitte aga nõukogu liikmeks valimise aeg seetõttu jäi nõukogu liikme volituste lõppemine tähelepanuta kuni uue nõukogu liikme äriregistrisse kandmise avalduse esitamiseni robin jan georg bade roll seltsi juhtorgani liikmena on olnud väga väärtuslik seltsi nõukogu ja juhatus teevad seetõttu seltsi korralisele üldkoosolekule mis kutsutakse kokku 2025 aasta esimesel poolaastal ettepaneku valida robin jan georg bade tagasi seltsi nõukogu liikmeks tagamaks seltsi juhtimise stabiilsus jätkab robin jan georg bade seltsi soovil praegu tegutsemist nõuandva hääleõiguseta liikmena nõukogu juures käesoleva teate avaldamise seisuga k
11626,all_events,DOWN,,media release
1795,all_events,UP,UP,dfds ebit outlook range for 2024 is revised following results below expectations driven by mainly a more widespread slowdown in europe than previously expected as well as intensified competition in northern european land transport markets and the mediterranean freight ferry market
9726,all_events,UP,,this message has been corrected click here to view the corrected message vilnius lithuania 2024 10 15 09 02 cest omx baltic benchmark fund share price on october 14 2024 13 1462 eur omx baltic benchmark fund number of shares issued on october 14 2024 0 units omx baltic benchmark fund number of shares redeemed on october 14 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of october 14 2024 125 362 units nter asset management
5519,all_events,UP,,15 11 2024 09 12 57 cet carlsberg a s managers transactions the attached documents discloses the data of the transactions made in carlsberg shares by the company s executive directors in accordance with article 19 of regulation no 596 2014 on market abuse attachments 20241115_henrik poulsen pdf
5527,all_events,DOWN,,media release
330,all_events,UP,DOWN,11 oct 2024 22 08 cest interoil exploration and prod oslo 11 october 2024 reference is made to the announcements published by interoil exploration and production asa the company on 26 august 2024 regarding the termination of anh contracts on 28 august 2024 concerning the summons for a related written resolution with respect to the company s senior secured callable bonds with isin no 001 0729908 the bonds and on 11 september 2024 reporting the passing of such written resolution by the holders of the bonds the company announces that its colombian subsidiary and the national hydrocarbons agency of colombia agencia nacional de hidrocarburos anh have entered into a partial termination agreement the partial termination agreement of the exploration and production agreement corresponding to the lla 47 block the lla 47 e p agreement upon the terms and conditions anticipated in the company s announcement of 26 august 2024 in accordance with the part
12636,all_events,UP,,media release
1285,all_events,DOWN,DOWN,11 nov 2024 11 44 cet høland og setskog sparebank finansiell kalender for høland og setskog sparebank regnskapsår 2024 20 03 2025 årsrapport 19 03 2025 ordinær generalforsamling 28 02 2025 kvartalsrapport q4 regnskapsår 2025 15 08 2025 halvårsrapport 29 04 2025 kvartalsrapport q1 31 10 2025 kvartalsrapport q3 denne informasjonen offentliggjøres i henhold til kravene i løpende forpliktelser more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site høland og setskog sparebank oslo børs newspoint høland og setskog sparebank høland og setskog spb 20 25 frn holand og setskog spb 21 26 frn holand og setsk spb 21 perp frn c hybrid holand og setskog spb 21 31 frn c sub holand og setskog spb 22 25 frn holand og setskog spb 23 26 frn holand og setskog spb 23 28 frn høland og setskog spb 24 34 frn c sub høland og setsk spb 24 perp frn c hybrid høland og setskog spb 24 27 frn h
7518,all_events,DOWN,,november 08 2024 08 00 et source baltic horizon fund northern horizon capital baltic horizon fund northern horizon capital baltic horizon fund kutsub osakuomanikke investoreid analüütikuid ja teisi huvilisi osalema oma investorite veebiseminaril 15 november 2024 a kell 13 00 cet 14 00 eet veebiseminari juhib baltic horizon fund fondijuht tarmo karotam presentatsioonile järgneb küsimustevoor piiratud aja tõttu soovitame osalejatel saata oma küsimused hiljemalt üks päev varem enne veebiseminari toimumist e mailile tarmo karotam nh cap com veebiseminaril osalemiseks palume teil registreerida järgneva lingi kaudu https nasdaq zoom us webinar register wn_y09gf4nwrgagufqhbiphxa teile saadetakse link ning juhised veebiseminariga liitumiseks kui osalete veebiseminaril esimest korda palutakse teil alla laadida vajalik rakendus mis võtab vaid mõned sekundid juhul kui rakenduse allalaadimine ei õnnestu avaneb automaatselt veebib
7663,all_events,UP,,media release
2036,all_events,DOWN,UP,petach tikva israel april 24 2024 globe newswire polypid ltd nasdaq pypd polypid or the company a late stage biopharma company aiming to improve surgical outcomes today announced that it will report its first quarter 2024 financial results and operational highlights before the open of the u s financial markets on wednesday may 8 2024 the company will host a conference call and webcast at 8 30 am eastern time to discuss the results and provide an update on business operations
7948,all_events,UP,,sampo plc stock exchange release 1 november 2024 at 8 30 am eet
4489,all_events,UP,,palo alto calif oct 28 2024 globe newswire scilex holding company nasdaq sclx scilex or company an innovative revenue generating company focused on acquiring developing and commercializing non opioid pain management products for the treatment of acute and chronic pain today announced that it has set a record date of november 7 2024 the record date for the dividend of scilex preferred stock the dividend to its stockholders and certain other securityholders of scilex subject to the board s right to change the record date and conditioned upon the effectiveness of the filing of the certificate of designation with the secretary of state of the state of delaware the payment date the payment date will be determined by subsequent resolutions of the board which will be within 60 days following the record date
1091,all_events,DOWN,UP,media release
3251,all_events,UP,,ab akola group company code 148030011 address of the head office subaciaus str 5 lt 01302 vilnius lithuania ab akola group invites shareholders investors analysts and other stakeholders to join its investor conference webinar for the 3 months results of the financial year 2024 2025 scheduled on november 21st 2024 at 9 00 am eet the language of the event is english the webinar will be hosted by the chief financial officer of the company mažvydas šileika who will introduce the financial results and comment on the recent developments in the company after the presentation investors are welcome to ask questions due to limited webinar time we encourage attendees to send their questions before the webinar until november 20th 2024 to emilija paulauskaite nasdaq com how to join the webinar to join the webinar please register via following link https nasdaq zoom us webinar register wn_cjypf7g_tpyztain7nj2pq you will receive the webinar link and the instructions on how t
73,all_events,UP,UP,south san francisco calif oct 24 2024 globe newswire septerna inc nasdaq sepn a clinical stage biotechnology company pioneering a new era of g protein coupled receptor gpcr oral small molecule drug discovery today announced the pricing of its upsized initial public offering of 16 000 000 shares of its common stock at a public offering price of 18 00 per share in addition septerna has granted the underwriters a 30 day option to purchase up to an additional 2 400 000 shares of its common stock at the public offering price less underwriting discounts and commissions all of the shares are being offered by septerna and the common stock is expected to begin trading on the nasdaq global market on october 25 2024 under the ticker symbol sepn
4096,all_events,UP,,08 nov 2024 12 01 cet high co information concerning the total number of voting rights and shares declaration pursuant to articles l 233 8 ii of the french commercial code and 223 16 of the general regulations of the autorité des marchés financiers amf date of settlementof informationtotal number of sharesnumber of shares without voting rights number of voting rights for threshold calculation number of actual voting rights exercisable at shareholders meeting october 31 202420 455 403818 99422 281 84121 462 847september 30 202420 455 403819 05122 330 22621 511 175august 31 202420 455 403817 85122 352 33621 534 485july 31 202420 455 403818 15022 352 33621 534 186june 30 202420 455 403813 39222 352 34021 538 948may 31 202420 455 403758 86122 374 87821 616 017april 30 202420 455 403714 86422 375 86021 660 996march 31 202420 455 403696 39122 376 74221 680 351february 29 202420 455 403700 84722 376 63621 675 789january 31 202420 455 403697 32822 376 63621 679
11277,all_events,UP,,november 6 2024 copenhagen denmark interim report for the first nine months ended september 30 2024 highlights the third quarter of 2024 presented genmab with additional opportunities to progress towards our goal of fundamentally transforming the lives of people with cancer and other serious diseases the additional approval for tepkinly along with positive data presentations for our promising late stage assets acasunlimab and rinatabart sesutecan rina s underscore the potential of our pipeline and our commitment to the development of innovative antibody based therapeutics said jan van de winkel ph d chief executive officer of genmab financial performance first nine months of 2024 outlookgenmab is updating the lower end of its revenue range of 2024 financial guidance driven by higher total royalty revenues from darzalex genmab is also lowering the upper end of its operating expense range to reflect a continued focused and disciplined approach to investments and portfoli
11132,all_events,DOWN,,08 nov 2024 12 15 cet lagardere s a see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1296461_241108_lhg_press_release_publication_of_information_document_en pdf lagardere les echos lagardere sa fr0000130213 mmb euronext
5331,all_events,DOWN,,media release
5046,all_events,DOWN,,07 oct 2024 18 05 cest opmobility see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1288925_opmobility__declaration_des_transactions_sur_actions_propres_du_300924_au_041024 pdf opmobility les echos opmobility fr0000124570 opm euronext
8545,all_events,DOWN,,05 nov 2024 18 30 cet vallourec vallourec announces the creation of an operations department and strengthens its process and engineering department meudon france november 5 2024 since its launch new vallourec plan has relied on industrial excellence to enable the premiumization of vallourec s offerings and solutions to further the drive towards best in class global performance vallourec announces the creation of a new operations department and a strengthened process and engineering department to provide vallourec with the best technologies and the most efficient and advanced industrial processes the process and engineering department will henceforth include the process communities the global engineering department and the investment department philippe carlier as part of the executive committee will lead this department with the primary mission of enabling vallourec to deliver its products and services with increasing efficiency this process and engineerin
291,all_events,DOWN,DOWN,media release
5914,all_events,DOWN,,13 nov 2024 18 16 cet atenor 2024 11 13 trading update q3 2024 fr pdf atenor euronext atenor be0003837540 ateb euronext
1288,all_events,UP,DOWN,supports licensing partner s phase 3 activities in acute heart failure supports licensing partner s phase 3 activities in acute heart failure
3724,all_events,UP,,sampo plc managers transactions 2 october 2024 at 3 00 pm eest sampo plc managers transactions janbu holthe sampo plc business code 0142213 3 has received the following notification under article 19 of the market abuse regulation shares have been acquired in accordance with terms and conditions of the long term incentive scheme 2020 1 ____________________________________________ person subject to the notification requirement name ingrid janbu holtheposition other senior managerissuer sampo plclei 743700uf3rl386wida22notification type initial notificationreference number 80017 4 6____________________________________________ transaction date 2024 09 30venue nasdaq helsinki ltd xhel instrument type shareisin fi4000552500nature of transaction receipt of a share based incentive transaction details 1 volume 2 639 unit price 41 9316 eur aggregated transactions 1 volume 2 639 volume weighted average price 41 9316 eur____________________________________________
1530,all_events,UP,DOWN,media release
8675,all_events,UP,,oral presentation of new data demonstrating the activity of lysin cf 370 against xdr pseudomonas aeruginosa
1720,all_events,UP,DOWN,08 nov 2024 06 58 cet aperam s a aperam s a mot clé s résultat trimestriel aperam résultats du troisième trimestre 2024 l amélioration de l empreinte industrielle commence à avoir un impact positif 08 nov 2024 06 58 cet cest résultats du troisième trimestre 20241 l amélioration de l empreinte industrielle commence à avoir un impact positif luxembourg le 8 november 2024 07 00 cet aperam aperam ou la société amsterdam luxembourg paris bruxelles apam et nyrs apemy a annoncé aujourd hui ses résultats pour le trimestre se terminant le 30 septembre 2024 faits marquants taux de fréquence en matière de santé et sécurité de 2 4 au 3ème trimestre 2024 contre 2 0 au 2ème trimestre 2024 expéditions de 617 milliers de tonnes au 3ème trimestre 2024 soit une hausse de 5 par rapport aux expéditions de 583 milliers de tonnes au 2ème trimestre 2024 ebitda ajusté de 99 millions d euros au 3ème trimestre 2024 comparé à un ebitda
9954,all_events,UP,,neo finance ab has received the notification of transactions conducted by uab era capital a person which is closely associated with evaldas remeikis and aiva remeikienė who are discharging managerial responsibilities within an issuer please find attachment enclosed evaldas remeikis head of administration email evaldas remeikis neofinance com attachments 2024 11 18 era capital pranesimas pdf
41,all_events,DOWN,UP,zug switzerland and boston feb 15 2024 globe newswire crispr therapeutics nasdaq crsp a biopharmaceutical company focused on creating transformative gene based medicines for serious diseases today announced that members of its senior management team will present at the citi 2024 virtual oncology leadership summit on wednesday february 21 2024 at 1 00 p m et
3027,all_events,DOWN,,west lafayette ind nov 13 2023 globe newswire inotiv inc nasdaq notv a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services today provides business updates related to inotiv s operations and an update regarding its participation in upcoming investor conferences
7811,all_events,UP,,results in performance of the upper limb pul 2 0 continue to show benefits in skeletal muscle function after 3 years of cap 1002 treatment p 0 001 stabilization in left ventricular ejection fraction lvef suggests preservation of cardiac function
11876,all_events,UP,,tamtron group plc company release november 14 2024 at 18 30 00 eet nasdaq omx helsinki tamtron group plc now holds a total of 3 745 shares including the shares repurchased on 14 11 2024 on behalf of tamtron group plcnordea pankki suomi oyj janne sarvikivisami huttunen for further informationmiika tuominen cfodirect 358 40 522 2210email miika tuominen tamtron com attachments tamtron 14 11 trades xlsx
5933,all_events,UP,,media release
2692,all_events,DOWN,,09 oct 2024 18 00 cest hermes international communiqué paris le 9 octobre 2024 informations relatives au nombre total de droits de vote et d actions composant le capital social conformément aux dispositions de l article l 233 8 du code de commerce et de l article 223 16 du règlement général de l autorité des marchés financiers amf hermès international publie chaque mois avant le 15 du mois suivant le nombre total de droits de vote et le nombre d actions composant le capital social s ils ont variés par rapport à ceux publiées antérieurement datenombre d actions composant le capital nombre total de droits de vote théoriques y compris les actions privées de droit de vote nombre total de droits de vote réels exerçables en assemblée générale date de mise en ligne30 septembre 2024105 569 412179 441 272178 707 8259 octobre 202431 août 2024105 569 412179 446 014178 732 4646 septembre 202431 juillet 2024105 569 412179 445 914178 732 8437 août 202430 juin 2024105 569 412179
11809,all_events,UP,,12 nov 2024 18 00 cet lebon compagnie programme de rachat ce formulaire constitue l annexe 3 de l instruction amf n 2005 06 relative aux modalités de déclaration des programmes de rachat des actions propres et des opérations de stabilisationsiren 552018731 lei 969500q0txusfdlh3940 dénomination sociale de l émetteur lebon nature des titres nom du titre caractéristiques adp cci actions date de début du programme 29 05 2024 tableau de declaration mensuelle des operations realiseespar un emetteur sur ses propres titres opérations du mois de octobre 24 i informations cumulees capital autodétenu de manière directe et indirecte au début du programme en titres en pourcentage 1 173 000 solde au 30 09 2024 date de la dernière déclaration 36 522 3 nombre de titres achetés dans le mois 823 nombre de titres vendus dans le mois
318,all_events,UP,UP,november 18 2024 03 00 et source ilkka oyj ilkka oyj ilkka oyj johdon liiketoimet 18 11 2024 klo 10 00 ilkka oyj johdon liiketoimet otala ____________________________________________ilmoitusvelvollinennimi veikko heikkilän kuolinpesäasema lähipiiriin kuuluva henkilö x oikeushenkilö 1 liikkeeseenlaskijassa johtotehtävissä toimiva henkilönimi satu otalaasema hallintoneuvoston jäsenliikkeeseenlaskija ilkka oyjlei 743700kmzl7e8pli5x73ilmoituksen luonne ensimmäinen ilmoitusviitenumero 85005 4 4____________________________________________liiketoimen päivämäärä 2024 11 15kauppapaikka nasdaq helsinki ltd xhel instrumenttityyppi osakeisin fi0009800205liiketoimen luonne luovutus liiketoimien yksityiskohtaiset tiedot 1 volyymi 3 yksikköhinta 3 03 eur 2 volyymi 40 yksikköhinta 3 04 eur 3 volyymi 100 yksikköhinta 3 1 eur 4 volyymi 100 yksikköhinta 3 05 eur 5 volyymi 127 yksikköh
2453,all_events,UP,UP,november 19 2024 07 11 et source danske bank a s danske bank a s 19 november 2024 indberetning nr 118 2024 ændring i aktiebesiddelser hos danske banks indberetningspligtige i henhold til eu forordningen om markedsmisbrug i forbindelse med danske bank a s aktietilbagekøbsprogram sælger apmh invest a s løbende aktier i danske bank a s pro rata for yderligere detaljer henvises til de vedhæftede skemaer hvori transaktioner udført af personer med ledelsesansvar og personer med nær tilknytning til disse skal indberettes og offentliggøres kontakt stefan singh kailay head of media relations tel 45 45 14 14 00 vedhæftet fil
4504,all_events,DOWN,,the government securities auction of additional offers will be held on 2024 10 21 auction participants can submit competitive and non competitive bids the competitive bids shall be submitted in the order books of the vse new issue yield market whereas the non competitive bids shall be placed in the order books of the vse new issue yield non market the parameters of the emission to be issued shall be the following with the written consent of the ministry of finance this amount may be increased by one additional amount up to a maximum of eur 5 000 000 for one of the auction participants the securities shall be redeemed by paying to their holders the total amount of par value the paid up securities shall be admitted to the regulated market to the debt securities list of the nasdaq vilnius ab nasdaq baltic transaction services 370 5 253 14 54 www nasdaqbaltic com
11833,all_events,DOWN,,announcement no 243 11 november 2024 in connection with the announced share buy back program in norden a s motortramp continuously sells shares pro rata and the market is to be informed accordingly see the attached file and announcements nos 235 24 and 237 24 kind regards dampskibsselskabet norden a s martin badsted cfo for further information therese möllevinge head of investor relations tel 45 41 37 16 38 e mail thm norden com isabella zaugg hansen investor relations manager tel 45 27 62 90 96 e mail izh norden com attachments no 243 managers transactions etc pdf transactions by persons discharging managerial responsibilities and persons pdf
10870,all_events,DOWN,,vilnius lithuania 2024 11 19 10 14 cet omx baltic benchmark fund share price on november 18 2024 12 7627 eur omx baltic benchmark fund number of shares issued on november 18 2024 0 units omx baltic benchmark fund number of shares redeemed on november 18 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of november 18 2024 125 362 units nter asset management
6562,all_events,UP,,vilnius lithuania 2024 11 13 07 18 cet omx baltic benchmark fund share price on november 12 2024 12 8155 eur omx baltic benchmark fund number of shares issued on november 12 2024 0 units omx baltic benchmark fund number of shares redeemed on november 12 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of november 12 2024 125 362 units nter asset management
3532,all_events,UP,,robit plc stock exchange release 7 november 2024 at 18 45 eet robit plc repurchase of own shares 7 november 2024 robit plc now holds a total of 55 329 shares including the shares repurchased on 7 november 2024 detailed information concerning the repurchase is attached to this stock exchange release on behalf of robit plc op corporate bank further information robit plc arto halonen group ceo 358 40 028 0717 arto halonen robitgroup com distribution nasdaq helsinki ltd key media www robitgroup com robit is the specialist focused on high quality drilling consumables for the mining and construction markets globally to help you drill even further faster robit strives to be the world s number one drilling consumables company through our proven high quality top hammer down the hole and geotechnical products and our expert services we deliver drilling cost savings to our customers robit has its own sales and service points in seven countries and an active network of distributors
3314,all_events,DOWN,,between november 4 2024 and november 8 2024 essity aktiebolag publ repurchased a total of 270 000 own class b shares isin se0009922164 under the framework of the buyback program as resolved by the board of directors the share purchase is part of the sek 3bn buyback program announced by essity on june 17 2024 the buyback program will extend from june 17 2024 until the 2025 annual general meeting and be implemented in accordance with the eu market abuse regulation mar and the european commission s delegated regulation 2016 1052 safe harbour regulation the share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of essity s capital allocation class b shares in essity were repurchased as follows all purchases were conducted on nasdaq stockholm by danske bank on behalf of essity following the above purchases essity s holding of treasury shares amoun
5030,all_events,DOWN,,november 06 2024 09 10 et source oma säästöpankki oyj oma säästöpankki oyj oma savings bank plc stock exchange release 6 november 2024 at 16 10 p m eet inside information insider information the shareholders nomination committee proposes the election of five new members to the board of directors of oma savings bank plc and recommends an extraordinary general meeting to elect the board of directors the shareholders nomination committee which represents the five largest shareholders recommends that the board of directors of oma savings bank plc omasp or the company convene an extraordinary general meeting already before the annual general meeting in spring 2025 and proposes the following to the next general meeting of omasp regarding the composition and remuneration of the board of directors proposal of the shareholders nomination committee on the number and composition of the members of the board of directors of omasp the number of
8582,all_events,DOWN,,kone corporation stock exchange release november 13 2024 at 5 30 p m eet kone corporation notice pursuant to the finnish securities market act chapter 9 section 10 kone corporation has received an announcement from blackrock inc on november 13 2024 in accordance with the finnish securities market act chapter 9 section 5 according to the announcement the total number of kone corporation shares owned by blackrock inc and its funds increased to above five 5 per cent of the share capital of kone corporation on november 12 2024 total position of blackrock inc and its funds subject to the notification 4 shares below voting rights 0 shares below voting rights 5 shares below voting rights 529 395 860 shares 121 527 427 voting rights below shares below voting rights below shares below voting rights below shares below voting rights notified details of the resulting situation on the date on which the threshold was crossed a shares
12128,all_events,UP,,alvotech nasdaq alvo birtir í dag óendurskoðað uppgjör fyrir fyrstu níu mánuði ársins 2024 og kynnir nýjustu áfanga í rekstri félagsins stjórnendur félagsins munu kynna uppgjörið og nýjustu áfanga í rekstri á fundi í beinu streymi sem hefst kl 13 að íslenskum tíma fimmtudaginn 14 nóvember nk nánari upplýsingar um hvernig hægt er að hlusta á streymi af fundinum er að finna á vefsíðunni https investors alvotech com events event details q3 2024 earnings
12534,all_events,DOWN,,neola medical ab announces that the company s neola logotype featuring a lung symbol has been registered as trademark in the u s trademark protection is a cornerstone of neola medical s commercialization strategy reinforcing the company s position in the neonatal market and further enhancing its competitiveness ahead of market launch in the u s of the company s medical device for continuous lung monitoring of preterm born babies securing trademark registration of the neola logotype in the u s is a key component of our market launch strategy this trademark not only safeguards our intellectual property in our most important market but also elevates the neola brand as a symbol of trust and innovation in neonatal care our brand represents quality safety and an aim to transform the standard of care in neonatal intensive care units around the world says ceo hanna sjöström neola medical introduced its new company name and branding platform in 2022 to align with the company s
8803,all_events,UP,,after more than four years as president and ceo annacarin grandin will leave coor to take on new challenges outside the company the board of directors will now initiate the process of recruiting a successor annacarin grandin will remain in her current position until a replacement is appointed or no later than 10 may 2025 annacarin grandin who took over as ceo in connection with the pandemic is a skilled operational and appreciated leader who has created growth and innovations and accelerated sustainability work at coor we have built a strong platform and it is now time for the next phase in the company s journey i would like to thank annacarin for her commitment and for all the significant contributions made to coor over many years in the company commented mats granryd chairman of the board i m very grateful and proud that i along with all the fantastic employees have been part of coor s development journey for more than 20 years now it s time to hand over the baton
8882,all_events,DOWN,,11 nov 2024 11 44 cet høland og setskog sparebank finansiell kalender for høland og setskog sparebank regnskapsår 2024 20 03 2025 årsrapport 19 03 2025 ordinær generalforsamling 28 02 2025 kvartalsrapport q4 regnskapsår 2025 15 08 2025 halvårsrapport 29 04 2025 kvartalsrapport q1 31 10 2025 kvartalsrapport q3 denne informasjonen offentliggjøres i henhold til kravene i løpende forpliktelser more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site høland og setskog sparebank oslo børs newspoint høland og setskog sparebank høland og setskog spb 20 25 frn holand og setskog spb 21 26 frn holand og setsk spb 21 perp frn c hybrid holand og setskog spb 21 31 frn c sub holand og setskog spb 22 25 frn holand og setskog spb 23 26 frn holand og setskog spb 23 28 frn høland og setskog spb 24 34 frn c sub høland og setsk spb 24 perp frn c hybrid høland og setskog spb 24 27 frn h
2232,all_events,DOWN,UP,media release
10266,all_events,UP,,zug switzerland oct 15 2024 globe newswire oculis holding ag nasdaq ocs oculis a global biopharmaceutical company purposefully driven to save sight and improve eye care today announced that an update on the diamond phase 3 program with ocs 01 an optireach formulation of high concentration dexamethasone eye drop for diabetic macular edema dme will be presented by david eichenbaum m d at innovate retina in addition riad sherif m d oculis chief executive officer will be presenting at eyecelerator 2024 ahead of the american academy of ophthalmology annual meeting where oculis will be exhibiting booth 5452
11402,all_events,UP,,šiaulių bankas ab plans an offering of fixed rate reset perpetual additional tier 1 temporary write down notes subject to market conditions this notice does not constitute or form part of any offer invitation to sell or issue or any solicitation of an offer to purchase or subscribe for any securities of akcinė bendrovė šiaulių bankas on 14 october 2024 the management board of šiaulių bankas ab approved an offering of fixed rate reset perpetual additional tier 1 temporary write down which would follow subject to market conditions šiaulių bankas ab has mandated goldman sachs bank europe se as lead manager to arrange a series of virtual fixed income investor meetings commencing on 14 october relevant stabilisation regulations including fca icma will apply this communication is not an offer of securities or investments for sale nor a solicitation of an offer to buy securities or investments in any jurisdiction where such offer or solicitation would be unlawful no action has been
9530,all_events,DOWN,,19 nov 2024 19 13 cet synergie acquisition des actions de l actionnaire minoritaire de synergie italia synergie acquiert la part minoritaire de synergie italia et poursuit son développement sur ce marché stratégique synergie annonce l acquisition de la participation de l actionnaire minoritaire de synergie italia et renforce ainsi sa position sur le marché italien du recrutement et des solutions rh cette acquisition marque une étape importante dans notre développement international en intégrant pleinement synergie italia nous consolidons notre présence en italie et renforçons notre capacité à répondre aux besoins spécifiques du marché local cette prise de participation à est le résultat d une croissance organique forte sur ce marché et représente un succès majeur pour notre groupe synergie italia est désormais encore mieux positionnée pour capitaliser sur les opportunités de croissance en italie et continuer à innover dans le domaine des ressources humaines sur ce
11300,all_events,DOWN,,petach tikva israel june 10 2024 globe newswire polypid ltd nasdaq pypd polypid or the company a late stage biopharma company aiming to improve surgical outcomes today announced that it will host a virtual key opinion leader kol event on monday june 17 2024 at 10 00 am et to discuss the significant unmet medical need in surgical site infections and provide an update on the company s ongoing d plex100 phase 3 trial to register click here
9023,all_events,DOWN,,arcutis today announced regulatory approval from health canada for zoryve roflumilast topical foam 0 for the treatment of seborrheic dermatitis
9038,all_events,DOWN,,07 oct 2024 18 15 cest alpes proven csa reg cr mut caisse regionale de credit agricole mutuel alpes provence société coopérative à capital variable25 chemin des trois cyprès 13097 aix en provence cedex 2381 976 448 r c s aix en provence aix en provence le 7 octobre 2024 achats effectués dans les conditions de l article 5 du règlement abus de marché dans le cadre du programme de rachat des certificats coopératifs d investissement autorisé par l assemblée générale mixte des sociétaires du 26 mars 2024 le détail des transactions est disponible en annexe le crédit agricole alpes provence vous informe que le document est disponible sur son site internet http www ca alpesprovence fr et a été transmis à l autorité des marchés financiers nom de l émetteurcode identifiant de l émetteurjour de la transactioncode identifiant de l instrument financiervolume total journalier en nombre d actions prix pondéré moyen journ
2894,all_events,DOWN,,09 oct 2024 18 00 cest orapi communique du 9 octobre 2024 depot d un projet d offre publique de retrait suvie d un retrait obligatoire visant les actions ordinaires de la société initiée par présentée par etablissements présentateurs et garants communique relatif au depot d un projet de note d information etabli par groupe paredes orapi prix de l offre publique de retrait 6 50 euros par action ordinaire orapi duree de l offre publique de retrait 10 jours de négociation le calendrier de l offre publique de retrait sera déterminé par l autorité des marchés financiers amf conformément aux dispositions de son règlement général le présent communiqué le communiqué a été établi et est diffusé en application de l article 231 16 du règlement général de l amf le projet d offre publique de retrait suivie d un retrait obligatoire et le projet de note d information déposé ce jour auprès de l amf le projet de note d information restent soumis à l examen de l amf a
6624,all_events,UP,,19 nov 2024 08 00 cet longship group b v the company is pleased to announce that it has successfully listed the bonds under its frn senior secured eur 60 000 000 bonds 2024 2027 isin no0013233171 on nordic abm as of today attached is the bond terms as well as the admission document and the loan description prepared in connection with the listing for further queries please contact dirk jan miedema chief financial officer 31 6 1074 7001 djm longship com about longship group b v longship group b v is a privately owned ship operator and logistics company incorporated under duch law longship group b v currently operates a fleet in the range of 14 vessels in addition to 8 newbuildings under construction while also having 6 ship newbuildings under negotiation longship group b v is per today invested in pure european shortsea operations transporting various type of cargo longship group b v s ownership in the fleet of vessels are structured through own
1347,all_events,DOWN,DOWN,media release
3449,all_events,UP,,copenhagen denmark april 17 2024 globe newswire evaxion biotech a s nasdaq evax evaxion or the company a clinical stage techbio company specializing in developing ai immunology powered vaccines announces that the first patient in its evx 01 phase 2 trial in metastatic melanoma received the last vaccine dose in combination with keytruda nct05309421
1830,all_events,UP,DOWN,media release
10467,all_events,UP,,13 nov 2024 15 00 cet beerenberg as beerenberg as will release its third quarter 2024 results on friday 15 november 2024 at 08 00 cet the results will be available at www beerenberg com and published on www newsweb no beerenberg as will not hold a live presentation of the third quarter 2024 but investors are welcome to contact the company if any questions to the report for further information please contact harald haldorsen cfo tel 47 982 34 834 e mail harhal beerenberg com about beerenberg as beerenberg has delivered cost efficient solutions to a wide range of industrial enterprises for 47 years beerenberg is one of the leading suppliers of maintenance and modifications services on the norwegian continental shelf as well as a global provider of insulating products the group s expertise covers the entire life cycle of the petroleum industry from field studies and newbuilds to maintenance modifications and lifetime extensions the operational
85,all_events,UP,UP,media release
4708,all_events,DOWN,,more than 100 patients enrolled in ongoing shield ii phase 3 trial of d plex100 for the prevention of abdominal colorectal surgical site infections
1954,all_events,DOWN,DOWN,14 nov 2024 18 00 cet kering press release bond issue november 2024 press release november 14 2024 bond issue for a total amount of eur 750 million kering has issued a single tranche bond for a total of eur 750 million with a 10 year maturity and a 3 coupon this issue in line with the group s active liquidity management enables kering to enhance its financial flexibility the great success of this issue with bond investors underscores the market s confidence in kering s credit quality kering has a long term rating of bbb from standard poor s about kering a global luxury group kering manages the development of a series of renowned houses in fashion leather goods and jewelry gucci saint laurent bottega veneta balenciaga alexander mcqueen brioni boucheron pomellato dodo qeelin and ginori 1735 as well as kering eyewear and kering beauté by placing creativity at the heart of its strategy kering enables its houses to set new limits in te
2442,all_events,DOWN,DOWN,media release
1955,all_events,DOWN,UP,alexandria group oyj notification 08 11 2024 at 18 30 eet alexandria group oyj acquisition of own shares 08 11 2024 date 08 11 2024 exchange transaction buy share class alex amount 275 average price share 8 4027 eur highest price share 8 4500 eur lowest price share 8 3500 eur total price 2 310 74 eur the shares held by alexandria group oyj on 08 11 2024 alex 41 575 on behalf of alexandria group oyj skandinaviska enskilda banken ab publ helsinki branch antti salakka janne tiihonen for more information please contact jan åkesson ceo jan akesson alexandria fi 358 40 731 2325 attachments alex sbb 08112024 xlsx
6658,all_events,UP,,led by long standing investor ecor1 capital with participation from additional existing and new investors including sanofi led by long standing investor ecor1 capital with participation from additional existing and new investors including sanofi
4091,all_events,DOWN,,company announcement nanoform finland plc november 18 2024 08 10 a m finnish time 07 10 a m swedish time nanoform q3 2024 report record number of new projects signed a record number of new non gmp projects signed in the quarter helped by a significantly increased interest in our biologics offering revenue growth is back and is expected to accelerate in coming quarters and years most gmp quality control analytical activities insourced after receiving fimea license in august manufacturing of gmp material for pivotal studies and registration batches in project nanoenzalutamide continues pivotal studies to start in 1q25 with first read out in 2q25 further progress on dealmaking around our product kernels half a dozen term sheets received first letter of intent signed and several license commercial supply agreements on multiple product kernels expected to be signed in coming quarters 7 9 2024 key financials 1 9 2024 key financials numbers in brackets refer to the correspond
12785,all_events,DOWN,,arcutis today reported financial results for the quarter ended june 30 2024 and provided a business update
1035,all_events,UP,DOWN,based on preliminary data from ongoing clinical trials focusing on next generation car t product candidates ctx112 targeting cd19 and ctx131 targeting cd70
8985,all_events,DOWN,,15 nov 2024 08 00 cet totalenergies se regulatory news totalenergies paris tte lse tte nyse tte bp equinor and shell announce a commitment to invest in support of the un sustainable development goal 7 un sdg7 which aims to ensure access to affordable reliable sustainable and modern energy for all the four energy majors have come together with a 500 million joint investment commitment intended to create positive energy access impact for people in key regions over the coming years a growing number of people without access to electricity and clean cooking despite ongoing efforts progress towards universal energy access has stalled particularly amidst recent macroeconomic shocks and rising energy prices in 2022 the number of people without access to electricity globally increased by around 10 million to 685 million 1 additionally approximately 2 1 billion people primarily in sub saharan africa and southeast asia lack access to clean cooking
6014,all_events,UP,,all patients treated in the edithal trial maintained hemoglobin levels above the transfusion threshold and are transfusion free post renizgamglogene autogedtemcel reni cel infusion
7816,all_events,UP,,08 nov 2024 21 30 cet nordea bank nordea bank abp stock exchange release changes in company s own shares 08 11 2024 at 22 30 eet nordea bank abp lei 529900odi3047e2liv03 has on 08 11 2024 completed repurchases of own shares isin fi4000297767 as follows trading number weighted average total cost eur venue mic of price share eur code shares xhel 141 442 10 77 1 523 726 38 xsto 111 459 10 80 1 204 306 05 xcse 27 618 10 77 297 562 04 total 280 519 10 79 3 025 594
594,all_events,UP,UP,november 05 2024 11 30 et source kalmar oyj kalmar oyj liite
4560,all_events,DOWN,,la jolla calif nov 19 2023 globe newswire medicinova inc a biopharmaceutical company traded on the nasdaq global market nasdaq mnov and the standard market of the tokyo stock exchange code number 4875 today announced that medicinova s collaborator justin lathia phd co director of the brain tumor research and therapeutic development center of excellence at cleveland clinic lerner research institute and professor department of molecular medicine at cleveland clinic lerner college of medicine of case western reserve university and patrick wen director at the center for neuro oncology at dana farber cancer institute professor of neurology harvard medical school presented new data and results of a phase 2 clinical trial of mn 166 ibudilast in glioblastoma gbm patients at the 28th annual meeting of the society for neuro oncology sno held november 15 19 2023 in vancouver canada the presentation also included data from preclinical studies which evaluated the combination of mn 166 ibudilast and anti pd1 or anti pd l1 therapy in gbm models
11430,all_events,DOWN,,12 nov 2024 14 54 cet 4finance s a operational highlights online loan issuance volume was stable year on year in the period at 423 5 million compared with 423 8 million in the prior year period demand for credit remains strong in most markets particularly in the czech republic and spain new growth opportunities taking a deliberate step by step approach the uk joint venture ondal co uk and the mexican business kimbi mx progressing steadily showing gradual growth tbi bank loan issuance increased by to 832 8 million in the period compared to 652 3 million in 9m 2023 financial highlights interest income up year on year to 326 7 million in the period compared with 288 8 million in 9m 2023 cost to income ratio for the period was 41 an improvement from 44 in the prior year period cost discipline and operational efficiency remain a focus for the business adjusted ebitda was 116 2 million for the period up
7105,all_events,UP,,media release
8081,all_events,UP,,not for release publication or distribution in or into or to any person located or resident in the united states its territories and possessions including puerto rico the u s virgin islands guam american samoa wake island and the northern mariana islands any state of the united states or the district of columbia the united states or in or into any other jurisdiction where it is unlawful to release publish or distribute this announcement see offer and distribution restrictions in the attached launch announcement íslandsbanki hf the offeror announces today an invitation to the holders of its outstanding eur300 000 000 0 750 per cent notes due 25 march 2025 isin xs2411447043 the notes to tender their notes for purchase by the offeror for cash such invitation the offer as further described in the attached tender launch announcement the offer is being made on the terms and subject to the conditions contained in the tender launch announcement and in the tender o
4850,all_events,UP,,14 nov 2024 07 06 cet sbm offshore n v amsterdam november 14 2024 sbm offshore announces that it has been awarded contracts for the granmorgu field development project located in block 58 in suriname by the operator totalenergies ep suriname b v an affiliate of totalenergies under these contracts sbm offshore will in partnership with technip energies construct and install a floating production storage and offloading vessel fpso the award follows completion of front end engineering and design studies and the final investment decision on the project by the joint venture operated by totalenergies ep suriname b v sbm offshore is expected to operate the unit under an operations and maintenance agreement the granmorgu project is the first development within block 58 circa 150 kilometers offshore suriname totalenergies is the operator holding a 50 percent interest in block 58 alongside apa corporation staatsolie has announced its intent to exercise its option
11219,all_events,DOWN,,riga tallinn vilnius nasdaq baltic market october 16 2024 nasdaq ndaq announces that the shares of eleving group ticker elevr have been listed on the nasdaq baltic main list by nasdaq riga as of today a total of 4 515 investors subscribed to the eleving group shares for a total of 33 million euros as the base volume of the offer was oversubscribed by 1 2 times the offer attracted 4 466 retail investors constituting of the overall allocation of the issued shares estonia led the retail demand split by baltic states with followed by latvia with and lithuania with of subscriptions the average retail subscription was 1 994 euros congratulations to eleving group on the successful ipo it is undoubtedly one of the most significant events in the baltic capital markets this year firstly it is the largest ipo in latvia s history and secondly starting today the company s shares are available for trading on the nasdaq baltic and frankfurt stock exchang
8637,all_events,DOWN,,oslo norway 19 november 2024 reference is made to the stock exchange announcement published by zwipe as the company or zwipe earlier on 7 november 2024 regarding a contemplated rights issue in the company raising gross proceeds of approximately nok 40 million the rights issue in relation thereto the board of directors of zwipe the board calls for an extraordinary general meeting the egm to be held on 3 december 2024 at 10 00 cet the general meeting will be held as a virtual meeting on microsoft teams please find attached the notice to the egm the notice is also available on the company s website https zwipe com investors the deadline for registration of attendance proxies and advance voting for direct shareholders is 2 december 2024 at 16 00 hours cet holders of nominee registered shares must register attendance proxies and advance voting no later than within 29 november 2024 at 16 00 hours cet shareholders are encouraged to register their
12572,all_events,UP,,media release
12520,all_events,UP,,fondia plc company release 5 11 2024 at 6 45 p m eet fondia acquisition of own shares 5 11 2024 fondia plc first north finland date 5 11 2024 exchange transactions buy share class fondia amount shares 305 average price share eur 5 90 total price eur 1799 50 the shares held by fondia plc on 5 11 2024 199 960 shares on behalf of fondia plc op corporate bank fondia in brief fondia solves the legal needs of companies by combining the best services from internal legal departments and law firms fondia operates in finland sweden estonia and lithuania and the group s net sales in 2023 were eur 26 1 million fondia employs around 190 people www fondia com distribution nasdaq helsinki ltd key media attachments fondia trades_0511 xlsx
3210,all_events,UP,,adelaide australia and cambridge mass oct 07 2024 globe newswire bionomics limited nasdaq bnox bionomics or company a clinical stage biotechnology company developing novel first in class allosteric ion channel modulators to treat patients suffering from serious central nervous system cns disorders with high unmet medical need today announced that spyridon spyros papapetropoulos m d ph d president and chief executive officer of bionomics issued the following letter to bionomics shareholders regarding recent achievements executional efficiencies and the positive outlook for the company s future
61,all_events,UP,DOWN,research triangle park n c oct 06 2023 globe newswire science 37 holdings inc nasdaq snce the industry leading metasite today announced the granting of inducement equity awards under the science 37 holdings inc 2022 employment inducement incentive award plan the plan the plan was approved by science 37 s board of directors in november 2022 in accordance with nasdaq listing rule 5635 c 4 the awards were approved by science 37 s compensation committee and made as a material inducement to the non executive employees entry into employment with the company
2435,all_events,DOWN,DOWN,arcutis announced the fda approval for zoryve roflumilast cream 0 for the treatment of atopic dermatitis
4695,all_events,DOWN,,06 nov 2024 08 00 cet xplora technologies as as of october 31 2024 xplora technologies has 327k subscriptions a increase from october 2023 229k this month s highlight 11k new subscriptions gross launched the service bundle with freenet ag announced 2 april 2024 generating 1k new premium subscriptions in two weeks we expect our churn rate to be consistent with historic numbers but now churning from a higher subscription base we expect a more moderate net growth in subscriptions note subscriptions encompass connectivity plans mobile subscriptions premium services b2b service revenues and service fees for xplora smartwatches without xplora mobile subscriptions nordics xplora has seasonal changes especially related to back to school and the festive season the net growth in the subscription base will therefore fluctuate throughout the year for further information please contact sten kirkbak ceo 47 92203710 sten kirkbak xplora com kn
7163,all_events,DOWN,,nasdaq vilnius decided to apply observation status to investment company omx baltic benchmark fund oamobbf1l isin code lt0000990012 regarding decision adopted by the extraordinary general meeting of shareholders to terminate company s activities and liquidate the company as well as to delist company s securities from trading on the regulated market investment company omx baltic benchmark fund publicly announced about that in the announcement on 7 november 2024 the purpose of applying observation status is to alert the market participants nasdaq baltic transaction services 370 5 253 14 59 www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative markets first north operated by nasdaq companies in the baltic states i e nasdaq tallinn as nasdaq riga as and ab nasdaq vilnius
10483,all_events,DOWN,,fiskars corporation stock exchange release november 19 2024 at 11 15 a m eet fiskars corporation to start to acquire the company s own shares the board of directors of fiskars corporation has decided to commence acquiring the company s own shares on the basis of the authorization given by the annual general meeting held on march 13 2024 the maximum number of shares to be acquired is 200 000 corresponding to approximately 0 of the total number of shares the shares shall be acquired through public trading on the nasdaq helsinki exchange at the market price prevailing at the time of purchase the share buyback shall start on november 20 2024 at the earliest and end by february 28 2025 at the latest the annual general meeting held on march 13 2024 decided to authorize the board of directors to decide on the acquisition in total of a maximum of 4 000 000 own shares in one or several instalments using the unrestricted shareholders equity of the company the authorizati
10050,all_events,DOWN,,danske bank a s ledende medarbejderes transaktioner
2167,all_events,UP,DOWN,19 nov 2024 12 42 cet everfuel a s herning denmark 19 november 2024 reference is made to the previous stock exchange announcement on 19 november 2024 where faro bidco aps announced the completion of its unregulated recommended voluntary cash offer the offer to the shareholders of everfuel a s everfuel as further described therein and in the offer document dated 2 september 2024 as part of the completion of the offer martin skov hansen has transferred 9 500 shares in everfuel to faro bidco aps against cash consideration at the offer price of nok 13 per everfuel share please see the attached notification form received by everfuel from martin skov hansen for details of the transaction about everfuel www everfuel com everfuel owns and operates green hydrogen infrastructure and partner with industry and vehicle oems to connect the entire hydrogen value chain and seamlessly provide hydrogen fuel to enterprise customers under long term contracts green h
2029,all_events,DOWN,DOWN,ölgerðin egill skallagrímsson hf hefur lokið sölu á nýjum sex mánaða víxli olgerd250513 fyrir 1 000 m kr að nafnverði á kjörum sem samsvara 9 flötum vöxtum en óskað verður eftir því að víxillinn verði skráður í kauphöll nasdaq iceland við útgáfudag
12440,all_events,UP,,san francisco june 05 2023 globe newswire vir biotechnology inc nasdaq vir today announced that marianne de backer m sc ph d mba chief executive officer is scheduled to participate in a fireside chat at the 44th annual goldman sachs global healthcare conference on monday june 12 at 10 40 a m pt 1 40 p m et
10275,all_events,DOWN,,this message has been corrected click here to view the corrected message from october 7th 2024 10 00 eest as citadele banka bonds offer subscription process is launched the subscription process closing date is october 10th 2024 15 30 eest up to 3 500 bonds are being offered to qualified investors in latvia and estonia as well as elsewhere in the eea the price of one security is fixed at eur 10 000 or of the nominal amount of the security note the minimum investment amount is eur 100 000 10 bonds the interest rate of the bonds is 5 per cent per annum the bonds are registered in the nasdaq csd under the isin code lv0000804334 the subscription offer will be carried out using the stock exchange trading system market rse equities ipo genium inet trading system order book lv0000804334 cblbbond the auction period during which the order collection will take place is october 7th 2024 from 10 00 until 16 00 october 8th october 9th 2024 from
10461,all_events,UP,,in q3 2024 inbank earned a consolidated net profit of 3 1 million euros increasing year on year profit for the first nine months of 2024 reached 10 8 million euros marking a increase compared to the previous year the return on equity roe in q3 stood at 8 and for the first nine months of the year 10 priit põldoja chairman of the management board comments on the results during the third quarter inbank continued to deliver strong results and steady revenue growth inbank s net interest income grew by and total net income grew by for the quarter compared to last year our q3 revenue was negatively impacted by a 1 2 million euro fair value adjustment on financial instruments used to manage interest rate risks during the first two quarters of the year the company made a fair value gain on the same instruments auto marketplaces and dealers financing continued to show very strong results during the third quarter reaching 64 million euros of gmv which is
10715,all_events,DOWN,,significant demand for amtagvi lifileucel continues with 58 6m in total 3q24 product revenue
2534,all_events,UP,DOWN,today opticept technologies opti inaugurated a new innovation center at thammasat university thammasat in bangkok thailand the center will be equipped with opticept s pef pulsed electric field technology for development and research within the food industry in southeast asia saab is sponsoring the innovation center on wednesday november 13 2024 the new innovation center was inaugurated at thammasat university in bangkok thailand one of asia s most prominent academic institutions the center aims to drive technological progress and foster collaboration between industry and academia thereby promoting innovation and economic development in thailand and southeast asia the center will focus on productivity improvements within the food sector a core area of opticept s expertise opticept will be able to bring customers to the center to demonstrate and test the technology we have identified thailand and southeast asia as strategically important markets for opticept n
9615,all_events,UP,,media release
3710,all_events,UP,,attachments 10184530 pdf alma media 18 10 trades xlsx
12863,all_events,UP,,media release
9780,all_events,DOWN,,november 04 2024 07 00 et source alvotech alvotech iceland germany india u s iceland germany india u s alvotech nasdaq alvo og samstarfsaðili þess alþjóðlega lyfjafyrirtækið advanz pharma tilkynntu í dag að lyfjastofnun evrópu ema hafi samþykkt að taka til umsagnar umsókn um markaðsleyfi fyrir avt05 sem er fyrirhuguð líftæknilyfjahliðstæða alvotech við simponi golimumab sem notað er til meðferðar við ýmsum þrálátum bólgusjúkdómum þetta er talin vera fyrsta umsókn um markaðsleyfi fyrir fyrirhugaða líftæknilyfjahliðstæðu við simponi sem tikynnt hefur verið um alþjóðlega markaðsleyfi í evrópu gæti legið fyrir á síðasta ársfjórðungi 2025 þetta er mikilvægur áfangi fyrir alvotech samstarfsaðila okkar sjúklinga og meðferðaraðila þar sem við færumst nú skrefi nær því að geta boðið upp á líftæknilyfjahliðstæðu við simponi sagði joseph mcclellan framkvæmdastjóri
2995,all_events,DOWN,,media release
898,all_events,UP,DOWN,data demonstrates kronos bio s approach to targeting oncogenic transcription factors and the strong relationship between irf4 and p300 in multiple myeloma
11092,all_events,DOWN,,media release
9212,all_events,DOWN,,media release
958,all_events,UP,DOWN,06 nov 2024 18 05 cet citycon treasury b v citycon oyj inside information 6 november 2024 at 19 05 hrs the board of directors of citycon oyj has today decided on the basis of the authorisation by the annual general meeting 2024 that an equity repayment of eur 0 075 per share will be distributed from the invested unrestricted equity fund of the company the equity repayment will be paid to a shareholder registered in the company s shareholders register maintained by euroclear finland ltd on the record date of the repayment 20 december 2024 the equity repayment will be paid on 31 december 2024 following the asset distribution on 31 december 2024 citycon oyj has distributed a total equity repayment of eur 0 30 per share during the year 2024 and the board of directors has fully exercised the asset distribution authorisation granted by the annual general meeting citycon oyj for further information please contact sakari järvelä chief financial officer tel
9526,all_events,UP,,july september 2024 net sales tsek 0 992 other operating revenues tsek 793 173 profit from financial items tsek 8 959 8 403 earnings per share sek 0 45 0 42 january september 2024 net sales tsek 326 4 948 other operating revenues tsek 1 347 588 profit from financial items tsek 30 720 29 305 earnings per share sek 1 55 1 48 cash and cash equivalents tsek 76 685 107 187 events during the period combigene announces new preclinical research results in the epilepsy project cg01 västra hamnen takes over as certified adviser on 25 august 2024 the rights to the lipodystrophy project cgt2 have returned to lipigon on august 5 2024 and the project has beenterminated events after the end of the period combigene initiates measures to extend the liquidity horizon by sharpening the strategic focus on gene therapyand implementing a cost reduction program contacts combigene ab publ peter ekolind ceophone 46 0 8 35 73 55peter eko
6461,all_events,UP,,conference call and webcast today at 8 30 a m et
12806,all_events,UP,,adelaide australia and cambridge mass june 15 2023 globe newswire bionomics limited nasdaq bnox asx bno bionomics or company a clinical stage biotechnology company developing novel first in class allosteric ion channel modulators to treat patients suffering from serious central nervous system cns disorders with high unmet medical need today announced that it will present at the following upcoming investor conferences in june
1513,all_events,DOWN,DOWN,latvian fintech company delfingroup is expanding its operations in the baltic region and launching consumer lending in lithuania this strategic move strengthens the position of the company in the lithuanian financial services market where delfingroup has already been successfully offering pawn loans as well as buying and selling services for pre owned slightly pre owned and new goods this summer the bank of lithuania granted delfingroup a licence to provide consumer loan services allowing it to expand its range of services in lithuania and to offer convenient affordable and competitive financial solutions to customers with a loan portfolio exceeding 100 million euros and a market share in the consumer loan segment delfingroup has already gained a strong position in the latvian market proving its ability to provide high quality services the introduction of new and competitive financial services in lithuania is not only in line with the development goals of delfingrou
8869,all_events,DOWN,,media release
465,all_events,DOWN,DOWN,eurobio scientific suspension du contrat de liquidité
7428,all_events,DOWN,,19 nov 2024 10 15 cet idex biometrics asa oslo norway and seoul south korea 19 november 2024 idex biometrics has entered into a commercial development agreement with south korean smart card manufacturer cellfie global formerly ick to design manufacture and market biometric metal and pvc cards for bank and fintech launches in usa europe and asia this gives idex biometrics full coverage across all four card manufacturers in south korea representing a production capacity in excess of 100 million smart cards annually and with world leading metal card manufacturing capabilities cellfie global has a strong customer base in mainly usa and europe markets representing of the 40 million annual metal card shipments cellfie global s leading metal cards provide a unique sensory experience that is driven by card weight card sound card technology and a unique design perspective bringing a different metal card solution to banks and fintechs globally we are exc
8743,all_events,UP,,13 nov 2024 14 37 cet skagerrak sparebank se vedlegg på www newsweb no more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632084_interests 2024 11 13 pdf skagerrak sparebank oslo børs newspoint skagerrak spb 20 25 frn skagerrak spb 21 25 frn skagerrak spb 21 26 frn skagerrak spb 22 25 frn skagerrak spb 22 perp frn c hybrid skagerrak spb 23 perp frn c hybrid skagerrak spb 23 27 frn skagerrak spb 24 34 frn c sub skagerrak spb 24 28 frn skagerrak spb 24 29 frn no0010911837 no0010922933 no0011017121 no0011129561 no0012654518 no0012759085 no0012832239 no0012916123 no0013030965 no0013319335 no0013339770 no0013351155 nordic alternative bond market
1479,all_events,UP,DOWN,paris et cambridge mass 02 juin 2024 globe newswire nanobiotix euronext nano nasdaq nbtx la société société française de biotechnologie en phase de développement clinique avancé pionnière des approches fondées sur la physique pour élargir les possibilités de traitement des patients atteints de cancer annonce aujourd hui présenter des données mises à jour et nouvelles des parties d escalade de dose et d expansion de l étude 1100 une étude de phase 1 en cours aux états unis évaluant nbtxr3 activé par radiothérapie en association à des inhibiteurs de point de contrôle immunitaire immune checkpoints inhibitors ici anti pd 1 comme traitement de deuxième intention ou plus pour les patients atteints de tumeurs solides et métastatiques avancées ces données ont été présentées par l investigatrice coordinatrice de l étude 1100 colette shen md phd lors de la réunion annuelle 2024 de l american society for clinical oncology asco 2024
6307,all_events,UP,,valberedningen inför scandics årsstämma 2025 utgörs enligt valberedningens instruktion av scandics tre största aktieägare per den 31 augusti 2024 samt styrelsens ordförande och har följande sammansättning aktieägare som vill lägga fram förslag till valberedningen kan göra detta via e post till nominationcommittee scandichotels com senast den 31 december 2024 årsstämman kommer att äga rum den 6 maj 2025 på vasateatern scandic grand central i stockholm för mer information vänligen kontakta rasmus blomqvist director investor relations scandic hotels group email rasmus blomqvist scandichotels com telefon 46 702 335 367 camilla köhler general counsel scandic hotels group email camilla kohler scandichotels com telefon 46 709 735 159 om scandic hotels group scandic är det största hotellföretaget i norden med ett nätverk av omkring 280 hotell och 58 000 hotellrum i drift och under utveckling på över 130 destinationer scandic är ledande när det kommer till att integrera hållb
4960,all_events,UP,,november 06 2024 02 30 et source suominen oyj suominen oyj suominen oyj osavuosikatsaus 6 11 2024 klo 9 30suominen oyj n osavuosikatsaus 1 1 30 9 2024 operatiiviset haasteet vaikuttivat kannattavuuteen näkymät ennallaan avainlukuja tässä osavuosikatsauksessa sulkeissa esitetyt luvut viittaavat viime vuoden vastaavaan ajankohtaan ellei muuta ole mainittu heinä syyskuu 2024 lyhyesti liikevaihto kasvoi 5 edellisvuoden vastaavasta kaudesta ja oli 111 6 milj euroa 106 4 vertailukelpoinen käyttökate laski ja oli 3 3 milj euroa 5 2 liiketoiminnan rahavirta oli 2 6 milj euroa 8 0 tammi syyskuu 2024 lyhyesti liikevaihto kasvoi 2 edellisvuoden vastaavasta kaudesta ja oli 343 8 milj euroa 335 9 vertailukelpoinen käyttökate nousi ja oli 12 8 milj euroa 10 5 liiketoiminnan rahavirta oli 2 6 milj euroa 17 6 näkymät vuodelle 2024 suominen odottaa että sen vertailukelpoinen käyttökate ebitda vuonna 2024 nousee vuode
12821,all_events,UP,,longeveron reports 3q24 financial results pivotal phase 2b clinical trial in hlhs achieves enrollment positive phase 2 data for alzheimer s disease
868,all_events,DOWN,DOWN,media release
11910,all_events,DOWN,,norwood mass feb 28 2024 globe newswire corbus pharmaceuticals holdings inc nasdaq crbp corbus or the company a precision oncology company with a diversified portfolio today announced the appointment of dr dominic smethurst ma mrcp as the company s chief medical officer cmo in this role dr smethurst will lead the clinical development of the company s investigational oncology drugs crb 701 a next generation nectin 4 targeting antibody drug conjugate adc developed in partnership with cspc and crb 601 a tgfβ blocking monoclonal antibody targeting the integrin αvβ8 additionally dr smethurst will help guide strategic development of crb 913 the company s highly peripherally restricted cb1 inverse agonist for the treatment of obesity
3785,all_events,UP,,wetteri plc stock exchange release 8 november 2024 at 13 00 wetteri plc has terminated the liquidity providing service with lago kapital oy to end on 8 january 2025 the company estimates that the liquidity of the share is sufficient without market making more information aarne simula ceo and president wetteri plc tel 358 400 689 613 aarne simula wetteri fi wetteri plc an entrepreneur driven growth company in the automotive sector wetteri plc is an entrepreneur driven growth company in the automotive sector the company engages in the retail sales of passenger cars commercial vehicles and heavy vehicles and produces maintenance and repair shop services for vehicles from passenger cars to heavy vehicles headquartered in oulu the company has 50 locations in finland the company employs app 1 000 people of whom around work in maintenance and repair services wetteri promotes digitalisation in the automotive sector and is an important player on the common journey toward
7556,all_events,DOWN,,west lafayette ind may 14 2024 globe newswire inotiv inc nasdaq notv the company or inotiv a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services today announced that it will issue its financial results for the fiscal 2024 second quarter ended march 31 2024 on wednesday may 15 2024 after the close of the stock market the company will host a conference call that same day at 4 30 p m eastern time to discuss the results
4119,all_events,UP,,240 million private placement financing led by ra capital management with significant participation by bain capital life sciences as well as bvf partners and canaan partners to fund phase 2b clinical trial
8131,all_events,UP,,november 11 2024 02 00 et source tallink grupp tallink grupp person subject to the notification requirementname nõgene paavoposition chairman of the management board of as tallink grupp issuer as tallink grupp lei 529900qrmwakkr3l9w75 notification type initial notification _____________________________________ transaction date 08 11 2024venue nasdaq omx tallinninstrument type shareisin ee3100004466nature of the transaction acquisition transaction details 1 volume 13 932 unit price 0 598 eur 2 volume 4 788 unit price 0 599 eur 3 volume 1 280 unit price 0 600 eur aggregated transactions 3 volume 20 000 volume weighted average price 0 598 eur anneli simminvestor relations manager as tallink gruppsadama 510111 tallinnphone 372 56157170e mail anneli simm tallink ee
12698,all_events,UP,,07 nov 2024 18 00 cet carmat déclaration au titre de l article 223 16 du règlement général de l autorité des marchés financiers regulatory news carmat paris alcar date nombre d actions composant le capital nombre de droits de vote brut nombre de droits de vote net 31 10 2024 42 723 356 47 213 359 47 197 263 dont 233 550 actions émises dans le cadre de l équitization de l emprunt contracté auprès de la banque européenne d investissement le nombre total de droits de vote calculé sur la base de l ensemble des actions auxquelles sont attachés des droits de vote y compris les actions privées de droit de vote société anonyme au capital social de 1 697 303 84 siège social 36 avenue de l europe immeuble l etendard energy iii 78140 vélizy villacoublay 504 937 905 rcs versailles consultez la version source sur businesswire com https www businesswire com news home 20241107875970 fr carmat décl
9332,all_events,UP,,transcode therapeutics announces first patients treated in phase 1 clinical trial with first in class lead therapeutic candidate
10366,all_events,DOWN,,norwood mass feb 28 2024 globe newswire corbus pharmaceuticals holdings inc nasdaq crbp corbus or the company a precision oncology company with a diversified portfolio today announced the appointment of dr dominic smethurst ma mrcp as the company s chief medical officer cmo in this role dr smethurst will lead the clinical development of the company s investigational oncology drugs crb 701 a next generation nectin 4 targeting antibody drug conjugate adc developed in partnership with cspc and crb 601 a tgfβ blocking monoclonal antibody targeting the integrin αvβ8 additionally dr smethurst will help guide strategic development of crb 913 the company s highly peripherally restricted cb1 inverse agonist for the treatment of obesity
6698,all_events,UP,,as longo group the largest used car retailer in the baltic region launches a public bond offering of 10 million euros today in all three baltic states with a fixed annual interest rate of and a maturity of three years the subscription period will last until 25 november and is open to both retail and professional investors since its inception longo group s mission as a leading player in the baltics has been to bring new meaning to the used car market it is grounded in offering a wide assortment high quality and a fair transparent experience for our clients we have laid all the necessary groundwork to elevate the company s expansion to the next level and this bond offering will further accelerate our growth plans says edgars cērps founder and the member of the management board at as longo group the proceeds from the bond offering will be used to refinance existing liabilities and to finance the group s growth plans through investments in new car stock and expansion
10664,all_events,UP,,12 nov 2024 07 53 cet askim og spydeberg sparebank per 30 september 2024 er resultatet av ordinær drift før skatt mnok 163 mot mnok 142 3 per 30 september 2023 resultat av ordinær drift før skatt for tredje kvartal 2024 er mnok 61 8 mot mnok 46 7 i tredje kvartal i 2023 totale utlån til kunder inkludert lån formidlet til boligkredittselskap utgjør mnok 14 182 fordelt på 80 2 til privatkunder og 19 8 til næringslivskunder på 12 måneders basis er det en økning i utlån til kunder på mnok 638 4 7 inkl lån overført til boligkredittselskap hittil i år har utlån til kunder økt med mnok 700 5 2 innskudd fra kunder utgjør mnok 8 804 per 30 september 2024 en økning på mnok 516 6 2 siste 12 mnd hittil i år har innskudd fra kunder økt med mnok 297 3 5 per 30 september 2024 den henvises for øvrig til vedlagte delårsrapport kontaktperson konstituert administrerende banksjef john tore østby tlf 98 67 25 54 more information access the news o
3705,all_events,DOWN,,warrington pa nov 09 2023 globe newswire windtree therapeutics inc windtree or the company nasdaqcm wint a biotechnology company focused on advancing late stage interventions for cardiovascular disorders today reported financial results for the third quarter ended september 30 2023 and provided key business updates
5042,all_events,DOWN,,12 nov 2024 16 01 cet sparebank 1 boligkreditt oslo børs har mottatt søknad om børsnotering av isin no0013405084 markedsmisbruksforordningen mar gjelder fra søknadstidspunktet herunder låntagers informasjonsplikt om innsideinformasjon more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sparebank 1 boligkreditt oslo børs newspoint spb 1 boligkreditt as 11 26 4 covd spb 1 boligkreditt as 16 28 2 covd spb 1 boligkreditt as 16 26 adj c covd spb 1 boligkredi as 18 25 0 eur covd spb 1 boligkreditt as 19 29 adj covd spb 1 boligkreditt as 20 25 frn covd spb 1 boligkreditt as 20 25 sek frn covd spb 1 boligkreditt as 21 26 frn covd spb 1 boligkreditt as 21 23 1 73 pct covd spb 1 boligkreditt as 22 27 frn covd spb 1 boligkreditt as 22 34 adj covd spb 1 boligkreditt as 23 28 frn covd spb 1 boligkreditt as 23 33 3 45pct covd spb 1 boligkreditt as 23 30 4 covd spb 1 boligkredi
11978,all_events,DOWN,,vilnius lithuania 2024 10 18 08 33 cest omx baltic benchmark fund share price on october 17 2024 13 1603 eur omx baltic benchmark fund number of shares issued on october 17 2024 0 units omx baltic benchmark fund number of shares redeemed on october 17 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of october 17 2024 125 362 units nter asset management
12416,all_events,DOWN,,portland maine aug 29 2023 globe newswire immucell corporation nasdaq iccc immucell or the company a growing animal health company that develops manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle announced today that it recently submitted the chemistry manufacturing and controls cmc technical section for re tain to the fda
10928,all_events,UP,,secured additional r d collaborations with solventum and mölnlycke for optimal trial consistency and patient outcomes
542,all_events,UP,DOWN,12 nov 2024 18 00 cet asm international n v almere the netherlands november 12 2024 6 00 p m cet asm international n v euronext amsterdam asm informs the market that asmpt in which asm has a shareholding of approximately announced that it ceased discussions in relation to a possible privatization of asmpt asmpt ltd asmpt in which asm is a shareholder announced on october 14 2024 that its board had received a preliminary non binding approach from an independent third party the potential offeror in relation to a possible privatization of asmpt meanwhile asmpt made an announcement that asmpt and the potential offeror ceased these discussions in respect of a possible privatization of asmpt about asm international asm international n v headquartered in almere the netherlands and its subsidiaries design and manufacture equipment and process solutions to produce semiconductor devices for wafer processing and have facilities in the united stat
10291,all_events,UP,,13 nov 2024 07 00 cet interparfums see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1297215_perspectives2025an pdf inter parfums les echos interparfums fr0004024222 itp euronext
6872,all_events,DOWN,,media release
7012,all_events,DOWN,,13 nov 2024 15 46 cet vow asa vow asa ose vow will release its report for the third quarter 2024 on tuesday 26 november 2024 the update will be published on https newsweb oslobors no and on the company s web site www vowasa com http www vowasa com vow asa is pleased to invite shareholders investors analysts and other interested parties to a presentation of the results and a q a at 09 00 cet on the same day personal attendance is welcomed at haakon vii s gate 2 0161 oslo the session will also be streamed via webcast to register and follow the presentation online please copy and paste the following link into your browser click attend and register your e mail https channel royalcast com landingpage vowasa 20241126_1 for further information please contact tina tønnessen cfo vow asa tel 47 406 39 556 email tina tonnessen vowasa com mailto tina tonnessen vowasa com about vow asa vow and its subsidiaries scanship c h evensen and et
127,all_events,DOWN,DOWN,results from ovation 2 study of imnn 001 to be highlighted in late breaking acceptance
10434,all_events,UP,,19 nov 2024 17 56 cet gentoo media inc mj foundation fundacja rodzinna a company related to mateusz juroszek board member and primary insider of gentoo media inc gentoo has today acquired 3 422 shares in gentoo at a price of sek 24 30 per share after this transaction close associates of mateusz juroszek hold 24 098 346 shares in gentoo this information is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act about gentoo media gentoo media is a market leading affiliate connecting operators and players in the online gambling and sports betting industry gentoo media offers an array of igaming affiliate solutions such as paid marketing expertise and quality traffic through our prominent industry sites including askgamblers time2play casinotopsonline wsn and casinomeister in 2024 gentoo media formerly gig media became gentoo media inc following a legal split separating the media and platform and sports
5821,all_events,DOWN,,novaturas group the leader in the baltic tourism market generated revenues of eur 22 6 mln in september compared to eur 24 1 mln during the same period last year the number of customers served was 27 thsnd compared to 29 thsnd in september last year in total between january and september 2024 the company recorded revenues of eur 152 mln and 192 thsnd customers compared to revenues of eur 164 mln and 210 thsnd customers in the corresponding period in 2023 we noticed a drop in demand in the summer season due to the very wide travel offer on the market however we started october with a load factor of almost for travel this month and we see the increasing load factor in autumn as a sign of strong customer trust in our services this results in a lower balance of last minute trips which implies a positive outlook for the company we are optimizing the winter travel program taking into account travelers behavior and choices however when evaluating winter sales
9319,all_events,DOWN,,marlborough mass april 22 2024 globe newswire akoya biosciences inc nasdaq akya akoya the spatial biology company today announced that it will release financial results for the first quarter of 2024 after the market close on may 13th 2024 company management will host a conference call to discuss financial results at 5 00 p m et
12232,all_events,DOWN,,nasdaq vilnius decided to apply observation status to investment company omx baltic benchmark fund oamobbf1l isin code lt0000990012 regarding decision adopted by the extraordinary general meeting of shareholders to terminate company s activities and liquidate the company as well as to delist company s securities from trading on the regulated market investment company omx baltic benchmark fund publicly announced about that in the announcement on 7 november 2024 the purpose of applying observation status is to alert the market participants nasdaq baltic transaction services 370 5 253 14 59 www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative markets first north operated by nasdaq companies in the baltic states i e nasdaq tallinn as nasdaq riga as and ab nasdaq vilnius
5380,all_events,UP,,media release
7781,all_events,UP,,media release
12387,all_events,DOWN,,media release
8047,all_events,UP,,19 nov 2024 16 12 cet sidetrade sidetrade leader mondial des applications order to cash alimentées par l ia annonce son calendrier de publications financières pour l exercice 2025 chiffre d affaires de l exercice 2024mardi 21 janvier 2025 après bourse résultats annuels 2024mercredi 26 mars 2025 après bourse chiffre d affaires du premier trimestre 2025mardi 15 avril 2025 après bourse assemblée générale des actionnairesmercredi 18 juin 2025 à partir de 11h00 chiffre d affaires du premier semestre 2025mercredi 16 juillet 2025 après bourse résultats du premier semestre 2025mercredi 17 septembre 2025 après bourse chiffre d affaires du troisième trimestre 2025mardi 14 octobre 2025 après bourse chiffre d affaires de l exercice 2025mardi 20 janvier 2026 après bourse relations investisseurs relations médiaschristelle dhrif 33 6 10 46 72 00 cdhrif sidetrade com a propos de sidetrade www sidetrade com sidetrade euronext growth albfr pa propos
9249,all_events,DOWN,,18 nov 2024 19 24 cet norsk titanium as oslo norway 18 november 2024 reference is made to the stock exchange announcements by norsk titanium as the company on 14 november 2024 regarding pre commitments for warrants exercise and on 18 november 2024 regarding the commencement of the final exercise period for warrants the warrants issued in connection with the company rights issue completed in february 2024 the company has been notified that scatec innovation as has exercised all its 20 279 518 warrants scatec innovation as is a company closely associated with john andersen who is the chairman of the company s board of directors please see the attached notification of trade for information regarding the transaction for more information please contact ashar ashary cfo norsk titanium as email ashar ashary norsktitanium com tel 1 518 556 8966 this information is subject to the disclosure requirements pursuant to article 19 of the eu market abuse
6143,all_events,UP,,15 oct 2024 22 05 cest sanofi information concerning the total number of voting rights and shares provided pursuant to article l 233 8 ii of the code de commerce the french commercial code and article 223 16 of the règlement général de l autorité des marchés financiers regulation of the french stock market authority sanofia french société anonyme with a registered share capital of 2 537 214 304 registered office 46 avenue de la grande armée 75017 paris franceregistered at the paris commercial and companies registry under number 395 030 844 date total number of issued shares number of real voting rights excluding treasury shares theoretical number of voting rights including treasury shares september 30 20241 268 914 3661 413 296 4971 428 630 140 pursuant to article 223 11 of the règlement général de l autorité des marchés financiers this information is also available on the internet website of sanofi under regulated information in france https www
7614,all_events,UP,,uppsala sweden november 20 2024 the first participants in dicot pharma s phase 2a clinical study have now been dosed the company s drug candidate lib 01 is being developed as a new first line treatment for erectile dysfunction dicot pharma has recently started its phase 2a clinical study with the potency drug candidate lib 01 the purpose of the study is to evaluate the efficacy of lib 01 in men with erectile dysfunction the first participants in the study have now been dosed at sites in stockholm and gothenburg all participants will be dosed for three consecutive days and then followed for eight weeks to monitor efficacy and safety recruitment is ongoing throughout the clinical phase of the study now we are underway the first participants have been dosed and the 2a study is now entering an intensive period this study is an important milestone that will bring us closer to the launch of a whole new generation of potency drugs says dicot pharma s ceo elin trampe about t
3059,all_events,DOWN,,18 oct 2024 18 30 cest umicore déclarations de transparence par blackrock inc et bank of america corp conformément à l article 14 1 de la loi du 2 mai 2007 relative à la publicité des participations importantes umicore a récemment été informée par bank of america corp a annoncé que sa filiale merrill lynch international a franchi à la baisse le 14 octobre 2024 le seuil réglementaire de 3 relatifs aux instruments financiers équivalents la détention totale de droits de vote directs et d instruments financiers équivalents de bank of america s élève désormais à 3 80 blackrock inc a franchi à la baisse le 14 octobre 2024 le seuil légal de des droits de vote directs et des instruments financiers équivalents la détention totale des droits de vote directs et des instruments financiers équivalents de blackrock inc s élevant désormais à 2 résumé des transactions 1 bank of america corp date de franchissement du seuildate de la notificationdr
1111,all_events,DOWN,UP,media release
3877,all_events,DOWN,,on december 3 2024 essity holds its capital markets day at the company s production facility for hygiene products in valls spain over the course of the day essity will present the company s strategy for accelerating profitable growth and the roadmap to achieving the company s new financial targets which were presented on june 17 2024 the day will also include a guided tour of the production facility in valls as well as a demonstration of innovations within the company s various categories and of the global planning logistics hub the day starts at 08 00 and ends at 14 30 register for essity s capital markets day here november 15 2024 at the latest the day will not be livestreamed material from parts of the day will be available on essity s website after the event agenda accelerating profitable growth magnus groth president and ceo sahil tesfu chief strategy officer fredrik rystedt cfo and evp global supply chain driving margin expansion including
2366,all_events,DOWN,DOWN,sunnyvale calif may 14 2024 globe newswire biocardia inc nasdaq bcda a developer of cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary diseases today reported financial results for the first quarter of 2024 and filed its quarterly report on form 10 q for the three months ended march 31 2024 with the securities and exchange commission the company will also hold a conference call at 4 30 pm et today in which it will discuss business highlights following management s formal remarks there will be a question and answer session
275,all_events,DOWN,DOWN,announcement no 243 11 november 2024 in connection with the announced share buy back program in norden a s motortramp continuously sells shares pro rata and the market is to be informed accordingly see the attached file and announcements nos 235 24 and 237 24 kind regards dampskibsselskabet norden a s martin badsted cfo for further information therese möllevinge head of investor relations tel 45 41 37 16 38 e mail thm norden com isabella zaugg hansen investor relations manager tel 45 27 62 90 96 e mail izh norden com attachments no 243 managers transactions etc pdf transactions by persons discharging managerial responsibilities and persons pdf
3387,all_events,DOWN,,clinical trial demonstrates the ability of nvns to accelerate sensorimotor learning in usaf simulator based pilot training clinical trial demonstrates the ability of nvns to accelerate sensorimotor learning in usaf simulator based pilot training
2057,all_events,DOWN,UP,15 oct 2024 21 17 cest greenvolt energias renovavei greenvolt20241015 informacao privilegiada gamma lux pdf greenvolt euronext greenvolt energias renovaveis s a ptgnv0am0001 gvolt euronext
9479,all_events,DOWN,,yield10 bioscience files rsr with usda aphis for elite camelina designed to produce epa dha omega 3 oils
2919,all_events,UP,,media release
9532,all_events,UP,,media release
4220,all_events,DOWN,,alvotech nasdaq alvo a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide announced today its participation in the jefferies london healthcare conference november 19 20 2024 members of the management team will host one on one meetings on both days alvotech will be presenting at the conference on tuesday november 19 2024 at 9 00 9 25 am gmt
10896,all_events,UP,,toronto aug 28 2024 globe newswire revive therapeutics ltd revive or the company otcqb rvvtf cse rvv frankfurt 31r a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases medical countermeasures and rare disorders announced today an update on the research study evaluating bucillamine as a potential treatment for nerve agent exposure in partnership with defence r d canada suffield research centre drdc an agency of the canadian department of national defence the drdc is investigating pharmacological compounds including bucillamine that can mitigate nerve agent induced brain injury the research study is progressing and is expected to be now completed in october 2024
5980,all_events,DOWN,,media release
1897,all_events,DOWN,UP,18 nov 2024 17 35 cet eurazeo see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1298589_declarationamf11au15novembre2024 pdf eurazeo les echos eurazeo se fr0000121121 rf euronext
1489,all_events,DOWN,DOWN,novaturas group the leader in the baltic tourism market announces that darius undzėnas will take up the position of the company s chief financial officer cfo from october 7 with many years of comprehensive experience in financial management mr undzėnas joins the group s top management team in lithuania latvia and estonia we are confident that darius s diverse experience in finance and his management skills gained in international companies will contribute to the goal of strengthening the position of novaturas in the tourism market at the same time we set a strategic goal for the new cfo to strengthen the company s financial position which is important both for ensuring the long term trust of our customers and partners and for creating long term value for the company s shareholders said kristijonas kaikaris chief executive officer of novaturas group the new cfo of the company has more than 15 years of experience in various financial management positions in the transpor
7881,all_events,UP,,los angeles and amsterdam april 30 2024 globe newswire renovarocube wholly owned subsidiary of renovaro inc nasdaq renb a company at the forefront of ai driven healthcare innovation proudly unveils flamingo a potentially groundbreaking multi cancer detection model contributing to its mission to transform early cancer diagnostics leveraging ultra low pass whole genome sequencing ulp wgs of cell free dna cfdna flamingo represents a promising leap forward in the fight against cancer
6152,all_events,DOWN,,vilnius lithuania 2024 11 06 14 42 cet sun investment group invites investors to join the investor webinar scheduled on the 8 november 2024 at 10 00 am in english eest baltic time during the call sun investement group issuer ceo deividas varabauskas and orion securities issue organizer head of corporate finance mykantas urba will present bond issue details and answer investor questions 8 november 2024 at 10 00 am in english register here key bond issue details the existing bondholders of sun investment group uab bonds isin lt0000313256 issued in 2023 will be able to exchange these bonds to newly issued ones through the nasdaq csd securities exchange offer for more information and full documentation click here attachments 2024106_sun investment group investor webinar en_2 pdf
4696,all_events,UP,,media release
7738,all_events,DOWN,,14 nov 2024 08 26 cet bouvet asa the shares in bouvet asa will be traded ex dividend nok 1 00 as from today 14 november 2024 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site bouvet asa oslo børs newspoint bouvet no0010360266 bouv oslo børs
1272,all_events,UP,UP,11 oct 2024 16 30 cest hunter group asa oslo 11 october 2024 hunter group asa achieved the following vlcc time charter tc results for september 2024 avg spot linked tc out rate 37 510 day avg fixed tc in rate 51 750 day avg tc margin 14 240 day vessel days 60 60 net tc result 854 400 contact erik a s frydendal ceo ef a huntergroup no ph 47 957 72 947 lars m brynildsrud cfo lb a huntergroup no ph 47 932 60 882 this information is considered to be inside information pursuant to the eu market abuse regulation and subject to the disclosure requirements pursuant to section 5 12 of the
12730,all_events,DOWN,,cambridge mass and rostock germany and berlin feb 28 2024 globe newswire centogene n v nasdaq cntg the company the essential life science partner for data driven answers in rare and neurodegenerative diseases today announced that the company has decided to explore a range of strategic alternatives focused on sustainable long term value creation for the benefit of its stakeholders
1219,all_events,DOWN,DOWN,la jolla calif dec 21 2023 globe newswire medicinova inc a biopharmaceutical company traded on the nasdaq global market nasdaq mnov and the standard market of the tokyo stock exchange code number 4875 today announced that an abstract regarding results of a nonclinical study of mn 166 ibudilast in chlorine gas induced acute lung injury has been selected for a poster presentation at the society of toxicology sot 63rd annual meeting and toxexpo to be held march 10 14 2024 in salt lake city utah the poster will be presented by medicinova s collaborator perenlei enkhbaatar md phd faha professor department of anesthesiology director translational intensive care unit charles robert allen professor in anesthesiology at the university of texas medical branch
9947,all_events,UP,,san diego june 27 2024 globe newswire bioatla inc nasdaq bcab a global clinical stage biotechnology company focused on the development of conditionally active biologic cab antibody therapeutics for the treatment of solid tumors today announced it will host a virtual r d day around the company s clinical programs and pipeline updates on thursday july 25 2024 at 10 00 am et to register click here
5639,all_events,DOWN,,vancouver british columbia feb 02 2024 globe newswire mydecine innovations group inc mydecine or the company cse myco aqse myig otc mycof fse 0nf0 a forefront biotechnology company dedicated to revolutionizing mental health and addiction treatment announces that neil stevenson moore has resigned as a director of the company the company would like to thank mr stevenson moore for his contributions to the company and wishes him well in this future endeavors
3520,all_events,DOWN,,new 38 7 million term loan with a may 2029 maturity 37 5 million royalty monetization financing based on future sales of loqtorzi and udenyca
9824,all_events,DOWN,,seattle feb 07 2024 globe newswire kineta inc nasdaq ka a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance announced today that the company will participate in a virtual h c wainwright home fireside chat series on february 13 2024 shawn iadonato ph d chief executive officer of kineta and thierry guillaudeux ph d chief scientific officer of kineta will present an overview of recent clinical results of kva12123 the company s vista blocking immunotherapy in development for patients with advanced solid tumors
9043,all_events,UP,,media release
1713,all_events,UP,DOWN,cambridge mass june 14 2024 globe newswire intellia therapeutics inc nasdaq ntla a leading clinical stage gene editing company focused on revolutionizing medicine with crispr based therapies today announced the appointment of brian goff to its board of directors
5026,all_events,DOWN,,12 nov 2024 08 30 cet himalaya shipping ltd hamilton bermuda november 12 2024 on november 11 2024 mr bjorn isaksen entered into a forward purchase agreement with drew holdings ltd to purchase 200 000 common shares in himalaya shipping ltd for settlement on june 15 2026 at a price of 7 13 per share to be adjusted by interest less any dividends paid between november 11 2024 and the settlement date mr isaksen is the chairman of himalaya shipping ltd s board and thus as per the market abuse directive a person discharging managerial responsibilities in himalaya shipping ltd mr isaksen and his close associates currently own 400 000 shares and have options on 150 000 shares in himalaya shipping ltd following the settlement of the forward purchase agreement mr isaksen and his close associates will on this basis own 600 000 shares please refer to the attached form of notification of a transaction by a person discharging managerial responsibilities
7861,all_events,UP,,media release
3651,all_events,DOWN,,boston jan 17 2024 globe newswire elicio therapeutics inc nasdaq eltx elicio therapeutics or elicio a clinical stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer today announced a trial in progress poster presentation on the phase 1 2 amplify 7p study design at the asco gastrointestinal cancers asco gi symposium being held january 18 20 2024 in san francisco ca
9128,all_events,UP,,09 oct 2024 18 48 cest eqva asa eqva asa the company has been informed by primary insiders rune skarveland and trond narve skarveland that their respective closely associated investment companies eikestø as eikestø eiendom as fureneset eiendom as and fureneset invest as have entered into an agreement with nordic corporate bank to transfer all of their 15 9 million 21 2 percent shares in eqva asa see attached forms krt 1500 for details the agreed price is nok 4 80 per share corresponding to the price in the private placement carried out by the company on 3 october this year the total consideration in the transaction is nok 76 4 million the two primary insiders have stated that the share sale is due to a requirement to realise values in the respective investment companies after they have had to book significant losses related to investments in real estate we are proud of the development that has taken place in eqva the company has shown solid progress i
1493,all_events,UP,DOWN,stockholm 2024 11 05
7732,all_events,DOWN,,october 02 2024 11 01 et source curium us llc curium us llc 巴黎 oct 02 2024 globe newswire 全球核医学领域的领先企业 curium 今日宣布与 peptidream 的全资子公司 pdradiopharma inc 达成战略合作 在日本开展 177lu psma i t 和 64cu psma i t 的临床开发 监管备案及商业化进程 177lu psma i t 和 64cu psma i t 这两种药物旨在靶向前列腺特异性膜抗原 psma 该抗原在前列腺癌细胞上表达 现被用于前列腺癌的治疗与诊断研究 这两种药物均靶向 psma 表达水平较高的肿瘤 因而有望形成一种治疗与诊断相结合的创新组合 根据合作协议 curium 与 pdradiopharma 将在日本联合开展 177lu psma i t 和 64cu psma i t 的临床开发活动 在这一战略合作中 pdradiopharma 将负责监管备案 生产 商业化及分销等一系列关键任务 curium 将继续负责这两种药物的全球开发 并通过技术转让支持 pdradiopharma 在日本辅助建立生产线 其中包括一条基于 curium 独有技术的高通量铜 64 生产线 peptidream 总裁兼首席执行官 patrick c reid 表示 靶向放射性药物正迅速改变我们的癌症诊断和治疗方式 在 peptidream 和 pdradiopharma 我们专注于拓展这一系列强大的靶向疗法 我们非常高兴能与 curium 合作 加速推动这方面的努力 将其极具潜力的前列腺癌靶向放射性药物带给日本的患者 pdradiopharma 总裁兼 peptidream 首席营销官 masato murakami 表示 我们很高兴能与 curium 合作 共同开发 177lu psma i t 和 64cu psma i t 这两款产品在 psma 表达的前列腺癌诊断和治疗中表现出极大的潜力 我们期待与 curium 携手合作 力争尽快为日本前列腺癌患者提供这些亟需的药物 curium 国际市场首席执行官 ch
7054,all_events,UP,,company to host an investor conference call and webcast at 4 30pm edt company to host an investor conference call and webcast at 4 30pm edt
1118,all_events,DOWN,DOWN,pihlajalinna plc managers transactions 11 november 2024 at 3 00 p m pihlajalinna plc managers transactions pihlajalinna plc has received the following notification on 11 november 2024 person subject to the notification requirement name anu kallio position other senior manager issuer pihlajalinna oyj lei 74370058mtrledochv67 notification type initial notification reference number 84438 5 6 ____________________________________________ transaction date 2024 11 07 venue nasdaq helsinki ltd xhel instrument type share isin fi4000092556 nature of transaction acquisition transaction details 1 volume 540 unit price 10 9 eur aggregated transactions 1 volume 540 volume weighted average price 10 9 eur ____________________________________________ transaction date 2024 11 08 venue nasdaq helsinki ltd xhel instrument type share isin fi4000092556 nature of transaction acquisition transaction details 1 volume 2336 unit price 10 95 eur aggregated transact
12413,all_events,UP,,07 nov 2024 18 36 cet esker s a nombre de droits de vote et actions composant le capital social mai 24juin 24juil 24août 24sept 24oct 24nombre d actions composant le capital 604796860687276069762607109160813926083311nombre d actions propres143685143877143164143132143474143474nombre total de droits de vote théorique711695071412957119702711677971149327109207nombre total de droits de vote exerçable697326569974196976538697364769714586965733 pièce jointe esker droit_de_vote_et_actions_capital_1024 pièce jointe esker globenewswire esker fr0000035818 alesk euronext growth
5924,all_events,UP,,new york nov 19 2024 globe newswire tiziana life sciences ltd nasdaq tlsa tiziana or the company a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate intranasal foralumab a fully human anti cd3 monoclonal antibody today announced that its grant application to the als association has been approved for funding the grant is awarded as part of the hoffman als clinical trial awards program and is titled modulation of als neuroinflammation by nasal anti cd3 monoclonal antibody the association s grant will fund a 20 patient clinical trial of two doses of tiziana s novel and patented therapeutic candidate intranasal foralumab aimed at evaluating the safety and early stage parameters of disease improvement in amyotrophic lateral sclerosis als also known as lou gehrig s disease
8922,all_events,DOWN,,media release
3289,all_events,UP,,10 oct 2024 18 30 cest wallix group successful transition to the subscription model monthly recurring revenue up 30 and recurring business accounted for 71 of turnover half year turnover of 15 1 million up 8 operating profit and net earnings stable and continuous improvement of the operating expenses turnover ratio robust growth drivers to reach hypergrowth in recurring business for full year 2024 and aim for positive operating profit in the second half of the year paris october 10 2024 wallix euronext allix a european cybersecurity software developer and expert in identity and access management iam and privileged access management pam announces its earnings for the first half of 2024 1 000 french gaap h1 2023 h1 2024 turnover 13 943 15 149 other operating income 2 298 2 358 operating profit loss 6 100 6 243 net financial income expense 20 30 non recurring income expense 60 8 tax income expense 625 671 net pr
10618,all_events,DOWN,,05 nov 2024 18 30 cet vallourec vallourec announces the creation of an operations department and strengthens its process and engineering department meudon france november 5 2024 since its launch new vallourec plan has relied on industrial excellence to enable the premiumization of vallourec s offerings and solutions to further the drive towards best in class global performance vallourec announces the creation of a new operations department and a strengthened process and engineering department to provide vallourec with the best technologies and the most efficient and advanced industrial processes the process and engineering department will henceforth include the process communities the global engineering department and the investment department philippe carlier as part of the executive committee will lead this department with the primary mission of enabling vallourec to deliver its products and services with increasing efficiency this process and engineerin
7172,all_events,UP,,07 oct 2024 18 10 cest brunel international n v amsterdam oct 07 2024 globe newswire shareholders and other persons entitled to attend the meetings of brunel international n v company are invited to attend the extraordinary general meeting of shareholders that will take place on monday november 25 2024 at 4 p m cet at the offices of brunel international n v at john m keynesplein 33 1066 ep amsterdam the netherlands agenda 1 opening2 proposal to appoint mr a aad kuiper as member of the supervisory board voting item 3 close the agenda with notes is available for inspection and can be obtained free of charge from brunel international n v john m keynesplein 33 1066 ep amsterdam the netherlands and can be viewed on the website of brunel international n v www brunelinternational net persons who are in possession of shares of brunel international n v on october 28 2024 after processing of all subscriptions and withdra
7645,all_events,DOWN,,06 nov 2024 17 45 cet mauna kea technologies article l233 8 ii du code du commerce article 223 16 du règlement général de l autorité des marchés financiers regulatory news place de cotation euronext growth paris code isin fr0010609263 mnémonique almkt site web www maunakeatech com date nombre de titres composant le capital en circulation nombre total de droits de vote total brut 1 total net 2 31 octobre 2024 67 219 997 68 512 596 68 425 638 650 000 actions nouvelles ont été émises au cours du mois dans le cadre de la ligne de financement paceo dont les caractéristiques sont décrites dans les communiqués de presse du 31 mai 2023 et du 25 juillet 2024 1 le nombre de droits de vote bruts ou droits de vote théoriques sert de base de calcul pour les franchissements de seuil conformément à l article 223 11 du règlement général de l amf ce nombre est calculé sur la base de l ensemble des actions auxque
8034,all_events,DOWN,,tampa fla march 06 2024 globe newswire pacira biosciences inc nasdaq pcrx today announced that it will participate in an analyst led fireside chat at the barclays 26th annual global healthcare conference at 1 35 pm et on wednesday march 13 2024 in miami live audio of the event can be accessed by visiting the events page of the company s website at investor pacira com a replay of the webcast will also be available for two weeks following the event
4420,all_events,UP,,media release
4989,all_events,DOWN,,november 18 2024 05 45 et source dfds a s dfds a s den 9 februar 2024 meddelte dfds a s dfds iværksættelsen af et aktietilbage købsprogram til gennemførsel i henhold til eus markedsmisbrugsforordning eu forordning nr 596 2014 af 16 april 2014 samt eu kommissionens delegerede forordning eu nr 2016 1052 af 8 marts 2016 safe harbour reglerne under programmet vil dfds tilbagekøbe egne aktier for op til dkk 431 mio i perioden fra 12 februar 2024 til 31 december 2024 der vil maksimalt blive tilbagekøbt 3 400 000 aktier disse begrænsninger omfatter såvel aktier købt under safe harbour reglerne som aktier købt fra lauritzen fonden holding aps på en pro rata basis i forhold til aktier købt under programmet i henhold til en separat aftale med dfds udenfor safe harbour reglerne handler i perioden 11 15 november de følgende handler er gennemført under aktietilbagekøbsprogrammet i perioden mandag 11 november 2024 til fredag 15 no
5381,all_events,DOWN,,canatu plc managers transactions 8 november 2024 at 1 00 pm eet canatu plc managers transactions ta ventures oy ____________________________________________ person subject to the notification requirement name ta ventures oy position closely associated person x legal person 1 person discharging managerial responsibilities in issuer name timo ahopelto position member of the board issuer canatu plc lei 743700ckop7ihgi98b12 notification type initial notification reference number 84186 4 4 ____________________________________________ transaction date 2024 11 07 outside a trading venue instrument type share isin fi4000512496 nature of transaction exchange conversion into another financial instrument transaction details 1 volume 228695 unit price 0 eur aggregated transactions 1 volume 228695 volume weighted average price 0 eur additional information juha kokkonen ceo juha kokkonen canatu com t 358 40 543 0367 certified adviser carnegie investment bank ab
543,all_events,DOWN,UP,media release
10702,all_events,UP,,new york aug 21 2024 globe newswire eyenovia inc eyenovia or the company nasdaq eyen a commercial stage ophthalmic company announced today that it has agreed to sell 12 850 000 shares of common stock at a price per share of 0 40 the offering
410,all_events,UP,UP,media release
2899,all_events,DOWN,,zug switzerland nov 07 2024 globe newswire oculis holding ag nasdaq ocs xice ocs oculis or the company a global biopharmaceutical company purposefully driven to save sight and improve eye care today announced results for the quarter ended september 30 2024 and provided an overview of the company s progress
3991,all_events,DOWN,,06 nov 2024 09 02 cet hoteles bestprice s a hoteles bestprice celebra su investor day con el anuncio de nuevas estimaciones al alza de sus resultados a nivel de facturación y beneficios con una cifra de inversión que supera en estos meses los 13 millones de euros la cadena hotelera eleva sus previsiones de ingresos para el 2026 a 13 5 millones de euros con unos beneficios operativos esperados de 7 millones de euros excluyendo nuevas inversiones de capex y costes de estructura las inversiones se están desarrollando en los últimos 4 hoteles incorporados a su portfolio que ya suma 10 establecimientos hoteleros el grado de ejecución de las cifras de capex alcanza el asimismo la cadena hotelera dibuja un escenario de incorporación de nuevos establecimientos hoteleros en régimen de arrendamiento dentro de su plan estratégico bianual de 2026 de disponer de hasta 14 hoteles operativos una cifra de negocios que se elevaría a los 16 millones de euros y un beneficio de op
12679,all_events,UP,,media release
5781,all_events,DOWN,,13 nov 2024 14 58 cet aurskog sparebank vedlagt er bankens delårsrapport pr 30 09 2024 denne opplysningen er informasjonspliktig etter verdipapirhandelloven 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632088_delaarsrapport 3q24 pdf aurskog sparebank oslo børs newspoint aurskog sparebank aurskog spb 20 25 frn aurskog spb 21 26 frn aurskog spb 21 31 frn c sub aurskog spb 21 25 frn aurskog spb 22 27 frn aurskog spb 23 27 frn aurskog spb 23 28 frn aurskog spb 23 33 frn c sub aurskog spb 23 29 frn aurskog spb 23 perp adj c hybrid aurskog spb 24 27 frn aurskog spb 24 34 adj c sub aurskog spb 24 perp adj c hybrid aurskog spb 24 29 frn aurskog spb 24 30 frn no0006001601 no0010892284 no0010920861 no0011018400 no0011086944 no0011184731 no0012757733 no0012894577 no0012902792 no0012916149 no0013004531 no0013073080 no0013071936 no0013182741 no00131886
11124,all_events,UP,,media release
3853,all_events,UP,,arcutis today announced results from the integument ole long term open label study of once daily roflumilast cream 0
12140,all_events,UP,,13 nov 2024 17 45 cet alstom premier semestre de l exercice fiscal 2024 25 d alstom bonne performance commerciale et confirmation des perspectives pour l exercice fiscal 2024 25 faits marquants du s1 2024 25 ratio commandes sur chiffre d affaires à 1 25 et croissance organique du chiffre d affaires en hausse de 5 6 1résultat d exploitation ajusté2 de 515 millions d euros en hausse de 18 soit 5 9 de margecash flow libre2 de 138 millions d euros bénéficiant d une distribution favorable des acomptes à la commandedette nette à 927 millions d euros en baisse par rapport à 2 994 millions d euros suivant l exécution du plan de désendettement perspectives pour l exercice fiscal 2024 25 ratio commandes sur chiffre d affaires au dessus de 1 et croissance organique du chiffre d affaires d environ 5 marge d exploitation ajustée prévue à environ 6 5 cash flow libre dans une fourchette de 300 à 500 millions d euros 13 novembre 2024 au premier semest
7588,all_events,DOWN,,media release
7089,all_events,UP,,19 nov 2024 09 00 cet europris asa fredrikstad 19 november 2024 europris opened a new store today at gulskogen shopping centre in drammen in buskerud county today s opening is the first and only new store in 2024 the group has a robust pipeline of new stores for 2025 and beyond europris nationwide network of 283 stores covers every norwegian county we re excited to open a store at gulskogen shopping centre filled with all that is needed for the christmas season this is the sixth store in the densely populated drammen region and the europris chain continues to provide customers with everyday low prices convenience and enjoyable shopping experiences says ceo espen eldal while europris also offers online shopping physical stores will continue to be the main sales channel in europris for the foreseeable future in may 2024 the group took full ownership of the swedish discount variety retailer öob which consists of a network of 94 stores in sweden the group
3851,all_events,UP,,as nordecon group company embach ehitus oü and lidl eesti oü signed a contract for the construction of a lidl store located at riia 1 viljandi the total value of the contract is 4 81 million euros without vat and the works will be completed in october of 2025 nordecon www nordecon com is a group of construction companies whose core business is construction project management and general contracting in the buildings and infrastructures segment geographically the group operates in estonia ukraine and sweden the parent of the group is nordecon as a company registered and located in tallinn estonia the consolidated revenue of the group in 2023 was 278 million euros currently nordecon group employs close to 440 people since 18 may 2006 the company s shares have been quoted in the main list of the nasdaq tallinn stock exchange andri hõbemäginordecon ashead of investor relationstel 372 6272 022e mail andri hobemagi nordecon comwww nordecon com
4226,all_events,UP,,san carlos calif april 19 2024 globe newswire iovance biotherapeutics inc nasdaq iova iovance or the company a biotechnology company focused on innovating developing and delivering novel polyclonal tumor infiltrating lymphocyte til therapies for patients with cancer today announced that on april 18 2024 the date of grant the company approved the grant of inducement stock options covering an aggregate of 79 310 shares of iovance s common stock to thirty seven new non executive employees
1864,all_events,DOWN,DOWN,senzime ab publ senzime or the company announced on 27 september 2024 the board of directors resolution to carry out a directed share issue of up to 13 873 000 shares at the subscription price sek 6 20 per share the share issue all newly issued shares in the first tranche of the share issue have been subscribed as previously communicated the share issue will be carried out in two separate tranches the first tranche tranche 1 comprises 12 769 000 shares which with the subscription price mentioned above correspond to approximately msek 79 2 and is issued by the board of directors based on the authorization received at the annual general meeting on 16 may 2024 the persons entitled to subscribe for tranche 1 were a limited number of investors who expressed a long term commitment to the company including the new investor ab strati and the existing shareholders segulah medical acceleration the crafoord family fjärde ap fonden carnegie fonder swedbank robur fo
10465,all_events,DOWN,,yield10 bioscience files rsr with usda aphis for elite camelina designed to produce epa dha omega 3 oils
8724,all_events,DOWN,,media release
7572,all_events,DOWN,,leading immunotherapy and immunobiology experts will offer strategic direction and expertise in translational clinical and diagnostic applications of akoya s spatial biology solutions leading immunotherapy and immunobiology experts will offer strategic direction and expertise in translational clinical and diagnostic applications of akoya s spatial biology solutions
5825,all_events,UP,,media release
3100,all_events,DOWN,,media release
9050,all_events,DOWN,,media release
1786,all_events,UP,DOWN,vilnius lithuania 2024 11 15 09 32 cet omx baltic benchmark fund share price on november 14 2024 12 7852 eur omx baltic benchmark fund number of shares issued on november 14 2024 0 units omx baltic benchmark fund number of shares redeemed on november 14 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of november 14 2024 125 362 units nter asset management
2337,all_events,DOWN,UP,media release
12472,all_events,UP,,media release
4148,all_events,UP,,san diego aug 08 2024 globe newswire bioatla inc nasdaq bcab a global clinical stage biotechnology company focused on the development of conditionally active biologic cab antibody therapeutics for the treatment of solid tumors today announced its financial results for the second quarter ended june 30 2024 and provided highlights on its clinical programs
3527,all_events,UP,,hear from the 30 000 relapsed or refractory al amyloidosis patients in the united states today in their own words hear from the 30 000 relapsed or refractory al amyloidosis patients in the united states today in their own words
733,all_events,DOWN,DOWN,new york may 13 2024 globe newswire tiziana life sciences ltd nasdaq tlsa tiziana or the company a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery today announced it has submitted an fda request to obtain orphan drug designation for intranasal foralumab for the treatment of non active secondary progressive multiple sclerosis na spms this request would make foralumab the first therapy for na spms to receive orphan drug designation our request is supported by clinical and non clinical evidence of foralumab s effectiveness in na spms the prevalence estimates in part are supported from the brigham women s hospital boston massachusetts longitudinal study the climb data of which allowed the estimate of na spms in the population
7838,all_events,DOWN,,media release
4209,all_events,UP,,media release
12728,all_events,DOWN,,media release
9329,all_events,DOWN,,ab utenos trikotažas hereinafter the company dinary of the extraordinary general meeting of shareholders agenda and decisions of the meeting it was of the decided grant thornton baltic uab to be the auditor of ab utenos trikotažas for the audit of the set of financial statements for the years 2024 2025 determine that the remuneration for the audit is as follows in the first year eur 32 900 plus vat in the second year eur 34 300 plus vat additional information is available from aurimas likus finance director tel no 370 618 07809 nomeda kaučikienė managing director of ab utenos trikotažas
11135,all_events,DOWN,,phase 2 open label connect1 edo51 study open in canada
3858,all_events,UP,,19 nov 2024 08 00 cet equinor asa nedenfor følger informasjon om transaksjoner foretatt under fjerde transje av equinor asas ose eqnr nyse eqnr ceux eqnro tqex eqnro tilbakekjøpsprogram for 2024 dato for når fjerde transje av 2024 programmet ble annonsert 24 oktober 2024 varigheten til fjerde transje av 2024 programmet 25 oktober til senest 31 januar 2025 ytterligere informasjon om transjen kan finnes i børsmelding om dens oppstart datert 24 oktober 2024 tilgjengelig her https newsweb oslobors no message 630241 fra 11 november til 15 november 2024 har equinor asa kjøpt tilbake totalt 1 500 000 egne aksjer til en gjennomsnittspris på nok 254 1340 pr aksje oversikt over transaksjoner dato handels aggregert plattform daglig
4337,all_events,DOWN,,châtillon france october 22 2024
3045,all_events,DOWN,,zug switzerland aug 15 2024 globe newswire oculis holding ag nasdaq ocs oculis a global biopharmaceutical company purposefully driven to save sight and improve eye care today announced the appointment of dr sharon klier an executive leader with extensive experience in clinical development across early and late stage programs regulatory submissions and approvals to the role of chief development officer in this key role dr klier will oversee and provide strategic leadership across the clinical development and operations of oculis robust ophthalmology pipeline
2012,all_events,DOWN,UP,16 oct 2024 07 00 cest euroapi s a communiqué de presse paris le 16 octobre 2024 olivier falut a été nommé directeur financier d euroapi à compter du 17 octobre 2024 et sera membre du comité exécutif il succède à evelyne nguyen qui restera au sein de la société jusqu à la fin octobre afin d assurer la transition je suis très heureux d accueillir olivier un directeur financier chevronné doté d une très grande expérience du secteur industriel son rôle sera déterminant dans la mise en place de notre projet de transformation focus 27 a indiqué ludwig de mot directeur général d euroapi l ensemble de l entreprise et le conseil d administration se joignent à moi pour exprimer notre gratitude à evelyne pour avoir mené à bien sa mission consistant à assurer le financement de notre plan stratégique olivier falut apporte à euroapi près de 30 ans d expérience en management et en finance dans le secteur industriel au cours de sa carrière il a occupé différ
10569,all_events,DOWN,,lexington mass april 24 2024 globe newswire t2 biosystems inc nasdaq ttoo a leader in the rapid detection of sepsis causing pathogens and antibiotic resistance genes announced today that it will report financial results for the first quarter 2024 and business updates after market close on monday may 6 2024 company management will host a corresponding conference call beginning at 4 30 p m eastern time
4215,all_events,UP,,media release
2656,all_events,DOWN,,petach tikva israel april 24 2024 globe newswire polypid ltd nasdaq pypd polypid or the company a late stage biopharma company aiming to improve surgical outcomes today announced that it will report its first quarter 2024 financial results and operational highlights before the open of the u s financial markets on wednesday may 8 2024 the company will host a conference call and webcast at 8 30 am eastern time to discuss the results and provide an update on business operations
9724,all_events,UP,,media release
9855,all_events,DOWN,,november 18 2024 01 30 et source sampo oyj sampo oyj sampo oyj pörssitiedote 18 11 2024 klo 8 30 sampo oyj n omien osakkeiden ostot 15 11 2024 sampo oyj y tunnus 0142213 3 lei 743700uf3rl386wida22 on hankkinut omia a osakkeitaan isin koodi fi4000552500 omistukseensa 15 11 2024 seuraavasti kahden desimaalin tarkkuuteen pyöristettynä sampo ilmoitti 17 6 2024 enintään 400 miljoonan euron suuruisen omien osakkeiden osto ohjelman käynnistämisestä markkinoiden väärinkäyttöasetuksen eu 596 2014 mar ja euroopan komission delegoidun asetuksen eu 2016 1052 mukaisesti sampo oyj n hallitus päätti 16 9 2024 kasvattaa omien osakkeiden osto ohjelmaa 475 miljoonaan euroon 18 6 2024 aloitetulla osto ohjelmalla on sammon varsinaisen yhtiökokouksen 25 4 2024 myöntämä valtuutus sammon omistuksessa on nyt ilmoitettujen transaktioiden jälkeen 10 808 319 sammon a osaketta mikä on 1 97 prosenttia sampo oyj n kaikista
10601,all_events,DOWN,,media release
5838,all_events,UP,,media release
5931,all_events,DOWN,,08 nov 2024 18 00 cet covivio see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1296427_20241031__covivio__droits_de_vote pdf covivio les echos covivio covivio reit fr0000064578 fr0000064578 cov 4cov euronext
6575,all_events,UP,,seventh consecutive record quarterly net sales of 6 1 million an increase of over second quarter 2023
3751,all_events,DOWN,,san carlos calif jan 30 2024 globe newswire vaxcyte inc nasdaq pcvx a clinical stage vaccine innovation company engineering high fidelity vaccines to protect humankind from the consequences of bacterial diseases announced today the pricing of an underwritten public offering of common stock and pre funded warrants vaxcyte is selling 10 937 500 shares of common stock and pre funded warrants to purchase 781 250 shares of common stock in the offering the shares of common stock are being sold at a public offering price of 64 00 per share and the pre funded warrants are being sold at a public offering price of 63 999 per pre funded warrant the exercise price of the pre funded warrants is 0 001 per share the aggregate gross proceeds to vaxcyte from this offering are expected to be approximately 750 0 million before deducting underwriting discounts and commissions and other offering expenses and excluding the exercise of any pre funded warrants all shares of common stock and pre funded warrants to be sold in the offering will be offered by vaxcyte vaxcyte has granted the underwriters a 30 day option to purchase up to an additional 1 757 812 shares of its common stock at the public offering price per share less underwriting discounts and commissions
4918,all_events,DOWN,,18 nov 2024 18 00 cet eramet paris 18 november 2024 6 00 p m press release eramet purchase of own shares eramet announces the purchase of 9 900 of its own shares related to the allocation of bonus shares under the provisions of articles l 225 197 1 et seq and l 22 10 59 and l 22 10 60 of the french commercial code to cover the free allocation of shares to employees and corporate officer aggregated presentation per day and per market name of issuer identification code of issuer legal entity identifier day of transaction identification code of financial instrument aggregated daily volume in number of shares daily weighted average price of the purchased shares market mic code eramet 549300luh78pg2mp6n64 13 11 2024 fr0000131757 82 52 70 aqeu eramet 549300luh78pg2mp6n64 13 11 2024 fr0000131757 496 52 27 ceux eramet 549300luh78pg2mp6n64 13 11 2024 fr0000131757 109 53 01 tqex eramet 549300luh78pg2mp6n64 13 11 2024 fr0000131757 2
2519,all_events,DOWN,UP,07 nov 2024 17 55 cet credit agricole s a montrouge le 7 novembre 2024 achèvement du programme de rachat d actions crédit agricole s a le programme de rachat d actions de crédit agricole s a qui a débuté le 1er octobre 2024 a été entièrement achevé le 6 novembre 2024 au 6 novembre 2024 15 128 677 actions crédit agricole s a ont été achetées sur instruction irrévocable donnée à un prestataire de services d investissement indépendant pour un prix d achat global de 208 465 605 euros cette instruction irrévocable a donc pris fin à la même date comme annoncé précédemment cette opération vise à compenser l effet dilutif de l augmentation de capital 2024 réservée aux salariés et les actions achetées dans le cadre de ce programme de rachat d actions seront annulées l impact de cette opération sur le ratio cet1 de crédit agricole s a est de 5 points de base et 3 points de base sur celui du groupe crédit agricole l exécution du contrat de liquidité existant avec k
12926,all_events,UP,,media release
2238,all_events,UP,DOWN,missing
6384,all_events,UP,,media release
5960,all_events,DOWN,,media release
8373,all_events,UP,,media release
12613,all_events,DOWN,,07 nov 2024 19 00 cet altareit see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1296251_altareit__dclaration_mensuelle_des_rachats_dactions__octobre_2024 pdf altareit les echos altareit fr0000039216 areit euronext
12398,all_events,UP,,san diego aug 07 2023 globe newswire anaptysbio inc nasdaq anab a clinical stage biotechnology company focused on delivering innovative immunology therapeutics today reported operating results for the second quarter ended june 30 2023 and provided a business update
9808,all_events,DOWN,,19 nov 2024 13 51 cet lillestrøm kommune det er fastsatt ny obligasjonsrente for no0012991340 ny obligasjonsrente i renteperioden 21 11 2024 21 02 2025 er 5 197 ticker lsko13 den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632637_75fb170b6ea645d49f26b2dcaaa75859 pdf lillestrøm kommune oslo børs newspoint lillestrøm kommune 20 25 1 lillestrom komm 21 26 lillestrom komm 22 26 frn lillestrom komm 22 25 frn lillestrom komm 23 25 frn lillestrom komm 23 26 frn lillestrøm komm 24 26 frn lillestrøm komm 24 27 frn lillestrøm komm 24 28 3 no0010876543 no0010921562 no0012489394 no0012555475 no0012654484 no0012943184 no0012991340 no0013008714 no0013030213 no0013209254 no0013257550 no00133348
2455,all_events,UP,DOWN,07 nov 2024 17 45 cet lagardere s a see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1296179_lagarderepublicationdroitsvote311024gb pdf lagardere les echos lagardere sa fr0000130213 mmb euronext
7405,all_events,UP,,south san francisco calif and san diego aug 26 2024 globe newswire oric pharmaceuticals inc nasdaq oric a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance today announced that management will participate in the following investor conferences in september
8565,all_events,DOWN,,the resolutions of the general extraordinary shareholders meeting hereinafter the meeting of special closed ended type real estate investment company invl baltic real estate hereinafter the company that was held on 19 november 2024 1 presentation of the recommendation of invl baltic real estate investment committee regarding the new wording of the articles of association 1 1 shareholders of invl baltic real estate were presented with the company s investment committee s recommendation on the new wording of the articles of association there is no voting on this issue of agenda 2 regarding invl baltic real estate participation in the reorganisation 2 1 pursuant to article 2 97 3 of the civil code of the republic of lithuania invl baltic real estate participates in the reorganisation by way of merger whereby the company terminating the activity without liquidation procedure namely pramogų bankas ab company code 300044665 registered office address vilnius a stu
7324,all_events,DOWN,,media release
7333,all_events,DOWN,,management report real estate development in 2024 we are continuing the construction and sales activities of the last stage of kalaranna 8 tallinn the final stage consists of 4 residential buildings with 146 apartments and 4 commercial units which upon completion brings the total count of the buildings to 12 in q3 we are continuing with internal finishing works of the buildings and as per current conditions we are meeting the schedule deadlines we expect to deliver the first units from the first two buildings by the end of 2024 and complete the remaining two buildings by the first quarter of 2025 with respect to sales in kalaranna as of the publishing of this report we have reached ca threshold in presales and signed reservations we deem this a success in today s challenging market especially so when our location warrants above average pricing in kristiine city we have continued the sales and construction activities of our new project uus kindrali by the end of q
2039,all_events,DOWN,DOWN,nokia corporationstock exchange release14 november 2024 at 22 30 eet nokia corporation repurchase of own shares on 14 11 2024 espoo finland on 14 november 2024 nokia corporation lei 549300a0jprwg1ki7u06 has acquired its own shares isin fi0009000681 as follows rounded to two decimals on 25 january 2024 nokia announced that its board of directors is initiating a share buyback program to return up to eur 600 million of cash to shareholders in tranches over a period of two years the first phase of the share buyback program started on 20 march 2024 on 19 july 2024 nokia decided to accelerate the share buybacks by increasing the number of shares to be repurchased during the year 2024 the post increase repurchases in compliance with the market abuse regulation eu 596 2014 mar the commission delegated regulation eu 2016 1052 and under the authorization granted by nokia s annual general meeting on 3 april 2024 started on 22 july 2024 and end by 31 december 2024 with a ma
10731,all_events,DOWN,,november 11 2024 11 00 et source zealand pharma zealand pharma company announcement no 50 2024 transactions in zealand pharma shares and or related securities by persons discharging managerial responsibilities and or their closely associated persons copenhagen denmark november 11 2024 zealand pharma a s zealand nasdaq zeal cvr no 20 04 50 78 a copenhagen based biotechnology company focused on the discovery and development of innovative peptide based medicines has received information on transactions in zealand pharma s shares or related securities conducted by persons discharging managerial responsibilities and or their closely associated persons and hereby publishes the information on such transactions please see the attached file s about zealand pharma a s zealand pharma a s nasdaq zeal zealand is a biotechnology company focused on the discovery and development of peptide based medicines more than 10 dru
9392,all_events,UP,,06 nov 2024 16 04 cet virbac societe declaration of the number of shares and voting rights information on the total number of voting rights and of shares representing the share capital article 223 16 of the general regulations of the french financial market authority autoritédes marchés financiers quotation place euronext pariscompartiment aisin code fr0000031577 datetotal number of shares representing the share capitaltotal number of voting rightsoctober 31 20248 390 660gross total of voting rights 12 707 824net total of voting rights 12 691 758 net total total number of voting rights attached to the total number of shares net of shares with no voting rights virbac shaping the future of animal healthnyse euronext compartiment a code isin fr0000031577 mnemo virpcorporate finance tel 33 4 92 08 71 32 email finances virbac comwebsite www virbac com attachment total_nb_of_voting_rights_and_shares_31_10_2024 declaration of the number of s
4105,all_events,UP,,media release
902,all_events,DOWN,UP,appointment brings more than 30 years of medical technology general management and commercial leadership experience to the inspiremd team
8677,all_events,UP,,10 oct 2024 18 10 cest emeis regulatory news emeis paris emeis annonce avoir déposé ce jour son rapport financier semestriel établi au titre de la période allant du 1er janvier 2024 au 30 juin 2024 auprès de l autorité des marchés financiers amf le rapport financier semestriel peut être consulté et téléchargé sur le site internet de la société à l adresse suivante www emeis group com actionnaires investisseurs rubriques documentation rapports financiers il est également disponible au siège social de la société emeis service relations investisseurs 12 rue jean jaurès 92813 puteaux cedex une version anglaise sera disponible sur le site internet de la société dans les meilleurs délais a propos de emeis avec près de 78 000 experts et professionnels de la santé du soin et de l accompagnement des plus fragiles emeis est présent dans une vingtaine de pays et couvre cinq métiers les cliniques psychiatriques les cliniques de soins médicaux e
5070,all_events,DOWN,,11 oct 2024 18 11 cest alpes compagnie des see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1290175_cda__cp_compo_ca_va pdf compagnie des alpes les echos alpes compagnie fr0000053324 cda euronext
1793,all_events,UP,DOWN,7 october 2024 erste group one off the largest banking groups in central and eastern europe cee region has initiated sponsored research of ab šiaulių bankas at buy rating and published the initiation of coverage research analysis suggests a target price of eur 1 00 the research highlights that šiaulių bankas presents an attractive investment opportunity due to its position in lithuania s structurally strong economy and a banking market with significant growth potential the bank s strategic focus on high margin lending segments like sme and consumer finance allows for above average returns research further highlights that investors will also be drawn to the bank s solid capitalization which supports an increased dividend payout ratio minimum under the new policy and share buybacks offering strong total shareholder returns finally analysts reiterate šiaulių bankas having a proven track record of high growth and profitability while its new strategy sets ambitious goal
1692,all_events,DOWN,UP,invl baltic real estate hereinafter the company hereby gives notification that on 08 october 2024 a real estate purchase and sale agreement was concluded with bohnenkamp sia legal entity code 40003506739 the agreement pertains to the sale of a 2 9 ha plot of land located at franču iela 1 stūnīši olaines pag olaines nov lv 2127 latvia which is owned by the company s subsidiary dommo gruppa sia along with a warehouse of 12 800 sq m situated on the land owned by dommo biznesa parks sia the value of the transaction is eur 7 45 million it is estimated to have a positive impact of eur 1 6 million on the company s 2024 results and its impact on the company s net asset value nav per share will be eur 0 20 the transaction is expected to be completed by december 2024 upon completion of the transaction the company will continue to manage 52 ha of land plots in latvia owned by the company s subsidiary dommo gruppa sia which are designated for further development or
5725,all_events,UP,,saab north america inc a u s subsidiary of saab has received a subpoena from the u s department of justice doj the doj has requested information about the brazilian government s acquisition of 36 gripen e f fighter aircraft for its air force the contract was signed in 2014 brazil s fighter procurement the fx 2 programme took place between 2008 and 2014 and saab was awarded the contract saab intends to comply with the request to supply information and to cooperate with the doj in this matter both brazilian and swedish authorities have previously investigated parts of the brazilian fighter procurement process these investigations were closed without indicating any wrongdoings by saab due to secrecy obligations saab is not able to communicate further regarding this contacts mattias rådström head of media relations 46 0 734 180 018 presscentre saabgroup com merton kaplan head of investor relations 46 0 734 182 071 merton kaplan saabgroup com saab is a leading defen
9056,all_events,DOWN,,15 nov 2024 16 01 cet norse atlantic asa one year after making history as the first dreamliner to land on antarctica s unique blue ice runway at troll airfield norse atlantic airways has successfully completed its second charter for the purpose of scientific research on the continent on november 15 2024 at 10 55 local time norse atlantic s boeing 787 dreamliner registered as ln fnc and named everglades successfully touched down carrying 10 5 tons of research equipment and scientists for the norwegian polar institute and aircontact the journey followed the oslo cape town troll airfield cape town oslo route similar the airline s historic first landing last year https news cision com norse atlantic airways as r norse atlantic airways achieves historic milestone first boeing 787 dreamliner landing in antarctic c3877587 including a stop in cape town south africa before the final antarctic leg norse atlantic is set to complete a total of four charter
5224,all_events,DOWN,,topline data from the phase 1 portion of phase 1 2a trial of imm 1 104 expected in march 2024
493,all_events,UP,UP,vilnius lithuania 2024 11 18 08 00 cet for more information please visit full investor calendar https nasdaqbaltic com statistics en calendar nasdaq baltic issuer services 370 525 31459 vilnius 371 672 12431 riga 372 640 8800 tallinn https www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative markets first north operated by nasdaq companies in the baltic states i e nasdaq tallinn as nasdaq riga as and ab nasdaq vilnius
9012,all_events,UP,,media release
157,all_events,DOWN,UP,november 09 2024 17 30 et source alk abello alk abello alk alkb dc omx alk b today announced that it has entered into a strategic license agreement with us based ars pharmaceuticals inc ars pharma nasdaq spry the agreement grants alk exclusive global rights to the neffy adrenaline epinephrine nasal spray with exception of the usa australia new zealand japan and china the deal delivers on key elements in alk s new strategy allergy and supports alk s long term financial ambitions neffy is the first and only approved needle free emergency treatment for patients experiencing acute and potentially life threatening allergic reactions the european commission granted eurneffy the trade name for neffy in the eu market authorisation in the eu in august 2024 furthermore neffy was approved by the us food and drug administration also in august 2024 submission for regulatory approval in canada is planned for by the end of 20
11676,all_events,DOWN,,media release
2412,all_events,DOWN,UP,in8bio to present at international society for cell gene therapy isct 2024
4676,all_events,DOWN,,management board of arctic paper s a company issuer informs that on november 13th 2024 it received information about the conclusion by its subsidiary arctic power sp z o o arctic power with coral w perkowski j perkowski sp k coral purchase agreement the agreement of the existing garwolin photovoltaic installation with a capacity of up to 4 mw garwolin installation located in garwolin in the masovian voivodeship the transfer of rights to the garwolin installation will take place at the moment of concluding an agreement for the provision of distribution services with the distribution system operator appropriate for the garwolin installation the total price of the purchase transaction of the garwolin installation does not exceed of the issuer s equity and was determined on market terms the conclusion of the agreement is another step to implement the 4p strategy in the company s energy segment increasing the segment s revenues and supporting arcti
4999,all_events,DOWN,,15 nov 2024 06 30 cet desert control as sandnes norway 15 november 2024 desert control as dsrt announces its third quarter report and interim financial results for the fiscal period ending 30 september 2024 desert control continued its positive momentum in the third quarter of 2024 achieving milestones in market expansion pilot progress and initiation of licensing revenues in the middle east the quarter saw strong results from pilots in agriculture and landscaping supporting negotiations for larger commercial projects in the united states growing traction in the middle east further strengthens the foundation for sustainable growth under the company s royalty based licensed operator model operational highlights solid pilot results strengthen validation and support negotiations for larger contracts in the united states landscaping success in the u s landscaping pilots in california achieved over irrigation savings with some clients reporting wa
12150,all_events,DOWN,,arco vara plans to issue bonds on 13 12 2024 in the maximum amount of 4 million euros with maturity date no later than 12 12 2026 the maximum amount of bonds shall be 400 with the nominal value of 10 000 euros planned interest rate is per annum and interest payments will be made quarterly the priority of subscribing bonds is the order of applications i e first come first served management board is authorized to change the conditions of the issue
3938,all_events,DOWN,,media release
3574,all_events,DOWN,,18 nov 2024 19 44 cet pershing square holdings ltd regulatory news pershing square holdings ltd ln psh ln pshd na psh notes that the information set out below is provided in accordance with the requirements of article 19 3 of the market abuse regulation eu no 596 2014 as it forms part of uk law by virtue of the european union withdrawal act 2018 the information below relates to transactions in psh public shares by bronwyn curtis on 13 november 2024 in order to undertake a bed and isa transaction bronwyn curtis sold 554 psh public shares at 36 13363 from her personal trading account and purchased 552 shares at 36 174241 into her isa account 1 details of the person discharging managerial responsibilities person closely associated a name bronwyn curtis 2 reason for the notification a position status director b initial notification amendment initial 3 detai
8721,all_events,UP,,oslo october 31 2024 ultimovacs asa ultimovacs ose ulti a clinical stage biotechnology company developing immunotherapeutic cancer vaccines invites to a webcast presentation of its third quarter 2024 results on wednesday november 6 2024
438,all_events,DOWN,DOWN,03 oct 2024 23 37 cest eqva asa valen 3 october 2024 reference is made to the stock exchange announcement by eqva asa the company on 3 october 2024 the announcement regarding a successfully completed private placement of 3 125 000 new shares in the company the offer shares at a subscription price of nok 4 80 the private placement the company has engaged clarksons securities as and fearnley securities as as joint managers and bookrunners the managers of the private placement mandatory notification of trades the following primary insiders in the company and close associates of primary insiders were allocated offer shares in the private placement at the offer price as follows nintor as close associate of tore thorkildsen board member of the company was allocated 260 416 offer shares neve eiendom as close associate of even matre ellingsen the company s ceo was allocated 104 166 offer shares south valley invest as close associate of pette
6041,all_events,UP,,kverva industrier as a close associate of pernille skarstein christensen who is a board member in bewi asa has today acquired 1 386 549 shares in bewi asa for nok 22 75 per share please see further details in the attached notification of trade this announcement is made in accordance with article 19 of the eu market abuse regulation and sections 5 12 of the norwegian securities trading act attachments 241114 bewi_pdmr form kverva pdf
12665,all_events,DOWN,,media release
1614,all_events,UP,UP,november 13 2024 04 36 et source danmarks nationalbank danmarks nationalbank bids sales stop rates and prices are presented in the table below the sale will settle 15 november 2024
8237,all_events,UP,,transaction aligns to coherus strategic focus on oncology conference call monday january 22 2024 at 8 30 a m eastern time
8868,all_events,DOWN,,cantargia ab publ hereby provides notification that the nomination committee nc has been appointed ahead of the 2025 annual general meeting agm and consists of arne lööw fjärde ap fonden daniel kristiansson alecta tjänstepension mats larsson första ap fonden and magnus persson chairman of the board the nomination committee has been appointed in accordance with the guidelines established at the 2023 agm as of september 30 2024 the nomination committee represents a total of 23 per cent of the shares in cantargia in accordance with the guideline arne lööw representing the largest shareholder will be the chairman of the nc the annual general meeting will be held on may 15 2025 at ideon gateway scheelevägen 27 in lund sweden the nomination committee s tasks for the agm are to propose a chairman for the agm members of the board of directors and chairman of the board of directors remuneration to the members and the chairman respectively and potential remunera
8422,all_events,UP,,marlborough mass dec 20 2023 globe newswire akoya biosciences inc nasdaq akya akoya the spatial biology company today announced that it will be participating in the 42nd annual j p morgan healthcare conference
11324,all_events,UP,,12 nov 2024 09 05 cet inin group as end of offer period in the voluntary share exchange offer directed to all shareholders in inin group as not for release publication or distribution in whole or in part directly or indirectly into or within the australia belarus canada hong kong india japan new zealand russia singapore south africa switzerland the united states or any other jurisdiction in which the distribution or release would be unlawful reference is made to the stock exchange announcement announced regarding launch of the voluntary exchange offer published on 4 november 2024 as set out in the offer prospectus dated 4 november 2024 the offer period expired on 11 november 2024 at 16 30 cet the offeror will publish a separate stock exchange announcement with information on the status of received acceptances when ongoing counting and verification procedures have been completed non norwegian shareholders who have experienced issues with accepti
4872,all_events,UP,,12 nov 2024 08 47 cet laboratoires euromedis see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1296931_laboratoires_euromedis__communiqu_de_presse_lancement_oca pdf euromedis groupe les echos laboratoires euromedis fr0000075343 alemg euronext growth
756,all_events,UP,DOWN,līdzīgi kā 2023 gadā situācija dabasgāzes tirgos 2024 gada pirmajā ceturksnī ir bijusi labvēlīga dabasgāzes patērētājiem neskatoties uz dabasgāzes cenu kāpumu 2023 gada novembrī un decembrī saistībā ar ģeopolitiskajiem notikumiem tuvajos austrumos dabasgāzes cenas 2024 gada pirmajā ceturksnī turpināja samazināties un martā sasniedza zemāko punktu kopš 2021 gada jūnija dabasgāzes cenu samazinājums galvenokārt skaidrojams ar siltākiem laikapstākļiem eiropā apkures sezonas laikā nekā ierasts kā arī augstu dabasgāzes krātuvju aizpildījumu pēc zemākā punkta sasniegšanas martā dabasgāzes cenas aprīlī un maijā ir pieredzējušas nelielu kāpumu tas galvenokārt saistīts ar dabasgāzes iesūknēšanas sezonas sākšanos eiropas dabasgāzes krātuvēs no 1 aprīļa kā rezultātā dabasgāzes tirgotājiem eiropā ir jāsacenšas par sašķidrinātās dabasgāzes piegādēm ar tirgotājiem āzijā tāpat dabasgāzes cenu ietekmēja plānoti un neplānoti dabasgāzes piegāžu pārtraukumi no norvēģijas kura kopš kara sākuma ukrainā ir kļuvusi par eiropas lielāko dabasgāzes piegādātāju
4755,all_events,DOWN,,10 oct 2024 07 00 cest pharming group n v proof of concept clinical trial will evaluate leniolisib in pids with immune dysregulation linked to altered pi3kẟ signaling in lymphocytes pids to include alps fas ctla4 haploinsufficiency nfkb1 haploinsufficiency and pten deficiency with prevalence approximately five times that of apds clinical trial being conducted at the national institutes of health nih leiden the netherlands october 10 2024 pharming group n v pharming or the company euronext amsterdam pharm nasdaq phar announces the start of a phase ii proof of concept clinical trial evaluating leniolisib in primary immunodeficiencies pids with immune dysregulation linked to altered pi3kẟ signaling in lymphocytes the clinical trial is open for enrollment and will include pid patients with alps fas ctla4 haploinsufficiency nfkb1 haploinsufficiency and pten deficiency among others these pid patients exhibit altered pi3kẟ signaling in lymphocytes an
1090,all_events,DOWN,DOWN,08 nov 2024 07 30 cet lea bank asa english version to follow det vises til fusjonsplan datert 21 08 24 godkjent av ekstraordinær generalforsamling 26 09 24 hvor lea bank ab vil overta alle eiendeler og forpliktelser i lea bank asa og aksjonærer vil motta vederlagsaksjer i lea bank ab ettersom lea bank ab blir et svensk allmennaksjeselskap notert på nasdaq stockholm vil vederlagsaksjene ved utstedelse bli registrert hos euroclear sweden ab det svenske sentrale verdipapirregisteret vpc aksjene i lea bank asa er registrert i verdipapirsentralen i norge vps ettersom vederlagsaksjene vil bli utstedt gjennom vpc vil selskapet ikke kunne distribuere vederlagsaksjer til sine aksjonærer gjennom vps systemet for å motta vederlagsaksjer må aksjonæren ha tilgang til en svensk depotkonto konto for internasjonal handel der vederlagsaksjene kan plasseres og nødvendig kontoinformasjon må sendes til lea bank i det vedlagte aksjonærbrevet finner aksjonærene mer
2746,all_events,UP,,warrington pa jan 25 2024 globe newswire windtree therapeutics inc windtree or the company nasdaqcm wint a biotechnology company focused on advancing late stage interventions for critical cardiovascular disorders today announced that the company entered an exchange and termination agreement with affiliates of deerfield management company collectively deerfield pursuant to which deerfield has agreed to terminate its rights under the company s 2017 exchange and termination agreement to receive up to 15 000 000 in development and commercial milestone payments associated with aerosurf an acute pulmonary drug device combination intended to treat premature infants with respiratory distress syndrome windtree out licensed global rights to aerosurf in 2022
7828,all_events,UP,,08 nov 2024 17 47 cet courtois s a courtois s a toulouse le 8 novembre 2024 decomposition des droits de vote au 31 10 2024 emetteur courtois code emetteur 3290 code valeur 1ère ligne fr0000065393 code valeur 2ième ligne code valeur capital constate au 29 10 2019 72 780actions issues de conversions d obligations ndc 069 actions issues d exercices de bons ndc 070 actions issues de levées d options ndc 071 0 0 0actions issues de conversions d actions de préférences ndc 073 0nombre total d actions en circulation 72 780 nombre d actions ayant droit de vote double 64 948 nombre total de droits de vote bruts 137 728 nombre d actions privées de droit de vote 423 sur le nominatifccn 423 courtois112
2680,all_events,DOWN,,san carlos calif sept 02 2024 globe newswire vaxcyte inc nasdaq pcvx a clinical stage vaccine innovation company engineering high fidelity vaccines to protect humankind from the consequences of bacterial diseases today announced it will hold a webcast and conference call tomorrow september 3 2024 at 8 00 a m eastern time to present topline results from the phase 1 2 study evaluating the safety tolerability and immunogenicity of vax 31 the company s 31 valent pneumococcal conjugate vaccine pcv candidate designed to prevent invasive pneumococcal disease ipd in healthy adults aged 50 and older
4914,all_events,UP,,november 08 2024 01 00 et source stockwik förvaltning ab stockwik förvaltning ab continued strong organic growth and improved cash flow revenue and earnings continued to improve during the third quarter net sales increased by 5 4 percent to msek 182 7 173 3 and operating profit ebita by 27 4 percent to msek 12 6 9 9 compared to the same quarter last year cash flow from operating activities improved to msek 6 1 10 3 which in addition to the increased operating profit is mainly due to changes in working capital the strong growth despite the economic downturn is proof of the effect of the group s increased focus on the development of existing holdings and on the strategy of investing in stable companies with low cyclical dependence the revenue increase in the quarter is attributable to the segments property services and healthcare while the improvement in earnings was primarily generated by the segments industry and property serv
7068,all_events,DOWN,,media release
3058,all_events,DOWN,,media release
8251,all_events,UP,,media release
4328,all_events,DOWN,,eik fasteignafélag hf hefur lokið stækkun á skuldabréfaflokknum eik 050734 bréfið er verðtryggt jafngreiðslubréf sem ber 3 nafnvexti og eru greiðslur tvisvar á ári lokagjalddagi bréfsins er 5 júlí 2034
4759,all_events,DOWN,,07 oct 2024 21 58 cest sparebank 1 nordmøre finansiell kalender for sparebank 1 nordmøre regnskapsår 2024 25 03 2025 årsrapport 08 04 2025 ordinær generalforsamling 14 11 2024 kvartalsrapport q3 12 02 2025 kvartalsrapport q4 regnskapsår 2025 15 08 2025 halvårsrapport 25 03 2026 årsrapport 08 04 2026 ordinær generalforsamling 09 05 2025 kvartalsrapport q1 12 11 2025 kvartalsrapport q3 11 02 2026 kvartalsrapport q4 denne informasjonen offentliggjøres i henhold til kravene i løpende forpliktelser more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sparebank 1 nordmøre oslo børs newspoint sparebank 1 nordmøre spb 1 nordvest 19 29 frn c sub spb 1 nordvest 19 24 frn spb 1 nordvest 20 25 frn surnadal spb 20 25 frn spb 1 nordvest 20 26 1 spb 1 nordvest 21 perp frn c hybrid spb 1 nordvest 21 31 frn c sub spb 1 nordvest 21 28 frn spb 1 nordvest 21 26 frn
10183,all_events,UP,,media release
9260,all_events,DOWN,,from october 8th 2024 10 00 eest bigbank as bonds isin code ee3300004977 public offer subscription process is launched the last trading day of the subscription period is october 18th 2024 15 30 eest up to 3 000 bonds are being publicly offered to investors in estonia latvia and lithuania the offer price is 1 000 eur per bond which is equal to the nominal value of a bond the interest rate is 6 per annum payed quarterly and the maturity is 10 years the bonds will be registered in the nasdaq csd under the isin code ee3300004977 in case of over subscription bigbank has the right to increase the volume of the offering to a total of 8 000 bonds and the offering may also be decreased by the amount unsubscribed the subscription offer will be carried out using the stock exchange trading system and nasdaq csd offering via stock exchange trading system for investors in latvia and lithuania market tse equity auctions genium inet trading system order book bigbbo
12529,all_events,UP,,alexandria group oyj notification 11 11 2024 at 18 30 eet alexandria group oyj acquisition of own shares 11 11 2024 date 11 11 2024 exchange transaction buy share class alex amount 250 average price share 8 4500 eur highest price share 8 4500 eur lowest price share 8 4500 eur total price 2 112 50 eur the shares held by alexandria group oyj on 11 11 2024 alex 41 825 on behalf of alexandria group oyj skandinaviska enskilda banken ab publ helsinki branch antti salakka janne tiihonen for more information please contact jan åkesson ceo jan akesson alexandria fi 358 40 731 2325 attachments alex sbb 11112024 xlsx
4024,all_events,UP,,yavne israel feb 05 2024 globe newswire mediwound ltd nasdaq mdwd a fully integrated biopharmaceutical company focused on next generation enzymatic therapeutics for tissue repair today announced its participation in the upcoming oppenheimer 34th annual life sciences conference taking place virtually on february 13 14 2024 as well as the upcoming td cowen 44th annual health care conference taking place in boston on march 4 6 2024
5292,all_events,UP,,09 oct 2024 21 02 cest bpost sa nv press release pdf bpost euronext bpost be0974268972 bpost euronext
11456,all_events,UP,,media release
11599,all_events,DOWN,,media release
5411,all_events,UP,,19 nov 2024 14 54 cet mowi asa ekstraordinær generalforsamling i mowi asa ble avholdt 19 november 2024 og alle de foreslåtte sakene på agendaen ble godkjent protokollen fra generalforsamlingen er vedlagt denne opplysningen er informasjonspliktig etter verdipapirhandelloven 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632656_protokoll egm 2024 pdf mowi asa oslo børs newspoint mowi mowi asa 20 25 frn eur floor c mowi asa 24 32 5 mowi asa 24 29 frn no0003054108 no0010874050 no0013220905 no0013220897 mowi oslo børs
11356,all_events,DOWN,,for 9 months of 2024 the unaudited consolidated net profit of the ab invl baltic farmland was eur 344 thousand and the revenue was eur 605 thousand for 9 months of 2023 consolidated net profit was eur 315 thousand and the revenue was eur 569 thousand additional information invl baltic farmland a company that invests in agricultural land had revenue of eur 605 000 in the first nine months of 2024 which is 6 more than in the same period last year the company earned a net profit of eur 344 000 in january september this year or 9 more than in the first nine months of 2023 invl baltic farmland s equity at the end of september 2024 was eur 18 25 million or eur 5 65 per share compared to a year earlier and taking into account the impact of dividends equity per share grew 16 the agriculture sector has faced challenges this year related to climate conditions and purchasing prices for grain but the situation is now under control and the dominant mood is rather optimisti
4329,all_events,DOWN,,08 nov 2024 07 00 cet omda as oslo norge 8 november 2024 i dag publiserte omda as omda den ledende nordiske leverandøren av programvare for spesialisthelse og akuttmedisin sine resultater for tredje kvartal 2024 totalomsetningen økte til 103 mnok sammenlignet med 100 mnok i q3 23 selskapets portefølje av langvarige kundeforhold fortsetter å være et solid fundament repeterbare inntekter økte med og utgjorde av omsetningen i q3 24 omda leverte 22 mnok i ebitda for kvartalet som ga en ebitda margin på bruttomarginen for kvartalet var stabil på omdas ceo sverre flatby er optimistisk med tanke på de underliggende trendene repeterbare inntekter øker jevnt samtidig som implementeringen av kostnadsreduserende tiltak gir effekt denne kombinasjonen legger til rette for at marginforbedringene vil fortsette inn i 2025 i q3 inngikk helse sør øst rhf en kontrakt med omda for implementering av en regional løsning for medikamentell kreftbeh
4410,all_events,UP,,alm brand a s share buy back program transactions during 4 november 2024 8 november 2024on 15 august 2024 alm brand a s announced a share buy back program of up to dkk 150 million as described in company announcement no 40 2024 on 7 november 2024 alm brand a s announced an increase of the existing share buy back program by dkk 70 million to dkk 220 million with the intention of purchasing shares for the employee share scheme in 2025 additionally the program was extended until and including 31 january 2025 the program is carried out in accordance with the regulation no 596 2014 of the european parliament and council of 16 april 2014 mar and the commission delegated regulation eu 2016 1052 also referred to as the safe harbour regulations the following transactions were made under the share buy back program during week number 45 with the transactions stated above alm brand a s holds a total of 33 262 769 own shares corresponding to 2 16 of the total number of outsta
7474,all_events,DOWN,,aktia bank plcstock exchange release 8 november 2024 at 10 00 a m aktia bank plc managers transactions anssi huhta person subject to the notification requirementname huhta anssiposition other senior managerissuer aktia bank plclei 743700gc62jlhfbund16notification type initial notificationreference number 743700gc62jlhfbund16_20241106115439_210____________________________________________ transaction date 2024 11 06venue not applicableinstrument type shareisin fi4000058870nature of the transaction subscription transaction details 1 volume 2 067 unit price 8 36 eur aggregated transactions 1 volume 2 067 volume weighted average price 8 36 eur aktia bank plc further information oscar taimitarha director investor relations tel 358 40 562 2315 ir at aktia fi distribution nasdaq helsinki ltdmass mediawww aktia com aktia is a finnish asset manager bank and life insurer that has been creating wealth and wellbeing from one generation to the next for 200 years we
9334,all_events,DOWN,,stockholm 15 november 2024 safello the leading cryptocurrency exchange in the nordics announces the election of åsa leander skålén to the board of directors of safello ab with extensive experience in both legal and compliance roles within the financial sector åsa brings invaluable insights as safello advances its regulatory roadmap including the upcoming markets in crypto assets mica application process åsa leander skålén has worked as a lawyer since 2003 serving in both business law firms and as in house legal counsel and compliance officer in 2013 she founded realjuridik i sverige ab a consultancy firm offering legal compliance and regulatory services to financial institutions across both traditional finance and the blockchain and crypto markets her expertise spans commercial contracts corporate law financial regulations and compliance complemented by her work as a lecturer in financial ethics regulations and compliance her knowledge of blockchain technology
3254,all_events,DOWN,,cambridge mass oct 03 2024 globe newswire intellia therapeutics inc nasdaq ntla a leading clinical stage gene editing company focused on revolutionizing medicine with crispr based therapies today announced that on october 1 2024 it awarded inducement grants to nine new employees under intellia s 2024 inducement plan as a material inducement to employment
1432,all_events,DOWN,DOWN,zurich switzerland november 14 2024 abb share buybacks november 7 2024 november 13 2024 during the period november 7 2024 to november 13 2024 abb repurchased a total of 501 734 shares as part of its share buyback program announced on march 28 2024 the buyback program is being carried out in accordance with the swiss ordinance on financial market infrastructures and market conduct in securities and derivatives trading fmio the market abuse regulation eu no 596 2014 mar and the commission delegated regulation eu no 2016 1052 the safe harbour regulation date aggregated daily volume number of shares daily weighted average share price chf daily buyback amount chf nov 7 2024 65 245 50 1695 3 273 309 42 nov 8 2024 113 723 50 0150 5 687 854 82 nov 11 2024 100 800 50 7506 5 115 656 04 nov 12 2024 115 000 50 1735 5 769 949 97 nov 13 2024 106 966 49 4836 5 293 064 15 all share purchases above have been carried out on a separate trading line on the six
12208,all_events,UP,,the extraordinary general meeting in sivers semiconductors ab publ the company has been held on 11 october 2024 and in particular the following decisions were resolved the required majority was not obtained to approve the board of directors resolution on a new issue of shares to the ceo the board of directors resolution from 17 september 2024 on a new issue of shares to the ceo did not obtain the required majority for approval by the general meeting however the board of directors intends to revert within short with a new proposal for a directed new share issue to the ceo to be approved by an extraordinary general meeting resolution on a long term incentive program the general meeting resolved to introduce an incentive an program the p09 for the employees of the sivers semiconductors group the group p09 shall consist of a maximum of 7 500 000 new stock options the stock options entitling to purchase of the same number of shares in the company corresponding to
4521,all_events,UP,,third quarter fiscal 2024 revenue down 32 to 105 8 million year to date fiscal 2024 revenue down 16 to 360 3 million conclusion of certain government investigations site optimization projects complete conference call begins today at 4 30 pm et
2596,all_events,UP,,18 nov 2024 19 00 cet banijay group n v press release paris 18 november 2024 share transactions disclosure banijay group n v 1 894500g73k46h93rf180 declares the following transactions made on its own shares nl0015000x07 from 11 november to 15 november 2024 in accordance with the authorization given by the shareholder s annual meeting on 23 may 2024 trade datesidetotal daily volume number of shares average priceamount of transactionsmarket identification code2024 11 11buy338 600000283 80xams2024 11 11sell1598 6500001 375 35xams2024 11 12sell188 650000155 70xams2024 11 13buy2308 5765221 972 60xams2024 11 14buy88 55000068 40xams2024 11 15buy698 550000589 95xams the disclosure of all share transactions was made publicly available and can be consulted on the company s website https group banijay com liquidity agreement under the section investors agenda q3 2024 results 6 march 2025 investor relations caroline cohen phone 33 1 44 95 23 34 c cohen group b
2102,all_events,UP,UP,06 nov 2024 18 00 cet actia group see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1295569_ddv_au_311024 pdf actia les echos actia group s a fr0000076655 alati euronext growth
12526,all_events,UP,,media release
5538,all_events,UP,,media release
4606,all_events,UP,,media release
1934,all_events,DOWN,DOWN,petach tikva israel feb 28 2024 globe newswire polypid ltd nasdaq pypd polypid or the company a late stage biopharma company aiming to improve surgical outcomes today announced that company management will participate in a fireside chat at the barclays 26th annual global healthcare conference taking place in miami beach fl march 12 14 2024
7188,all_events,DOWN,,06 nov 2024 11 19 cet askøy kommune oslo børs has received an application for isin no0013392340 to be admitted to stock exchange listing the market abuse regulation mar applies from the time the application has been made including the issuer s disclosure obligation on inside information more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site askøy kommune oslo børs newspoint askøy komm 20 25 frn askoy komm 23 26 frn askøy komm 24 27 frn no0010901143 no0013066340 no0013260315 oslo børs
12671,all_events,DOWN,,media release
11143,all_events,UP,,november 12 2024 03 57 et source bioporto a s bioporto a s 12 november 2024 pressemeddelelse bioporto a s inviterer til webcast københavn danmark og boston ma usa 12 november 2024 globe newswire bioporto a s bioporto eller selskabet cph biopor der udvikler og markedsfører diagnostiske biomarkører afholder i forbindelse med offentliggørelse af kvartalsrapporten for 3 kvartal 2024 et online investormøde den 14 november 2024 kl 10 30 via hc andersen capital deltagere kan registrere sig på følgende link https hca videosync fi 2024 11 14 bioporto register for modtagelse af selskabsmeddelelser pressemeddelelser og andre nyheder om bioporto kan man tilmelde sig her https bioporto com investor contact investor relations tim eriksen bioporto 45 4529 0000 investor bioporto com om bioporto bioporto er en in vitro diagnostisk virksomhed som på baggrund af biomarkører udvikler og markedsfører diagnostiske tes
11454,all_events,UP,,19 nov 2024 13 51 cet eidsvoll kommun det er fastsatt ny obligasjonsrente for no0012990607 ny obligasjonsrente i renteperioden 21 11 2024 21 02 2025 er 5 19 ticker edko09 den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632636_6d6acde9ddff49498fab3c0dfd6d31b2 pdf eidsvoll kommune oslo børs newspoint eidsvoll komm 22 25 frn eidsvoll komm 23 25 frn eidsvoll komm 23 26 frn eidsvoll komm 24 27 frn no0012508557 no0012813098 no0012857319 no0012990607 no0013220913 oslo børs
758,all_events,DOWN,UP,15 nov 2024 06 30 cet mowi asa aksjene i mowi asa noteres eks utbytte på nok 1 50 fra og med i dag 15 november 2024 denne opplysningen er informasjonspliktig etter verdipapirhandelloven 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site mowi asa oslo børs newspoint mowi mowi asa 20 25 frn eur floor c mowi asa 24 32 5 mowi asa 24 29 frn no0003054108 no0010874050 no0013220905 no0013220897 mowi oslo børs
7798,all_events,UP,,on the basis of the bondholders interest protection agreement no osp 23 09 dated april 5 2023 uab audifina acting on behalf of the bondholders holding securities issued by uab integre trans company code 301888546 hereinafter referred to as the company has submitted a creditor claim on behalf of the bondholders to the company s insolvency administrator uab admivita legal entity code 125841325 on november 11 2024 this creditor claim concerns the company s bond issuance registered on may 5 2023 with a total principal amount of eur 4 000 000 bearing isin code lt0000407553 hereinafter referred to as the issuance the total claim amount is eur 4 312 000 comprised of eur 4 000 000 in principal eur 292 000 in accrued interest and a eur 20 000 premium as previously pledged by the company in submitting this creditor claim uab audifina translated the terms of the issuance into lithuanian and allocated the respective claim amounts to the bondholders based on the
7685,all_events,UP,,media release
7261,all_events,UP,,media release
12025,all_events,DOWN,,new haven conn aug 07 2024 globe newswire bioxcel therapeutics inc nasdaq btai a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno oncology today announced that vimal mehta ph d ceo of bioxcel therapeutics will participate in a fireside chat at the canaccord genuity 44th annual growth conference in boston on tuesday august 13 2024 at 1 p m et dr mehta will be joined by vincent j o neill m d executive vice president chief of product development and medical officer
10669,all_events,UP,,on the 7th of november 2024 ieva bauma member of the board of the indexo group s company has disposed ipas indexo shares detailed information is in the attached document about indexo indexo is a financial services group that includes pension management companies and indexo bank indexo an investment management company licensed by the bank of latvia offers modern 2nd and 3rd pillar pension plans in latvia and is one of the fastest growing pension managers in the baltics with over 139 thousand customers and more than eur 1 24 billion under management meanwhile indexo bank is a credit institution licensed by the european central bank which will provide a full range of convenient and advantageous banking services to latvian residents with plans to start serving latvian companies in the second half of next year indexo is founded and based in latvia and is listed on the nasdaq riga stock exchange with nearly 6 000 shareholders indexo fights for
4978,all_events,UP,,15 nov 2024 08 34 cet sparebanken møre informasjon om transaksjoner utført under tilbakekjøpsprogram følger under dato for offentliggjøring av tilbakekjøpsprogrammet 28 10 24 gjennomføringsperiode for tilbakekjøpsprogrammet 29 10 2024 21 11 2024 fra 07 11 2024 til og med 14 11 2024 har sparebanken møre kjøpt totalt 27 553 egne egenkapitalbevis til en gjennomsnittlig pris på nok 91 4998 pr egenkapitalbevis sparebanken møre eier 232 891 egne egenkapitalbevis tilsvarende 0 av egenkapitalbeviskapitalen oversikt over alle transaksjoner utført under tilbakekjøpsprogrammet i ovennevnte periode følger i vedlegg kontaktperson ove t ness tlf 95762524 dette er informasjon sparebanken møre er forpliktet til å offentliggjøre i henhold til eus markedsmisbruksforordning og informasjonspliktig i henhold til vphl 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632353_transaksj
4691,all_events,UP,,the gen 2 optejet is designed for an optimized user experience while ensuring extended patent protection for products using the platform through 2041 the gen 2 optejet is designed for an optimized user experience while ensuring extended patent protection for products using the platform through 2041
9464,all_events,DOWN,,casgevy approved for the treatment of patients 12 years of age and older with sickle cell disease scd and transfusion dependent beta thalassemia tdt in switzerland and canada
11994,all_events,DOWN,,06 nov 2024 08 05 cet imerys see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1295463_imeryscommuniqudepressetalcus06112024_vfr pdf imerys les echos imerys fr0000120859 nk euronext
2470,all_events,DOWN,DOWN,media release
3025,all_events,UP,,media release
10242,all_events,UP,,19 nov 2024 17 45 cet charwood energy s a charwood energy charwood energy charwood energy partners with schmid energy solutions to distribute eco responsible heating systems in france 19 nov 2024 17 45 cet cest dissemination of a french regulatory news transmitted by eqs group the issuer is solely responsible for the content of this announcement press release saint nolff november 19 2024 charwood energy partners with schmid energy solutions to distribute eco responsible heating systems in france charwood energy isin fr001400aj60 ticker alcwe a french company specializing in custom solutions for recovering energy from biomass announces the signature of a strategic partnership between its subsidiary energy and the swiss group schmid energy solutions world leader in eco responsible heating systems for the distribution of its systems in france s grand ouest region founded in 1936 schmid energy solutions is a swiss family owned group recogni
1459,all_events,UP,UP,11 nov 2024 14 00 cet stmicroelectronics n v stmicroelectronics announces status ofcommon share repurchase program disclosure of transactions in own shares period from nov 04 2024 to nov 08 2024 amsterdam november 11 2024 stmicroelectronics n v the company or stmicroelectronics a global semiconductor leader serving customers across the spectrum of electronics applications announces full details of its common share repurchase program the program disclosed via a press release dated june 21 2024 the program was approved by a shareholder resolution dated may 22 2024 and by the supervisory board stmicroelectronics n v registered with the trade register under number 33194537 lei 213800z8nohikri42w10 announces the repurchase by a broker acting for the company on the regulated market of euronext paris in the period between nov 04 2024 to nov 08 2024 the period of 547 000 ordinary shares equal to 0 of its issued share capital at the
6350,all_events,DOWN,,cambridge mass nov 16 2024 globe newswire intellia therapeutics inc nasdaq ntla a leading clinical stage gene editing company focused on revolutionizing medicine with crispr based therapies today announced positive new clinical data from the ongoing phase 1 trial of nexiguran ziclumeran nex z also known as ntla 2001 in patients with transthyretin attr amyloidosis nex z is an investigational in vivo crispr based gene editing therapy in development as a one time treatment for attr amyloidosis development and commercialization of nex z is led by intellia as part of a multi target collaboration with regeneron
8185,all_events,DOWN,,media release
3488,all_events,DOWN,,11 oct 2024 15 30 cest gigante salmon as bodø 11 oktober 2024 i forbindelse med publiseringen av rapporten for 3 kvartal 2024 inviterer gigante salmon til en selskapspresentasjon tirsdag 22 oktober kl 09 00 på hotel bristol kristian iv s gate 7 oslo det serveres enkel frokost kaffe og te fra klokken 08 30 presentasjonen holdes av administrerende direktør kjell lorentsen og finansdirektør rune johansen den kan også følges digitalt https gigantesalmon no investor 2 websendinger gigante salmon quarterly earn ing reports 2024 95e74jb9 det er mulig å sende inn skriftlige spørsmål under den digitale sendingen disse blir lest opp og besvart mot slutten av presentasjonen kvartalsrapporten er tilgjengelig på selskapets nettside www gigantesalmon no fra 22 oktober kl 07 00 og oslo børs www newsweb no et opptak av sendingen vil bli gjort tilgjengelig på selskapets nettside i etterkant for ytterligere informasjon vennligst kontakt kjell loren
6182,all_events,UP,,12 nov 2024 08 43 cet totalenergies se regulatory news totalenergies se the company paris tte lse tte nyse tte announces the launch of a tender offer the tender offer intended to repurchase its 2 500 000 000 undated non call 10 year deeply subordinated fixed rate resettable notes with a first call date on 26 february 2025 isin xs1195202822 issued by the company on 26 february 2015 all of which are currently outstanding and admitted to trading on euronext paris the notes for cash up to a maximum aggregate principal amount expected to be equal to the aggregate principal amount of the new notes as defined herein to be issued and to be announced as soon as reasonably practicable after the pricing of the new notes subject to the right of the company to increase or decrease such amount in its sole and absolute discretion the maximum acceptance amount the terms of the tender offer are as set out in the tender offer memorandum dated 12 novembe
2611,all_events,DOWN,,14 nov 2024 11 31 cet havila shipping asa vedlagt informasjon til obligasjonseiere i havi04 og havi07 kontakt finansdirektør arne johan dale 47 909 87 706 denne opplysningen er informasjonspliktig etter verdipapirhandelloven 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632183_havi04 q424 pdf 632183_havi07 q424 pdf havila shipping asa oslo børs newspoint havila shipping havila shipping asa 10 16 frn c havila shipping asa 11 17 frn c no0010257728 no0010590441 no0010605033 havi oslo børs
3315,all_events,DOWN,,13 nov 2024 17 20 cet å energi as å energi as med rating a stable fra scope har i dag utstedt ett nytt grønt usikret obligasjonslån på nok 300 millioner med en kupongrente på 3 måneder nibor 0 p a og forfallsdato 28 februar 2028 lånet vil søkes notert på oslo børs å energi as har også utvidet følgende grønne usikrede obligasjonslån nok 250 millioner i isin no0013251843 med forfallsdato 5 september 2029 etter utvidelsen er utestående beløp nok 700 millioner nok 250 millioner i isin no0013251850 med forfallsdato 5 september 2029 etter utvidelsen er utestaånde beløp nok 900 millioner nok 400 millioner i isin no0013013920 med forfallsdato 19 september 2030 etter utvidelsen er utestående beløp nok 900 millioner oppgjørsdato for alle lånene er 27 november 2024 seb var tilrettelegger av transaksjonen for ytterligere informasjon vennligst kontakt stein johnsgård finanssjef 47 95 29 82 30 stein johnsgard aenergi no more information ac
4900,all_events,DOWN,,18 nov 2024 11 04 cet fleury michon programme de rachat declaration des transactions sur actions propres societe fleury michon présentation agrégée par jour et par marché période 11 11 2024 au 15 11 2024 publication du 18 11 2024 nom de l émetteurcode identifiant de l émetteurjour de la transactioncode identifiant de l instrument financiervolume total journalier en nombre d actions prix pondéré moyen journalier d acquisition des actionsmarchéfleury michon96950009em1d72ngcv2711 11 2024fr0000074759 162 23 67407xparfleury michon96950009em1d72ngcv2712 11 2024fr0000074759 41 23 80xparfleury michon96950009em1d72ngcv2713 11 2024fr0000074759 48 23 90xparfleury michon96950009em1d72ngcv2714 11 2024fr0000074759 71 23 95775xparfleury michon96950009em1d72ngcv2715 11 2024fr0000074759 123 24 0813xpar détail transaction par transaction nom de l émetteurcode identifiantnom du psicode identifiant psijour heure de la transactioncode identifiant de l instrument financierprix unitaire unité
134,all_events,DOWN,DOWN,media release
5709,all_events,DOWN,,media release
8187,all_events,UP,,media release
799,all_events,DOWN,DOWN,south san francisco calif and san diego oct 23 2024 globe newswire oric pharmaceuticals inc nasdaq oric a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance today announced the company presented a poster highlighting certain best in class properties of oric 114 a brain penetrant orally bioavailable irreversible egfr her2 inhibitor to treat egfr exon 20 insertions and other atypical mutations at the eortc nci aacr symposium on molecular targets and cancer therapeutics
11999,all_events,UP,,urbo bankas uab hereinafter the bank company code 112027077 address konstitucijos pr 18b vilnius we hereby inform you that on 15 october 2024 a new version of the articles of association of the bank was registered in the register of legal entities the new version of the articles of association was approved on 30 september 2024 by the board ot the bank in addition we inform you that the reorganization of the bank and uab saugus kreditas was completed after the above mentioned version of the bank s articles of association was registered uab saugus kreditas was merged with the bank the reorganization of the bank and uab saugus kreditas was implemented in accordance with the procedure and deadlines established by the law on joint stock companies of the republic of lithuania after the reorganization the bank took over all the rights and obligations and assets of uab saugus kreditas as well as rights and obligations under the transactions they are included in the
427,all_events,DOWN,UP,media release
9318,all_events,DOWN,,the shareholders are hereby called to the extraordinary general meeting of climeon ab publ 556846 1643 to be held on monday december 9 2024 at 15 30 the extraordinary general meeting will be held in kista gates premises at torshamnsgatan 44 in kista registration will take place from 15 00 participation in the meetingshareholders that wish to participate in the meeting must information regarding administration of personal data please see https www euroclear com dam esw legal integritetspolicy bolagsstammor svenska pdf nominee sharesshareholders with nominee shares must in order to be entitled to participate in the meeting in addition to the notification in accordance with the above arrange to be temporarily registered by euroclear sweden ab the nominee must be notified of this in good time before november 29 2024 so that the shareholder is listed in the presentation of the share register made by euroclear sweden concerning the circumstances that day such temporary ow
10586,all_events,UP,,alisa bank plc manager transactions 19 11 2024 at 10 20 eet person subject to the notification requirement name wrcc invest oy position member of the board deputy member x legal person 1 person discharging managerial responsibilities in issuer name tero weckroth position member of the board issuer alisa pankki oyj lei 743700vk1nb8hrgtqh74 notification type initial notification reference number 85039 5 4 transaction date 2024 11 15 24 venue nasdaq helsinki ltd xhel instrument type share isin fi4000170915 nature of transaction acquisition transaction details 1 volume 161545 unit price 0 18 eur 2 volume 20966 unit price 0 1871 eur aggregated transactions 2 volume 182511 volume weighted average price 0 18082 eur further information juha saari interim ceo alisa bank plc juha saari alisapankki fi tel 358 40 672 0595 alisa bank in brief alisa bank plc is a finnish digital bank that helps both personal and business customers to manage their day to
9677,all_events,UP,,13 nov 2024 16 32 cet ayfie international as oslo november 13 2024 reference is made to the stock exchange announcement by ayfie international as ayfie or the company on october 30 2024 regarding a successfully completed private placement the private placement of new shares in the company the offer shares the share capital increase related to issuance of offer shares in the private placement has today been registered with the norwegian register of business enterprises the new share capital of the company is nok 42 023 796 divided on 21 011 898 shares each with a nominal value of nok 2 00 this information is subject to a duty of disclosure pursuant to the company s continuing obligations as a company listed on euronext growth oslo for further information please contact olav gram degnes cfo ir tel 47 906 25 168 e mail olav degnes ayfie com about ayfie ayfie is a leading innovator in search solutions and artificial intelligence
3576,all_events,UP,,norwood mass nov 07 2024 globe newswire corbus pharmaceuticals holdings inc nasdaq crbp corbus or the company an oncology and obesity company with a diversified portfolio today provided a corporate update and reported financial results for the quarter ended september 30 2024
2760,all_events,UP,,media release
1255,all_events,UP,DOWN,18 nov 2024 13 50 cet eviny as det er fastsatt ny obligasjonsrente for no0011073819 ny obligasjonsrente i renteperioden 20 11 2024 20 02 2025 er 5 18 ticker bkk52 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632525_5200d87800ca4078aa29b916bcf3d008 pdf eviny as oslo børs newspoint bkk as 20 26 frn bkk as 20 27 frn bkk as 20 25 frn bkk as 21 27 1 85 pct bkk as 21 26 frn eviny as 23 28 frn eviny as 23 31 5 eviny as 23 28 5 eviny as 24 34 4 eviny as 24 29 frn eviny as 24 27 frn eviny as 24 31 frn no0010872948 no0010873003 no0010901838 no0011073181 no0011073819 no0013004572 no0013062273 no0013060715 no0013257477 no0013311902 no0013314658 no0013323485 nordic alternative b
7048,all_events,DOWN,,media release
4149,all_events,DOWN,,in october eften real estate fund as earned a consolidated rental income of 2 570 thousand euros an increase of 19 thousand euros compared to september this increase is primarily attributed to the first month of rental income from the new investment härgmäe logistics center the fund s consolidated ebitda for october was 2 155 thousand euros which is 36 thousand euros lower than in the previous month the decrease in ebitda was mainly due to autumn marketing campaigns in shopping centers and year end valuation expenses for the investment portfolio in october the fund s subsidiary eften härgmäe oü entered into a real rights contract to acquire the logistics center paying 8 314 thousand euros for the property in addition to the advance payment of 515 thousand euros made in september the acquisition was financed through a bank loan of 7 300 thousand euros and the fund s own resources the initial rental yield on the investment is 7 the weighted average interest rate on th
9965,all_events,DOWN,,15 nov 2024 11 17 cet aurora eiendom as eiendomsspar as closely related to sigurd stray board member of aurora eiendom as has today bought 200 498 shares in aurora eiendom for a price of nok 81 00 per share after the transaction eiendomsspar as holds 6 202 960 shares in aurora eiendom please refer to the attached notification for further details more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632374_aura pdmr form eiendomsspar as 15 11 2024 pdf aurora eiendom as oslo børs newspoint aurora eiendom as no0011032310 aura euronext growth
8885,all_events,DOWN,,18 nov 2024 08 00 cet storebrand asa transaksjoner foretatt under tilbakekjøpsprogram for storebrand asa dato for når tilbakekjøpsprogrammet ble annonsert 24 april 2024 tilbakekjøpsprogrammets varighet 20 desember 2024 oversikt over transaksjoner dato aggregert daglig vektet total volum antall gjennomsnittspris transaksjonsverdi aksjer nok nok 11 11 2024 42 105 124 08 5 224 224 12 11 2024 86 852 121 52 10 554 281 13 11 2024 207 000 118 42 24 513 168 14 11 2024 25 000 118 70 2 967 600 15 11 2024 6 073 119 68 726 803 totalt 9 281 125 111 98 1 039 285 240 tidligere offentliggjorte tilbakekjøp under programmet totalt kjøpt 9
6259,all_events,DOWN,,alvotech nasdaq alvo fundar með erlendum fjárfestum á heilbrigðisráðstefnu fjárfestingabankans jefferies í london dagana 19 20 nóvember n k stjórnendur alvotech munu einnig flytja kynningu á ráðstefnunni þriðjudaginn 19 nóvember n k kl 9 00 9 25 að íslenskum tíma
7747,all_events,DOWN,,media release
4048,all_events,UP,,west lafayette ind oct 16 2023 globe newswire inotiv inc nasdaq notv a leading contract research organization today announced the appointment of terry coelho to its board of directors ms coelho is replacing richard a johnson phd who is leaving the board as part of the board s succession planning ms coelho was also appointed to serve as a member of the compensation committee and the audit committee and as a member and the chair of the nominating corporate governance committee of the board
7220,all_events,DOWN,,14 nov 2024 10 00 cet atos se paris france november 14 2024 eviden the atos group business leading in advanced computing today announces the launch of bxi v3 the third generation of the only european scale out networking technology specifically designed for artificial intelligence ai and high performance computing hpc workloads set to be available in the second half 2025 ai and hpc domains are witnessing an exponential increase in compute power with exascale1 workloads trillion parameters large language models being developed in contrast scale out networking the backbone of the system has not seen the same performance improvements which represents a networking wall for advancing ai hpc science and requires a radically different approach to address this challenge eviden has developed the third generation of its patented bullsequana exascale interconnect bxi v3 in partnership with the french cea atomic energy commission and alternative energies
7228,all_events,DOWN,,needham mass march 05 2024 globe newswire candel therapeutics inc candel or the company nasdaq cadl a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer today announced the company will present a poster presentation at the american association for cancer research aacr annual meeting taking place april 5 10 2024 in san diego ca the presentation will describe the second candidate from the enlighten discovery platform a first in class multimodal immunotherapy candidate for induction of tertiary lymphoid structures as a novel therapeutic strategy for solid tumors this abstract presentation at aacr accelerates the milestone associated with the unveiling of the second enlighten program which was originally planned for the third quarter of 2024
12281,all_events,UP,,november 07 2024 01 00 et source nordecon nordecon in the third quarter of this year the downward trend in the construction market did not experience a significant shift forward looking indicators that characterize both the construction market and the broader macroeconomic environment are contradictory making it difficult to predict a market upturn in the coming quarters this uncertainty affects both the public and private sectors willingness and confidence to make broad based investments in buildings and infrastructure despite the challenging market conditions all three key economic indicators of nordecon as show a positive trend in the third quarter the group continued to see growth in profitability and sales revenue and the backlog of unfinished work increased as well the group s gross profit margin reached 7 for the first nine months of 2024 compared to 3 in the first nine months of 2023 and 8 in the third quarter compa
9804,all_events,DOWN,,12 nov 2024 08 00 cet ing groep n v progress on share buyback programme ing announced today that as part of our 2 0 billion share buyback programme announced on 31 october 2024 in total 7 704 055 shares were repurchased during the week of 4 november 2024 up to and including 8 november 2024 the shares were repurchased at an average price of 15 35 or a total amount of 118 240 205 76 for detailed information on the daily repurchased shares individual share purchase transactions and weekly reports see share buy back programme in line with the purpose of the programme to reduce the share capital of ing the total number of shares repurchased under this programme to date is 11 720 329 ordinary shares at an average price of 15 45 for a total consideration of 181 038 327 77 to date approximately 9 of the maximum total value of the share buyback programme has been completed note for editors for more on ing please visit www ing com frequent news updates can be f
5363,all_events,DOWN,,on november 7 2024 nasdaq riga decided to temporarily suspend trading in bonds of delfingroup dgrbflot28fa isin lv0000802700 dgrbflot26fb isin lv0000860146 trading is suspended due to technical updates to the bond configuration trading shall be resumed on november 8 2024 nasdaq baltic transaction services 372 640 8800 www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative markets first north operated by nasdaq companies in the baltic states i e nasdaq tallinn as nasdaq riga as and ab nasdaq vilnius
5857,all_events,DOWN,,new haven conn july 30 2024 globe newswire bioxcel therapeutics inc nasdaq btai a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno oncology today announced that it will release its second quarter 2024 financial results on tuesday august 6 2024 before the open of the u s financial markets the company s management team will also host a conference call and webcast at 8 00 am et that day to discuss these results and provide a general business update
10546,all_events,DOWN,,philogen new production facility in rosia has received the gmp certificate by competent authorities
12865,all_events,UP,,media release
3120,all_events,UP,,14 nov 2024 08 00 cet noram drilling as the shares in noram drilling as will be traded ex cash distribution usd 0 04 nok 0 446 as from today november 14 2024 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site noram drilling as oslo børs newspoint noram drilling as no0010360019 noram euronext growth
8963,all_events,UP,,immuneering granted orphan drug designation for imm 1 104 by fda in the treatment of pancreatic cancer
5611,all_events,UP,,hydro is pleased to invite investors analysts financial media and other stakeholders to its capital markets day on november 27 2024
0,all_events,DOWN,UP,qiastat dx respiratory panel mini targets the five most actionable respiratory pathogens in outpatient settings to help clinicians make precise treatment decisions with the new test and the 21 target qiastat dx respiratory panel plus clinicians can fine tune their diagnostic approach for individual patients promoting better diagnostic stewardship fda decision marks third positive u s regulatory outcome for qiastat dx to date in 2024 qiastat dx respiratory panel mini targets the five most actionable respiratory pathogens in outpatient settings to help clinicians make precise treatment decisions with the new test and the 21 target qiastat dx respiratory panel plus clinicians can fine tune their diagnostic approach for individual patients promoting better diagnostic stewardship fda decision marks third positive u s regulatory outcome for qiastat dx to date in 2024
3989,all_events,DOWN,,publication in the journal of ocular pharmacology and therapeutics highlights the ability of the optejet to achieve a therapeutic dose of medication with far less exposure to harmful preservatives
8204,all_events,DOWN,,media release
2319,all_events,UP,UP,media release
2963,all_events,DOWN,,citycon oyj inside information 6 november 2024 at 19 05 hrs the board of directors of citycon oyj has today decided on the basis of the authorisation by the annual general meeting 2024 that an equity repayment of eur 0 075 per share will be distributed from the invested unrestricted equity fund of the company the equity repayment will be paid to a shareholder registered in the company s shareholders register maintained by euroclear finland ltd on the record date of the repayment 20 december 2024 the equity repayment will be paid on 31 december 2024 following the asset distribution on 31 december 2024 citycon oyj has distributed a total equity repayment of eur 0 30 per share during the year 2024 and the board of directors has fully exercised the asset distribution authorisation granted by the annual general meeting citycon oyj for further information please contact sakari järvelä chief financial officer tel 358 50 387 8180 sakari jarvela citycon com citycon is a
9434,all_events,UP,,dna vaccine proof of concept study expected to demonstrate an mrna better platform
5922,all_events,DOWN,,media release
5174,all_events,UP,,media release
2420,all_events,UP,UP,media release
5361,all_events,UP,,radnor pa aug 28 2024 globe newswire mineralys therapeutics inc nasdaq mlys a clinical stage biopharmaceutical company focused on developing medicines to target hypertension chronic kidney disease ckd and other diseases driven by dysregulated aldosterone today announced that management will be participating in a fireside chat at the wells fargo healthcare conference being held in boston ma on september 4 6 2024
7854,all_events,UP,,thunderful group invites to a webcast november 11 2024 09 00 cet the q3 report for 2024 is presented and thereafter there is an opportunity to askquestions questions can be posed in writing via the webcast a recorded version of the presentation will also be available on thunderful group s website the presentation will be held in english the q3 report is published at 07 30 cet november 11 2024 the presentation will be moderated by anton hoof analyst at redeye present martin walfisz ceoper alnefelt interim cfo to access the webcast please click on the link below https www redeye se events 1044922 live q thunderful group 2 for more information please contact martin walfisz ceo thunderful group 46 705 37 19 10per alnefelt interim cfo thunderful group 46 727 17 02 17 about thunderful groupthunderful group focuses on publishing and developing high quality digital games for pc and console platforms headquartered in gothenburg sweden thunderful group spans a signif
5220,all_events,UP,,new york may 31 2024 globe newswire tg therapeutics inc nasdaq tgtx today announced presentations highlighting study designs for post marketing studies being undertaken for briumvi ublituximab xiiy in patients with relapsing forms of multiple sclerosis rms at the 2024 consortium of multiple sclerosis centers cmsc annual meeting presentations are now public and can be viewed using the below links
6315,all_events,DOWN,,media release
6750,all_events,DOWN,,november 11 2024 01 00 et source bigbank as bigbank as bigbank as carries out a private placement of additional tier 1 temporary write down notes at1 bonds due to the complexity of these at1 bonds they will not be offered to the general public instead the offering is targeted exclusively at selected investors the subscription of at1 bonds will take place from 11 november to 19 november 2024 up to 300 at1 bonds with a nominal value of eur 10 000 will be offered bigbank as reserves the right to adjust the issue volume as needed the at1 bonds carry an interest rate of per annum payable quarterly bonds are offered at a price of eur 10 000 per bond with a minimum investment amount of eur 20 000 the at1 bonds are perpetual unsecured debt obligations to investors subject to obtaining approval from the financial supervision authority bigbank as reserves the right to redeem the at1 bonds in part or in full after a period of 5 years
7712,all_events,UP,,06 nov 2024 19 23 cet nrc group asa not for release publication or distribution in whole or in part directly or indirectly in australia canada japan or the united states or any other jurisdiction in which the release publication or distribution would be unlawful this announcement does not constitute an offer of any of the securities described herein reference is made to the stock exchange notice from nrc group asa the company on 24 october 2024 regarding the commencement of the subscription period the subscription period in the subsequent offering the subsequent offering consisting of up to 20 000 000 new shares the offer shares in the company at a subscription price of nok 2 50 per share the subscription period expired today 6 november 2024 at 16 30 hours cet the company has been informed by the managers as defined below that at the end of the subscription period and based on a preliminary count valid subscriptions had been received
5766,all_events,DOWN,,pihlajalinna plc managers transactions 11 november 2024 at 3 00 p m pihlajalinna plc managers transactions pihlajalinna plc has received the following notification on 11 november 2024 person subject to the notification requirement name anu kallio position other senior manager issuer pihlajalinna oyj lei 74370058mtrledochv67 notification type initial notification reference number 84438 5 6 ____________________________________________ transaction date 2024 11 07 venue nasdaq helsinki ltd xhel instrument type share isin fi4000092556 nature of transaction acquisition transaction details 1 volume 540 unit price 10 9 eur aggregated transactions 1 volume 540 volume weighted average price 10 9 eur ____________________________________________ transaction date 2024 11 08 venue nasdaq helsinki ltd xhel instrument type share isin fi4000092556 nature of transaction acquisition transaction details 1 volume 2336 unit price 10 95 eur aggregated transact
8298,all_events,DOWN,,saniona omx sanion a clinical stage biopharmaceutical company today comments on medix s recent regulatory submission for tesofensine in obesity following cofepris s decision to withhold approval medix is engaging with the agency to clarify the situation and out of respect for that process saniona will refrain from further comments on november 6 saniona announced that productos medix s a de s v medix has not yet received approval from the mexican regulatory agency cofepris for tesofensine as a treatment for obesity medix has engaged with the agency to clarify the situation and the path forward as it appears that cofepris may not yet have reviewed the full data package saniona s november 6 press release was based on a very brief update from medix since then and after a more thorough review of the communication between cofepris and medix saniona has come to understand that the agency may not yet have completed a comprehensive assessment of the data package submitted
9164,all_events,UP,,media release
3804,all_events,UP,,durham n c nov 14 2024 globe newswire humacyte inc nasdaq huma a clinical stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale today announced that it entered into a securities purchase agreement with an institutional investor to purchase approximately 15 0 million worth of its common stock and warrants to purchase common stock in a registered direct offering
6149,all_events,DOWN,,14 nov 2024 19 00 cet abionyx pharma consolidated revenue of 3 4m at the end of september 2024 cash position of 4 1m before receipt of iris pharma s cir 610k as of september 30 2024 live broadcast of the general meeting on november 28 2024 at 2 00 pm cet regulatory news abionyx pharma fr0012616852 abnx eligible for pea pme a new generation biotech company dedicated to the discovery and development of innovative therapies based on the recombinant human apolipoprotein apoa i today provides an update on its business and its cash position as of september 30 2024 selected financial information ifrs m q3 2024 q3 2023 revenue from biotech activity 0 00 0 00 revenue from iris pharma 3 41 3 60 total revenue 3 41 3 60 other revenue income and revenue 0 00 0 00 total revenue income and revenue 3 41 3 60 cash and cash equivalents at the end of the p
5847,all_events,UP,,november 08 2024 09 17 et source amber grid amber grid ab amber grid legal entity code 303090867 address laisvės ave 10 lt 04215 vilnius lithuania ab amber grid delivers results for 9 months of 2024 prepared according to the international financial reporting standards revenue for 9 months of 2024 eur 51 6 million 9 months of 2023 eur 60 7 million net profit for 9 months of 2024 eur 5 7 million 9 months of 2023 eur 15 8 million ebitda earnings before interest taxes depreciation and amortisation for 9 months of 2024 eur 19 0 million 9 months of 2023 eur 18 1 million average return on equity roe for the last 12 month as of 30 september 2024 1 as of 30 september 2023 11 ab amber grid adjusted financial indicators for 9 months of 2024 adjusted net profit for 9 months of 2024 eur 7 7 million 9 months of 2023 eur 7 6 million adjusted ebitda earnings before interest taxes depreciation and am
12864,all_events,UP,,on 26 august 2024 sp group initiated a share buy back programme cf company announcement no 12 2024 of 23 august 2024 according to the programme sp group will in the period from 26 august 2024 until 10 april 2025 purchase own shares for a maximum amount of dkk 40 0 million the share buy back programme was initiated and structured in compliance with the eu commission regulation no 596 2014 of 16 april 2014 about market abuse the so called market abuse regulation that protects listed companies board and executive board against violation of insider legislation in connection with share buy backs see attachment attachment attachments meddelelse nr 29 share buy back 15 11 24 eng pdf
6505,all_events,DOWN,,toronto april 23 2024 globe newswire revive therapeutics ltd revive or the company otcqb rvvtf cse rvv frankfurt 31r a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases medical countermeasures and rare disorders announced today that the u s food drug administration fda has granted the company s type c meeting request for the evaluation of a proposed clinical study of bucillamine an oral thiol based drug with anti inflammatory and antiviral properties as a potential treatment for long covid the meeting date assigned by the fda is june 9 2024
10270,all_events,UP,,rockaway n j aug 02 2024 globe newswire electrocore inc the company nasdaq ecor a commercial stage bioelectronic medicine and wellness company today announced that on august 1 2024 stephen smith joined electrocore as the company s vp quality regulatory and compliance and the compensation committee of electrocore s board of directors granted 10 000 restricted stock units rsus to mr smith in connection with the commencement of his employment the rsus were granted as an inducement material to mr smith s commencement of employment pursuant to nasdaq listing rule 5635 c 4 of the rsus will vest on each of the first second and third anniversaries of the date of grant subject to mr smith s continued employment by the company on the applicable vesting date
3772,all_events,UP,,malvern pa march 20 2024 globe newswire annovis bio inc nyse anvs a clinical stage drug platform company developing novel therapies for neurodegenerative diseases today announced successful completion of data cleaning for its phase ii iii study of buntanetap in patients with mild to moderate alzheimer s disease ad topline efficacy data is expected in april
6064,all_events,DOWN,,18 nov 2024 08 12 cet hawk infinity software as please find enclosed the q3 2024 financial report and presentation the quarterly results will be presented in an audio webcast at 10 00 cet tomorrow tuesday november 19th by joakim s karlsen ceo and lars revling cfo the audio webcast targets investors analysts and media attendees will be able to post questions in a q a session following the webcast to join the audio webcast and post questions please go to https teams microsoft com l meetup join 3ameeting_ztjhngy2nwitntbhos00yzzhl thmzwqtyzy0otkwzty4zgu 40thread v2 0 context 7b 22tid 3a 22f8f86bd5 66c6 40 3b a154 dcd450b42b 2c 22oid 3a 2275342a20 ad98 4028 ab89 ddd330566e 22 7d for further information please contact joakim stavnes karlsen chief executive officer tel 47 483 88 583 e mail jk hawk no lars fredrik revling chief financial officer tel 47 412 22 772 e mail lr hawk no more information access the news on oslo bor
7819,all_events,UP,,19 nov 2024 07 30 cet kid asa the shares in kid asa will be traded ex dividend nok 3 00 per share as from today 19 november 2024 this information is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act enquiries mads kigen cfo kid asa 47 952 60 507 mads kid no more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site kid asa oslo børs newspoint kid no0010743545 kid oslo børs
4740,all_events,UP,,06 nov 2024 09 41 cet huddlestock fintech as 6 11 2024 09 41 02 cet huddlestock fintech as inside information bricknode holding ab bricknode a close associate of board members stefan willebrand and erik hagelin has sold 866 248 shares in huddlestock fintech as the company or huddlestock as follows on 4 november 2024 bricknode sold 518 734 shares in the company at an average price of nok 0 47460 per share on 5 november 2024 bricknode sold 347 514 shares in the company at an average price of nok 0 4878 per share following the transactions bricknode owns and controls 17 472 663 shares in the company attached are the notifications of the transactions in accordance with the market abuse regulation article 19 disclosure regulation this information is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act contacts leif arnold thomas chief executive officer huddlestock fintech as 47 98
216,all_events,UP,DOWN,bagsværd denmark 19 november 2024 this company announcement discloses the data of the transaction s made in novo nordisk shares by the company s board members executives and their associated persons in accordance with article 19 of regulation no 596 2014 on market abuse the company s board members executives and their associated persons have given novo nordisk power of attorney on their behalf to publish trading in novo nordisk shares by the company s board members executives and their associated persons please find below a statement of such trading in shares issued by novo nordisk novo nordisk is a leading global healthcare company founded in 1923 and headquartered in denmark our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes we do so by pioneering scientific breakthroughs expanding access to our medicines and working to prevent and ultimately cure disease novo nordisk employs about 72 000 people in 80 countries and
12007,all_events,DOWN,,nasdaq vilnius decided to admit 13 600 additional bond units of sostinės bokštai to the first north market operated by nasdaq vilnius proceeding from the above the additional bonds of sostinės bokštai will be listed on october 9 2024 thus altogether 33 100 bonds with nominal value each of eur 1000 of sostinės bokštai isin lt0000407629 will be traded under the trading code herobflot26fa as from october 9 nasdaq baltic issuer services 370 5 253 1459 www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative first north markets operated by nasdaq companies in the baltic states i e nasdaq tallinn as nasdaq riga as and ab nasdaq vilnius
4457,all_events,UP,,media release
5437,all_events,DOWN,,reykjavik iceland copenhagen denmark november 6 2024 embla medical nasdaq copenhagen embla a leading global provider of innovative mobility solutions today announced that hildur einarsdóttir executive vice president of research development since 2022 has decided to leave the company early next year to pursue a new opportunity outside embla medical the search for a new executive vice president of research development is already underway sveinn sölvason president and ceo comments hildur einarsdóttir is a valued leader who has played an important part in embla medical and össur s transformation into a leading global provider of innovative mobility solutions we are grateful to hildur for her passionate commitment and many contributions to the company reflecting on her time with embla medical hildur einarsdóttir commented i m extremely proud of my 16 years with the company and the many innovations we have brought to market it has been a huge privilege to work han
7150,all_events,DOWN,,14 nov 2024 20 00 cet be semiconductor industries nv press release 141124 pdf be semiconductor euronext be semiconductor industries n v nl0012866412 besi euronext
866,all_events,UP,DOWN,dear sirs transactions with shares in sydbank by managers and closely associated persons under article 19 of the market abuse regulation sydbank makes public transactions with shares in the bank conducted by managers and persons closely associated with them reference is made to the attached table showing detailed information about the transaction yours sincerely sydbank a s attachments attachments attachment jrn adam mller pdf attachment stig westergaard pdf
12691,all_events,UP,,november 19 2024 08 00 et source digitalist group oyj digitalist group oyj digitalist group plc oy johdon liiketoimet ilmoitusvelvollinen nimi wilhelm rosenlew asema hallituksen jäsen varajäsen liikkeeseenlaskija digitalist group plc oy lei 743700al68pux6jms644 ilmoituksen luonne ensimmäinen ilmoitus viitenumero 84921 5 4 liiketoimen päivämäärä 2024 11 12 kauppapaikka nasdaq helsinki ltd xhel instrumenttityyppi osake isin fi0009008007 liiketoimen luonne luovutus liiketoimien yksityiskohtaiset tiedot 1 volyymi 440000 yksikköhinta 0 0182 eur 2 volyymi 40000 yksikköhinta 0 0186 eur 3 volyymi 40000 yksikköhinta 0 0182 eur liiketoimien yhdistetyt tiedot 3 volyymi 520000 keskihinta 0 01823 eur lisätietoja antaa digitalist group oyj toimitusjohtaja magnus leijonborg puh 46 76 315 8422 magnus leijonborg digitalistgroup com hallituksen puheenjohtaja esa matikainen puh 358 40
43,all_events,DOWN,DOWN,media release
17,all_events,DOWN,UP,18 nov 2024 13 50 cet sunndal sparebank det er fastsatt ny obligasjonsrente for no0013073007 ny obligasjonsrente i renteperioden 20 11 2024 20 02 2025 er 6 06 ticker sunsb17 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632537_fc3874d8d7ec42bb8c089f5a64ce7386 pdf sunndal sparebank oslo børs newspoint sunndal spb 21 26 frn sunndal spb 21 perp frn c hybrid sunndal spb 21 25 frn sunndal spb 22 25 frn sunndal spb 23 27 frn sunndal spb 23 28 frn sunndal spb 24 34 adj c sub sunndal spb 24 29 frn sunndal sparebank no0010989239 no0011073801 no0011156689 no0012423492 no0012820069 no0013073007 no0013214072 no0013318741 no0010672900 sunsb nordic alternative bond market euronext growth
2955,all_events,DOWN,,07 nov 2024 18 10 cet rexel rexel statement relating to the total number of shares and voting rights pursuant to article l 233 8 ii of the french commercial code and article 223 16 of the general rules of the french autorité des marchés financiers datenumber of sharesnumber of voting rights2024 10 31 298 233 069 theoretical number of voting rights 1 298 233 069exercisable number of voting rights 2 296 658 211 1 number of voting rights including treasury shares deprived from voting rights 2 number of voting rights excluding treasury shares deprived from voting rights attachment statement relating to the total number of shares and voting rights rexel statement relating to the total number of shares and voting rights pursuant to article l 233 8 ii of the french commercial code and article 223 16 of the general rules of the french autorité des marchés financiers attachment rexel globenewswire rexel fr0010451203 rxl euronext
7599,all_events,DOWN,,jerusalem nov 14 2023 globe newswire entera bio ltd nasdaq entx entera or the company a leader in the development of orally delivered peptides and small therapeutic proteins today reported corporate updates and financial results for the third quarter ended september 30th 2023
1883,all_events,DOWN,DOWN,14 nov 2024 10 40 cet spotlio as 14 11 2024 10 40 18 cet spotlio as additional regulated information required to be disclosed under the laws of a member state oslo 14 november 2024 an extraordinary general meeting of spotlio as was held on 14 november 2024 at 10 00 cet please find the minutes of the meeting attached disclosure regulation this information is subject to the disclosure requirements pursuant to euronext growth oslo rule book part ii item 3 10 1 no 8 and item 3 15 5 contacts albert ferrando ceo spotlio as 34 932 20 35 45 albert ferrando spotlio com james price cfo spotlio as 34 972 001 021 james price spotlio com about spotlio as spotlio as is a trailblazing force in destination digital technology offering tailor made solutions from apps to e commerce and almost everything in between that redefine the way consumers interact with resorts parks and attractions with a decade long legacy of excellence spotlio
9366,all_events,UP,,13 nov 2024 09 00 cet å energi as å energi as med rating a stable fra scope har mandatert seb som tilrettelegger for å undersøke muligheten for utvidelse av utstående grønne obligasjonslån eventuelt å utstede ett eller flere nye usikrede grønne obligasjonslån med flytende eller fast rente avhengig av markedsforhold forventet løpetid på denne mulige utstedelsen vil være 3 til 7 år for ytterligere informasjon vennligst kontakt stein johnsgård finanssjef 47 95 29 82 30 stein johnsgard aenergi no more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site å energi as oslo børs newspoint agder energi as 16 26 3 agder energi as 17 27 2 agder energi as 17 27 2 agder energi as 19 26 frn agder energi as 19 29 2 agder energi as 20 25 frn glitre energi as 20 25 frn a energi as 23 30 5 a energi as 23 28 5 å energi as 24 29 frn å energi as 24 27 frn å energi as 24 31
8630,all_events,UP,,04 oct 2024 07 00 cest alstom alstom note q2 and h1 2024 25 preview 4 october 2024 alstom presents below a preview to its q2 and h1 2024 25 results q2 2024 25 orders the table below summarizes the large orders more than 200m published and booked during the quarter orders value in million descriptionlink to press releaseproxima 850france 12 very high speed trains with 15y maintenancelink to the pr s bahn köln 3 600germany frame agreement of 90 trains and 34 years maintenance for 4bn o w 3 6bn to be booked in q2 and the rest at a later stage options link to the pr perth signalling 650western australia high capacity signalling project link to the pr total large orders 5 100 deals announced previously but to be booked at a later stage haifa nazareth systems contract for 700m expected booking in fy 2025 26 link to the press releasecp portugal for 700m awarded to alstom expecting end of competitors challenge expected booking in fy 2024 25
10824,all_events,UP,,funds to be used for clinical development of escharex to treat diabetic foot ulcers dfus
10962,all_events,UP,,18 nov 2024 16 09 cet sparebank 1 nordmøre i forbindelse med utstedelse av senior preferred obligasjoner den 18 november 2024 har sparebank 1 nordmøre kjøpt tilbake følgende obligasjoner med oppgjør 22 november 2024 snor36 pro isin no0012493891 volum 75 millioner snor10 pro isin no0010893464 volum 95 millioner snor32 pro isin no0010894629 volum 180 millioner kontaktperson cfo direktør økonomi og finans steinar sogn tlf 47 906 16 167 steinar sogn bank no denne opplysningen er informasjonspliktig etter verdipapirhandelloven 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sparebank 1 nordmøre oslo børs newspoint sparebank 1 nordmøre spb 1 nordvest 20 25 frn surnadal spb 20 25 frn spb 1 nordvest 20 26 1 spb 1 nordvest 21 perp frn c hybrid spb 1 nordvest 21 31 frn c sub spb 1 nordvest 21 28 frn spb 1 nordvest 21 26 frn spb 1 nordmore 21 26 frn spb 1 nordmore 2
4029,all_events,UP,,media release
5928,all_events,DOWN,,west lafayette ind april 29 2024 globe newswire inotiv inc nasdaq notv the company or inotiv a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services today announced that it will issue its financial results for the fiscal 2024 second quarter ended march 31 2024 on friday may 10 2024 before the opening of the stock market the company will host a conference call that same day at 8 30 a m eastern time to discuss the results
10504,all_events,UP,,vancouver british columbia sept 27 2023 globe newswire mydecine innovations group inc mydecine or the company neo myco otc mycof fse 0nfa a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and ptsd is pleased to announce expected admission of its common shares to begin trading on the access segment of the aqse growth market in the uk is expected to take place on october 10th 2023 the aqse growth market is a multilateral trading facility operated by aquis stock exchange a copy of the application announcement can be accessed at the following link https aqx web prod s3 public read s3 eu west 2 amazonaws com 20230926_application_announcement_1_5533c9b702 pdf
4064,all_events,UP,,tel aviv israel and miami fla nov 02 2023 globe newswire inspiremd inc nasdaq nspr developer of the cguard embolic prevention stent system eps for treatment of carotid artery disease and prevention of stroke today announced that the marvin slosman chief executive officer will participate in three upcoming investor conferences in november
7884,all_events,UP,,this press release may not be made public published or distributed directly or indirectly in or into the united states of america australia canada hong kong japan new zeeland singapore south africa south korea switzerland or any other jurisdiction in which such actions wholly or in part would be unlawful or demand additional registration or other measures please refer to important information in the end of this press release xspray pharma ab publ xspray or the company nasdaq stockholm xspray announced on 6 november 2024 a rights issue of shares of approximately sek 135 million before deduction of issue costs the rights issue a prospectus that has been prepared in connection with the rights issue has today been approved and registered by the swedish financial supervisory authority today 14 november 2024 xspray announces that the prospectus relating to the rights issue has been approved by the swedish financial supervisory authority and has been mad
10727,all_events,DOWN,,15 nov 2024 07 00 cet kongsberg automotive asa kongsberg november 15 2024 kongsberg automotive ka has secured an extension of a contract worth over eur 21 5 million in estimated lifetime revenue for fluid transfer assemblies the six year contract which will start in january 2025 is awarded by a global original equipment manufacturer oem headquartered in europe for ka s fluid transfer assemblies coolant https www kongsbergautomotive com products services on highway fluid transfer fluid transfer assemblies oil coolant line fuel https www kongsbergautomotive com products services on highway fluid transfer fluid transfer assemblies fuel line egr doser injector https www kongsbergautomotive com products services on highway fluid transfer fluid transfer assemblies water coolant lines and oil transfer https www kongsbergautomotive com products services on highway fluid transfer fluid transfer assemblies oil actuation line applications us
12057,all_events,DOWN,,as reported previously the addition of efx to glp 1 receptor agonist therapy had a safety and tolerability profile comparable to that of efx alone and led to statistically significant improvements in non invasive markers of liver injury and fibrosis and of metabolic health
7702,all_events,UP,,municipality finance plcstock exchange release 4 november 2024 at 10 00 am eet
259,all_events,UP,DOWN,on 31 october 2024 the annual general meeting of shareholders of ab akola group approved financial statements consolidated annual report and independent auditor s report for the financial year ended 30 june 2024
7562,all_events,DOWN,,aktia bank plcstock exchange release 8 november 2024 at 10 00 a m aktia bank plc managers transactions anssi huhta person subject to the notification requirementname huhta anssiposition other senior managerissuer aktia bank plclei 743700gc62jlhfbund16notification type initial notificationreference number 743700gc62jlhfbund16_20241106115439_210____________________________________________ transaction date 2024 11 06venue not applicableinstrument type shareisin fi4000058870nature of the transaction subscription transaction details 1 volume 2 067 unit price 8 36 eur aggregated transactions 1 volume 2 067 volume weighted average price 8 36 eur aktia bank plc further information oscar taimitarha director investor relations tel 358 40 562 2315 ir at aktia fi distribution nasdaq helsinki ltdmass mediawww aktia com aktia is a finnish asset manager bank and life insurer that has been creating wealth and wellbeing from one generation to the next for 200 years we
12380,all_events,UP,,achieved double digit growth in sepsis product revenue and reduced debt by approximately compared to the prior year period achieved double digit growth in sepsis product revenue and reduced debt by approximately compared to the prior year period
4098,all_events,DOWN,,media release
10801,all_events,UP,,more than 25 authorized treatment centers atcs activated globally for casgevy and multiple patients have already had cells collected
532,all_events,UP,DOWN,turku finland and boston nov 02 2023 globe newswire faron pharmaceuticals ltd aim farn first north faron a clinical stage biopharmaceutical company focused on tackling cancers via novel immunotherapies today announces that it will present phase 1 2 data from its ongoing bexmab study of bexmarilimab in combination with standard of care soc in relapsed refractory r r acute myeloid leukemia aml and myelodysplastic syndromes mds patients having failed hypomethylating agents hmas at the 65th american society of hematology ash annual meeting
5835,all_events,UP,,media release
5957,all_events,UP,,hpn217 was well tolerated and demonstrated robust and durable clinical activity at doses ranging from 2 15 to 24 mg in heavily pre treated patients including patients with prior exposure to bcma targeted therapy
10029,all_events,DOWN,,dallas sept 26 2024 globe newswire taysha gene therapies inc nasdaq tsha taysha or the company a clinical stage biotechnology company focused on advancing adeno associated virus aav based gene therapies for severe monogenic diseases of the central nervous system cns today announced that it will present previously disclosed clinical data on its tsha 102 program in evaluation for rett syndrome during an oral presentation at the upcoming 9th world rett syndrome congress taking place in queensland australia from october 2 5 2024
11566,all_events,UP,,media release
8145,all_events,UP,,media release
11032,all_events,DOWN,,19 nov 2024 13 47 cet ovh groupe see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1298867_2024_11_19__ovhcloud__mise__disposition_deu_fy24 pdf ovh les echos ovh fr0014005hj9 ovh euronext
11892,all_events,DOWN,,liitteet 10111329 pdf alma media 11 10 trades xlsx
11577,all_events,DOWN,,07 nov 2024 17 45 cet lacroix group consolidated revenue of 494 2 million for the first 9 months of fy 2024 down 6 on a like for like basis a 3rd quarter 9 on a like for like basis reflecting the situation in north america and the downturn in the automotive market continued positive momentum for the activity environment annual targets confirmed 3rd quarter in line with trends announced at first half results in the 3rd quarter of the year lacroix recorded consolidated revenue of 143 9 million euros m compared to 172 5 m a year earlier as a reminder this consolidated revenue does not include the city mobility segment which has been treated as a discontinued operation as it is currently in the process of being sold in addition the 16 decline in group sales over the period is reduced to 9 on a like for like basis i e excluding the road signs segment which will be deconsolidated on april 30 2024 following its definitive divestment over the
4793,all_events,DOWN,,media release
9192,all_events,DOWN,,14 nov 2024 08 00 cet höegh evi ltd hamilton bermuda 14 november 2024 höegh evi ltd höegh evi today reports its interim financial results for the quarter ended 30 september 2024 the group reported an ebitda of usd 83 million for the third quarter of 2024 compared to usd 75 million for the preceding quarter subsequent to the quarter end höegh evi closed a new 7 year loan facility of usd 625 million consisting of a usd 375 million term loan and a usd 250 million revolving credit line the proceeds from the term loan tranche have been applied to repay the outstanding amounts under the existing debt facilities for hoegh giant höegh grace and höegh gallant höegh evi continues to develop its clean energy business in november höegh evi and port la nouvelle announced the signing of an mou to develop a floating terminal for hydrogen imports in france the terminal will facilitate the import of up to 210 000 tonnes of hydrogen per year as early as 2030 accord
12669,all_events,UP,,media release
577,all_events,UP,DOWN,18 oct 2024 22 30 cest dbv technologies châtillon france october 18 2024 dbv technologies to participate in upcoming acaai 2024 congress dbv technologies euronext dbv isin fr0010417345 nasdaq stock market dbvt a clinical stage biopharmaceutical company today announced upcoming participation at the american college of allergy asthma immunology acaai annual scientific meeting october 24 28th 2024 in boston massachusetts this year s meeting will feature a product theater on what defines an optimal peanut allergy treatment during this panel discussion drs shahzad mustafa edwin kim julia upton and ceo of food allergy research and education faact eleanor garrow holding will engage in a discussion around hallmarks of an optimal treatment for peanut allergy focusing on the goals of efficacy safety and practicality the product theater is scheduled for saturday october 26th from 11 35 a m to 1 00 p m edt dbv is also sponsoring the 33rd an
12044,all_events,DOWN,,october 02 2024 11 03 et source faruqi faruqi llp faruqi faruqi llp faruqi faruqi llp securities litigation partner james josh wilson encourages investors who suffered losses exceeding 100 000 in stellantis to contact him directly to discuss their options if you suffered losses exceeding 100 000 in stellantis between february 15 2024 and july 24 2024 and would like to discuss your legal rights call faruqi faruqi partner josh wilson directly at 877 247 4292 or 212 983 9330 ext 1310 you may also click here for additional information neww york oct 02 2024 globe newswire faruqi faruqi llp a leading national securities law firm is investigating potential claims against stellantis n v stellantis or the company nyse stla and reminds investors of the october 15 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the company faruqi faruqi i
6997,all_events,UP,,15 nov 2024 13 45 cet skue sparebank det er fastsatt ny obligasjonsrente for no0010875461 ny obligasjonsrente i renteperioden 19 11 2024 19 02 2025 er 5 37 ticker skue23 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632401_b26dab4ff1e646eb9335efba043f56ab pdf skue sparebank oslo børs newspoint skue sparebank skue spb 20 25 frn skue spb 21 31 frn c sub skue spb 21 26 frn skue spb 21 perp frn c hybrid skue spb 22 25 frn skue spb 22 27 frn skue spb 22 perp adj c hybrid skue spb 22 28 frn skue spb 23 perp frn c hybrid skue spb 23 27 frn skue spb 23 28 frn skue spb 24 29 frn skue spb 24 27 frn no0006001809 no0010873565 no0010875461 no0010935505 no0010977200 no0011031296 no0011031304 no0
6886,all_events,UP,,south san francisco calif june 27 2023 globe newswire harpoon therapeutics inc nasdaq harp a clinical stage immuno oncology company developing novel t cell engagers today announced the completion of planned patient enrollment in the phase 1 dose escalation study evaluating the safety tolerability and pharmacokinetics of hpn217 in patients with relapsed refractory multiple myeloma additional patients currently in screening will also be allowed to enroll
5627,all_events,UP,,san diego nov 07 2024 globe newswire cidara therapeutics inc nasdaq cdtx the company a biotechnology company using its proprietary cloudbreak platform to develop drug fc conjugate dfc immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases today reported financial results for the third quarter ended september 30 2024 and provided an update on its corporate activities and product pipeline
9830,all_events,DOWN,,06 nov 2024 09 12 cet bergen kommune oslo børs has received an application for isin no0013388439 to be admitted to stock exchange listing the market abuse regulation mar applies from the time the application has been made including the issuer s disclosure obligation on inside information more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site bergen kommune oslo børs newspoint bergen komm 22 25 frn bergen komm 22 26 frn bergen komm 22 27 3 68pct bergen komm 23 28 3 52pct bergen komm 23 25 3 bergen komm 23 25 frn bergen komm 23 25 4 bergen komm 23 26 4 bergen komm 24 26 frn bergen komm 24 27 3 no0012436288 no0012550138 no0012550146 no0012781907 no0012816844 no0012877374 no0012947458 no0013066910 no0013073627 no0013197665 no0013220830 no0013260950 no0013334086 oslo børs
761,all_events,DOWN,DOWN,media release
4772,all_events,UP,,15 nov 2024 16 50 cet agilyx asa 15 november 2024 reference is made to the announcement made by agilyx asa the company on 11 november 2024 the company is pleased to announce the successful placement of a usd 50 million senior secured green bond issue with a tenor of 3 years the bond with a fixed rate coupon of 13 per annum with quarterly interest payments underscores investor confidence in agilyx s growth and strategy the bond will be subscribed at a price of of nominal value net proceeds from the bond issue will be used to i fund capital calls related to the development and building of ccc 2 and ii general corporate purposes of the group the bond issue will fully replace the usd 40 million senior secured debt financing guaranteed by dnb markets a part of dnb bank asa dnb markets acted as manager in the bond issue for further information please contact investors agilyx com about agilyx agilyx asa is at the forefront of plastic waste rec
796,all_events,DOWN,UP,boca raton florida nov 13 2024 globe newswire inmune bio inc nasdaq inmb the company a clinical stage inflammation and immunology company focused on developing treatments that harness the patient s innate immune system to fight disease announced today that it completed randomization of patients for its phase 2 trial on monday november 11th this global blinded randomized phase 2 trial the ad02 trial is focused on patients with early ad and biomarkers of elevated neuroinflammation
4663,all_events,UP,,06 nov 2024 18 21 cet broadpeak s a revenue of 8 7m over the period up 10 at the end of september group revenue totalled 25 8m 0 growth of 8 in the biggest contributors to revenue over 9 months licenses services maintenance saas good visibility for year end thanks to orders already confirmedannual targets and ambitions for 2027 confirmed cesson sévigné france 6 november 2024broadpeak isin fr001400ajz7 ticker albpk a leading provider of video streaming software solutions is reporting its third quarter and 9 month 2024 revenue revenue in k 9m 20239m 2024changeq3 2023q3 2024changeemea11 05512 074 9 3 6784 428 20 americas11 22210 892 2 3 7392 595 30 apac3 6732 881 21 4731 658 250 total25 95025 847 0 7 8908 680 10 licenses services12 57112 327 1 2 9654 319 45 maintenance saas9 22611 270 22 3 1943 854 20 equipment4 1542 250 45 1 729507 70 at 30 september 2024 group revenue totalled 25 8m virtually unchanged
11609,all_events,UP,,media release
10705,all_events,DOWN,,18 nov 2024 07 00 cet lexibook linguistic elect sys lexibook sales s1 24 25 24 6m vs 22 2m 2 4m operating income 2 5m 1 1m vs s1 23 24 due to increased advertising expenses 1 2m and changes in method of accounting for certain provisions net profit withdrawn to 2 4m vs 3 1m in 23 24 over the half year sales in europe excluding france were unchanged on the same period last year while sales in france were up on h1 23 24 sales in the rest of the world rose sharply driven in particular by growth in the united states revenues from licensed products rose by non licensed products also grew by sales of licensed products account for 2 3 of total sales a proportion consistent with sales for fiscal year 2023 2024 advertising spend for the half year was up 2 9m vs 1 7 in h1 2023 24 gross margin margin 1 rose to 15 0m vs 12 8m for h1 2023 24 2 1m mainly influenced by sales growth margin 4 net was impacted by gr
11175,all_events,UP,,the enefit green group s operating income for q3 2024 decreased by while operating expenses excl d a decreased by compared to the same period last year as a result ebitda decreased by to 15 7m net profit for the period increased by 0 4m to 5 4m earnings per share 0 021
10950,all_events,DOWN,,media release
10631,all_events,DOWN,,phase 3 synchrony studies actively screening and on track to begin enrolling by the end of 2023 south san francisco calif nov 13 2023 globe newswire akero therapeutics inc nasdaq akro a clinical stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need today reported third quarter financial results for the period ending september 30 2023 and provided business updates
1941,all_events,UP,DOWN,mainz biomed reports positive topline results from pooled study evaluating novel mrna biomarkers and proprietary ai algorithm
8842,all_events,UP,,topline results expected in early january 2025 topline results expected in early january 2025
6291,all_events,DOWN,,14 nov 2024 20 00 cet be semiconductor industries nv press release 141124 pdf be semiconductor euronext be semiconductor industries n v nl0012866412 besi euronext
2471,all_events,DOWN,UP,rapt to host a conference call today at 8 30 am et
9478,all_events,UP,,media release
12000,all_events,DOWN,,media release
3369,all_events,UP,,qiagen and mcgill university to collaborate on microbiome research projects to generate evidence based knowledge for medicine and public health mcgill will serve as a beta testing site for new qiagen microbiome solutions partnership strengthens qiagen s efforts in microbiome research while supporting innovation at the mcgill centre for microbiome research qiagen and mcgill university to collaborate on microbiome research projects to generate evidence based knowledge for medicine and public health mcgill will serve as a beta testing site for new qiagen microbiome solutions partnership strengthens qiagen s efforts in microbiome research while supporting innovation at the mcgill centre for microbiome research
5424,all_events,DOWN,,toronto march 19 2024 globe newswire revive therapeutics ltd revive or the company otcqb rvvtf cse rvv frankfurt 31r a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders announced today that the fda advised the company to submit a type c meeting request to discuss evaluating a proposed phase 2 clinical study of bucillamine an oral thiol based drug with anti inflammatory and antiviral properties as a potential treatment for long covid the company expects to submit the type c meeting request by next week
11311,all_events,UP,,media release
3613,all_events,UP,,07 nov 2024 17 50 cet roctool roctool roctool information mensuelle relative au nombre total de droits de vote et actions composant le capital social 07 nov 2024 17 50 cet cest information réglementaire transmise par eqs group le contenu de ce communiqué est de la responsabilité de l émetteur communiqué de presse jeudi 07 novembre 2024 information mensuelle relative au nombre total de droits de vote et actions composant le capital social article 223 16 du règlement général de l autorité des marchés financiers place de cotation euronext growth paris mnémonique alroc éligible pea pme code isin fr0010523167 site web www roctool com date nombre total d actions composant le capital social nombre total de droits de vote 31 juillet 2024 6 801 186 7 719 741 contacts relations investisseurs presse aelyon advisors jerome gacoin valentine boivin 33 1 75 77 54 65 roctool aelium fr fichier pdf dépôt réglementai
6247,all_events,DOWN,,san diego feb 12 2024 globe newswire cidara therapeutics inc nasdaq cdtx a biotechnology company using its proprietary cloudbreak platform to develop drug fc conjugate dfc immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases today announced receipt of an 11 14 million milestone payment from mundipharma following the european approval of rezzayo rezafungin acetate a novel once weekly echinocandin antifungal approved for the treatment of invasive candidiasis in adults
8653,all_events,DOWN,,media release
1041,all_events,UP,UP,immunocore reports third quarter financial results and provides a business update
2221,all_events,DOWN,DOWN,media release
10581,all_events,UP,,san diego april 24 2024 globe newswire bioatla inc nasdaq bcab a global clinical stage biotechnology company focused on the development of conditionally active biologic cab antibody therapeutics for the treatment of solid tumors today announced a poster presentation at the upcoming 2024 american society of clinical oncology asco annual meeting to be held virtually and at the mccormick place convention center in chicago illinois from may 31 june 4 2024
8504,all_events,UP,,arcutis today announced that management will participate in the morgan stanley 22nd annual global healthcare conference
12083,all_events,DOWN,,vilnius lithuania 2024 10 07 08 00 cest for more information please visit full investor calendar https nasdaqbaltic com statistics en calendar nasdaq baltic issuer services 370 525 31459 vilnius 371 672 12431 riga 372 640 8800 tallinn https www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative markets first north operated by nasdaq companies in the baltic states i e nasdaq tallinn as nasdaq riga as and ab nasdaq vilnius
8443,all_events,UP,,media release
3540,all_events,UP,,media release
12852,all_events,UP,,liitteet 10111285 pdf relais 11 10 trades xlsx
960,all_events,DOWN,DOWN,this notice is published with reference to the initial public offering of the shares of eleving group eleving and should be read in conjunction with eleving s public offering listing and admission to trading prospectus dated 20 september 2024 the prospectus together with eleving s notification on the results of the initial public offering of its shares and final price dated 9 october 2024 eleving informs that during the stabilisation period from 16 october 2024 to 14 november 2024 the following stabilisation measures on following conditions were carried out by lhv pank as as the stabilising agent acting based on instructions by stabilising manager signet bank as for each of the dates during the stabilisation period when stabilisation transactions were carried out the price range and volume were the following stabilisation transaction s further enquiries stabilising manager aleksejs generalovs signet bank as head of brokerage division e mail aleksejs g
2507,all_events,DOWN,DOWN,media release
5130,all_events,DOWN,,12 nov 2024 00 31 cet arctic fish holding as arctic fish holding as afish announces that stein ove tveiten ceo has informed the company s board of directors of his decision to step down from his role serving as ceo of arctic fish has been an incredible journey over the past seven years i ve had the privilege of working with a fantastic team and witnessing rapid and substantial growth for both the company and the industry as a whole it has been an honor to serve in this role and i believe arctic fish and iceland are uniquely positioned for continued growth and sustainable development said tveiten the chairman of the board øyvind oaland commented stein ove has dedicated a lot of efforts and time into arctic fish and is handing over a company with solid volume development and great future growth projections we are highly appreciative of his contribution the board of directors will commence the recruitment process for a new ceo tveiten will continu
5727,all_events,UP,,san diego sept 12 2023 globe newswire anaptysbio inc nasdaq anab a clinical stage biotechnology company focused on delivering innovative immunology therapeutics today announced that daniel faga president and chief executive officer and dr paul lizzul chief medical officer will present at the stifel 2023 immunology and inflammation virtual summit later this month
883,all_events,DOWN,UP,07 nov 2024 18 40 cet eutelsat communications regulatory news eutelsat communications isin fr0010221234 euronext paris london stock exchange etl a signé un contrat de liquidité avec bnp paribas exane le 1er décembre 2007 les ressources en espèces et en instruments financiers allouées à la mise en œuvre du contrat de liquidité ont été réexaminées sur la base des données de marché au 1er juillet 2024 afin que les ressources restent proportionnées et adaptées aux objectifs du contrat conformément à la décision amf n 2021 01 du 22 juin 2021 il a été décidé un réajustement des ressources en titres par conséquent un retrait de 175 000 cent soixante quinze mille titres a été réalisé pour rappel lors du dernier bilan semestriel en date du 1er juillet 2024 les moyens suivants figuraient au compte de liquidité 497 082 titres eutelsat communications 890 555 à propos d eutelsat communications eutelsat group est l un des principaux opérateurs mo
4257,all_events,UP,,november 06 2024 01 30 et source sampo oyj sampo oyj sampo oyj pörssitiedote 6 11 2024 klo 8 30 sampo oyj n omien osakkeiden ostot 5 11 2024 sampo oyj y tunnus 0142213 3 lei 743700uf3rl386wida22 on hankkinut omia a osakkeitaan isin koodi fi4000552500 omistukseensa 5 11 2024 seuraavasti kahden desimaalin tarkkuuteen pyöristettynä sampo ilmoitti 17 6 2024 enintään 400 miljoonan euron suuruisen omien osakkeiden osto ohjelman käynnistämisestä markkinoiden väärinkäyttöasetuksen eu 596 2014 mar ja euroopan komission delegoidun asetuksen eu 2016 1052 mukaisesti sampo oyj n hallitus päätti 16 9 2024 kasvattaa omien osakkeiden osto ohjelmaa 475 miljoonaan euroon 18 6 2024 aloitetulla osto ohjelmalla on sammon varsinaisen yhtiökokouksen 25 4 2024 myöntämä valtuutus sammon omistuksessa on nyt ilmoitettujen transaktioiden jälkeen 10 055 400 sammon a osaketta mikä on 1 83 prosenttia sampo oyj n kaikista lii
10087,all_events,UP,,media release
8878,all_events,UP,,media release
6339,all_events,UP,,ab ignitis grupė hereinafter the group announces its financial calendar for 2025 including the dates of the general meetings of shareholders in addition the group expects to announce the strategic plan 2025 2028 in q2 2025 the group expects to announce its financial results at around 9 00 am vilnius 7 00 am london time on the above mentioned dates upon its publication the group will organize earnings calls for investors and analysts the group will inform about each earnings call separately through the stock exchanges the owners of global depositary receipts representing the group s ordinary registered shares hereinafter gdr should consider the specifics of gdr regulation market differences and consult with gdr issuer the bank of new york mellon link its authorized party or their securities manager regarding the timing of the right to receive dividends and other relevant aspects the group will notify in due time the market of any changes to the above infor
3455,all_events,UP,,certara completes acquiring chemaxon a leading cheminformatics company that develops scientific informatics software used by the life sciences industry
9322,all_events,DOWN,,november 18 2024 08 16 et source pandora a s pandora a s in accordance with section 30 of the capital markets act pandora a s hereby announces thatblackrock inc has notified the company of its control over voting rights for 7 225 900 shares representing 8 of the total share capital and voting rights previously 8 additionally blackrock inc controls voting rights attached to financial instruments amounting to 1 previously 1 in total blackrock inc controls 10 of the company s voting rights previously 9 about pandorapandora is the world s largest jewellery brand the company designs manufactures and markets hand finished jewellery made from high quality materials at accessible price points pandora jewellery is sold in more than 100 countries through 6 700 points of sale including more than 2 600 concept stores headquartered in copenhagen denmark pandora employs 33 000 people worldwide and crafts its
4094,all_events,UP,,vilnius lithuania 2024 11 18 09 31 cet sun investment group bondholders isin lt0000313256 issued in 2023 can conveniently exchange their current bonds into the new ones isin lt0000409963 by subscribing the newly issued bonds and settling the payment with the nominal value of the existing bonds after completing this action the coupon for your currently held bonds isin lt0000313256 will be fully paid out on november 29 on the same day the new bonds isin lt0000409963 will become valid all or part of existing bonds can be exchanged before november 22 2024 3 30 pm this exchange can be carried out in the bank that holds your securities account lhv swedbank seb bank or others the allocation of the newly issued bonds will follow a first come first served principle key bond issue details for more information and full documentation click here the recording of the investor call is available in the following link presentation can be downloaded here
6654,all_events,DOWN,,consortium includes top universities hospitals and industry partners led by the francis crick institute and the royal marsden nhs foundation trust
7174,all_events,DOWN,,14 nov 2024 10 00 cet atos se paris france november 14 2024 eviden the atos group business leading in advanced computing today announces the launch of bxi v3 the third generation of the only european scale out networking technology specifically designed for artificial intelligence ai and high performance computing hpc workloads set to be available in the second half 2025 ai and hpc domains are witnessing an exponential increase in compute power with exascale1 workloads trillion parameters large language models being developed in contrast scale out networking the backbone of the system has not seen the same performance improvements which represents a networking wall for advancing ai hpc science and requires a radically different approach to address this challenge eviden has developed the third generation of its patented bullsequana exascale interconnect bxi v3 in partnership with the french cea atomic energy commission and alternative energies
6728,all_events,DOWN,,filed pursuant to rule 433
11393,all_events,DOWN,,november 15 2024 15 30 et source nokia oyj nokia oyj nokia corporationstock exchange release15 november 2024 at 22 30 eet nokia corporation repurchase of own shares on 15 11 2024 espoo finland on 15 november 2024 nokia corporation lei 549300a0jprwg1ki7u06 has acquired its own shares isin fi0009000681 as follows rounded to two decimals on 25 january 2024 nokia announced that its board of directors is initiating a share buyback program to return up to eur 600 million of cash to shareholders in tranches over a period of two years the first phase of the share buyback program started on 20 march 2024 on 19 july 2024 nokia decided to accelerate the share buybacks by increasing the number of shares to be repurchased during the year 2024 the post increase repurchases in compliance with the market abuse regulation eu 596 2014 mar the commission delegated regulation eu 2016 1052 and under the authorization granted by nokia s annua
3405,all_events,UP,,media release
3611,all_events,DOWN,,19 nov 2024 07 56 cet avance gas holding ltd bermuda november 19 2024 avance gas holding ltd ticker agas will on wednesday november 27 2024 release its unaudited results for the third quarter of 2024 in connection with the earnings release an audio webcast and conference call will be held at 14 00 cest the presentation and webcast link will be available from the investor relation section at avance gas website www avancegas com prior the presentation and available by using the following links webcast https edge media server com mmc p j6q2r66p conference call https register vevent com register bid9585c6a8c7a46fdaad8f2f978059a2d a q a session will be held after the conference call webcast for further queries please contact randi navdal bekkelund cfo telephone 47 23 11 40 00 email ir avancegas com about avance gas avance gas operates in the global market for transporting liquefied petroleum gas lpg in august 2024 the company entered i
8297,all_events,UP,,05 nov 2024 18 00 cet getlink se regulatory news getlink se paris get déclarant raison sociale getlink se société européenne rcs paris 483 385 142 37 39 rue de la bienfaisance 75008 paris nombre d actions ordinaires composant le capital social 1 550 000 000 nombre de droits de vote théoriques 2 3 785 003 809 date 31 octobre 2024 nombre des droits de vote exerçables au 31 octobre 2024 hors actions privées de droit de vote 776 417 661 1 le capital social est divisé en 550 000 000 actions ordinaires d une valeur nominale de 0 40 euro chacune 2 nombre théorique calculé sur la base de l ensemble des actions ordinaires y compris les actions privées de droit de vote 3 l article 11 des statuts de la société prévoit un droit de vote double des actions ordinaires pour lesquelles il est justifié d une inscription nominative depuis deux ans au nom du même actionnaire con
7171,all_events,UP,,15 nov 2024 14 27 cet landkreditt bank as landkreditt bank a stable fra scope har i dag utvidet isin no0013387282 landk61 pro med 100 mnok det er da 300 mnok utestående i det åpne lånet med en ramme på 1 0 mrd sparebank 1 markets var tilrettelegger av transaksjonen oslo 15 november 2024 kontaktperson landkreditt bank as per bjarne kvande finanssjef tlf 23 00 08 16 95 25 58 17 denne opplysningen er informasjonspliktig etter verdipapirhandelloven 5 12 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site landkreditt bank as oslo børs newspoint landkreditt bank as 20 25 frn landkreditt bank as 21 26 frn landkreditt bank as 22 perp frn c hybrid landkreditt bank as 23 33 frn c sub landkreditt bank as 23 perp frn c hybrid landkreditt bank as 23 28 frn landkreditt bank as 23 34 frn c sub landkreditt bank as 24 29 4 no0010890056 no0011123564 no0012433293 no0012834904 n
6492,all_events,UP,,13 nov 2024 08 18 cet sparebank 1 smn not for release publication or distribution in whole or in part directly or indirectly in or into the united states australia canada hong kong japan or any jurisdiction in which such release publication or distribution would be unlawful this announcement is not an offer of securities and the securities referred to herein may not be offered or sold in the united states absent registration except pursuant to an exemption from or in a transaction not subject to the registration requirements of the u s securities act any public offering of such securities to be made in the united states will be made by means of a prospectus that may be obtained from the company which would contain detailed information about the company and management as well as financial statements there will be no public offering of the securities in the united states reference is made to the stock exchange notice published on 11 november 2024 regard
4012,all_events,DOWN,,vilnius lithuania 2024 11 06 08 02 cet omx baltic benchmark fund share price on november 05 2024 12 9411 eur omx baltic benchmark fund number of shares issued on november 05 2024 0 units omx baltic benchmark fund number of shares redeemed on november 05 2024 0 units the total number of omx baltic benchmark fund shares admitted to trading as of november 05 2024 125 362 units nter asset management
1160,all_events,UP,UP,media release
11673,all_events,UP,,november 13 2024 12 00 et source idex biometrics asa idex biometrics asa reference is made to the stock exchange announcement issued by idex biometrics asa the company on 17 september 2024 regarding the successful private placement of 466 666 666 new shares private placement and the private placement shares and the possible subsequent offering of up to 140 000 000 new shares subsequent offering and the subsequent offering shares as stated in the announcement on 17 september 2024 the listing of the private placement shares and the offering and listing of the subsequent offering shares remained subject to approval of a prospectus prospectus by the financial supervisory authority of norway fsa and the subsequent publication of such prospectus by the company further the admission to trading of warrants issued to participants in the private placement and the subsequent offering as well as the listing of certain shares
7654,all_events,UP,,hms networks ab publ har idag slutfört det sedan tidigare aviserade förvärvet av samtliga aktier i peak system technik gmbh peak system en väletablerad tysk leverantör av industriella kommunikationslösningar
10400,all_events,UP,,media release
12465,all_events,UP,,modera as i annab teada et ettevõtte juhatuse esimees raido toonekurg lahkub omal soovil juhatusest alates 2025 aasta 15 jaanuarist et keskenduda uutele isiklikele ja professionaalsetele väljakutsetele modera as i nõukogu esimees siim vips me oleme tänulikud tema panuse eest mille tulemusel on ettevõte kogenud märkimisväärset kasvu ja arengu kiirenemist raido toonekurg on juhtinud moderat alates 2020 aastast mil ettevõte on teinud läbi märkimisväärse arenguhüppe viimase nelja aasta jooksul on modera as i käive kasvanud kolm korda ning platvormi kaudu müüdud autode arv ületanud 113 000 sõiduki piiri kasvades enam kui neli korda modera as i nõukogu esimees siim vips modera as i börsidebüüt ipoga 2021 aastal ja sellele järgnenud edukas võlakirja emissioon näitavad tugevat usaldust ettevõtte vastu aktsionäride ja investorite seas samuti on ettevõte edukalt ellu viinud mitmeid strateegiliselt olulisi projekte modera as on täna tugev ja heas seisus mistõtt
2154,all_events,UP,UP,19 nov 2024 08 30 cet compagnie du bois sauvage see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1298399_2024_11_19_cbs_rap_fr pdf compagnie bois sauvage les echos cie bois sauvage be0003592038 comb euronext
10484,all_events,UP,,02 oct 2024 07 00 cest lifecare asa bergen norway 2 october 2024 today lifecare asa life a clinical stage medical sensor company developing the next generation continuous glucose monitor cgm can announce that we have completed a successful production based on automated processes of our glucose sensor sencell reference is made to the q2 report when the company described the necessary steps of preparations towards automated production lifecare manufacturing department has successfully executed production of sencell sensors at our laboratory in reutlingen based on automated processes these processes will now be repeated at our production facilities in mainz at the end of the 1st quarter we reached our goal of successful pilot production of sencell we have now automated the most critical steps in the production process transitioning from partially hand made sensors towards automated production the achievement demonstrates our ability to conduct auto
6824,all_events,DOWN,,14 nov 2024 12 18 cet 2crsi s a 2crsi sa 2crsi sa monthly information regarding the total number of voting rights and shares comprising the share capital as of october 31 2024 14 nov 2024 12 18 cet cest dissemination of a french regulatory news transmitted by eqs group the issuer is solely responsible for the content of this announcement press release monthly information regarding the total number of voting rights and shares comprising the share capital as of october 31 2024 article l 233 8 ii of the french commercial code and article 223 16 of the general regulation of the autorité des marchés financiers amf date total number of shares comprising the share capital total number of theoretical voting rights total number of exercisable voting rights1 31 10 2024 22 306 095 30 885 627 30 863 646 1 number of exercisable voting rights total number of voting rights attached to the total number of shares minus the number of shares d
2837,all_events,DOWN,,media release
4256,all_events,DOWN,,media release
8255,all_events,UP,,media release
7606,all_events,DOWN,,jupiter fla may 30 2024 globe newswire dyadic international inc dyadic or the company nasdaq dyai a biotechnology company focused on the efficient large scale manufacture of proteins for use in human and animal vaccines and therapeutics as well as non pharmaceutical applications including food nutrition and wellness today announced that its management will be attending the following industry events during june 2024
3194,all_events,UP,,media release
4335,all_events,DOWN,,media release
1147,all_events,DOWN,DOWN,13 nov 2024 10 38 cet luster sparebank kvartalsrapport for luster sparebank pr 30 09 2024 vedteken i styremøte 12 november 2024 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632045_kvartalsrapport luster sparebank 30 09 2024 pdf pdf luster sparebank oslo børs newspoint luster spb 21 26 frn luster spb 21 25 frn no0010993033 no0011036766 no0011150534 nordic alternative bond market
5961,all_events,DOWN,,19 nov 2024 19 13 cet synergie acquisition of the minority shareholder s stake in synergie italia synergie acquires full ownership in synergie italia and continues to grow on this strategic market synergie is happy to announce the acquisition of its minority shareholder s stake in synergie italia further strengthening its position in the italian recruitment and human resources solutions market this strategic move represents a key milestone in our international growth and reflects our commitment to keep delivering innovative high quality solutions to our clients it reinforces our ability to address the specific needs of the italian market this takeover is the result of a successful organic growth and represents a major achievement for our group synergie italia is now better positioned to capitalize on growth opportunities in italy and to continue innovating in the field of human resources solutions on a very dynamic market next meetings publication of 2024 revenue on
10228,all_events,DOWN,,14 nov 2024 07 00 cet eqva asa 14 november 2024 eqva asa ose eqva delivered strong performance in the third quarter of 2024 our consolidated statement of profit and loss shows a ytd group revenues of nok 751 million demonstrating a growth of 59 percent compared to the corresponding period in 2023 nok 471 million adjusted for discontinued operations the ytd ebitda was nok 70 million nok 26 million same period in 2023 adjusted for discontinued operations the ebitda margin was 9 3 percent up from 5 5 percent ytd q3 2023 after the acquisition of kvinnherad elektro and vassnes group we have prepared our third quarter presentation on a pro forma basis as if the acquisition was from the beginning of the year following eqva shows a pro forma ytd group revenues of nok 935 million nok 602 million the ytd ebitda was nok 79 million nok 26 million same period 2023 the ebitda margin was 8 4 percent up from 4 3 percent same period 2023 eqva s main operational
6822,all_events,UP,,media release
5328,all_events,DOWN,,07 nov 2024 22 10 cet genfit trésorerie et équivalents de trésorerie s élevant à 96 0 millions d euros au 30 septembre 202459 7 millions d euros de revenus des neuf premiers mois de 2024 dont 48 7 millions d euros de paiement d étape facturés en juin 2024 reçu en août 2024 lors de la première vente d iqirvo élafibranor d ipsen aux états unis pour le traitement de la cholangite biliaire primitive pbc lille france cambridge massachusetts états unis zurich suisse le 7 novembre 2024 genfit nasdaq et euronext gnft société biopharmaceutique de stade clinique avancé engagée dans l amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le pronostic vital annonce aujourd hui sa trésorerie au 30 septembre 2024 et son chiffre d affaires pour les neuf premiers mois de 20241 situation de trésorerie au 30 septembre 2024 la trésorerie et les équivalents de trésorerie de la société s élevaient à 96 0 millions d euros contre 61 6 m
11097,all_events,DOWN,,media release
9157,all_events,UP,,14 nov 2024 08 00 cet norlandia health care group 13 november 2024 the board of directors of norlandia health care group as has approved the unaudited group financial results for the third quarter of 2024 please find attached the q3 2024 interim report for further information please contact yngvar tov herbjørnssønn ceo 47 91 83 71 89 roger larsen cfo 47 90 63 73 29 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632157_nhc q324 financial report pdf norlandia health care group as oslo børs newspoint norlandia healt as 24 28 frn sek floor c norlandia health as 24 28 frn floor c no0013266684 no0013266676 oslo børs
9095,all_events,DOWN,,riga latvia 2024 11 18 08 00 cet for more information please visit full investor calendar https nasdaqbaltic com statistics en calendar nasdaq baltic issuer services 370 525 31459 vilnius 371 672 12431 riga 372 640 8800 tallinn https www nasdaqbaltic com nasdaq baltic is a common name for exchanges regulated markets alternative markets first north operated by nasdaq companies in the baltic states i e nasdaq tallinn as nasdaq riga as and ab nasdaq vilnius
3353,all_events,UP,,media release
7583,all_events,UP,,adelaide australia and cambridge mass may 31 2024 globe newswire bionomics limited nasdaq bnox bionomics or the company a clinical stage biotechnology company developing novel potential first in class allosteric ion channel modulators to treat patients suffering from serious central nervous system cns disorders with high unmet medical need today announced it has entered into a securities purchase agreement with an institutional accredited investor to purchase american depository shares ads or pre funded warrants in lieu thereof and accompanying warrants in a three tranche private placement
12815,all_events,DOWN,,media release
2906,all_events,DOWN,,principaux éléments financiers pour les neuf premiers mois de l exercice 2024
2328,all_events,DOWN,DOWN,13 nov 2024 10 38 cet luster sparebank kvartalsrapport for luster sparebank pr 30 09 2024 vedteken i styremøte 12 november 2024 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632045_kvartalsrapport luster sparebank 30 09 2024 pdf pdf luster sparebank oslo børs newspoint luster spb 21 26 frn luster spb 21 25 frn no0010993033 no0011036766 no0011150534 nordic alternative bond market
3116,all_events,DOWN,,copenhagen denmark june 17 2024 globe newswire evaxion biotech a s nasdaq evax evaxion or the company a clinical stage techbio company specializing in developing ai immunology powered vaccines announces publication of data from its phase 1 dose escalation study of its lead personalized cancer vaccine candidate evx 01 for metastatic melanoma the study results published in the journal for immunotherapy of cancer demonstrated that eight out of 12 patients experienced objective clinical responses orr with six partial and two complete responses further evx 01 immunization did not induce vaccine related serious adverse events in patients co administered with anti pd1 therapy
7821,all_events,UP,,12 nov 2024 14 00 cet avinor as 4 7 million passengers traveled to and from avinor s airports in october this is an increase of 4 percent compared to october 2023 there is also a 4 percent increase in the number of passengers when looking at the figures for the year so far in october there was an increase in both domestic and international travelers compared to october last year the number of international travelers continues to increase the most with a 6 percent growth in october this is a growth we have seen for a while so far this year the growth among international travelers is a whole 8 percent the growth among domestic travelers is at 3 percent the overall traffic growth is 1 percent higher than the forecast for october and 1 percent higher than the forecast for the year so far fuller flights there was also an increase among domestic travelers in september and the trend has been positive through october in this market as well this means that
1501,all_events,DOWN,DOWN,in week 46 heimar hf heimar purchased 4 000 000 own shares at a total purchase price of 137 700 000 isk as follows the transactions are in accordance with heimar s buyback program which was announced on october 16 2024 according to the program the buybacks will amount to a maximum of isk 500 000 000 in total and the program will remain in effect until that limit is reached but no later than the company s 2025 annual general meeting heimar owned 27 312 500 shares prior to the above transaction and following these purchases now holds 31 312 500 shares or approximately 1 of the company s issued shares with a total purchase price of isk 995 400 000 the execution of the buyback program will comply with the icelandic public limited companies act no 2 1995 article 5 of the european parliament and council regulation eu no 596 2014 on market abuse as referred to in the icelandic act on measures against market abuse no 60 2021 as well as the european commission
12198,all_events,UP,,pratteln switzerland september 10 2024 santhera pharmaceuticals six sann announces the signing of an exclusive distribution agreement with genesis pharma for agamree vamorolone for the treatment of duchenne muscular dystrophy dmd in 20 markets in central and eastern europe
8198,all_events,UP,,correction editorial corrections have been made to the third paragraph of the announcement in english which do not change the substance of the announcement ecoservice the lithuanian environmental services company of eco baltia the largest environmental resource management and recycling group in the baltics has brought an action before the riga city court demanding the insurance company compensa vienna insurance group adb latvian branch to fulfil its obligations and to pay out the insurance indemnity for the damage suffered by ecoservice as a result of a fire the fire that broke out on 5 august 2023 in the company s waste sorting centre caused widespread damage destroying the buildings the waste sorting equipment and part of the inventory ecoservice s application submitted to the court states that the latvian branch of compensa unreasonably delays the decision on the insurance claim more than a year after the accident the insurance company not only does not take a deci
8657,all_events,DOWN,,media release
2864,all_events,DOWN,,07 nov 2024 18 00 cet roctool roctool roctool information mensuelle relative au nombre total de droits de vote et actions composant le capital social 07 nov 2024 18 00 cet cest information réglementaire transmise par eqs group le contenu de ce communiqué est de la responsabilité de l émetteur communiqué de presse jeudi 07 novembre 2024 information mensuelle relative au nombre total de droits de vote et actions composant le capital social article 223 16 du règlement général de l autorité des marchés financiers place de cotation euronext growth paris mnémonique alroc éligible pea pme code isin fr0010523167 site web www roctool com date nombre total d actions composant le capital social nombre total de droits de vote 31 août 2024 6 801 186 7 719 741 contacts relations investisseurs presse aelyon advisors jerome gacoin valentine boivin 33 1 75 77 54 65 roctool aelium fr fichier pdf dépôt régle
10081,all_events,DOWN,,06 nov 2024 22 30 cet dbv technologies châtillon france november 6 2024 dbv technologies reports third quarter 2024 financial results dbv closes q3 2024 with a cash balance of 46 4 million cash runway into q1 2025 dbv technologies euronext dbv isin fr0010417345 nasdaq stock market dbvt cusip 23306j200 a clinical stage biopharmaceutical company today reported financial results for the third quarter of 2024 the quarterly and nine months financial statements were approved by the board of directors on november 6 2024 financial highlights for the third quarter ended september 30 2024 the company s interim condensed consolidated financial statements for the nine months ended september 30 2024 are prepared in accordance with accounting principles generally accepted in the united states u s gaap cash and cash equivalentscash and cash equivalents amounted to 46 4 million as of september 30 2024 compared to 141 4 million as of december 31 2023 a
10607,all_events,UP,,05 nov 2024 18 00 cet selectirente dans un environnement macro économique et sectoriel contraint avec cependant des perspectives de progression de la consommation des ménages en 2025 en raison de la baisse de l inflation et de la hausse des salaires1 selectirente maintient des performances opérationnelles soutenues avec des loyers en progression de 2 3 à périmètre constant sur les 9 premiers mois de l année par rapport à la même période de 2023 un taux d occupation financier moyen élevé de 94 1 sur les douze derniers mois un refinancement de 80 m de crédits corporate réalisé par anticipation courant juillet et converti à fin octobre en sustainability linked loan avec une indexation à trois critères esg activité du troisième trimestre le chiffre d affaires de selectirente en normes ifrs ressort à 22 6 m au 30 septembre 2024 en légère baisse de 1 9 par rapport à la même période de l année précédente le repli de des loyers seuls provenant essentiellement d
3011,all_events,DOWN,,kraig labs otcqb kblb confirmed the exceptional strength and toughness of its commercially produced recombinant spider silk
5354,all_events,DOWN,,sugar land texas november 13 2023 prnewswire noble corporation plc noble cse noble nyse ne today announces that the persons listed below the pdmrs have conducted transactions in the a ordinary shares of noble each with a nominal value of usd 0 00001 further details are set out in the notifications below made in accordance with the requirements of article 19 of regulation eu no 596 2014 of the european parliament and of the council of 16 april 2014 on market abuse the market abuse regulation as amended notification and public disclosure in accordance with the requirements of the market abuse regulation of transactions by persons discharging managerial responsibilities and persons closely associated with them public disclosure of transactions made by joey kawaja 1 details of the person discharging managerial responsibilities person closely associated a name joey kawaja 2 reason for the notification a position status senior vice president operations b
4742,all_events,UP,,new york sept 26 2024 globe newswire ovid therapeutics inc nasdaq ovid a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain conditions presented the results of a head to head animal study evaluating whether ov329 could be found to accumulate in mouse retinas and brains as has been previously shown to occur with vigabatrin vgb the only fda approved gaba aminotransferase gaba at inhibitor
10656,all_events,UP,,media release
10490,all_events,DOWN,,clinical laserthermia systems ab cls or the company has received additional guarantee commitments from external investors of approximately sek 5 8 million meaning that the total amount of guarantee commitments the so called top down guarantee amounts to a total of sek 11 2 million corresponding to approximately of the proceeds of approximately sek 22 4 million that the company can contribute through full exercise of the warrants of series to 7 b issue proceeds subscription undertakings and guarantee commitments the company announces that it has increased the amount of top down guarantee commitments from previously approximately sek 5 4 million to a total of approximately sek 11 2 million corresponding to a total of approximately 50 percent of the issue proceeds subscription commitments from existing owners already amount to approximately sek 3 3 million corresponding to approximately 14 6 percent of the issue proceeds neither the subscription undertakings no
4077,all_events,DOWN,,new haven conn feb 13 2024 globe newswire bioxcel therapeutics inc nasdaq btai a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno oncology today announced that it has terminated its proposed public offering of 60 0 million of shares of its common stock or in lieu of common stock to certain investors pre funded warrants to purchase shares of its common stock previously announced on february 8 2024 as a result of such termination no securities of the company are being sold pursuant to the offering
5814,all_events,UP,,phase 3 startup activities are underway with trial initiation expected in q1 2024 phase 3 startup activities are underway with trial initiation expected in q1 2024
4315,all_events,UP,,norwood mass march 06 2024 globe newswire corbus pharmaceuticals holdings inc nasdaq crbp corbus or the company today announced that yuval cohen ph d chief executive officer of corbus will participate in a panel discussion at bmo capital markets inaugural bmo obesity summit to be held on march 20 2024 in new york city ny
6896,all_events,DOWN,,20 11 2024 13 18 44 eet pohjolan voima oyj financial calendar pohjolan voima oyj stock exchange release 20 november 2024 pohjolan voima oyj s financial reporting in 2025 pohjolan voima oyj will publish financial reports in 2025 as follows the annual report 2024 including the financial statements and the report of the board of directors will be published on company s website during the week 12 distribution nasdaq helsinki www pohjolanvoima fi further enquiries cfo minna laakso pohjolan voima oyj 358 40 506 802 minna laakso pvo fi pohjolan voima is a long lived finnish energy company we are one of finland s largest energy producers our production accounts for over of the nation s total electricity production the electricity we produce is almost completely carbon neutral we produce electricity and heat at cost price for the needs of our owners finnish industrial and energy companies with reliable and adjustable hydropower thermal power and nuclear power
3995,all_events,DOWN,,03 oct 2024 20 36 cest b c p bco comercial portugues banco comercial português s a informa sobre upgrade do rating da dívida sénior unsecured e dos depósitos pela morningstar dbrs anexo 2024 10 03 upgrade dbrs_pt banco comercial português s a informa sobre upgrade do rating da dívida sénior unsecured e dos depósitos pela morningstar dbrs anexo 2024 10 03 upgrade dbrs_pt pdf banco comercial portugues s a globenewswire b c p bco comercial portugues ptbcp0am0015 bcp euronext
9349,all_events,DOWN,,media release
6044,all_events,DOWN,,mainz biomed establishes strategic partnership with tomalab to expand availability of coloalert in italy
5212,all_events,UP,,as citadele banka citadele hereby announces the public offering of the first tranche of the senior unsecured preferred bonds bonds under the 100 000 000 first senior unsecured preferred fixed floating rate bonds programme the programme this offering is conducted on the basis of the base prospectus approved by the bank of latvia on 2 october 2024 prospectus and initial final terms of the bonds as approved by citadele s management board on 3 october 2024 final terms the prospectus and the final terms documents are available in electronic form on the website of citadele https www cblgroup com en investors bonds the net proceeds from the offer are to be used by citadele for general corporate purposes including compliance with the minimum requirement for own funds and eligible liabilities mrel applicable to citadele at the consolidated group level the bonds will be offered to qualified investors in the baltic states and elsewhere in the european economi
11483,all_events,DOWN,,november 12 2024 08 00 et source evaxion biotech evaxion biotech copenhagen denmark november 12 2024 evaxion biotech a s nasdaq evax evaxion a clinical stage techbio company specializing in developing ai immunology powered vaccines announces new positive preclinical data from its ongoing cytomegalovirus cmv vaccine program named evx v1 the data will be presented today at the 9th international conference on vaccines research development taking place in boston usa the data demonstrates that the antigens identified with evaxion s ai immunology platform effectively trigger targeted immune responses including induction of both cmv reactive b and t cells to further enhance vaccine effectiveness evaxion has additionally designed a proprietary prefusion gb antigen a well established cmv vaccine component known to offer partial virus neutralization new preclinical data confirms that evaxion s proprietary gb antigen successfu
4023,all_events,DOWN,,certara today announced the launch of phoenix version 8 5 software the pharmaceutical industry s gold standard in pk pd modeling and simulation
3463,all_events,DOWN,,bayport management ltd extension of deadline to release unaudited financial results attachments attachments bml communique extension qr 30 sept 2024 pdf bml communique extension qr 30 sept 2024 pdf
5970,all_events,DOWN,,03 oct 2024 23 37 cest eqva asa valen 3 october 2024 reference is made to the stock exchange announcement by eqva asa the company on 3 october 2024 the announcement regarding a successfully completed private placement of 3 125 000 new shares in the company the offer shares at a subscription price of nok 4 80 the private placement the company has engaged clarksons securities as and fearnley securities as as joint managers and bookrunners the managers of the private placement mandatory notification of trades the following primary insiders in the company and close associates of primary insiders were allocated offer shares in the private placement at the offer price as follows nintor as close associate of tore thorkildsen board member of the company was allocated 260 416 offer shares neve eiendom as close associate of even matre ellingsen the company s ceo was allocated 104 166 offer shares south valley invest as close associate of pette
1472,all_events,DOWN,UP,media release
9341,all_events,UP,,zug switzerland and boston nov 07 2024 globe newswire crispr therapeutics nasdaq crsp a biopharmaceutical company focused on creating transformative gene based medicines for serious diseases today announced that samarth kulkarni ph d chief executive officer and chairman of crispr therapeutics will present at the guggenheim inaugural healthcare innovation conference on tuesday november 12 2024 at 2 00 p m et
5192,all_events,DOWN,,jerusalem and miami sept 25 2024 globe newswire entera bio ltd nasdaq entx entera a leader in the development of orally delivered peptides and opko health inc nasdaq opk opko announced today topline pharmacokinetic pharmacodynamic pk pd results from their ongoing collaborative research combining a proprietary long acting oxyntomodulin oxm analog developed by opko and entera s proprietary n tab technology the program is focused on developing the first oral dual agonist glp 1 glucagon peptide as a potential once daily treatment for patients with obesity metabolic and fibrotic disorders oxm is a naturally occurring peptide hormone found in the small intestine that acts to suppress appetite and induce weight loss
7623,all_events,UP,,the retail turnover including vat of the apranga group amounted to eur 33 1 million in october 2024 and increased by 3 compared to october 2023 the retail turnover including vat of apranga group reached eur 284 5 million in january october 2024 and increased by 8 compared to the corresponding period of 2023 in january october 2024 the retail turnover of apranga group in lithuania increased by 6 year to year in latvia increased by 14 and in estonia increased by 3 currently apranga group operates the chain of 171 stores 103 in lithuania 44 in latvia and 24 in estonia covering the gross area of 92 0 thousand sq m or by 1 more than a year ago rimantas perveneckas apranga group general manager 370 5 2390801
3328,all_events,DOWN,,pursuant to section 30 of the danish capital markets act novonesis hereby announces that blackrock inc has notified novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments per november 11 2024 blackrock inc has adjusted its holding of shares to an equivalent of 23 180 630 shares corresponding to 4 previously 5 of the total share capital attached to shares the combined total of share capital attached to shares and share capital through financial instruments is 5 previously 5 attachments attachments 2024_46_major_shareholders_announcement pdf novozymes b 11 nov 2024 final pdf
8500,all_events,UP,,media release
7912,all_events,UP,,bíldudalur 15th of november 2024 icelandic salmon will be presenting results for the third quarter of 2024 on monday the 18th of november 2024 the presentation will be held in english via webcast please copy and paste the following link into your browser arnarlax webcast is the company s ceo bjørn hembre and cfo jónas heiðar birgisson will be presenting the company s results at 9 00 icelandic time 11 00 cest there will be a q a session after the presentations so you can send in questions during the presentation to questions arnarlax is a recording of the presentation will be made available on the company s website after the presentation there is an opportunity to book one on one meeting either at our office in kópavogur urðarhvarf 14 or on teams between 10 15 15 00 icelandic time if interested to do so please send an email to hjortur arnarlax is the results will be available from 06 30 cest that morning at the company s homepage www arnarlax is and on globe newswire news
6595,all_events,DOWN,,06 nov 2024 08 50 cet ses multi year agreement ensures orf programming and numerous satellite customers of ors group will continue to distribute their channels via ses s satellites ses announced today it has extended its multi year contracts with austria s largest media provider and public broadcaster orf and its content distribution subsidiary ors group on ses s prime tv neighbourhood at 19 2 degrees east the agreement covers the satellite transmission of orf s offerings including the distribution of orf 1 hd orf 2 hd orf iii hd orf sport plus hd regional programmes from the austrian states as well as orf s portfolio of radio channels satellite remains the leading platform for tv reception in austria and is therefore crucial for the distribution of orf s tv and radio programmes said harald kräuter director of technology and digitization at orf with this contract extension we are able to provide our audience with the highest quality programming via s
3668,all_events,UP,,on the 29th of november at 08 00 a m cet hexicon ab publ will publish its interim report for the period july to september 2024 at 10 00 a m on the same day the ceo of hexicon marcus thor will give a webcast presentation you are welcome to ask questions during the webcast at the end of the presentation which will be held in english webcast if you wish to participate via the webcast please go to the link below https ir financialhearings com hexicon q3 report 2024 for more information please contact hexicon s communications departmentcommunications hexicongroup com about hexicon hexicon is an early project developer in floating wind opening new markets in deep water areas and a technology provider with a patented floating wind design twinwind the dual business model supports the world s transition to sustainable energy floating wind is an important part of the future energy mix it can be deployed quickly and at scale contributing to the electrification of soci
2210,all_events,UP,UP,media release
578,all_events,DOWN,DOWN,clinical trial demonstrates the ability of nvns to accelerate sensorimotor learning in usaf simulator based pilot training clinical trial demonstrates the ability of nvns to accelerate sensorimotor learning in usaf simulator based pilot training
1511,all_events,UP,UP,berwyn pa dec 05 2023 globe newswire annovis bio inc nyse anvs a clinical stage drug platform company developing novel therapies for neurodegenerative diseases today announced last patient last visit in the phase iii study of its lead candidate buntanetap in patients with early parkinson s disease pd topline data results are expected in january 2024
6569,all_events,UP,,november 18 2024 03 18 et source síminn hf síminn hf í 46 viku 2024 keypti síminn hf 4 000 000 eigin hluti að kaupverði 48 550 000 kr skv sundurliðun hér á eftir viðskiptin eru samkvæmt endurkaupaáætlun símans sem tilkynnt var um í kauphöll íslands hf þann 28 ágúst 2024 endurkaup núna samkvæmt áætluninni munu að hámarki nema 500 milljónum króna endurkaupaáætlunin er í gildi í 18 mánuði frá síðasta aðalfundi en þó aldrei lengur en fram að aðalfundi félagsins árið 2025 eða skemur ef skilyrði um hámarkskaup eru uppfyllt fyrir þann tíma síminn átti 141 778 744 eigin hluti fyrir viðskiptin en á að þeim loknum 145 778 744 eða sem nemur 5 af útgefnum hlutum í félaginu síminn hefur keypt samtals 41 000 000 eigin hluti samkvæmt áætluninni eða sem nemur 1 af útgefnum hlutum í félaginu og nemur heildarkaupverð þeirra 443 275 000 kr framkvæmd endurkaupaáætlunarinnar verður í samræmi við lög um hlutafélög nr 2 1995 5 gr regluger
4562,all_events,UP,,media release
2954,all_events,UP,,alvotech nasdaq alvo a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide announced today its participation in citi s 2024 global healthcare conference in miami florida on december 4 2024 and in evercore s healthconx conference in coral gables florida on december 5 2024 members of the management team will host one on one meetings at both conferences alvotech will also hold a fire side chat at evercore s healthconx conference on thursday december 5 2024 starting at 12 55 et 17 55 gmt
7500,all_events,DOWN,,media release
414,all_events,UP,DOWN,investor webcast on monday march 4 at 8 00 a m et to present clinical data investor webcast on monday march 4 at 8 00 a m et to present clinical data
6157,all_events,DOWN,,dfds has today completed the acquisition of the international transport network of ekol logistics the company ekol logistics is a leading turkish transport and logistics company headquartered in istanbul the acquisition is based on a revised set of terms agreed since the termination of the share purchase agreement on 1 november 2024 the main change in terms relates to the amount of debt included in the transaction in addition dfds now has an option to extend the duration of the terminal agreement with yalova port the company transports goods between türkiye and europe with own offices and facilities in 10 european countries more than half of transports provided are intermodal using combinations of road ferry and rail making the company the largest customer of dfds mediterranean ferry route network dfds acquisition of ekol s international transport network greatly enhances our ability to provide a reliable and efficient transport infrastructure supporting türkiye s con
8986,all_events,DOWN,,this message has been corrected click here to view the corrected message from october 7th 2024 10 00 eest as citadele banka bonds offer subscription process is launched the subscription process closing date is october 10th 2024 15 30 eest up to 3 500 bonds are being offered to qualified investors in latvia and estonia as well as elsewhere in the eea the price of one security is fixed at eur 10 000 or of the nominal amount of the security note the minimum investment amount is eur 100 000 10 bonds the interest rate of the bonds is 5 per cent per annum the bonds are registered in the nasdaq csd under the isin code lv0000804334 the subscription offer will be carried out using the stock exchange trading system market rse equities ipo genium inet trading system order book lv0000804334 cblbbond the auction period during which the order collection will take place is october 7th 2024 from 10 00 until 16 00 october 8th october 9th 2024 from
8376,all_events,UP,,study to enroll 15 acute stroke patients across three u s sites study to enroll 15 acute stroke patients across three u s sites
11822,all_events,DOWN,,irvine calif april 12 2024 globe newswire biomerica inc nasdaq bmra the company a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the third quarter of fiscal 2024 ended february 29 2024
426,all_events,UP,DOWN,november 06 2024 15 30 et source nokia oyj nokia oyj nokia corporationstock exchange release6 november 2024 at 22 30 eet nokia corporation repurchase of own shares on 06 11 2024 espoo finland on 6 november 2024 nokia corporation lei 549300a0jprwg1ki7u06 has acquired its own shares isin fi0009000681 as follows rounded to two decimals on 25 january 2024 nokia announced that its board of directors is initiating a share buyback program to return up to eur 600 million of cash to shareholders in tranches over a period of two years the first phase of the share buyback program started on 20 march 2024 on 19 july 2024 nokia decided to accelerate the share buybacks by increasing the number of shares to be repurchased during the year 2024 the post increase repurchases in compliance with the market abuse regulation eu 596 2014 mar the commission delegated regulation eu 2016 1052 and under the authorization granted by nokia s annual
621,all_events,UP,DOWN,06 nov 2024 16 58 cet saga pure asa tycoon industrier as a company associated to board member and primary insider øystein stray spetalen and martin nes has on 6 november purchased 7 381 973 shares in saga pure asa at nok 1 28 per share after the transaction tycoon industrier as has a holding of 52 465 154 shares corresponding to 10 ownership in saga pure asa attached is details of the transaction more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631432_20241106_ose_filing_mandatory_notification_of_trade pdf saga pure asa oslo børs newspoint saga pure no0010572589 saga oslo børs
2094,all_events,DOWN,UP,media release
9689,all_events,UP,,media release
5440,all_events,UP,,media release
2340,all_events,DOWN,DOWN,november 19 2024 07 36 et source eften united property fund eften united property fund eften united property fund invests 2 5 million euros ca of fund aum in eften real estate fund 5 aimed at institutional investors the latter acquires kristiine shopping centre in tallinn kristiine keskus is one of the best known shopping centers in estonia with 45 300 square meters of leasable area on two floors opened in 1999 the center underwent renovation in 2019 around 120 trade and service tenants and eateries operate in the kristiine center the center s anchor tenants are prisma h m sportland reserved rademar apollo o learys new yorker and jysk the transaction is expected to be completed before the 2024 year end and is dependent on a positive decision from the competition authority after the transaction the eften united property fund is basically fully invested as the investment is to another fund managed by the eften capital as
265,all_events,UP,DOWN,modulight corporation company release november 08 2024 at 10 25 00 eet modulight corporation has received commitments covering several customers utilizing its pay per treatment model ppt across various therapeutic indications the pay per treatment model typically allows customers to pay per use without upfront commitments however under the agreements announced today customers have committed to minimum treatment volumes which differs from modulight s standard ppt offering total proceeds may be higher if the number of treated patients exceeds the estimates in the agreements revenue recognition will occur in the usual manner following the delivery of service the total minimum value of these customer commitments for ppt in clinical trials and commercial pilots exceeds 1 5 million dollars over the next two years these contracts cover approximately 20 sites and involve customers including pharmaceutical and managed care companies as well as leading hospitals and clinics in
12904,all_events,UP,,longeveron reports q2 2024 financial results and provides business update phase 2b clinical trial in hlhs achieves enrollment
8037,all_events,DOWN,,06 nov 2024 17 50 cet mastrad télécharger la pièce jointe cette publication dispose du service actusnews security master security master key l2txkzdmywyxy5trkpxuazvsz2asmmffmwkvnjnxz8vibw1llwlnnjxlznfpm2pq pour contrôler cette clé https www security master key com information réglementée rapports financiers et d audit annuels rapport annuel euronext growth euronext accesscommuniqué intégral et original au format pdf https www actusnews com news 88654 mastrad rapport de gestion 30 06 2024 pdf information réglementée rapports financiers et d audit annuels rapport annuel euronext growth euronext access communiqué intégral et original au format pdf https www actusnews com news 88654 mastrad rapport de gestion 30 06 2024 pdf 88654_fr0004155687 pdf mastrad actusnewswire mastrad fr0004155687 almas euronext growth
3351,all_events,UP,,media release
4901,all_events,DOWN,,sunnyvale calif aug 29 2024 globe newswire biocardia inc nasdaq bcda a global leader in cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary diseases announced today that the food and drug administration fda has cleared biocardia to market the morph dna steerable introducer product family subject to the general controls provisions of the federal food drug and cosmetic act
9057,all_events,DOWN,,media release
11790,all_events,UP,,08 nov 2024 21 00 cet la francaise de l energie télécharger la pièce jointe cette publication dispose du service actusnews security master security master key x2melpxrlmevl21qampmmpnpazpllwwzlpezxmseaj cbhcvx2lqbjswznfpngdt pour contrôler cette clé https www security master key com information réglementée rapports financiers et d audit annuels euronext compartiments a b c rapport financier annuel euronext compartiments a b ccommuniqué intégral et original au format pdf https www actusnews com news 88727 hg3176 fde fy2024 rapport financier annuel vf esef pdf information réglementée rapports financiers et d audit annuels euronext compartiments a b c rapport financier annuel euronext compartiments a b c communiqué intégral et original au format pdf https www actusnews com news 88727 hg3176 fde fy2024 rapport financier annuel vf esef pdf 88727_fr0013030152 pdf la francaise de l energie actusnewswire franc
4885,all_events,DOWN,,partial response and stable disease reported in combination cohort and durable stable disease observed in monotherapy cohorts
9044,all_events,UP,,jerusalem oct 16 2023 globe newswire entera bio ltd nasdaq entx entera or the company a leader in the development of orally delivered peptides and therapeutic proteins presented 2 posters at the annual society of bone and mineral research asbmr 2023 annual meeting held on october 13 16 2023 in vancouver bc canada both posters will be available on the company s website www enterabio com
2088,all_events,UP,UP,november 18 2024 01 50 et source equinor asa equinor asa the shares in equinor asa ose eqnr nyse eqnr will as from today be traded on oslo børs exclusive the second quarter 2024 cash dividend as detailed below ex date 18 november 2024 ordinary cash dividend amount 0 35 extraordinary cash dividend amount 0 35 announced currency usd this information is published in accordance with the requirements of the continuing obligations and is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act
12498,all_events,UP,,south san francisco calif june 07 2023 globe newswire rapt therapeutics inc nasdaq rapt a clinical stage immunology based therapeutics company focused on discovering developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology today announced that brian wong m d ph d president and chief executive officer will participate in a fireside chat at the goldman sachs global healthcare conference on monday june 12 2023 at 1 20 p m pt
2142,all_events,UP,DOWN,media release
8496,all_events,UP,,media release
9590,all_events,UP,,media release
3465,all_events,DOWN,,jerusalem march 26 2024 globe newswire entera bio ltd nasdaq entx entera or the company a leader in the development of orally delivered peptides announced today that the american society for bone and mineral research asbmr announced on march 25 2024 that the u s food and drug administration fda has communicated to the sabre study to advance bmd as a regulatory endpoint project team that a ruling to qualify the treatment related change in bone mineral density bmd as a surrogate endpoint for fractures in future trials of new anti osteoporosis drugs would be provided within 10 months
1082,all_events,DOWN,UP,media release
1671,all_events,UP,DOWN,media release
5066,all_events,DOWN,,15 nov 2024 08 47 cet beerenberg as bergen november 15th 2024 beerenberg reports revenue growth in q3 2024 compared to last year the ebitda margin ended at 9 in the quarter compared to 7 in the same quarter last year 3q 2024 financial highlights revenue nok 802 million ebitda nok 72 million ebitda margin 9 order intake nok 100 million order backlog nok 9 7 billion another quarter with high demand for our services it s a good basis for developing our business in the future says ceo arild apelthun in beerenberg the results will be available at www beerenberg com and published on www newsweb no for further information please contact harald haldorsen cfo tel 47 982 34 834 e mail harhal beerenberg com about beerenberg as beerenberg has delivered cost efficient solutions to a wide range of industrial enterprises for more than 40 years beerenberg is on
3244,all_events,UP,,06 nov 2024 10 05 cet odfjell rig iii ltd odfjell rig iii ltd ose odrg odrg is pleased to report its financial and operational results for the three months period ended 30 september 2024 the period odfjell drilling limited odrg s guarantor has also announced its third quarter results for 2024 today in connection with these results chief executive officer kjetil gjersdal chief financial officer frode syslak and investor relations officer james crothers will be hosting a webcast and q a session at 1 30pm cet to discuss those results stakeholders can either use the following link for the webcast or listen via telephone using the details below webcast details https brrmedia news od3_q3_24 conference call usa local 1 786 697 3501 norway local oslo 47 2 156 3318 uk wide 44 0 33 0551 0200 password if prompted quote odfjell drilling q3 results when prompted by the operator for further queries please contact james crothers inv
11607,all_events,UP,,12 nov 2024 18 11 cet amundi programme de rachat d actions déclaration des transactions sur actions propres réalisées du4 novembre au 8 novembre 2024 article 5 du règlement ue n 596 2014 sur les abus de marché et article 3 3 du règlement délégué ue 2016 1052 complétant le règlement ue n 596 2014 par des normes techniques de réglementation concernant les conditions applicables aux programmes de rachat et aux mesures de stabilisation nom de l émetteurcode identifiant de l émetteurjour de la transactioncode identifiant de l instrument financiervolume total journalier en nombre d actions prix pondéré moyen journalier d acquisition des actionsmarchéamundi96950010fl2t1tjkr5312024 11 04fr0004125920366866 693402aqeuamundi96950010fl2t1tjkr5312024 11 04fr00041259201649666 712091ccxeamundi96950010fl2t1tjkr5312024 11 04fr0004125920279166 709208tqexamundi96950010fl2t1tjkr5312024 11 04fr00041259203478566 691876xparamundi96950010fl2t1tjkr5312024 11 05fr0004125920344966 969266
8898,all_events,UP,,november 07 2024 01 30 et source sampo plc sampo plc sampo plc stock exchange release 7 november 2024 at 8 30 am eet sampo plc s share buybacks 6 november 2024 on 6 november 2024 sampo plc business code 0142213 3 lei 743700uf3rl386wida22 has acquired its own a shares isin code fi4000552500 as follows rounded to two decimals on 17 june 2024 sampo announced a share buyback programme of up to a maximum of eur 400 million in compliance with the market abuse regulation eu 596 2014 mar and the commission delegated regulation eu 2016 1052 on 16 september 2024 the board of directors of sampo plc resolved to increase the share buyback programme to eur 475 million the programme which started on 18 june 2024 is based on the authorisation granted by sampo s annual general meeting on 25 april 2024 after the disclosed transactions the company owns in total 10 146 355 sampo a shares representing 1 84 per
1971,all_events,DOWN,DOWN,november 13 2024 11 30 et source kalmar oyj kalmar oyj liite
3386,all_events,UP,,november 13 2024 03 00 et source kuntarahoitus oyj kuntarahoitus oyj kuntarahoitus oyjpörssitiedote13 11 2024 klo 10 00 kuntarahoitus laskee liikkeeseen 15 miljoonan euron joukkovelkakirjalainan osana joukkovelkakirjalainaohjelmaa kuntarahoitus oyj laskee liikkeeseen 15 miljoonan euron joukkovelkakirjalainan 14 11 2024 lainan eräpäivä on 14 11 2034 kuntarahoituksella on oikeus mutta ei velvollisuutta eräännyttää joukkovelkakirjalaina ennenaikaisesti takaisinmaksettavaksi 14 11 2025 ja 14 11 2027 lainalle maksetaan vuosittaista korkoa 4 00 prosenttia 14 11 2025 asti jonka jälkeen korkoa maksetaan vuosittain 3 02 prosenttia ellei kuntarahoitus eräännytä lainaa ennenaikaisesti liikkeeseenlasku tapahtuu yhtiön 50 miljardin euron joukkovelkakirjalainaohjelman alla ohjelmaa koskeva esite sen täydennys ja lainan lopulliset ehdot ovat saatavilla englanninkielisinä yhtiön verkkosivuilla osoitteessa https www kuntarahoitus fi en for investors
9254,all_events,UP,,14 nov 2024 17 43 cet bewi asa kverva industrier as a close associate of pernille skarstein christensen who is a board member in bewi asa has today acquired 1 386 549 shares in bewi asa for nok 22 75 per share please see further details in the attached notification of trade this announcement is made in accordance with article 19 of the eu market abuse regulation and sections 5 12 of the norwegian securities trading act more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 632293_241114_bewi_pdmr_form_kverva pdf bewi asa oslo børs newspoint bewi no0010890965 bewi oslo børs
694,all_events,UP,UP,13 nov 2024 08 00 cet 2020 bulkers ltd oslo norway november 13 2024 2020 bulkers ltd 2020 bulkers or the company today announced its unaudited financial and operating results for the three and nine months ended september 30 2024 key events during the third quarter of 2024 the company reported net profit of us 11 6 million and ebitda of us 14 7 million for the third quarter of 2024 the company achieved average time charter equivalent earnings of approximately us 36 600 per day gross the company declared total dividends of us 0 57 per share for the months of july august and september 2024 subsequent events achieved average time charter equivalent earnings for october 2024 of approximately us 31 400 per day gross in november 2024 the company declared a dividend of us 0 15 per share for october 2024 the board of directors report the condensed consolidated financial statements and the q3 20
5749,all_events,UP,,media release
11015,all_events,UP,,november 06 2024 10 34 et source landsbankinn hf landsbankinn hf landsbankinn lauk í dag útboði sértryggðra skuldabréfa þar sem tveir flokkar voru boðnir til sölu þrettán tilboð að fjárhæð 4 040 m kr að nafnverði bárust í flokkinn lbank cbi 30 á ávöxtunarkröfu á bilinu 3 3 tilboðum að fjárhæð 3 740 m kr var tekið í flokkinn á ávöxtunarkröfunni 3 heildarstærð flokksins eftir viðbótarútgáfuna verður 42 900 m kr tíu tilboð að fjárhæð 1 680 m kr að nafnverði bárust í flokkinn lbank cb 29 á ávöxtunarkröfu á bilinu 7 7 tilboðum að fjárhæð 1 120 m kr var tekið í flokkinn á ávöxtunarkröfunni 7 heildarstærð flokksins eftir viðbótarútgáfuna verður 14 100 m kr uppgjörsdagur er 13 nóvember 2024 arion banki íslandsbanki og kvika sinna viðskiptavakt með sértryggða skuldabréfaflokka landsbankans lánshæfiseinkunn sértryggðra skuldabréfa landsbankans er a með stöðugum horfum samkvæmt mati s p sértryggðu skuldabréfin
5778,all_events,DOWN,,19 nov 2024 12 12 cet arctic bioscience as an extraordinary general meeting in arctic bioscience as was held tuesday 19 november 2024 at 10 00 cet all the items on the agenda were addressed and approved attached is the minutes of the extraordinary general meeting this information is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act for more information please contact christer l valderhaug ceo phone 47 920 84 601 e mail christer arctic bioscience com jone r slinning cfo mobile 47 948 75 469 e mail jone arctic bioscience com about arctic bioscience arctic bioscience is a biotech company developing and commercializing pharmaceutical and nutraceutical products based on unique bioactive marine compounds the company is developing hro350 a novel oral drug candidate hro350 is being developed for treatment of patients with mild to moderate psoriasis this is a large patient group in need of n
7528,all_events,UP,,13 nov 2024 17 40 cet eiffage see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1297589_communiqu_eiffage_t3_2024 pdf eiffage les echos eiffage fr0000130452 fgr euronext
3817,all_events,UP,,media release
12488,all_events,UP,,media release
7949,all_events,UP,,informations réglementéesmontrouge france le 8 juillet 2024
9581,all_events,UP,,15 nov 2024 12 53 cet dfds a s company announcement no 83 15 november 2024 dfds acquires international transport network connecting türkiye and europe from ekol logistics acquisition replicates dfds ferry road business model to the mediterranean and connects türkiye to dfds existing logistics network network expected revenue for 2024 of dkk 3 3bn and 3 700 employees share purchase agreement revised since 1 november 2024 transaction enterprise value of dkk 1 8bn corresponding to 0 55x ev sales for q3 2024 ltm investor analyst conference call friday 15 november 2024 at 1 30pm cet see registration details below dfds has today completed the acquisition of the international transport network of ekol logistics the company ekol logistics is a leading turkish transport and logistics company headquartered in istanbul the acquisition is based on a revised set of terms agreed since the termination of the share purchase agr
4581,all_events,UP,,12 nov 2024 08 50 cet romsdal sparebank romsb15pro nøkkelinformasjon ved delvis innfrielse av obligasjonslån utsteder romsdal sparebank isin no0012433319 forfallsdato 31 januar 2025 innfrielsesdato 12 november 2024 beløp som innfris nok 20 000 000 utestående beløp etter innfrielse nok 105 000 000 innløsningskurs 100 066 denne informasjonen offentliggjøres i henhold til kravene i løpende forpliktelser more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site romsdal sparebank oslo børs newspoint romsdal spb 20 25 frn romsdal spb 21 26 frn romsdal spb 22 25 frn romsdal spb 22 32 frn c sub romsdal spb 22 perp frn c hybrid romsdal spb 22 33 adj c sub romsdal spb 23 99 frn c hybrid romsdal spb 23 27 frn romsdal spb 23 28 frn romsdal spb 23 29 frn romsdal spb 24 29 frn romsdal spb 24 28 frn romsdal spb 24 27 frn romsdal sparebank no0010891807 no0011083388 no0012433319 no00125
3421,all_events,DOWN,,06 nov 2024 10 45 cet sparebank 1 østfold akershus sparebank 1 østfold akershus har engasjert sparebank 1 markets as for å undersøke muligheten for tilbakekjøp av egenkapitalbevis i banken for et totalt beløp på inntil nok 1 500 000 til bruk i bankens spareprogram for ansatte egenkapitalbevisene skal viderefordeles til bankens ansatte i overensstemmelse med bankens spareprogram tilbakekjøpet vil bli gjennomført som en omvendt bookbuilding banken eier i dag 2 657 egne egenkapitalbevis akseptperioden starter omgående med forventet avslutning 19 november 2024 kl 16 30 akseptperioden kan bli stengt på et tidligere tidspunkt banken og tilrettelegger forbeholder seg retten til å utvide akseptperioden og å akseptere ordre mottatt etter avslutning av akseptperioden endelig kjøpspris per egenkapitalbevis vil bli fastsatt basert på mottatte salgsordre som etter bankens vurdering representerer en tilfredsstillende pris og transaksjonsvolum den endelige kjøpsprisen v
6888,all_events,DOWN,,funding extends company s cash runway into second quarter 2025 which is beyond the anticipated timing for shield ii top line results if warrants are fully exercised
6029,all_events,DOWN,,gigasun s chinese subsidiary has entered into an agreement with a food industry company in hubei province the agreement covers the installation of a solar power plant with a capacity of approximately 2 5 megawatts mw the plant is expected to generate annual revenues of approximately sek 1 25 million from electricity sales which amounts to a total of approximately sek 25 million during the 20 year contract period all electricity produced will be sold directly to the grid the investment in the plant which will be owned by gigasun s wholly owned subsidiary in china amounts to approximately sek 10 7 million construction is scheduled to start in the first quarter of 2025 the plant is estimated to reduce carbon dioxide emissions by about 1 300 tonnes annually the project is located in hubei province and is profitable without any subsidies max metelius ceo of gigasun comments despite fierce competition and challenges in the chinese economy gigasun continues to secure profita
9566,all_events,UP,,to nasdaq omx copenhagen a s
12476,all_events,UP,,18 nov 2024 17 35 cet eurazeo see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1298587_declarationamf11au15novembre2024 pdf eurazeo les echos eurazeo se fr0000121121 rf euronext
5937,all_events,UP,,attachments 11084874 pdf alma media 8 11 trades xlsx
12417,all_events,UP,,november 12 2024 04 15 et source sveriges riksbank sveriges riksbank
10528,all_events,UP,,this class of serca2a activators selectively activates serca2a and may lead to novel therapies for heart failure beyond the company s current lead program this class of serca2a activators selectively activates serca2a and may lead to novel therapies for heart failure beyond the company s current lead program
10795,all_events,DOWN,,barda project nextgen contract to support a phase 2b trial potentially positions vaxart s oral pill vaccine platform as a next generation approach to combating covid 19 and future pandemic threats
1463,all_events,DOWN,DOWN,pratteln switzerland september 24 2024 santhera pharmaceuticals six sann announces that swissmedic the swiss agency for therapeutic products has accepted for review the marketing authorization application maa for agamree vamorolone for the treatment of duchenne muscular dystrophy dmd
7624,all_events,DOWN,,15 nov 2024 09 36 cet sparebank 1 østfold akershus børsmeldingen fra 14 11 24 korrigeres som følge av at det i børsmeldingen sto at sparebank 1 østfold akershus hadde solgt egenkapitalbevis til ansatte i spareprogrammet mens det i realiteten var tildeling av bonusbevis for spareprogrammet fra perioden 2022 2023 ny melding sparebank 1 østfold akershus har 14 november 2024 viderefordelt 5 938 bonusegenkapitalbevis av egen beholdning til ansatte som deltok i bankens spareprogram i perioden september 2022 til august 2023 til kurs 379 48 nok per egenkapitalbevis etter viderefordelingen eier banken 719 egne egenkapitalbevis det er totalt viderefordelt 18 502 egenkapitalbevis av egen beholdning i dette spareprogrammet primærinnsideres kjøp i spareprogrammet følger som vedlegg det henvises for øvrig til børsmelding datert 12 august 2022 for nærmere informasjon om spareprogrammet moss 15 november 2024 kontaktperson i banken viseadm direktør investorkonta
5654,all_events,DOWN,,14 nov 2024 20 00 cet be semiconductor industries nv press release 141124 pdf be semiconductor euronext be semiconductor industries n v nl0012866412 besi euronext
11366,all_events,UP,,media release
9869,all_events,DOWN,,media release
2216,all_events,UP,DOWN,stockholm sverige 5 november 2024 karolinska development ab nasdaq stockholm kdev meddelar idag att portföljbolaget boost pharma framgångsrikt har genomfört ett rådgivande möte så kallat pre ind möte med den amerikanska läkemedelsmyndigheten fda för sin cellterapi som utvecklas som behandling av barn med den sällsynta bensjukdomen osteogenesis imperfecta oi det positiva utfallet från mötet utlöser den andra delen av en tidigare avtalad investering från karolinska development
3207,all_events,DOWN,,dallas sept 06 2024 globe newswire taysha gene therapies inc nasdaq tsha a clinical stage biotechnology company focused on advancing adeno associated virus aav based gene therapies for severe monogenic diseases of the central nervous system cns today announced that on september 3 2024 the compensation committee of taysha s board of directors granted one new employee an option to purchase 311 000 shares of the company s common stock in connection with their employment the stock option was granted under the taysha gene therapies inc 2023 inducement plan as an inducement material to the individual entering employment with taysha in accordance with nasdaq listing rule 5635 c 4
11283,all_events,UP,,november 07 2024 03 30 et source sparekassen sjælland fyn a s sparekassen sjælland fyn a s selskabsmeddelelse nr 56 2024 holbæk den 7 november 2024 sparekassen sjælland fyn a s leverer et resultat før skat på 635 5 mio kr for årets første tre kvartaler i 2024 hvilket er en fremgang på 22 i forhold til samme periode i 2023 efter skat udgør resultatet 478 0 mio kr hvilket svarer til en stigning på 18 perioden i overskrifter med venlig hilsen lars petersson jakob anderssonadm direktør formand yderligere information presse og direktionsrådgiver morten huse eikrem jeppesen tlf 53 85 07 70administrerende direktør lars petersson sparekassedirektør lars bolding www spks dk ir vedhæftede filer
8856,all_events,UP,,19 nov 2024 08 00 cet equinor asa please see below information about transactions made under the fourth tranche of the 2024 share buy back programme for equinor asa ose eqnr nyse eqnr ceux eqnro tqex eqnro date on which the fourth tranche of the 2024 programme was announced 24 october 2024 the duration of the fourth tranche of the 2024 programme 25 october to no later than 31 january 2025 further information on the tranche can be found in the stock market announcement on its commencement dated 24 october 2024 available here https newsweb oslobors no message 630240 from 11 november until 15 november 2024 equinor asa has purchased a total of 1 500 000 own shares at an average price of nok 254 1340 per share overview of transactions date trading aggregated weighted venue daily volume average
7592,all_events,UP,,hørsholm denmark 18 november 2024 expres2ion biotech holding ab s subsidiary expres2ion biotechnologies aps expres2ion will participate in upcoming investor and scientific events including the biostock life science summit the immunotherapies and innovations for infectious diseases congress and aktiespararna s stora aktiedagen by attending relevant industry and investor events the company aims to increase the awareness of its technology platform and its exciting development pipeline more information on each event and how to register is found below and on the company s website and via the links below 21 november 2024 biostock life science summit lund sweden the biostock life science summit is a nordic meeting place for entrepreneurs industry and investors and offers a peek into the future of biotech pharma diagnostics and health care devices on november 21 ceo bent frandsen will present to schedule a meeting please contact us via email on info expres2ionbio com
8159,all_events,DOWN,,13 nov 2024 08 29 cet signaux girod signaux girod société anonyme au capital de 13 422 500 siège social 881 route des fontaines 39400 bellefontaine 646 050 476 r c s lons le saunier code isin fr0000060790 declaration transactions sur actions propres réalisées en novembre 2024 semaine 45 en application de l article 5 du règlement u e n 596 2014 du 16 avril 2014 relatif aux abus de marché et du règlement délégué u e n 2016 1052 du 8 mars 2016 sur les conditions applicables aux programmes de rachat et aux mesures de stabilisation signaux girod déclare ci après les transactions réalisées sur ses propres actions pour la période du 04 11 2024 au 08 11 2024 présentation agrégée par jour et par marché nom de l émetteurcode identifiant de l émetteurjour de la transactioncode identifiant de l instrument financiervolume total journalier en nombre d actions prix pondéré moyen journalier d acquisition des actionsmarchésignaux girod969500ybz13ntsg2xl4404 11 2024fr00
11815,all_events,UP,,palo alto calif july 02 2024 globe newswire semnur pharmaceuticals inc semnur a wholly owned subsidiary of scilex holding company nasdaq sclx scilex an innovative revenue generating company focused on acquiring developing and commercializing non opioid pain management products for the treatment of acute and chronic pain and denali capital acquisition corp a cayman islands corporation and special purpose acquisition company nasdaq deca spac today announced the signing of a letter of intent for a proposed business combination which provides for a pre transaction equity value of semnur up to 2 0 billion subject to adjustment based on third party fairness opinion with expected gross proceeds of up to 40 million depending on the number of spac shares that are redeemed prior to the completion of the business combination
2392,all_events,UP,UP,18 nov 2024 11 46 cet guillemot corp see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1298491_gcorp_communiqu_hebdo_rachat_actions_s46_2024_eng pdf guillemot les echos guillemot fr0000066722 gui euronext
3231,all_events,UP,,on 11 november 2024 tallinna sadam held a webinar for investors where the chairman of the management board valdo kalm and the member of the management board cfo andrus ait presented unaudited results of the group for 2024 9 months and q3 tallinna sadam would like to thank all participants the recording of the webinars can be followed up in estonian and in english language the presentation is attached to this notice and is also available at the company s web page https www ts ee en investor presentations angelika annushead of investor relationstel 372 5649 6230angelika annus ts ee attachment attachments 2024 9 months webinar pdf
12704,all_events,DOWN,,09 10 2024 at 18 30 united bankers plc acquisition of own shares 09 10 2024 the shares held by united bankers plc on 09 10 2024 on behalf of united bankers plc skandinaviska enskilda banken ab publ helsinki branch antti salakka janne tiihonen for more information please contact patrick anderson ceo united bankers plce mail patrick anderson unitedbankers fiphone 358 400 244 544 358 9 25 380 236 www unitedbankers fi attachments ub sbb 09102024 xlsx
11798,all_events,DOWN,,media release
10391,all_events,UP,,13 nov 2024 17 50 cet theon international plc venetus limited to start a purchase programme of theon shares bloomberg theon na reuters theon as nicosia 13 november 2024 theon international plc theon has been informed that its majority shareholder venetus limited venetus intends to start a purchase programme for up to of the issued share capital of theon the initiative underscores venetus strong belief that the current share price does not reflect theon s performance and true value particularly compared against the strong growth profile theon expects nor does it mirror the significant growth strategy that theon is undertaking christian hadjiminas founder and ceo of theon as well as controlling shareholder of venetus commented that this share p
2046,all_events,UP,UP,panevėžys regional court has approved the restructuring of sba group company utenos trikotažas which aims to shift toward profitability and ensure sustainable continuity the court has also approved the company s four year restructuring plan which outlines the necessary measures and funding sources for its transformation we have been anticipating this court decision as we have already initiated important processes and negotiations that are crucial for the company s successful transformation the restructuring will give us time to reorganize our business model and ensure the company s solvency as well as the long term fulfillment of its obligations says dovilė tamoševičienė chair of the management board of utenos trikotažas the restructuring plan approved by the court focuses on further efficiency improvements in the operations of utena trikotažas by reducing costs and eliminating loss making activities while maintaining as much of the company s viable operations as possible d
6378,all_events,DOWN,,18 nov 2024 18 00 cet theravet s a regulatory news egeiro pharma isin be0974387194 mnemo alvet a biopharmaceutical company specializing in the repositioning and reformulation of existing drugs notably in idiopathic pulmonary fibrosis announces that its board of directors meeting on november 15 2024 has acknowledged the resignation of enrico bastianelli as a director and has decided to modify its governance gaëtan terrasse has been appointed managing director and emmanuel huynh chairman catherine bur remains a director about egeiro pharma egeiro pharma is a biopharmaceutical company specializing in the repositioning and reformulation of existing drugs to deliver impactful improvements for patients and meet the new needs of healthcare professionals and organizations the company s strategy is currently focused on the clinical development of an innovative drug for idiopathic pulmonary fibrosis a chronic devastating and fatal disease characterized
1254,all_events,UP,UP,alm brand a s share buy back program transactions during 11 november 2024 15 november 2024on 15 august 2024 alm brand a s announced a share buy back program of up to dkk 150 million as described in company announcement no 40 2024 on 7 november 2024 alm brand a s announced an increase of the existing share buy back program by dkk 70 million to dkk 220 million with the intention of purchasing shares for the employee share scheme in 2025 additionally the program was extended until and including 31 january 2025 the program is carried out in accordance with the regulation no 596 2014 of the european parliament and council of 16 april 2014 mar and the commission delegated regulation eu 2016 1052 also referred to as the safe harbour regulations the following transactions were made under the share buy back program during week number 46 with the transactions stated above alm brand a s holds a total of 34 235 715 own shares corresponding to 2 22 of the total number of outs
952,all_events,UP,UP,media release
11488,all_events,DOWN,,zug switzerland nov 07 2024 globe newswire oculis holding ag nasdaq ocs xice ocs oculis or the company a global biopharmaceutical company purposefully driven to save sight and improve eye care today announced results for the quarter ended september 30 2024 and provided an overview of the company s progress
10206,all_events,UP,,media release
4299,all_events,DOWN,,new york aug 13 2024 globe newswire ovid therapeutics inc nasdaq ovid a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain conditions today reported business updates and financial results for the second quarter ended june 30 2024
6571,all_events,UP,,12 nov 2024 17 40 cet ageas ageas rapporteert over de inkoop van eigen aandelen naar aanleiding van het aandelen inkoopprogramma dat op 28 augustus 2024 aangekondigd werd maakt ageas bekend dat er 114 483 eigen aandelen ingekocht werden tussen 04 11 2024 en 08 11 2024 datumaantalaandelentotaal bedrag eur gemiddelde koers eur laagste koers eur hoogste koers eur 04 11 202421 5461 038 22448 1948 1048 4005 11 202420 9611 016 94248 5248 1848 7806 11 202421 5531 048 64248 6548 0849 3407 11 202424 3471 181 94348 5548 1848 9408 11 202426 0761 253 57148 0748 2648 52totaal114 4835 539 32248 3948 0849 34 vanaf de start van het aandelen inkoopprogramma op 16 september 2024 heeft ageas een totaal van 861 147 aandelen ingekocht voor een bedrag van eur 41 517 011 ofwel 0 van het totale aantal uitstaande aandelen het overzicht van het aandelen inkoopprogramma is beschikbaar op onze website bijlage pdf versie van het persbericht ageas rapporteert over de inkoop van eigen
8805,all_events,UP,,istaroxime significantly improved primary endpoint of the systolic blood pressure profile over six hours and showed significant improvements in many secondary endpoint assessments
1718,all_events,UP,DOWN,15 nov 2024 14 40 cet sola kommune oslo børs has received an application for isin no0013407080 to be admitted to stock exchange listing the market abuse regulation mar applies from the time the application has been made including the issuer s disclosure obligation on inside information more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sola kommune oslo børs newspoint sola komm 19 29 1 sola komm 21 26 2 005 pct sola komm 24 26 frn no0010860554 no0011151888 no0013335661 oslo børs
3547,all_events,UP,,14 nov 2024 08 30 cet casino guichard perrachon mise à disposition de la présentation du plan stratégique le groupe indique avoir mis à disposition du public la présentation de son plan stratégique renouveau 2028 sur son site à l adresse suivante https www groupe casino fr wp content uploads 2024 11 2024 11 14 casino presentation plan strategique pdf contacts analystes et investisseurs charlotte izabel 33 0 6 89 19 88 33cizabel groupe casino frrelations investisseurs 33 0 1 53 65 24 17ir_casino groupe casino fr contacts presse direction de la communication groupe casino stéphanie abadie 33 0 6 26 27 37 05sabadie groupe casino frdirection communication investisseurs 33 0 1 53 65 24 78directiondelacommunication groupe casino fr disclaimer ce communiqué a été préparé uniquement à titre informatif et ne doit pas être interprété comme une sollicitation ou une offre d achat ou de vente de valeurs mobilières ou instruments financiers connexes de même il ne donne p
8806,all_events,DOWN,,the improved results presented at esmo and the collaboration agreement with eisai have strengthened fostrox s chances of becoming the first approved therapy in second line liver cancer july septemberfinancial summary for the quarter significant events during the quarter january septemberfinancial summary for the period events after the end of the period conference call for investors analysts and the mediathe interim report january september 2024 will be presented by medivir s ceo jens lindberg time wednesday november 6 2024 at 14 00 cet to access the webcast and find information about the teleconference please klick here the conference call will also be streamed via a link on the website www medivir com investors calendarthe presentation will be available on medivir s website after completion of the conference ceo s messagetoday there are no approved drugs for the second line treatment of advanced liver cancer at the esmo congress in barcelona in september
6282,all_events,UP,,olaine 2024 11 13 16 01 cet crosschem a manufacturer of chemical products invests hundreds of thousands of euros every year in research and development including securing patents for its intellectual property today one of the company s products etex an anti friction additive has been granted a patent confirming its uniqueness says richard anderson chairman of the board of crosschem etex anti friction additive optimizes friction contact points and reduces friction between them thus preventing wear of machinery components and reducing energy consumption the product is environmentally friendly and biodegradable significantly increasing the car s dynamic performance and reducing running costs etex is one of the solutions to reduce running costs while positively impacting both your car and the environment for more information please visit www crosschem lv under products services etex crosschem is a latvian company which is part of crosschem
3429,all_events,DOWN,,15 nov 2024 06 00 cet okeanis eco tankers corp athens greece november 15 2024 reference is made to the key information relating to q3 2024 dividend announced by okeanis eco tankers corp oet or the company nyse eco ose oet on november 8 2024 the company s shares will be traded ex dividend usd 0 45 per common share on the oslo stock exchange from today november 15 2024 and on the new york stock exchange from november 18 2024 contacts company iraklis sbarounis cfo tel 30 210 480 4200 ir okeanisecotankers com investor relations media contact nicolas bornozis president capital link inc 230 park avenue suite 1540 new york n y 10169 tel 1 212 661 7566 okeanisecotankers capitallink com about oet oet is a leading international tanker company providing seaborne transportation of crude oil and refined products the company was incorporated on april 30 2018 under the laws of the republic of the marshall islands and is listed on oslo b
12171,all_events,DOWN,,november 13 2024 06 04 et source nova nova sjá meðfylgjandi tilkynningu um flöggun viðhengi
7223,all_events,DOWN,,please see below information about transactions made under the fourth tranche of the 2024 share buy back programme for equinor asa ose eqnr nyse eqnr ceux eqnro tqex eqnro
12593,all_events,DOWN,,16 oct 2024 07 30 cest boussard gavaudan holding ltd boussard gavaudan holding limited ordinary shares the directors of boussard gavaudan holding limited would like to announce the following information for the company close of business 15 oct 2024 estimated nav euro sharessterling sharesestimated nav 28 4129 25 5457estimated mtd return 0 19 0 21 estimated ytd return 3 14 3 97 estimated itd return 184 13 155 46 nav and returns are calculated net of management and performance fees market information euro sharesamsterdam aex london lse market close 27 40n apremium discount to estimated nav 3 56 n a sterling sharesamsterdam aex london lse market closen agbx 2 380 00premium discount to estimated navn a 6 83 transactions in own securities purchased into treasury ordinary shares euro sharessterling sharesnumber of sharesn an aaverage pricen an arange of pricen an a
4128,all_events,DOWN,,châtillon france le 11 novembre 22 30 cet 2024
8563,all_events,DOWN,,media release
11992,all_events,UP,,12 oct 2024 12 00 cest lokotech group as in reference to our previous exchange notices dated june 26 2024 and september 4 2024 lokotech group as is updating the market on the adjusted timeline for the tapeout of our commercial scale scrypt and ai asic the tapeout initially scheduled for late october 2024 has been rescheduled due to the previous events outlined in the september 4 notice we are pleased to announce that our asic design team is now operating at full capacity lokotech remains committed to delivering the world s most efficient scrypt asic we will issue a separate announcement when the tapeout begins more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site lokotech group as oslo børs newspoint lokotech group as no0010921299 loko euronext growth
8113,all_events,DOWN,,stockholm november 4 2024 virtune a swedish regulated crypto asset manager today announced the launch of virtune crypto altcoin index etp on nasdaq stockholm the largest stock exchange in the nordic region
3615,all_events,DOWN,,company to host webcast on 12th july at 9am aest 7pm et 11 july
1056,all_events,DOWN,DOWN,08 nov 2024 12 13 cet m r m ne pas publier diffuser ou distribuer directement ou indirectement aux états unis d amérique ou dans tout autre pays dans lequel la distribution ou la diffusion du communiqué est interdite par la loi communiqué du 8 novembre 2024 relatif au dépôt d un projet de note établi par la société mrmen réponse au projet d offre publique d achat simplifiée visant ses actions initiée par la société scor amfle présent communiqué relatif au dépôt par m r m s a auprès de l autorité des marchés financiers l amf le 8 novembre 2024 d un projet de note en réponse le projet de note en réponse au projet d offre publique d achat simplifiée initiée par scor se visant les actions de m r m s a a été établi par m r m s a et diffusé conformément aux dispositions de l article 231 26 du règlement général de l amf le rgamf le communiqué le projet d offre le projet de note d information et le projet de note en réponse restent soumis à l
1146,all_events,DOWN,UP,15 nov 2024 08 30 cet dolfines dolfinescpconstatation laugmentation capital pdf dolfines euronext dolfines fr001400sp13 aldol euronext growth
3016,all_events,UP,,november 07 2024 03 00 et source akva group asa akva group asa klepp 7 november 2024 reference is made to the stock exchange announcement by akva group asa akva on 26 september 2024 regarding the entering into of merger plans for the intragroup mergers of akva s wholly owned subsidiaries akva group software as and polarcirkel as both as non surviving entities the subsidiaries with akva as the surviving entity due to accounting purposes relating to the timing of completion of the mergers the board of directors of akva and the subsidiaries have today resolved to make certain minor amendments to the merger plans and their appendices the revised merger plans with appendices are available on akva s webpage https www akvagroup com investors financial info other presentations reports the mergers are expected to be completed in february 2025 the purpose of the mergers is to simplify the corporate structure in the group by akva acquiri
1937,all_events,UP,DOWN,14 nov 2024 18 30 cet evs broadcasting equipment evs q3 2024 business update reaffirming growth expectations for 2024 setting a new revenue high for evs while actively building the future liège belgium november 14th 2024 evs financial results are firming up in line with expectations while the final weeks of production and deliveries are being planned we primarily focus on building the future order intake for the fourth quarter looks promising ensuring a kick start in 2025 we have significant commercial opportunities in the pipeline which are bound to play a substantial role in our future success and contribute to overall order intake highlights revenue performance continues to demonstrate strong growth supported by the successful completion of major summer sporting events the secured revenue allows evs to confirm the higher end range of the existing revenue guidance eur 190 200 million gross margin levels continue to improve and operational expenses rem
11572,all_events,UP,,we hereby inform that telia lietuva ab financial results in 2025 will be released according to the following annual general meeting of shareholders is planned to be held on 28 april 2025 88 15 per cent of telia lietuva shares are owned by telecommunication company telia company ab sweden telia lietuva shares are listed on nasdaq vilnius stock exchange ticker tel1l the shares of telia company are listed on nasdaq stockholm and nasdaq helsinki stock exchanges darius džiaugyshead of investor relationstel 370 5 236 78 78 e mail darius dziaugys telia lt
1031,all_events,DOWN,DOWN,new york oct 10 2023 globe newswire ovid therapeutics inc nasdaq ovid a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure related disorders today announced that management will participate in a presentation at the jefferies inaugural biotech cns neuro summit on thursday october 12 2023 at 3 30 p m et in new york
7249,all_events,DOWN,,boca raton florida sept 13 2024 globe newswire inmune bio inc nasdaq inmb the company or inmune bio a clinical stage inflammation and immunology company focused on developing treatments that harness a patient s innate immune system to fight disease today announced it has entered into securities purchase agreements with new and existing institutional investors and certain directors and officers and employees of the company the directors and officers and employees herein referred to as the insiders for the purchase and sale of 2 341 260 shares of its common stock and warrants to purchase up to an aggregate of 2 341 260 shares of common stock at a combined purchase price per share and accompanying warrant of 5 50 for the institutional investors and 6 50 per share and accompanying warrant for the insiders pursuant to a registered direct offering the warrants will be exercisable commencing six months from the date of issuance at a price of 6 40 per share and will expire five years from the initial exercise date the warrant term may be subject to acceleration following the satisfaction of certain conditions in the case of insiders that participated in the offering if the warrant termination date is on a blackout date then the insiders will have an additional 60 days from the termination of the blackout date to exercise the warrant
2754,all_events,DOWN,,06 nov 2024 17 45 cet alten see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1295581_droitsdevote__2024_10_31 pdf alten les echos alten fr0000071946 ate euronext
4313,all_events,DOWN,,media release
11218,all_events,DOWN,,07 nov 2024 17 56 cet dnb bank asa the financial supervisory authority of norway the fsa regularly carries out a supervisory review and evaluation process srep where they evaluate the risks and capital needs of dnb the srep includes a decision regarding the pillar 2 requirement and the pillar 2 guidance which comes in addition to the minimum requirements and combined buffer requirements under pillar 1 dnb has now received this year s decision from the fsa which will apply from 31 december 2024 the fsa has decided that the pillar 2 requirement for dnb on a group level shall be reduced from 2 0 to 1 7 of the total risk exposure amount trea at least 56 25 of the requirement shall be met with common equity tier 1 cet1 capital while 75 must be met with tier 1 capital the new pillar 2 requirement will therefore reduce the total capital requirement by 0 3 percentage points the tier 1 requirement by 0 23 percentage points and the cet1 requiremen
5910,all_events,DOWN,,media release
96,all_events,DOWN,DOWN,divio has signed three new high potential customers adding usd 2 000 to mrr sales activity and negotiations are intense and remain ongoing involving both new and existing customers while most customers start with smaller projects the real growth begins once we are onboarded both our internal sales team and partners are performing exceptionally well and progress is moving in the right direction says jon levin ceo of divio technologies press enquiries for further information about divio technologies please visit divio com or contact ceo jon levin ir divio com the company s certified adviser is fnca sweden ab about divio technologies divio technologies ab publ is the paas and cloud management software development group behind the divio platform which simplifies cloud hosting deployment and development via a paas solution the platform allows enterprises to reduce costs time to market and the burden on employees as well as decreasing dependency on cloud vendors atta
4414,all_events,UP,,media release
2239,all_events,UP,UP,transcode therapeutics and debiopharm announce collaboration to develop targeted nucleic acid therapeutics for cancer
4176,all_events,DOWN,,media release
6607,all_events,UP,,fourth quarter and full year 2023 briumvi u s net revenue of approximately 40 million and 89 million respectively
7211,all_events,UP,,media release
1042,all_events,UP,UP,media release
2389,all_events,DOWN,UP,06 nov 2024 12 22 cet paratus energy services ltd oslo børs vedtok å ta aksjene i paratus energy services ltd opp til handel på euronext oslo børs det forutsettes at selskapet før første handelsdag oppfyller opptakskravene på euronext oslo børs børsdirektøren gis fullmakt til å fastsette første handelsdag senest 7 januar 2024 more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site paratus energy services ltd oslo børs newspoint paratus energy services ltd bmg6904d1083 plsv euronext growth
12607,all_events,DOWN,,media release
1592,all_events,UP,DOWN,jerusalem jan 30 2024 globe newswire entera bio ltd nasdaq entx entera or the company a leader in the development of orally delivered peptides and therapeutic proteins announced that it will participate and be available for investor meetings at the oppenheimer 34th annual healthcare life sciences conference being held february 13 14 2024 in a virtual format
2391,all_events,DOWN,UP,reference is made to the private placement announced by hexagon purus asa the company on 30 october 2024 the private placement please find attached pdmr forms related to the subscription of shares in the private placement by primary insiders of the company
3344,all_events,UP,,i overensstemmelse med bemyndigelsen fra generalforsamlingen den 18 april 2024 har bestyrelsen i dag indført et incitamentsprogram for selskabets bestyrelse incitamentetprogrammet er designet og struktureret omkring konceptet med at fastholde medlemmer af bestyrelsen samtidig med at der skabes incitament til en positiv aktiekursudvikling og virksomhedens resultater til gavn for selskabets aktionærer
7756,all_events,DOWN,,media release
11389,all_events,DOWN,,vancouver british columbia sept 20 2023 globe newswire mydecine innovations group inc mydecine or the company neo myco otc mycof fse 0nfa a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and ptsd is pleased to announce that further to the company s news release dated september 15 2023 and september 19 2023 the company has closed its previously announced offering by way of prospectus supplement the offering pursuant to the offering the company issued 18 750 000 common shares of the company each a share at a price of 0 20 per share for aggregate gross proceeds of 3 750 000 a previous news release incorrectly stated that the company issued 18 7500 000 shares for aggregate gross proceeds of 3 7500 000
12577,all_events,DOWN,,10 oct 2024 08 00 cest getlink se regulatory news getlink paris get sept 24 sept 23 variation jan sept 2024 jan sept 2023 variation navettes camions camions 96 570 95 651 890 559 908 090 navettes passagers véhicules de tourisme 200 353 211 819 1 745 667 1 789 865 y compris voitures motos véhicules avec remorques caravanes camping cars et autocars en septembre 2024 leshuttle freight a transporté 96 570 camions en hausse de par rapport au mois de septembre 2023 depuis le 1er janvier ce sont plus de 890 000 camions qui ont traversé la manche à bord des navettes leshuttle a transporté 200 353 véhicules de tourisme au mois de septembre en baisse de par rapport à septembre 2023 pour mémoire le trafic de septembre 2023 avait profité de la coupe du monde de rugby près de 1 750 000 véhicules de tourisme ont ainsi été tr
2527,all_events,UP,UP,media release
3014,all_events,DOWN,,12 nov 2024 14 54 cet 4finance s a operational highlights online loan issuance volume was stable year on year in the period at 423 5 million compared with 423 8 million in the prior year period demand for credit remains strong in most markets particularly in the czech republic and spain new growth opportunities taking a deliberate step by step approach the uk joint venture ondal co uk and the mexican business kimbi mx progressing steadily showing gradual growth tbi bank loan issuance increased by to 832 8 million in the period compared to 652 3 million in 9m 2023 financial highlights interest income up year on year to 326 7 million in the period compared with 288 8 million in 9m 2023 cost to income ratio for the period was 41 an improvement from 44 in the prior year period cost discipline and operational efficiency remain a focus for the business adjusted ebitda was 116 2 million for the period up
12773,all_events,UP,,turku finland and boston april 16 2024 globe newswire faron pharmaceuticals ltd faron or the company aim farn first north faron a clinical stage biopharmaceutical company pursuing a clever approach to reprogramming myeloid cells to activate anti tumor immunity in hematological and solid tumor microenvironments today announces ongoing plans and activities for the coming months following the recent announcement of the proposed appointment of dr juho jalkanen as chief executive officer effective 1 may 2024
3,all_events,UP,UP,west lafayette ind nov 27 2023 globe newswire inotiv inc nasdaq notv the company we our or inotiv a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services today announced that it will issue its financial results for the fiscal 2023 fourth quarter and full year ended september 30 2023 on monday december 11 2023 after the close of the stock market the company will host a conference call that same day at 4 30 p m eastern time to discuss the results
5357,all_events,UP,,media release
3131,all_events,UP,,planegg martinsried july 3 2024 medigene ag medigene or the company fse mdg1 prime standard an immuno oncology platform company focusing on the discovery and development of t cell immunotherapies for solid tumors announces today that the company has been issued a patent by the chinese patent office protecting its t cell receptor tcr targeting ny eso 1 new york esophageal squamous cell carcinoma 1 and lage 1a l antigen family member 1a both being well recognized and validated cancer testis antigens expressed in multiple tumor types
11546,all_events,DOWN,,november 18 2024 02 30 et source innofactor oyj innofactor oyj innofactor oyj n johtohenkilöiden liiketoimet 18 11 2024 klo 9 30 innofactor oyj johdon liiketoimet ____________________________________________ ilmoitusvelvollinennimi onni bidco oyasema lähipiiriin kuuluva henkilö x oikeushenkilö 1 liikkeeseenlaskijassa johtotehtävissä toimiva henkilönimi sami ensioasema toimitusjohtaja 2 liikkeeseenlaskijassa johtotehtävissä toimiva henkilönimi antti kummuasema hallituksen jäsen varajäsen liikkeeseenlaskija innofactor oyjlei 7437008oskqfedzyd835ilmoituksen luonne ensimmäinen ilmoitusviitenumero 85033 4 4 ____________________________________________ liiketoimen päivämäärä 2024 11 15kauppapaikka nasdaq helsinki ltd xhel instrumenttityyppi osakeisin fi0009007637liiketoimen luonne hankinta liiketoimien yksityiskohtaiset tiedot 1 volyymi 3710 yksikköhinta 1 68 eur 2 volyymi 5000 yksikköhinta 1 68 eur 3 volyymi 5000
10599,all_events,UP,,11 nov 2024 20 02 cet schibsted asa 11 11 2024 20 02 51 cet schibsted acquisition or disposal of the issuer s own shares please see below information about transactions made under the buyback programme announced on 9 september 2024 date on which the repurchase programme was announced 9 september 2024 the duration of the repurchase programme the buyback programme is planned to be finalised within 2 may 2025 size of the repurchase programme the purchases will be split 50 50 in nominal terms between a and b shares buying up to nok 1 billion for each of the share classes for the period 5 until 11 november 2024 schibsted has purchased a total of 77 750 own a shares at an average price of nok 383 3184 per share and a total of 82 800 own b shares at an average price of nok 356 7845 per share a shares date trading venue aggregated weighted total daily daily volume average share transaction
3467,all_events,DOWN,,south san francisco calif june 08 2024 globe newswire akero therapeutics inc nasdaq akro a clinical stage biotechnology company developing transformational treatments for patients with serious metabolic disorders marked by high unmet medical need today announced two presentations featuring its lead product candidate efruxifermin efx at the european association for the study of the liver easl congress 2024 in milan italy the presentations will also be available on akero s website following the meeting
3037,all_events,UP,,financing led by deep track capital with new investments from driehaus capital management and funds and accounts advised by t rowe price associates inc
7149,all_events,DOWN,,october 02 2024 11 02 et source faruqi faruqi llp faruqi faruqi llp faruqi faruqi llp securities litigation partner james josh wilson encourages investors who suffered losses exceeding 75 000 in orthofix to contact him directly to discuss their options if you suffered losses exceeding 75 000 in orthofix between october 11 2022 and september 12 2023 and would like to discuss your legal rights call faruqi faruqi partner josh wilson directly at 877 247 4292 or 212 983 9330 ext 1310 you may also click here for additional information new york oct 02 2024 globe newswire faruqi faruqi llp a leading national securities law firm is investigating potential claims against orthofix medical inc orthofix or the company nasdaq ofix and reminds investors of the october 21 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the company faruqi faruq
12084,all_events,DOWN,,oxurion provides clarification on the agenda of the extraordinary general shareholders meeting to be held on 24 july 2024
439,all_events,UP,UP,san carlos calif april 30 2024 globe newswire iovance biotherapeutics inc nasdaq iova a biotechnology company focused on innovating developing and delivering novel polyclonal tumor infiltrating lymphocyte til therapies for patients with cancer today announced that senior leadership plans to present at the following conferences
3570,all_events,DOWN,,today 16 october the shares of eleving group a baltic headquartered fintech group start trading on the nasdaq riga baltic main list and on the frankfurt stock exchange s prime standard as previously reported on 8 october eleving group completed the largest ever initial public offering ipo in latvia by a private capital company during the ipo eleving group raised eur 29 million and attracted 4 515 new shareholders all funds raised will be used to further develop the business eleving group saw high demand from both private and institutional investors institutional investors including funds and family offices from the baltics and western europe accounted for of the total number of shares issued while were made up of retail investors primarily from the baltic states measured by the volume of demand from retail investors in the baltic states investors from estonia were the most active with followed by investors from latvia and lithuania with and o
10615,all_events,DOWN,,norwood mass may 07 2024 globe newswire corbus pharmaceuticals holdings inc nasdaq crbp corbus or the company a precision oncology company with a diversified portfolio today provided a corporate update and reported financial results for the quarter ended march 31 2024
11536,all_events,UP,,media release
4394,all_events,DOWN,,15 nov 2024 14 16 cet jungle21 s a call notice of the extraordinary general shareholders meeting call notice of the extraordinary general shareholders meeting j21 gsm call pdf jungle21 euronext jungle21 s a es0105636007 mlj21 euronext access
7766,all_events,UP,,november 11 2024 10 00 et source as tallinna sadam as tallinna sadam on 11 november 2024 tallinna sadam held a webinar for investors where the chairman of the management board valdo kalm and the member of the management board cfo andrus ait presented unaudited results of the group for 2024 9 months and q3 tallinna sadam would like to thank all participants the recording of the webinars can be followed up in estonian and in english language the presentation is attached to this notice and is also available at the company s web page https www ts ee en investor presentations angelika annushead of investor relationstel 372 5649 6230angelika annus ts ee attachment
9988,all_events,UP,,media release
11912,all_events,UP,,november 15 2024 10 15 et source baltic horizon fund northern horizon capital baltic horizon fund northern horizon capital the net asset value nav per unit of the baltic horizon fund the fund amounted to eur 0 7080 at the end of october 2024 0 7099 as of 30 september 2024 the month end total net asset value of the fund was eur 101 6 million eur 101 9 million as of 30 september 2024 the epra nrv as of 31 october 2024 stood at eur 0 7493 per unit in october 2024 the consolidated net rental income of the fund remained at the level of eur 1 0 million eur 1 0 million in september 2024 at the end of october 2024 the fund s consolidated cash and cash equivalents amounted to eur 7 3 million 30 september 2024 eur 10 0 million as of 31 october 2024 the total consolidated assets of the fund were eur 255 6 million 30 september 2024 eur 256 8 million in october the fund prepaid bank loans in the amount of eur 1 2 million and i
88,all_events,UP,DOWN,stockholm november 11 2024 intervacc ab publ will publish its interim report for the period january to september 2024 on thursday 14 november 2024 at 08 30 cet ceo jonas sohlman and cfo jan persson will present the report at a conference call and audiocast held on the same day at 11 00 cet if you wish to participate via the audiocast please go to the link below https intervacc videosync fi intervacc q3 report 2024 if you prefer to participate via conference call please register using the link below after registration you will receive a phone number and a conference id to log in to the conference through the telephone conference there is an opportunity to ask questions verbally https conference financialhearings com teleconference id 5009525 for more information please contact jonas sohlman ceo phone 46 0 8 120 10 600 e mail jonas sohlman intervacc se the information was submitted for publication through the agency of the contact person set out above on
5528,all_events,DOWN,,media release
5909,all_events,DOWN,,at the end of september 2024 the net asset value nav of uab atsinaujinančios energetikos investicijos including success fee accrual decreased to eur 110 652 666 compared to the previously determined nav at the end of june 2024 which amounted to eur 112 755 226 the share price including success fee accrual decreased to eur 1 8865 compared to the previously determined share price which at the end of june 2024 amounted to eur 1 9223 the pro forma internal rate of return irr since inception including success fee accrual decreased to 6 compared to the previously announced irr of june 2024 which amounted to 8 at the end of september 2024 the nav excluding success fee accrual decreased to eur 110 652 656 compared to the previously determined nav at the end of june 2024 which amounted to eur 112 836 039 the share price excluding the success fee accrual decreased to eur 1 8865 compared to the previously determined share price which at the end of june 2024 which amounted
8280,all_events,UP,,media release
12780,all_events,UP,,media release
274,all_events,UP,DOWN,tampa fla may 07 2024 globe newswire pacira biosciences inc nasdaq pcrx today announced that it will participate in an analyst led fireside chat at the 2024 rbc capital markets global healthcare conference at 10 30 am et on tuesday may 14 2024 in new york live audio of the event can be accessed by visiting the events page of the company s website at investor pacira com a replay of the webcast will also be available for two weeks following the event
1281,all_events,DOWN,DOWN,boca raton florida april 22 2024 globe newswire inmune bio inc nasdaq inmb the company a clinical stage immunology company focused on developing treatments that harness the patient s innate immune system to fight disease today announced today that it has entered into definitive agreements for the sale and purchase of 571 592 shares of its common stock with above market warrant exercise price that include an acceleration clause upon positive top line data in the company s phase 2 alzhzimer s disease program as further described below the warrants give the investor the right to purchase 571 592 additional shares of its common stock in a registered direct offering the offering was priced at the market based on the friday april 19th nasdaq consolidated closing bid price of 8 32 per share the exercise price of the warrants is 9 152 which represents a premium to the price at which the common shares were offered the warrants terminate on the earlier of 1 the two 2 year anniversary of the initial exercise date of the warrant or 2 thirty 30 trading days following the reporting of top line data emacc in the phase 2 alzheimer s program of xpro1595 the termination date the gross proceeds of this offering are approximately 4 8 million before deducting placement agent fees and expenses the closing of the offering is expected to occur on or about april 24 2024 subject to the satisfaction of customary closing conditions members of management and the company s board of directors and certain key employees participated in the offering and will pay a combined offering price for the common stock and warrants of 8 445 per share and warrant and in the case of officers and directors that participated in the offering if the warrant termination date is on a blackout date then the officers and directors will have an additional 60 days from the termination of the blackout date to exercise the warrant
6930,all_events,UP,,08 nov 2024 07 30 cet veritas bureau press release neuilly sur seine france november 8 2024 bureau veritas successfully completes the bond issuance of eur 500 million with a maturity in november 2031 bureau veritas a world leader in testing inspection and certification tic services announces the successful placement of a eur 500 million bond issue maturing in november 2031 and carrying a coupon of 3 this bond issuance was largely oversubscribed 2 3 times enabling bureau veritas to price with a final spread much below initial price indications this underlines the strong investors confidence in bureau veritas business model its leap 28 strategy as well as the quality of its credit profile this issuance would be assigned an a3 rating by moody s this new bond allows bureau veritas to seize attractive market conditions for general corporate purposes and refinancing of existing indebtedness which may include some of the existing uspp admission of th
11448,all_events,DOWN,,the annual general meeting hereinafter the meeting of ab akola group hereinafter the company was held on 31 october 2024 on the day the meeting is convened the total number of the company s shares is 167 170 481 and the number of shares granting voting rights is 166 508 509 the own shares in the amount of 661 972 acquired by the company do not grant voting rights in total 25 company s shareholders who owned shares of the company at the end of the accounting day of the meeting 24 october 2024 participated in the meeting having 138 965 128 share votes which amounted to 83 46 percent of the total number of the company s share votes 22 duly filled general voting ballots were presented before the meeting the board member and cfo of the company mažvydas šileika deputizing company s ceo participated in the meeting the quorum existed decisions of the meeting 1 presentation of the company s audit committee activity report presented no voting 2 presentation of the independent auditor s report presented no voting 3 presentation of the consolidated annual report of the company for the financial year 2023 2024 presented no voting 4 approval of the company s remuneration report approve the company s remuneration report results of voting for 138 965 128 votes including 138 885 287 share votes of shareholders who voted in advance against 0 did not vote 0 5 approval of the consolidated and the company s set of financial statements for the financial year ended 30 june 2024 approve the consolidated and the company s set of financial statements for the financial year ended 30 june 2024 results of voting for 138 965 128 votes including 138 885 287 share votes of shareholders who voted in advance against 0 did not vote 0 6 approval of the distribution of the company s profit loss approve the distribution of the company s profit loss
4828,all_events,DOWN,,discontinuing development of istisociclib a cdk9 inhibitor benefit risk profile in platinum resistant high grade serous ovarian cancer does not support further development
9735,all_events,UP,,media release
10497,all_events,DOWN,,media release
12893,all_events,DOWN,,12 nov 2024 11 40 cet citycon treasury b v citycon oyj stock exchange release 12 november 2024 at 12 40 hrs citycon oyj s extraordinary general meeting took place today 12 november 2024 the extraordinary general meeting was held without a meeting venue using remote connection in real time in accordance with section 11 of the articles of association of the company and chapter 5 section 16 subsection 3 of the finnish limited liability companies act the general meeting approved all the proposals made by the board of directors to the general meeting the number of members of the board of directors was resolved to be ten mr eero sihvonen was elected as new member of the board of directors for a term that will continue until the close of the next annual general meeting other current members of the board of directors continue in their position until the close of the next annual general meeting the personal details of the new member of the board of directors are
9040,all_events,UP,,november 14 2024 01 30 et source alk abello alk abello company release no 19 2024 alk delivers organic revenue growth and an operating profit margin of in q3 revenue growth was mainly driven by a continued strong momentum in tablet sales and a recovery in jext sales europe and international markets were key contributors to growth the operating profit improved in line with alk s financial ambitions and the full year outlook remains unchanged q3 performance highlights comparative figures for q3 2023 are shown in brackets revenue growth rates are stated in local currencies unless otherwise indicated financial highlights l c local currency r c reported currency progress on strategic priorities 2024 full year outlook remains unchanged commenting on the results ceo peter halling said the results in q3 confirm that we are on track to improve revenue and earnings for the sixth consecutive year and we are particularly enco
8116,all_events,UP,,07 nov 2024 18 00 cet voltalia total number of shares and voting rights in the share capital as of october 31 2024 articles l 233 8 ii of the french commercial code and 223 16 of the general regulations of the french financial markets authority date total number of shares in the capital number of theoretical voting rights number of exercisable voting rights 10 31 2024 131 318 716197 716 492197 280 094 next on the agenda q4 2024 turnover january 29 2025 after market close about voltalia www voltalia com voltalia is an international player in the renewable energy sector the group produces and sells electricity generated from wind solar hydraulic biomass and storage facilities that it owns and operates voltalia has generating capacity in operation and under construction of more than 3 1 gw and a portfolio of projects under development representing total capacity of 17 2 gw voltalia is also a service provider and supports its investor clients in renewable en
9856,all_events,DOWN,,arcutis today announced new results from the integument ole long term open label study of investigational once daily roflumilast cream 0
7176,all_events,UP,,06 nov 2024 07 00 cet solvay s a communiqué de presse information réglementée publiée le 6 novembre 2024 à 7h00 cet des performances financières saines avec l accélération des économies de coûts confirmation des prévisions d ebitda et de fcf pour l année 2024 faits marquants le chiffre d affaires net du t3 2024 s élève à 1 156 millions en hausse organique de 3 par rapport au t3 2023 avec un impact positif des volumes pour le troisième trimestre consécutif alors que les prix sont en baisse d une année sur l autre l ebitda sous jacent au t3 2024 est resté stable à 259 millions 0 par rapport à l année précédente organiquement l impact négatif modéré de l effet net des prix étant compensé par l impact positif des volumes la marge d ebitda a atteint 22 les initiatives de réduction des coûts structurels ont permis de dégager 77 millions d économies au cours des neuf premiers mois de 2024 le bénéfice net sous jacent des activités poursuivies est
415,all_events,DOWN,UP,milestone achievement advances commercialization timeline for deepview system for burn indication milestone achievement advances commercialization timeline for deepview system for burn indication
5034,all_events,UP,,media release
2250,all_events,DOWN,DOWN,12 nov 2024 17 40 cet ageas rapport d ageas sur le programme de rachat d actions dans le cadre du programme de rachat d actions annoncé le 28 août 2024 ageas indique que 114 483 actions ageas ont été achetées durant la période du 04 11 2024 au 08 11 2024 datenombred actionsmontant total eur cours moyen eur cours le plus bas eur cours le plus élevé eur 04 11 202421 5461 038 22448 1948 1048 4005 11 202420 9611 016 94248 5248 1848 7806 11 202421 5531 048 64248 6548 0849 3407 11 202424 3471 181 94348 5548 1848 9408 11 202426 0761 253 57148 0748 2648 52total114 4835 539 32248 3948 0849 34 depuis le lancement du programme de rachat d actions le 16 septembre 2024 ageas a acheté 861 147 actions pour un montant d eur 41 517 011 représentant 0 du total des actions en circulation le récapitulatif relatif au programme de rachat d actions est disponible sur notre site pièce jointe version pdf du communiqué de presse rapport d ageas sur le programme de rachat d actio
9473,all_events,DOWN,,new data show istisociclib kb 0742 triggered cell death in preclinical ovarian cancer models of platinum and parp inhibitor parpi resistance
7250,all_events,DOWN,,media release
710,all_events,UP,DOWN,company announcement no 51 2024 15 november 2024 on 31 october 2024 netcompany group a s netcompany announced that a share buyback programme of up to dkk 250m and a maximum of 1 300 000 shares had been initiated with the purpose of adjusting netcompany s capital structure and meeting its obligations relating to share based incentive programmes the share buyback programme is executed in accordance with eu market abuse regulation eu regulation no 596 2014 of 16 april 2014 and the provisions of commission delegated regulation eu 2016 1052 of 8 march 2016 the safe harbour regulation the share buyback programme will end no later than 24 january 2024 transactions made under the share buyback programme will be announced through nasdaq copenhagen on a weekly basis the following transactions have been executed in the period 7 november 2024 to 13 november 2024 detailed information on all transactions under the share buyback pr
8369,all_events,DOWN,,06 nov 2024 17 45 cet carmila regulatory news carmila paris carm date nombre d actions composant le capital social nombre réel de droits de vote déduction faite des actions auto détenues nombre théorique de droits de vote y compris les actions auto détenues 31 octobre 2024 141 594 500 141 417 620 141 594 500 en application de l article 223 11 du règlement général de l autorité des marchés financiers carmila société anonyme au capital de 849 567 000 euros siège social 25 rue d astorg 75008 paris rcs paris 381 844 471 consultez la version source sur businesswire com https www businesswire com news home 20241106081798 fr carmila regulatory news carmila paris carm date nombre d actions composant le capital social nombre réel de droits de vote déduction faite des actions auto détenues nombre théorique de droits de vote y compris les actions auto détenues 31 octobre 2024
9166,all_events,UP,,durham n c sept 03 2024 globe newswire humacyte inc nasdaq huma a clinical stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale today announced that laura niklason m d ph d founder president and chief executive officer and dale sander chief financial officer will represent humacyte at the following conferences in september
407,all_events,UP,UP,media release
3101,all_events,DOWN,,18 nov 2024 07 15 cet norsk titanium as not for distribution or release directly or indirectly in or into the united states canada australia the hong kong special administrative region of the people s republic of china or japan or any other jurisdiction in which the distribution or release would be unlawful other restrictions are applicable please see the important notice at the end of this announcement oslo norway 18 november 2024 reference is made to the stock exchange announcement by norsk titanium as the company on 18 november 2024 regarding the exercise price and further information regarding the final exercise period for the remaining 135 796 540 outstanding warrants the warrants issued to investors in the partially underwritten rights issue of 229 038 7887 new shares in the company each warrant gives the holder a right to subscribe for one new share such new shares jointly the new shares in the company at an exercise price of nok 1 06892
10667,all_events,UP,,the panevėžys regional court has decided to open a restructuring case against alinita uab a member of the panevėžio statybos trestas group of companies the decision which entered into force on 11 october 2024 gives the company the opportunity to restore its solvency and to continue its operations while addressing temporary financial challenges the company s management notes that restructuring is a necessary measure to stabilise the company s operations as recent economic shocks such as the consequences of the covid 19 pandemic supply chain disruptions caused by the war in ukraine and the continuously rising cost of raw materials have had a significant impact on the company s financial situation the court also appointed valeksa uab as the restructuring administrator and confirmed that the company s accounts will be limited to a maximum amount of eur 328 230 per month in order to ensure the necessary payments and the continuity of the company s business operations vitalijus
8012,all_events,DOWN,,07 nov 2024 18 19 cet median technologies two globally leading pulmonologists reviewed reality data ai and the potential impact on lung cancer screening replay in english is available on the link here a french subtitled replay will be made available a few days afterwards on median website regulatory news median technologies fr0011049824 almdt pea sme eligible median or the company a leading developer of eyonis a suite of artificial intelligence ai powered software as a medical device samd candidates for early cancer diagnostics and a globally leading provider of ai analyses and imaging services for oncology drug developers today announced that it hosted a successful event with two key opinion leaders kols in the field of pulmonology approximately 80 institutional investors individual shareholders analysts journalists and other stakeholders attended the november 7 event two leading u s pulmonology experts prof anil vachani from th
3366,all_events,DOWN,,south san francisco calif and san diego nov 01 2024 globe newswire oric pharmaceuticals inc nasdaq oric a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance today announced that on november 1 2024 the grant date oric granted a total of 61 800 non qualified stock options and 10 400 restricted stock units to two new non executive employees who began their employment with oric in october 2024
12749,all_events,UP,,11 nov 2024 22 10 cet okeanis eco tankers corp athens greece november 11 2024 okeanis eco tankers corp oet or the company nyse eco ose oet announced today the publication of its 3rd environmental social and governance report the 2023 esg report which has been developed in accordance with the global reporting initiative gri 2021 standards and the sustainability accounting standards board sasb for marine transportation the 2023 esg report is available on the company s website https www okeanisecotankers com sustainability esg reports contacts company iraklis sbarounis cfo tel 30 210 480 4200 ir okeanisecotankers com investor relations media contact nicolas bornozis president capital link inc 230 park avenue suite 1540 new york n y 10169 tel 1 212 661 7566 okeanisecotankers capitallink com about oet oet is a leading international tanker company providing seaborne transportation of crude oil and refined products the
3275,all_events,DOWN,,media release
8825,all_events,UP,,november 12 2024 scibase holding ab scibase sto scib a leading developer of augmented intelligence based solutions for skin disorders announced today its engagement in a collaboration with the skin research group of the department of dermatology at the vrije universiteit brussel vub university hospital in brussels uz brussels for a study geared toward predicting atopic dermatitis a special form of eczema and concomitant atopic diseases such as asthma and hay fever in infants scibase is excited to announce a new collaboration aimed at revolutionizing early detection of atopic diseases in infants through the use of electrical impedance spectroscopy eis technology this partnership seeks to unlock the potential of nevisense to predict an infant s risk of developing these conditions empowering researchers with critical insights early in a child s life the data gathered will play a key role in developing an innovative product that could pave the way for improved hea
8292,all_events,DOWN,,media release
6672,all_events,DOWN,,today 16 october the shares of eleving group a baltic headquartered fintech group start trading on the nasdaq riga baltic main list and on the frankfurt stock exchange s prime standard as previously reported on 8 october eleving group completed the largest ever initial public offering ipo in latvia by a private capital company during the ipo eleving group raised eur 29 million and attracted 4 515 new shareholders all funds raised will be used to further develop the business eleving group saw high demand from both private and institutional investors institutional investors including funds and family offices from the baltics and western europe accounted for of the total number of shares issued while were made up of retail investors primarily from the baltic states measured by the volume of demand from retail investors in the baltic states investors from estonia were the most active with followed by investors from latvia and lithuania with and o
11569,all_events,DOWN,,13 nov 2024 21 30 cet nordea bank nordea bank abp stock exchange release changes in company s own shares 13 11 2024 at 22 30 eet nordea bank abp lei 529900odi3047e2liv03 has on 13 11 2024 completed repurchases of own shares isin fi4000297767 as follows trading number weighted average total cost eur venue mic of price share eur code shares xhel 144 436 10 54 1 522 297 67 xsto 114 181 10 54 1 203 160 66 xcse 28 134 10 55 296 688 53 total 286 751 10 54 3 022 146
3702,all_events,UP,,07 oct 2024 19 15 cest citycon treasury b v citycon oyj inside information 7 october 2024 at 20 15 hrs citycon lowers its guidance for the financial year 2024 the change in guidance is mainly due to the combined effect of the executed divestments of kongssenteret and trekanten the weakening nok and sek fx rates in q3 2024 postponed completion of barkarby residential project as well as previously announced one time reorganisation costs following the organisational savings program additionally the total number of shares increased following the share issue completed in february 2024 which also affects negatively the epra eps and the adjusted epra eps citycon s updated guidance for 2024 direct operating profit meur 183 187 epra earnings per share basic eur 0 59 0 63 adjusted epra earnings per share basic eur 0 45 0 49 the outlook assumes that there are no major changes in macroeconomic factors and no major disruption
8330,all_events,DOWN,,media release
1523,all_events,DOWN,DOWN,media release
10337,all_events,UP,,media release
1110,all_events,DOWN,UP,media release
10643,all_events,UP,,san francisco may 03 2023 globe newswire vir biotechnology inc nasdaq vir today announced that marianne de backer m sc ph d mba chief executive officer is scheduled to present at the bofa securities 2023 health care conference on wednesday may 10 at 8 00 a m pt 11 00 a m et
1406,all_events,UP,DOWN,warrington pa april 08 2024 globe newswire windtree therapeutics inc windtree or the company nasdaqcm wint today announced that on april 2 2024 the company entered into an asset purchase agreement with varian biopharmaceuticals inc varian to acquire certain of its assets including a proprietary atypical protein kinase c iota inhibitor apkci the company also completed a 1 5 million convertible note bridge financing
7488,all_events,UP,,preliminary data from the 5 mg kg pgn edo51 dose level in the connect1 edo51 phase 2 trial are expected mid 2024 including initial safety exon 51 skipping and dystrophin protein production data
10939,all_events,UP,,alzinova ab publ ticker alz a swedish biopharmaceutical company focused on the development of treatments for alzheimer s disease announces today that patient data from the extension part of the phase 1b study is now being processed alzinova is processing data collected up to week 42 of the extension part i e patients have been in the phase 1b study for at least 84 weeks the 42 week analysis in the extension part of our phase 1b study is an important step forward we look forward to analysing and communicating the results which will provide us with valuable insights into the long term safety and efficacy of the vaccine these data will be central to the planning of our upcoming phase 2 study and our efforts to apply for a fast track designation with the fda it is also very pleasing to note the great interest in our ongoing study and upcoming results from the major pharmaceutical companies during last week s bio europe conference in stockholm says tord labuda ceo of alzi
7523,all_events,DOWN,,11 oct 2024 15 30 cest gigante salmon as bodø 11 oktober 2024 in connection with the third quarter 2024 report gigante salmon is pleased to invite you to a management presentation on tuesday 22 october at 09 00 at hotel bristol kristian iv s gate 7 oslo breakfast coffee and tea is served from 08 30 the presentation will be held by ceo kjell lorentsen and cfo rune johansen the presentation will also be webcasted via the following link https gigantesalmon no investor 2 websendinger gigante salmon quarterly earn ing reports 2024 95e74jb9 the presentation will be held in norwegian and will finish off with a q a session where you may submit questions in writing the q3 report will be available from 22 october at 07 00 cet on the company s homepage www gigantesalmon no and oslo stock exchange s page www newsweb no a recording of the webinar in norwegian will be made available on the company s webpage for further information please contact kjell loren
10646,all_events,DOWN,,science 37 opens new state of the art facility to enhance collaboration and improve patient recruitment and study support for clinical trials
10398,all_events,DOWN,,south san francisco calif march 20 2024 globe newswire vaxart inc nasdaq vxrt the company or vaxart today announced that the compensation committee of the board of directors approved certain equity awards to the company s new president and chief executive officer steven lo effective march 18 2024 the awards were made pursuant to the company s previously disclosed offer letter with mr lo and as a material inducement to his joining the company as president and chief executive officer and a member of the board of directors
6069,all_events,DOWN,,12 nov 2024 16 01 cet sparebank 1 boligkreditt oslo børs har mottatt søknad om børsnotering av isin no0013405084 markedsmisbruksforordningen mar gjelder fra søknadstidspunktet herunder låntagers informasjonsplikt om innsideinformasjon more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site sparebank 1 boligkreditt oslo børs newspoint spb 1 boligkreditt as 11 26 4 covd spb 1 boligkreditt as 16 28 2 covd spb 1 boligkreditt as 16 26 adj c covd spb 1 boligkredi as 18 25 0 eur covd spb 1 boligkreditt as 19 29 adj covd spb 1 boligkreditt as 20 25 frn covd spb 1 boligkreditt as 20 25 sek frn covd spb 1 boligkreditt as 21 26 frn covd spb 1 boligkreditt as 21 23 1 73 pct covd spb 1 boligkreditt as 22 27 frn covd spb 1 boligkreditt as 22 34 adj covd spb 1 boligkreditt as 23 28 frn covd spb 1 boligkreditt as 23 33 3 45pct covd spb 1 boligkreditt as 23 30 4 covd spb 1 boligkredi
11360,all_events,UP,,11 nov 2024 13 54 cet haltdalen sparebank det er fastsatt ny obligasjonsrente for no0010875123 ny obligasjonsrente i renteperioden 13 11 2024 13 02 2025 er 5 51 ticker hdsb10 pro den nye obligasjonsrenten og renteperioden er fastsatt i henhold til obligasjonsavtalen se vedlagt dokument for utfyllende informasjon publisert av nordic trustee more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631838_608a6f50832445ecb536c4f1352e9a91 pdf haltdalen sparebank oslo børs newspoint haltdalen spb 20 25 frn haltdalen spb 21 31 frn c sub haltdalen spb 22 25 frn haltdalen spb 22 26 frn haltdalen spb 23 26 frn haltdalen spb 23 27 frn haltdalen spb 24 28 frn no0010875123 no0011155962 no0012451261 no0012655630 no0012838327 no0012948118 no0013054148 no0013256198 no0013329946 nordic alternative bond market
11945,all_events,DOWN,,04 oct 2024 07 30 cest boussard gavaudan holding ltd boussard gavaudan holding limited ordinary shares the directors of boussard gavaudan holding limited would like to announce the following information for the company close of business 03 oct 2024 estimated nav euro sharessterling sharesestimated nav 28 3746 25 5064estimated mtd return 0 05 0 05 estimated ytd return 3 00 3 81 estimated itd return 183 75 155 06 nav and returns are calculated net of management and performance fees market information euro sharesamsterdam aex london lse market close 27 40n apremium discount to estimated nav 3 43 n a sterling sharesamsterdam aex london lse market closen agbx 2 360 00premium discount to estimated navn a 7 47 transactions in own securities purchased into treasury ordinary shares euro sharessterling sharesnumber of sharesn an aaverage pricen an arange of pricen an a
633,all_events,UP,DOWN,12 nov 2024 17 35 cet eurazeo see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1297233_declarationamf1erau8novembre2024 pdf eurazeo les echos eurazeo se fr0000121121 rf euronext
12556,all_events,DOWN,,media release
11708,all_events,DOWN,,07 nov 2024 21 04 cet magnora asa 7 11 2024 21 04 08 cet magnora asa additional regulated information required to be disclosed under the laws of a member state erik sneve ceo of magnora asa has been granted 75 000 options with a strike price of nok 23 76 which gives him the rights to acquire 75 000 additional shares in the company vesting period is 3 years and the options expire 5 years from vesting date mr sneve s total ownership directly and through affiliated ownership through close family and other accounts is 1 183 871 shares which equal to 1 8 percent of the issued shares and votes in the company mr sneve holds 525 000 share options in magnora asa including the 75 000 options mentioned above disclosure regulation this information is subject to the disclosure requirements pursuant to section 5 12 of the norwegian securities trading act contacts erik sneve ceo email es at magnoraasa com torstein sanness executive chairman email
2168,all_events,UP,UP,fda lifts partial clinical holds on ersodetug for the treatment of congenital hi phase 3 sunrize study to proceed in the u s
10798,all_events,UP,,november 13 2024 02 00 et source ignitis grupe ignitis grupe ab ignitis grupė hereinafter the group publishes its first nine months 2024 interim report which is attached to this notice and announces that our adjusted ebitda amounted to eur 397 0 million 15 yoy the growth was driven by better results in the green capacities and networks segments the green capacities segment remains the largest contributor with a 45 share of our total adjusted ebitda we invested eur 583 7 million and directed eur 335 2 million or 57 of it towards the green capacities segment 7 yoy the majority going to new onshore wind farms in lithuania 85 of the total investments were made in lithuania our leverage metrics remained strong with ffo ltm net debt ratio improved to 34 compared to 29 as of 31 december 2023 also s p global ratings reaffirmed the group s bbb stable outlook credit rating business development in 9m
12855,all_events,DOWN,,dallas nov 19 2024 globe newswire spectral ai inc nasdaq mdai spectral ai or the company an artificial intelligence ai company focused on revolutionizing medical diagnostics to enable faster more accurate treatment decisions in wound care today announced the successful completion of an approximate 5 0 million equity financing in an at the market transaction the closing is to be completed in two tranches part of the proceeds will be used for the retirement of its outstanding obligations with yorkville advisors this transaction supports spectral ai s growth trajectory and progress toward a submission to the u s food and drug administration fda for approval of its deepview ai burn system a crucial milestone targeted for the first half of 2025
131,all_events,DOWN,DOWN,helstu niðurstöður
5163,all_events,DOWN,,02 oct 2024 18 00 cest bic societe disclosure of trading in own sharesfor september 2024 clichy oct 02 2024 in compliance with general regulation on share buy backs société bic declares below the transactions made on its own shares for september 2024 datenumber of sharesaverage weighted price in amount in 09 02 202412160 95877 376 0009 05 20241 55862 450097 297 1009 06 20249 10062 3661567 531 5109 09 20245 03462 4902314 575 6709 10 202411 83061 9124732 423 6909 13 20248 47062 2970527 655 5909 16 20249 75960 2825588 296 9209 16 20243 41060 3000205 623 0009 17 202410 43560 9674636 194 8209 17 202440 00061 20002 448 000 0009 18 20242 76660 4869167 306 7709 23 202419 74460 00001 184 640 0009 25 20247 56061 2581463 111 3009 26 202421 57861 05001 317 336 9009 26 202452 42861 05003 200 729 40total203 79361 131112 458 098 66 about bic a world leader in stationery lighters and shavers bic brings simplicity and joy to everyday life for more than 75 years the company has h
3477,all_events,DOWN,,media release
8023,all_events,UP,,media release
10203,all_events,UP,,in connection with the changes in the market and the evaluation of the perspectives of the company s future development the supervisory board of punktid technologies as has made a decision to find new strategic opportunities for attracting investments which may include the partial or complete sale of the listed holding company or the entire group despite the challenges encountered during the previous two years the punktid project has reached a stable phase having managed to balance the decline in the baltic market with sales from outside markets however in order to realize future growth opportunities we need to explore new directions the goal is to ensure the sustainability of the company increase the value of investors and ensure competitiveness in a rapidly changing business environment at the moment an nda non disclosure agreement has already been signed with two foreign interested parties with whom negotiations are also open however no contracts have yet been si
774,all_events,DOWN,UP,media release
10984,all_events,UP,,13 nov 2024 18 20 cet shelf drilling ltd press release shelf drilling reports third quarter 2024 results dubai uae november 13 2024 shelf drilling ltd shelf drilling sdl and together with its subsidiaries the company ose shlf announces results for the third quarter of 2024 ended september 30 the results highlights will be presented by audio conference call on november 14 2024 at 6 00 pm dubai time 3 00 pm oslo time dial in details for the call are included in the press release posted on november 6 2024 and on page 3 of this release greg o brien chief executive officer commented during the third quarter of 2024 our adjusted ebitda increased to 114 million primarily due to the acceleration of mobilization revenue for two suspended rigs in saudi arabia as anticipated we were impacted by a lower level of utilization with a few rigs preparing for new contracts o brien added since the end of the second quarter we have achieved se
10711,all_events,UP,,media release
1631,all_events,DOWN,UP,07 nov 2024 18 40 cet eutelsat communications regulatory news eutelsat communications isin fr0010221234 euronext paris london stock exchange etl a signé un contrat de liquidité avec bnp paribas exane le 1er décembre 2007 les ressources en espèces et en instruments financiers allouées à la mise en œuvre du contrat de liquidité ont été réexaminées sur la base des données de marché au 1er juillet 2024 afin que les ressources restent proportionnées et adaptées aux objectifs du contrat conformément à la décision amf n 2021 01 du 22 juin 2021 il a été décidé un réajustement des ressources en titres par conséquent un retrait de 175 000 cent soixante quinze mille titres a été réalisé pour rappel lors du dernier bilan semestriel en date du 1er juillet 2024 les moyens suivants figuraient au compte de liquidité 497 082 titres eutelsat communications 890 555 à propos d eutelsat communications eutelsat group est l un des principaux opérateurs mo
2333,all_events,DOWN,DOWN,media release
4441,all_events,DOWN,,november 19 2024 01 30 et source sampo plc sampo plc sampo plc stock exchange release 19 november 2024 at 8 30 am eet sampo plc s share buybacks 18 november 2024 on 18 november 2024 sampo plc business code 0142213 3 lei 743700uf3rl386wida22 has acquired its own a shares isin code fi4000552500 as follows rounded to two decimals on 17 june 2024 sampo announced a share buyback programme of up to a maximum of eur 400 million in compliance with the market abuse regulation eu 596 2014 mar and the commission delegated regulation eu 2016 1052 on 16 september 2024 the board of directors of sampo plc resolved to increase the share buyback programme to eur 475 million the programme which started on 18 june 2024 is based on the authorisation granted by sampo s annual general meeting on 25 april 2024 after the disclosed transactions the company owns in total 10 902 324 sampo a shares representing 1 98
2540,all_events,DOWN,UP,media release
469,all_events,DOWN,DOWN,november 11 2024 01 00 et source as tallinna sadam as tallinna sadam tallinna sadam earned 91 million euros in sales revenue in 9 months 2 more than a year earlier ebitda of 41 million euros increased by 5 and the profit was 14 higher 15 million euros sales revenue in the third quarter was 31 million euros 0 ebitda 13 million euros 1 and profit nearly 6 million euros 6 in 9 months we invested a total of over 33 million euros including 8 million euros in the third quarter the results of the third quarter in terms of cargo volumes exceeded expectations comments valdo kalm the chairman of the management board cargo volumes increased in all types the number of passengers has also increased we are especially pleased with the increase in the number of ship visits both for cargo and passenger ships which account for the majority of port operating revenues turnover increased both in ports and ferries un
6651,all_events,UP,,media release
12663,all_events,UP,,united bankers plcstock exchange release 12 november 2024 at 15 00 eet united bankers plc notification of manager s transactions jarafi oy ____________________________________________ person subject to the notification requirement name jarafi oy position closely associated person x legal person 1 person discharging managerial responsibilities in issuer name rasmus finnilä position member of the board issuer united bankers plc lei 743700j2wo3j6xgfpg77 notification type initial notification reference number 84571 4 4 ____________________________________________ transaction date 2024 11 08 venue nasdaq helsinki ltd xhel instrument type share isin fi4000081427 nature of the transaction acquisition transaction details 1 volume 200 unit price 17 5 eur 2 volume 160 unit price 17 75 eur 3 volume 137 unit price 17 55 eur 4 volume 27 unit price 17 9 eur 5 volume 18 unit price 17 9 eur 6 volume 39 unit price 17 9 eur 7 volume 419 unit p
9238,all_events,DOWN,,06 nov 2024 13 52 cet navamedic asa oslo november 6 2024 lars hjarrand cfo and a primary insider of navamedic asa has today bought 20 000 navamedic asa shares at an average price of nok 23 80 per share see attachment for further details about the transaction following this transaction lars hjarrand holds 355 882 shares and 200 000 options in the company this release is an announcement issued pursuant to legal information obligations and is subject of the disclosure requirements pursuant to the market abuse regulation mar article 19 no 3 and section 5 12 of the norwegian securities trading act more information access the news on oslo bors newsweb site more information access the news on oslo bors newsweb site 631415_notification_of_trade pdf navamedic asa oslo børs newspoint navamedic no0010205966 nava oslo børs
8176,all_events,DOWN,,auga group the producer of more sustainable organic food and developer of agricultural technology by decision of its board is convening a general shareholders meeting to initiate restructuring of the parent company auga group ab hereinafter the company the goal is to ensure continuity of operations the long term solvency of the group of companies and fulfilment of commitments to creditors to achieve this goal auga group and its subsidiaries hereinafter the group is postponing its technology development plans indefinitely and giving all its attention to activities that generate cash flow namely agriculture biomethane production and the supply of consumer end products we have dedicated time and energy to seeking agreements with financial institutions regarding the deferral of long term loans and the sale of some assets to avoid having to enter restructuring as of today though we do not have a common agreement and achieving these goals requires additional time so
4112,all_events,UP,,redwood city calif may 08 2024 globe newswire coherus biosciences inc coherus nasdaq chrs today announced that the cancer research institute cri and its immunotherapy platform study in platinum resistant high grade serous ovarian cancer iproc drug selection committee dsc have selected loqtorzi toripalimab tpzi anti pd 1 antibody to explore in combination with enb 003 a first in class small molecule inhibitor of endothelin b receptor etbr for the treatment of drug resistant cancers in the iproc platform study endothelin b receptor is implicated in tumorigenesis and tumor immune suppression for several solid tumors including melanoma ovarian and pancreatic cancers
7286,all_events,UP,,08 nov 2024 17 45 cet chargeurs see attachment s voir document s joint s zie bijlage ver documento s em anexo 16165_1296405_ddv_monthly_statement_at_october_31st_2024 pdf chargeurs les echos chargeurs fr0000130692 cri euronext
7853,all_events,UP,,this message has been corrected click here to view the corrected message from september 23rd 2024 11 00 eest eleving group shares public offer subscription process is launched the subscription process closing date is october 8th 2024 15 30 eest up to 24 500 000 shares are being publicly offered to investors retail investors may place their subscription orders at a price of eur 1 85 per one offer share of eleving group the final price per share will not be higher than eur 1 85 for retail investors each investor may subscribe for the minimum of one share the offered shares are registered in the nasdaq csd under the isin code lu2818110020 the subscription process will be carried out using the exchange s trading system market rse equities ipo genium inet trading system order book lu2818110020 eagleipo the auction period during which the order collection will take place is september 23rd 2024 from 11 00 until 16 00 september 24th october 7th 2024 f
12955,all_events,UP,,media release
563,all_events,DOWN,DOWN,the board of directors of as rīgas kuģu būvētava company publishes the draft decisions for the extraordinary shareholders meeting held on november 19th 2024 in accordance with request of shareholder sia madesta unified registration number 40003440441 in the agenda of the meeting are included additional questions 3 4 and 5 the board of directors of as rīgas kuģu būvētava attachments pazinojums birzai rkb akcionaru lemumu projekti 2024 2 eng pdf
1905,all_events,DOWN,DOWN,november 13 2024 06 00 et source sato oyj sato oyj sato corporation stock exchange release 13 november 2024 at 1 00 pm on 13 november s p global ratings affirmed sato corporation s bbb credit rating with stable outlook for more information please contact sato corporation markku honkasalo cfo phone 358 201 34 4226 firstname lastname sato fi distrubution euronext dublin main media www sato fi en sato corporation is an expert in sustainable rental housing and one of finland s largest rental housing providers sato owns more than 26 000 rental homes in the helsinki metropolitan area tampere and turku sato aims to provide excellent customer experience and a comprehensive range of urban rental housing alternatives with good access to public transport and services we promote sustainable development and work in open interaction with our stakeholders sato invests profitably sustainably and with a long term view we increase the value of
9426,all_events,UP,,november 14 2024 04 03 et source green hydrogen systems a s green hydrogen systems a s green hydrogen systems a sdecisions at extraordinary general meeting green hydrogen systems extraordinary general meeting on 14 november 2024 today on 14 november 2024 an extraordinary general meeting of green hydrogen a s was held at plesner law firm p s on amerika plads 37 dk 2100 copenhagen denmark on the extraordinary general meeting of the shareholders resolved 1 to adopt a share capital reduction by way of transfer to a special reserve including a proposal to adopt a reduction in the nominal value of each share 2 to issue an an authorisation to the board of directors to issue shares without pre emption rights 3 to issue authorisations to the board of directors to issue shares with pre emption rights and warrants without pre emption rights and 4 to issue an authorisation to the board of directors to issue convertible bonds without
4003,all_events,UP,,riga 2024 11 14 08 07 cet to focus activities and resources within latvenergo group on the development of new green energy projects and electricity generation from renewable energy resources res elektrum next sia owned by latvenergo as has been established and commenced its work the establishment of elektrum next separates new res assets from the group s other business functions concentrating the group s res competencies and accelerating the development of new projects in latvia the baltic states and the region this approach is in line with international industry and peer energy company practice and will ensure a unified group management structure to facilitate the further development of latvenergo business while guaranteeing the efficient operation of generation assets and electricity trading elektrum next will include the res assets and projects developed by latvenergo group in recent years currently elektrum next already includes the solar power plant proje
11918,all_events,UP,,i april 2024 indgik dfds en aktiekøbsaftale om at købe ekol logistics internationale transportnetværk
1576,all_events,UP,DOWN,13 nov 2024 09 54 cet eurolog canola socimi s a devolucion aportaciones prima emision pdf eurolog canola euronext eurolog canola socimi es0105586004 mlcan euronext access
2900,all_events,UP,,media release
6027,all_events,UP,,08 nov 2024 08 00 cet obiz 4 associations prometteuses soutenues en 2024 promouvant des projets au service d un avenir durable en france lyon le 8 novembre 2024 8h00 obiz euronext growth fr0014003711 albiz plateforme digitale de marketing relationnel responsable et première goodtech sur le marché d euronext growth à paris dresse aujourd hui un premier bilan annuel des actions menées à travers la fondation obiz avec le soutien de quatre associations innovantes dont le projet est lié à l entrepreneuriat à impact et à la revitalisation des territoires au service du bien commun premier bilan de la fondation obiz un soutien aux initiatives entrepreneuriales à impact social créée en 2023 à l occasion du 13ème anniversaire d obiz la fondation obiz a pour mission de permettre aux catégories sociales les plus fragilisées de retrouver une place dans la société et d exprimer pleinement leur potentiel en soutenant leurs initiatives entrepreneuriales un a
6117,all_events,UP,,multiple refractory pd1 failure patients experienced prolonged progression free survival 10 months ongoing confirmed responses observed in patients receiving evalstotug
3846,all_events,DOWN,,saistībā ar as latvijas gāze valdes locekļu pilnvaru termiņa notecējumu atbilstoši 2024 gada 18 jūlija padomes lēmumam sākot ar 2024 gada 16 augustu as latvijas gāze valdes locekļu amatos atkārtoti ievēlēti aigars kalvītis elita dreimane deniss jemeļjanovs un egīls lapsalis nosakot valdes pilnvaru termiņu viens gads
3305,all_events,UP,,04 oct 2024 07 00 cest deep value driller as oslo 4 october 2024 reference is made to the stock exchange notice by deep value driller as dvd or the company on 26 march 2024 where dvd announced its dividend distribution policy and to the board authorisation granted by dvd s annual general meeting on 14 may 2024 to resolve and distribute dividends in line with the company s dividend policy based on the annual accounts for 2023 dvd s board of directors has today resolved to distribute a dividend in the amount of nok 1 00 per share in total approximately nok 86 4 million the dividend is expected to be paid on or about 11 october 2024 and will be regarded as repayment of paid in capital by the shareholders of dvd dvd notes that pursuant to the company s loan facility as amended 26 march 2024 the company is required to retain an amount equal to 12 months of interest payments which is not available for distribution as set out in the company s stock exchange n
79,all_events,DOWN,DOWN,oxurion share consolidation
7516,all_events,DOWN,,152 0 million cash runway into the second half of 2026
4874,all_events,DOWN,,media release
2372,all_events,UP,DOWN,07 nov 2024 17 55 cet credit agricole s a montrouge november 7th 2024 end of crédit agricole s a s share repurchase program crédit agricole s a s share repurchase program which started on 1 october 2024 was fully completed on 6 november 2024 as of 6 november 2024 15 128 677 shares of crédit agricole s a have been purchased pursuant to the irrevocable instruction given to an independent investment services provider for an aggregate purchase price of 208 465 605 euros such irrevocable instruction was therefore terminated as of the same date as previously announced this transaction aims at offsetting the dilutive effect of the 2024 capital increase reserved for employees and the shares purchased in the context of this share repurchase program will be cancelled this transaction s impact on crédit agricole s a s cet1 ratio is 5 basis points and 3 basis points on crédit agricole group s one execution of the existing liquidity agreement with kepler cheuvreux
8108,all_events,UP,,18 oct 2024 17 06 cest amundi physical metal plc amundi physical metals plc glda amundi physical metals plc final terms 18 oct 2024 17 06 cet cest final terms final terms dated 15 october 2024 amundi physical metals plc etc securities of amundi physical gold etc issued under its secured precious metal linked etc securities programme the etc securities issue of 12 500 00 etc securities being tranche 607 of amundi physical gold etc specified in these final terms part a contractual terms terms used herein shall be deemed to be defined as such for the purposes of the conditions set forth in the base prospectus dated 20 may 2019 as supplemented by the supplement to the base prospectus dated 4 march 2020 this document constitutes the final terms of the etc securities described herein for the purposes of article 8 4 of the prospectus regulation regulation eu 2017 1129 the prospectus regulation and must be read in conjunction with the base prospectu
4115,all_events,UP,,03 oct 2024 20 30 cest be semiconductor industries nv share repurchase 031024 pdf be semiconductor euronext be semiconductor industries n v nl0012866412 besi euronext
3334,all_events,UP,,13 nov 2024 17 45 cet quadient s a monthly information on number of shares and voting rights of quadient s a in accordance with article 223 11 of autorité des marchés financiers french securities and investment board general regulations ordinary shares isin fr0000120560 as at 31 october 2024total number of shares34 468 912theoretical total number of voting rights34 468 912net total number of voting rights33 950 567 for more information please contact catherine hubert dorel quadient 33 0 1 45 36 30 56c hubert dorel quadient comfinancial communication quadient comcaroline baude quadient 33 0 1 45 36 31 82c baude quadient com or visit our website https invest quadient com attachment pdf monthly information on number of shares and voting rights of quadient s a in accordance with article 223 11 of autorité des marchés financiers french securities and investment board general regulations ordinary shares isin fr0000120560 for more information pl
